data_1d9n_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1d9n _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.473 ' CE3' ' HB2' ' A' ' 18' ' ' ARG . 69.7 m95 . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 18.1 mt -109.28 160.87 15.78 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.215 -0.928 . . . . 0.0 109.615 -179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.44 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 0.2 OUTLIER -49.72 130.36 20.93 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.323 -0.861 . . . . 0.0 109.592 -179.885 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.522 ' SG ' ' CZ ' ' A' ' 17' ' ' ARG . 26.9 t -81.61 115.17 55.19 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.276 -0.89 . . . . 0.0 109.4 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.455 ' O ' ' C ' ' A' ' 10' ' ' ALA . 36.2 Cg_endo -78.57 -55.62 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.498 2.132 . . . . 0.0 111.088 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.455 ' C ' ' O ' ' A' ' 9' ' ' PRO . . . -39.69 -56.73 1.65 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.36 -0.838 . . . . 0.0 110.098 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.507 HD11 ' CG ' ' A' ' 15' ' ' TRP . 12.0 mt -83.31 -56.94 3.48 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.282 -0.886 . . . . 0.0 109.706 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 140.04 -146.48 17.96 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.57 158.15 32.26 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.62 2.214 . . . . 0.0 110.802 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.15 -38.89 3.14 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.774 -1.331 . . . . 0.0 109.774 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.585 ' CZ3' HD22 ' A' ' 53' ' ' LEU . 17.1 t-105 -89.0 130.0 35.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.268 -1.137 . . . . 0.0 109.585 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.427 ' HG2' ' HB3' ' A' ' 5' ' ' TRP . 0.1 OUTLIER -97.54 127.75 43.75 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.2 -0.937 . . . . 0.0 108.919 179.626 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.623 ' NH1' ' CE1' ' A' ' 62' ' ' PHE . 1.6 ttm180 -107.32 98.84 8.42 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.142 -0.974 . . . . 0.0 109.917 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.473 ' HB2' ' CE3' ' A' ' 5' ' ' TRP . 0.4 OUTLIER -100.24 145.65 27.82 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.316 -0.865 . . . . 0.0 109.201 179.601 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -121.91 158.33 29.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.11 -0.994 . . . . 0.0 109.802 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.3 t . . . . . 0 N--CA 1.489 1.515 0 O-C-N 121.396 -0.815 . . . . 0.0 109.205 179.922 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.444 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 0.3 OUTLIER -135.26 124.36 24.36 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.983 -1.073 . . . . 0.0 110.254 -179.456 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.574 ' CD1' ' HG2' ' A' ' 44' ' ' ARG . 16.7 m-85 -123.62 143.8 50.01 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 179.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.578 ' CE1' ' HG3' ' A' ' 17' ' ' ARG . 9.8 m-85 -116.01 154.42 29.89 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.107 -0.995 . . . . 0.0 110.204 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -122.41 120.41 33.87 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.473 ' HB3' ' HD2' ' A' ' 38' ' ' PRO . 0.7 OUTLIER -68.41 168.35 14.46 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 121.394 -0.816 . . . . 0.0 109.023 179.915 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.473 ' HD2' ' HB3' ' A' ' 37' ' ' SER . 34.7 Cg_endo -78.0 6.12 4.85 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.502 2.134 . . . . 0.0 110.577 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.3 t -116.56 -21.7 9.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.131 -0.981 . . . . 0.0 109.498 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 119.18 15.91 5.42 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.468 ' O ' ' OG ' ' A' ' 37' ' ' SER . 3.5 m-20 -96.81 107.03 19.44 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.248 -1.149 . . . . 0.0 109.297 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.26 132.29 33.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.132 -0.98 . . . . 0.0 109.658 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.484 HG22 ' N ' ' A' ' 49' ' ' LEU . 3.0 mp -130.04 149.93 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.325 -0.859 . . . . 0.0 109.239 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.574 ' HG2' ' CD1' ' A' ' 34' ' ' TYR . 51.5 mtm180 -142.17 9.35 1.88 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.091 -1.006 . . . . 0.0 110.058 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.526 ' HB3' ' CB ' ' A' ' 48' ' ' GLU . 0.5 OUTLIER -97.19 14.08 27.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.039 -1.038 . . . . 0.0 109.393 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.577 ' HA ' ' CE1' ' A' ' 64' ' ' PHE . 5.9 ttpp 62.73 -94.09 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.442 -0.786 . . . . 0.0 109.98 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.433 ' N ' ' HG2' ' A' ' 46' ' ' LYS . 48.6 t -52.87 -31.9 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.904 -1.122 . . . . 0.0 109.485 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.526 ' CB ' ' HB3' ' A' ' 45' ' ' SER . 67.4 tt0 -53.33 -45.54 69.1 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.067 -1.021 . . . . 0.0 108.784 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.575 HD13 ' CZ2' ' A' ' 15' ' ' TRP . 0.9 OUTLIER -71.88 -28.71 63.7 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.114 -0.991 . . . . 0.0 108.547 179.281 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.526 ' OG1' ' CD1' ' A' ' 59' ' ' LEU . 2.3 m -61.96 -65.28 0.71 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.0 -24.26 16.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.465 -0.772 . . . . 0.0 109.23 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.41 ' O ' ' C ' ' A' ' 53' ' ' LEU . 29.9 t80 -70.55 -68.11 0.45 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.227 -0.92 . . . . 0.0 108.992 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.585 HD22 ' CZ3' ' A' ' 15' ' ' TRP . 1.0 OUTLIER -45.17 -36.03 3.55 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.267 -0.896 . . . . 0.0 109.293 179.661 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 112.69 -157.6 14.84 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.81 6.13 4.77 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.567 2.178 . . . . 0.0 110.532 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -85.31 -21.45 28.95 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.216 -0.928 . . . . 0.0 109.614 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 50.9 m -135.89 164.38 28.08 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.037 -1.039 . . . . 0.0 109.663 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.41 ' HA ' ' CG2' ' A' ' 50' ' ' THR . 26.3 p30 -152.97 150.73 29.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.243 -0.91 . . . . 0.0 109.433 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.637 ' CD2' ' CD2' ' A' ' 62' ' ' PHE . 2.6 mp -143.71 12.09 1.67 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.242 -0.911 . . . . 0.0 109.593 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.472 ' HB ' HD22 ' A' ' 61' ' ' LEU . 3.4 m -46.04 -46.08 16.47 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.174 -0.954 . . . . 0.0 109.401 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.585 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 2.4 mm? -101.58 0.53 36.55 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.272 -0.893 . . . . 0.0 109.512 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.637 ' CD2' ' CD2' ' A' ' 59' ' ' LEU . 65.1 t80 -66.36 137.48 56.92 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.364 -0.835 . . . . 0.0 109.944 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.31 111.75 22.66 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.261 -0.899 . . . . 0.0 109.04 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.577 ' CE1' ' HA ' ' A' ' 46' ' ' LYS . 0.6 OUTLIER -70.26 59.33 0.18 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.207 -0.933 . . . . 0.0 109.11 -179.632 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.52 -40.46 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.378 -0.826 . . . . 0.0 109.093 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -90.4 -29.25 18.13 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.293 -0.88 . . . . 0.0 109.356 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.577 ' HA2' ' CE1' ' A' ' 62' ' ' PHE . . . 87.15 33.93 11.37 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.429 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 1.3 pt -140.98 155.39 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.065 -1.256 . . . . 0.0 110.004 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.502 ' HB3' ' HA ' ' A' ' 62' ' ' PHE . 1.9 pt? -143.26 146.24 33.44 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.49 1.568 0 O-C-N 120.983 -1.073 . . . . 0.0 109.937 -179.636 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.579 ' CZ2' ' HD3' ' A' ' 18' ' ' ARG . 66.6 m95 . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -101.54 159.16 15.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.279 -0.888 . . . . 0.0 109.538 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.472 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 12.3 t70 -48.85 132.55 18.21 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.282 -0.886 . . . . 0.0 109.213 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.457 ' O ' ' O ' ' A' ' 12' ' ' GLY . 23.5 t -96.42 109.33 47.19 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.24 -0.912 . . . . 0.0 109.337 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 36.1 Cg_endo -78.43 -32.96 2.02 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.297 1.998 . . . . 0.0 110.552 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.428 ' HB3' ' CD1' ' A' ' 62' ' ' PHE . . . -49.1 -56.99 7.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.272 -0.892 . . . . 0.0 109.506 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.638 ' CD1' ' CD1' ' A' ' 15' ' ' TRP . 4.7 mt -87.28 -56.36 3.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.177 -0.952 . . . . 0.0 109.613 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 8' ' ' CYS . . . 155.2 -150.37 21.83 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.19 159.47 33.4 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.681 2.254 . . . . 0.0 110.409 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 83.54 -52.77 4.78 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.638 ' CD1' ' CD1' ' A' ' 11' ' ' LEU . 4.4 t-105 -64.62 126.15 26.99 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.213 -1.169 . . . . 0.0 109.505 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.498 ' CG ' ' HB3' ' A' ' 5' ' ' TRP . 5.5 tptt -107.28 112.75 25.75 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.135 -0.978 . . . . 0.0 109.316 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.577 ' HG3' ' CE2' ' A' ' 35' ' ' TYR . 1.0 OUTLIER -87.15 116.28 25.12 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.242 -0.911 . . . . 0.0 109.457 -179.964 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.579 ' HD3' ' CZ2' ' A' ' 5' ' ' TRP . 10.0 ttp180 -95.63 141.04 29.6 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.222 -0.924 . . . . 0.0 109.483 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.495 ' CG ' ' O ' ' A' ' 19' ' ' GLU . 3.4 pt-20 -115.05 119.47 36.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.229 -0.92 . . . . 0.0 109.472 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.499 HG23 ' CZ ' ' A' ' 18' ' ' ARG . 20.5 t . . . . . 0 N--CA 1.49 1.529 0 O-C-N 121.233 -0.917 . . . . 0.0 109.634 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.443 HG22 ' O ' ' A' ' 18' ' ' ARG . 57.6 m -115.05 121.46 43.16 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.188 -0.945 . . . . 0.0 109.711 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.548 ' CD2' ' HG3' ' A' ' 44' ' ' ARG . 12.5 m-85 -103.8 157.25 17.21 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.258 -0.901 . . . . 0.0 109.179 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.577 ' CE2' ' HG3' ' A' ' 17' ' ' ARG . 11.5 m-85 -129.33 139.66 51.66 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.111 -0.993 . . . . 0.0 109.897 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.54 ' HB2' ' CZ3' ' A' ' 5' ' ' TRP . 22.0 tt0 -124.83 130.16 51.84 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.364 -0.835 . . . . 0.0 109.385 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.527 ' HA ' ' CZ3' ' A' ' 15' ' ' TRP . 0.5 OUTLIER -69.94 175.92 2.07 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.227 -0.92 . . . . 0.0 109.368 179.989 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.497 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 35.0 Cg_endo -78.11 -2.03 12.16 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.6 2.2 . . . . 0.0 110.283 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 p -109.38 -17.24 13.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.327 -0.858 . . . . 0.0 109.29 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 119.75 4.35 11.74 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.427 ' CB ' ' OG ' ' A' ' 37' ' ' SER . 0.1 OUTLIER -77.67 109.0 11.28 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.199 -1.177 . . . . 0.0 109.155 179.87 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.6 mtt180 -97.05 124.36 41.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.336 -0.852 . . . . 0.0 109.889 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.535 ' CG2' ' HB3' ' A' ' 49' ' ' LEU . 3.0 mp -118.56 163.5 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.379 -0.826 . . . . 0.0 109.047 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.587 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 4.5 ttp180 -126.77 -23.82 3.63 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.126 -0.984 . . . . 0.0 110.327 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.577 ' CB ' ' HB2' ' A' ' 48' ' ' GLU . 0.5 OUTLIER -75.24 166.47 23.58 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.76 -1.212 . . . . 0.0 108.615 179.543 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.571 ' HB2' ' CD1' ' A' ' 64' ' ' PHE . 7.6 ttpt -86.56 -63.77 1.26 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.123 -0.985 . . . . 0.0 110.529 -178.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.489 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 89.3 t -76.58 -16.8 14.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.11 -0.994 . . . . 0.0 109.773 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.577 ' HB2' ' CB ' ' A' ' 45' ' ' SER . 14.3 mt-10 -72.57 -46.86 52.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.965 -1.084 . . . . 0.0 108.495 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.538 ' O ' ' CD1' ' A' ' 53' ' ' LEU . 2.9 pp -66.76 -21.64 66.05 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 178.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.524 ' OG1' ' CD1' ' A' ' 59' ' ' LEU . 27.3 m -73.07 -64.49 0.96 Allowed 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.489 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -49.66 -23.73 1.88 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.224 -0.922 . . . . 0.0 108.611 179.665 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.468 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 63.9 t80 -62.68 -61.5 2.38 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.319 -0.863 . . . . 0.0 108.732 179.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.578 HD23 ' CE3' ' A' ' 15' ' ' TRP . 0.9 OUTLIER -53.36 -59.25 4.82 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.294 -0.879 . . . . 0.0 109.227 179.521 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 147.88 -162.55 28.75 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.72 -2.96 13.09 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.566 2.177 . . . . 0.0 110.144 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.87 -28.62 35.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.292 -0.88 . . . . 0.0 109.61 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 5.8 m -115.32 139.52 49.91 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.171 -0.955 . . . . 0.0 109.353 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.464 ' HA ' HG23 ' A' ' 50' ' ' THR . 2.0 p30 -132.76 153.26 51.38 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.078 -1.013 . . . . 0.0 109.905 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.524 ' CD1' ' OG1' ' A' ' 50' ' ' THR . 6.0 mp -146.35 12.04 1.18 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.412 -0.805 . . . . 0.0 109.223 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.527 HG22 ' CD2' ' A' ' 61' ' ' LEU . 97.2 m -50.59 -31.55 16.23 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.237 -0.915 . . . . 0.0 109.093 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.587 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 1.2 mm? -111.11 -9.04 14.38 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.452 -0.78 . . . . 0.0 109.053 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.495 ' CZ ' ' HA2' ' A' ' 67' ' ' GLY . 61.7 t80 -56.08 129.68 40.95 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.412 -0.805 . . . . 0.0 109.168 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.466 ' O ' ' N ' ' A' ' 65' ' ' LYS . 19.2 t0 -79.04 104.01 9.38 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.246 -0.909 . . . . 0.0 109.141 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.587 ' CE2' ' O ' ' A' ' 44' ' ' ARG . 1.1 t80 -66.94 63.0 0.05 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.477 -0.764 . . . . 0.0 109.452 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.466 ' N ' ' O ' ' A' ' 63' ' ' ASP . 37.4 ttpt -179.65 -43.7 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.458 -0.776 . . . . 0.0 109.173 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -88.31 -45.57 9.92 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.314 -0.866 . . . . 0.0 109.315 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.495 ' HA2' ' CZ ' ' A' ' 62' ' ' PHE . . . 110.48 31.86 2.89 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.473 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 2.8 pp -140.35 166.85 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.208 -1.172 . . . . 0.0 109.431 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.478 ' CB ' ' HA ' ' A' ' 62' ' ' PHE . 0.7 OUTLIER -145.54 177.63 8.72 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.202 -0.936 . . . . 0.0 109.482 -179.869 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.449 ' SG ' ' O ' ' A' ' 69' ' ' LEU . 72.2 m . . . . . 0 N--CA 1.49 1.533 0 O-C-N 121.366 -0.833 . . . . 0.0 109.292 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.547 ' CE3' ' HB2' ' A' ' 18' ' ' ARG . 73.3 m95 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.263 0.554 . . . . 0.0 109.534 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.422 ' O ' ' C ' ' A' ' 7' ' ' ASP . 51.8 mt -114.49 148.97 37.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.214 -0.929 . . . . 0.0 109.358 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.446 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 0.2 OUTLIER -43.63 133.74 4.45 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.297 -0.877 . . . . 0.0 109.424 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.494 ' HB3' ' HB3' ' A' ' 15' ' ' TRP . 39.7 t -88.37 113.38 55.03 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.298 -0.876 . . . . 0.0 109.563 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.446 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 34.8 Cg_endo -77.47 -40.02 0.48 Allowed 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 122.287 1.992 . . . . 0.0 110.003 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.495 ' CB ' ' NH1' ' A' ' 17' ' ' ARG . . . -47.04 -42.44 18.48 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.318 -0.864 . . . . 0.0 109.452 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.488 HD21 ' CD1' ' A' ' 59' ' ' LEU . 13.1 mt -101.15 -61.34 1.38 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.322 -0.861 . . . . 0.0 109.491 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 8' ' ' CYS . . . 156.7 -149.06 19.73 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -77.27 153.21 31.37 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.517 2.145 . . . . 0.0 110.327 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.408 ' O ' ' C ' ' A' ' 15' ' ' TRP . . . 93.76 -74.79 1.13 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.542 ' NE1' ' HB3' ' A' ' 35' ' ' TYR . 22.2 t-105 -44.24 122.6 3.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.275 -1.133 . . . . 0.0 109.304 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.3 mmtt -97.04 108.75 21.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.173 -0.954 . . . . 0.0 109.66 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.603 ' NH1' ' CE1' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -87.1 106.33 17.79 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.199 -0.938 . . . . 0.0 109.389 179.863 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.547 ' HB2' ' CE3' ' A' ' 5' ' ' TRP . 5.1 ttt180 -100.02 147.52 25.52 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.235 -0.915 . . . . 0.0 109.749 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.441 ' HA ' HG22 ' A' ' 33' ' ' THR . 22.0 pt-20 -116.67 155.27 29.11 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.356 -0.84 . . . . 0.0 109.241 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.528 HG21 ' CE1' ' A' ' 34' ' ' TYR . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.165 -0.96 . . . . 0.0 109.407 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.487 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.512 ' CG2' ' O ' ' A' ' 18' ' ' ARG . 2.1 m -139.56 142.9 37.15 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.245 -0.909 . . . . 0.0 109.619 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.559 ' CD1' ' N ' ' A' ' 34' ' ' TYR . 6.1 m-85 -135.58 151.86 50.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.337 -0.852 . . . . 0.0 109.243 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.649 ' CE2' ' CZ ' ' A' ' 64' ' ' PHE . 9.8 m-85 -117.61 146.34 43.71 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.207 -0.933 . . . . 0.0 109.735 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.487 ' CB ' ' CZ3' ' A' ' 5' ' ' TRP . 35.7 tt0 -131.27 123.62 28.77 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.373 -0.83 . . . . 0.0 109.259 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.46 ' CB ' ' HD2' ' A' ' 38' ' ' PRO . 0.4 OUTLIER -66.15 173.07 2.41 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.263 -0.898 . . . . 0.0 108.965 179.823 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.46 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 36.1 Cg_endo -78.0 4.13 6.42 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.51 2.14 . . . . 0.0 110.291 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.4 p -111.62 -17.37 13.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.331 -0.855 . . . . 0.0 109.444 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 120.46 5.41 10.29 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.458 ' O ' ' HA ' ' A' ' 36' ' ' GLN . 6.7 t0 -74.9 136.78 41.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.199 -1.177 . . . . 0.0 109.364 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.4 mtp180 -121.07 116.46 25.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.196 -0.94 . . . . 0.0 109.277 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.527 HG22 ' CA ' ' A' ' 49' ' ' LEU . 4.4 mt -123.35 152.93 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.228 -0.92 . . . . 0.0 109.924 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.577 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 4.9 ttt-85 -128.49 -24.04 3.11 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.282 -0.886 . . . . 0.0 109.909 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.527 ' CB ' ' HB2' ' A' ' 48' ' ' GLU . 1.7 m -73.56 147.89 43.5 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.979 -1.076 . . . . 0.0 108.909 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.483 ' HA ' HD22 ' A' ' 49' ' ' LEU . 24.4 ttpt -68.96 -71.84 0.2 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.287 -0.883 . . . . 0.0 110.811 -178.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.483 ' HA ' ' OG1' ' A' ' 50' ' ' THR . 62.5 t -67.37 -14.96 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.031 -1.043 . . . . 0.0 110.274 -178.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.527 ' HB2' ' CB ' ' A' ' 45' ' ' SER . 2.4 tt0 -72.45 -51.97 17.9 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.884 -1.135 . . . . 0.0 108.502 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.527 ' CA ' HG22 ' A' ' 43' ' ' ILE . 1.9 pp -63.17 -28.7 70.24 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.523 ' OG1' ' HB2' ' A' ' 59' ' ' LEU . 0.2 OUTLIER -68.2 -55.41 12.38 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 178.376 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.417 ' HD3' ' HA ' ' A' ' 51' ' ' ARG . 48.6 mmt-85 -52.0 -24.3 6.39 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.469 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 44.4 t80 -73.3 -50.76 20.41 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.532 -0.73 . . . . 0.0 109.196 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.52 HD23 ' CE3' ' A' ' 15' ' ' TRP . 0.4 OUTLIER -66.57 -53.0 39.33 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -0.909 . . . . 0.0 109.063 179.739 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 121.9 -146.42 17.01 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.62 -34.74 1.28 Allowed 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.512 2.141 . . . . 0.0 110.495 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -45.18 -33.95 2.52 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.302 -0.874 . . . . 0.0 109.837 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 67.2 m -122.07 148.51 44.77 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.165 -0.959 . . . . 0.0 109.767 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -126.82 146.27 50.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.276 -0.89 . . . . 0.0 109.422 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.523 ' HB2' ' OG1' ' A' ' 50' ' ' THR . 0.2 OUTLIER -144.99 6.85 1.18 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.277 -0.889 . . . . 0.0 110.332 -179.157 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.45 ' HB ' HD22 ' A' ' 61' ' ' LEU . 5.0 m -47.09 -41.88 17.95 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.062 -1.024 . . . . 0.0 109.861 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.545 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 1.4 mm? -110.1 13.2 23.3 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.166 -0.959 . . . . 0.0 110.113 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.603 ' CE1' ' NH1' ' A' ' 17' ' ' ARG . 51.5 t80 -69.5 136.1 51.01 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.201 -0.937 . . . . 0.0 109.549 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' A' ' 65' ' ' LYS . 0.3 OUTLIER -89.81 105.13 17.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.315 -0.866 . . . . 0.0 109.248 179.728 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.649 ' CZ ' ' CE2' ' A' ' 35' ' ' TYR . 0.4 OUTLIER -69.98 61.33 0.19 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.245 -0.909 . . . . 0.0 109.411 -179.594 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 63' ' ' ASP . 5.6 ttpt -174.46 -37.37 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.318 -0.864 . . . . 0.0 109.018 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -97.59 -38.74 9.43 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.419 -0.801 . . . . 0.0 109.111 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.424 ' C ' HG21 ' A' ' 68' ' ' ILE . . . 103.67 32.36 4.51 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 2.7 pp -139.87 173.38 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.162 -1.199 . . . . 0.0 109.58 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.495 ' CB ' ' HA ' ' A' ' 62' ' ' PHE . 0.6 OUTLIER -149.89 -165.07 2.17 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.243 -0.911 . . . . 0.0 109.385 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.425 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.488 1.459 0 O-C-N 121.334 -0.854 . . . . 0.0 109.344 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.574 ' CE3' ' HB2' ' A' ' 18' ' ' ARG . 84.1 m95 . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.419 ' O ' ' C ' ' A' ' 7' ' ' ASP . 0.5 OUTLIER -110.26 154.33 23.58 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.221 -0.924 . . . . 0.0 109.509 -179.947 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.419 ' C ' ' O ' ' A' ' 6' ' ' LEU . 2.0 m-20 -43.9 146.31 0.6 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.291 -0.881 . . . . 0.0 109.471 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.469 ' HB2' ' HB2' ' A' ' 17' ' ' ARG . 45.4 t -111.88 100.75 49.7 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.197 -0.94 . . . . 0.0 109.457 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.506 ' HD2' ' NH2' ' A' ' 17' ' ' ARG . 34.4 Cg_endo -76.6 -33.89 2.85 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.438 2.092 . . . . 0.0 110.569 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.439 ' HB1' HD23 ' A' ' 11' ' ' LEU . . . -42.47 -48.43 5.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.308 -0.87 . . . . 0.0 109.609 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.567 HD11 ' CD1' ' A' ' 15' ' ' TRP . 3.1 mt -94.13 -61.99 1.42 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.247 -0.908 . . . . 0.0 109.457 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 8' ' ' CYS . . . 168.69 -158.67 31.45 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.94 145.92 20.11 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.592 2.195 . . . . 0.0 110.452 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.03 -49.83 1.22 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.567 ' CD1' HD11 ' A' ' 11' ' ' LEU . 15.7 t-105 -65.66 129.77 40.93 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.233 -1.157 . . . . 0.0 109.468 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.8 mmtp -100.99 123.02 44.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.172 -0.955 . . . . 0.0 109.394 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.506 ' NH2' ' HD2' ' A' ' 9' ' ' PRO . 7.7 ttp85 -94.19 110.65 22.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.16 -0.962 . . . . 0.0 109.588 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.574 ' HB2' ' CE3' ' A' ' 5' ' ' TRP . 0.5 OUTLIER -99.71 141.77 32.08 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.325 -0.859 . . . . 0.0 109.053 179.653 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -124.46 141.84 51.77 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.186 -0.947 . . . . 0.0 109.875 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 87.7 t . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.24 -0.913 . . . . 0.0 109.349 179.763 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.469 ' O ' ' CE1' ' A' ' 35' ' ' TYR . 4.5 m -139.34 98.52 3.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.298 -0.876 . . . . 0.0 109.542 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.515 ' CD1' ' HB3' ' A' ' 44' ' ' ARG . 13.0 m-85 -99.95 160.65 14.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.401 -0.812 . . . . 0.0 108.984 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.64 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 1.6 m-85 -131.78 156.46 45.94 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.977 -1.077 . . . . 0.0 109.912 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.539 ' HB2' ' CZ3' ' A' ' 5' ' ' TRP . 11.3 tt0 -129.66 129.97 44.97 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.441 -0.787 . . . . 0.0 109.047 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.448 ' CB ' ' HD2' ' A' ' 38' ' ' PRO . 0.6 OUTLIER -68.68 172.06 5.25 Favored Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 121.269 -0.894 . . . . 0.0 109.257 -179.976 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.448 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 35.1 Cg_endo -77.66 4.56 5.92 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.623 2.215 . . . . 0.0 110.408 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.6 t -122.13 -20.23 6.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.307 -0.871 . . . . 0.0 109.58 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 128.59 6.51 4.62 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.402 ' CB ' ' HB2' ' A' ' 37' ' ' SER . 0.5 OUTLIER -80.29 105.88 11.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.123 -1.222 . . . . 0.0 109.146 179.79 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.405 ' HG3' ' HG3' ' A' ' 36' ' ' GLN . 15.6 mtp180 -97.5 125.43 42.18 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.181 -0.95 . . . . 0.0 110.078 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.557 ' CG2' ' HB3' ' A' ' 49' ' ' LEU . 4.8 mt -127.65 163.91 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.515 ' HB3' ' CD1' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -160.31 18.17 0.14 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.894 -1.129 . . . . 0.0 110.654 -179.575 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.535 ' HB2' ' CB ' ' A' ' 48' ' ' GLU . 0.4 OUTLIER -99.98 18.13 19.24 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.856 -1.152 . . . . 0.0 109.397 179.761 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.597 ' HB2' ' CD1' ' A' ' 64' ' ' PHE . 12.7 tttt 64.36 -92.49 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.502 -0.749 . . . . 0.0 110.473 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.482 ' HA ' ' OG1' ' A' ' 50' ' ' THR . 74.8 t -62.33 -27.93 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.018 -1.051 . . . . 0.0 109.369 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.535 ' CB ' ' HB2' ' A' ' 45' ' ' SER . 23.9 tt0 -61.06 -49.28 77.99 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.557 ' HB3' ' CG2' ' A' ' 43' ' ' ILE . 0.8 OUTLIER -68.13 -23.72 64.93 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.814 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.544 ' OG1' ' CB ' ' A' ' 59' ' ' LEU . 26.9 m -65.65 -70.87 0.21 Allowed 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.425 ' C ' ' O ' ' A' ' 50' ' ' THR . 0.0 OUTLIER -43.57 -26.79 0.24 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.507 -0.746 . . . . 0.0 109.028 179.547 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.422 ' N ' ' O ' ' A' ' 50' ' ' THR . 37.1 t80 -64.16 -62.95 1.29 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.286 -0.884 . . . . 0.0 109.565 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.527 ' CD1' ' O ' ' A' ' 49' ' ' LEU . 0.5 OUTLIER -55.57 -57.94 9.84 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.125 -0.984 . . . . 0.0 109.274 -179.92 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 131.06 -155.01 21.07 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.48 -9.5 16.11 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.623 2.216 . . . . 0.0 110.528 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -81.14 -13.99 58.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.302 -0.874 . . . . 0.0 109.638 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.449 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 88.1 m -134.07 79.27 1.8 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.191 -0.943 . . . . 0.0 109.596 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.54 137.23 56.64 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.145 -0.972 . . . . 0.0 109.133 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.567 HD21 ' CG ' ' A' ' 62' ' ' PHE . 0.1 OUTLIER -140.46 5.42 2.04 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.276 -0.89 . . . . 0.0 109.878 -179.288 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.419 ' C ' HD23 ' A' ' 61' ' ' LEU . 54.5 m -62.15 -21.36 64.98 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.215 -0.928 . . . . 0.0 109.156 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.603 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 1.7 mm? -107.31 -11.74 15.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.387 -0.821 . . . . 0.0 109.217 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.571 ' CZ ' ' OH ' ' A' ' 35' ' ' TYR . 6.1 t80 -54.81 133.41 47.56 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.399 -0.813 . . . . 0.0 109.735 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.547 ' O ' ' CE1' ' A' ' 62' ' ' PHE . 2.4 t0 -80.57 104.74 11.31 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.283 -0.886 . . . . 0.0 108.882 179.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.597 ' CD1' ' HB2' ' A' ' 46' ' ' LYS . 0.6 OUTLIER -67.19 65.04 0.06 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.264 -0.898 . . . . 0.0 109.319 -179.426 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.472 ' N ' ' O ' ' A' ' 63' ' ' ASP . 6.3 mtpt 171.48 -37.9 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.396 -0.815 . . . . 0.0 109.388 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -88.16 -46.63 9.11 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.163 -0.961 . . . . 0.0 109.3 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.496 ' HA2' ' CZ ' ' A' ' 62' ' ' PHE . . . 111.77 25.69 4.75 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.457 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -140.72 171.43 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.011 -1.288 . . . . 0.0 109.69 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.458 ' HA ' ' HA ' ' A' ' 62' ' ' PHE . 1.1 pt? -140.49 -174.3 3.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.22 -0.925 . . . . 0.0 109.337 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 23.0 m . . . . . 0 N--CA 1.491 1.582 0 O-C-N 121.187 -0.945 . . . . 0.0 109.592 -179.928 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.558 ' CZ3' ' HB2' ' A' ' 18' ' ' ARG . 97.9 m95 . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 81.4 mt -111.3 164.35 12.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.22 -0.925 . . . . 0.0 109.562 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 7' ' ' ASP . 0.5 OUTLIER -59.99 145.06 47.59 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.262 -0.898 . . . . 0.0 109.572 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.514 ' SG ' ' N ' ' A' ' 17' ' ' ARG . 7.1 m -91.24 113.89 59.85 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.258 -0.901 . . . . 0.0 109.886 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.409 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 36.3 Cg_endo -78.98 -27.35 4.66 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.344 2.029 . . . . 0.0 110.412 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.579 ' CB ' ' CE1' ' A' ' 62' ' ' PHE . . . -70.71 -37.34 73.54 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.106 -0.996 . . . . 0.0 109.839 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.542 HD11 ' CG ' ' A' ' 15' ' ' TRP . 6.5 mt -105.08 -46.37 4.28 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.134 -0.979 . . . . 0.0 109.635 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 135.06 -145.98 18.04 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.38 164.66 26.23 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.626 2.217 . . . . 0.0 110.405 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.8 -51.97 4.64 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.542 ' CG ' HD11 ' A' ' 11' ' ' LEU . 7.9 t-105 -75.72 125.75 29.66 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.292 -1.122 . . . . 0.0 109.346 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.427 ' C ' ' SG ' ' A' ' 8' ' ' CYS . 10.6 mmtp -103.14 132.4 49.43 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.213 -0.929 . . . . 0.0 109.526 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.514 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 0.0 OUTLIER -99.22 111.43 23.81 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.507 -0.745 . . . . 0.0 109.413 -179.6 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.558 ' HB2' ' CZ3' ' A' ' 5' ' ' TRP . 1.6 ttt180 -100.11 131.76 45.87 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.174 -0.954 . . . . 0.0 109.61 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -112.35 142.79 44.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.299 -0.876 . . . . 0.0 109.328 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 39.3 t . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.139 -0.976 . . . . 0.0 109.778 -179.745 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.497 ' HB3' ' CZ ' ' A' ' 34' ' ' TYR . 3.7 m-20 . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.78 109.4 17.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.203 -0.936 . . . . 0.0 109.827 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.591 ' CD1' ' CD ' ' A' ' 44' ' ' ARG . 11.4 m-85 -112.49 138.07 49.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.256 -0.902 . . . . 0.0 108.992 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.622 ' CE2' ' CE1' ' A' ' 64' ' ' PHE . 5.3 m-85 -108.18 151.11 26.36 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.136 -0.977 . . . . 0.0 109.827 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -132.24 128.73 38.52 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.361 -0.837 . . . . 0.0 109.533 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.517 ' OG ' ' CB ' ' A' ' 41' ' ' ASP . 0.4 OUTLIER -71.94 174.68 3.77 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.28 -0.888 . . . . 0.0 109.511 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.494 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 35.9 Cg_endo -78.61 -4.49 14.15 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.722 2.282 . . . . 0.0 110.417 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.4 t -103.92 -18.55 14.57 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.241 -0.912 . . . . 0.0 109.518 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 120.71 12.44 6.04 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.517 ' CB ' ' OG ' ' A' ' 37' ' ' SER . 0.4 OUTLIER -83.25 127.6 33.78 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -1.151 . . . . 0.0 109.571 -179.908 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.08 131.71 56.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.244 -0.91 . . . . 0.0 109.277 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.6 mp -137.64 161.49 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.225 -0.922 . . . . 0.0 109.611 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.591 ' CD ' ' CD1' ' A' ' 34' ' ' TYR . 34.8 mtm180 -143.79 18.42 1.81 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.316 -0.865 . . . . 0.0 109.557 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.503 ' O ' ' CB ' ' A' ' 46' ' ' LYS . 0.5 OUTLIER -91.88 -88.54 0.2 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.293 -0.879 . . . . 0.0 108.907 179.504 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.571 ' HB2' ' CD1' ' A' ' 64' ' ' PHE . 19.3 ttpt 159.52 -63.39 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.464 ' O ' ' CG ' ' A' ' 51' ' ' ARG . 77.2 t -85.38 -21.54 7.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.486 ' O ' ' HG3' ' A' ' 51' ' ' ARG . 98.3 mt-10 -68.71 -44.81 73.13 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.54 ' O ' ' CD1' ' A' ' 53' ' ' LEU . 3.4 pp -71.05 -25.07 62.49 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 178.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.51 ' CG2' HD13 ' A' ' 59' ' ' LEU . 20.5 m -68.59 -63.29 1.09 Allowed 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.486 ' HG3' ' O ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -49.45 -23.96 1.79 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.394 -0.816 . . . . 0.0 108.872 179.391 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.496 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 2.6 t80 -67.32 -64.64 0.81 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.303 -0.873 . . . . 0.0 109.159 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.54 ' CD1' ' O ' ' A' ' 49' ' ' LEU . 0.6 OUTLIER -51.1 -57.85 7.63 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.04 -1.038 . . . . 0.0 109.257 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 141.16 -157.15 25.94 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.07 -9.7 16.62 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.592 2.195 . . . . 0.0 110.248 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.17 -13.56 59.93 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.297 -0.877 . . . . 0.0 109.438 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 73.3 m -132.99 130.23 39.23 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.356 -0.84 . . . . 0.0 109.19 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -126.19 152.56 45.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.168 -0.958 . . . . 0.0 109.832 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.548 HD23 ' CD2' ' A' ' 62' ' ' PHE . 5.2 mp -148.64 14.7 0.96 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.388 -0.82 . . . . 0.0 109.395 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.463 ' C ' ' CD2' ' A' ' 61' ' ' LEU . 22.3 m -46.35 -37.35 7.38 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.323 -0.861 . . . . 0.0 109.84 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.58 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 1.1 mm? -111.38 2.43 17.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.3 -0.875 . . . . 0.0 109.606 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.579 ' CE1' ' CB ' ' A' ' 10' ' ' ALA . 78.3 t80 -58.68 146.33 36.8 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.353 -0.842 . . . . 0.0 109.656 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.496 ' O ' ' N ' ' A' ' 65' ' ' LYS . 5.1 t0 -98.44 103.32 15.26 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.33 -0.856 . . . . 0.0 108.972 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.622 ' CE1' ' CE2' ' A' ' 35' ' ' TYR . 0.7 OUTLIER -66.61 69.64 0.07 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.149 -0.97 . . . . 0.0 109.426 -179.36 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.496 ' N ' ' O ' ' A' ' 63' ' ' ASP . 11.9 ttpp 177.07 -46.22 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.266 -0.896 . . . . 0.0 109.579 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -92.41 -39.35 11.48 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.24 -0.912 . . . . 0.0 109.728 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.485 ' HA2' ' CZ ' ' A' ' 62' ' ' PHE . . . 106.03 35.17 3.02 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.469 ' O ' ' N ' ' A' ' 63' ' ' ASP . 2.0 pp -140.52 173.41 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.16 -1.2 . . . . 0.0 109.628 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.465 ' HB3' ' HA ' ' A' ' 62' ' ' PHE . 0.7 OUTLIER -147.24 -164.83 2.09 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.78 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.451 ' SG ' ' O ' ' A' ' 69' ' ' LEU . 62.1 m . . . . . 0 N--CA 1.489 1.481 0 O-C-N 120.947 -1.096 . . . . 0.0 110.134 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.405 ' CE3' ' HB2' ' A' ' 18' ' ' ARG . 71.9 m95 . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.72 158.77 17.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.194 -0.941 . . . . 0.0 109.684 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.431 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 0.5 OUTLIER -53.16 138.93 30.35 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.222 -0.923 . . . . 0.0 109.126 179.695 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.468 ' HB2' ' HB2' ' A' ' 17' ' ' ARG . 40.3 t -98.99 109.17 52.99 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.101 -0.999 . . . . 0.0 109.878 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.445 ' HD2' ' CZ ' ' A' ' 17' ' ' ARG . 34.4 Cg_endo -77.23 -38.79 0.69 Allowed 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.205 1.937 . . . . 0.0 110.111 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.488 ' HB1' ' CD1' ' A' ' 62' ' ' PHE . . . -42.97 -32.18 0.61 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.28 -0.887 . . . . 0.0 109.473 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.651 ' CD1' ' CD1' ' A' ' 15' ' ' TRP . 5.3 mt -115.93 -67.01 1.03 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.21 -0.931 . . . . 0.0 109.48 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 167.1 -149.1 14.17 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.88 169.21 20.99 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.688 2.259 . . . . 0.0 110.666 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.35 -56.18 2.84 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.634 -1.387 . . . . 0.0 109.634 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.651 ' CD1' ' CD1' ' A' ' 11' ' ' LEU . 10.0 t-105 -62.15 123.41 18.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.256 -1.143 . . . . 0.0 109.774 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -103.54 120.53 41.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.281 -0.887 . . . . 0.0 109.547 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.572 ' HG3' ' CE2' ' A' ' 35' ' ' TYR . 3.2 ttp85 -95.3 114.94 26.78 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.217 -0.927 . . . . 0.0 109.347 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.405 ' HB2' ' CE3' ' A' ' 5' ' ' TRP . 4.0 tmm_? -100.24 139.37 36.01 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.183 -0.948 . . . . 0.0 109.571 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -108.68 144.69 36.12 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.209 -0.932 . . . . 0.0 109.482 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.533 HG21 ' CE1' ' A' ' 34' ' ' TYR . 42.7 t . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.184 -0.947 . . . . 0.0 109.428 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.522 HG22 ' CZ ' ' A' ' 35' ' ' TYR . 31.2 m -128.72 126.06 39.26 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.22 -0.925 . . . . 0.0 109.778 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.615 ' CD1' ' N ' ' A' ' 34' ' ' TYR . 1.7 m-85 -115.14 167.18 11.05 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.64 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 2.5 m-85 -136.72 146.27 45.64 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.866 -1.146 . . . . 0.0 110.08 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -128.49 124.8 37.0 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.478 -0.763 . . . . 0.0 109.344 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.5 ' CB ' ' HD2' ' A' ' 38' ' ' PRO . 0.3 OUTLIER -68.19 174.98 2.02 Favored Pre-proline 0 N--CA 1.487 1.417 0 O-C-N 121.285 -0.884 . . . . 0.0 109.32 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.5 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 35.1 Cg_endo -78.14 5.35 5.46 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.65 2.234 . . . . 0.0 110.335 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.419 HG22 ' N ' ' A' ' 40' ' ' GLY . 15.3 t -114.6 -24.83 8.58 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.254 -0.904 . . . . 0.0 109.417 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.419 ' N ' HG22 ' A' ' 39' ' ' THR . . . 124.24 13.34 3.98 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.451 ' HB2' ' OH ' ' A' ' 52' ' ' TYR . 0.3 OUTLIER -90.95 112.53 24.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.132 -1.217 . . . . 0.0 109.24 179.882 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.481 ' CZ ' ' HB2' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -95.57 139.33 31.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -0.891 . . . . 0.0 109.618 -179.75 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.411 HG23 ' HB3' ' A' ' 49' ' ' LEU . 4.0 mt -135.98 161.21 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.187 -0.946 . . . . 0.0 109.566 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.595 ' HG3' ' CD2' ' A' ' 34' ' ' TYR . 0.1 OUTLIER -152.6 15.12 0.58 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.239 -0.913 . . . . 0.0 110.257 -179.37 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.547 ' CB ' ' HB3' ' A' ' 48' ' ' GLU . 0.3 OUTLIER -99.61 21.55 12.15 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.924 -1.11 . . . . 0.0 109.456 179.949 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.606 ' HA ' ' CE1' ' A' ' 64' ' ' PHE . 8.1 ttpt 59.3 -94.01 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.365 -0.834 . . . . 0.0 109.973 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.459 ' HA ' ' OG1' ' A' ' 50' ' ' THR . 26.3 t -59.0 -38.0 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.036 -1.04 . . . . 0.0 109.314 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.547 ' HB3' ' CB ' ' A' ' 45' ' ' SER . 71.3 tt0 -51.26 -43.44 61.56 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.002 -1.061 . . . . 0.0 108.356 179.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.528 ' O ' ' CD1' ' A' ' 53' ' ' LEU . 0.5 OUTLIER -66.45 -27.86 68.15 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 179.393 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.526 ' CG2' HD11 ' A' ' 59' ' ' LEU . 1.5 m -71.27 -66.22 0.65 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.464 ' CD ' ' HA ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -47.84 -24.33 0.97 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.357 -0.839 . . . . 0.0 108.778 179.321 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.469 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 62.4 t80 -63.34 -60.18 3.73 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.264 -0.898 . . . . 0.0 109.114 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.578 HD21 ' CZ3' ' A' ' 15' ' ' TRP . 0.3 OUTLIER -60.74 -55.19 36.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.182 -0.949 . . . . 0.0 108.969 179.642 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 142.74 -155.33 25.78 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -78.02 -18.84 12.71 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.537 2.158 . . . . 0.0 110.366 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.22 -10.52 51.37 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.326 -0.859 . . . . 0.0 109.56 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.472 ' CB ' HD12 ' A' ' 53' ' ' LEU . 18.0 m -133.41 136.71 45.42 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.227 -0.921 . . . . 0.0 109.522 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.471 ' HA ' ' CG2' ' A' ' 50' ' ' THR . 18.3 t70 -130.95 148.59 52.73 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.272 -0.893 . . . . 0.0 109.49 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.526 HD11 ' CG2' ' A' ' 50' ' ' THR . 4.1 mp -148.24 10.5 0.88 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.208 -0.932 . . . . 0.0 109.696 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.445 ' C ' ' CD2' ' A' ' 61' ' ' LEU . 94.5 m -49.92 -29.06 7.59 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.146 -0.971 . . . . 0.0 109.145 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.576 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 1.5 mm? -111.07 -8.42 14.44 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.322 -0.861 . . . . 0.0 109.381 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.508 ' CE1' ' HA2' ' A' ' 67' ' ' GLY . 48.0 t80 -59.18 131.1 50.01 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.378 -0.826 . . . . 0.0 109.337 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.63 117.49 20.6 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.192 -0.943 . . . . 0.0 109.261 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.606 ' CE1' ' HA ' ' A' ' 46' ' ' LYS . 0.4 OUTLIER -73.89 56.75 0.59 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.219 -0.926 . . . . 0.0 109.065 -179.94 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.14 -41.6 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.378 -0.826 . . . . 0.0 109.022 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -81.14 -46.66 14.58 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.267 -0.895 . . . . 0.0 109.113 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.508 ' HA2' ' CE1' ' A' ' 62' ' ' PHE . . . 104.22 28.63 5.74 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.46 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 1.1 pp -140.6 161.48 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.022 -1.281 . . . . 0.0 109.757 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.415 ' HB3' ' HA ' ' A' ' 62' ' ' PHE . 0.7 OUTLIER -143.74 173.84 11.33 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.339 -0.851 . . . . 0.0 108.935 179.74 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 21.6 p . . . . . 0 N--CA 1.489 1.511 0 O-C-N 121.118 -0.989 . . . . 0.0 109.767 179.802 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.537 ' CE2' ' HG3' ' A' ' 18' ' ' ARG . 98.7 m95 . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -110.8 160.75 16.46 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.181 -0.949 . . . . 0.0 109.617 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -56.39 149.32 17.03 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.237 -0.914 . . . . 0.0 109.206 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.459 ' HB2' ' HB2' ' A' ' 17' ' ' ARG . 38.0 t -111.75 103.83 55.51 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.128 -0.983 . . . . 0.0 109.848 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.92 -26.21 6.88 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.373 2.049 . . . . 0.0 109.878 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.495 ' HB2' ' CE2' ' A' ' 62' ' ' PHE . . . -54.06 -34.63 60.56 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.406 -0.809 . . . . 0.0 109.314 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.626 ' CD1' ' CD1' ' A' ' 15' ' ' TRP . 12.2 mt -105.88 -66.79 0.97 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.292 -0.88 . . . . 0.0 109.358 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 157.98 -153.16 24.37 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.79 137.34 15.89 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.669 2.246 . . . . 0.0 110.353 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.29 23.25 17.35 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.626 ' CD1' ' CD1' ' A' ' 11' ' ' LEU . 27.6 t-105 -150.1 125.59 10.24 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.24 -1.153 . . . . 0.0 109.334 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.9 mmmt -105.9 134.66 48.67 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.15 -0.969 . . . . 0.0 109.538 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.503 ' HG3' ' CE2' ' A' ' 35' ' ' TYR . 3.7 ttp85 -103.6 111.68 24.26 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.311 -0.868 . . . . 0.0 109.643 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.537 ' HG3' ' CE2' ' A' ' 5' ' ' TRP . 0.3 OUTLIER -97.65 155.41 17.0 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.224 -0.923 . . . . 0.0 109.151 179.716 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.415 ' C ' HG23 ' A' ' 20' ' ' VAL . 5.5 pt-20 -123.03 168.61 12.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.116 -0.99 . . . . 0.0 109.731 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.493 HG22 ' CE2' ' A' ' 34' ' ' TYR . 3.4 t . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.349 -0.845 . . . . 0.0 109.383 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.409 ' HB2' HG22 ' A' ' 20' ' ' VAL . 1.1 m-20 . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.38 106.31 11.33 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.129 -0.982 . . . . 0.0 109.772 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.493 ' CE2' HG22 ' A' ' 20' ' ' VAL . 15.0 m-85 -101.99 167.27 10.15 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.275 -0.89 . . . . 0.0 109.054 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.578 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 3.9 m-85 -135.1 155.16 51.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.067 -1.02 . . . . 0.0 109.913 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.532 ' HB2' ' CZ3' ' A' ' 5' ' ' TRP . 4.4 tt0 -141.96 132.82 25.79 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.357 -0.839 . . . . 0.0 109.156 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.502 ' CB ' ' HD2' ' A' ' 38' ' ' PRO . 0.1 OUTLIER -70.78 176.13 2.18 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.238 -0.913 . . . . 0.0 109.213 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.502 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 35.7 Cg_endo -78.69 0.29 10.1 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.535 2.156 . . . . 0.0 110.289 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.464 HG21 ' N ' ' A' ' 40' ' ' GLY . 10.1 t -106.48 -21.58 13.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.338 -0.851 . . . . 0.0 109.575 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.464 ' N ' HG21 ' A' ' 39' ' ' THR . . . 122.51 10.95 5.76 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.437 ' CB ' ' OG ' ' A' ' 37' ' ' SER . 0.1 OUTLIER -79.76 102.97 9.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.232 -1.158 . . . . 0.0 109.472 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.3 mtp85 -90.48 117.3 29.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.281 -0.887 . . . . 0.0 109.477 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.496 HG21 ' N ' ' A' ' 49' ' ' LEU . 2.9 mp -121.63 153.04 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.277 -0.889 . . . . 0.0 109.494 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.47 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 8.7 mtm-85 -148.73 16.9 1.0 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.233 -0.917 . . . . 0.0 110.237 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.557 ' HB3' ' CB ' ' A' ' 48' ' ' GLU . 1.6 t -100.66 16.75 23.84 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.979 -1.076 . . . . 0.0 110.368 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.605 ' HA ' ' CE1' ' A' ' 64' ' ' PHE . 25.6 tttt 63.73 -94.18 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.221 -0.924 . . . . 0.0 110.92 178.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.446 ' N ' ' HG2' ' A' ' 46' ' ' LYS . 54.9 t -58.72 -27.88 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.906 -1.121 . . . . 0.0 109.656 -178.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.557 ' CB ' ' HB3' ' A' ' 45' ' ' SER . 14.7 tt0 -61.12 -47.79 84.65 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.093 -1.004 . . . . 0.0 108.525 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.585 HD13 ' CZ2' ' A' ' 15' ' ' TRP . 1.0 OUTLIER -67.75 -23.79 65.28 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.94 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.547 ' OG1' ' CB ' ' A' ' 59' ' ' LEU . 17.0 m -66.92 -68.76 0.35 Allowed 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.66 -20.41 2.04 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.533 -0.73 . . . . 0.0 109.23 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.476 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 44.5 t80 -66.76 -50.57 62.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.223 -0.923 . . . . 0.0 109.276 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.574 ' CD2' ' CE3' ' A' ' 15' ' ' TRP . 0.3 OUTLIER -70.56 -48.52 55.0 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.19 -0.944 . . . . 0.0 109.093 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 121.6 -156.59 16.5 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -78.9 8.08 3.96 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.574 2.183 . . . . 0.0 110.552 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -88.53 -23.56 23.14 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.141 -0.974 . . . . 0.0 109.558 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.419 ' HB2' HD12 ' A' ' 53' ' ' LEU . 95.8 m -133.28 101.1 5.05 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.285 -0.884 . . . . 0.0 109.499 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -75.62 131.12 39.76 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.178 -0.951 . . . . 0.0 109.448 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.582 HD23 ' CD2' ' A' ' 62' ' ' PHE . 0.1 OUTLIER -132.37 0.9 3.74 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.369 -0.832 . . . . 0.0 109.697 -179.689 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.2 m -47.54 -34.35 7.53 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.335 -0.853 . . . . 0.0 110.24 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.499 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 0.7 OUTLIER -108.09 0.24 21.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.057 -1.027 . . . . 0.0 109.93 -179.321 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.582 ' CD2' HD23 ' A' ' 59' ' ' LEU . 3.4 t80 -51.61 131.55 29.8 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.17 -0.956 . . . . 0.0 109.358 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.47 ' O ' ' N ' ' A' ' 65' ' ' LYS . 99.0 m-20 -79.22 104.16 9.65 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.21 -0.931 . . . . 0.0 108.768 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.605 ' CE1' ' HA ' ' A' ' 46' ' ' LYS . 0.5 OUTLIER -68.62 58.86 0.09 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.337 -0.852 . . . . 0.0 109.658 -179.138 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.47 ' N ' ' O ' ' A' ' 63' ' ' ASP . 2.7 tmmt? 178.09 -33.63 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.272 -0.892 . . . . 0.0 109.432 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -92.12 -44.04 9.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.18 -0.95 . . . . 0.0 109.501 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.462 ' O ' ' HB1' ' A' ' 10' ' ' ALA . . . 110.95 25.31 5.16 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.492 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 1.3 pp -140.31 -170.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.286 -1.126 . . . . 0.0 109.557 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.498 ' HB3' ' HA ' ' A' ' 62' ' ' PHE . 1.1 pt? -153.42 178.53 9.69 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.378 -0.826 . . . . 0.0 109.0 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.457 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.497 0 O-C-N 121.139 -0.976 . . . . 0.0 109.24 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.574 ' CE3' ' HB2' ' A' ' 18' ' ' ARG . 73.5 m95 . . . . . 0 N--CA 1.494 1.728 0 CA-C-O 121.344 0.592 . . . . 0.0 109.912 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.9 mt -102.78 152.62 21.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.117 -0.989 . . . . 0.0 109.685 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.477 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 5.3 m-20 -50.75 131.12 25.79 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.282 -0.886 . . . . 0.0 109.587 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.522 ' SG ' ' CZ ' ' A' ' 17' ' ' ARG . 12.1 t -82.06 113.94 47.11 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.33 -0.856 . . . . 0.0 109.629 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 36.5 Cg_endo -80.63 -55.61 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.282 0 C-N-CA 122.508 2.139 . . . . 0.0 110.909 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.491 ' CB ' ' CE1' ' A' ' 62' ' ' PHE . . . -37.99 -58.62 0.92 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.559 -0.713 . . . . 0.0 110.216 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.567 HD11 ' CG ' ' A' ' 15' ' ' TRP . 13.6 mt -79.38 -58.52 3.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.323 -0.861 . . . . 0.0 109.633 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 131.29 -140.82 12.11 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.81 138.0 16.44 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.509 2.139 . . . . 0.0 110.477 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.464 ' O ' ' HD3' ' A' ' 38' ' ' PRO . . . 99.3 14.14 36.63 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.632 ' CZ3' ' CD2' ' A' ' 53' ' ' LEU . 7.5 t-105 -148.36 137.06 21.59 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.229 -1.159 . . . . 0.0 109.532 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.76 129.22 55.64 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.261 -0.899 . . . . 0.0 109.313 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.64 ' NH1' ' CZ ' ' A' ' 62' ' ' PHE . 0.6 OUTLIER -98.38 98.04 9.32 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.249 -0.907 . . . . 0.0 109.436 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.574 ' HB2' ' CE3' ' A' ' 5' ' ' TRP . 1.5 ttm180 -100.45 134.81 42.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.253 -0.904 . . . . 0.0 109.337 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.404 ' C ' HG21 ' A' ' 20' ' ' VAL . 2.1 pt-20 -115.14 156.91 24.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.19 -0.944 . . . . 0.0 109.379 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.404 HG21 ' C ' ' A' ' 19' ' ' GLU . 3.6 t . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.153 -0.967 . . . . 0.0 109.434 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 . . . . . 0 N--CA 1.488 1.474 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.568 HG22 ' CE1' ' A' ' 35' ' ' TYR . 87.2 m -114.9 132.96 56.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.171 -0.956 . . . . 0.0 109.525 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.416 ' CD1' ' HB3' ' A' ' 44' ' ' ARG . 27.9 m-85 -129.68 149.27 51.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.293 -0.88 . . . . 0.0 109.409 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.689 ' CD2' ' CZ ' ' A' ' 64' ' ' PHE . 12.3 m-85 -113.81 154.2 27.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.254 -0.904 . . . . 0.0 109.178 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.571 ' HB2' ' CZ3' ' A' ' 5' ' ' TRP . 0.7 OUTLIER -131.11 126.45 35.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.188 -0.945 . . . . 0.0 109.613 -179.877 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.411 ' CB ' ' HD2' ' A' ' 38' ' ' PRO . 0.4 OUTLIER -62.97 170.97 2.15 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.356 -0.84 . . . . 0.0 109.364 179.864 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 14' ' ' GLY . 35.6 Cg_endo -78.41 5.99 5.1 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.577 2.185 . . . . 0.0 110.472 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.7 t -115.14 -16.13 11.61 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.247 -0.908 . . . . 0.0 109.524 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 124.55 3.52 7.82 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.456 ' O ' ' HA ' ' A' ' 36' ' ' GLN . 0.7 OUTLIER -76.87 157.0 31.74 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.276 -1.132 . . . . 0.0 109.325 -179.988 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.438 ' O ' ' HG2' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -143.32 122.75 13.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.224 -0.922 . . . . 0.0 109.618 -179.874 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.519 HD13 ' CB ' ' A' ' 49' ' ' LEU . 2.6 mp -128.95 153.44 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.277 -0.89 . . . . 0.0 109.559 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.589 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 8.5 ptt85 -117.3 -15.14 10.41 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.273 -0.892 . . . . 0.0 109.242 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.551 ' CB ' ' HB2' ' A' ' 48' ' ' GLU . 1.1 m -91.02 124.82 35.55 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.217 -0.927 . . . . 0.0 108.813 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.551 ' CG ' ' N ' ' A' ' 47' ' ' VAL . 33.6 pttt -60.46 -48.18 82.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.268 -0.895 . . . . 0.0 110.442 -178.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.551 ' N ' ' CG ' ' A' ' 46' ' ' LYS . 86.6 t -77.22 -31.49 18.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.067 -1.021 . . . . 0.0 109.668 -179.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.551 ' HB2' ' CB ' ' A' ' 45' ' ' SER . 39.1 tt0 -59.25 -51.71 68.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.96 -1.087 . . . . 0.0 108.604 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.528 ' O ' ' CD1' ' A' ' 53' ' ' LEU . 3.2 pp -69.22 -33.62 73.59 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 178.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.517 ' OG1' ' HB2' ' A' ' 59' ' ' LEU . 22.8 m -52.33 -67.27 0.26 Allowed 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.468 ' HG3' ' O ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -50.05 -30.88 11.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.416 -0.803 . . . . 0.0 109.213 179.801 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.511 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 28.5 t80 -64.41 -63.01 1.25 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.122 -0.986 . . . . 0.0 108.861 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.632 ' CD2' ' CZ3' ' A' ' 15' ' ' TRP . 0.5 OUTLIER -55.27 -48.49 73.94 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.989 -1.069 . . . . 0.0 108.898 179.391 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.84 -159.26 20.27 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.23 -2.34 12.55 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.541 2.161 . . . . 0.0 110.225 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.98 -25.15 55.53 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.287 -0.883 . . . . 0.0 109.348 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 59.7 m -135.11 103.03 5.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.242 -0.911 . . . . 0.0 109.231 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.433 ' C ' ' CD1' ' A' ' 59' ' ' LEU . 10.0 p30 -95.41 161.43 14.08 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.177 -0.952 . . . . 0.0 109.869 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.568 HD22 ' CD2' ' A' ' 62' ' ' PHE . 5.0 mp -154.6 20.02 0.47 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.441 -0.787 . . . . 0.0 109.282 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.467 ' C ' ' CD2' ' A' ' 61' ' ' LEU . 21.0 m -47.24 -40.3 16.12 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.326 -0.859 . . . . 0.0 109.75 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.585 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 0.8 OUTLIER -110.78 5.22 20.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.206 -0.934 . . . . 0.0 109.873 -179.387 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.64 ' CZ ' ' NH1' ' A' ' 17' ' ' ARG . 54.7 t80 -71.88 136.07 46.79 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.192 -0.943 . . . . 0.0 109.418 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.465 ' HB2' ' HB2' ' A' ' 66' ' ' GLN . 2.4 m-20 -95.94 120.09 35.59 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.34 -0.85 . . . . 0.0 108.977 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.689 ' CZ ' ' CD2' ' A' ' 35' ' ' TYR . 0.6 OUTLIER -66.61 -11.72 54.75 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.278 -0.888 . . . . 0.0 109.512 -179.55 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -101.92 -41.71 6.38 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.208 -0.933 . . . . 0.0 110.112 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.465 ' HB2' ' HB2' ' A' ' 63' ' ' ASP . 5.9 mt-30 -83.22 -37.8 23.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.101 -1.0 . . . . 0.0 109.856 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.581 ' HA2' ' CZ ' ' A' ' 62' ' ' PHE . . . 89.31 29.65 16.37 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.476 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -139.58 160.26 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.202 -1.176 . . . . 0.0 109.367 179.914 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.471 ' HB3' ' HA ' ' A' ' 62' ' ' PHE . 1.3 pt? -143.25 172.26 12.98 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.233 -0.917 . . . . 0.0 109.377 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.489 1.507 0 O-C-N 121.345 -0.847 . . . . 0.0 109.274 179.816 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.57 ' CE3' ' HB2' ' A' ' 18' ' ' ARG . 62.6 m95 . . . . . 0 N--CA 1.487 1.4 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 17.9 mt -119.28 165.44 14.25 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.2 -0.937 . . . . 0.0 109.429 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -55.58 131.87 47.35 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.11 -0.994 . . . . 0.0 109.483 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.512 ' CB ' ' HB2' ' A' ' 17' ' ' ARG . 53.9 t -82.03 117.43 68.32 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.275 -0.891 . . . . 0.0 109.642 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.95 -51.24 0.06 OUTLIER 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.418 2.079 . . . . 0.0 110.698 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -49.69 -38.05 31.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.177 -0.952 . . . . 0.0 109.929 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.511 HD11 ' CD1' ' A' ' 15' ' ' TRP . 13.1 mt -98.73 -54.87 2.89 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.139 -0.976 . . . . 0.0 109.656 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 134.45 -152.54 20.68 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.769 -1.333 . . . . 0.0 109.769 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.77 159.36 31.43 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.695 2.263 . . . . 0.0 110.533 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.405 ' O ' ' HD3' ' A' ' 38' ' ' PRO . . . 83.71 -10.13 60.57 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.516 ' NE1' ' HB3' ' A' ' 35' ' ' TYR . 15.6 t-105 -118.06 131.42 56.45 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.313 -1.11 . . . . 0.0 109.264 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.449 ' HB3' ' HB3' ' A' ' 5' ' ' TRP . 21.4 mmtt -95.71 116.6 29.11 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.185 -0.947 . . . . 0.0 109.316 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.512 ' HB2' ' CB ' ' A' ' 8' ' ' CYS . 3.2 ttt-85 -104.45 100.04 9.74 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.255 -0.903 . . . . 0.0 109.294 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.57 ' HB2' ' CE3' ' A' ' 5' ' ' TRP . 1.4 tpt180 -100.7 144.18 29.99 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.149 -0.97 . . . . 0.0 110.052 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.433 ' HG2' ' CZ ' ' A' ' 18' ' ' ARG . 15.0 pt-20 -113.83 144.94 42.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.349 -0.844 . . . . 0.0 109.258 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.426 HG23 ' CE2' ' A' ' 34' ' ' TYR . 20.8 t . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.112 -0.993 . . . . 0.0 109.72 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.454 ' CG2' ' O ' ' A' ' 18' ' ' ARG . 56.5 m -125.4 122.0 35.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.084 -1.01 . . . . 0.0 110.126 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.468 ' CD1' ' N ' ' A' ' 34' ' ' TYR . 3.3 m-85 -100.76 159.68 14.98 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.516 ' HB3' ' NE1' ' A' ' 15' ' ' TRP . 16.4 m-85 -130.49 137.08 49.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.943 -1.098 . . . . 0.0 110.114 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -118.99 116.18 25.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.489 -0.757 . . . . 0.0 109.327 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.466 ' OG ' HG21 ' A' ' 39' ' ' THR . 0.7 OUTLIER -57.07 168.86 0.78 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.327 -0.858 . . . . 0.0 109.448 -179.943 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.405 ' HD3' ' O ' ' A' ' 14' ' ' GLY . 35.5 Cg_endo -78.38 5.39 5.52 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.641 2.227 . . . . 0.0 110.379 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.466 HG21 ' OG ' ' A' ' 37' ' ' SER . 6.5 t -115.61 -11.63 11.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.155 -0.966 . . . . 0.0 109.648 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 116.98 3.86 17.26 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.81 142.45 40.3 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.163 -1.199 . . . . 0.0 109.108 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.0 117.5 24.15 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.227 -0.92 . . . . 0.0 109.707 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.517 ' CG2' ' HB3' ' A' ' 49' ' ' LEU . 3.4 mp -123.19 162.53 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.347 -0.845 . . . . 0.0 109.332 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.479 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 34.6 mtp180 -149.1 15.57 0.93 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.141 -0.975 . . . . 0.0 109.805 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.546 ' O ' ' CB ' ' A' ' 46' ' ' LYS . 0.6 OUTLIER -85.34 -85.45 0.14 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.212 -0.93 . . . . 0.0 109.119 179.609 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.546 ' CB ' ' O ' ' A' ' 45' ' ' SER . 12.4 ttpt 157.92 -62.82 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.446 HG22 ' HE2' ' A' ' 46' ' ' LYS . 61.0 t -88.52 -21.83 6.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 178.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.478 ' O ' ' HG3' ' A' ' 51' ' ' ARG . 18.0 mt-10 -69.05 -41.78 77.18 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.523 ' O ' ' CD1' ' A' ' 53' ' ' LEU . 3.0 pp -71.87 -25.16 61.83 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 178.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.531 ' OG1' ' HB2' ' A' ' 59' ' ' LEU . 8.8 m -69.75 -61.5 1.75 Allowed 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.478 ' HG3' ' O ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -51.11 -23.21 2.98 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 179.297 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.47 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 65.2 t80 -69.63 -65.99 0.64 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.334 -0.854 . . . . 0.0 108.982 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.523 ' CD1' ' O ' ' A' ' 49' ' ' LEU . 0.9 OUTLIER -49.9 -58.68 4.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.163 -0.961 . . . . 0.0 109.124 179.611 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 132.04 -146.89 18.47 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.71 -29.35 3.61 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.599 2.2 . . . . 0.0 110.139 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -54.63 -26.3 32.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.33 -0.856 . . . . 0.0 109.287 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 11.7 m -121.71 170.58 9.6 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.323 -0.861 . . . . 0.0 109.22 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.488 ' HA ' ' CG2' ' A' ' 50' ' ' THR . 17.6 p-10 -165.19 148.57 8.33 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.164 -0.96 . . . . 0.0 109.441 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.531 ' HB2' ' OG1' ' A' ' 50' ' ' THR . 4.1 mp -153.0 21.02 0.58 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.206 -0.934 . . . . 0.0 109.716 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.435 ' C ' HD22 ' A' ' 61' ' ' LEU . 1.9 m -43.59 -49.59 7.52 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.268 -0.895 . . . . 0.0 109.647 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.506 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 1.5 mm? -106.97 9.8 30.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.324 -0.86 . . . . 0.0 109.755 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.517 ' CD2' ' CD2' ' A' ' 59' ' ' LEU . 72.0 t80 -55.87 139.94 44.2 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.402 -0.811 . . . . 0.0 109.999 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.528 ' O ' ' N ' ' A' ' 65' ' ' LYS . 0.7 OUTLIER -95.08 96.86 9.52 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.973 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.479 ' CE2' ' O ' ' A' ' 44' ' ' ARG . 0.5 OUTLIER -63.0 73.67 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.369 -0.832 . . . . 0.0 109.311 -179.119 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.528 ' N ' ' O ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER 168.35 -32.37 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.457 -0.777 . . . . 0.0 109.057 -179.757 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -103.57 -27.31 12.42 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.296 -0.878 . . . . 0.0 109.389 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.481 ' HA2' ' CZ ' ' A' ' 62' ' ' PHE . . . 89.42 33.16 9.57 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.441 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -140.43 169.67 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.197 -1.178 . . . . 0.0 109.914 -179.833 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.475 ' CD2' ' N ' ' A' ' 69' ' ' LEU . 0.7 OUTLIER -145.11 -165.94 2.29 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.376 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.303 -1.454 0 O-C-N 121.094 -1.004 . . . . 0.0 109.897 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.583 ' CE3' ' HB2' ' A' ' 18' ' ' ARG . 72.6 m95 . . . . . 0 N--CA 1.489 1.486 0 CA-C-O 121.21 0.528 . . . . 0.0 109.658 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.41 ' O ' ' C ' ' A' ' 7' ' ' ASP . 69.2 mt -114.05 151.17 32.89 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.22 -0.925 . . . . 0.0 109.328 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.449 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 7.7 m-20 -44.42 139.23 2.83 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.188 -0.945 . . . . 0.0 109.484 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.48 ' HB2' ' N ' ' A' ' 17' ' ' ARG . 38.3 t -103.65 104.78 44.16 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.302 -0.874 . . . . 0.0 109.639 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.449 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 35.1 Cg_endo -76.87 -35.26 1.96 Allowed 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 122.441 2.094 . . . . 0.0 110.415 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 9' ' ' PRO . . . -43.89 -45.57 7.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.264 -0.897 . . . . 0.0 109.401 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.641 ' CD1' ' CD1' ' A' ' 15' ' ' TRP . 11.5 mt -97.67 -60.63 1.53 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.201 -0.937 . . . . 0.0 109.404 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 154.3 -153.15 24.61 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.07 145.0 21.67 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.71 2.273 . . . . 0.0 110.323 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.94 -24.44 31.19 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.641 ' CD1' ' CD1' ' A' ' 11' ' ' LEU . 5.5 t-105 -98.61 132.64 43.86 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.41 -1.053 . . . . 0.0 109.264 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -111.08 120.48 42.47 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.108 -0.995 . . . . 0.0 109.888 -179.793 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.48 ' N ' ' HB2' ' A' ' 8' ' ' CYS . 1.3 ttp85 -93.35 115.97 28.53 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.346 -0.846 . . . . 0.0 108.891 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.583 ' HB2' ' CE3' ' A' ' 5' ' ' TRP . 12.0 ttt180 -100.15 147.33 25.8 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.291 -0.88 . . . . 0.0 110.28 -179.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.472 ' O ' ' HG3' ' A' ' 19' ' ' GLU . 6.1 pt-20 -125.11 144.16 50.56 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.423 HG21 ' C ' ' A' ' 19' ' ' GLU . 2.5 t . . . . . 0 N--CA 1.489 1.502 0 O-C-N 121.076 -1.015 . . . . 0.0 109.843 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.574 ' HB3' ' CE1' ' A' ' 34' ' ' TYR . 2.2 m-20 . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 8.7 m -131.74 108.59 9.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.249 -0.907 . . . . 0.0 109.656 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.597 ' CD1' ' CG ' ' A' ' 44' ' ' ARG . 6.5 m-85 -105.69 165.2 11.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.232 -0.918 . . . . 0.0 109.345 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.605 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 4.3 m-85 -133.66 140.24 46.95 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.102 -0.999 . . . . 0.0 109.921 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -123.0 128.25 49.94 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.425 -0.797 . . . . 0.0 109.246 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.48 ' HB2' ' HD2' ' A' ' 38' ' ' PRO . 1.7 p -80.17 167.99 29.15 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.301 -0.874 . . . . 0.0 109.42 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.48 ' HD2' ' HB2' ' A' ' 37' ' ' SER . 35.6 Cg_endo -78.37 5.85 5.19 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.647 2.231 . . . . 0.0 110.414 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.9 p -113.21 -24.93 9.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.217 -0.927 . . . . 0.0 109.479 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 123.38 16.18 3.53 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.17 105.35 17.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.148 -1.207 . . . . 0.0 109.254 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.75 105.1 17.59 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.318 -0.864 . . . . 0.0 109.689 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.512 ' CG2' ' HB3' ' A' ' 49' ' ' LEU . 3.2 mt -110.09 151.77 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.307 -0.87 . . . . 0.0 109.092 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.597 ' CG ' ' CD1' ' A' ' 34' ' ' TYR . 7.5 ttp180 -126.85 -0.25 6.65 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.133 -0.979 . . . . 0.0 110.04 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.542 ' CB ' ' HB2' ' A' ' 48' ' ' GLU . 1.1 m -93.73 172.05 8.49 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.142 -0.974 . . . . 0.0 108.525 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.578 ' HB2' ' CD1' ' A' ' 64' ' ' PHE . 22.8 ttpt -91.12 -63.27 1.29 Allowed 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.034 -1.042 . . . . 0.0 110.146 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.9 t -80.8 -10.82 12.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.048 -1.033 . . . . 0.0 109.316 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.542 ' HB2' ' CB ' ' A' ' 45' ' ' SER . 0.1 OUTLIER -77.3 -46.52 22.72 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 178.485 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.579 HD23 ' CG ' ' A' ' 35' ' ' TYR . 2.5 pp -68.84 -25.89 64.88 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 178.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.541 ' CG2' HD12 ' A' ' 59' ' ' LEU . 8.5 m -72.86 -49.28 31.02 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.23 -25.99 49.58 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.4 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 40.9 t80 -65.8 -60.46 2.86 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.54 -0.725 . . . . 0.0 109.288 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.564 ' CD2' ' CZ3' ' A' ' 15' ' ' TRP . 0.5 OUTLIER -58.44 -56.3 23.93 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.194 -0.941 . . . . 0.0 109.3 179.908 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 131.42 -149.44 19.26 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.5 -11.85 17.08 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.556 2.171 . . . . 0.0 110.302 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.21 -19.11 63.18 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.211 -0.93 . . . . 0.0 109.205 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 53.0 m -135.42 146.95 48.79 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.352 -0.842 . . . . 0.0 109.194 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.475 ' HA ' ' CG2' ' A' ' 50' ' ' THR . 0.6 OUTLIER -138.04 152.66 49.06 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.144 -0.972 . . . . 0.0 109.872 -179.754 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.541 HD12 ' CG2' ' A' ' 50' ' ' THR . 4.5 mp -148.47 9.88 0.84 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.266 -0.897 . . . . 0.0 109.541 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.456 ' C ' ' CD2' ' A' ' 61' ' ' LEU . 23.2 m -48.93 -28.05 3.56 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.175 -0.953 . . . . 0.0 109.007 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.579 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 1.3 mm? -111.74 -13.75 13.68 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.437 -0.79 . . . . 0.0 109.164 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.543 ' CD1' ' C ' ' A' ' 62' ' ' PHE . 7.8 t80 -49.37 131.71 20.38 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.401 -0.812 . . . . 0.0 109.517 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.506 ' O ' ' N ' ' A' ' 65' ' ' LYS . 2.3 m-20 -79.72 100.57 7.96 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.223 -0.923 . . . . 0.0 108.811 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.578 ' CD1' ' HB2' ' A' ' 46' ' ' LYS . 1.1 t80 -66.63 61.12 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.405 -0.809 . . . . 0.0 109.519 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.506 ' N ' ' O ' ' A' ' 63' ' ' ASP . 20.0 ttpt 177.22 -38.55 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.464 -0.772 . . . . 0.0 108.963 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -86.8 -47.8 8.76 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.313 -0.867 . . . . 0.0 109.203 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 115.21 23.05 4.66 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.473 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 2.4 pp -140.11 -173.3 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.079 -1.247 . . . . 0.0 109.576 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.505 ' CB ' ' HA ' ' A' ' 62' ' ' PHE . 0.7 OUTLIER -151.43 -166.64 2.57 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.282 -0.886 . . . . 0.0 109.124 -179.874 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.429 ' O ' ' HG ' ' A' ' 61' ' ' LEU . 2.7 t . . . . . 0 N--CA 1.489 1.496 0 O-C-N 121.179 -0.951 . . . . 0.0 109.72 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.576 ' CE2' ' HG3' ' A' ' 18' ' ' ARG . 89.1 m95 . . . . . 0 N--CA 1.489 1.476 0 CA-C-O 121.304 0.573 . . . . 0.0 109.671 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.21 151.18 38.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.238 -0.913 . . . . 0.0 109.394 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -45.04 145.43 1.0 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.336 -0.853 . . . . 0.0 109.33 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.463 ' HB3' ' HB3' ' A' ' 15' ' ' TRP . 26.8 t -105.55 105.56 53.02 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.198 -0.939 . . . . 0.0 109.678 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.492 ' HD2' ' CZ ' ' A' ' 17' ' ' ARG . 35.2 Cg_endo -76.97 -33.57 2.69 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.441 2.094 . . . . 0.0 110.129 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -47.33 -42.23 20.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.226 -0.921 . . . . 0.0 109.329 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.642 ' CD1' ' CD1' ' A' ' 15' ' ' TRP . 8.8 mt -99.98 -62.41 1.24 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.306 -0.871 . . . . 0.0 109.349 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.432 ' O ' ' O ' ' A' ' 8' ' ' CYS . . . 165.5 -153.03 22.82 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.44 150.31 25.01 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.643 2.229 . . . . 0.0 110.361 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.55 -65.85 1.76 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.642 ' CD1' ' CD1' ' A' ' 11' ' ' LEU . 6.4 t-105 -48.98 130.5 18.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.264 -1.139 . . . . 0.0 109.409 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -107.85 118.67 37.35 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.119 -0.988 . . . . 0.0 109.406 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.492 ' CZ ' ' HD2' ' A' ' 9' ' ' PRO . 1.2 ttp85 -93.16 116.76 29.34 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.275 -0.891 . . . . 0.0 109.368 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.576 ' HG3' ' CE2' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -96.99 142.36 29.04 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.341 -0.85 . . . . 0.0 109.437 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.434 ' CG ' ' O ' ' A' ' 19' ' ' GLU . 17.9 pt-20 -127.24 116.68 20.95 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.231 -0.918 . . . . 0.0 109.306 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.443 HG21 ' CE1' ' A' ' 34' ' ' TYR . 82.0 t . . . . . 0 N--CA 1.491 1.578 0 O-C-N 121.166 -0.958 . . . . 0.0 109.683 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.468 ' OD2' ' CZ ' ' A' ' 34' ' ' TYR . 3.0 t70 . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.547 HG21 ' CZ ' ' A' ' 35' ' ' TYR . 70.0 m -110.62 125.4 53.38 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.191 -0.943 . . . . 0.0 109.868 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.572 ' CD1' ' N ' ' A' ' 34' ' ' TYR . 3.7 m-85 -112.9 155.41 24.76 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.29 -0.881 . . . . 0.0 108.888 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.578 ' CG ' HD21 ' A' ' 49' ' ' LEU . 39.4 m-85 -126.03 131.07 52.26 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.019 -1.05 . . . . 0.0 109.905 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -122.42 128.19 50.61 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.465 -0.772 . . . . 0.0 109.151 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.482 ' CB ' ' HD2' ' A' ' 38' ' ' PRO . 0.9 OUTLIER -73.54 173.58 6.02 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.309 -0.869 . . . . 0.0 109.675 -179.73 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.482 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 34.5 Cg_endo -77.35 1.23 8.97 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.668 2.245 . . . . 0.0 110.297 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 p -111.04 -24.13 10.52 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.255 -0.903 . . . . 0.0 109.147 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 125.3 18.29 2.54 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.533 ' HB2' ' CZ ' ' A' ' 52' ' ' TYR . 5.1 t70 -79.64 119.28 22.37 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.086 -1.244 . . . . 0.0 109.35 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.404 ' O ' ' HG2' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -103.4 107.74 18.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.285 -0.884 . . . . 0.0 109.737 -179.717 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.519 ' CG2' ' HB3' ' A' ' 49' ' ' LEU . 3.3 mt -120.33 151.38 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.321 -0.862 . . . . 0.0 109.133 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.591 ' O ' ' CZ ' ' A' ' 64' ' ' PHE . 10.6 ttm180 -126.81 -1.13 6.66 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.087 -1.008 . . . . 0.0 109.884 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.546 ' O ' ' CE1' ' A' ' 64' ' ' PHE . 0.4 OUTLIER -88.84 179.26 6.24 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.073 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.551 ' HA ' ' CE1' ' A' ' 64' ' ' PHE . 28.7 ttpt -97.87 -59.68 1.72 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.977 -1.077 . . . . 0.0 109.657 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.444 ' O ' HG11 ' A' ' 47' ' ' VAL . 99.2 t -84.24 -16.66 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.108 -0.995 . . . . 0.0 108.889 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.54 ' HB2' ' CB ' ' A' ' 45' ' ' SER . 1.9 tt0 -70.05 -45.36 67.28 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.578 HD21 ' CG ' ' A' ' 35' ' ' TYR . 2.0 pp -71.36 -27.12 63.13 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 178.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.534 ' OG1' ' CD1' ' A' ' 59' ' ' LEU . 27.7 m -67.36 -47.08 71.49 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.508 ' NH1' ' HG3' ' A' ' 51' ' ' ARG . 7.2 mmt85 -55.34 -31.33 61.63 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.533 ' CZ ' ' HB2' ' A' ' 41' ' ' ASP . 86.0 t80 -63.71 -51.24 65.89 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.934 -0.706 . . . . 0.0 109.431 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.57 HD21 ' CE3' ' A' ' 15' ' ' TRP . 1.5 mt -59.63 -58.86 6.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.305 -0.872 . . . . 0.0 109.536 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 135.71 -155.27 22.18 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -79.41 -10.17 14.79 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.621 2.214 . . . . 0.0 110.494 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.22 -15.81 56.18 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.228 -0.92 . . . . 0.0 109.711 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 72.7 m -128.45 139.77 52.17 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.254 -0.904 . . . . 0.0 109.39 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.511 ' HA ' ' CG2' ' A' ' 50' ' ' THR . 2.8 p30 -137.02 151.73 49.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.257 -0.902 . . . . 0.0 109.523 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.534 ' CD1' ' OG1' ' A' ' 50' ' ' THR . 6.6 mp -142.53 -0.2 1.24 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.22 -0.925 . . . . 0.0 110.076 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.521 HG21 ' CD2' ' A' ' 61' ' ' LEU . 17.1 m -48.16 -27.44 2.39 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 120.996 -1.065 . . . . 0.0 108.521 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.602 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 1.3 mm? -105.53 -21.08 13.28 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.551 ' CE1' ' HA2' ' A' ' 67' ' ' GLY . 51.2 t80 -55.85 140.62 41.86 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.64 -0.662 . . . . 0.0 109.267 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.519 ' O ' ' N ' ' A' ' 65' ' ' LYS . 4.9 m-20 -88.32 108.64 19.44 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.189 -0.945 . . . . 0.0 109.578 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.591 ' CZ ' ' O ' ' A' ' 44' ' ' ARG . 1.7 t80 -66.62 66.9 0.06 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.288 -0.882 . . . . 0.0 109.214 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 63' ' ' ASP . 1.2 ttpm? 166.92 -36.55 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -88.18 -40.45 13.7 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.413 -0.804 . . . . 0.0 109.46 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.551 ' HA2' ' CE1' ' A' ' 62' ' ' PHE . . . 98.56 25.22 10.16 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 1.6 pp -140.47 160.31 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.201 -1.176 . . . . 0.0 109.812 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.476 ' CA ' ' HA ' ' A' ' 62' ' ' PHE . 0.6 OUTLIER -137.45 -167.57 2.14 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.338 -0.852 . . . . 0.0 108.875 179.481 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 37.7 t . . . . . 0 N--CA 1.489 1.498 0 O-C-N 121.085 -1.01 . . . . 0.0 109.61 179.955 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.571 ' CE3' ' HB2' ' A' ' 18' ' ' ARG . 64.3 m95 . . . . . 0 N--CA 1.489 1.491 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.3 mt -106.06 169.31 8.57 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.13 -0.981 . . . . 0.0 109.855 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.471 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 0.7 OUTLIER -56.85 132.25 51.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.338 -0.851 . . . . 0.0 109.474 -179.853 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.519 ' SG ' ' CZ ' ' A' ' 17' ' ' ARG . 18.9 t -89.02 112.76 52.89 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.224 -0.922 . . . . 0.0 109.398 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 35.9 Cg_endo -77.72 -52.86 0.07 OUTLIER 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.366 2.044 . . . . 0.0 110.822 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 9' ' ' PRO . . . -39.81 -46.77 2.01 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.427 -0.795 . . . . 0.0 110.045 -179.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.604 ' CD1' ' CD1' ' A' ' 15' ' ' TRP . 11.6 mt -94.16 -60.63 1.69 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.169 -0.957 . . . . 0.0 109.467 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.443 ' O ' ' O ' ' A' ' 8' ' ' CYS . . . 148.36 -145.4 13.81 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.04 156.48 30.29 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.608 2.205 . . . . 0.0 110.342 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.99 -57.82 4.31 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.299 -1.521 . . . . 0.0 109.299 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.604 ' CD1' ' CD1' ' A' ' 11' ' ' LEU . 4.8 t-105 -65.49 129.27 39.17 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.298 -1.119 . . . . 0.0 109.526 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.47 123.08 46.84 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.305 -0.872 . . . . 0.0 109.59 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.565 ' NH1' ' CZ ' ' A' ' 62' ' ' PHE . 0.2 OUTLIER -93.48 106.03 18.04 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.273 -0.892 . . . . 0.0 109.365 179.881 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.571 ' HB2' ' CE3' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -100.35 142.68 31.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.239 -0.913 . . . . 0.0 109.524 -179.891 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.53 ' N ' ' HG2' ' A' ' 18' ' ' ARG . 6.1 pt-20 -99.95 159.09 15.35 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.292 -0.88 . . . . 0.0 109.825 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.504 ' HB ' ' CB ' ' A' ' 32' ' ' ASP . 98.9 t . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.325 -0.86 . . . . 0.0 109.038 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.504 ' CB ' ' HB ' ' A' ' 20' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.28 0.562 . . . . 0.0 109.495 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -134.81 116.0 14.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.239 -0.913 . . . . 0.0 109.585 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.492 ' CE1' ' HD3' ' A' ' 44' ' ' ARG . 20.8 m-30 -116.22 140.06 49.71 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.245 -0.91 . . . . 0.0 109.247 179.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.551 ' CE2' ' CE1' ' A' ' 64' ' ' PHE . 4.3 m-85 -112.02 147.05 36.8 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.199 -0.938 . . . . 0.0 109.636 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.445 ' HA ' ' O ' ' A' ' 41' ' ' ASP . 26.1 tt0 -131.24 128.17 39.34 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.334 -0.854 . . . . 0.0 109.342 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.469 ' OG ' ' HB2' ' A' ' 41' ' ' ASP . 0.9 OUTLIER -69.72 173.9 3.64 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.249 -0.907 . . . . 0.0 109.304 179.999 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.468 ' HD2' ' HB3' ' A' ' 37' ' ' SER . 36.3 Cg_endo -78.12 -3.79 13.76 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.597 2.198 . . . . 0.0 110.602 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.463 HG23 ' HB2' ' A' ' 37' ' ' SER . 10.7 t -101.42 -9.78 20.8 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.2 -0.938 . . . . 0.0 109.594 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 111.46 9.68 21.06 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.469 ' HB2' ' OG ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -78.76 141.56 37.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.186 -1.185 . . . . 0.0 109.424 179.889 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.456 ' O ' ' HG2' ' A' ' 42' ' ' ARG . 0.1 OUTLIER -128.37 120.41 26.92 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.154 -0.966 . . . . 0.0 109.703 -179.753 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.546 ' CG2' ' HB3' ' A' ' 49' ' ' LEU . 2.4 mp -126.73 162.23 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.19 -0.944 . . . . 0.0 109.328 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.576 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 29.3 mtt85 -147.35 20.07 1.21 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.217 -0.927 . . . . 0.0 109.756 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.532 ' O ' ' CB ' ' A' ' 46' ' ' LYS . 0.5 OUTLIER -95.06 -86.78 0.29 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.386 -0.821 . . . . 0.0 108.821 179.433 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.551 ' HB2' ' CD1' ' A' ' 64' ' ' PHE . 24.2 ttmt 159.72 -64.96 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 43.7 t -87.25 -19.58 7.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.473 ' HB2' ' HB2' ' A' ' 45' ' ' SER . 16.2 mt-10 -69.89 -41.44 74.73 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.546 ' HB3' ' CG2' ' A' ' 43' ' ' ILE . 3.0 pp -72.39 -33.09 66.94 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.525 ' CG2' ' O ' ' A' ' 57' ' ' CYS . 1.4 m -63.91 -48.62 75.87 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.22 -28.13 57.28 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.482 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 41.6 t80 -72.58 -56.98 4.51 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.624 -0.672 . . . . 0.0 109.353 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.582 HD23 ' CZ3' ' A' ' 15' ' ' TRP . 0.5 OUTLIER -55.03 -57.09 13.13 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.098 -1.001 . . . . 0.0 109.139 179.681 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 134.28 -157.98 23.16 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.1 3.17 7.29 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.559 2.173 . . . . 0.0 110.343 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -84.87 -27.27 26.81 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.228 -0.92 . . . . 0.0 109.465 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.525 ' O ' ' CG2' ' A' ' 50' ' ' THR . 54.3 m -122.33 138.48 54.5 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.303 -0.873 . . . . 0.0 109.245 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.497 ' HA ' HG23 ' A' ' 50' ' ' THR . 29.0 t70 -127.05 142.83 51.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.165 -0.96 . . . . 0.0 109.511 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.525 HD11 ' CD2' ' A' ' 11' ' ' LEU . 3.6 mp -141.3 8.89 2.04 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.191 -0.943 . . . . 0.0 109.803 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.469 ' HB ' HD23 ' A' ' 61' ' ' LEU . 4.0 m -47.43 -42.78 23.02 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.113 -0.992 . . . . 0.0 109.282 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.58 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 1.7 mm? -99.66 -3.08 33.87 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.333 -0.854 . . . . 0.0 109.56 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.569 ' CZ ' ' HA2' ' A' ' 67' ' ' GLY . 83.3 t80 -61.51 139.37 58.25 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.354 -0.841 . . . . 0.0 109.744 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.434 ' O ' ' N ' ' A' ' 65' ' ' LYS . 3.4 m-20 -92.24 104.65 16.99 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.443 -0.786 . . . . 0.0 108.967 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.576 ' CE2' ' O ' ' A' ' 44' ' ' ARG . 0.8 OUTLIER -68.51 65.11 0.11 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.239 -0.913 . . . . 0.0 109.479 -179.526 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 63' ' ' ASP . 1.7 ttpt -178.41 -33.36 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.17 -0.956 . . . . 0.0 109.625 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -107.23 -32.85 7.62 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.264 -0.898 . . . . 0.0 109.704 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.569 ' HA2' ' CZ ' ' A' ' 62' ' ' PHE . . . 97.92 38.63 4.06 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.472 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 1.9 pp -139.88 165.84 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.246 -1.15 . . . . 0.0 109.581 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.505 ' CB ' ' HA ' ' A' ' 62' ' ' PHE . 0.5 OUTLIER -153.79 -176.04 5.65 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.276 -0.89 . . . . 0.0 109.589 179.946 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.459 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.361 -0.837 . . . . 0.0 109.355 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.536 ' CE3' ' HB2' ' A' ' 18' ' ' ARG . 76.7 m95 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.351 0.596 . . . . 0.0 109.45 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.2 mt -107.18 161.32 14.88 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.148 -0.97 . . . . 0.0 109.739 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -53.91 149.28 9.15 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.394 -0.816 . . . . 0.0 109.519 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.466 ' HB2' ' HB2' ' A' ' 17' ' ' ARG . 50.2 t -111.18 103.42 54.89 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.369 -0.832 . . . . 0.0 109.331 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -77.03 -23.85 10.23 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.354 2.036 . . . . 0.0 110.31 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.65 -48.66 66.28 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.189 -0.944 . . . . 0.0 109.173 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.579 ' CD1' ' CD1' ' A' ' 15' ' ' TRP . 0.7 OUTLIER -96.64 -59.86 1.72 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.375 -0.828 . . . . 0.0 109.245 179.882 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 158.82 -153.69 24.81 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.35 154.41 28.17 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.614 2.209 . . . . 0.0 110.596 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.18 -12.32 68.24 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.579 ' CD1' ' CD1' ' A' ' 11' ' ' LEU . 16.5 t-105 -111.7 126.21 54.8 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.175 -1.191 . . . . 0.0 109.52 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 18.3 mmtp -101.27 119.58 38.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.282 -0.887 . . . . 0.0 109.581 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.514 ' HG3' ' CE2' ' A' ' 35' ' ' TYR . 5.8 ttp85 -94.89 114.69 26.57 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.224 -0.922 . . . . 0.0 109.359 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.536 ' HB2' ' CE3' ' A' ' 5' ' ' TRP . 0.2 OUTLIER -100.29 128.47 46.35 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.351 -0.843 . . . . 0.0 109.321 179.997 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -118.24 134.06 55.35 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.263 -0.898 . . . . 0.0 109.248 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 O-C-N 121.246 -0.909 . . . . 0.0 109.474 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 32' ' ' ASP . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.457 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 46.2 m -128.78 108.94 10.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.087 -1.008 . . . . 0.0 110.042 -179.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.535 ' CD1' ' N ' ' A' ' 34' ' ' TYR . 2.7 m-30 -99.66 151.73 20.88 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.333 -0.854 . . . . 0.0 108.922 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.603 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 3.8 m-85 -123.68 148.77 46.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.962 -1.086 . . . . 0.0 109.914 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.525 ' HB2' ' CZ3' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -128.32 119.59 25.39 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.497 -0.752 . . . . 0.0 109.01 179.753 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.417 ' OG ' ' O ' ' A' ' 41' ' ' ASP . 0.6 OUTLIER -63.99 170.32 3.52 Favored Pre-proline 0 N--CA 1.488 1.437 0 O-C-N 121.317 -0.865 . . . . 0.0 109.374 -179.918 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.404 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 35.1 Cg_endo -78.26 -2.58 12.64 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.619 2.213 . . . . 0.0 110.161 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.8 p -102.75 -23.8 13.78 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.269 -0.895 . . . . 0.0 109.645 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 123.81 9.44 5.76 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.452 ' HB2' ' OH ' ' A' ' 52' ' ' TYR . 0.7 OUTLIER -92.07 112.3 24.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.19 -1.182 . . . . 0.0 109.362 179.951 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.418 ' HB3' ' HG3' ' A' ' 36' ' ' GLN . 0.0 OUTLIER -99.43 122.36 42.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.343 -0.848 . . . . 0.0 109.808 -179.738 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.458 HG22 ' HB3' ' A' ' 49' ' ' LEU . 2.7 mp -117.68 154.04 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.346 -0.846 . . . . 0.0 109.169 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.583 ' O ' ' CZ ' ' A' ' 64' ' ' PHE . 5.6 ttp180 -123.46 -0.21 8.75 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.001 -1.062 . . . . 0.0 109.956 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.526 ' CB ' ' HB2' ' A' ' 48' ' ' GLU . 0.4 OUTLIER -96.61 154.54 17.22 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.231 -0.918 . . . . 0.0 108.558 179.228 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.558 ' HB2' ' CD1' ' A' ' 64' ' ' PHE . 17.4 ttpt -72.85 -67.36 0.57 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.069 -1.019 . . . . 0.0 110.402 -178.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.483 ' O ' ' CG ' ' A' ' 51' ' ' ARG . 53.5 t -72.1 -25.69 24.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 120.862 -1.149 . . . . 0.0 109.956 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.526 ' HB2' ' CB ' ' A' ' 45' ' ' SER . 6.9 tt0 -62.72 -49.03 76.68 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.759 -1.213 . . . . 0.0 108.278 179.021 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.481 HD23 ' O ' ' A' ' 45' ' ' SER . 1.8 pp -70.26 -23.85 62.96 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.564 ' OG1' ' CB ' ' A' ' 59' ' ' LEU . 33.0 m -65.5 -68.55 0.36 Allowed 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.484 ' HG3' ' O ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -42.9 -31.56 0.52 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 179.269 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.473 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 51.4 t80 -55.09 -56.88 14.81 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.326 -0.859 . . . . 0.0 108.74 179.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.556 HD21 ' CE3' ' A' ' 15' ' ' TRP . 0.3 OUTLIER -65.07 -43.14 93.17 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.214 -0.929 . . . . 0.0 109.16 179.379 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 110.26 -152.7 17.28 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.284 -1.527 . . . . 0.0 109.284 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.43 -10.92 15.99 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.545 2.163 . . . . 0.0 110.205 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.1 -32.15 66.73 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.296 -0.878 . . . . 0.0 109.371 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.496 ' HB2' ' CB ' ' A' ' 53' ' ' LEU . 4.0 m -121.86 97.84 5.68 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 0.0 109.251 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -74.99 137.42 41.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.255 -0.903 . . . . 0.0 109.731 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.565 HD23 ' CG ' ' A' ' 62' ' ' PHE . 0.1 OUTLIER -142.21 7.91 1.8 Allowed 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.37 -0.831 . . . . 0.0 109.54 -179.731 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.428 ' C ' HD21 ' A' ' 61' ' ' LEU . 97.9 m -56.69 -28.39 60.73 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.348 -0.845 . . . . 0.0 109.645 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.599 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 2.4 mm? -107.33 -10.47 15.78 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.261 -0.899 . . . . 0.0 109.485 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.572 ' CE1' ' OH ' ' A' ' 35' ' ' TYR . 38.5 t80 -45.27 128.83 7.9 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.361 -0.837 . . . . 0.0 109.53 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.495 ' O ' ' N ' ' A' ' 65' ' ' LYS . 11.1 m-20 -79.67 100.99 8.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.326 -0.859 . . . . 0.0 109.194 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.583 ' CZ ' ' O ' ' A' ' 44' ' ' ARG . 0.7 OUTLIER -65.55 72.95 0.06 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.374 -0.829 . . . . 0.0 109.333 -179.672 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.495 ' N ' ' O ' ' A' ' 63' ' ' ASP . 0.6 OUTLIER 166.5 -43.6 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.824 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.422 ' HG3' ' HD3' ' A' ' 65' ' ' LYS . 3.8 mt-30 -86.33 -44.67 11.9 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.373 -0.829 . . . . 0.0 109.305 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.413 ' HA2' ' CZ ' ' A' ' 62' ' ' PHE . . . 108.77 25.18 5.78 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.891 -1.283 . . . . 0.0 109.891 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.45 HG13 ' OD2' ' A' ' 63' ' ' ASP . 1.1 pt -140.23 162.58 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.199 -1.177 . . . . 0.0 109.48 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 69' ' ' LEU . 1.7 pt? -133.0 146.38 51.72 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.125 -0.984 . . . . 0.0 109.472 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 40.7 m . . . . . 0 C--N 1.301 -1.504 0 O-C-N 121.325 -0.859 . . . . 0.0 108.824 179.427 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 73.3 m95 . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.245 0.545 . . . . 0.0 109.773 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.417 ' O ' ' C ' ' A' ' 7' ' ' ASP . 0.4 OUTLIER -130.92 147.97 52.63 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.29 -0.881 . . . . 0.0 109.487 179.839 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.465 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 48.4 t0 -44.02 138.07 3.03 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.348 -0.845 . . . . 0.0 109.104 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.47 ' HB2' ' HB2' ' A' ' 17' ' ' ARG . 32.6 t -102.77 105.67 46.02 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.198 -0.939 . . . . 0.0 109.505 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 34.4 Cg_endo -77.33 -27.49 6.46 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.297 1.998 . . . . 0.0 109.991 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.449 ' O ' HD23 ' A' ' 69' ' ' LEU . . . -45.5 -57.95 3.74 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.347 -0.846 . . . . 0.0 109.41 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.444 HD23 ' HB3' ' A' ' 10' ' ' ALA . 0.9 OUTLIER -89.34 -58.44 2.53 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.321 -0.862 . . . . 0.0 109.327 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 159.02 -152.88 23.99 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.84 164.1 28.06 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.557 2.172 . . . . 0.0 110.351 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.463 ' O ' ' HD3' ' A' ' 38' ' ' PRO . . . 75.49 8.81 84.36 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.582 ' CZ2' HD12 ' A' ' 49' ' ' LEU . 9.2 t-105 -130.6 126.08 35.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.171 -1.194 . . . . 0.0 109.46 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 12.5 mmtt -106.4 120.32 41.57 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.225 -0.922 . . . . 0.0 109.579 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.47 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 1.4 ttp85 -88.38 115.86 26.19 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.474 -0.766 . . . . 0.0 109.325 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.41 ' HD2' ' CG2' ' A' ' 20' ' ' VAL . 3.8 ttm180 -99.53 131.14 45.73 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.173 -0.955 . . . . 0.0 109.371 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.5 ' CG ' ' O ' ' A' ' 19' ' ' GLU . 1.7 pp20? -116.39 117.38 29.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.209 -0.932 . . . . 0.0 109.352 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.498 HG23 ' CE1' ' A' ' 34' ' ' TYR . 8.5 t . . . . . 0 C--N 1.303 -1.423 0 O-C-N 121.229 -0.92 . . . . 0.0 109.172 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.402 HG21 ' CZ ' ' A' ' 35' ' ' TYR . 42.0 m -127.49 111.51 13.89 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.122 -0.987 . . . . 0.0 109.953 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.498 ' CE1' HG23 ' A' ' 20' ' ' VAL . 19.8 m-85 -99.76 152.98 19.48 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.295 -0.878 . . . . 0.0 108.806 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.622 ' CE1' ' CE1' ' A' ' 64' ' ' PHE . 7.5 m-85 -124.5 142.74 51.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.983 -1.073 . . . . 0.0 109.934 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -126.63 138.98 53.5 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.375 -0.828 . . . . 0.0 109.402 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.458 ' OG ' HG21 ' A' ' 39' ' ' THR . 0.9 OUTLIER -77.89 172.52 9.59 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.287 -0.883 . . . . 0.0 109.506 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 14' ' ' GLY . 35.0 Cg_endo -79.29 13.4 2.04 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.77 2.313 . . . . 0.0 110.98 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.458 HG21 ' OG ' ' A' ' 37' ' ' SER . 14.6 t -123.34 -21.62 5.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.981 -1.074 . . . . 0.0 109.852 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . 0.413 ' N ' HG21 ' A' ' 39' ' ' THR . . . 127.27 8.23 4.59 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.457 ' OD2' ' OH ' ' A' ' 52' ' ' TYR . 6.0 m-20 -88.86 133.3 34.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.083 -1.245 . . . . 0.0 109.324 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.406 ' O ' ' HG2' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -116.37 137.06 52.46 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.263 -0.898 . . . . 0.0 109.432 -179.734 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.536 HD12 ' CG ' ' A' ' 52' ' ' TYR . 4.5 mt -132.7 156.21 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.264 -0.897 . . . . 0.0 109.922 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.592 ' O ' ' CZ ' ' A' ' 64' ' ' PHE . 13.3 ttp180 -123.5 -45.72 2.06 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.581 -0.699 . . . . 0.0 110.067 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.546 ' HB2' ' CB ' ' A' ' 48' ' ' GLU . 0.6 OUTLIER -59.28 122.7 14.54 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.915 -1.115 . . . . 0.0 108.831 -179.965 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.57 ' HA ' ' CE1' ' A' ' 64' ' ' PHE . 4.9 ttpm? -40.34 -83.17 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.543 -0.723 . . . . 0.0 110.724 -179.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.484 ' HA ' ' OG1' ' A' ' 50' ' ' THR . 42.7 t -55.64 -30.4 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.205 -0.935 . . . . 0.0 110.641 -178.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.546 ' CB ' ' HB2' ' A' ' 45' ' ' SER . 14.2 tt0 -54.8 -45.88 74.4 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.663 -1.273 . . . . 0.0 108.813 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.582 HD12 ' CZ2' ' A' ' 15' ' ' TRP . 1.4 pp -69.83 -20.67 63.42 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.038 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.545 ' CG2' ' HA ' ' A' ' 58' ' ' ASP . 17.0 m -71.95 -67.21 0.55 Allowed 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.464 ' HG3' ' O ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -44.58 -26.96 0.42 Allowed 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.795 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.536 ' CG ' HD12 ' A' ' 43' ' ' ILE . 76.5 t80 -67.75 -64.68 0.81 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.455 -0.778 . . . . 0.0 109.191 179.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.523 ' CD2' ' CE3' ' A' ' 15' ' ' TRP . 1.3 mt -44.5 -57.27 3.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.189 -0.945 . . . . 0.0 109.04 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 141.01 -162.16 26.75 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.95 -16.17 14.45 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.648 2.232 . . . . 0.0 110.218 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.29 -8.19 56.54 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.307 -0.871 . . . . 0.0 109.585 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 39.8 m -124.98 168.17 13.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.242 -0.911 . . . . 0.0 109.553 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.545 ' HA ' ' CG2' ' A' ' 50' ' ' THR . 9.3 p-10 -165.46 141.95 5.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.273 -0.892 . . . . 0.0 109.44 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.505 HD13 ' CG2' ' A' ' 50' ' ' THR . 6.7 mp -139.43 1.28 1.95 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.097 -1.002 . . . . 0.0 109.955 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 67.5 m -47.25 -31.28 3.62 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.044 -1.035 . . . . 0.0 108.876 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.622 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 2.7 mm? -103.43 -15.95 15.74 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.54 ' CZ ' ' HA2' ' A' ' 67' ' ' GLY . 64.9 t80 -57.61 132.87 54.53 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.551 -0.718 . . . . 0.0 109.702 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.497 ' O ' ' N ' ' A' ' 65' ' ' LYS . 1.1 m-20 -79.71 104.79 10.54 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.331 -0.856 . . . . 0.0 108.915 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.622 ' CE1' ' CE1' ' A' ' 35' ' ' TYR . 0.4 OUTLIER -67.74 63.81 0.08 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.183 -0.948 . . . . 0.0 109.424 -179.584 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.497 ' N ' ' O ' ' A' ' 63' ' ' ASP . 1.4 ttmm 173.61 -32.62 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -94.01 -46.45 7.14 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.374 -0.829 . . . . 0.0 109.012 179.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.54 ' HA2' ' CZ ' ' A' ' 62' ' ' PHE . . . 108.45 28.54 4.55 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 1.3 pp -140.74 159.13 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.017 -1.284 . . . . 0.0 109.909 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.493 HD22 ' N ' ' A' ' 69' ' ' LEU . 1.1 pt? -141.54 -176.09 4.61 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.037 -1.04 . . . . 0.0 109.828 179.794 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.567 ' CZ3' ' HB2' ' A' ' 36' ' ' GLN . 65.3 m95 . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.0 mt -103.86 176.48 5.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.37 -0.831 . . . . 0.0 109.644 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 7' ' ' ASP . 6.6 p-10 -62.17 137.27 58.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.391 -0.818 . . . . 0.0 109.422 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.528 ' SG ' ' CZ ' ' A' ' 17' ' ' ARG . 13.4 t -95.5 109.99 48.48 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.259 -0.901 . . . . 0.0 109.231 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.48 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 36.2 Cg_endo -79.45 -46.7 0.1 OUTLIER 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.446 2.097 . . . . 0.0 110.795 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 9' ' ' PRO . . . -43.21 -44.03 5.02 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.162 -0.962 . . . . 0.0 109.935 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.57 HD11 ' CD1' ' A' ' 15' ' ' TRP . 10.7 mt -97.23 -61.53 1.39 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.203 -0.936 . . . . 0.0 109.777 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 8' ' ' CYS . . . 155.74 -155.02 25.97 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.95 158.63 30.92 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.582 2.188 . . . . 0.0 110.335 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.4 -43.01 3.09 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.571 ' CE3' HD22 ' A' ' 53' ' ' LEU . 15.9 t-105 -79.35 130.66 35.65 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.221 -1.164 . . . . 0.0 109.424 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.3 mmtm -97.97 124.04 42.25 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.256 -0.903 . . . . 0.0 109.235 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.528 ' CZ ' ' SG ' ' A' ' 8' ' ' CYS . 0.7 OUTLIER -99.63 108.92 21.42 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.256 -0.902 . . . . 0.0 109.318 -179.944 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.447 ' O ' HG22 ' A' ' 33' ' ' THR . 0.2 OUTLIER -99.85 137.78 37.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.175 -0.953 . . . . 0.0 109.744 -179.779 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -123.83 152.93 41.74 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.37 -0.831 . . . . 0.0 109.272 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.439 HG22 ' O ' ' A' ' 32' ' ' ASP . 1.9 t . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.22 -0.925 . . . . 0.0 109.467 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.581 ' HB3' ' CZ ' ' A' ' 34' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.447 HG22 ' O ' ' A' ' 18' ' ' ARG . 2.7 m -139.79 123.61 17.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.184 -0.948 . . . . 0.0 109.546 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.581 ' CZ ' ' HB3' ' A' ' 32' ' ' ASP . 0.7 OUTLIER -120.63 163.06 18.61 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.258 -0.901 . . . . 0.0 109.474 179.911 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.525 ' HB3' ' NE1' ' A' ' 15' ' ' TRP . 8.8 m-85 -130.45 156.99 43.83 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.182 -0.949 . . . . 0.0 109.834 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.567 ' HB2' ' CZ3' ' A' ' 5' ' ' TRP . 12.4 tt0 -139.18 114.33 9.55 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.398 -0.814 . . . . 0.0 109.001 179.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.488 ' OG ' ' CZ3' ' A' ' 15' ' ' TRP . 0.8 OUTLIER -63.2 163.05 19.53 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.291 -0.88 . . . . 0.0 109.615 -179.686 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.58 3.08 7.15 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.625 2.217 . . . . 0.0 110.241 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.8 t -103.56 -16.77 15.43 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.334 -0.854 . . . . 0.0 109.233 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.0 14.8 8.96 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.513 ' OD2' ' CE1' ' A' ' 52' ' ' TYR . 0.8 OUTLIER -95.39 115.93 28.1 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.221 -1.164 . . . . 0.0 109.504 179.947 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.42 ' O ' ' HG2' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -99.51 121.35 41.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.184 -0.948 . . . . 0.0 109.541 179.961 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.49 ' CG2' ' HB3' ' A' ' 49' ' ' LEU . 2.7 mp -126.36 156.53 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.337 -0.852 . . . . 0.0 109.207 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.584 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 2.2 ttm180 -133.37 -8.68 2.92 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.088 -1.007 . . . . 0.0 110.773 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.569 ' CB ' ' HB2' ' A' ' 48' ' ' GLU . 0.4 OUTLIER -79.71 -178.27 6.3 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.73 -1.231 . . . . 0.0 108.391 179.296 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.549 ' HA ' ' CE1' ' A' ' 64' ' ' PHE . 29.4 ttpt -102.15 -57.32 2.09 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.988 -1.07 . . . . 0.0 109.845 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 57.4 t -84.57 -14.8 11.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.12 -0.988 . . . . 0.0 109.387 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.569 ' HB2' ' CB ' ' A' ' 45' ' ' SER . 1.9 mt-10 -74.7 -42.21 58.78 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.066 -1.021 . . . . 0.0 108.389 179.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.563 HD12 ' CZ2' ' A' ' 15' ' ' TRP . 1.5 pp -70.96 -29.13 65.05 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.023 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.53 ' OG1' ' CD1' ' A' ' 59' ' ' LEU . 0.4 OUTLIER -71.86 -43.8 64.87 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.301 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.416 ' N ' HG21 ' A' ' 50' ' ' THR . 0.3 OUTLIER -61.24 -21.81 64.22 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.993 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.513 ' CE1' ' OD2' ' A' ' 41' ' ' ASP . 90.2 t80 -75.81 -60.21 2.42 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.558 -0.714 . . . . 0.0 109.448 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.571 HD22 ' CE3' ' A' ' 15' ' ' TRP . 1.0 OUTLIER -56.02 -46.28 78.87 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.155 -0.965 . . . . 0.0 109.254 179.726 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 128.63 -151.34 18.92 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -79.08 -24.31 6.94 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.638 2.225 . . . . 0.0 110.504 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.7 -20.47 66.34 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.269 -0.894 . . . . 0.0 109.854 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 49.3 m -133.52 103.48 5.94 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.179 -0.95 . . . . 0.0 109.687 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.49 150.82 24.25 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.226 -0.921 . . . . 0.0 109.044 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.537 HD21 ' CD2' ' A' ' 62' ' ' PHE . 0.6 OUTLIER -134.42 9.11 3.69 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.236 -0.915 . . . . 0.0 109.466 -179.876 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.416 ' HB ' HD21 ' A' ' 61' ' ' LEU . 2.5 m -47.76 -46.8 30.51 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.326 -0.858 . . . . 0.0 109.303 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.585 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 3.5 mm? -99.26 -2.15 37.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.353 -0.842 . . . . 0.0 109.528 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.537 ' CD2' HD21 ' A' ' 59' ' ' LEU . 69.2 t80 -60.1 129.04 39.81 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.264 -0.898 . . . . 0.0 109.488 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.503 ' O ' ' N ' ' A' ' 65' ' ' LYS . 3.2 m-20 -79.3 101.05 7.84 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.242 -0.911 . . . . 0.0 108.931 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.584 ' CE2' ' O ' ' A' ' 44' ' ' ARG . 0.9 OUTLIER -67.32 61.21 0.06 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.35 -0.844 . . . . 0.0 109.435 -179.494 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.503 ' N ' ' O ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -174.08 -38.54 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.312 -0.868 . . . . 0.0 109.449 -179.819 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -100.37 -39.87 7.77 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.288 -0.882 . . . . 0.0 109.511 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.438 ' HA2' ' CE1' ' A' ' 62' ' ' PHE . . . 107.22 35.96 2.6 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.0 pp -140.64 163.73 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.129 -1.218 . . . . 0.0 109.726 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.471 ' HB3' ' HA ' ' A' ' 62' ' ' PHE . 0.7 OUTLIER -145.59 173.66 11.86 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.271 -0.893 . . . . 0.0 109.032 179.76 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.462 ' O ' ' HG ' ' A' ' 61' ' ' LEU . 1.6 p . . . . . 0 N--CA 1.489 1.513 0 O-C-N 121.184 -0.948 . . . . 0.0 109.362 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 67.7 m95 . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.425 ' O ' ' C ' ' A' ' 7' ' ' ASP . 89.9 mt -113.62 145.9 40.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.24 -0.912 . . . . 0.0 109.284 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.483 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 12.5 t0 -43.21 129.07 4.76 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.183 -0.948 . . . . 0.0 109.469 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.462 ' SG ' ' HD2' ' A' ' 17' ' ' ARG . 14.8 t -80.36 113.25 37.64 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.408 -0.808 . . . . 0.0 109.505 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.483 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 36.5 Cg_endo -80.14 -53.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.353 2.036 . . . . 0.0 110.461 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.52 ' CB ' ' CE1' ' A' ' 62' ' ' PHE . . . -42.66 -33.4 0.71 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.38 -0.825 . . . . 0.0 109.867 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.639 ' CD1' ' CD1' ' A' ' 15' ' ' TRP . 16.8 mt -105.89 -63.78 1.22 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.189 -0.944 . . . . 0.0 109.299 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 146.8 -151.5 23.77 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.66 155.04 31.18 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.639 2.226 . . . . 0.0 110.26 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.438 ' O ' ' HD3' ' A' ' 38' ' ' PRO . . . 90.57 -33.55 4.54 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.639 ' CD1' ' CD1' ' A' ' 11' ' ' LEU . 13.7 t-105 -94.91 122.85 37.97 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.394 -1.062 . . . . 0.0 108.958 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.6 121.52 39.6 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.142 -0.973 . . . . 0.0 109.172 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.598 ' CG ' ' CE1' ' A' ' 35' ' ' TYR . 0.2 OUTLIER -90.56 104.91 17.44 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.365 -0.834 . . . . 0.0 109.772 -179.774 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.473 ' O ' HG23 ' A' ' 33' ' ' THR . 0.7 OUTLIER -97.55 143.34 28.34 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.397 -0.815 . . . . 0.0 109.028 179.584 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -137.35 141.97 41.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.014 -1.054 . . . . 0.0 109.92 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.2 t . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.348 -0.845 . . . . 0.0 109.24 179.677 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.551 ' HB3' ' CE1' ' A' ' 34' ' ' TYR . 60.9 m-20 . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.579 ' CG2' ' CE1' ' A' ' 35' ' ' TYR . 6.1 m -113.35 138.29 50.27 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.23 -0.919 . . . . 0.0 109.385 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.551 ' CE1' ' HB3' ' A' ' 32' ' ' ASP . 13.1 m-85 -131.13 151.18 51.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.235 -0.916 . . . . 0.0 109.393 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.682 ' CZ ' ' CE1' ' A' ' 64' ' ' PHE . 14.7 m-85 -122.17 133.93 54.73 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.291 -0.881 . . . . 0.0 109.224 179.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.443 ' HG3' ' HG3' ' A' ' 42' ' ' ARG . 39.6 tt0 -115.85 124.73 51.39 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.215 -0.928 . . . . 0.0 109.606 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.521 ' CB ' ' HD2' ' A' ' 38' ' ' PRO . 0.1 OUTLIER -75.48 175.66 3.91 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.234 -0.916 . . . . 0.0 109.368 179.888 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.521 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 35.2 Cg_endo -77.63 -4.75 14.89 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.64 2.227 . . . . 0.0 110.55 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.1 t -101.85 -0.43 34.13 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.212 -0.93 . . . . 0.0 109.536 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 94.99 19.6 30.64 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.435 ' CB ' ' OG ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -84.77 118.02 24.19 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.291 -1.123 . . . . 0.0 109.335 -179.996 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.443 ' HG3' ' HG3' ' A' ' 36' ' ' GLN . 0.0 OUTLIER -105.58 107.08 17.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.362 -0.836 . . . . 0.0 109.535 -179.839 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.518 ' CG2' ' HB3' ' A' ' 49' ' ' LEU . 1.8 mp -120.5 153.53 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.289 -0.882 . . . . 0.0 109.448 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.586 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 13.6 ptt180 -122.11 -26.16 4.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.135 -0.978 . . . . 0.0 109.466 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.502 ' CB ' ' HB2' ' A' ' 48' ' ' GLU . 0.3 OUTLIER -83.2 139.9 32.87 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.217 -0.927 . . . . 0.0 109.022 179.751 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.48 ' O ' ' HB ' ' A' ' 50' ' ' THR . 9.0 pttt -66.91 -52.01 48.32 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.304 -0.872 . . . . 0.0 110.932 -178.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.456 ' O ' HG23 ' A' ' 50' ' ' THR . 48.4 t -74.92 -23.25 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.818 -1.176 . . . . 0.0 109.958 -179.17 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.502 ' HB2' ' CB ' ' A' ' 45' ' ' SER . 28.8 mt-10 -65.28 -50.49 65.55 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.895 -1.128 . . . . 0.0 108.297 179.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.528 ' O ' ' CD1' ' A' ' 53' ' ' LEU . 3.7 pp -72.58 -35.81 68.03 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.51 ' N ' HD13 ' A' ' 49' ' ' LEU . 0.5 OUTLIER -59.29 -39.66 83.68 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.025 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.1 mmt180 -69.38 -25.11 64.0 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.474 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 5.6 t80 -71.32 -57.66 4.26 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.658 -0.651 . . . . 0.0 109.326 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.638 ' CD2' ' CZ3' ' A' ' 15' ' ' TRP . 0.2 OUTLIER -65.95 -40.21 91.12 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.094 -1.004 . . . . 0.0 109.248 179.724 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 122.44 -153.86 16.89 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.422 ' O ' ' C ' ' A' ' 56' ' ' ALA . 34.8 Cg_endo -77.57 -36.23 1.3 Allowed 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.534 2.156 . . . . 0.0 110.331 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 55' ' ' PRO . . . -44.86 -39.86 5.73 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.213 -0.93 . . . . 0.0 109.227 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.43 ' O ' ' OG1' ' A' ' 50' ' ' THR . 1.3 m -114.48 84.0 1.98 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.32 -0.862 . . . . 0.0 109.05 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.445 ' O ' HD13 ' A' ' 59' ' ' LEU . 19.8 m-20 -77.86 163.97 25.58 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.224 -0.922 . . . . 0.0 109.883 -179.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.577 HD22 ' CD2' ' A' ' 62' ' ' PHE . 0.5 OUTLIER -160.01 23.23 0.17 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.444 -0.785 . . . . 0.0 109.27 179.964 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.454 ' HB ' HD22 ' A' ' 61' ' ' LEU . 3.6 m -55.35 -48.2 74.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.331 -0.856 . . . . 0.0 109.95 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.535 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 2.2 mm? -103.98 4.07 34.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.28 -0.887 . . . . 0.0 109.95 -179.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.577 ' CD2' HD22 ' A' ' 59' ' ' LEU . 54.3 t80 -63.64 136.75 57.73 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.205 -0.934 . . . . 0.0 109.909 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.98 114.95 27.25 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.501 -0.749 . . . . 0.0 108.995 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.682 ' CE1' ' CZ ' ' A' ' 35' ' ' TYR . 0.3 OUTLIER -74.58 62.27 1.02 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.222 -0.924 . . . . 0.0 109.797 -179.458 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.45 ' HB3' ' O ' ' A' ' 64' ' ' PHE . 17.5 pttt 178.91 -38.41 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.273 -0.892 . . . . 0.0 109.178 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.402 ' N ' ' CG ' ' A' ' 65' ' ' LYS . 0.4 OUTLIER -94.23 -18.46 21.67 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.285 -0.884 . . . . 0.0 108.991 179.407 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.58 ' CA ' ' CZ ' ' A' ' 17' ' ' ARG . . . 73.32 43.08 39.83 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.507 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 1.4 pp -140.48 -167.47 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.152 -1.205 . . . . 0.0 109.511 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.543 ' HB3' ' HA ' ' A' ' 62' ' ' PHE . 0.6 OUTLIER 179.95 178.47 0.59 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.799 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.494 0 O-C-N 121.007 -1.058 . . . . 0.0 109.909 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.583 ' CE3' ' HB2' ' A' ' 18' ' ' ARG . 48.4 m95 . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 28.6 mt -103.0 152.52 21.23 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.153 -0.967 . . . . 0.0 109.484 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.47 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 37.1 m-20 -47.43 129.57 13.19 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.211 -0.931 . . . . 0.0 109.133 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.519 ' CB ' ' HB2' ' A' ' 17' ' ' ARG . 54.1 t -79.9 114.05 43.06 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.302 -0.874 . . . . 0.0 109.653 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.47 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 36.4 Cg_endo -78.64 -46.1 0.12 Allowed 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.292 1.995 . . . . 0.0 110.195 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.575 ' CB ' ' CE1' ' A' ' 62' ' ' PHE . . . -46.57 -29.83 1.99 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.307 -0.871 . . . . 0.0 109.644 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.582 HD12 ' CD1' ' A' ' 15' ' ' TRP . 10.2 mt -115.54 -61.76 1.69 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.082 -1.011 . . . . 0.0 110.004 -179.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.47 ' O ' ' O ' ' A' ' 8' ' ' CYS . . . 158.79 -152.14 23.19 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.509 ' O ' ' N ' ' A' ' 15' ' ' TRP . 35.1 Cg_endo -77.79 179.32 6.62 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.633 2.222 . . . . 0.0 110.352 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.425 ' O ' ' HD3' ' A' ' 16' ' ' LYS . . . 67.2 -63.95 0.23 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 108.951 -1.66 . . . . 0.0 108.951 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.582 ' CD1' HD12 ' A' ' 11' ' ' LEU . 6.2 t-105 -53.09 126.95 22.41 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.385 -1.068 . . . . 0.0 109.089 179.356 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.425 ' HD3' ' O ' ' A' ' 14' ' ' GLY . 0.3 OUTLIER -100.33 114.71 28.42 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.061 -1.024 . . . . 0.0 109.761 -179.579 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.568 ' HG3' ' CE1' ' A' ' 35' ' ' TYR . 8.7 ttt-85 -95.93 102.99 14.85 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.361 -0.837 . . . . 0.0 109.174 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.583 ' HB2' ' CE3' ' A' ' 5' ' ' TRP . 8.4 ttt180 -99.94 151.41 21.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.154 -0.966 . . . . 0.0 109.973 -179.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -126.16 138.46 53.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.393 -0.817 . . . . 0.0 109.316 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.4 t . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.242 -0.912 . . . . 0.0 109.359 -179.999 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.549 ' HB3' ' CZ ' ' A' ' 34' ' ' TYR . 7.8 m-20 . . . . . 0 N--CA 1.488 1.467 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.476 HG21 ' NH2' ' A' ' 17' ' ' ARG . 18.5 m -101.87 137.02 40.71 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.138 -0.976 . . . . 0.0 110.061 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.549 ' CZ ' ' HB3' ' A' ' 32' ' ' ASP . 46.5 m-85 -129.13 148.49 51.07 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.568 ' CE1' ' HG3' ' A' ' 17' ' ' ARG . 38.6 m-85 -110.81 137.64 48.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.079 -1.013 . . . . 0.0 109.897 -179.577 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.528 ' HB2' ' CZ3' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -116.38 116.86 28.49 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.273 -0.892 . . . . 0.0 109.257 179.536 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.464 ' CB ' ' HD2' ' A' ' 38' ' ' PRO . 0.6 OUTLIER -58.12 173.65 0.38 Allowed Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.303 -0.873 . . . . 0.0 109.309 -179.971 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.464 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 35.7 Cg_endo -78.72 0.67 9.77 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.621 2.214 . . . . 0.0 110.382 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.404 HG21 ' HB3' ' A' ' 37' ' ' SER . 5.5 t -111.88 -22.9 10.86 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.295 -0.878 . . . . 0.0 109.417 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.8 -2.37 5.22 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.417 ' CB ' ' HB2' ' A' ' 37' ' ' SER . 0.2 OUTLIER -65.31 171.09 4.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.188 -1.184 . . . . 0.0 109.427 179.952 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.456 ' HA ' ' O ' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -154.67 108.31 2.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.26 -0.9 . . . . 0.0 109.277 -179.962 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.48 HG22 ' CA ' ' A' ' 49' ' ' LEU . 2.4 mp -107.49 163.36 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.279 -0.888 . . . . 0.0 109.623 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.567 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 7.7 ttp180 -130.59 -32.51 1.71 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.316 -0.865 . . . . 0.0 109.851 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.572 ' CB ' ' HB2' ' A' ' 48' ' ' GLU . 0.6 OUTLIER -68.13 151.75 46.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.056 -1.027 . . . . 0.0 108.877 179.825 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.473 ' HA ' HD23 ' A' ' 49' ' ' LEU . 7.5 ttpm? -70.59 -68.78 0.4 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.272 -0.893 . . . . 0.0 111.185 -178.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.466 ' O ' ' CG ' ' A' ' 51' ' ' ARG . 54.5 t -71.9 -18.6 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.052 -1.03 . . . . 0.0 110.705 -178.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.572 ' HB2' ' CB ' ' A' ' 45' ' ' SER . 5.5 mt-10 -72.12 -42.74 65.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.656 -1.278 . . . . 0.0 108.745 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.484 ' O ' ' CD1' ' A' ' 53' ' ' LEU . 1.6 pp -69.42 -25.83 64.31 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 178.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.544 ' CG2' HD12 ' A' ' 59' ' ' LEU . 20.6 m -70.44 -62.7 1.29 Allowed 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.486 ' HG3' ' O ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -51.0 -22.56 2.36 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.477 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.479 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 59.2 t80 -64.03 -56.25 16.36 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.39 -0.819 . . . . 0.0 108.92 179.351 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.578 HD22 ' CE3' ' A' ' 15' ' ' TRP . 0.7 OUTLIER -61.87 -49.27 76.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.197 -0.94 . . . . 0.0 109.221 179.704 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 130.91 -156.03 21.53 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.79 3.42 6.95 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.536 2.157 . . . . 0.0 110.231 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -87.83 -12.89 43.62 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.384 -0.823 . . . . 0.0 109.325 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.46 ' O ' ' CG2' ' A' ' 50' ' ' THR . 52.9 m -139.02 131.68 28.95 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.233 -0.917 . . . . 0.0 109.703 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.48 ' HA ' HG23 ' A' ' 50' ' ' THR . 12.4 t70 -124.27 155.11 39.19 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.274 -0.891 . . . . 0.0 109.472 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.544 HD12 ' CG2' ' A' ' 50' ' ' THR . 5.5 mp -148.49 15.06 0.99 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.191 -0.943 . . . . 0.0 109.61 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.472 ' C ' ' CD2' ' A' ' 61' ' ' LEU . 12.7 m -46.01 -37.54 6.74 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.22 -0.925 . . . . 0.0 109.484 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.583 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 1.4 mm? -112.72 11.1 19.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.22 -0.925 . . . . 0.0 109.744 -179.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.575 ' CE1' ' CB ' ' A' ' 10' ' ' ALA . 51.5 t80 -69.3 151.05 46.7 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.329 -0.857 . . . . 0.0 110.317 -179.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -107.08 106.42 16.91 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.567 ' CE2' ' O ' ' A' ' 44' ' ' ARG . 0.2 OUTLIER -71.09 60.76 0.27 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.182 -0.949 . . . . 0.0 109.577 -179.224 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 15.5 ttpt -177.28 -35.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.196 -0.94 . . . . 0.0 109.585 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -101.08 -30.83 11.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.216 -0.928 . . . . 0.0 109.529 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.18 39.72 5.65 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.424 ' O ' ' CD1' ' A' ' 62' ' ' PHE . 2.2 pp -140.11 -178.64 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.168 -1.195 . . . . 0.0 109.967 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.5 ' HB3' ' HA ' ' A' ' 62' ' ' PHE . 0.8 OUTLIER -172.17 -175.97 1.54 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.36 -0.838 . . . . 0.0 108.99 -179.954 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.461 ' SG ' HD11 ' A' ' 61' ' ' LEU . 31.9 p . . . . . 0 C--N 1.303 -1.452 0 O-C-N 121.183 -0.948 . . . . 0.0 109.337 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.57 ' CE2' ' HD2' ' A' ' 18' ' ' ARG . 62.5 m95 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.266 0.555 . . . . 0.0 109.584 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.455 HD11 ' O ' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -107.58 150.26 27.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.234 -0.916 . . . . 0.0 109.596 179.984 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.52 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 0.4 OUTLIER -45.88 147.53 0.96 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.3 -0.875 . . . . 0.0 109.352 179.774 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.515 ' SG ' ' N ' ' A' ' 17' ' ' ARG . 52.3 m -93.8 109.81 43.67 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.329 -0.857 . . . . 0.0 109.77 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.52 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 35.8 Cg_endo -80.02 -29.43 2.66 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.26 1.973 . . . . 0.0 109.561 179.291 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.476 ' HB1' ' NH1' ' A' ' 17' ' ' ARG . . . -69.55 -34.77 74.68 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.376 -0.827 . . . . 0.0 109.357 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.541 HD11 ' CD1' ' A' ' 15' ' ' TRP . 10.4 mt -105.51 -50.27 3.25 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.208 -0.932 . . . . 0.0 109.509 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 139.08 -151.68 21.9 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -77.74 161.66 30.41 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.627 2.218 . . . . 0.0 110.268 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.94 -48.61 4.09 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.607 ' CZ2' ' HB2' ' A' ' 49' ' ' LEU . 11.4 t-105 -76.61 125.78 29.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.26 -1.141 . . . . 0.0 109.195 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.497 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 0.1 OUTLIER -102.21 127.53 49.11 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.386 -0.821 . . . . 0.0 109.448 -179.655 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.553 ' HG3' ' CE1' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -100.58 104.1 15.43 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.423 -0.798 . . . . 0.0 109.899 -179.311 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.57 ' HD2' ' CE2' ' A' ' 5' ' ' TRP . 1.0 OUTLIER -100.74 135.09 42.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.17 -0.956 . . . . 0.0 109.569 179.624 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -115.49 146.51 41.61 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.274 -0.891 . . . . 0.0 109.351 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.49 ' O ' ' N ' ' A' ' 32' ' ' ASP . 2.9 t . . . . . 0 N--CA 1.491 1.614 0 O-C-N 121.175 -0.953 . . . . 0.0 109.876 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.529 ' HB3' ' CZ ' ' A' ' 34' ' ' TYR . 3.6 m-20 . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.438 ' OG1' ' HA ' ' A' ' 65' ' ' LYS . 1.5 m -100.65 120.26 39.8 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.278 -0.889 . . . . 0.0 109.841 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.564 ' CD1' ' HG2' ' A' ' 44' ' ' ARG . 15.2 m-85 -123.35 152.92 41.01 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.355 -0.84 . . . . 0.0 108.979 179.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.692 ' CE2' ' CE1' ' A' ' 64' ' ' PHE . 4.1 m-85 -118.57 145.16 45.59 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.117 -0.989 . . . . 0.0 109.593 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.491 ' NE2' ' O ' ' A' ' 37' ' ' SER . 0.0 OUTLIER -132.93 141.71 48.5 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.216 -0.928 . . . . 0.0 109.868 -179.802 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.491 ' O ' ' NE2' ' A' ' 36' ' ' GLN . 0.3 OUTLIER -81.26 173.4 7.75 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.45 -0.781 . . . . 0.0 109.183 179.616 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.45 ' CD ' ' CB ' ' A' ' 37' ' ' SER . 36.0 Cg_endo -78.89 7.2 4.43 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.605 2.203 . . . . 0.0 110.573 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.2 p -110.49 -13.59 14.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.212 -0.93 . . . . 0.0 109.502 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 110.59 24.3 5.64 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.469 ' OD2' ' CD1' ' A' ' 43' ' ' ILE . 9.5 t70 -97.42 123.23 41.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.279 -1.13 . . . . 0.0 109.393 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.26 124.84 50.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.29 -0.881 . . . . 0.0 109.645 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.584 ' CD1' ' N ' ' A' ' 43' ' ' ILE . 3.1 mp -128.05 150.43 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.255 -0.903 . . . . 0.0 109.447 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.564 ' HG2' ' CD1' ' A' ' 34' ' ' TYR . 11.9 mtt180 -144.92 9.68 1.31 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.253 -0.904 . . . . 0.0 110.235 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.545 ' CB ' ' HB2' ' A' ' 48' ' ' GLU . 0.3 OUTLIER -98.41 12.66 34.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.033 -1.042 . . . . 0.0 109.355 179.833 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.58 ' HA ' ' CE1' ' A' ' 64' ' ' PHE . 0.0 OUTLIER 63.22 -93.4 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.365 -0.834 . . . . 0.0 110.225 179.374 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.457 HG11 ' O ' ' A' ' 47' ' ' VAL . 75.5 t -55.35 -22.45 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.127 -0.983 . . . . 0.0 109.812 -179.161 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.545 ' HB2' ' CB ' ' A' ' 45' ' ' SER . 2.5 mt-10 -63.56 -47.83 79.96 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.038 -1.039 . . . . 0.0 108.766 179.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.607 ' HB2' ' CZ2' ' A' ' 15' ' ' TRP . 1.3 pp -67.56 -24.92 65.58 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 179.113 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.496 ' N ' ' HG ' ' A' ' 49' ' ' LEU . 4.9 m -66.95 -62.59 1.36 Allowed 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.496 ' HG3' ' O ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -52.4 -21.64 3.84 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.306 -0.957 . . . . 0.0 108.459 179.299 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.418 ' O ' ' C ' ' A' ' 53' ' ' LEU . 2.0 t80 -77.19 -64.51 1.12 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.463 -0.773 . . . . 0.0 108.989 179.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.514 HD21 ' CE3' ' A' ' 15' ' ' TRP . 2.2 mt -45.07 -63.64 0.88 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.18 -0.95 . . . . 0.0 109.047 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 143.8 -163.6 27.61 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.97 -7.26 16.32 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.604 2.203 . . . . 0.0 110.116 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -79.36 -11.3 59.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.341 -0.849 . . . . 0.0 109.453 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.413 ' SG ' ' HB3' ' A' ' 11' ' ' LEU . 1.0 OUTLIER -136.74 150.41 48.39 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.245 -0.909 . . . . 0.0 109.456 -179.986 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.475 ' C ' ' CD1' ' A' ' 59' ' ' LEU . 13.7 p-10 -139.97 156.15 46.79 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.234 -0.916 . . . . 0.0 109.43 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.48 HD13 HD12 ' A' ' 49' ' ' LEU . 6.0 mp -150.86 15.51 0.75 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.167 -0.958 . . . . 0.0 109.549 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.48 HG23 ' CD2' ' A' ' 61' ' ' LEU . 32.1 m -47.32 -41.03 18.45 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.277 -0.889 . . . . 0.0 109.336 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.598 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 2.4 mm? -109.27 -4.62 16.33 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.279 -0.888 . . . . 0.0 109.597 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.571 ' CE2' ' O ' ' A' ' 63' ' ' ASP . 33.4 t80 -56.93 136.48 56.0 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.273 -0.892 . . . . 0.0 109.73 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.571 ' O ' ' CE2' ' A' ' 62' ' ' PHE . 11.6 m-20 -85.13 129.23 34.84 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.361 -0.837 . . . . 0.0 109.11 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.692 ' CE1' ' CE2' ' A' ' 35' ' ' TYR . 0.6 OUTLIER -84.39 54.92 3.16 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.133 -0.98 . . . . 0.0 109.489 -179.61 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.438 ' HA ' ' OG1' ' A' ' 33' ' ' THR . 7.3 ttmt -175.91 -42.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.428 -0.795 . . . . 0.0 109.033 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 -83.25 -45.69 13.54 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.36 -0.838 . . . . 0.0 109.105 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.548 ' HA2' ' CE1' ' A' ' 62' ' ' PHE . . . 103.32 32.64 4.51 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.463 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 2.2 pp -140.52 162.21 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.108 -1.231 . . . . 0.0 109.692 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.454 ' HB3' ' HA ' ' A' ' 62' ' ' PHE . 1.1 pt? -143.6 164.16 31.19 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.301 -0.875 . . . . 0.0 108.982 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.487 ' O ' ' HG ' ' A' ' 61' ' ' LEU . 7.7 p . . . . . 0 N--CA 1.489 1.509 0 O-C-N 121.12 -0.987 . . . . 0.0 109.577 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.577 ' CZ3' ' HB2' ' A' ' 18' ' ' ARG . 71.2 m95 . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 17' ' ' ARG . 0.2 OUTLIER -110.01 148.74 31.1 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.237 -0.914 . . . . 0.0 109.527 179.921 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.405 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 0.6 OUTLIER -47.43 147.32 1.71 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.203 -0.936 . . . . 0.0 109.49 -179.884 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.506 ' HB2' ' HB3' ' A' ' 15' ' ' TRP . 6.1 m -89.69 114.46 60.69 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.344 -0.848 . . . . 0.0 109.818 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.405 ' HD2' ' HD3' ' A' ' 17' ' ' ARG . 36.0 Cg_endo -79.04 -39.51 0.34 Allowed 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.362 2.041 . . . . 0.0 110.371 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' ' 67' ' ' GLY . . . -64.58 -46.26 83.45 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.213 -0.93 . . . . 0.0 109.595 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.581 HD12 ' CD1' ' A' ' 15' ' ' TRP . 6.8 mt -90.12 -48.06 7.42 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.117 -0.989 . . . . 0.0 109.776 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 129.81 -153.26 19.93 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -77.41 155.81 32.44 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.732 2.288 . . . . 0.0 110.497 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.71 -26.66 8.0 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.229 -1.549 . . . . 0.0 109.229 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.592 ' CZ2' HD12 ' A' ' 49' ' ' LEU . 8.7 t-105 -101.74 132.8 47.26 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.345 -1.091 . . . . 0.0 108.9 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.423 ' C ' ' SG ' ' A' ' 8' ' ' CYS . 14.5 mptt -106.39 129.24 54.42 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.191 -0.943 . . . . 0.0 110.078 -179.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.577 ' HG3' ' CE2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -105.27 113.25 26.72 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.376 -0.828 . . . . 0.0 109.097 179.611 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.577 ' HB2' ' CZ3' ' A' ' 5' ' ' TRP . 0.1 OUTLIER -100.16 144.44 29.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.365 -0.834 . . . . 0.0 109.588 -179.728 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.449 ' OE1' HD22 ' A' ' 6' ' ' LEU . 5.2 pt-20 -130.83 131.06 44.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.341 -0.849 . . . . 0.0 109.197 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.464 ' CG2' ' HD3' ' A' ' 18' ' ' ARG . 14.5 t . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.205 -0.934 . . . . 0.0 109.514 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.491 ' HB3' ' CE1' ' A' ' 34' ' ' TYR . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.6 m -137.82 109.28 6.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.11 -0.994 . . . . 0.0 109.829 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.582 ' CE1' ' HD2' ' A' ' 44' ' ' ARG . 8.8 m-30 -109.11 160.25 16.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.338 -0.851 . . . . 0.0 108.748 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.577 ' CE2' ' HG3' ' A' ' 17' ' ' ARG . 19.6 m-85 -131.76 145.56 51.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.047 -1.033 . . . . 0.0 109.776 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.427 ' HA ' ' O ' ' A' ' 41' ' ' ASP . 0.9 OUTLIER -133.17 130.44 39.15 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.286 -0.884 . . . . 0.0 109.248 179.931 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.421 ' HA ' ' CZ3' ' A' ' 15' ' ' TRP . 0.8 OUTLIER -71.54 170.42 12.04 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.247 -0.908 . . . . 0.0 109.386 -179.951 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.406 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 35.9 Cg_endo -78.27 5.61 5.32 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.592 2.195 . . . . 0.0 110.457 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.3 p -113.09 -23.03 10.24 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.251 -0.905 . . . . 0.0 109.227 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 125.47 23.36 1.72 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.836 -1.305 . . . . 0.0 109.836 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.573 ' OD2' ' CE1' ' A' ' 52' ' ' TYR . 2.8 t70 -87.73 136.16 33.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.153 -1.204 . . . . 0.0 109.07 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.96 100.71 7.74 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.219 -0.925 . . . . 0.0 109.844 -179.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.523 ' CG2' ' HB3' ' A' ' 49' ' ' LEU . 3.3 mt -112.87 154.09 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.404 -0.81 . . . . 0.0 109.146 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.582 ' HD2' ' CE1' ' A' ' 34' ' ' TYR . 8.1 ttp180 -129.02 -2.76 5.15 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.108 -0.995 . . . . 0.0 109.981 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.542 ' HB3' ' CB ' ' A' ' 48' ' ' GLU . 5.8 t -88.57 173.27 8.74 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.23 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.543 ' HA ' ' CE1' ' A' ' 64' ' ' PHE . 5.6 ttpm? -91.98 -60.49 1.84 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.894 -1.129 . . . . 0.0 110.113 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.443 ' O ' ' CG ' ' A' ' 51' ' ' ARG . 77.6 t -81.48 -22.04 10.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.01 -1.057 . . . . 0.0 109.33 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.542 ' CB ' ' HB3' ' A' ' 45' ' ' SER . 1.2 tt0 -66.21 -45.95 78.96 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 178.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.592 HD12 ' CZ2' ' A' ' 15' ' ' TRP . 1.7 pp -69.95 -22.53 63.16 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.525 ' CG2' HD12 ' A' ' 59' ' ' LEU . 25.5 m -69.09 -69.11 0.35 Allowed 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 178.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.449 ' HD2' ' HA ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -44.15 -28.45 0.5 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.494 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.573 ' CE1' ' OD2' ' A' ' 41' ' ' ASP . 87.5 t80 -59.23 -60.02 4.52 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.173 -0.954 . . . . 0.0 108.845 179.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.541 HD22 ' CE3' ' A' ' 15' ' ' TRP . 1.0 OUTLIER -52.7 -54.8 28.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.305 -0.872 . . . . 0.0 109.265 179.616 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 137.43 -162.74 25.44 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.44 -5.51 15.64 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.559 2.173 . . . . 0.0 110.192 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.19 -26.93 53.37 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.387 -0.82 . . . . 0.0 109.396 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 1.1 m -109.55 -171.61 1.88 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.302 -0.874 . . . . 0.0 109.323 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.456 ' C ' ' CD1' ' A' ' 59' ' ' LEU . 6.9 t0 -178.81 149.43 0.46 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.909 . . . . 0.0 109.655 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.559 HD22 ' CD2' ' A' ' 62' ' ' PHE . 5.5 mp -153.86 14.46 0.47 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.187 -0.945 . . . . 0.0 109.705 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.424 ' C ' HD23 ' A' ' 61' ' ' LEU . 98.4 m -47.94 -39.88 20.48 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.122 -0.987 . . . . 0.0 109.16 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.574 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 1.3 mm? -104.42 -14.05 15.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.396 -0.815 . . . . 0.0 109.229 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.559 ' CD2' HD22 ' A' ' 59' ' ' LEU . 64.6 t80 -44.96 156.19 0.09 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.441 -0.787 . . . . 0.0 109.811 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.499 ' O ' ' N ' ' A' ' 65' ' ' LYS . 5.1 m-20 -109.34 108.35 18.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.282 -0.887 . . . . 0.0 109.403 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.575 ' CZ ' ' O ' ' A' ' 44' ' ' ARG . 0.9 OUTLIER -67.48 61.72 0.06 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.405 -0.809 . . . . 0.0 109.03 179.964 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.499 ' N ' ' O ' ' A' ' 63' ' ' ASP . 0.7 OUTLIER 173.75 -28.11 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.319 -0.863 . . . . 0.0 109.69 -179.738 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -103.75 -26.45 12.73 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.125 -0.984 . . . . 0.0 110.11 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.502 ' CA ' ' NH2' ' A' ' 17' ' ' ARG . . . 85.53 30.26 24.9 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.686 -1.365 . . . . 0.0 109.686 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.494 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 1.9 pp -140.09 173.2 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.226 -1.161 . . . . 0.0 109.517 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.493 ' CB ' ' HA ' ' A' ' 62' ' ' PHE . 0.8 OUTLIER -150.38 -168.48 3.12 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.393 -0.817 . . . . 0.0 109.416 179.984 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.219 -0.926 . . . . 0.0 109.358 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.572 ' CE3' ' HB2' ' A' ' 18' ' ' ARG . 84.2 m95 . . . . . 0 N--CA 1.489 1.486 0 CA-C-O 121.253 0.549 . . . . 0.0 109.695 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 79.6 mt -112.69 154.05 26.72 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.27 -0.894 . . . . 0.0 109.366 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.482 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 0.4 OUTLIER -49.01 139.52 10.25 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.232 -0.918 . . . . 0.0 108.897 179.704 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.455 ' O ' ' O ' ' A' ' 12' ' ' GLY . 44.0 t -91.04 111.94 51.07 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.219 -0.925 . . . . 0.0 109.696 -179.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.482 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 36.7 Cg_endo -79.63 -48.68 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.255 1.97 . . . . 0.0 109.975 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.637 ' CB ' ' CE2' ' A' ' 62' ' ' PHE . . . -50.15 -35.44 26.03 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.398 -0.814 . . . . 0.0 109.476 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.598 ' CD1' ' CD1' ' A' ' 15' ' ' TRP . 14.5 mt -98.16 -64.98 0.99 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.262 -0.899 . . . . 0.0 109.555 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 8' ' ' CYS . . . 158.61 -158.88 29.72 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -76.77 159.91 34.63 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.551 2.167 . . . . 0.0 110.402 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.91 -68.15 3.54 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 -179.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.599 ' CE3' ' CD2' ' A' ' 53' ' ' LEU . 26.9 t-105 -49.87 128.64 18.82 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.296 -1.12 . . . . 0.0 108.82 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.3 mmtm -99.33 120.83 40.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.118 -0.989 . . . . 0.0 109.552 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.583 ' CZ ' ' CA ' ' A' ' 67' ' ' GLY . 23.7 ttt-85 -93.4 105.11 17.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.366 -0.834 . . . . 0.0 109.295 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.572 ' HB2' ' CE3' ' A' ' 5' ' ' TRP . 1.2 tmm_? -100.23 152.21 20.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.206 -0.934 . . . . 0.0 110.055 -179.572 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -137.98 155.13 49.18 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.642 0 O-C-N 120.983 -1.073 . . . . 0.0 109.735 -179.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.44 ' O ' ' CD1' ' A' ' 34' ' ' TYR . 93.6 m -137.96 134.37 34.84 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.065 -1.022 . . . . 0.0 109.956 -179.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.44 ' CD1' ' O ' ' A' ' 33' ' ' THR . 18.1 m-85 -136.04 153.94 51.2 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.365 -0.834 . . . . 0.0 109.077 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.573 ' CE2' ' HG3' ' A' ' 17' ' ' ARG . 27.5 m-85 -121.02 161.51 21.53 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.996 -1.065 . . . . 0.0 109.752 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.559 ' HB2' ' CZ3' ' A' ' 5' ' ' TRP . 0.1 OUTLIER -128.13 115.29 18.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.289 -0.882 . . . . 0.0 109.287 179.723 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.529 ' CB ' ' HD2' ' A' ' 38' ' ' PRO . 0.8 OUTLIER -53.44 176.41 0.11 Allowed Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.354 -0.841 . . . . 0.0 109.24 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.529 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 35.4 Cg_endo -77.62 -8.88 17.18 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.442 2.095 . . . . 0.0 110.25 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.441 HG23 ' OG ' ' A' ' 37' ' ' SER . 12.9 t -110.17 -16.08 13.85 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.231 -0.918 . . . . 0.0 109.545 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 121.03 20.63 3.33 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.432 ' CB ' ' HB3' ' A' ' 37' ' ' SER . 0.2 OUTLIER -89.73 101.87 14.57 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.197 -1.178 . . . . 0.0 109.249 179.877 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.41 126.26 30.59 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.278 -0.889 . . . . 0.0 108.845 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.553 ' CG2' ' HB3' ' A' ' 49' ' ' LEU . 0.9 OUTLIER -116.47 162.61 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.148 -0.97 . . . . 0.0 110.348 -179.121 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.588 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 0.0 OUTLIER -131.83 -21.83 2.41 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.546 -0.721 . . . . 0.0 110.094 -179.909 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.459 ' HB2' ' HB2' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -99.9 119.2 37.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.886 -1.134 . . . . 0.0 109.269 179.865 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.48 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 0.1 OUTLIER -46.89 -46.69 21.32 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.382 -0.824 . . . . 0.0 110.501 -179.442 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.427 ' HA ' ' HB ' ' A' ' 50' ' ' THR . 73.5 t -74.79 -41.7 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.851 -1.156 . . . . 0.0 109.317 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.481 ' O ' ' HG3' ' A' ' 51' ' ' ARG . 28.4 tt0 -48.53 -49.94 34.03 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.204 -0.935 . . . . 0.0 109.445 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.553 ' HB3' ' CG2' ' A' ' 43' ' ' ILE . 1.1 pp -72.67 -34.92 67.56 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.941 -1.1 . . . . 0.0 108.739 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.531 ' OG1' ' CD1' ' A' ' 59' ' ' LEU . 0.4 OUTLIER -54.63 -54.66 38.56 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.047 -1.033 . . . . 0.0 108.413 179.124 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.523 ' N ' ' CG2' ' A' ' 50' ' ' THR . 0.0 OUTLIER -67.97 -16.63 64.14 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.335 -0.853 . . . . 0.0 108.937 179.496 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.487 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 24.7 t80 -71.51 -56.15 6.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.278 -0.889 . . . . 0.0 109.058 179.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.599 ' CD2' ' CE3' ' A' ' 15' ' ' TRP . 0.4 OUTLIER -66.87 -48.84 67.55 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.199 -0.938 . . . . 0.0 108.983 179.523 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 138.64 -153.88 22.81 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.91 -26.9 6.28 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.55 2.167 . . . . 0.0 110.294 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.47 -27.28 65.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.346 -0.846 . . . . 0.0 109.357 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.487 ' CB ' HD13 ' A' ' 53' ' ' LEU . 6.0 m -121.0 104.54 9.88 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.276 -0.89 . . . . 0.0 109.308 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.465 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 0.4 OUTLIER -100.4 158.66 15.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.297 -0.877 . . . . 0.0 109.405 -179.903 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.592 HD21 ' CG ' ' A' ' 62' ' ' PHE . 0.7 OUTLIER -151.8 19.68 0.7 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.206 -0.934 . . . . 0.0 109.414 179.932 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.459 ' O ' HD23 ' A' ' 61' ' ' LEU . 28.6 m -49.95 -40.25 43.16 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.312 -0.867 . . . . 0.0 109.724 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.549 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 1.2 mm? -112.09 2.56 16.84 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.267 -0.896 . . . . 0.0 109.887 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.637 ' CE2' ' CB ' ' A' ' 10' ' ' ALA . 2.4 t80 -52.44 125.27 15.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.193 -0.942 . . . . 0.0 110.037 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.523 ' O ' ' N ' ' A' ' 65' ' ' LYS . 1.4 t0 -84.77 97.84 9.92 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.588 ' CE2' ' O ' ' A' ' 44' ' ' ARG . 0.7 OUTLIER -65.7 68.14 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.344 -0.848 . . . . 0.0 109.14 -179.243 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 63' ' ' ASP . 7.9 mtpt 174.82 -41.49 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.43 -0.794 . . . . 0.0 108.94 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -93.44 -39.65 10.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.358 -0.839 . . . . 0.0 109.092 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.583 ' CA ' ' CZ ' ' A' ' 17' ' ' ARG . . . 99.71 34.08 5.08 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 pp -140.52 151.04 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.053 -1.263 . . . . 0.0 110.059 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.48 ' HB3' ' HA ' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -139.59 160.52 39.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.326 -0.859 . . . . 0.0 109.179 179.305 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 1.7 p . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.15 -0.968 . . . . 0.0 109.602 179.995 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.408 ' CZ3' ' HB2' ' A' ' 36' ' ' GLN . 75.3 m95 . . . . . 0 N--CA 1.488 1.472 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 17' ' ' ARG . 0.7 OUTLIER -115.92 158.63 22.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.236 -0.915 . . . . 0.0 109.52 -179.801 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.404 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 12.5 m-20 -50.71 145.36 6.97 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.198 -0.938 . . . . 0.0 109.453 179.96 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.478 ' O ' ' O ' ' A' ' 12' ' ' GLY . 42.3 t -89.45 114.5 60.71 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.224 -0.923 . . . . 0.0 109.664 -179.869 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 35.8 Cg_endo -78.47 -55.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.284 1.99 . . . . 0.0 110.443 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.65 ' CB ' ' CE2' ' A' ' 62' ' ' PHE . . . -48.14 -39.21 19.94 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.315 -0.866 . . . . 0.0 109.937 -179.742 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.501 HD12 ' CG ' ' A' ' 15' ' ' TRP . 11.2 mt -94.18 -60.69 1.68 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.047 -1.033 . . . . 0.0 109.693 -179.996 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 8' ' ' CYS . . . 147.88 -148.76 20.57 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.854 -1.299 . . . . 0.0 109.854 -179.932 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.42 159.29 32.68 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.621 2.214 . . . . 0.0 110.845 -179.652 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.17 -70.27 3.14 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.825 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.565 ' CE3' HD23 ' A' ' 53' ' ' LEU . 14.2 t-105 -50.39 126.24 14.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.24 -1.153 . . . . 0.0 109.728 -179.861 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.0 mmtm -98.89 110.56 23.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.208 -0.932 . . . . 0.0 109.227 179.723 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.58 ' HG3' ' CE1' ' A' ' 35' ' ' TYR . 8.6 ttt-85 -89.13 105.02 17.52 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.389 -0.82 . . . . 0.0 109.863 -179.55 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.48 ' HB3' ' O ' ' A' ' 34' ' ' TYR . 11.9 ttt180 -94.94 138.54 32.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.924 . . . . 0.0 109.194 179.638 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -119.92 147.11 45.13 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.279 -0.888 . . . . 0.0 109.465 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 84.5 t . . . . . 0 N--CA 1.489 1.511 0 O-C-N 121.292 -0.88 . . . . 0.0 109.131 179.902 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.56 ' HB3' ' CE1' ' A' ' 34' ' ' TYR . 7.5 m-20 . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.537 ' O ' ' CE1' ' A' ' 64' ' ' PHE . 0.0 OUTLIER -137.15 128.01 27.33 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.163 -0.96 . . . . 0.0 109.986 -179.658 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.56 ' CE1' ' HB3' ' A' ' 32' ' ' ASP . 1.1 m-85 -124.8 141.17 52.3 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.388 -0.82 . . . . 0.0 109.008 179.531 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.58 ' CE1' ' HG3' ' A' ' 17' ' ' ARG . 9.7 m-85 -118.17 143.9 46.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.004 -1.06 . . . . 0.0 109.751 -179.767 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.412 ' OE1' ' N ' ' A' ' 41' ' ' ASP . 8.7 tp-100 -117.86 134.43 54.94 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.371 -0.831 . . . . 0.0 109.474 179.931 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.441 ' OG ' ' HB3' ' A' ' 41' ' ' ASP . 0.0 OUTLIER -81.92 171.77 11.21 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.354 -0.841 . . . . 0.0 109.172 179.852 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.42 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 35.6 Cg_endo -78.01 6.13 4.85 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.486 2.124 . . . . 0.0 110.343 179.841 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.9 p -114.31 -9.92 12.75 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.185 -0.947 . . . . 0.0 109.409 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 102.82 17.3 19.29 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.894 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.567 ' OD2' ' CE1' ' A' ' 52' ' ' TYR . 19.5 t0 -96.61 111.0 23.31 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.135 -1.215 . . . . 0.0 109.327 179.805 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.88 121.63 31.43 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.277 -0.889 . . . . 0.0 109.778 -179.715 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.535 ' CG2' ' HB3' ' A' ' 49' ' ' LEU . 3.9 mt -121.72 150.02 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.344 -0.847 . . . . 0.0 109.202 179.74 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.569 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 1.8 ttp180 -128.51 -6.59 5.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.233 -0.917 . . . . 0.0 109.94 179.758 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.564 ' HB3' ' CB ' ' A' ' 48' ' ' GLU . 12.9 t -90.29 142.66 27.51 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.093 -1.005 . . . . 0.0 108.923 179.598 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.508 ' HG2' ' N ' ' A' ' 47' ' ' VAL . 21.0 ttpt -63.97 -74.79 0.09 Allowed 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.338 -0.851 . . . . 0.0 110.862 -178.692 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.508 ' N ' ' HG2' ' A' ' 46' ' ' LYS . 58.3 t -62.16 -26.81 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.218 -0.926 . . . . 0.0 110.604 -178.431 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.564 ' CB ' ' HB3' ' A' ' 45' ' ' SER . 1.7 tt0 -66.45 -52.14 49.47 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.697 -1.252 . . . . 0.0 109.059 179.861 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.535 ' HB3' ' CG2' ' A' ' 43' ' ' ILE . 1.3 pp -63.51 -23.3 67.33 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.331 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.531 ' CG2' ' HB2' ' A' ' 59' ' ' LEU . 25.2 m -67.86 -70.83 0.24 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.235 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.443 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 0.1 OUTLIER -46.95 -24.43 0.61 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.402 -0.811 . . . . 0.0 109.131 179.975 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.567 ' CE1' ' OD2' ' A' ' 41' ' ' ASP . 69.8 t80 -62.96 -55.8 22.66 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.279 -0.888 . . . . 0.0 109.439 179.761 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.565 HD23 ' CE3' ' A' ' 15' ' ' TRP . 0.3 OUTLIER -65.78 -50.0 66.29 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.178 -0.951 . . . . 0.0 109.344 179.996 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 121.23 -152.79 16.74 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 -179.697 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.9 -9.51 16.85 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.553 2.169 . . . . 0.0 110.462 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.96 -24.86 58.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.299 -0.875 . . . . 0.0 109.3 179.9 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.422 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 54.5 m -127.98 94.77 4.01 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.292 -0.88 . . . . 0.0 109.0 179.741 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.456 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 2.2 m-20 -76.91 157.26 31.47 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.347 -0.846 . . . . 0.0 110.168 -179.343 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.592 HD21 ' CD2' ' A' ' 62' ' ' PHE . 1.2 mp -152.09 39.56 0.6 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.538 -0.726 . . . . 0.0 109.062 -179.709 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.528 ' O ' ' CD2' ' A' ' 61' ' ' LEU . 0.1 OUTLIER -38.51 -44.72 0.97 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.669 -0.644 . . . . 0.0 110.421 -179.447 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.528 ' CD2' ' O ' ' A' ' 60' ' ' THR . 10.8 mt -142.35 33.41 1.49 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.096 -1.002 . . . . 0.0 109.759 -179.813 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.65 ' CE2' ' CB ' ' A' ' 10' ' ' ALA . 10.9 t80 -47.27 117.35 1.71 Allowed 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.283 -0.885 . . . . 0.0 109.617 179.907 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.476 ' O ' ' N ' ' A' ' 65' ' ' LYS . 1.5 m-20 -79.42 102.34 8.67 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.388 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.569 ' CE2' ' O ' ' A' ' 44' ' ' ARG . 0.1 OUTLIER -67.35 62.07 0.06 Allowed 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.292 -0.88 . . . . 0.0 109.568 -178.914 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.478 ' HA ' ' OG1' ' A' ' 33' ' ' THR . 0.0 OUTLIER 171.82 -30.48 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.285 -0.884 . . . . 0.0 109.51 179.895 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -99.58 -42.77 6.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.204 -0.935 . . . . 0.0 109.411 179.843 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.448 ' HA2' ' NE ' ' A' ' 17' ' ' ARG . . . 101.78 30.79 5.67 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.733 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.4 pp -140.21 178.45 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.246 -1.149 . . . . 0.0 109.573 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.522 ' HB3' ' HA ' ' A' ' 62' ' ' PHE . 0.8 OUTLIER -164.7 -176.79 4.44 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.334 -0.854 . . . . 0.0 109.427 179.809 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.523 ' O ' ' CG2' ' A' ' 60' ' ' THR . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.28 -0.888 . . . . 0.0 109.537 179.693 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.573 ' CE3' ' HB2' ' A' ' 18' ' ' ARG . 73.7 m95 . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.425 ' O ' ' C ' ' A' ' 7' ' ' ASP . 0.5 OUTLIER -106.93 147.88 29.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.216 -0.927 . . . . 0.0 109.702 -179.757 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.483 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 12.3 m-20 -43.85 130.04 5.69 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.294 -0.879 . . . . 0.0 109.257 179.819 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.52 ' SG ' ' CZ ' ' A' ' 17' ' ' ARG . 12.2 t -86.56 113.37 52.4 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.294 -0.878 . . . . 0.0 109.583 -179.796 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.483 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 36.6 Cg_endo -80.62 -47.97 0.07 OUTLIER 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 122.411 2.074 . . . . 0.0 110.33 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 9' ' ' PRO . . . -41.66 -35.58 0.79 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.327 -0.858 . . . . 0.0 109.85 -179.716 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.562 HD11 ' CD1' ' A' ' 15' ' ' TRP . 14.7 mt -106.1 -65.94 1.03 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.176 -0.952 . . . . 0.0 109.659 -179.873 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 153.5 -150.91 22.7 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.7 153.55 30.02 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.651 2.234 . . . . 0.0 110.535 -179.9 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.455 ' O ' ' HD3' ' A' ' 38' ' ' PRO . . . 90.18 -24.98 13.49 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.854 -1.299 . . . . 0.0 109.854 179.667 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.582 ' CE3' HD21 ' A' ' 53' ' ' LEU . 10.9 t-105 -98.74 133.38 43.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.176 -1.191 . . . . 0.0 109.752 -179.749 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 26.1 mmtp -105.67 116.87 32.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.246 -0.909 . . . . 0.0 109.546 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.627 ' NH1' ' CE1' ' A' ' 62' ' ' PHE . 0.4 OUTLIER -89.97 103.82 16.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.156 -0.965 . . . . 0.0 109.228 179.869 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.573 ' HB2' ' CE3' ' A' ' 5' ' ' TRP . 2.0 ttm180 -97.12 140.62 31.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.244 -0.91 . . . . 0.0 110.006 -179.537 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.422 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 21.8 pt-20 -138.45 132.65 31.65 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.309 -0.869 . . . . 0.0 109.026 179.582 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.3 t . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.179 -0.951 . . . . 0.0 109.719 -179.681 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.553 ' HB3' ' CZ ' ' A' ' 34' ' ' TYR . 22.3 m-20 . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.339 0.59 . . . . 0.0 109.557 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.494 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 0.0 OUTLIER -127.61 90.92 3.2 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.276 -0.89 . . . . 0.0 109.595 -179.966 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.582 ' CD1' ' HG2' ' A' ' 44' ' ' ARG . 10.4 m-85 -99.68 140.66 33.55 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.309 -0.87 . . . . 0.0 109.086 179.758 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.58 ' CE2' ' CE1' ' A' ' 64' ' ' PHE . 4.8 m-85 -116.58 158.21 24.06 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.214 -0.929 . . . . 0.0 109.99 -179.324 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -138.88 121.74 16.57 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.477 -0.764 . . . . 0.0 109.229 179.904 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.478 ' HB2' ' HD2' ' A' ' 38' ' ' PRO . 1.1 p -73.68 173.61 6.04 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.331 -0.856 . . . . 0.0 109.253 179.911 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.478 ' HD2' ' HB2' ' A' ' 37' ' ' SER . 36.2 Cg_endo -79.38 9.7 3.31 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.664 2.242 . . . . 0.0 110.662 -179.871 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.4 p -120.24 12.53 11.8 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.097 -1.002 . . . . 0.0 109.83 -179.76 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 85.47 18.92 59.46 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.811 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.504 ' OD2' ' CE2' ' A' ' 52' ' ' TYR . 44.0 t0 -97.21 114.14 25.83 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.205 -1.174 . . . . 0.0 109.339 179.84 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.417 ' C ' HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -108.3 135.94 48.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.189 -0.944 . . . . 0.0 109.814 -179.726 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.493 ' CG2' ' HB3' ' A' ' 49' ' ' LEU . 2.4 mp -138.28 156.72 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.277 -0.889 . . . . 0.0 109.292 179.81 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.582 ' HG2' ' CD1' ' A' ' 34' ' ' TYR . 0.3 OUTLIER -140.69 17.6 2.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.132 -0.98 . . . . 0.0 109.739 -179.994 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.534 ' O ' ' CB ' ' A' ' 46' ' ' LYS . 0.6 OUTLIER -91.4 -87.21 0.21 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.202 -0.936 . . . . 0.0 108.805 179.445 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.534 ' CB ' ' O ' ' A' ' 45' ' ' SER . 4.9 ttpp 159.4 -60.49 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 179.632 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 26.9 t -87.71 -20.67 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.389 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -69.61 -42.92 73.73 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.802 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.533 ' O ' ' CD1' ' A' ' 53' ' ' LEU . 2.8 pp -75.99 -32.65 59.55 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.951 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.481 ' HB ' ' HB2' ' A' ' 59' ' ' LEU . 0.4 OUTLIER -64.01 -42.99 96.96 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 178.687 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.7 mmt85 -66.02 -26.61 67.6 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.18 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.504 ' CE2' ' OD2' ' A' ' 41' ' ' ASP . 28.8 t80 -68.53 -62.66 1.29 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.515 -0.741 . . . . 0.0 109.308 179.87 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.582 HD21 ' CE3' ' A' ' 15' ' ' TRP . 0.7 OUTLIER -53.74 -54.26 40.52 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.193 -0.942 . . . . 0.0 109.222 179.797 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 137.62 -156.33 23.55 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -179.807 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.35 -6.43 15.56 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.581 2.188 . . . . 0.0 110.442 179.915 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -78.44 -23.53 46.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.196 -0.94 . . . . 0.0 109.568 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 91.1 m -129.79 98.08 4.69 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.248 -0.908 . . . . 0.0 109.534 -179.911 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.19 148.05 22.36 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.214 -0.929 . . . . 0.0 109.49 -179.933 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.602 ' CD2' ' CD2' ' A' ' 62' ' ' PHE . 0.4 OUTLIER -138.78 16.94 2.68 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.374 -0.829 . . . . 0.0 109.18 -179.98 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.457 ' HB ' HD22 ' A' ' 61' ' ' LEU . 2.8 m -50.1 -50.32 48.69 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.429 -0.794 . . . . 0.0 109.579 -179.968 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.594 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 3.6 mm? -100.89 11.37 39.72 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.292 -0.88 . . . . 0.0 109.676 -179.704 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.627 ' CE1' ' NH1' ' A' ' 17' ' ' ARG . 70.9 t80 -68.86 129.68 40.62 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.233 -0.917 . . . . 0.0 109.826 -179.754 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.509 ' O ' ' N ' ' A' ' 65' ' ' LYS . 3.0 t0 -82.32 103.43 11.89 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.331 -0.855 . . . . 0.0 108.973 179.555 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.58 ' CE1' ' CE2' ' A' ' 35' ' ' TYR . 0.8 OUTLIER -67.44 67.74 0.09 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.126 -0.984 . . . . 0.0 109.126 -179.616 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.509 ' N ' ' O ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER 171.23 -32.43 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -179.899 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -95.15 -46.32 6.83 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.344 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.545 ' HA2' ' CE1' ' A' ' 62' ' ' PHE . . . 104.48 30.13 5.09 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 179.426 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.469 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 1.1 pp -141.01 162.02 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.898 -1.354 . . . . 0.0 110.106 179.845 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.489 ' HB3' ' HA ' ' A' ' 62' ' ' PHE . 1.5 pt? -151.83 164.78 36.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.327 -0.858 . . . . 0.0 109.364 179.973 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 6.1 p . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.204 -0.935 . . . . 0.0 109.269 179.704 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.567 ' CZ2' ' HD3' ' A' ' 18' ' ' ARG . 93.0 m95 . . . . . 0 N--CA 1.488 1.467 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -99.36 166.39 11.22 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.239 -0.913 . . . . 0.0 109.488 -179.816 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.478 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 0.7 OUTLIER -66.72 145.27 55.73 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.242 -0.911 . . . . 0.0 109.1 179.711 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.507 ' SG ' ' N ' ' A' ' 17' ' ' ARG . 13.8 m -87.57 112.98 52.08 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.277 -0.89 . . . . 0.0 109.74 -179.595 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.478 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 36.3 Cg_endo -79.51 -40.87 0.23 Allowed 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.239 1.96 . . . . 0.0 109.749 179.441 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.469 ' HB2' ' NH1' ' A' ' 17' ' ' ARG . . . -61.4 -53.27 58.79 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.429 -0.794 . . . . 0.0 109.782 -179.951 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.636 ' CD1' ' CD1' ' A' ' 15' ' ' TRP . 6.6 mt -82.46 -47.94 11.65 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.164 -0.96 . . . . 0.0 109.676 -179.751 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 130.02 -148.18 18.39 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -76.71 155.59 35.2 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.624 2.216 . . . . 0.0 110.717 -179.879 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.91 -46.33 3.1 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.963 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.636 ' CD1' ' CD1' ' A' ' 11' ' ' LEU . 5.1 t-105 -80.31 131.14 35.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.259 -1.142 . . . . 0.0 110.074 -179.621 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.423 ' C ' ' SG ' ' A' ' 8' ' ' CYS . 17.5 mmtp -105.65 126.88 52.66 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.3 -0.875 . . . . 0.0 109.365 179.696 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.523 ' NH1' ' HG ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -99.12 107.47 19.85 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.294 -0.879 . . . . 0.0 109.587 -179.713 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.567 ' HD3' ' CZ2' ' A' ' 5' ' ' TRP . 25.1 ttp180 -100.54 143.72 30.38 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.247 -0.908 . . . . 0.0 109.853 -179.887 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -113.58 149.47 34.45 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.311 -0.868 . . . . 0.0 109.326 179.64 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 13.6 t . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.213 -0.93 . . . . 0.0 109.55 -179.981 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.459 ' HB2' ' OH ' ' A' ' 34' ' ' TYR . 4.7 m-20 . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.418 ' OG1' ' HA ' ' A' ' 65' ' ' LYS . 5.6 m -136.98 121.86 18.8 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.153 -0.967 . . . . 0.0 110.105 -179.444 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.459 ' OH ' ' HB2' ' A' ' 32' ' ' ASP . 1.4 m-85 -123.3 149.22 45.08 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.292 -0.88 . . . . 0.0 108.717 179.168 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.654 ' CE2' ' CE1' ' A' ' 64' ' ' PHE . 7.2 m-85 -113.91 150.87 33.08 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.933 -1.105 . . . . 0.0 109.809 -179.89 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.437 ' CB ' ' CZ3' ' A' ' 5' ' ' TRP . 12.4 tt0 -129.79 124.88 34.45 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.331 -0.856 . . . . 0.0 109.595 -179.835 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.474 ' HB3' ' HD2' ' A' ' 38' ' ' PRO . 0.9 OUTLIER -71.3 173.15 5.38 Favored Pre-proline 0 N--CA 1.488 1.437 0 O-C-N 121.347 -0.845 . . . . 0.0 109.04 179.785 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.474 ' HD2' ' HB3' ' A' ' 37' ' ' SER . 34.9 Cg_endo -78.34 8.82 3.4 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.55 2.167 . . . . 0.0 110.9 -179.895 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.3 t -115.55 -24.37 8.35 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.013 -1.054 . . . . 0.0 109.514 179.899 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 122.73 16.09 3.8 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.36 111.24 23.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.158 -1.201 . . . . 0.0 109.674 -179.924 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.69 148.59 22.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.191 -0.943 . . . . 0.0 109.34 179.79 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.552 ' CG2' ' HB3' ' A' ' 49' ' ' LEU . 4.5 mp -140.39 158.27 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.11 -0.994 . . . . 0.0 109.921 -179.825 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.495 ' HA ' ' CZ ' ' A' ' 64' ' ' PHE . 0.9 OUTLIER -137.05 -8.63 1.79 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.249 -0.907 . . . . 0.0 110.737 -179.778 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.527 ' CB ' ' HB2' ' A' ' 48' ' ' GLU . 0.6 OUTLIER -63.48 -86.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.782 -1.199 . . . . 0.0 109.334 179.905 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.5 ' NZ ' ' O ' ' A' ' 59' ' ' LEU . 42.7 tttm 161.97 -63.99 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 -179.769 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.417 HG23 ' HG2' ' A' ' 46' ' ' LYS . 75.0 t -87.94 -19.98 7.59 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 178.518 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.527 ' HB2' ' CB ' ' A' ' 45' ' ' SER . 2.8 mt-10 -66.83 -43.62 83.29 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.353 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.552 ' HB3' ' CG2' ' A' ' 43' ' ' ILE . 1.9 pp -70.07 -23.63 63.1 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 178.647 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.492 ' OG1' ' HB2' ' A' ' 59' ' ' LEU . 30.3 m -70.96 -64.48 0.9 Allowed 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.969 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.458 ' HG3' ' O ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -49.73 -29.46 7.66 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.361 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.419 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 86.2 t80 -57.82 -60.93 2.95 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.377 -0.827 . . . . 0.0 108.909 179.417 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.597 ' CD2' ' CE3' ' A' ' 15' ' ' TRP . 0.4 OUTLIER -58.17 -51.94 67.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.287 -0.883 . . . . 0.0 109.221 179.576 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 133.19 -154.1 21.05 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.394 -1.483 . . . . 0.0 109.394 -179.914 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.76 -17.93 13.72 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.614 2.209 . . . . 0.0 110.176 179.752 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.57 -24.47 66.35 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.31 -0.869 . . . . 0.0 109.507 179.925 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 1.7 m -117.13 156.15 28.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.242 -0.911 . . . . 0.0 109.517 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' A' ' 59' ' ' LEU . 62.0 t0 -149.22 147.95 29.02 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.334 -0.854 . . . . 0.0 109.291 179.937 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.513 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 5.7 mp -148.51 17.56 1.03 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.188 -0.945 . . . . 0.0 109.489 -179.64 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.484 ' C ' ' CD2' ' A' ' 61' ' ' LEU . 3.6 m -42.52 -49.25 5.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.422 -0.799 . . . . 0.0 109.29 -179.876 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.574 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 1.2 mm? -113.09 18.64 17.85 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.395 -0.816 . . . . 0.0 109.455 -179.92 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.569 ' CE1' ' O ' ' A' ' 63' ' ' ASP . 9.8 t80 -77.24 133.97 38.72 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.315 -0.866 . . . . 0.0 109.289 179.945 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.569 ' O ' ' CE1' ' A' ' 62' ' ' PHE . 0.9 OUTLIER -84.92 136.08 33.78 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.355 -0.84 . . . . 0.0 109.211 179.792 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.654 ' CE1' ' CE2' ' A' ' 35' ' ' TYR . 0.3 OUTLIER -86.79 43.61 1.1 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.141 -0.974 . . . . 0.0 109.2 179.957 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.418 ' HA ' ' OG1' ' A' ' 33' ' ' THR . 0.0 OUTLIER -165.12 -44.15 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.409 -0.807 . . . . 0.0 109.052 -179.898 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -81.59 -36.1 29.38 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.328 -0.858 . . . . 0.0 109.259 179.73 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.528 ' HA2' ' CE2' ' A' ' 62' ' ' PHE . . . 88.89 35.15 8.45 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.854 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.473 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 1.8 pp -140.04 155.97 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.172 -1.193 . . . . 0.0 109.781 -179.823 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.49 ' HB3' ' HA ' ' A' ' 62' ' ' PHE . 1.3 pt? -143.56 166.92 23.49 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.31 -0.869 . . . . 0.0 109.043 179.667 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.425 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.483 0 O-C-N 121.129 -0.982 . . . . 0.0 109.658 -179.987 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.626 ' CH2' ' NH1' ' A' ' 18' ' ' ARG . 67.4 m95 . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.407 ' O ' ' C ' ' A' ' 7' ' ' ASP . 54.2 mt -109.75 153.24 24.61 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.149 -0.97 . . . . 0.0 109.63 -179.809 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.407 ' C ' ' O ' ' A' ' 6' ' ' LEU . 7.5 t70 -45.64 140.39 3.4 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.255 -0.903 . . . . 0.0 109.062 179.77 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.475 ' HB2' ' HB2' ' A' ' 17' ' ' ARG . 44.5 t -102.29 108.79 58.5 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.182 -0.949 . . . . 0.0 109.869 -179.599 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.408 ' HD2' ' CZ ' ' A' ' 17' ' ' ARG . 34.1 Cg_endo -77.01 -32.77 3.06 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.154 1.903 . . . . 0.0 109.767 179.194 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.474 ' CB ' ' CE1' ' A' ' 62' ' ' PHE . . . -50.55 -30.13 12.36 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.302 -0.874 . . . . 0.0 108.954 179.319 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.636 ' CD1' ' CD1' ' A' ' 15' ' ' TRP . 9.6 mt -117.25 -65.54 1.17 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.383 -0.823 . . . . 0.0 109.485 179.848 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.412 ' O ' ' O ' ' A' ' 8' ' ' CYS . . . 168.38 -147.42 11.39 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -179.885 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . 0.514 ' O ' ' N ' ' A' ' 15' ' ' TRP . 35.9 Cg_endo -78.08 175.39 11.2 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.681 2.254 . . . . 0.0 110.618 -179.701 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . 0.426 ' O ' ' C ' ' A' ' 15' ' ' TRP . . . 65.66 -68.39 0.11 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.97 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.636 ' CD1' ' CD1' ' A' ' 11' ' ' LEU . 4.5 t-105 -43.55 119.62 1.7 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.374 -1.074 . . . . 0.0 109.515 179.9 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.454 ' HD2' ' HB3' ' A' ' 5' ' ' TRP . 1.0 OUTLIER -101.7 114.91 29.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.185 -0.947 . . . . 0.0 109.659 -179.937 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.475 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 10.4 ttp85 -92.95 111.2 22.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.232 -0.917 . . . . 0.0 109.309 179.771 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.626 ' NH1' ' CH2' ' A' ' 5' ' ' TRP . 41.2 ttp180 -100.38 148.47 24.67 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.185 -0.947 . . . . 0.0 109.488 -179.933 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -102.98 145.15 30.3 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.221 -0.924 . . . . 0.0 109.369 179.924 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.437 HG21 ' CE2' ' A' ' 34' ' ' TYR . 2.9 t . . . . . 0 N--CA 1.489 1.521 0 O-C-N 121.187 -0.946 . . . . 0.0 109.547 -179.918 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.528 ' O ' ' CE1' ' A' ' 64' ' ' PHE . 9.7 m -131.15 144.14 51.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.255 -0.903 . . . . 0.0 109.428 179.972 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.484 ' HB2' ' NH1' ' A' ' 18' ' ' ARG . 20.0 m-85 -124.75 164.94 18.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.383 -0.823 . . . . 0.0 109.142 179.819 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.585 ' OH ' ' CZ ' ' A' ' 62' ' ' PHE . 10.4 m-85 -121.27 147.99 44.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.058 -1.026 . . . . 0.0 110.483 -179.332 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.58 ' HB2' ' CZ3' ' A' ' 5' ' ' TRP . 0.1 OUTLIER -131.81 114.37 14.63 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.352 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.488 ' CB ' ' HD2' ' A' ' 38' ' ' PRO . 0.9 OUTLIER -72.4 173.79 5.17 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.354 -0.841 . . . . 0.0 109.455 -179.719 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.488 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 35.1 Cg_endo -76.89 -7.05 17.26 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.549 2.166 . . . . 0.0 110.246 179.939 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 p -105.07 -23.19 12.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.373 -0.829 . . . . 0.0 109.243 179.842 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 122.2 27.33 1.69 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -90.36 114.92 27.12 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.255 -1.144 . . . . 0.0 109.531 179.968 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.1 99.82 11.11 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.265 -0.897 . . . . 0.0 109.351 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.538 ' CG2' ' HB3' ' A' ' 49' ' ' LEU . 1.9 mp -114.44 146.95 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.2 -0.937 . . . . 0.0 109.661 -179.995 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.596 ' HA ' ' CZ ' ' A' ' 64' ' ' PHE . 7.5 ptt180 -140.28 3.41 1.95 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.37 -0.831 . . . . 0.0 109.995 179.962 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.529 ' O ' ' CB ' ' A' ' 46' ' ' LYS . 1.9 t -62.16 -82.39 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.049 -1.032 . . . . 0.0 109.292 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.529 ' CB ' ' O ' ' A' ' 45' ' ' SER . 6.6 ttmt 159.71 -61.74 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.477 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 21.5 t -96.19 -18.3 6.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.795 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.485 ' HB2' ' HB3' ' A' ' 45' ' ' SER . 40.2 mt-10 -73.54 -32.05 63.99 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.884 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.538 ' HB3' ' CG2' ' A' ' 43' ' ' ILE . 1.7 pp -78.81 -29.56 44.9 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.283 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.539 ' HA ' ' CD1' ' A' ' 53' ' ' LEU . 0.5 OUTLIER -70.16 -50.17 43.13 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.181 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.528 ' N ' ' CG2' ' A' ' 50' ' ' THR . 0.0 OUTLIER -59.62 -29.68 68.17 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.18 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.438 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 36.6 t80 -56.7 -57.15 13.65 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.327 -0.858 . . . . 0.0 108.702 179.252 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.568 HD21 ' CE3' ' A' ' 15' ' ' TRP . 0.5 OUTLIER -62.33 -40.7 97.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.228 -0.92 . . . . 0.0 109.077 179.536 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 127.17 -158.71 21.13 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 -179.689 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.91 -7.16 16.35 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.421 2.081 . . . . 0.0 110.304 179.852 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.79 -12.79 60.48 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.227 -0.921 . . . . 0.0 109.578 -179.985 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 69.6 m -138.77 132.06 30.07 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.263 -0.898 . . . . 0.0 109.514 -179.96 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -119.66 155.68 31.91 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.182 -0.949 . . . . 0.0 109.532 179.873 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.547 HD22 ' CD2' ' A' ' 62' ' ' PHE . 0.5 OUTLIER -148.83 16.78 0.98 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.204 -0.935 . . . . 0.0 109.779 -179.758 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.444 ' HB ' HD22 ' A' ' 61' ' ' LEU . 13.1 m -56.0 -37.41 69.08 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.257 -0.902 . . . . 0.0 109.415 -179.973 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.583 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 1.9 mm? -110.37 8.88 23.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.327 -0.858 . . . . 0.0 109.776 -179.653 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.585 ' CZ ' ' OH ' ' A' ' 35' ' ' TYR . 63.7 t80 -71.29 133.54 46.13 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.25 -0.906 . . . . 0.0 110.074 -179.617 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.51 ' O ' ' N ' ' A' ' 65' ' ' LYS . 15.9 t70 -86.98 100.72 12.81 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.248 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.596 ' CZ ' ' HA ' ' A' ' 44' ' ' ARG . 0.1 OUTLIER -66.22 67.87 0.05 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.299 -0.876 . . . . 0.0 109.391 -179.23 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.51 ' N ' ' O ' ' A' ' 63' ' ' ASP . 0.3 OUTLIER 176.01 -40.96 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.481 -0.762 . . . . 0.0 108.957 -179.917 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.72 -27.53 18.0 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.318 -0.864 . . . . 0.0 109.195 179.709 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . 0.455 ' HA3' ' NH2' ' A' ' 17' ' ' ARG . . . 90.55 33.52 8.5 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.851 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.469 ' CD1' ' C ' ' A' ' 68' ' ' ILE . 2.3 pp -140.42 174.84 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.086 -1.244 . . . . 0.0 109.76 179.967 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.536 ' CB ' ' HA ' ' A' ' 62' ' ' PHE . 0.6 OUTLIER -155.4 -167.97 2.69 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.373 -0.829 . . . . 0.0 109.277 179.676 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . 0.448 ' SG ' ' O ' ' A' ' 69' ' ' LEU . 7.8 m . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.33 -0.856 . . . . 0.0 109.27 179.67 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' TRP . . . . . 0.633 ' CE3' ' CB ' ' A' ' 18' ' ' ARG . 52.7 m95 . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 57.0 mt -100.51 159.59 15.03 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.327 -0.858 . . . . 0.0 109.585 -179.698 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . 0.466 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 0.3 OUTLIER -49.83 132.71 22.37 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.256 -0.902 . . . . 0.0 109.319 179.792 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' CYS . . . . . 0.523 ' CB ' ' HB2' ' A' ' 17' ' ' ARG . 29.3 t -88.26 112.82 52.09 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.26 -0.9 . . . . 0.0 109.718 -179.74 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.466 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 36.5 Cg_endo -79.75 -59.41 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.46 2.107 . . . . 0.0 110.75 179.905 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 9' ' ' PRO . . . -38.52 -39.66 0.49 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.59 -0.694 . . . . 0.0 110.424 -179.455 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.58 ' CD1' ' CD1' ' A' ' 15' ' ' TRP . 13.3 mt -95.34 -64.61 1.04 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.054 -1.029 . . . . 0.0 109.711 -179.931 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.404 ' O ' ' O ' ' A' ' 8' ' ' CYS . . . 152.98 -152.05 23.76 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -179.824 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.13 148.51 21.62 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.655 2.237 . . . . 0.0 110.399 -179.878 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.17 -51.82 1.64 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.893 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.635 ' CZ3' ' CD2' ' A' ' 53' ' ' LEU . 15.3 t-105 -69.24 126.68 30.53 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.307 -1.114 . . . . 0.0 109.504 -179.991 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.472 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -94.87 114.03 25.84 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.249 -0.907 . . . . 0.0 108.947 179.751 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.627 ' NH1' ' CZ ' ' A' ' 62' ' ' PHE . 2.9 ttm180 -94.67 96.71 9.58 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.161 -0.962 . . . . 0.0 109.844 -179.534 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.633 ' CB ' ' CE3' ' A' ' 5' ' ' TRP . 9.7 tpt180 -100.7 146.0 27.75 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.198 -0.939 . . . . 0.0 109.526 179.63 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.508 ' HG2' ' NH1' ' A' ' 18' ' ' ARG . 8.6 pt-20 -109.0 164.36 12.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.191 -0.943 . . . . 0.0 109.43 179.871 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . 0.454 ' HB ' ' HB2' ' A' ' 32' ' ' ASP . 96.7 t . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.216 -0.928 . . . . 0.0 109.463 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' ASP . . . . . 0.454 ' HB2' ' HB ' ' A' ' 20' ' ' VAL . 8.5 m-20 . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.579 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 0.0 OUTLIER -103.94 110.1 22.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.165 -0.959 . . . . 0.0 109.637 -179.727 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.528 ' CD1' ' HB3' ' A' ' 44' ' ' ARG . 19.3 m-30 -106.26 143.1 34.87 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.138 -0.976 . . . . 0.0 109.164 179.803 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.573 ' CE1' ' HG3' ' A' ' 17' ' ' ARG . 5.0 m-85 -122.02 156.71 32.92 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.172 -0.955 . . . . 0.0 109.832 -179.507 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.425 ' OE1' ' HD2' ' A' ' 42' ' ' ARG . 44.5 tt0 -130.61 121.45 25.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.385 -0.822 . . . . 0.0 109.166 179.953 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.445 ' CB ' ' HD2' ' A' ' 38' ' ' PRO . 0.5 OUTLIER -76.37 171.56 11.88 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.154 -0.966 . . . . 0.0 109.746 -179.748 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.445 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 36.0 Cg_endo -77.93 -4.58 14.57 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.729 2.286 . . . . 0.0 110.437 179.994 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.475 ' CG2' ' OH ' ' A' ' 52' ' ' TYR . 12.3 t -100.11 -12.82 19.32 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.225 -0.922 . . . . 0.0 109.343 179.881 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 106.04 18.06 11.96 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.996 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.8 112.23 24.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -1.131 . . . . 0.0 109.354 -179.978 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' ARG . . . . . 0.425 ' HD2' ' OE1' ' A' ' 36' ' ' GLN . 2.2 mtp180 -99.1 121.04 40.47 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.179 -0.95 . . . . 0.0 109.503 -179.943 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.522 ' CG2' ' HB3' ' A' ' 49' ' ' LEU . 2.2 mp -118.46 168.03 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.251 -0.906 . . . . 0.0 109.472 179.98 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . 0.574 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 0.0 OUTLIER -153.74 14.99 0.49 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.338 -0.851 . . . . 0.0 109.845 -179.627 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.556 ' O ' ' CB ' ' A' ' 46' ' ' LYS . 7.5 t -95.67 -79.31 0.44 Allowed 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.028 -1.045 . . . . 0.0 108.452 179.346 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.584 ' HB2' ' CD1' ' A' ' 64' ' ' PHE . 4.6 ttpm? 153.45 -61.77 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 179.421 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.524 ' O ' ' CG ' ' A' ' 51' ' ' ARG . 50.0 t -82.93 -24.52 8.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 178.63 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.438 ' O ' ' HG3' ' A' ' 51' ' ' ARG . 23.3 tt0 -64.66 -48.21 75.6 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 179.012 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' LEU . . . . . 0.522 ' HB3' ' CG2' ' A' ' 43' ' ' ILE . 2.3 pp -68.8 -30.81 69.46 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 178.918 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' THR . . . . . 0.523 ' CG2' ' HA ' ' A' ' 58' ' ' ASP . 24.0 m -61.24 -67.96 0.36 Allowed 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.857 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.524 ' CG ' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -47.19 -31.13 3.39 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.375 -0.828 . . . . 0.0 108.934 179.456 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.475 ' OH ' ' CG2' ' A' ' 39' ' ' THR . 2.1 t80 -64.68 -62.56 1.5 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.287 -0.883 . . . . 0.0 108.95 179.422 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.635 ' CD2' ' CZ3' ' A' ' 15' ' ' TRP . 0.8 OUTLIER -49.82 -51.91 36.29 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.285 -0.884 . . . . 0.0 109.238 179.569 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 124.19 -151.23 17.13 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 -179.592 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.45 -12.74 16.91 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.562 2.174 . . . . 0.0 110.168 179.746 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.18 -3.18 31.5 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.337 -0.852 . . . . 0.0 109.358 179.749 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' CYS . . . . . 0.452 ' SG ' ' CB ' ' A' ' 53' ' ' LEU . 60.0 m -135.53 -176.2 4.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.196 -0.94 . . . . 0.0 109.5 -179.906 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.523 ' HA ' ' CG2' ' A' ' 50' ' ' THR . 12.1 t70 179.26 142.31 0.12 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.348 -0.845 . . . . 0.0 108.964 179.876 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.547 HD23 ' CD2' ' A' ' 62' ' ' PHE . 5.1 mp -152.89 16.77 0.58 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.135 -0.978 . . . . 0.0 109.55 -179.483 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.464 HG21 ' CD2' ' A' ' 61' ' ' LEU . 58.5 m -44.38 -40.23 5.24 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.377 -0.827 . . . . 0.0 109.412 -179.956 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' LEU . . . . . 0.543 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 1.4 mm? -111.57 -8.54 14.23 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.395 -0.815 . . . . 0.0 109.67 -179.834 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.627 ' CZ ' ' NH1' ' A' ' 17' ' ' ARG . 80.6 t80 -50.53 138.45 17.54 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.227 -0.921 . . . . 0.0 109.835 -179.368 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.525 ' OD1' ' CG ' ' A' ' 65' ' ' LYS . 3.9 t0 -89.44 113.52 24.88 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.447 -0.783 . . . . 0.0 109.158 179.714 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.584 ' CD1' ' HB2' ' A' ' 46' ' ' LYS . 1.1 t80 -72.06 63.78 0.51 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.126 -0.984 . . . . 0.0 109.728 -179.781 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.525 ' CG ' ' OD1' ' A' ' 63' ' ' ASP . 0.0 OUTLIER 167.82 -36.32 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.394 -0.816 . . . . 0.0 109.079 179.639 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -83.77 -41.57 17.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.142 -0.974 . . . . 0.0 108.948 179.411 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.84 28.0 8.07 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 179.666 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' ILE . . . . . 0.496 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 2.6 pp -140.52 179.47 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.114 -1.227 . . . . 0.0 109.668 179.938 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' LEU . . . . . 0.505 ' HB3' ' HA ' ' A' ' 62' ' ' PHE . 0.6 OUTLIER -160.34 -175.78 5.24 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.409 -0.807 . . . . 0.0 109.111 179.934 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 32.1 p . . . . . 0 N--CA 1.489 1.513 0 O-C-N 121.237 -0.914 . . . . 0.0 109.444 179.587 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 176.54 -175.54 0.12 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.317 -0.864 . . . . 0.0 109.276 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.439 ' HG2' ' HD3' ' A' ' 18' ' ' ARG . 0.5 OUTLIER -127.67 -92.16 0.48 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.229 -0.919 . . . . 0.0 109.587 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.449 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 1.2 t0 -139.32 35.45 2.07 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.173 -0.954 . . . . 0.0 109.585 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.473 ' CE3' ' HB2' ' A' ' 18' ' ' ARG . 69.7 m95 -54.68 94.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.2 -0.938 . . . . 0.0 109.431 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' A' ' 4' ' ' ASP . 18.1 mt -109.28 160.87 15.78 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.215 -0.928 . . . . 0.0 109.615 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.44 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 0.2 OUTLIER -49.72 130.36 20.93 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.323 -0.861 . . . . 0.0 109.592 -179.885 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.522 ' SG ' ' CZ ' ' A' ' 17' ' ' ARG . 26.9 t -81.61 115.17 55.19 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.276 -0.89 . . . . 0.0 109.4 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.455 ' O ' ' C ' ' A' ' 10' ' ' ALA . 36.2 Cg_endo -78.57 -55.62 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.498 2.132 . . . . 0.0 111.088 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.455 ' C ' ' O ' ' A' ' 9' ' ' PRO . . . -39.69 -56.73 1.65 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.36 -0.838 . . . . 0.0 110.098 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.507 HD11 ' CG ' ' A' ' 15' ' ' TRP . 12.0 mt -83.31 -56.94 3.48 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.282 -0.886 . . . . 0.0 109.706 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 140.04 -146.48 17.96 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.57 158.15 32.26 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.62 2.214 . . . . 0.0 110.802 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.15 -38.89 3.14 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.774 -1.331 . . . . 0.0 109.774 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.585 ' CZ3' HD22 ' A' ' 53' ' ' LEU . 17.1 t-105 -89.0 130.0 35.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.268 -1.137 . . . . 0.0 109.585 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.427 ' HG2' ' HB3' ' A' ' 5' ' ' TRP . 0.1 OUTLIER -97.54 127.75 43.75 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.2 -0.937 . . . . 0.0 108.919 179.626 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.623 ' NH1' ' CE1' ' A' ' 62' ' ' PHE . 1.6 ttm180 -107.32 98.84 8.42 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.142 -0.974 . . . . 0.0 109.917 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.473 ' HB2' ' CE3' ' A' ' 5' ' ' TRP . 0.4 OUTLIER -100.24 145.65 27.82 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.316 -0.865 . . . . 0.0 109.201 179.601 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -121.91 158.33 29.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.11 -0.994 . . . . 0.0 109.802 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.46 ' O ' ' HB2' ' A' ' 31' ' ' SER . 2.3 t -139.9 161.13 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.396 -0.815 . . . . 0.0 109.205 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 9.8 m-85 48.59 27.95 1.63 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.141 -0.974 . . . . 0.0 109.328 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.23 -40.07 6.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.258 -0.901 . . . . 0.0 109.65 -179.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.67 -83.92 0.09 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.224 -0.922 . . . . 0.0 109.422 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.2 t -64.54 133.85 53.21 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.238 -0.914 . . . . 0.0 109.459 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 142.21 153.6 5.95 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.92 172.55 0.08 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.314 -1.109 . . . . 0.0 109.463 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 6.2 m -59.96 -14.84 17.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 0.0 109.485 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 37.1 t -119.38 31.59 6.52 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.195 -0.94 . . . . 0.0 109.385 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.86 99.88 0.88 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 -46.66 116.42 1.31 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.24 -1.153 . . . . 0.0 109.361 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.46 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 2.2 p -96.95 122.44 39.94 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.903 . . . . 0.0 109.486 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -79.42 157.14 27.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.21 -0.931 . . . . 0.0 108.652 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.444 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 0.3 OUTLIER -135.26 124.36 24.36 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.983 -1.073 . . . . 0.0 110.254 -179.456 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.574 ' CD1' ' HG2' ' A' ' 44' ' ' ARG . 16.7 m-85 -123.62 143.8 50.01 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 179.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.578 ' CE1' ' HG3' ' A' ' 17' ' ' ARG . 9.8 m-85 -116.01 154.42 29.89 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.107 -0.995 . . . . 0.0 110.204 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -122.41 120.41 33.87 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.473 ' HB3' ' HD2' ' A' ' 38' ' ' PRO . 0.7 OUTLIER -68.41 168.35 14.46 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 121.394 -0.816 . . . . 0.0 109.023 179.915 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.473 ' HD2' ' HB3' ' A' ' 37' ' ' SER . 34.7 Cg_endo -78.0 6.12 4.85 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.502 2.134 . . . . 0.0 110.577 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.3 t -116.56 -21.7 9.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.131 -0.981 . . . . 0.0 109.498 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 119.18 15.91 5.42 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.468 ' O ' ' OG ' ' A' ' 37' ' ' SER . 3.5 m-20 -96.81 107.03 19.44 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.248 -1.149 . . . . 0.0 109.297 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.26 132.29 33.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.132 -0.98 . . . . 0.0 109.658 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.484 HG22 ' N ' ' A' ' 49' ' ' LEU . 3.0 mp -130.04 149.93 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.325 -0.859 . . . . 0.0 109.239 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.574 ' HG2' ' CD1' ' A' ' 34' ' ' TYR . 51.5 mtm180 -142.17 9.35 1.88 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.091 -1.006 . . . . 0.0 110.058 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.526 ' HB3' ' CB ' ' A' ' 48' ' ' GLU . 0.5 OUTLIER -97.19 14.08 27.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.039 -1.038 . . . . 0.0 109.393 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.577 ' HA ' ' CE1' ' A' ' 64' ' ' PHE . 5.9 ttpp 62.73 -94.09 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.442 -0.786 . . . . 0.0 109.98 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.433 ' N ' ' HG2' ' A' ' 46' ' ' LYS . 48.6 t -52.87 -31.9 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.904 -1.122 . . . . 0.0 109.485 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.526 ' CB ' ' HB3' ' A' ' 45' ' ' SER . 67.4 tt0 -53.33 -45.54 69.1 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.067 -1.021 . . . . 0.0 108.784 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.575 HD13 ' CZ2' ' A' ' 15' ' ' TRP . 0.9 OUTLIER -71.88 -28.71 63.7 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.114 -0.991 . . . . 0.0 108.547 179.281 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.526 ' OG1' ' CD1' ' A' ' 59' ' ' LEU . 2.3 m -61.96 -65.28 0.71 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.0 -24.26 16.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.465 -0.772 . . . . 0.0 109.23 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.41 ' O ' ' C ' ' A' ' 53' ' ' LEU . 29.9 t80 -70.55 -68.11 0.45 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.227 -0.92 . . . . 0.0 108.992 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.585 HD22 ' CZ3' ' A' ' 15' ' ' TRP . 1.0 OUTLIER -45.17 -36.03 3.55 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.267 -0.896 . . . . 0.0 109.293 179.661 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 112.69 -157.6 14.84 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.81 6.13 4.77 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.567 2.178 . . . . 0.0 110.532 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -85.31 -21.45 28.95 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.216 -0.928 . . . . 0.0 109.614 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 50.9 m -135.89 164.38 28.08 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.037 -1.039 . . . . 0.0 109.663 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.41 ' HA ' ' CG2' ' A' ' 50' ' ' THR . 26.3 p30 -152.97 150.73 29.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.243 -0.91 . . . . 0.0 109.433 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.637 ' CD2' ' CD2' ' A' ' 62' ' ' PHE . 2.6 mp -143.71 12.09 1.67 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.242 -0.911 . . . . 0.0 109.593 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.472 ' HB ' HD22 ' A' ' 61' ' ' LEU . 3.4 m -46.04 -46.08 16.47 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.174 -0.954 . . . . 0.0 109.401 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.585 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 2.4 mm? -101.58 0.53 36.55 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.272 -0.893 . . . . 0.0 109.512 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.637 ' CD2' ' CD2' ' A' ' 59' ' ' LEU . 65.1 t80 -66.36 137.48 56.92 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.364 -0.835 . . . . 0.0 109.944 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.31 111.75 22.66 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.261 -0.899 . . . . 0.0 109.04 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.577 ' CE1' ' HA ' ' A' ' 46' ' ' LYS . 0.6 OUTLIER -70.26 59.33 0.18 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.207 -0.933 . . . . 0.0 109.11 -179.632 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.52 -40.46 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.378 -0.826 . . . . 0.0 109.093 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -90.4 -29.25 18.13 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.293 -0.88 . . . . 0.0 109.356 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.577 ' HA2' ' CE1' ' A' ' 62' ' ' PHE . . . 87.15 33.93 11.37 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.429 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 1.3 pt -140.98 155.39 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.065 -1.256 . . . . 0.0 110.004 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.502 ' HB3' ' HA ' ' A' ' 62' ' ' PHE . 1.9 pt? -143.26 146.24 33.44 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 3.5 m -121.49 156.79 32.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.983 -1.073 . . . . 0.0 109.937 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.571 ' CG ' ' O ' ' A' ' 71' ' ' TYR . 5.0 p90 -146.11 98.84 4.33 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.407 -0.808 . . . . 0.0 109.251 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -76.74 91.12 1.17 Allowed 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.46 2.107 . . . . 0.0 110.367 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 48.22 91.24 0.07 OUTLIER Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.243 -0.911 . . . . 0.0 109.401 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.4 69.88 7.03 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.581 2.187 . . . . 0.0 110.277 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.6 mttt . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 117.978 -1.01 . . . . 0.0 109.527 -179.902 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.425 ' HG2' ' O ' ' A' ' 1' ' ' MET . 17.4 ttt . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.15 0.5 . . . . 0.0 109.671 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -55.75 133.24 50.79 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.247 -0.908 . . . . 0.0 109.278 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -97.66 -71.63 0.68 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.224 -0.922 . . . . 0.0 109.554 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.514 ' O ' ' N ' ' A' ' 6' ' ' LEU . 0.2 OUTLIER -148.06 27.12 0.96 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.183 -0.948 . . . . 0.0 109.479 -179.921 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.579 ' CZ2' ' HD3' ' A' ' 18' ' ' ARG . 66.6 m95 -49.54 92.24 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.309 -0.869 . . . . 0.0 109.338 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.514 ' N ' ' O ' ' A' ' 4' ' ' ASP . 0.6 OUTLIER -101.54 159.16 15.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.279 -0.888 . . . . 0.0 109.538 -179.82 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.472 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 12.3 t70 -48.85 132.55 18.21 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.282 -0.886 . . . . 0.0 109.213 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.457 ' O ' ' O ' ' A' ' 12' ' ' GLY . 23.5 t -96.42 109.33 47.19 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.24 -0.912 . . . . 0.0 109.337 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 36.1 Cg_endo -78.43 -32.96 2.02 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.297 1.998 . . . . 0.0 110.552 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.428 ' HB3' ' CD1' ' A' ' 62' ' ' PHE . . . -49.1 -56.99 7.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.272 -0.892 . . . . 0.0 109.506 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.638 ' CD1' ' CD1' ' A' ' 15' ' ' TRP . 4.7 mt -87.28 -56.36 3.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.177 -0.952 . . . . 0.0 109.613 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 8' ' ' CYS . . . 155.2 -150.37 21.83 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.19 159.47 33.4 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.681 2.254 . . . . 0.0 110.409 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 83.54 -52.77 4.78 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.638 ' CD1' ' CD1' ' A' ' 11' ' ' LEU . 4.4 t-105 -64.62 126.15 26.99 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.213 -1.169 . . . . 0.0 109.505 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.498 ' CG ' ' HB3' ' A' ' 5' ' ' TRP . 5.5 tptt -107.28 112.75 25.75 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.135 -0.978 . . . . 0.0 109.316 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.577 ' HG3' ' CE2' ' A' ' 35' ' ' TYR . 1.0 OUTLIER -87.15 116.28 25.12 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.242 -0.911 . . . . 0.0 109.457 -179.964 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.579 ' HD3' ' CZ2' ' A' ' 5' ' ' TRP . 10.0 ttp180 -95.63 141.04 29.6 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.222 -0.924 . . . . 0.0 109.483 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.495 ' CG ' ' O ' ' A' ' 19' ' ' GLU . 3.4 pt-20 -115.05 119.47 36.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.229 -0.92 . . . . 0.0 109.472 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.499 HG23 ' CZ ' ' A' ' 18' ' ' ARG . 20.5 t -126.36 156.89 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.233 -0.917 . . . . 0.0 109.634 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.479 ' CB ' ' HA ' ' A' ' 31' ' ' SER . 7.5 m-85 56.57 16.36 2.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.337 -0.852 . . . . 0.0 109.61 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.469 ' HA ' ' CB ' ' A' ' 31' ' ' SER . 0.0 OUTLIER -80.99 -20.37 41.98 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.121 -0.987 . . . . 0.0 108.882 179.619 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 25' ' ' GLY . 25.9 mttt -119.79 -76.26 0.58 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.429 -0.795 . . . . 0.0 109.299 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.476 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 13.3 t 63.2 -70.89 0.06 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.436 -0.79 . . . . 0.0 109.67 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . -158.52 -107.18 0.24 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.16 -159.11 0.11 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.284 -1.127 . . . . 0.0 109.109 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -96.96 84.45 3.56 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.096 -1.003 . . . . 0.0 109.288 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 7.7 p -158.18 64.64 0.45 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.348 -0.845 . . . . 0.0 109.572 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -168.5 113.54 0.53 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.418 ' O ' ' OG ' ' A' ' 31' ' ' SER . 0.0 OUTLIER -54.3 -20.42 7.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.199 -1.177 . . . . 0.0 109.591 -179.94 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.479 ' HA ' ' CB ' ' A' ' 21' ' ' PHE . 3.6 p 63.81 123.52 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.28 -0.887 . . . . 0.0 109.664 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -94.84 144.31 25.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.357 -0.84 . . . . 0.0 109.317 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.443 HG22 ' O ' ' A' ' 18' ' ' ARG . 57.6 m -115.05 121.46 43.16 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.188 -0.945 . . . . 0.0 109.711 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.548 ' CD2' ' HG3' ' A' ' 44' ' ' ARG . 12.5 m-85 -103.8 157.25 17.21 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.258 -0.901 . . . . 0.0 109.179 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.577 ' CE2' ' HG3' ' A' ' 17' ' ' ARG . 11.5 m-85 -129.33 139.66 51.66 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.111 -0.993 . . . . 0.0 109.897 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.54 ' HB2' ' CZ3' ' A' ' 5' ' ' TRP . 22.0 tt0 -124.83 130.16 51.84 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.364 -0.835 . . . . 0.0 109.385 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.527 ' HA ' ' CZ3' ' A' ' 15' ' ' TRP . 0.5 OUTLIER -69.94 175.92 2.07 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.227 -0.92 . . . . 0.0 109.368 179.989 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.497 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 35.0 Cg_endo -78.11 -2.03 12.16 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.6 2.2 . . . . 0.0 110.283 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 p -109.38 -17.24 13.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.327 -0.858 . . . . 0.0 109.29 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 119.75 4.35 11.74 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.427 ' CB ' ' OG ' ' A' ' 37' ' ' SER . 0.1 OUTLIER -77.67 109.0 11.28 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.199 -1.177 . . . . 0.0 109.155 179.87 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.6 mtt180 -97.05 124.36 41.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.336 -0.852 . . . . 0.0 109.889 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.535 ' CG2' ' HB3' ' A' ' 49' ' ' LEU . 3.0 mp -118.56 163.5 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.379 -0.826 . . . . 0.0 109.047 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.587 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 4.5 ttp180 -126.77 -23.82 3.63 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.126 -0.984 . . . . 0.0 110.327 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.577 ' CB ' ' HB2' ' A' ' 48' ' ' GLU . 0.5 OUTLIER -75.24 166.47 23.58 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.76 -1.212 . . . . 0.0 108.615 179.543 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.571 ' HB2' ' CD1' ' A' ' 64' ' ' PHE . 7.6 ttpt -86.56 -63.77 1.26 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.123 -0.985 . . . . 0.0 110.529 -178.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.489 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 89.3 t -76.58 -16.8 14.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.11 -0.994 . . . . 0.0 109.773 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.577 ' HB2' ' CB ' ' A' ' 45' ' ' SER . 14.3 mt-10 -72.57 -46.86 52.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.965 -1.084 . . . . 0.0 108.495 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.538 ' O ' ' CD1' ' A' ' 53' ' ' LEU . 2.9 pp -66.76 -21.64 66.05 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 178.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.524 ' OG1' ' CD1' ' A' ' 59' ' ' LEU . 27.3 m -73.07 -64.49 0.96 Allowed 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.489 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -49.66 -23.73 1.88 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.224 -0.922 . . . . 0.0 108.611 179.665 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.468 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 63.9 t80 -62.68 -61.5 2.38 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.319 -0.863 . . . . 0.0 108.732 179.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.578 HD23 ' CE3' ' A' ' 15' ' ' TRP . 0.9 OUTLIER -53.36 -59.25 4.82 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.294 -0.879 . . . . 0.0 109.227 179.521 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 147.88 -162.55 28.75 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.72 -2.96 13.09 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.566 2.177 . . . . 0.0 110.144 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.87 -28.62 35.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.292 -0.88 . . . . 0.0 109.61 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 5.8 m -115.32 139.52 49.91 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.171 -0.955 . . . . 0.0 109.353 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.464 ' HA ' HG23 ' A' ' 50' ' ' THR . 2.0 p30 -132.76 153.26 51.38 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.078 -1.013 . . . . 0.0 109.905 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.524 ' CD1' ' OG1' ' A' ' 50' ' ' THR . 6.0 mp -146.35 12.04 1.18 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.412 -0.805 . . . . 0.0 109.223 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.527 HG22 ' CD2' ' A' ' 61' ' ' LEU . 97.2 m -50.59 -31.55 16.23 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.237 -0.915 . . . . 0.0 109.093 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.587 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 1.2 mm? -111.11 -9.04 14.38 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.452 -0.78 . . . . 0.0 109.053 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.495 ' CZ ' ' HA2' ' A' ' 67' ' ' GLY . 61.7 t80 -56.08 129.68 40.95 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.412 -0.805 . . . . 0.0 109.168 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.466 ' O ' ' N ' ' A' ' 65' ' ' LYS . 19.2 t0 -79.04 104.01 9.38 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.246 -0.909 . . . . 0.0 109.141 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.587 ' CE2' ' O ' ' A' ' 44' ' ' ARG . 1.1 t80 -66.94 63.0 0.05 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.477 -0.764 . . . . 0.0 109.452 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.466 ' N ' ' O ' ' A' ' 63' ' ' ASP . 37.4 ttpt -179.65 -43.7 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.458 -0.776 . . . . 0.0 109.173 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -88.31 -45.57 9.92 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.314 -0.866 . . . . 0.0 109.315 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.495 ' HA2' ' CZ ' ' A' ' 62' ' ' PHE . . . 110.48 31.86 2.89 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.473 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 2.8 pp -140.35 166.85 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.208 -1.172 . . . . 0.0 109.431 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.478 ' CB ' ' HA ' ' A' ' 62' ' ' PHE . 0.7 OUTLIER -145.54 177.63 8.72 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.202 -0.936 . . . . 0.0 109.482 -179.869 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.449 ' SG ' ' O ' ' A' ' 69' ' ' LEU . 72.2 m -153.11 -179.33 7.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.366 -0.833 . . . . 0.0 109.292 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.519 ' CD1' ' N ' ' A' ' 71' ' ' TYR . 7.4 m-85 -117.02 154.35 49.74 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.151 -0.968 . . . . 0.0 109.497 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.71 -161.02 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.559 2.173 . . . . 0.0 110.18 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 56.79 78.73 0.36 Allowed Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.203 -0.935 . . . . 0.0 109.428 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.91 -174.11 2.1 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.657 2.238 . . . . 0.0 110.37 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.541 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -54.59 134.58 46.74 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.284 -0.885 . . . . 0.0 109.553 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -92.69 -147.25 0.23 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.289 -0.882 . . . . 0.0 109.411 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -104.45 40.38 1.49 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.157 -0.965 . . . . 0.0 109.664 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.547 ' CE3' ' HB2' ' A' ' 18' ' ' ARG . 73.3 m95 -57.88 104.89 0.22 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.243 -0.911 . . . . 0.0 109.534 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.422 ' O ' ' C ' ' A' ' 7' ' ' ASP . 51.8 mt -114.49 148.97 37.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.214 -0.929 . . . . 0.0 109.358 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.446 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 0.2 OUTLIER -43.63 133.74 4.45 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.297 -0.877 . . . . 0.0 109.424 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.494 ' HB3' ' HB3' ' A' ' 15' ' ' TRP . 39.7 t -88.37 113.38 55.03 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.298 -0.876 . . . . 0.0 109.563 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.446 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 34.8 Cg_endo -77.47 -40.02 0.48 Allowed 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 122.287 1.992 . . . . 0.0 110.003 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.495 ' CB ' ' NH1' ' A' ' 17' ' ' ARG . . . -47.04 -42.44 18.48 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.318 -0.864 . . . . 0.0 109.452 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.488 HD21 ' CD1' ' A' ' 59' ' ' LEU . 13.1 mt -101.15 -61.34 1.38 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.322 -0.861 . . . . 0.0 109.491 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 8' ' ' CYS . . . 156.7 -149.06 19.73 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -77.27 153.21 31.37 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.517 2.145 . . . . 0.0 110.327 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.408 ' O ' ' C ' ' A' ' 15' ' ' TRP . . . 93.76 -74.79 1.13 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.542 ' NE1' ' HB3' ' A' ' 35' ' ' TYR . 22.2 t-105 -44.24 122.6 3.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.275 -1.133 . . . . 0.0 109.304 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.3 mmtt -97.04 108.75 21.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.173 -0.954 . . . . 0.0 109.66 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.603 ' NH1' ' CE1' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -87.1 106.33 17.79 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.199 -0.938 . . . . 0.0 109.389 179.863 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.547 ' HB2' ' CE3' ' A' ' 5' ' ' TRP . 5.1 ttt180 -100.02 147.52 25.52 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.235 -0.915 . . . . 0.0 109.749 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.441 ' HA ' HG22 ' A' ' 33' ' ' THR . 22.0 pt-20 -116.67 155.27 29.11 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.356 -0.84 . . . . 0.0 109.241 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.528 HG21 ' CE1' ' A' ' 34' ' ' TYR . 0.9 OUTLIER -140.28 143.35 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.165 -0.96 . . . . 0.0 109.407 -179.972 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.515 ' O ' ' N ' ' A' ' 23' ' ' LYS . 2.3 p90 -110.91 40.56 2.0 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.273 -0.892 . . . . 0.0 109.469 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.447 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 29.4 mtp180 60.68 -79.8 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.312 -0.867 . . . . 0.0 109.329 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.515 ' N ' ' O ' ' A' ' 21' ' ' PHE . 1.3 mttt -153.57 -169.23 3.23 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.278 -0.889 . . . . 0.0 109.396 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.8 p -80.3 124.48 28.88 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.253 -0.904 . . . . 0.0 109.398 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 123.35 103.14 1.62 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -88.82 137.74 32.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.245 -1.15 . . . . 0.0 109.684 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.05 -46.16 0.78 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.292 -0.88 . . . . 0.0 109.399 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 6.4 m -138.89 47.72 1.92 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.277 -0.89 . . . . 0.0 109.388 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.456 ' O ' ' HB3' ' A' ' 30' ' ' ARG . . . 49.88 -131.77 27.83 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.476 ' HG3' ' N ' ' A' ' 31' ' ' SER . 2.5 tpt85 65.07 153.99 0.07 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.276 -1.132 . . . . 0.0 109.611 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.476 ' N ' ' HG3' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -177.77 133.01 0.16 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.298 -0.876 . . . . 0.0 109.363 -179.991 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.74 157.91 27.03 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.225 -0.922 . . . . 0.0 109.291 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.512 ' CG2' ' O ' ' A' ' 18' ' ' ARG . 2.1 m -139.56 142.9 37.15 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.245 -0.909 . . . . 0.0 109.619 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.559 ' CD1' ' N ' ' A' ' 34' ' ' TYR . 6.1 m-85 -135.58 151.86 50.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.337 -0.852 . . . . 0.0 109.243 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.649 ' CE2' ' CZ ' ' A' ' 64' ' ' PHE . 9.8 m-85 -117.61 146.34 43.71 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.207 -0.933 . . . . 0.0 109.735 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.487 ' CB ' ' CZ3' ' A' ' 5' ' ' TRP . 35.7 tt0 -131.27 123.62 28.77 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.373 -0.83 . . . . 0.0 109.259 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.46 ' CB ' ' HD2' ' A' ' 38' ' ' PRO . 0.4 OUTLIER -66.15 173.07 2.41 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.263 -0.898 . . . . 0.0 108.965 179.823 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.46 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 36.1 Cg_endo -78.0 4.13 6.42 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.51 2.14 . . . . 0.0 110.291 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.4 p -111.62 -17.37 13.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.331 -0.855 . . . . 0.0 109.444 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 120.46 5.41 10.29 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.458 ' O ' ' HA ' ' A' ' 36' ' ' GLN . 6.7 t0 -74.9 136.78 41.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.199 -1.177 . . . . 0.0 109.364 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.4 mtp180 -121.07 116.46 25.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.196 -0.94 . . . . 0.0 109.277 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.527 HG22 ' CA ' ' A' ' 49' ' ' LEU . 4.4 mt -123.35 152.93 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.228 -0.92 . . . . 0.0 109.924 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.577 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 4.9 ttt-85 -128.49 -24.04 3.11 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.282 -0.886 . . . . 0.0 109.909 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.527 ' CB ' ' HB2' ' A' ' 48' ' ' GLU . 1.7 m -73.56 147.89 43.5 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.979 -1.076 . . . . 0.0 108.909 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.483 ' HA ' HD22 ' A' ' 49' ' ' LEU . 24.4 ttpt -68.96 -71.84 0.2 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.287 -0.883 . . . . 0.0 110.811 -178.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.483 ' HA ' ' OG1' ' A' ' 50' ' ' THR . 62.5 t -67.37 -14.96 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.031 -1.043 . . . . 0.0 110.274 -178.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.527 ' HB2' ' CB ' ' A' ' 45' ' ' SER . 2.4 tt0 -72.45 -51.97 17.9 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.884 -1.135 . . . . 0.0 108.502 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.527 ' CA ' HG22 ' A' ' 43' ' ' ILE . 1.9 pp -63.17 -28.7 70.24 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.523 ' OG1' ' HB2' ' A' ' 59' ' ' LEU . 0.2 OUTLIER -68.2 -55.41 12.38 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 178.376 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.417 ' HD3' ' HA ' ' A' ' 51' ' ' ARG . 48.6 mmt-85 -52.0 -24.3 6.39 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.469 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 44.4 t80 -73.3 -50.76 20.41 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.532 -0.73 . . . . 0.0 109.196 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.52 HD23 ' CE3' ' A' ' 15' ' ' TRP . 0.4 OUTLIER -66.57 -53.0 39.33 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -0.909 . . . . 0.0 109.063 179.739 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 121.9 -146.42 17.01 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.62 -34.74 1.28 Allowed 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.512 2.141 . . . . 0.0 110.495 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -45.18 -33.95 2.52 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.302 -0.874 . . . . 0.0 109.837 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 67.2 m -122.07 148.51 44.77 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.165 -0.959 . . . . 0.0 109.767 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -126.82 146.27 50.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.276 -0.89 . . . . 0.0 109.422 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.523 ' HB2' ' OG1' ' A' ' 50' ' ' THR . 0.2 OUTLIER -144.99 6.85 1.18 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.277 -0.889 . . . . 0.0 110.332 -179.157 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.45 ' HB ' HD22 ' A' ' 61' ' ' LEU . 5.0 m -47.09 -41.88 17.95 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.062 -1.024 . . . . 0.0 109.861 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.545 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 1.4 mm? -110.1 13.2 23.3 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.166 -0.959 . . . . 0.0 110.113 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.603 ' CE1' ' NH1' ' A' ' 17' ' ' ARG . 51.5 t80 -69.5 136.1 51.01 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.201 -0.937 . . . . 0.0 109.549 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' A' ' 65' ' ' LYS . 0.3 OUTLIER -89.81 105.13 17.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.315 -0.866 . . . . 0.0 109.248 179.728 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.649 ' CZ ' ' CE2' ' A' ' 35' ' ' TYR . 0.4 OUTLIER -69.98 61.33 0.19 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.245 -0.909 . . . . 0.0 109.411 -179.594 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.417 ' N ' ' O ' ' A' ' 63' ' ' ASP . 5.6 ttpt -174.46 -37.37 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.318 -0.864 . . . . 0.0 109.018 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -97.59 -38.74 9.43 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.419 -0.801 . . . . 0.0 109.111 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.424 ' C ' HG21 ' A' ' 68' ' ' ILE . . . 103.67 32.36 4.51 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 2.7 pp -139.87 173.38 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.162 -1.199 . . . . 0.0 109.58 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.495 ' CB ' ' HA ' ' A' ' 62' ' ' PHE . 0.6 OUTLIER -149.89 -165.07 2.17 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.243 -0.911 . . . . 0.0 109.385 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.425 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 0.5 OUTLIER -160.36 168.46 25.19 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.334 -0.854 . . . . 0.0 109.344 179.628 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -138.71 77.42 33.28 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.179 -0.95 . . . . 0.0 109.408 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.515 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 35.1 Cg_endo -77.75 -159.67 0.1 Allowed 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.603 2.202 . . . . 0.0 110.187 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.54 ' N ' ' HD2' ' A' ' 74' ' ' PRO . . . 164.07 -52.97 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.171 -0.956 . . . . 0.0 109.989 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 73' ' ' ALA . 35.8 Cg_endo -77.75 -61.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.435 2.09 . . . . 0.0 110.46 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 118.007 -0.996 . . . . 0.0 109.486 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 tpt . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -54.72 178.1 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.285 -0.884 . . . . 0.0 109.608 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.449 ' O ' ' OD1' ' A' ' 4' ' ' ASP . 82.3 mt-10 -95.6 156.29 16.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.282 -0.886 . . . . 0.0 109.392 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.449 ' OD1' ' O ' ' A' ' 3' ' ' GLU . 47.2 m-20 -150.63 67.86 0.95 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.182 -0.949 . . . . 0.0 109.647 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.574 ' CE3' ' HB2' ' A' ' 18' ' ' ARG . 84.1 m95 -44.14 102.73 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.234 -0.916 . . . . 0.0 109.416 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.448 HD22 ' O ' ' A' ' 4' ' ' ASP . 0.5 OUTLIER -110.26 154.33 23.58 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.221 -0.924 . . . . 0.0 109.509 -179.947 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.419 ' C ' ' O ' ' A' ' 6' ' ' LEU . 2.0 m-20 -43.9 146.31 0.6 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.291 -0.881 . . . . 0.0 109.471 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.469 ' HB2' ' HB2' ' A' ' 17' ' ' ARG . 45.4 t -111.88 100.75 49.7 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.197 -0.94 . . . . 0.0 109.457 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.506 ' HD2' ' NH2' ' A' ' 17' ' ' ARG . 34.4 Cg_endo -76.6 -33.89 2.85 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.438 2.092 . . . . 0.0 110.569 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.439 ' HB1' HD23 ' A' ' 11' ' ' LEU . . . -42.47 -48.43 5.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.308 -0.87 . . . . 0.0 109.609 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.567 HD11 ' CD1' ' A' ' 15' ' ' TRP . 3.1 mt -94.13 -61.99 1.42 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.247 -0.908 . . . . 0.0 109.457 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 8' ' ' CYS . . . 168.69 -158.67 31.45 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.94 145.92 20.11 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.592 2.195 . . . . 0.0 110.452 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.03 -49.83 1.22 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.567 ' CD1' HD11 ' A' ' 11' ' ' LEU . 15.7 t-105 -65.66 129.77 40.93 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.233 -1.157 . . . . 0.0 109.468 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.8 mmtp -100.99 123.02 44.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.172 -0.955 . . . . 0.0 109.394 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.506 ' NH2' ' HD2' ' A' ' 9' ' ' PRO . 7.7 ttp85 -94.19 110.65 22.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.16 -0.962 . . . . 0.0 109.588 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.574 ' HB2' ' CE3' ' A' ' 5' ' ' TRP . 0.5 OUTLIER -99.71 141.77 32.08 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.325 -0.859 . . . . 0.0 109.053 179.653 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.5 pt-20 -124.46 141.84 51.77 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.186 -0.947 . . . . 0.0 109.875 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 87.7 t -132.64 146.82 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.24 -0.913 . . . . 0.0 109.349 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -98.59 71.26 1.97 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.286 -0.884 . . . . 0.0 109.592 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.408 ' O ' ' C ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -72.46 81.89 1.07 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.263 -0.898 . . . . 0.0 109.391 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.408 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -45.82 138.75 4.6 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.225 -0.922 . . . . 0.0 109.162 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.1 t -125.24 -47.57 1.75 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.212 -0.93 . . . . 0.0 109.641 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -126.84 -144.99 6.16 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -69.77 -71.45 0.23 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.285 -1.126 . . . . 0.0 109.57 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.404 ' O ' ' C ' ' A' ' 28' ' ' CYS . 21.1 p -135.65 27.56 3.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.215 -0.928 . . . . 0.0 109.596 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.404 ' C ' ' O ' ' A' ' 27' ' ' THR . 35.9 m -46.09 -76.98 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.169 -0.957 . . . . 0.0 109.27 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.85 41.08 0.8 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.75 -69.14 0.4 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.263 -1.14 . . . . 0.0 109.571 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.1 m 65.86 175.01 0.22 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.26 -0.9 . . . . 0.0 109.22 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -136.09 164.36 28.21 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.179 -0.951 . . . . 0.0 109.406 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.469 ' O ' ' CE1' ' A' ' 35' ' ' TYR . 4.5 m -139.34 98.52 3.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.298 -0.876 . . . . 0.0 109.542 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.515 ' CD1' ' HB3' ' A' ' 44' ' ' ARG . 13.0 m-85 -99.95 160.65 14.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.401 -0.812 . . . . 0.0 108.984 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.64 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 1.6 m-85 -131.78 156.46 45.94 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.977 -1.077 . . . . 0.0 109.912 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.539 ' HB2' ' CZ3' ' A' ' 5' ' ' TRP . 11.3 tt0 -129.66 129.97 44.97 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.441 -0.787 . . . . 0.0 109.047 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.448 ' CB ' ' HD2' ' A' ' 38' ' ' PRO . 0.6 OUTLIER -68.68 172.06 5.25 Favored Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 121.269 -0.894 . . . . 0.0 109.257 -179.976 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.448 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 35.1 Cg_endo -77.66 4.56 5.92 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.623 2.215 . . . . 0.0 110.408 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.6 t -122.13 -20.23 6.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.307 -0.871 . . . . 0.0 109.58 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 128.59 6.51 4.62 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.402 ' CB ' ' HB2' ' A' ' 37' ' ' SER . 0.5 OUTLIER -80.29 105.88 11.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.123 -1.222 . . . . 0.0 109.146 179.79 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.405 ' HG3' ' HG3' ' A' ' 36' ' ' GLN . 15.6 mtp180 -97.5 125.43 42.18 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.181 -0.95 . . . . 0.0 110.078 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.557 ' CG2' ' HB3' ' A' ' 49' ' ' LEU . 4.8 mt -127.65 163.91 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.515 ' HB3' ' CD1' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -160.31 18.17 0.14 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.894 -1.129 . . . . 0.0 110.654 -179.575 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.535 ' HB2' ' CB ' ' A' ' 48' ' ' GLU . 0.4 OUTLIER -99.98 18.13 19.24 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.856 -1.152 . . . . 0.0 109.397 179.761 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.597 ' HB2' ' CD1' ' A' ' 64' ' ' PHE . 12.7 tttt 64.36 -92.49 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.502 -0.749 . . . . 0.0 110.473 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.482 ' HA ' ' OG1' ' A' ' 50' ' ' THR . 74.8 t -62.33 -27.93 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.018 -1.051 . . . . 0.0 109.369 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.535 ' CB ' ' HB2' ' A' ' 45' ' ' SER . 23.9 tt0 -61.06 -49.28 77.99 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.557 ' HB3' ' CG2' ' A' ' 43' ' ' ILE . 0.8 OUTLIER -68.13 -23.72 64.93 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.814 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.544 ' OG1' ' CB ' ' A' ' 59' ' ' LEU . 26.9 m -65.65 -70.87 0.21 Allowed 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.425 ' C ' ' O ' ' A' ' 50' ' ' THR . 0.0 OUTLIER -43.57 -26.79 0.24 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.507 -0.746 . . . . 0.0 109.028 179.547 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.422 ' N ' ' O ' ' A' ' 50' ' ' THR . 37.1 t80 -64.16 -62.95 1.29 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.286 -0.884 . . . . 0.0 109.565 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.527 ' CD1' ' O ' ' A' ' 49' ' ' LEU . 0.5 OUTLIER -55.57 -57.94 9.84 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.125 -0.984 . . . . 0.0 109.274 -179.92 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 131.06 -155.01 21.07 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.48 -9.5 16.11 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.623 2.216 . . . . 0.0 110.528 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -81.14 -13.99 58.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.302 -0.874 . . . . 0.0 109.638 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.449 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 88.1 m -134.07 79.27 1.8 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.191 -0.943 . . . . 0.0 109.596 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.54 137.23 56.64 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.145 -0.972 . . . . 0.0 109.133 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.567 HD21 ' CG ' ' A' ' 62' ' ' PHE . 0.1 OUTLIER -140.46 5.42 2.04 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.276 -0.89 . . . . 0.0 109.878 -179.288 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.419 ' C ' HD23 ' A' ' 61' ' ' LEU . 54.5 m -62.15 -21.36 64.98 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.215 -0.928 . . . . 0.0 109.156 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.603 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 1.7 mm? -107.31 -11.74 15.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.387 -0.821 . . . . 0.0 109.217 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.571 ' CZ ' ' OH ' ' A' ' 35' ' ' TYR . 6.1 t80 -54.81 133.41 47.56 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.399 -0.813 . . . . 0.0 109.735 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.547 ' O ' ' CE1' ' A' ' 62' ' ' PHE . 2.4 t0 -80.57 104.74 11.31 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.283 -0.886 . . . . 0.0 108.882 179.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.597 ' CD1' ' HB2' ' A' ' 46' ' ' LYS . 0.6 OUTLIER -67.19 65.04 0.06 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.264 -0.898 . . . . 0.0 109.319 -179.426 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.472 ' N ' ' O ' ' A' ' 63' ' ' ASP . 6.3 mtpt 171.48 -37.9 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.396 -0.815 . . . . 0.0 109.388 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -88.16 -46.63 9.11 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.163 -0.961 . . . . 0.0 109.3 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.496 ' HA2' ' CZ ' ' A' ' 62' ' ' PHE . . . 111.77 25.69 4.75 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.457 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -140.72 171.43 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.011 -1.288 . . . . 0.0 109.69 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.458 ' HA ' ' HA ' ' A' ' 62' ' ' PHE . 1.1 pt? -140.49 -174.3 3.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.22 -0.925 . . . . 0.0 109.337 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 23.0 m -147.09 146.24 29.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.187 -0.945 . . . . 0.0 109.592 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.462 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 56.4 m-85 -97.35 161.31 26.47 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.253 -0.905 . . . . 0.0 109.4 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.462 ' HD2' ' HB3' ' A' ' 71' ' ' TYR . 35.7 Cg_endo -78.2 173.11 14.36 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.655 2.237 . . . . 0.0 110.664 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -144.11 79.76 12.81 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.3 -0.875 . . . . 0.0 109.277 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.25 116.74 3.95 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.674 2.249 . . . . 0.0 110.374 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.487 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ttt . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.17 -166.98 1.66 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.278 -0.889 . . . . 0.0 109.403 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.522 ' HG2' ' CZ ' ' A' ' 18' ' ' ARG . 23.4 mp0 -86.07 -171.81 3.76 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.222 -0.924 . . . . 0.0 109.428 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -102.85 55.98 0.77 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.3 -0.875 . . . . 0.0 109.42 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.558 ' CZ3' ' HB2' ' A' ' 18' ' ' ARG . 97.9 m95 -64.86 97.93 0.25 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.202 -0.936 . . . . 0.0 109.398 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 81.4 mt -111.3 164.35 12.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.22 -0.925 . . . . 0.0 109.562 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 7' ' ' ASP . 0.5 OUTLIER -59.99 145.06 47.59 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.262 -0.898 . . . . 0.0 109.572 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.514 ' SG ' ' N ' ' A' ' 17' ' ' ARG . 7.1 m -91.24 113.89 59.85 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.258 -0.901 . . . . 0.0 109.886 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.409 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 36.3 Cg_endo -78.98 -27.35 4.66 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.344 2.029 . . . . 0.0 110.412 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.579 ' CB ' ' CE1' ' A' ' 62' ' ' PHE . . . -70.71 -37.34 73.54 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.106 -0.996 . . . . 0.0 109.839 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.542 HD11 ' CG ' ' A' ' 15' ' ' TRP . 6.5 mt -105.08 -46.37 4.28 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.134 -0.979 . . . . 0.0 109.635 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 135.06 -145.98 18.04 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.38 164.66 26.23 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.626 2.217 . . . . 0.0 110.405 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.8 -51.97 4.64 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.542 ' CG ' HD11 ' A' ' 11' ' ' LEU . 7.9 t-105 -75.72 125.75 29.66 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.292 -1.122 . . . . 0.0 109.346 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.427 ' C ' ' SG ' ' A' ' 8' ' ' CYS . 10.6 mmtp -103.14 132.4 49.43 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.213 -0.929 . . . . 0.0 109.526 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.514 ' N ' ' SG ' ' A' ' 8' ' ' CYS . 0.0 OUTLIER -99.22 111.43 23.81 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.507 -0.745 . . . . 0.0 109.413 -179.6 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.558 ' HB2' ' CZ3' ' A' ' 5' ' ' TRP . 1.6 ttt180 -100.11 131.76 45.87 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.174 -0.954 . . . . 0.0 109.61 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -112.35 142.79 44.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.299 -0.876 . . . . 0.0 109.328 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.407 ' O ' ' C ' ' A' ' 21' ' ' PHE . 39.3 t -140.34 91.66 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.139 -0.976 . . . . 0.0 109.778 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.407 ' C ' ' O ' ' A' ' 20' ' ' VAL . 0.7 OUTLIER -44.71 102.16 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.205 -0.934 . . . . 0.0 109.193 179.736 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.484 ' CG ' ' OD2' ' A' ' 32' ' ' ASP . 0.5 OUTLIER -75.05 -69.06 0.49 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.348 -0.845 . . . . 0.0 110.026 -179.596 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.509 ' O ' ' CB ' ' A' ' 24' ' ' SER . 4.7 mttm -73.46 -58.86 3.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.224 -0.923 . . . . 0.0 109.906 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.509 ' CB ' ' O ' ' A' ' 23' ' ' LYS . 5.2 t 75.39 111.74 0.07 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.164 -0.96 . . . . 0.0 109.417 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 129.83 -30.95 3.46 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.58 65.8 0.69 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.213 -1.169 . . . . 0.0 109.523 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.415 ' O ' ' C ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER 45.09 53.69 7.59 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.29 -0.881 . . . . 0.0 109.546 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.415 ' C ' ' O ' ' A' ' 27' ' ' THR . 1.2 m 43.77 50.34 6.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.278 -0.889 . . . . 0.0 109.414 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -131.47 156.28 21.77 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 67.63 133.41 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.248 -1.148 . . . . 0.0 109.53 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.3 p -178.43 165.86 1.79 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.302 -0.874 . . . . 0.0 109.38 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.497 ' HB3' ' CZ ' ' A' ' 34' ' ' TYR . 3.7 m-20 -87.84 123.75 32.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.243 -0.911 . . . . 0.0 109.225 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.78 109.4 17.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.203 -0.936 . . . . 0.0 109.827 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.591 ' CD1' ' CD ' ' A' ' 44' ' ' ARG . 11.4 m-85 -112.49 138.07 49.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.256 -0.902 . . . . 0.0 108.992 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.622 ' CE2' ' CE1' ' A' ' 64' ' ' PHE . 5.3 m-85 -108.18 151.11 26.36 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.136 -0.977 . . . . 0.0 109.827 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -132.24 128.73 38.52 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.361 -0.837 . . . . 0.0 109.533 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.517 ' OG ' ' CB ' ' A' ' 41' ' ' ASP . 0.4 OUTLIER -71.94 174.68 3.77 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.28 -0.888 . . . . 0.0 109.511 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.494 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 35.9 Cg_endo -78.61 -4.49 14.15 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.722 2.282 . . . . 0.0 110.417 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.4 t -103.92 -18.55 14.57 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.241 -0.912 . . . . 0.0 109.518 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 120.71 12.44 6.04 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.517 ' CB ' ' OG ' ' A' ' 37' ' ' SER . 0.4 OUTLIER -83.25 127.6 33.78 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -1.151 . . . . 0.0 109.571 -179.908 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.08 131.71 56.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.244 -0.91 . . . . 0.0 109.277 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.6 mp -137.64 161.49 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.225 -0.922 . . . . 0.0 109.611 -179.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.591 ' CD ' ' CD1' ' A' ' 34' ' ' TYR . 34.8 mtm180 -143.79 18.42 1.81 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.316 -0.865 . . . . 0.0 109.557 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.503 ' O ' ' CB ' ' A' ' 46' ' ' LYS . 0.5 OUTLIER -91.88 -88.54 0.2 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.293 -0.879 . . . . 0.0 108.907 179.504 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.571 ' HB2' ' CD1' ' A' ' 64' ' ' PHE . 19.3 ttpt 159.52 -63.39 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.464 ' O ' ' CG ' ' A' ' 51' ' ' ARG . 77.2 t -85.38 -21.54 7.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.486 ' O ' ' HG3' ' A' ' 51' ' ' ARG . 98.3 mt-10 -68.71 -44.81 73.13 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.54 ' O ' ' CD1' ' A' ' 53' ' ' LEU . 3.4 pp -71.05 -25.07 62.49 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 178.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.51 ' CG2' HD13 ' A' ' 59' ' ' LEU . 20.5 m -68.59 -63.29 1.09 Allowed 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.486 ' HG3' ' O ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -49.45 -23.96 1.79 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.394 -0.816 . . . . 0.0 108.872 179.391 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.496 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 2.6 t80 -67.32 -64.64 0.81 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.303 -0.873 . . . . 0.0 109.159 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.54 ' CD1' ' O ' ' A' ' 49' ' ' LEU . 0.6 OUTLIER -51.1 -57.85 7.63 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.04 -1.038 . . . . 0.0 109.257 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 141.16 -157.15 25.94 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.07 -9.7 16.62 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.592 2.195 . . . . 0.0 110.248 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.17 -13.56 59.93 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.297 -0.877 . . . . 0.0 109.438 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 73.3 m -132.99 130.23 39.23 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.356 -0.84 . . . . 0.0 109.19 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 25.4 t0 -126.19 152.56 45.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.168 -0.958 . . . . 0.0 109.832 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.548 HD23 ' CD2' ' A' ' 62' ' ' PHE . 5.2 mp -148.64 14.7 0.96 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.388 -0.82 . . . . 0.0 109.395 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.463 ' C ' ' CD2' ' A' ' 61' ' ' LEU . 22.3 m -46.35 -37.35 7.38 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.323 -0.861 . . . . 0.0 109.84 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.58 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 1.1 mm? -111.38 2.43 17.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.3 -0.875 . . . . 0.0 109.606 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.579 ' CE1' ' CB ' ' A' ' 10' ' ' ALA . 78.3 t80 -58.68 146.33 36.8 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.353 -0.842 . . . . 0.0 109.656 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.496 ' O ' ' N ' ' A' ' 65' ' ' LYS . 5.1 t0 -98.44 103.32 15.26 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.33 -0.856 . . . . 0.0 108.972 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.622 ' CE1' ' CE2' ' A' ' 35' ' ' TYR . 0.7 OUTLIER -66.61 69.64 0.07 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.149 -0.97 . . . . 0.0 109.426 -179.36 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.496 ' N ' ' O ' ' A' ' 63' ' ' ASP . 11.9 ttpp 177.07 -46.22 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.266 -0.896 . . . . 0.0 109.579 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -92.41 -39.35 11.48 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.24 -0.912 . . . . 0.0 109.728 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.485 ' HA2' ' CZ ' ' A' ' 62' ' ' PHE . . . 106.03 35.17 3.02 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.469 ' O ' ' N ' ' A' ' 63' ' ' ASP . 2.0 pp -140.52 173.41 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.16 -1.2 . . . . 0.0 109.628 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.465 ' HB3' ' HA ' ' A' ' 62' ' ' PHE . 0.7 OUTLIER -147.24 -164.83 2.09 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.78 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.451 ' SG ' ' O ' ' A' ' 69' ' ' LEU . 62.1 m -151.71 -162.23 1.48 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.947 -1.096 . . . . 0.0 110.134 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.536 ' CD1' ' N ' ' A' ' 71' ' ' TYR . 1.7 p90 -147.82 164.37 22.8 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.432 -0.792 . . . . 0.0 109.424 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.465 ' HD2' ' HB2' ' A' ' 71' ' ' TYR . 35.1 Cg_endo -77.41 -175.02 2.45 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.486 2.124 . . . . 0.0 110.348 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -139.72 154.75 71.35 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.282 -0.886 . . . . 0.0 109.514 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.53 140.66 17.08 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.683 2.255 . . . . 0.0 110.296 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.565 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 65.53 17.9 11.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.292 -0.88 . . . . 0.0 109.546 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.456 ' OE1' ' NE ' ' A' ' 18' ' ' ARG . 48.0 mt-10 -151.92 145.05 24.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.272 -0.892 . . . . 0.0 109.413 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.436 ' O ' ' C ' ' A' ' 5' ' ' TRP . 0.7 OUTLIER -123.15 66.62 0.98 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.245 -0.909 . . . . 0.0 109.597 -179.933 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.436 ' C ' ' O ' ' A' ' 4' ' ' ASP . 71.9 m95 -43.4 108.39 0.11 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.301 -0.874 . . . . 0.0 109.316 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.72 158.77 17.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.194 -0.941 . . . . 0.0 109.684 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.431 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 0.5 OUTLIER -53.16 138.93 30.35 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.222 -0.923 . . . . 0.0 109.126 179.695 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.468 ' HB2' ' HB2' ' A' ' 17' ' ' ARG . 40.3 t -98.99 109.17 52.99 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.101 -0.999 . . . . 0.0 109.878 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.445 ' HD2' ' CZ ' ' A' ' 17' ' ' ARG . 34.4 Cg_endo -77.23 -38.79 0.69 Allowed 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.205 1.937 . . . . 0.0 110.111 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.488 ' HB1' ' CD1' ' A' ' 62' ' ' PHE . . . -42.97 -32.18 0.61 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.28 -0.887 . . . . 0.0 109.473 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.651 ' CD1' ' CD1' ' A' ' 15' ' ' TRP . 5.3 mt -115.93 -67.01 1.03 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.21 -0.931 . . . . 0.0 109.48 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 167.1 -149.1 14.17 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.88 169.21 20.99 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.688 2.259 . . . . 0.0 110.666 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.35 -56.18 2.84 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.634 -1.387 . . . . 0.0 109.634 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.651 ' CD1' ' CD1' ' A' ' 11' ' ' LEU . 10.0 t-105 -62.15 123.41 18.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.256 -1.143 . . . . 0.0 109.774 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -103.54 120.53 41.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.281 -0.887 . . . . 0.0 109.547 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.572 ' HG3' ' CE2' ' A' ' 35' ' ' TYR . 3.2 ttp85 -95.3 114.94 26.78 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.217 -0.927 . . . . 0.0 109.347 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.456 ' NE ' ' OE1' ' A' ' 3' ' ' GLU . 4.0 tmm_? -100.24 139.37 36.01 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.183 -0.948 . . . . 0.0 109.571 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -108.68 144.69 36.12 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.209 -0.932 . . . . 0.0 109.482 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.533 HG21 ' CE1' ' A' ' 34' ' ' TYR . 42.7 t -128.14 159.89 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.184 -0.947 . . . . 0.0 109.428 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.517 ' O ' ' N ' ' A' ' 23' ' ' LYS . 13.1 p90 -116.09 66.28 0.71 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.318 -0.864 . . . . 0.0 109.192 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.459 ' CG ' ' O ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -52.15 88.85 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.439 -0.788 . . . . 0.0 109.613 -179.886 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.517 ' N ' ' O ' ' A' ' 21' ' ' PHE . 7.7 mtmt 60.22 168.1 0.08 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.277 -0.889 . . . . 0.0 109.467 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 t -120.05 158.03 27.67 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.267 -0.895 . . . . 0.0 109.531 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -168.53 -117.8 0.42 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.7 169.0 0.16 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.129 -1.218 . . . . 0.0 109.12 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.47 ' CG2' ' O ' ' A' ' 27' ' ' THR . 7.9 t -61.88 96.92 0.07 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.134 -0.979 . . . . 0.0 109.401 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 48.89 52.06 14.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.199 -0.938 . . . . 0.0 109.279 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.51 -60.55 8.32 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -152.64 155.97 38.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.201 -1.176 . . . . 0.0 109.672 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.0 p -141.17 148.81 40.6 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.357 -0.839 . . . . 0.0 109.201 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.429 ' OD2' ' HB3' ' A' ' 22' ' ' ARG . 9.8 m-20 -79.81 139.85 37.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.193 -0.942 . . . . 0.0 109.245 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.522 HG22 ' CZ ' ' A' ' 35' ' ' TYR . 31.2 m -128.72 126.06 39.26 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.22 -0.925 . . . . 0.0 109.778 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.615 ' CD1' ' N ' ' A' ' 34' ' ' TYR . 1.7 m-85 -115.14 167.18 11.05 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.64 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 2.5 m-85 -136.72 146.27 45.64 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.866 -1.146 . . . . 0.0 110.08 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -128.49 124.8 37.0 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.478 -0.763 . . . . 0.0 109.344 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.5 ' CB ' ' HD2' ' A' ' 38' ' ' PRO . 0.3 OUTLIER -68.19 174.98 2.02 Favored Pre-proline 0 N--CA 1.487 1.417 0 O-C-N 121.285 -0.884 . . . . 0.0 109.32 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.5 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 35.1 Cg_endo -78.14 5.35 5.46 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.65 2.234 . . . . 0.0 110.335 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.419 HG22 ' N ' ' A' ' 40' ' ' GLY . 15.3 t -114.6 -24.83 8.58 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.254 -0.904 . . . . 0.0 109.417 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.419 ' N ' HG22 ' A' ' 39' ' ' THR . . . 124.24 13.34 3.98 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.451 ' HB2' ' OH ' ' A' ' 52' ' ' TYR . 0.3 OUTLIER -90.95 112.53 24.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.132 -1.217 . . . . 0.0 109.24 179.882 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.481 ' CZ ' ' HB2' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -95.57 139.33 31.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -0.891 . . . . 0.0 109.618 -179.75 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.411 HG23 ' HB3' ' A' ' 49' ' ' LEU . 4.0 mt -135.98 161.21 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.187 -0.946 . . . . 0.0 109.566 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.595 ' HG3' ' CD2' ' A' ' 34' ' ' TYR . 0.1 OUTLIER -152.6 15.12 0.58 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.239 -0.913 . . . . 0.0 110.257 -179.37 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.547 ' CB ' ' HB3' ' A' ' 48' ' ' GLU . 0.3 OUTLIER -99.61 21.55 12.15 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.924 -1.11 . . . . 0.0 109.456 179.949 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.606 ' HA ' ' CE1' ' A' ' 64' ' ' PHE . 8.1 ttpt 59.3 -94.01 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.365 -0.834 . . . . 0.0 109.973 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.459 ' HA ' ' OG1' ' A' ' 50' ' ' THR . 26.3 t -59.0 -38.0 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.036 -1.04 . . . . 0.0 109.314 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.547 ' HB3' ' CB ' ' A' ' 45' ' ' SER . 71.3 tt0 -51.26 -43.44 61.56 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.002 -1.061 . . . . 0.0 108.356 179.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.528 ' O ' ' CD1' ' A' ' 53' ' ' LEU . 0.5 OUTLIER -66.45 -27.86 68.15 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 179.393 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.526 ' CG2' HD11 ' A' ' 59' ' ' LEU . 1.5 m -71.27 -66.22 0.65 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.07 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.464 ' CD ' ' HA ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -47.84 -24.33 0.97 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.357 -0.839 . . . . 0.0 108.778 179.321 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.469 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 62.4 t80 -63.34 -60.18 3.73 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.264 -0.898 . . . . 0.0 109.114 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.578 HD21 ' CZ3' ' A' ' 15' ' ' TRP . 0.3 OUTLIER -60.74 -55.19 36.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.182 -0.949 . . . . 0.0 108.969 179.642 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 142.74 -155.33 25.78 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -78.02 -18.84 12.71 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.537 2.158 . . . . 0.0 110.366 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.22 -10.52 51.37 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.326 -0.859 . . . . 0.0 109.56 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.472 ' CB ' HD12 ' A' ' 53' ' ' LEU . 18.0 m -133.41 136.71 45.42 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.227 -0.921 . . . . 0.0 109.522 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.471 ' HA ' ' CG2' ' A' ' 50' ' ' THR . 18.3 t70 -130.95 148.59 52.73 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.272 -0.893 . . . . 0.0 109.49 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.526 HD11 ' CG2' ' A' ' 50' ' ' THR . 4.1 mp -148.24 10.5 0.88 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.208 -0.932 . . . . 0.0 109.696 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.445 ' C ' ' CD2' ' A' ' 61' ' ' LEU . 94.5 m -49.92 -29.06 7.59 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.146 -0.971 . . . . 0.0 109.145 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.576 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 1.5 mm? -111.07 -8.42 14.44 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.322 -0.861 . . . . 0.0 109.381 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.508 ' CE1' ' HA2' ' A' ' 67' ' ' GLY . 48.0 t80 -59.18 131.1 50.01 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.378 -0.826 . . . . 0.0 109.337 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.63 117.49 20.6 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.192 -0.943 . . . . 0.0 109.261 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.606 ' CE1' ' HA ' ' A' ' 46' ' ' LYS . 0.4 OUTLIER -73.89 56.75 0.59 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.219 -0.926 . . . . 0.0 109.065 -179.94 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.14 -41.6 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.378 -0.826 . . . . 0.0 109.022 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -81.14 -46.66 14.58 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.267 -0.895 . . . . 0.0 109.113 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.508 ' HA2' ' CE1' ' A' ' 62' ' ' PHE . . . 104.22 28.63 5.74 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.46 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 1.1 pp -140.6 161.48 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.022 -1.281 . . . . 0.0 109.757 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.415 ' HB3' ' HA ' ' A' ' 62' ' ' PHE . 0.7 OUTLIER -143.74 173.84 11.33 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.339 -0.851 . . . . 0.0 108.935 179.74 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 21.6 p -159.85 -169.08 2.42 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.118 -0.989 . . . . 0.0 109.767 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -162.92 88.54 1.3 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.331 -0.856 . . . . 0.0 109.4 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.515 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 35.5 Cg_endo -78.27 147.47 23.2 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.663 2.242 . . . . 0.0 110.544 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.543 ' CB ' ' HD3' ' A' ' 74' ' ' PRO . . . 163.41 -53.28 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.362 -0.837 . . . . 0.0 109.48 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.543 ' HD3' ' CB ' ' A' ' 73' ' ' ALA . 36.2 Cg_endo -78.7 -27.51 4.87 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.48 2.12 . . . . 0.0 110.394 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.6 mttt . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.414 -179.905 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.9 ptt? . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -112.1 154.7 25.05 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.301 -0.874 . . . . 0.0 109.453 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.424 ' HG2' ' HD3' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -116.37 -149.56 0.45 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.292 -0.88 . . . . 0.0 109.578 -179.877 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -95.81 30.42 2.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.248 -0.908 . . . . 0.0 109.644 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.537 ' CE2' ' HG3' ' A' ' 18' ' ' ARG . 98.7 m95 -48.77 104.06 0.05 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.221 -0.924 . . . . 0.0 109.212 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -110.8 160.75 16.46 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.181 -0.949 . . . . 0.0 109.617 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -56.39 149.32 17.03 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.237 -0.914 . . . . 0.0 109.206 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.459 ' HB2' ' HB2' ' A' ' 17' ' ' ARG . 38.0 t -111.75 103.83 55.51 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.128 -0.983 . . . . 0.0 109.848 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.92 -26.21 6.88 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.373 2.049 . . . . 0.0 109.878 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.495 ' HB2' ' CE2' ' A' ' 62' ' ' PHE . . . -54.06 -34.63 60.56 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.406 -0.809 . . . . 0.0 109.314 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.626 ' CD1' ' CD1' ' A' ' 15' ' ' TRP . 12.2 mt -105.88 -66.79 0.97 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.292 -0.88 . . . . 0.0 109.358 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 157.98 -153.16 24.37 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.79 137.34 15.89 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.669 2.246 . . . . 0.0 110.353 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.29 23.25 17.35 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.626 ' CD1' ' CD1' ' A' ' 11' ' ' LEU . 27.6 t-105 -150.1 125.59 10.24 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.24 -1.153 . . . . 0.0 109.334 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.9 mmmt -105.9 134.66 48.67 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.15 -0.969 . . . . 0.0 109.538 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.503 ' HG3' ' CE2' ' A' ' 35' ' ' TYR . 3.7 ttp85 -103.6 111.68 24.26 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.311 -0.868 . . . . 0.0 109.643 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.537 ' HG3' ' CE2' ' A' ' 5' ' ' TRP . 0.3 OUTLIER -97.65 155.41 17.0 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.224 -0.923 . . . . 0.0 109.151 179.716 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.415 ' C ' HG23 ' A' ' 20' ' ' VAL . 5.5 pt-20 -123.03 168.61 12.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.116 -0.99 . . . . 0.0 109.731 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.493 HG22 ' CE2' ' A' ' 34' ' ' TYR . 3.4 t -140.03 103.2 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.349 -0.845 . . . . 0.0 109.383 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -89.13 54.32 2.94 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.151 -0.968 . . . . 0.0 109.531 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.94 -25.37 3.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.332 -0.855 . . . . 0.0 109.489 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 47.0 25.19 0.45 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.156 -0.965 . . . . 0.0 109.362 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.24 90.74 3.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.304 -0.873 . . . . 0.0 109.443 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 175.03 135.21 2.03 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.29 -165.3 0.18 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.287 -1.125 . . . . 0.0 109.497 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.98 72.17 0.56 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.209 -0.932 . . . . 0.0 109.492 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 25.2 p -150.13 18.97 0.87 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.22 -0.925 . . . . 0.0 109.485 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 161.68 -159.47 31.38 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.482 ' CB ' ' HD3' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -161.46 -163.99 1.07 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.296 -1.12 . . . . 0.0 109.241 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.3 p -51.35 167.71 0.08 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.188 -0.945 . . . . 0.0 109.27 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.409 ' HB2' HG22 ' A' ' 20' ' ' VAL . 1.1 m-20 -110.43 150.21 29.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.223 -0.923 . . . . 0.0 109.33 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.38 106.31 11.33 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.129 -0.982 . . . . 0.0 109.772 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.493 ' CE2' HG22 ' A' ' 20' ' ' VAL . 15.0 m-85 -101.99 167.27 10.15 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.275 -0.89 . . . . 0.0 109.054 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.578 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 3.9 m-85 -135.1 155.16 51.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.067 -1.02 . . . . 0.0 109.913 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.532 ' HB2' ' CZ3' ' A' ' 5' ' ' TRP . 4.4 tt0 -141.96 132.82 25.79 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.357 -0.839 . . . . 0.0 109.156 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.502 ' CB ' ' HD2' ' A' ' 38' ' ' PRO . 0.1 OUTLIER -70.78 176.13 2.18 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.238 -0.913 . . . . 0.0 109.213 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.502 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 35.7 Cg_endo -78.69 0.29 10.1 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.535 2.156 . . . . 0.0 110.289 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.464 HG21 ' N ' ' A' ' 40' ' ' GLY . 10.1 t -106.48 -21.58 13.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.338 -0.851 . . . . 0.0 109.575 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.464 ' N ' HG21 ' A' ' 39' ' ' THR . . . 122.51 10.95 5.76 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.754 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.437 ' CB ' ' OG ' ' A' ' 37' ' ' SER . 0.1 OUTLIER -79.76 102.97 9.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.232 -1.158 . . . . 0.0 109.472 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.3 mtp85 -90.48 117.3 29.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.281 -0.887 . . . . 0.0 109.477 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.496 HG21 ' N ' ' A' ' 49' ' ' LEU . 2.9 mp -121.63 153.04 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.277 -0.889 . . . . 0.0 109.494 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.47 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 8.7 mtm-85 -148.73 16.9 1.0 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.233 -0.917 . . . . 0.0 110.237 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.557 ' HB3' ' CB ' ' A' ' 48' ' ' GLU . 1.6 t -100.66 16.75 23.84 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.979 -1.076 . . . . 0.0 110.368 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.605 ' HA ' ' CE1' ' A' ' 64' ' ' PHE . 25.6 tttt 63.73 -94.18 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.221 -0.924 . . . . 0.0 110.92 178.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.446 ' N ' ' HG2' ' A' ' 46' ' ' LYS . 54.9 t -58.72 -27.88 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.906 -1.121 . . . . 0.0 109.656 -178.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.557 ' CB ' ' HB3' ' A' ' 45' ' ' SER . 14.7 tt0 -61.12 -47.79 84.65 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.093 -1.004 . . . . 0.0 108.525 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.585 HD13 ' CZ2' ' A' ' 15' ' ' TRP . 1.0 OUTLIER -67.75 -23.79 65.28 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.94 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.547 ' OG1' ' CB ' ' A' ' 59' ' ' LEU . 17.0 m -66.92 -68.76 0.35 Allowed 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.074 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.66 -20.41 2.04 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.533 -0.73 . . . . 0.0 109.23 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.476 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 44.5 t80 -66.76 -50.57 62.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.223 -0.923 . . . . 0.0 109.276 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.574 ' CD2' ' CE3' ' A' ' 15' ' ' TRP . 0.3 OUTLIER -70.56 -48.52 55.0 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.19 -0.944 . . . . 0.0 109.093 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 121.6 -156.59 16.5 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -78.9 8.08 3.96 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.574 2.183 . . . . 0.0 110.552 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -88.53 -23.56 23.14 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.141 -0.974 . . . . 0.0 109.558 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.419 ' HB2' HD12 ' A' ' 53' ' ' LEU . 95.8 m -133.28 101.1 5.05 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.285 -0.884 . . . . 0.0 109.499 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -75.62 131.12 39.76 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.178 -0.951 . . . . 0.0 109.448 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.582 HD23 ' CD2' ' A' ' 62' ' ' PHE . 0.1 OUTLIER -132.37 0.9 3.74 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.369 -0.832 . . . . 0.0 109.697 -179.689 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.2 m -47.54 -34.35 7.53 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.335 -0.853 . . . . 0.0 110.24 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.499 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 0.7 OUTLIER -108.09 0.24 21.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.057 -1.027 . . . . 0.0 109.93 -179.321 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.582 ' CD2' HD23 ' A' ' 59' ' ' LEU . 3.4 t80 -51.61 131.55 29.8 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.17 -0.956 . . . . 0.0 109.358 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.47 ' O ' ' N ' ' A' ' 65' ' ' LYS . 99.0 m-20 -79.22 104.16 9.65 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.21 -0.931 . . . . 0.0 108.768 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.605 ' CE1' ' HA ' ' A' ' 46' ' ' LYS . 0.5 OUTLIER -68.62 58.86 0.09 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.337 -0.852 . . . . 0.0 109.658 -179.138 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.482 ' HD3' ' CB ' ' A' ' 30' ' ' ARG . 2.7 tmmt? 178.09 -33.63 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.272 -0.892 . . . . 0.0 109.432 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -92.12 -44.04 9.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.18 -0.95 . . . . 0.0 109.501 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.462 ' O ' ' HB1' ' A' ' 10' ' ' ALA . . . 110.95 25.31 5.16 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.492 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 1.3 pp -140.31 -170.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.286 -1.126 . . . . 0.0 109.557 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.498 ' HB3' ' HA ' ' A' ' 62' ' ' PHE . 1.1 pt? -153.42 178.53 9.69 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.378 -0.826 . . . . 0.0 109.0 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.457 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 0.8 OUTLIER -155.24 -165.16 1.94 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.139 -0.976 . . . . 0.0 109.24 179.635 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.482 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.3 OUTLIER -177.76 63.02 0.18 Allowed Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.166 -0.959 . . . . 0.0 109.909 -179.896 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.482 ' HD3' ' N ' ' A' ' 71' ' ' TYR . 35.0 Cg_endo -77.99 177.91 8.22 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.526 2.151 . . . . 0.0 110.123 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -80.49 139.67 51.57 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.076 -1.015 . . . . 0.0 109.436 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.83 61.75 8.18 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.548 2.165 . . . . 0.0 110.621 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 36.1 tttt . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.435 179.921 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.513 ' O ' ' CB ' ' A' ' 2' ' ' ALA . 1.4 mpt? . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.253 0.549 . . . . 0.0 109.565 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.513 ' CB ' ' O ' ' A' ' 1' ' ' MET . . . 75.89 179.49 0.17 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.362 -0.836 . . . . 0.0 109.377 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.4 105.0 17.02 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.232 -0.918 . . . . 0.0 109.588 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.482 ' O ' ' O ' ' A' ' 5' ' ' TRP . 11.5 m-20 -143.71 15.39 1.77 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.221 -0.925 . . . . 0.0 109.578 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.574 ' CE3' ' HB2' ' A' ' 18' ' ' ARG . 73.5 m95 48.41 102.38 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.656 -0.653 . . . . 0.0 109.912 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.9 mt -102.78 152.62 21.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.117 -0.989 . . . . 0.0 109.685 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.477 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 5.3 m-20 -50.75 131.12 25.79 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.282 -0.886 . . . . 0.0 109.587 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.522 ' SG ' ' CZ ' ' A' ' 17' ' ' ARG . 12.1 t -82.06 113.94 47.11 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.33 -0.856 . . . . 0.0 109.629 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 36.5 Cg_endo -80.63 -55.61 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.282 0 C-N-CA 122.508 2.139 . . . . 0.0 110.909 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.491 ' CB ' ' CE1' ' A' ' 62' ' ' PHE . . . -37.99 -58.62 0.92 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.559 -0.713 . . . . 0.0 110.216 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.567 HD11 ' CG ' ' A' ' 15' ' ' TRP . 13.6 mt -79.38 -58.52 3.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.323 -0.861 . . . . 0.0 109.633 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 131.29 -140.82 12.11 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.81 138.0 16.44 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.509 2.139 . . . . 0.0 110.477 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.464 ' O ' ' HD3' ' A' ' 38' ' ' PRO . . . 99.3 14.14 36.63 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.632 ' CZ3' ' CD2' ' A' ' 53' ' ' LEU . 7.5 t-105 -148.36 137.06 21.59 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.229 -1.159 . . . . 0.0 109.532 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.76 129.22 55.64 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.261 -0.899 . . . . 0.0 109.313 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.64 ' NH1' ' CZ ' ' A' ' 62' ' ' PHE . 0.6 OUTLIER -98.38 98.04 9.32 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.249 -0.907 . . . . 0.0 109.436 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.574 ' HB2' ' CE3' ' A' ' 5' ' ' TRP . 1.5 ttm180 -100.45 134.81 42.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.253 -0.904 . . . . 0.0 109.337 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.404 ' C ' HG21 ' A' ' 20' ' ' VAL . 2.1 pt-20 -115.14 156.91 24.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.19 -0.944 . . . . 0.0 109.379 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.404 HG21 ' C ' ' A' ' 19' ' ' GLU . 3.6 t -130.71 175.27 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.153 -0.967 . . . . 0.0 109.434 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -116.46 80.81 1.52 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.189 -0.944 . . . . 0.0 109.635 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 -46.53 -59.37 3.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.28 -0.888 . . . . 0.0 109.379 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.6 83.97 0.15 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.286 -0.884 . . . . 0.0 109.371 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.2 p -129.74 61.02 1.57 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.226 -0.921 . . . . 0.0 109.471 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.88 -162.37 13.09 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -91.73 65.99 5.14 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.2 -1.176 . . . . 0.0 109.496 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 90.8 m -129.9 85.04 2.26 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.25 -0.906 . . . . 0.0 109.435 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 12.4 t -72.29 87.29 1.12 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.268 -0.895 . . . . 0.0 109.458 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 169.84 -34.46 0.17 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.48 149.55 47.08 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.298 -1.119 . . . . 0.0 109.343 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -179.14 138.24 0.14 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.185 -0.947 . . . . 0.0 109.7 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -80.26 127.66 32.62 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.374 -0.829 . . . . 0.0 109.079 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.568 HG22 ' CE1' ' A' ' 35' ' ' TYR . 87.2 m -114.9 132.96 56.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.171 -0.956 . . . . 0.0 109.525 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.416 ' CD1' ' HB3' ' A' ' 44' ' ' ARG . 27.9 m-85 -129.68 149.27 51.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.293 -0.88 . . . . 0.0 109.409 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.689 ' CD2' ' CZ ' ' A' ' 64' ' ' PHE . 12.3 m-85 -113.81 154.2 27.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.254 -0.904 . . . . 0.0 109.178 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.571 ' HB2' ' CZ3' ' A' ' 5' ' ' TRP . 0.7 OUTLIER -131.11 126.45 35.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.188 -0.945 . . . . 0.0 109.613 -179.877 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.411 ' CB ' ' HD2' ' A' ' 38' ' ' PRO . 0.4 OUTLIER -62.97 170.97 2.15 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.356 -0.84 . . . . 0.0 109.364 179.864 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 14' ' ' GLY . 35.6 Cg_endo -78.41 5.99 5.1 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.577 2.185 . . . . 0.0 110.472 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.7 t -115.14 -16.13 11.61 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.247 -0.908 . . . . 0.0 109.524 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 124.55 3.52 7.82 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.456 ' O ' ' HA ' ' A' ' 36' ' ' GLN . 0.7 OUTLIER -76.87 157.0 31.74 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.276 -1.132 . . . . 0.0 109.325 -179.988 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.438 ' O ' ' HG2' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -143.32 122.75 13.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.224 -0.922 . . . . 0.0 109.618 -179.874 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.519 HD13 ' CB ' ' A' ' 49' ' ' LEU . 2.6 mp -128.95 153.44 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.277 -0.89 . . . . 0.0 109.559 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.589 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 8.5 ptt85 -117.3 -15.14 10.41 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.273 -0.892 . . . . 0.0 109.242 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.551 ' CB ' ' HB2' ' A' ' 48' ' ' GLU . 1.1 m -91.02 124.82 35.55 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.217 -0.927 . . . . 0.0 108.813 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.551 ' CG ' ' N ' ' A' ' 47' ' ' VAL . 33.6 pttt -60.46 -48.18 82.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.268 -0.895 . . . . 0.0 110.442 -178.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.551 ' N ' ' CG ' ' A' ' 46' ' ' LYS . 86.6 t -77.22 -31.49 18.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.067 -1.021 . . . . 0.0 109.668 -179.369 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.551 ' HB2' ' CB ' ' A' ' 45' ' ' SER . 39.1 tt0 -59.25 -51.71 68.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.96 -1.087 . . . . 0.0 108.604 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.528 ' O ' ' CD1' ' A' ' 53' ' ' LEU . 3.2 pp -69.22 -33.62 73.59 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 178.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.517 ' OG1' ' HB2' ' A' ' 59' ' ' LEU . 22.8 m -52.33 -67.27 0.26 Allowed 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.468 ' HG3' ' O ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -50.05 -30.88 11.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.416 -0.803 . . . . 0.0 109.213 179.801 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.511 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 28.5 t80 -64.41 -63.01 1.25 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.122 -0.986 . . . . 0.0 108.861 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.632 ' CD2' ' CZ3' ' A' ' 15' ' ' TRP . 0.5 OUTLIER -55.27 -48.49 73.94 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.989 -1.069 . . . . 0.0 108.898 179.391 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.84 -159.26 20.27 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.23 -2.34 12.55 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.541 2.161 . . . . 0.0 110.225 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.98 -25.15 55.53 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.287 -0.883 . . . . 0.0 109.348 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 59.7 m -135.11 103.03 5.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.242 -0.911 . . . . 0.0 109.231 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.433 ' C ' ' CD1' ' A' ' 59' ' ' LEU . 10.0 p30 -95.41 161.43 14.08 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.177 -0.952 . . . . 0.0 109.869 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.568 HD22 ' CD2' ' A' ' 62' ' ' PHE . 5.0 mp -154.6 20.02 0.47 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.441 -0.787 . . . . 0.0 109.282 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.467 ' C ' ' CD2' ' A' ' 61' ' ' LEU . 21.0 m -47.24 -40.3 16.12 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.326 -0.859 . . . . 0.0 109.75 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.585 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 0.8 OUTLIER -110.78 5.22 20.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.206 -0.934 . . . . 0.0 109.873 -179.387 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.64 ' CZ ' ' NH1' ' A' ' 17' ' ' ARG . 54.7 t80 -71.88 136.07 46.79 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.192 -0.943 . . . . 0.0 109.418 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.465 ' HB2' ' HB2' ' A' ' 66' ' ' GLN . 2.4 m-20 -95.94 120.09 35.59 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.34 -0.85 . . . . 0.0 108.977 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.689 ' CZ ' ' CD2' ' A' ' 35' ' ' TYR . 0.6 OUTLIER -66.61 -11.72 54.75 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.278 -0.888 . . . . 0.0 109.512 -179.55 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -101.92 -41.71 6.38 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.208 -0.933 . . . . 0.0 110.112 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.465 ' HB2' ' HB2' ' A' ' 63' ' ' ASP . 5.9 mt-30 -83.22 -37.8 23.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.101 -1.0 . . . . 0.0 109.856 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.581 ' HA2' ' CZ ' ' A' ' 62' ' ' PHE . . . 89.31 29.65 16.37 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.476 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -139.58 160.26 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.202 -1.176 . . . . 0.0 109.367 179.914 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.471 ' HB3' ' HA ' ' A' ' 62' ' ' PHE . 1.3 pt? -143.25 172.26 12.98 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.233 -0.917 . . . . 0.0 109.377 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 1.3 m -160.2 156.25 26.29 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.345 -0.847 . . . . 0.0 109.274 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -160.07 144.6 10.88 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.162 -0.961 . . . . 0.0 109.577 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.428 ' O ' ' O ' ' A' ' 73' ' ' ALA . 35.8 Cg_endo -78.59 108.75 2.5 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.647 2.231 . . . . 0.0 110.466 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.428 ' O ' ' O ' ' A' ' 72' ' ' PRO . . . 60.04 154.98 0.1 Allowed Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.294 -0.879 . . . . 0.0 109.408 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.09 102.99 1.63 Allowed 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.624 2.216 . . . . 0.0 110.457 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.536 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.477 ' O ' ' N ' ' A' ' 3' ' ' GLU . 5.7 ttt . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.256 0.551 . . . . 0.0 109.578 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.452 ' HB2' ' O ' ' A' ' 1' ' ' MET . . . 61.77 -81.71 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.249 -0.907 . . . . 0.0 109.468 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.477 ' N ' ' O ' ' A' ' 1' ' ' MET . 19.8 mm-40 -124.72 -178.03 4.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.216 -0.927 . . . . 0.0 109.307 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.45 ' N ' ' HD3' ' A' ' 18' ' ' ARG . 1.5 t0 -129.74 84.86 2.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.157 -0.964 . . . . 0.0 109.647 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.57 ' CE3' ' HB2' ' A' ' 18' ' ' ARG . 62.6 m95 -54.87 132.33 46.22 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.383 -0.823 . . . . 0.0 109.468 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 17.9 mt -119.28 165.44 14.25 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.2 -0.937 . . . . 0.0 109.429 179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -55.58 131.87 47.35 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.11 -0.994 . . . . 0.0 109.483 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.512 ' CB ' ' HB2' ' A' ' 17' ' ' ARG . 53.9 t -82.03 117.43 68.32 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.275 -0.891 . . . . 0.0 109.642 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.95 -51.24 0.06 OUTLIER 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.418 2.079 . . . . 0.0 110.698 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -49.69 -38.05 31.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.177 -0.952 . . . . 0.0 109.929 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.511 HD11 ' CD1' ' A' ' 15' ' ' TRP . 13.1 mt -98.73 -54.87 2.89 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.139 -0.976 . . . . 0.0 109.656 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 134.45 -152.54 20.68 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.769 -1.333 . . . . 0.0 109.769 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.77 159.36 31.43 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.695 2.263 . . . . 0.0 110.533 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.405 ' O ' ' HD3' ' A' ' 38' ' ' PRO . . . 83.71 -10.13 60.57 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.516 ' NE1' ' HB3' ' A' ' 35' ' ' TYR . 15.6 t-105 -118.06 131.42 56.45 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.313 -1.11 . . . . 0.0 109.264 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.449 ' HB3' ' HB3' ' A' ' 5' ' ' TRP . 21.4 mmtt -95.71 116.6 29.11 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.185 -0.947 . . . . 0.0 109.316 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.512 ' HB2' ' CB ' ' A' ' 8' ' ' CYS . 3.2 ttt-85 -104.45 100.04 9.74 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.255 -0.903 . . . . 0.0 109.294 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.57 ' HB2' ' CE3' ' A' ' 5' ' ' TRP . 1.4 tpt180 -100.7 144.18 29.99 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.149 -0.97 . . . . 0.0 110.052 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.449 ' O ' ' OE1' ' A' ' 3' ' ' GLU . 15.0 pt-20 -113.83 144.94 42.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.349 -0.844 . . . . 0.0 109.258 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.426 HG23 ' CE2' ' A' ' 34' ' ' TYR . 20.8 t -134.7 144.27 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.112 -0.993 . . . . 0.0 109.72 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -88.64 49.04 1.72 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.316 -0.865 . . . . 0.0 109.423 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 48.64 35.22 5.87 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.145 -0.972 . . . . 0.0 109.233 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 49.44 39.49 16.67 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.269 -0.894 . . . . 0.0 109.393 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 69.3 m -142.69 -61.27 0.44 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.206 -0.934 . . . . 0.0 109.669 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 124.92 11.43 4.36 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.52 127.95 34.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.229 -1.159 . . . . 0.0 109.391 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.8 t -113.42 27.01 9.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.226 -0.921 . . . . 0.0 109.575 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 98.3 m -60.91 -67.2 0.43 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.234 -0.916 . . . . 0.0 109.363 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 175.09 76.14 0.05 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.511 ' HG2' ' N ' ' A' ' 31' ' ' SER . 2.7 ttm180 -168.31 -92.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.272 -1.134 . . . . 0.0 109.257 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.511 ' N ' ' HG2' ' A' ' 30' ' ' ARG . 1.4 p 65.21 152.94 0.06 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.19 -0.944 . . . . 0.0 109.957 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -114.49 145.01 42.42 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.459 -0.776 . . . . 0.0 108.939 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.454 ' CG2' ' O ' ' A' ' 18' ' ' ARG . 56.5 m -125.4 122.0 35.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.084 -1.01 . . . . 0.0 110.126 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.468 ' CD1' ' N ' ' A' ' 34' ' ' TYR . 3.3 m-85 -100.76 159.68 14.98 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.071 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.516 ' HB3' ' NE1' ' A' ' 15' ' ' TRP . 16.4 m-85 -130.49 137.08 49.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.943 -1.098 . . . . 0.0 110.114 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -118.99 116.18 25.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.489 -0.757 . . . . 0.0 109.327 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.466 ' OG ' HG21 ' A' ' 39' ' ' THR . 0.7 OUTLIER -57.07 168.86 0.78 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.327 -0.858 . . . . 0.0 109.448 -179.943 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.405 ' HD3' ' O ' ' A' ' 14' ' ' GLY . 35.5 Cg_endo -78.38 5.39 5.52 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.641 2.227 . . . . 0.0 110.379 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.466 HG21 ' OG ' ' A' ' 37' ' ' SER . 6.5 t -115.61 -11.63 11.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.155 -0.966 . . . . 0.0 109.648 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 116.98 3.86 17.26 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.81 142.45 40.3 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.163 -1.199 . . . . 0.0 109.108 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.0 117.5 24.15 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.227 -0.92 . . . . 0.0 109.707 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.517 ' CG2' ' HB3' ' A' ' 49' ' ' LEU . 3.4 mp -123.19 162.53 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.347 -0.845 . . . . 0.0 109.332 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.479 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 34.6 mtp180 -149.1 15.57 0.93 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.141 -0.975 . . . . 0.0 109.805 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.546 ' O ' ' CB ' ' A' ' 46' ' ' LYS . 0.6 OUTLIER -85.34 -85.45 0.14 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.212 -0.93 . . . . 0.0 109.119 179.609 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.546 ' CB ' ' O ' ' A' ' 45' ' ' SER . 12.4 ttpt 157.92 -62.82 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.446 HG22 ' HE2' ' A' ' 46' ' ' LYS . 61.0 t -88.52 -21.83 6.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 178.5 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.478 ' O ' ' HG3' ' A' ' 51' ' ' ARG . 18.0 mt-10 -69.05 -41.78 77.18 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.523 ' O ' ' CD1' ' A' ' 53' ' ' LEU . 3.0 pp -71.87 -25.16 61.83 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 178.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.531 ' OG1' ' HB2' ' A' ' 59' ' ' LEU . 8.8 m -69.75 -61.5 1.75 Allowed 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.478 ' HG3' ' O ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -51.11 -23.21 2.98 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 179.297 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.47 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 65.2 t80 -69.63 -65.99 0.64 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.334 -0.854 . . . . 0.0 108.982 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.523 ' CD1' ' O ' ' A' ' 49' ' ' LEU . 0.9 OUTLIER -49.9 -58.68 4.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.163 -0.961 . . . . 0.0 109.124 179.611 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 132.04 -146.89 18.47 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.71 -29.35 3.61 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.599 2.2 . . . . 0.0 110.139 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -54.63 -26.3 32.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.33 -0.856 . . . . 0.0 109.287 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 11.7 m -121.71 170.58 9.6 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.323 -0.861 . . . . 0.0 109.22 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.488 ' HA ' ' CG2' ' A' ' 50' ' ' THR . 17.6 p-10 -165.19 148.57 8.33 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.164 -0.96 . . . . 0.0 109.441 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.531 ' HB2' ' OG1' ' A' ' 50' ' ' THR . 4.1 mp -153.0 21.02 0.58 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.206 -0.934 . . . . 0.0 109.716 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.435 ' C ' HD22 ' A' ' 61' ' ' LEU . 1.9 m -43.59 -49.59 7.52 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.268 -0.895 . . . . 0.0 109.647 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.506 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 1.5 mm? -106.97 9.8 30.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.324 -0.86 . . . . 0.0 109.755 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.517 ' CD2' ' CD2' ' A' ' 59' ' ' LEU . 72.0 t80 -55.87 139.94 44.2 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.402 -0.811 . . . . 0.0 109.999 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.528 ' O ' ' N ' ' A' ' 65' ' ' LYS . 0.7 OUTLIER -95.08 96.86 9.52 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.973 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.479 ' CE2' ' O ' ' A' ' 44' ' ' ARG . 0.5 OUTLIER -63.0 73.67 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.369 -0.832 . . . . 0.0 109.311 -179.119 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.528 ' N ' ' O ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER 168.35 -32.37 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.457 -0.777 . . . . 0.0 109.057 -179.757 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -103.57 -27.31 12.42 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.296 -0.878 . . . . 0.0 109.389 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.481 ' HA2' ' CZ ' ' A' ' 62' ' ' PHE . . . 89.42 33.16 9.57 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.441 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -140.43 169.67 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.197 -1.178 . . . . 0.0 109.914 -179.833 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.475 ' CD2' ' N ' ' A' ' 69' ' ' LEU . 0.7 OUTLIER -145.11 -165.94 2.29 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.376 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.454 ' C ' ' CD2' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -160.05 169.98 22.24 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.094 -1.004 . . . . 0.0 109.897 179.766 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.536 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 2.9 p90 -177.58 60.87 0.16 Allowed Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.421 -0.8 . . . . 0.0 109.283 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.536 ' HD3' ' N ' ' A' ' 71' ' ' TYR . 35.2 Cg_endo -78.04 65.86 8.31 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.639 2.226 . . . . 0.0 110.482 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -104.14 156.42 35.76 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.222 -0.924 . . . . 0.0 109.394 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.47 149.05 26.98 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.576 2.184 . . . . 0.0 110.426 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.422 -179.931 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.54 -170.58 0.54 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.318 -0.864 . . . . 0.0 109.529 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.496 ' HG3' ' CZ ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -132.96 -169.3 2.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.186 -0.946 . . . . 0.0 109.487 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.48 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 1.4 m-20 -87.51 46.92 1.43 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.258 -0.902 . . . . 0.0 109.523 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.583 ' CE3' ' HB2' ' A' ' 18' ' ' ARG . 72.6 m95 -55.44 111.66 0.93 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.255 -0.903 . . . . 0.0 109.658 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 4' ' ' ASP . 69.2 mt -114.05 151.17 32.89 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.22 -0.925 . . . . 0.0 109.328 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.449 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 7.7 m-20 -44.42 139.23 2.83 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.188 -0.945 . . . . 0.0 109.484 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.48 ' HB2' ' N ' ' A' ' 17' ' ' ARG . 38.3 t -103.65 104.78 44.16 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.302 -0.874 . . . . 0.0 109.639 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.449 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 35.1 Cg_endo -76.87 -35.26 1.96 Allowed 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 122.441 2.094 . . . . 0.0 110.415 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 9' ' ' PRO . . . -43.89 -45.57 7.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.264 -0.897 . . . . 0.0 109.401 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.641 ' CD1' ' CD1' ' A' ' 15' ' ' TRP . 11.5 mt -97.67 -60.63 1.53 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.201 -0.937 . . . . 0.0 109.404 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 154.3 -153.15 24.61 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.07 145.0 21.67 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.71 2.273 . . . . 0.0 110.323 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.94 -24.44 31.19 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.641 ' CD1' ' CD1' ' A' ' 11' ' ' LEU . 5.5 t-105 -98.61 132.64 43.86 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.41 -1.053 . . . . 0.0 109.264 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.432 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -111.08 120.48 42.47 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.108 -0.995 . . . . 0.0 109.888 -179.793 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.48 ' N ' ' HB2' ' A' ' 8' ' ' CYS . 1.3 ttp85 -93.35 115.97 28.53 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.346 -0.846 . . . . 0.0 108.891 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.583 ' HB2' ' CE3' ' A' ' 5' ' ' TRP . 12.0 ttt180 -100.15 147.33 25.8 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.291 -0.88 . . . . 0.0 110.28 -179.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.472 ' O ' ' HG3' ' A' ' 19' ' ' GLU . 6.1 pt-20 -125.11 144.16 50.56 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.423 HG21 ' C ' ' A' ' 19' ' ' GLU . 2.5 t -131.12 159.08 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.076 -1.015 . . . . 0.0 109.843 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.444 ' O ' ' CB ' ' A' ' 22' ' ' ARG . 1.6 m-30 -95.41 10.03 37.84 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.324 -0.86 . . . . 0.0 109.211 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.444 ' CB ' ' O ' ' A' ' 21' ' ' PHE . 0.0 OUTLIER 73.11 -70.26 0.17 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.32 -0.863 . . . . 0.0 109.349 -179.868 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.79 -57.62 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.269 -0.894 . . . . 0.0 109.435 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 17.1 m -87.79 176.94 7.15 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.245 -0.909 . . . . 0.0 109.425 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -122.24 28.17 5.89 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.66 170.42 9.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.25 -1.147 . . . . 0.0 109.509 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.6 p -92.51 15.13 14.82 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.255 -0.903 . . . . 0.0 109.628 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 4.3 t -121.34 -26.92 4.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.159 -0.963 . . . . 0.0 109.622 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.54 154.08 35.34 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.76 178.29 4.74 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.2 -1.176 . . . . 0.0 109.41 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.9 m -119.94 166.37 13.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.183 -0.948 . . . . 0.0 109.61 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.574 ' HB3' ' CE1' ' A' ' 34' ' ' TYR . 2.2 m-20 -112.81 155.47 24.55 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.3 -0.875 . . . . 0.0 109.419 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.469 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 8.7 m -131.74 108.59 9.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.249 -0.907 . . . . 0.0 109.656 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.597 ' CD1' ' CG ' ' A' ' 44' ' ' ARG . 6.5 m-85 -105.69 165.2 11.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.232 -0.918 . . . . 0.0 109.345 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.605 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 4.3 m-85 -133.66 140.24 46.95 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.102 -0.999 . . . . 0.0 109.921 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -123.0 128.25 49.94 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.425 -0.797 . . . . 0.0 109.246 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.48 ' HB2' ' HD2' ' A' ' 38' ' ' PRO . 1.7 p -80.17 167.99 29.15 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.301 -0.874 . . . . 0.0 109.42 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.48 ' HD2' ' HB2' ' A' ' 37' ' ' SER . 35.6 Cg_endo -78.37 5.85 5.19 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.647 2.231 . . . . 0.0 110.414 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.9 p -113.21 -24.93 9.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.217 -0.927 . . . . 0.0 109.479 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 123.38 16.18 3.53 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.17 105.35 17.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.148 -1.207 . . . . 0.0 109.254 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.75 105.1 17.59 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.318 -0.864 . . . . 0.0 109.689 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.512 ' CG2' ' HB3' ' A' ' 49' ' ' LEU . 3.2 mt -110.09 151.77 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.307 -0.87 . . . . 0.0 109.092 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.597 ' CG ' ' CD1' ' A' ' 34' ' ' TYR . 7.5 ttp180 -126.85 -0.25 6.65 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.133 -0.979 . . . . 0.0 110.04 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.542 ' CB ' ' HB2' ' A' ' 48' ' ' GLU . 1.1 m -93.73 172.05 8.49 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.142 -0.974 . . . . 0.0 108.525 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.578 ' HB2' ' CD1' ' A' ' 64' ' ' PHE . 22.8 ttpt -91.12 -63.27 1.29 Allowed 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.034 -1.042 . . . . 0.0 110.146 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.9 t -80.8 -10.82 12.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.048 -1.033 . . . . 0.0 109.316 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.542 ' HB2' ' CB ' ' A' ' 45' ' ' SER . 0.1 OUTLIER -77.3 -46.52 22.72 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 178.485 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.579 HD23 ' CG ' ' A' ' 35' ' ' TYR . 2.5 pp -68.84 -25.89 64.88 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 178.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.541 ' CG2' HD12 ' A' ' 59' ' ' LEU . 8.5 m -72.86 -49.28 31.02 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.23 -25.99 49.58 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.4 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 40.9 t80 -65.8 -60.46 2.86 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.54 -0.725 . . . . 0.0 109.288 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.564 ' CD2' ' CZ3' ' A' ' 15' ' ' TRP . 0.5 OUTLIER -58.44 -56.3 23.93 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.194 -0.941 . . . . 0.0 109.3 179.908 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 131.42 -149.44 19.26 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.5 -11.85 17.08 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.556 2.171 . . . . 0.0 110.302 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.21 -19.11 63.18 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.211 -0.93 . . . . 0.0 109.205 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 53.0 m -135.42 146.95 48.79 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.352 -0.842 . . . . 0.0 109.194 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.475 ' HA ' ' CG2' ' A' ' 50' ' ' THR . 0.6 OUTLIER -138.04 152.66 49.06 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.144 -0.972 . . . . 0.0 109.872 -179.754 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.541 HD12 ' CG2' ' A' ' 50' ' ' THR . 4.5 mp -148.47 9.88 0.84 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.266 -0.897 . . . . 0.0 109.541 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.456 ' C ' ' CD2' ' A' ' 61' ' ' LEU . 23.2 m -48.93 -28.05 3.56 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.175 -0.953 . . . . 0.0 109.007 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.579 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 1.3 mm? -111.74 -13.75 13.68 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.437 -0.79 . . . . 0.0 109.164 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.543 ' CD1' ' C ' ' A' ' 62' ' ' PHE . 7.8 t80 -49.37 131.71 20.38 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.401 -0.812 . . . . 0.0 109.517 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.506 ' O ' ' N ' ' A' ' 65' ' ' LYS . 2.3 m-20 -79.72 100.57 7.96 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.223 -0.923 . . . . 0.0 108.811 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.578 ' CD1' ' HB2' ' A' ' 46' ' ' LYS . 1.1 t80 -66.63 61.12 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.405 -0.809 . . . . 0.0 109.519 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.506 ' N ' ' O ' ' A' ' 63' ' ' ASP . 20.0 ttpt 177.22 -38.55 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.464 -0.772 . . . . 0.0 108.963 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -86.8 -47.8 8.76 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.313 -0.867 . . . . 0.0 109.203 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 115.21 23.05 4.66 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.473 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 2.4 pp -140.11 -173.3 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.079 -1.247 . . . . 0.0 109.576 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.505 ' CB ' ' HA ' ' A' ' 62' ' ' PHE . 0.7 OUTLIER -151.43 -166.64 2.57 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.282 -0.886 . . . . 0.0 109.124 -179.874 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.46 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 2.7 t -160.44 137.39 9.11 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.179 -0.951 . . . . 0.0 109.72 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -110.63 96.71 29.31 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.184 -0.948 . . . . 0.0 109.009 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.511 ' O ' ' CB ' ' A' ' 73' ' ' ALA . 35.1 Cg_endo -77.06 156.47 34.01 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.518 2.146 . . . . 0.0 110.497 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.546 ' N ' ' HD2' ' A' ' 74' ' ' PRO . . . 162.92 -52.89 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.387 -0.82 . . . . 0.0 109.305 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 73' ' ' ALA . 35.1 Cg_endo -78.24 -37.72 0.71 Allowed 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.408 2.072 . . . . 0.0 110.328 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.8 pttp . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 117.999 -1.001 . . . . 0.0 109.498 179.938 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.1 ttt . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.296 0.569 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -133.2 -143.29 0.22 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.273 -0.892 . . . . 0.0 109.251 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.2 pm0 -103.37 97.98 7.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.039 -1.038 . . . . 0.0 109.543 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.469 ' O ' ' O ' ' A' ' 5' ' ' TRP . 75.4 m-20 -128.93 23.53 5.7 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.268 -0.895 . . . . 0.0 109.345 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.576 ' CE2' ' HG3' ' A' ' 18' ' ' ARG . 89.1 m95 55.72 109.32 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.422 -0.799 . . . . 0.0 109.671 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.21 151.18 38.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.238 -0.913 . . . . 0.0 109.394 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -45.04 145.43 1.0 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.336 -0.853 . . . . 0.0 109.33 179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.463 ' HB3' ' HB3' ' A' ' 15' ' ' TRP . 26.8 t -105.55 105.56 53.02 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.198 -0.939 . . . . 0.0 109.678 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.492 ' HD2' ' CZ ' ' A' ' 17' ' ' ARG . 35.2 Cg_endo -76.97 -33.57 2.69 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.441 2.094 . . . . 0.0 110.129 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -47.33 -42.23 20.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.226 -0.921 . . . . 0.0 109.329 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.642 ' CD1' ' CD1' ' A' ' 15' ' ' TRP . 8.8 mt -99.98 -62.41 1.24 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.306 -0.871 . . . . 0.0 109.349 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.432 ' O ' ' O ' ' A' ' 8' ' ' CYS . . . 165.5 -153.03 22.82 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.44 150.31 25.01 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.643 2.229 . . . . 0.0 110.361 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.55 -65.85 1.76 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.642 ' CD1' ' CD1' ' A' ' 11' ' ' LEU . 6.4 t-105 -48.98 130.5 18.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.264 -1.139 . . . . 0.0 109.409 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -107.85 118.67 37.35 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.119 -0.988 . . . . 0.0 109.406 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.492 ' CZ ' ' HD2' ' A' ' 9' ' ' PRO . 1.2 ttp85 -93.16 116.76 29.34 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.275 -0.891 . . . . 0.0 109.368 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.576 ' HG3' ' CE2' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -96.99 142.36 29.04 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.341 -0.85 . . . . 0.0 109.437 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.434 ' CG ' ' O ' ' A' ' 19' ' ' GLU . 17.9 pt-20 -127.24 116.68 20.95 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.231 -0.918 . . . . 0.0 109.306 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.472 ' O ' ' HB3' ' A' ' 31' ' ' SER . 82.0 t -108.35 136.26 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.166 -0.958 . . . . 0.0 109.683 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -85.18 75.27 10.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.339 -0.85 . . . . 0.0 109.491 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -49.67 -62.34 1.61 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.364 -0.835 . . . . 0.0 109.438 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.452 ' O ' ' HG3' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -167.3 29.46 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.28 -0.888 . . . . 0.0 109.574 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -177.63 82.31 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.142 -0.974 . . . . 0.0 109.553 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -124.0 33.4 3.89 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.43 -68.95 0.57 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.341 -1.094 . . . . 0.0 109.664 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 48.8 p -122.67 73.46 1.13 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.184 -0.948 . . . . 0.0 109.707 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 62.21 40.91 11.11 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.329 -0.857 . . . . 0.0 109.756 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.79 -138.59 0.02 OUTLIER Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.452 ' HA ' ' HD2' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -87.28 -79.86 0.27 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.244 -1.15 . . . . 0.0 109.227 179.727 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.472 ' HB3' ' O ' ' A' ' 20' ' ' VAL . 5.8 m 61.4 166.61 0.1 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.177 -0.952 . . . . 0.0 109.673 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.468 ' OD2' ' CZ ' ' A' ' 34' ' ' TYR . 3.0 t70 -118.99 129.8 55.35 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.272 -0.892 . . . . 0.0 109.206 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.547 HG21 ' CZ ' ' A' ' 35' ' ' TYR . 70.0 m -110.62 125.4 53.38 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.191 -0.943 . . . . 0.0 109.868 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.572 ' CD1' ' N ' ' A' ' 34' ' ' TYR . 3.7 m-85 -112.9 155.41 24.76 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.29 -0.881 . . . . 0.0 108.888 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.578 ' CG ' HD21 ' A' ' 49' ' ' LEU . 39.4 m-85 -126.03 131.07 52.26 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.019 -1.05 . . . . 0.0 109.905 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -122.42 128.19 50.61 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.465 -0.772 . . . . 0.0 109.151 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.482 ' CB ' ' HD2' ' A' ' 38' ' ' PRO . 0.9 OUTLIER -73.54 173.58 6.02 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.309 -0.869 . . . . 0.0 109.675 -179.73 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.482 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 34.5 Cg_endo -77.35 1.23 8.97 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.668 2.245 . . . . 0.0 110.297 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 p -111.04 -24.13 10.52 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.255 -0.903 . . . . 0.0 109.147 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 125.3 18.29 2.54 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.533 ' HB2' ' CZ ' ' A' ' 52' ' ' TYR . 5.1 t70 -79.64 119.28 22.37 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.086 -1.244 . . . . 0.0 109.35 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.404 ' O ' ' HG2' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -103.4 107.74 18.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.285 -0.884 . . . . 0.0 109.737 -179.717 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.519 ' CG2' ' HB3' ' A' ' 49' ' ' LEU . 3.3 mt -120.33 151.38 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.321 -0.862 . . . . 0.0 109.133 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.591 ' O ' ' CZ ' ' A' ' 64' ' ' PHE . 10.6 ttm180 -126.81 -1.13 6.66 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.087 -1.008 . . . . 0.0 109.884 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.546 ' O ' ' CE1' ' A' ' 64' ' ' PHE . 0.4 OUTLIER -88.84 179.26 6.24 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.073 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.551 ' HA ' ' CE1' ' A' ' 64' ' ' PHE . 28.7 ttpt -97.87 -59.68 1.72 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.977 -1.077 . . . . 0.0 109.657 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.444 ' O ' HG11 ' A' ' 47' ' ' VAL . 99.2 t -84.24 -16.66 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.108 -0.995 . . . . 0.0 108.889 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.54 ' HB2' ' CB ' ' A' ' 45' ' ' SER . 1.9 tt0 -70.05 -45.36 67.28 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.59 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.578 HD21 ' CG ' ' A' ' 35' ' ' TYR . 2.0 pp -71.36 -27.12 63.13 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 178.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.534 ' OG1' ' CD1' ' A' ' 59' ' ' LEU . 27.7 m -67.36 -47.08 71.49 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.508 ' NH1' ' HG3' ' A' ' 51' ' ' ARG . 7.2 mmt85 -55.34 -31.33 61.63 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.533 ' CZ ' ' HB2' ' A' ' 41' ' ' ASP . 86.0 t80 -63.71 -51.24 65.89 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.934 -0.706 . . . . 0.0 109.431 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.57 HD21 ' CE3' ' A' ' 15' ' ' TRP . 1.5 mt -59.63 -58.86 6.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.305 -0.872 . . . . 0.0 109.536 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 135.71 -155.27 22.18 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -79.41 -10.17 14.79 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.621 2.214 . . . . 0.0 110.494 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.22 -15.81 56.18 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.228 -0.92 . . . . 0.0 109.711 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 72.7 m -128.45 139.77 52.17 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.254 -0.904 . . . . 0.0 109.39 -179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.511 ' HA ' ' CG2' ' A' ' 50' ' ' THR . 2.8 p30 -137.02 151.73 49.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.257 -0.902 . . . . 0.0 109.523 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.534 ' CD1' ' OG1' ' A' ' 50' ' ' THR . 6.6 mp -142.53 -0.2 1.24 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.22 -0.925 . . . . 0.0 110.076 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.521 HG21 ' CD2' ' A' ' 61' ' ' LEU . 17.1 m -48.16 -27.44 2.39 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 120.996 -1.065 . . . . 0.0 108.521 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.602 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 1.3 mm? -105.53 -21.08 13.28 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.551 ' CE1' ' HA2' ' A' ' 67' ' ' GLY . 51.2 t80 -55.85 140.62 41.86 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.64 -0.662 . . . . 0.0 109.267 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.519 ' O ' ' N ' ' A' ' 65' ' ' LYS . 4.9 m-20 -88.32 108.64 19.44 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.189 -0.945 . . . . 0.0 109.578 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.591 ' CZ ' ' O ' ' A' ' 44' ' ' ARG . 1.7 t80 -66.62 66.9 0.06 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.288 -0.882 . . . . 0.0 109.214 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 63' ' ' ASP . 1.2 ttpm? 166.92 -36.55 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -88.18 -40.45 13.7 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.413 -0.804 . . . . 0.0 109.46 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.551 ' HA2' ' CE1' ' A' ' 62' ' ' PHE . . . 98.56 25.22 10.16 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.444 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 1.6 pp -140.47 160.31 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.201 -1.176 . . . . 0.0 109.812 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.476 ' CA ' ' HA ' ' A' ' 62' ' ' PHE . 0.6 OUTLIER -137.45 -167.57 2.14 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.338 -0.852 . . . . 0.0 108.875 179.481 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 37.7 t -153.11 148.92 27.53 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.085 -1.01 . . . . 0.0 109.61 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -133.48 87.54 37.14 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.309 -0.87 . . . . 0.0 109.353 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.29 137.36 15.02 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.682 2.255 . . . . 0.0 110.365 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.44 ' HB2' ' HD2' ' A' ' 74' ' ' PRO . . . -163.02 169.9 8.27 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.274 -0.891 . . . . 0.0 109.419 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.44 ' HD2' ' HB2' ' A' ' 73' ' ' ALA . 35.7 Cg_endo -77.85 -5.57 15.39 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.591 2.194 . . . . 0.0 110.286 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.418 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.9 mmm . . . . . 0 N--CA 1.488 1.465 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -128.04 0.55 5.89 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.269 -0.894 . . . . 0.0 109.509 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -133.87 137.37 44.95 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.259 -0.901 . . . . 0.0 109.012 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.452 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 0.6 OUTLIER -145.83 76.4 1.46 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.136 -0.978 . . . . 0.0 110.081 -179.601 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.571 ' CE3' ' HB2' ' A' ' 18' ' ' ARG . 64.3 m95 -66.14 96.58 0.34 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.272 -0.892 . . . . 0.0 108.78 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.452 ' HG ' ' O ' ' A' ' 4' ' ' ASP . 1.3 mt -106.06 169.31 8.57 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.13 -0.981 . . . . 0.0 109.855 -179.282 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.471 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 0.7 OUTLIER -56.85 132.25 51.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.338 -0.851 . . . . 0.0 109.474 -179.853 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.519 ' SG ' ' CZ ' ' A' ' 17' ' ' ARG . 18.9 t -89.02 112.76 52.89 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.224 -0.922 . . . . 0.0 109.398 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 35.9 Cg_endo -77.72 -52.86 0.07 OUTLIER 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.366 2.044 . . . . 0.0 110.822 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.444 ' C ' ' O ' ' A' ' 9' ' ' PRO . . . -39.81 -46.77 2.01 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.427 -0.795 . . . . 0.0 110.045 -179.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.604 ' CD1' ' CD1' ' A' ' 15' ' ' TRP . 11.6 mt -94.16 -60.63 1.69 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.169 -0.957 . . . . 0.0 109.467 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.443 ' O ' ' O ' ' A' ' 8' ' ' CYS . . . 148.36 -145.4 13.81 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.04 156.48 30.29 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.608 2.205 . . . . 0.0 110.342 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.99 -57.82 4.31 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.299 -1.521 . . . . 0.0 109.299 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.604 ' CD1' ' CD1' ' A' ' 11' ' ' LEU . 4.8 t-105 -65.49 129.27 39.17 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.298 -1.119 . . . . 0.0 109.526 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.47 123.08 46.84 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.305 -0.872 . . . . 0.0 109.59 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.565 ' NH1' ' CZ ' ' A' ' 62' ' ' PHE . 0.2 OUTLIER -93.48 106.03 18.04 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.273 -0.892 . . . . 0.0 109.365 179.881 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.571 ' HB2' ' CE3' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -100.35 142.68 31.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.239 -0.913 . . . . 0.0 109.524 -179.891 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.53 ' N ' ' HG2' ' A' ' 18' ' ' ARG . 6.1 pt-20 -99.95 159.09 15.35 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.292 -0.88 . . . . 0.0 109.825 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.504 ' HB ' ' CB ' ' A' ' 32' ' ' ASP . 98.9 t -128.94 158.68 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.325 -0.86 . . . . 0.0 109.038 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.498 ' N ' HG13 ' A' ' 20' ' ' VAL . 0.3 OUTLIER -104.5 45.28 0.97 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.105 -0.997 . . . . 0.0 109.799 -179.821 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.431 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 0.0 OUTLIER 65.59 50.15 1.68 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.22 -0.925 . . . . 0.0 109.665 179.757 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.431 ' HG2' ' O ' ' A' ' 22' ' ' ARG . 0.9 OUTLIER -139.7 112.17 7.76 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.131 -0.98 . . . . 0.0 109.668 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.435 ' HB2' ' OH ' ' A' ' 34' ' ' TYR . 1.6 t -176.86 -81.45 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.303 -0.873 . . . . 0.0 109.327 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -143.43 -141.22 3.78 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -83.07 55.94 3.3 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.299 -1.118 . . . . 0.0 109.509 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -104.93 95.34 5.8 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.297 -0.877 . . . . 0.0 109.496 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -86.42 76.26 9.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.304 -0.873 . . . . 0.0 109.506 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -133.0 -163.45 10.55 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.408 ' O ' ' O ' ' A' ' 31' ' ' SER . 2.2 tpt180 -102.65 95.94 6.55 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.246 -1.149 . . . . 0.0 109.438 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.408 ' O ' ' O ' ' A' ' 30' ' ' ARG . 4.2 p 63.3 128.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.25 -0.907 . . . . 0.0 109.534 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.504 ' CB ' ' HB ' ' A' ' 20' ' ' VAL . 0.9 OUTLIER -83.91 158.43 21.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.21 -0.931 . . . . 0.0 109.495 -179.892 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -134.81 116.0 14.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.239 -0.913 . . . . 0.0 109.585 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.492 ' CE1' ' HD3' ' A' ' 44' ' ' ARG . 20.8 m-30 -116.22 140.06 49.71 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.245 -0.91 . . . . 0.0 109.247 179.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.551 ' CE2' ' CE1' ' A' ' 64' ' ' PHE . 4.3 m-85 -112.02 147.05 36.8 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.199 -0.938 . . . . 0.0 109.636 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.445 ' HA ' ' O ' ' A' ' 41' ' ' ASP . 26.1 tt0 -131.24 128.17 39.34 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.334 -0.854 . . . . 0.0 109.342 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.469 ' OG ' ' HB2' ' A' ' 41' ' ' ASP . 0.9 OUTLIER -69.72 173.9 3.64 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.249 -0.907 . . . . 0.0 109.304 179.999 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.468 ' HD2' ' HB3' ' A' ' 37' ' ' SER . 36.3 Cg_endo -78.12 -3.79 13.76 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.597 2.198 . . . . 0.0 110.602 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.463 HG23 ' HB2' ' A' ' 37' ' ' SER . 10.7 t -101.42 -9.78 20.8 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.2 -0.938 . . . . 0.0 109.594 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 111.46 9.68 21.06 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.469 ' HB2' ' OG ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -78.76 141.56 37.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.186 -1.185 . . . . 0.0 109.424 179.889 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.456 ' O ' ' HG2' ' A' ' 42' ' ' ARG . 0.1 OUTLIER -128.37 120.41 26.92 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.154 -0.966 . . . . 0.0 109.703 -179.753 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.546 ' CG2' ' HB3' ' A' ' 49' ' ' LEU . 2.4 mp -126.73 162.23 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.19 -0.944 . . . . 0.0 109.328 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.576 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 29.3 mtt85 -147.35 20.07 1.21 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.217 -0.927 . . . . 0.0 109.756 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.532 ' O ' ' CB ' ' A' ' 46' ' ' LYS . 0.5 OUTLIER -95.06 -86.78 0.29 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.386 -0.821 . . . . 0.0 108.821 179.433 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.551 ' HB2' ' CD1' ' A' ' 64' ' ' PHE . 24.2 ttmt 159.72 -64.96 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 43.7 t -87.25 -19.58 7.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.473 ' HB2' ' HB2' ' A' ' 45' ' ' SER . 16.2 mt-10 -69.89 -41.44 74.73 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.546 ' HB3' ' CG2' ' A' ' 43' ' ' ILE . 3.0 pp -72.39 -33.09 66.94 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.525 ' CG2' ' O ' ' A' ' 57' ' ' CYS . 1.4 m -63.91 -48.62 75.87 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.402 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.22 -28.13 57.28 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.926 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.482 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 41.6 t80 -72.58 -56.98 4.51 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.624 -0.672 . . . . 0.0 109.353 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.582 HD23 ' CZ3' ' A' ' 15' ' ' TRP . 0.5 OUTLIER -55.03 -57.09 13.13 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.098 -1.001 . . . . 0.0 109.139 179.681 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 134.28 -157.98 23.16 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.1 3.17 7.29 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.559 2.173 . . . . 0.0 110.343 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -84.87 -27.27 26.81 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.228 -0.92 . . . . 0.0 109.465 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.525 ' O ' ' CG2' ' A' ' 50' ' ' THR . 54.3 m -122.33 138.48 54.5 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.303 -0.873 . . . . 0.0 109.245 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.497 ' HA ' HG23 ' A' ' 50' ' ' THR . 29.0 t70 -127.05 142.83 51.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.165 -0.96 . . . . 0.0 109.511 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.525 HD11 ' CD2' ' A' ' 11' ' ' LEU . 3.6 mp -141.3 8.89 2.04 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.191 -0.943 . . . . 0.0 109.803 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.469 ' HB ' HD23 ' A' ' 61' ' ' LEU . 4.0 m -47.43 -42.78 23.02 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.113 -0.992 . . . . 0.0 109.282 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.58 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 1.7 mm? -99.66 -3.08 33.87 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.333 -0.854 . . . . 0.0 109.56 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.569 ' CZ ' ' HA2' ' A' ' 67' ' ' GLY . 83.3 t80 -61.51 139.37 58.25 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.354 -0.841 . . . . 0.0 109.744 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.434 ' O ' ' N ' ' A' ' 65' ' ' LYS . 3.4 m-20 -92.24 104.65 16.99 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.443 -0.786 . . . . 0.0 108.967 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.576 ' CE2' ' O ' ' A' ' 44' ' ' ARG . 0.8 OUTLIER -68.51 65.11 0.11 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.239 -0.913 . . . . 0.0 109.479 -179.526 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 63' ' ' ASP . 1.7 ttpt -178.41 -33.36 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.17 -0.956 . . . . 0.0 109.625 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -107.23 -32.85 7.62 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.264 -0.898 . . . . 0.0 109.704 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.569 ' HA2' ' CZ ' ' A' ' 62' ' ' PHE . . . 97.92 38.63 4.06 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.472 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 1.9 pp -139.88 165.84 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.246 -1.15 . . . . 0.0 109.581 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.505 ' CB ' ' HA ' ' A' ' 62' ' ' PHE . 0.5 OUTLIER -153.79 -176.04 5.65 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.276 -0.89 . . . . 0.0 109.589 179.946 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.459 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 0.1 OUTLIER -157.27 152.63 26.33 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.361 -0.837 . . . . 0.0 109.355 179.797 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.408 ' HB2' ' O ' ' A' ' 70' ' ' CYS . 1.6 t80 178.82 99.23 0.16 Allowed Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.107 -0.996 . . . . 0.0 109.653 -179.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -79.39 174.19 12.24 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.65 2.233 . . . . 0.0 110.615 -179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 62.48 71.53 0.69 Allowed Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.326 -0.859 . . . . 0.0 109.602 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.51 54.56 5.08 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.655 2.237 . . . . 0.0 110.432 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.02 -0.991 . . . . 0.0 109.561 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.412 ' O ' ' HB2' ' A' ' 2' ' ' ALA . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.412 ' HB2' ' O ' ' A' ' 1' ' ' MET . . . 59.31 -170.19 0.13 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.151 -0.968 . . . . 0.0 108.993 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.465 ' CG ' ' HG2' ' A' ' 18' ' ' ARG . 13.8 tp10 -117.59 156.78 27.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.024 -1.047 . . . . 0.0 109.532 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.474 ' O ' ' O ' ' A' ' 5' ' ' TRP . 0.4 OUTLIER -148.99 26.29 0.89 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.214 -0.929 . . . . 0.0 109.358 179.884 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.536 ' CE3' ' HB2' ' A' ' 18' ' ' ARG . 76.7 m95 55.03 107.38 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.375 -0.828 . . . . 0.0 109.45 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.2 mt -107.18 161.32 14.88 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.148 -0.97 . . . . 0.0 109.739 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -53.91 149.28 9.15 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.394 -0.816 . . . . 0.0 109.519 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.466 ' HB2' ' HB2' ' A' ' 17' ' ' ARG . 50.2 t -111.18 103.42 54.89 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.369 -0.832 . . . . 0.0 109.331 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -77.03 -23.85 10.23 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.354 2.036 . . . . 0.0 110.31 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.65 -48.66 66.28 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.189 -0.944 . . . . 0.0 109.173 179.71 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.579 ' CD1' ' CD1' ' A' ' 15' ' ' TRP . 0.7 OUTLIER -96.64 -59.86 1.72 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.375 -0.828 . . . . 0.0 109.245 179.882 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 158.82 -153.69 24.81 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.35 154.41 28.17 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.614 2.209 . . . . 0.0 110.596 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.18 -12.32 68.24 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.579 ' CD1' ' CD1' ' A' ' 11' ' ' LEU . 16.5 t-105 -111.7 126.21 54.8 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.175 -1.191 . . . . 0.0 109.52 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 18.3 mmtp -101.27 119.58 38.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.282 -0.887 . . . . 0.0 109.581 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.514 ' HG3' ' CE2' ' A' ' 35' ' ' TYR . 5.8 ttp85 -94.89 114.69 26.57 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.224 -0.922 . . . . 0.0 109.359 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.536 ' HB2' ' CE3' ' A' ' 5' ' ' TRP . 0.2 OUTLIER -100.29 128.47 46.35 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.351 -0.843 . . . . 0.0 109.321 179.997 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.427 ' HG2' ' OE2' ' A' ' 3' ' ' GLU . 9.3 pt-20 -118.24 134.06 55.35 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.263 -0.898 . . . . 0.0 109.248 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -111.51 -178.51 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.246 -0.909 . . . . 0.0 109.474 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.47 ' O ' ' HB2' ' A' ' 22' ' ' ARG . 28.1 m-85 -124.95 44.21 2.84 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.281 -0.887 . . . . 0.0 109.186 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.486 ' O ' ' CB ' ' A' ' 23' ' ' LYS . 0.8 OUTLIER 69.25 -60.83 0.45 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.325 -0.859 . . . . 0.0 109.532 -179.944 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.486 ' CB ' ' O ' ' A' ' 22' ' ' ARG . 1.3 tmtt? 74.98 -56.98 0.62 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.267 -0.896 . . . . 0.0 109.458 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.438 ' OG ' ' N ' ' A' ' 25' ' ' GLY . 9.9 t -161.91 179.79 7.77 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.184 -0.947 . . . . 0.0 109.435 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.438 ' N ' ' OG ' ' A' ' 24' ' ' SER . . . 119.4 -132.58 9.62 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -97.03 -175.89 3.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.256 -1.144 . . . . 0.0 109.518 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 20.2 p -92.44 27.65 2.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.267 -0.896 . . . . 0.0 109.375 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 85.9 m -48.05 -68.03 0.22 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.263 -0.898 . . . . 0.0 109.57 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 107.01 35.02 2.84 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.9 ptt85 -127.79 144.19 51.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.197 -1.178 . . . . 0.0 109.4 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.5 p -97.23 133.79 41.39 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.297 -0.877 . . . . 0.0 109.612 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 32' ' ' ASP . 0.3 OUTLIER -80.04 149.4 30.72 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.291 -0.881 . . . . 0.0 109.108 179.774 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.457 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 46.2 m -128.78 108.94 10.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.087 -1.008 . . . . 0.0 110.042 -179.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.535 ' CD1' ' N ' ' A' ' 34' ' ' TYR . 2.7 m-30 -99.66 151.73 20.88 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.333 -0.854 . . . . 0.0 108.922 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.603 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 3.8 m-85 -123.68 148.77 46.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.962 -1.086 . . . . 0.0 109.914 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.525 ' HB2' ' CZ3' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -128.32 119.59 25.39 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.497 -0.752 . . . . 0.0 109.01 179.753 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.417 ' OG ' ' O ' ' A' ' 41' ' ' ASP . 0.6 OUTLIER -63.99 170.32 3.52 Favored Pre-proline 0 N--CA 1.488 1.437 0 O-C-N 121.317 -0.865 . . . . 0.0 109.374 -179.918 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.404 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 35.1 Cg_endo -78.26 -2.58 12.64 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.619 2.213 . . . . 0.0 110.161 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.8 p -102.75 -23.8 13.78 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.269 -0.895 . . . . 0.0 109.645 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 123.81 9.44 5.76 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.452 ' HB2' ' OH ' ' A' ' 52' ' ' TYR . 0.7 OUTLIER -92.07 112.3 24.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.19 -1.182 . . . . 0.0 109.362 179.951 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.418 ' HB3' ' HG3' ' A' ' 36' ' ' GLN . 0.0 OUTLIER -99.43 122.36 42.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.343 -0.848 . . . . 0.0 109.808 -179.738 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.458 HG22 ' HB3' ' A' ' 49' ' ' LEU . 2.7 mp -117.68 154.04 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.346 -0.846 . . . . 0.0 109.169 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.583 ' O ' ' CZ ' ' A' ' 64' ' ' PHE . 5.6 ttp180 -123.46 -0.21 8.75 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.001 -1.062 . . . . 0.0 109.956 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.526 ' CB ' ' HB2' ' A' ' 48' ' ' GLU . 0.4 OUTLIER -96.61 154.54 17.22 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.231 -0.918 . . . . 0.0 108.558 179.228 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.558 ' HB2' ' CD1' ' A' ' 64' ' ' PHE . 17.4 ttpt -72.85 -67.36 0.57 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.069 -1.019 . . . . 0.0 110.402 -178.968 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.483 ' O ' ' CG ' ' A' ' 51' ' ' ARG . 53.5 t -72.1 -25.69 24.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 120.862 -1.149 . . . . 0.0 109.956 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.526 ' HB2' ' CB ' ' A' ' 45' ' ' SER . 6.9 tt0 -62.72 -49.03 76.68 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.759 -1.213 . . . . 0.0 108.278 179.021 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.481 HD23 ' O ' ' A' ' 45' ' ' SER . 1.8 pp -70.26 -23.85 62.96 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.564 ' OG1' ' CB ' ' A' ' 59' ' ' LEU . 33.0 m -65.5 -68.55 0.36 Allowed 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.484 ' HG3' ' O ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -42.9 -31.56 0.52 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 179.269 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.473 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 51.4 t80 -55.09 -56.88 14.81 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.326 -0.859 . . . . 0.0 108.74 179.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.556 HD21 ' CE3' ' A' ' 15' ' ' TRP . 0.3 OUTLIER -65.07 -43.14 93.17 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.214 -0.929 . . . . 0.0 109.16 179.379 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 110.26 -152.7 17.28 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.284 -1.527 . . . . 0.0 109.284 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.43 -10.92 15.99 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.545 2.163 . . . . 0.0 110.205 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.1 -32.15 66.73 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.296 -0.878 . . . . 0.0 109.371 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.496 ' HB2' ' CB ' ' A' ' 53' ' ' LEU . 4.0 m -121.86 97.84 5.68 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 0.0 109.251 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -74.99 137.42 41.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.255 -0.903 . . . . 0.0 109.731 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.565 HD23 ' CG ' ' A' ' 62' ' ' PHE . 0.1 OUTLIER -142.21 7.91 1.8 Allowed 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.37 -0.831 . . . . 0.0 109.54 -179.731 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.428 ' C ' HD21 ' A' ' 61' ' ' LEU . 97.9 m -56.69 -28.39 60.73 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.348 -0.845 . . . . 0.0 109.645 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.599 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 2.4 mm? -107.33 -10.47 15.78 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.261 -0.899 . . . . 0.0 109.485 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.572 ' CE1' ' OH ' ' A' ' 35' ' ' TYR . 38.5 t80 -45.27 128.83 7.9 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.361 -0.837 . . . . 0.0 109.53 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.495 ' O ' ' N ' ' A' ' 65' ' ' LYS . 11.1 m-20 -79.67 100.99 8.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.326 -0.859 . . . . 0.0 109.194 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.583 ' CZ ' ' O ' ' A' ' 44' ' ' ARG . 0.7 OUTLIER -65.55 72.95 0.06 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.374 -0.829 . . . . 0.0 109.333 -179.672 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.495 ' N ' ' O ' ' A' ' 63' ' ' ASP . 0.6 OUTLIER 166.5 -43.6 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.824 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.422 ' HG3' ' HD3' ' A' ' 65' ' ' LYS . 3.8 mt-30 -86.33 -44.67 11.9 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.373 -0.829 . . . . 0.0 109.305 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.413 ' HA2' ' CZ ' ' A' ' 62' ' ' PHE . . . 108.77 25.18 5.78 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.891 -1.283 . . . . 0.0 109.891 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.45 HG13 ' OD2' ' A' ' 63' ' ' ASP . 1.1 pt -140.23 162.58 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.199 -1.177 . . . . 0.0 109.48 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 69' ' ' LEU . 1.7 pt? -133.0 146.38 51.72 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.125 -0.984 . . . . 0.0 109.472 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 40.7 m -129.33 -148.94 0.39 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.325 -0.859 . . . . 0.0 108.824 179.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.454 ' HA ' ' HG ' ' A' ' 61' ' ' LEU . 1.3 m-85 -123.71 165.39 23.59 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.08 -1.013 . . . . 0.0 109.394 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.426 ' HD2' ' CD2' ' A' ' 71' ' ' TYR . 35.1 Cg_endo -77.99 122.91 5.98 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.72 2.28 . . . . 0.0 110.623 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -135.39 93.33 16.61 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.326 -0.859 . . . . 0.0 109.296 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.418 ' O ' ' CB ' ' A' ' 75' ' ' LYS . 35.2 Cg_endo -77.12 139.91 19.45 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.579 2.186 . . . . 0.0 110.422 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.418 ' CB ' ' O ' ' A' ' 74' ' ' PRO . 11.8 mttm . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.997 -1.002 . . . . 0.0 109.442 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.7 mtm . . . . . 0 N--CA 1.489 1.492 0 CA-C-O 121.246 0.546 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.523 ' O ' ' CZ ' ' A' ' 21' ' ' PHE . . . -156.0 32.82 0.34 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.236 -0.915 . . . . 0.0 109.392 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.403 ' HB2' ' HG2' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -116.94 -178.75 3.51 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.26 -0.9 . . . . 0.0 109.567 -179.949 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.451 ' O ' HD21 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -154.18 80.34 1.12 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.385 -0.822 . . . . 0.0 108.9 179.844 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.412 ' C ' ' O ' ' A' ' 4' ' ' ASP . 73.3 m95 -42.42 119.31 1.38 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.469 -0.769 . . . . 0.0 109.773 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.451 HD21 ' O ' ' A' ' 4' ' ' ASP . 0.4 OUTLIER -130.92 147.97 52.63 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.29 -0.881 . . . . 0.0 109.487 179.839 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.465 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 48.4 t0 -44.02 138.07 3.03 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.348 -0.845 . . . . 0.0 109.104 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.47 ' HB2' ' HB2' ' A' ' 17' ' ' ARG . 32.6 t -102.77 105.67 46.02 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.198 -0.939 . . . . 0.0 109.505 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 34.4 Cg_endo -77.33 -27.49 6.46 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.297 1.998 . . . . 0.0 109.991 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.449 ' O ' HD23 ' A' ' 69' ' ' LEU . . . -45.5 -57.95 3.74 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.347 -0.846 . . . . 0.0 109.41 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.444 HD23 ' HB3' ' A' ' 10' ' ' ALA . 0.9 OUTLIER -89.34 -58.44 2.53 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.321 -0.862 . . . . 0.0 109.327 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 159.02 -152.88 23.99 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.84 164.1 28.06 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.557 2.172 . . . . 0.0 110.351 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.463 ' O ' ' HD3' ' A' ' 38' ' ' PRO . . . 75.49 8.81 84.36 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.582 ' CZ2' HD12 ' A' ' 49' ' ' LEU . 9.2 t-105 -130.6 126.08 35.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.171 -1.194 . . . . 0.0 109.46 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 12.5 mmtt -106.4 120.32 41.57 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.225 -0.922 . . . . 0.0 109.579 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.47 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 1.4 ttp85 -88.38 115.86 26.19 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.474 -0.766 . . . . 0.0 109.325 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.41 ' HD2' ' CG2' ' A' ' 20' ' ' VAL . 3.8 ttm180 -99.53 131.14 45.73 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.173 -0.955 . . . . 0.0 109.371 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.5 ' CG ' ' O ' ' A' ' 19' ' ' GLU . 1.7 pp20? -116.39 117.38 29.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.209 -0.932 . . . . 0.0 109.352 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.53 ' O ' ' N ' ' A' ' 22' ' ' ARG . 8.5 t -113.71 83.73 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.229 -0.92 . . . . 0.0 109.172 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.523 ' CZ ' ' O ' ' A' ' 2' ' ' ALA . 1.1 p90 -45.95 91.75 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.413 -0.805 . . . . 0.0 109.878 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.53 ' N ' ' O ' ' A' ' 20' ' ' VAL . 0.2 OUTLIER -56.07 -35.27 66.79 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.254 -0.904 . . . . 0.0 109.138 179.784 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -176.01 42.07 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.394 -0.816 . . . . 0.0 109.21 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.9 p -57.31 105.86 0.27 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.216 -0.928 . . . . 0.0 109.338 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -86.42 -120.18 1.19 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.81 -89.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.281 -1.129 . . . . 0.0 109.485 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.416 ' O ' ' OG1' ' A' ' 27' ' ' THR . 0.3 OUTLIER -142.97 19.57 1.96 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.254 -0.904 . . . . 0.0 109.401 -179.96 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.5 m -126.35 45.28 2.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.191 -0.943 . . . . 0.0 109.403 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -99.81 -154.85 28.05 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.407 ' O ' ' O ' ' A' ' 31' ' ' SER . 0.0 OUTLIER -134.22 -50.28 0.81 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.252 -1.146 . . . . 0.0 109.417 179.957 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.407 ' O ' ' O ' ' A' ' 30' ' ' ARG . 1.9 m 60.95 116.39 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.37 -0.832 . . . . 0.0 109.657 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -81.49 149.61 28.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.263 -0.898 . . . . 0.0 109.152 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.402 HG21 ' CZ ' ' A' ' 35' ' ' TYR . 42.0 m -127.49 111.51 13.89 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.122 -0.987 . . . . 0.0 109.953 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.498 ' CE1' HG23 ' A' ' 20' ' ' VAL . 19.8 m-85 -99.76 152.98 19.48 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.295 -0.878 . . . . 0.0 108.806 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.622 ' CE1' ' CE1' ' A' ' 64' ' ' PHE . 7.5 m-85 -124.5 142.74 51.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.983 -1.073 . . . . 0.0 109.934 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -126.63 138.98 53.5 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.375 -0.828 . . . . 0.0 109.402 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.458 ' OG ' HG21 ' A' ' 39' ' ' THR . 0.9 OUTLIER -77.89 172.52 9.59 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.287 -0.883 . . . . 0.0 109.506 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 14' ' ' GLY . 35.0 Cg_endo -79.29 13.4 2.04 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.77 2.313 . . . . 0.0 110.98 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.458 HG21 ' OG ' ' A' ' 37' ' ' SER . 14.6 t -123.34 -21.62 5.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.981 -1.074 . . . . 0.0 109.852 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . 0.413 ' N ' HG21 ' A' ' 39' ' ' THR . . . 127.27 8.23 4.59 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.457 ' OD2' ' OH ' ' A' ' 52' ' ' TYR . 6.0 m-20 -88.86 133.3 34.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.083 -1.245 . . . . 0.0 109.324 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.406 ' O ' ' HG2' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -116.37 137.06 52.46 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.263 -0.898 . . . . 0.0 109.432 -179.734 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.536 HD12 ' CG ' ' A' ' 52' ' ' TYR . 4.5 mt -132.7 156.21 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.264 -0.897 . . . . 0.0 109.922 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.592 ' O ' ' CZ ' ' A' ' 64' ' ' PHE . 13.3 ttp180 -123.5 -45.72 2.06 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.581 -0.699 . . . . 0.0 110.067 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.546 ' HB2' ' CB ' ' A' ' 48' ' ' GLU . 0.6 OUTLIER -59.28 122.7 14.54 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.915 -1.115 . . . . 0.0 108.831 -179.965 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.57 ' HA ' ' CE1' ' A' ' 64' ' ' PHE . 4.9 ttpm? -40.34 -83.17 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.543 -0.723 . . . . 0.0 110.724 -179.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.484 ' HA ' ' OG1' ' A' ' 50' ' ' THR . 42.7 t -55.64 -30.4 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.205 -0.935 . . . . 0.0 110.641 -178.581 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.546 ' CB ' ' HB2' ' A' ' 45' ' ' SER . 14.2 tt0 -54.8 -45.88 74.4 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.663 -1.273 . . . . 0.0 108.813 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.582 HD12 ' CZ2' ' A' ' 15' ' ' TRP . 1.4 pp -69.83 -20.67 63.42 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.038 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.545 ' CG2' ' HA ' ' A' ' 58' ' ' ASP . 17.0 m -71.95 -67.21 0.55 Allowed 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.464 ' HG3' ' O ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -44.58 -26.96 0.42 Allowed 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.795 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.536 ' CG ' HD12 ' A' ' 43' ' ' ILE . 76.5 t80 -67.75 -64.68 0.81 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.455 -0.778 . . . . 0.0 109.191 179.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.523 ' CD2' ' CE3' ' A' ' 15' ' ' TRP . 1.3 mt -44.5 -57.27 3.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.189 -0.945 . . . . 0.0 109.04 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 141.01 -162.16 26.75 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.95 -16.17 14.45 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.648 2.232 . . . . 0.0 110.218 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.29 -8.19 56.54 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.307 -0.871 . . . . 0.0 109.585 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 39.8 m -124.98 168.17 13.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.242 -0.911 . . . . 0.0 109.553 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.545 ' HA ' ' CG2' ' A' ' 50' ' ' THR . 9.3 p-10 -165.46 141.95 5.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.273 -0.892 . . . . 0.0 109.44 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.505 HD13 ' CG2' ' A' ' 50' ' ' THR . 6.7 mp -139.43 1.28 1.95 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.097 -1.002 . . . . 0.0 109.955 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 67.5 m -47.25 -31.28 3.62 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.044 -1.035 . . . . 0.0 108.876 179.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.622 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 2.7 mm? -103.43 -15.95 15.74 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.54 ' CZ ' ' HA2' ' A' ' 67' ' ' GLY . 64.9 t80 -57.61 132.87 54.53 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.551 -0.718 . . . . 0.0 109.702 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.497 ' O ' ' N ' ' A' ' 65' ' ' LYS . 1.1 m-20 -79.71 104.79 10.54 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.331 -0.856 . . . . 0.0 108.915 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.622 ' CE1' ' CE1' ' A' ' 35' ' ' TYR . 0.4 OUTLIER -67.74 63.81 0.08 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.183 -0.948 . . . . 0.0 109.424 -179.584 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.497 ' N ' ' O ' ' A' ' 63' ' ' ASP . 1.4 ttmm 173.61 -32.62 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -94.01 -46.45 7.14 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.374 -0.829 . . . . 0.0 109.012 179.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.54 ' HA2' ' CZ ' ' A' ' 62' ' ' PHE . . . 108.45 28.54 4.55 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.456 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 1.3 pp -140.74 159.13 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.017 -1.284 . . . . 0.0 109.909 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.493 HD22 ' N ' ' A' ' 69' ' ' LEU . 1.1 pt? -141.54 -176.09 4.61 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 1.2 m -157.16 173.92 16.25 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.037 -1.04 . . . . 0.0 109.828 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -151.78 77.63 7.02 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.409 -0.807 . . . . 0.0 109.307 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.69 69.05 7.49 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.618 2.212 . . . . 0.0 110.346 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.561 ' N ' ' CD ' ' A' ' 74' ' ' PRO . . . -63.84 -52.39 57.79 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.319 -0.863 . . . . 0.0 109.911 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.561 ' CD ' ' N ' ' A' ' 73' ' ' ALA . 35.4 Cg_endo -78.13 -176.75 3.41 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.39 2.06 . . . . 0.0 110.611 -179.658 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.6 pttm . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.336 -179.862 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -169.54 -61.52 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.344 -0.848 . . . . 0.0 109.405 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.514 ' HG3' ' NH2' ' A' ' 18' ' ' ARG . 1.7 pm0 -103.28 73.09 1.19 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.202 -0.936 . . . . 0.0 109.481 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.45 ' O ' ' O ' ' A' ' 5' ' ' TRP . 12.3 m-20 -110.16 27.2 9.85 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.292 -0.88 . . . . 0.0 109.287 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.567 ' CZ3' ' HB2' ' A' ' 36' ' ' GLN . 65.3 m95 47.01 93.24 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.258 -0.901 . . . . 0.0 109.241 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.0 mt -103.86 176.48 5.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.37 -0.831 . . . . 0.0 109.644 -179.662 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 7' ' ' ASP . 6.6 p-10 -62.17 137.27 58.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.391 -0.818 . . . . 0.0 109.422 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.528 ' SG ' ' CZ ' ' A' ' 17' ' ' ARG . 13.4 t -95.5 109.99 48.48 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.259 -0.901 . . . . 0.0 109.231 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.48 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 36.2 Cg_endo -79.45 -46.7 0.1 OUTLIER 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.446 2.097 . . . . 0.0 110.795 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.43 ' C ' ' O ' ' A' ' 9' ' ' PRO . . . -43.21 -44.03 5.02 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.162 -0.962 . . . . 0.0 109.935 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.57 HD11 ' CD1' ' A' ' 15' ' ' TRP . 10.7 mt -97.23 -61.53 1.39 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.203 -0.936 . . . . 0.0 109.777 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 8' ' ' CYS . . . 155.74 -155.02 25.97 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.95 158.63 30.92 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.582 2.188 . . . . 0.0 110.335 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.4 -43.01 3.09 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.571 ' CE3' HD22 ' A' ' 53' ' ' LEU . 15.9 t-105 -79.35 130.66 35.65 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.221 -1.164 . . . . 0.0 109.424 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.3 mmtm -97.97 124.04 42.25 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.256 -0.903 . . . . 0.0 109.235 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.528 ' CZ ' ' SG ' ' A' ' 8' ' ' CYS . 0.7 OUTLIER -99.63 108.92 21.42 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.256 -0.902 . . . . 0.0 109.318 -179.944 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.514 ' NH2' ' HG3' ' A' ' 3' ' ' GLU . 0.2 OUTLIER -99.85 137.78 37.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.175 -0.953 . . . . 0.0 109.744 -179.779 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -123.83 152.93 41.74 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.37 -0.831 . . . . 0.0 109.272 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.463 ' O ' ' HB3' ' A' ' 31' ' ' SER . 1.9 t -129.05 175.26 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.22 -0.925 . . . . 0.0 109.467 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -129.16 60.01 1.56 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.316 -0.865 . . . . 0.0 109.094 179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.1 mtt85 -73.02 90.29 1.49 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.388 -0.82 . . . . 0.0 109.779 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -58.5 -47.67 83.35 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.095 -1.003 . . . . 0.0 108.974 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 47.93 -167.08 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.297 -0.877 . . . . 0.0 109.595 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -128.49 -57.33 0.11 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.11 162.14 0.52 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.213 -1.169 . . . . 0.0 109.42 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -100.91 56.74 0.87 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.288 -0.882 . . . . 0.0 109.516 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.9 m -125.65 84.37 2.27 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.253 -0.905 . . . . 0.0 109.449 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.43 124.65 5.43 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.48 ' O ' ' CB ' ' A' ' 31' ' ' SER . 4.9 tpt180 -109.75 94.62 5.12 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.223 -1.163 . . . . 0.0 109.338 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.48 ' CB ' ' O ' ' A' ' 30' ' ' ARG . 0.9 OUTLIER 72.91 136.12 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.246 -0.909 . . . . 0.0 109.27 -179.887 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.581 ' HB3' ' CZ ' ' A' ' 34' ' ' TYR . 0.4 OUTLIER -95.66 157.6 15.83 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.215 -0.928 . . . . 0.0 109.454 -179.896 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.447 HG22 ' O ' ' A' ' 18' ' ' ARG . 2.7 m -139.79 123.61 17.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.184 -0.948 . . . . 0.0 109.546 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.581 ' CZ ' ' HB3' ' A' ' 32' ' ' ASP . 0.7 OUTLIER -120.63 163.06 18.61 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.258 -0.901 . . . . 0.0 109.474 179.911 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.525 ' HB3' ' NE1' ' A' ' 15' ' ' TRP . 8.8 m-85 -130.45 156.99 43.83 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.182 -0.949 . . . . 0.0 109.834 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.567 ' HB2' ' CZ3' ' A' ' 5' ' ' TRP . 12.4 tt0 -139.18 114.33 9.55 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.398 -0.814 . . . . 0.0 109.001 179.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.488 ' OG ' ' CZ3' ' A' ' 15' ' ' TRP . 0.8 OUTLIER -63.2 163.05 19.53 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.291 -0.88 . . . . 0.0 109.615 -179.686 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.58 3.08 7.15 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.625 2.217 . . . . 0.0 110.241 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.8 t -103.56 -16.77 15.43 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.334 -0.854 . . . . 0.0 109.233 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.0 14.8 8.96 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.513 ' OD2' ' CE1' ' A' ' 52' ' ' TYR . 0.8 OUTLIER -95.39 115.93 28.1 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.221 -1.164 . . . . 0.0 109.504 179.947 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.42 ' O ' ' HG2' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -99.51 121.35 41.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.184 -0.948 . . . . 0.0 109.541 179.961 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.49 ' CG2' ' HB3' ' A' ' 49' ' ' LEU . 2.7 mp -126.36 156.53 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.337 -0.852 . . . . 0.0 109.207 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.584 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 2.2 ttm180 -133.37 -8.68 2.92 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.088 -1.007 . . . . 0.0 110.773 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.569 ' CB ' ' HB2' ' A' ' 48' ' ' GLU . 0.4 OUTLIER -79.71 -178.27 6.3 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.73 -1.231 . . . . 0.0 108.391 179.296 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.549 ' HA ' ' CE1' ' A' ' 64' ' ' PHE . 29.4 ttpt -102.15 -57.32 2.09 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.988 -1.07 . . . . 0.0 109.845 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 57.4 t -84.57 -14.8 11.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.12 -0.988 . . . . 0.0 109.387 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.569 ' HB2' ' CB ' ' A' ' 45' ' ' SER . 1.9 mt-10 -74.7 -42.21 58.78 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.066 -1.021 . . . . 0.0 108.389 179.083 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.563 HD12 ' CZ2' ' A' ' 15' ' ' TRP . 1.5 pp -70.96 -29.13 65.05 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.023 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.53 ' OG1' ' CD1' ' A' ' 59' ' ' LEU . 0.4 OUTLIER -71.86 -43.8 64.87 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.301 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.416 ' N ' HG21 ' A' ' 50' ' ' THR . 0.3 OUTLIER -61.24 -21.81 64.22 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.993 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.513 ' CE1' ' OD2' ' A' ' 41' ' ' ASP . 90.2 t80 -75.81 -60.21 2.42 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.558 -0.714 . . . . 0.0 109.448 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.571 HD22 ' CE3' ' A' ' 15' ' ' TRP . 1.0 OUTLIER -56.02 -46.28 78.87 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.155 -0.965 . . . . 0.0 109.254 179.726 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 128.63 -151.34 18.92 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -79.08 -24.31 6.94 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.638 2.225 . . . . 0.0 110.504 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.7 -20.47 66.34 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.269 -0.894 . . . . 0.0 109.854 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 49.3 m -133.52 103.48 5.94 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.179 -0.95 . . . . 0.0 109.687 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.49 150.82 24.25 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.226 -0.921 . . . . 0.0 109.044 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.537 HD21 ' CD2' ' A' ' 62' ' ' PHE . 0.6 OUTLIER -134.42 9.11 3.69 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.236 -0.915 . . . . 0.0 109.466 -179.876 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.416 ' HB ' HD21 ' A' ' 61' ' ' LEU . 2.5 m -47.76 -46.8 30.51 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.326 -0.858 . . . . 0.0 109.303 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.585 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 3.5 mm? -99.26 -2.15 37.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.353 -0.842 . . . . 0.0 109.528 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.537 ' CD2' HD21 ' A' ' 59' ' ' LEU . 69.2 t80 -60.1 129.04 39.81 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.264 -0.898 . . . . 0.0 109.488 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.503 ' O ' ' N ' ' A' ' 65' ' ' LYS . 3.2 m-20 -79.3 101.05 7.84 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.242 -0.911 . . . . 0.0 108.931 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.584 ' CE2' ' O ' ' A' ' 44' ' ' ARG . 0.9 OUTLIER -67.32 61.21 0.06 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.35 -0.844 . . . . 0.0 109.435 -179.494 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.503 ' N ' ' O ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -174.08 -38.54 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.312 -0.868 . . . . 0.0 109.449 -179.819 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -100.37 -39.87 7.77 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.288 -0.882 . . . . 0.0 109.511 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.438 ' HA2' ' CE1' ' A' ' 62' ' ' PHE . . . 107.22 35.96 2.6 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.0 pp -140.64 163.73 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.129 -1.218 . . . . 0.0 109.726 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.471 ' HB3' ' HA ' ' A' ' 62' ' ' PHE . 0.7 OUTLIER -145.59 173.66 11.86 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.271 -0.893 . . . . 0.0 109.032 179.76 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.462 ' O ' ' HG ' ' A' ' 61' ' ' LEU . 1.6 p -151.9 139.23 19.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.184 -0.948 . . . . 0.0 109.362 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -129.7 154.3 80.93 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.235 -0.916 . . . . 0.0 109.635 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.409 ' O ' ' HB2' ' A' ' 73' ' ' ALA . 35.2 Cg_endo -77.49 -160.38 0.12 Allowed 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.671 2.248 . . . . 0.0 110.441 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.409 ' HB2' ' O ' ' A' ' 72' ' ' PRO . . . 61.32 79.05 0.29 Allowed Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.211 -0.93 . . . . 0.0 109.472 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -77.81 -85.57 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.644 2.229 . . . . 0.0 110.463 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.9 pttm . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.477 179.978 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.238 0.542 . . . . 0.0 109.605 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.41 144.42 31.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.264 -0.897 . . . . 0.0 109.494 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.424 ' CD ' ' HD3' ' A' ' 18' ' ' ARG . 0.3 OUTLIER -86.03 -158.44 0.4 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.187 -0.946 . . . . 0.0 109.373 179.913 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -102.46 50.12 0.83 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.127 -0.983 . . . . 0.0 109.642 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 67.7 m95 -62.05 99.11 0.12 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.159 -0.963 . . . . 0.0 109.42 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.425 ' O ' ' C ' ' A' ' 7' ' ' ASP . 89.9 mt -113.62 145.9 40.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.24 -0.912 . . . . 0.0 109.284 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.483 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 12.5 t0 -43.21 129.07 4.76 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.183 -0.948 . . . . 0.0 109.469 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.462 ' SG ' ' HD2' ' A' ' 17' ' ' ARG . 14.8 t -80.36 113.25 37.64 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.408 -0.808 . . . . 0.0 109.505 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.483 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 36.5 Cg_endo -80.14 -53.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.353 2.036 . . . . 0.0 110.461 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.52 ' CB ' ' CE1' ' A' ' 62' ' ' PHE . . . -42.66 -33.4 0.71 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.38 -0.825 . . . . 0.0 109.867 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.639 ' CD1' ' CD1' ' A' ' 15' ' ' TRP . 16.8 mt -105.89 -63.78 1.22 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.189 -0.944 . . . . 0.0 109.299 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 146.8 -151.5 23.77 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.66 155.04 31.18 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.639 2.226 . . . . 0.0 110.26 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.438 ' O ' ' HD3' ' A' ' 38' ' ' PRO . . . 90.57 -33.55 4.54 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.639 ' CD1' ' CD1' ' A' ' 11' ' ' LEU . 13.7 t-105 -94.91 122.85 37.97 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.394 -1.062 . . . . 0.0 108.958 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.6 121.52 39.6 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.142 -0.973 . . . . 0.0 109.172 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.598 ' CG ' ' CE1' ' A' ' 35' ' ' TYR . 0.2 OUTLIER -90.56 104.91 17.44 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.365 -0.834 . . . . 0.0 109.772 -179.774 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.473 ' O ' HG23 ' A' ' 33' ' ' THR . 0.7 OUTLIER -97.55 143.34 28.34 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.397 -0.815 . . . . 0.0 109.028 179.584 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -137.35 141.97 41.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.014 -1.054 . . . . 0.0 109.92 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.453 ' O ' ' HB2' ' A' ' 31' ' ' SER . 2.2 t -127.11 178.57 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.348 -0.845 . . . . 0.0 109.24 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -116.08 3.6 13.58 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.191 -0.943 . . . . 0.0 109.739 -179.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.473 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 1.6 tmt_? 67.68 -73.6 0.08 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.19 -0.943 . . . . 0.0 109.748 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 22' ' ' ARG . 0.2 OUTLIER 177.36 -35.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.301 -0.875 . . . . 0.0 109.083 -179.916 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.6 m -151.01 178.01 9.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.292 -0.88 . . . . 0.0 109.384 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 171.83 81.39 0.05 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.23 -85.61 0.09 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.243 -1.151 . . . . 0.0 109.391 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.98 7.08 16.75 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.283 -0.885 . . . . 0.0 109.396 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.6 t -142.63 52.59 1.42 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.32 -0.862 . . . . 0.0 109.272 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -97.18 -177.15 34.68 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.97 -36.55 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.498 -1.001 . . . . 0.0 109.079 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.453 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 0.0 OUTLIER 68.82 132.59 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.271 -0.893 . . . . 0.0 109.73 179.55 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.551 ' HB3' ' CE1' ' A' ' 34' ' ' TYR . 60.9 m-20 -87.88 124.55 33.77 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.333 -0.854 . . . . 0.0 109.068 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.579 ' CG2' ' CE1' ' A' ' 35' ' ' TYR . 6.1 m -113.35 138.29 50.27 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.23 -0.919 . . . . 0.0 109.385 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.551 ' CE1' ' HB3' ' A' ' 32' ' ' ASP . 13.1 m-85 -131.13 151.18 51.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.235 -0.916 . . . . 0.0 109.393 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.682 ' CZ ' ' CE1' ' A' ' 64' ' ' PHE . 14.7 m-85 -122.17 133.93 54.73 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.291 -0.881 . . . . 0.0 109.224 179.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.443 ' HG3' ' HG3' ' A' ' 42' ' ' ARG . 39.6 tt0 -115.85 124.73 51.39 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.215 -0.928 . . . . 0.0 109.606 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.521 ' CB ' ' HD2' ' A' ' 38' ' ' PRO . 0.1 OUTLIER -75.48 175.66 3.91 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.234 -0.916 . . . . 0.0 109.368 179.888 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.521 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 35.2 Cg_endo -77.63 -4.75 14.89 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.64 2.227 . . . . 0.0 110.55 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 8.1 t -101.85 -0.43 34.13 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.212 -0.93 . . . . 0.0 109.536 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 94.99 19.6 30.64 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.435 ' CB ' ' OG ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -84.77 118.02 24.19 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.291 -1.123 . . . . 0.0 109.335 -179.996 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.443 ' HG3' ' HG3' ' A' ' 36' ' ' GLN . 0.0 OUTLIER -105.58 107.08 17.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.362 -0.836 . . . . 0.0 109.535 -179.839 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.518 ' CG2' ' HB3' ' A' ' 49' ' ' LEU . 1.8 mp -120.5 153.53 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.289 -0.882 . . . . 0.0 109.448 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.586 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 13.6 ptt180 -122.11 -26.16 4.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.135 -0.978 . . . . 0.0 109.466 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.502 ' CB ' ' HB2' ' A' ' 48' ' ' GLU . 0.3 OUTLIER -83.2 139.9 32.87 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.217 -0.927 . . . . 0.0 109.022 179.751 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.48 ' O ' ' HB ' ' A' ' 50' ' ' THR . 9.0 pttt -66.91 -52.01 48.32 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.304 -0.872 . . . . 0.0 110.932 -178.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.456 ' O ' HG23 ' A' ' 50' ' ' THR . 48.4 t -74.92 -23.25 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.818 -1.176 . . . . 0.0 109.958 -179.17 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.502 ' HB2' ' CB ' ' A' ' 45' ' ' SER . 28.8 mt-10 -65.28 -50.49 65.55 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.895 -1.128 . . . . 0.0 108.297 179.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.528 ' O ' ' CD1' ' A' ' 53' ' ' LEU . 3.7 pp -72.58 -35.81 68.03 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.51 ' N ' HD13 ' A' ' 49' ' ' LEU . 0.5 OUTLIER -59.29 -39.66 83.68 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.025 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.1 mmt180 -69.38 -25.11 64.0 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.474 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 5.6 t80 -71.32 -57.66 4.26 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.658 -0.651 . . . . 0.0 109.326 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.638 ' CD2' ' CZ3' ' A' ' 15' ' ' TRP . 0.2 OUTLIER -65.95 -40.21 91.12 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.094 -1.004 . . . . 0.0 109.248 179.724 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 122.44 -153.86 16.89 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.422 ' O ' ' C ' ' A' ' 56' ' ' ALA . 34.8 Cg_endo -77.57 -36.23 1.3 Allowed 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.534 2.156 . . . . 0.0 110.331 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 55' ' ' PRO . . . -44.86 -39.86 5.73 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.213 -0.93 . . . . 0.0 109.227 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.43 ' O ' ' OG1' ' A' ' 50' ' ' THR . 1.3 m -114.48 84.0 1.98 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.32 -0.862 . . . . 0.0 109.05 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.445 ' O ' HD13 ' A' ' 59' ' ' LEU . 19.8 m-20 -77.86 163.97 25.58 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.224 -0.922 . . . . 0.0 109.883 -179.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.577 HD22 ' CD2' ' A' ' 62' ' ' PHE . 0.5 OUTLIER -160.01 23.23 0.17 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.444 -0.785 . . . . 0.0 109.27 179.964 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.454 ' HB ' HD22 ' A' ' 61' ' ' LEU . 3.6 m -55.35 -48.2 74.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.331 -0.856 . . . . 0.0 109.95 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.535 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 2.2 mm? -103.98 4.07 34.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.28 -0.887 . . . . 0.0 109.95 -179.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.577 ' CD2' HD22 ' A' ' 59' ' ' LEU . 54.3 t80 -63.64 136.75 57.73 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.205 -0.934 . . . . 0.0 109.909 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.98 114.95 27.25 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.501 -0.749 . . . . 0.0 108.995 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.682 ' CE1' ' CZ ' ' A' ' 35' ' ' TYR . 0.3 OUTLIER -74.58 62.27 1.02 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.222 -0.924 . . . . 0.0 109.797 -179.458 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.45 ' HB3' ' O ' ' A' ' 64' ' ' PHE . 17.5 pttt 178.91 -38.41 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.273 -0.892 . . . . 0.0 109.178 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.402 ' N ' ' CG ' ' A' ' 65' ' ' LYS . 0.4 OUTLIER -94.23 -18.46 21.67 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.285 -0.884 . . . . 0.0 108.991 179.407 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.58 ' CA ' ' CZ ' ' A' ' 17' ' ' ARG . . . 73.32 43.08 39.83 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.507 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 1.4 pp -140.48 -167.47 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.152 -1.205 . . . . 0.0 109.511 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.543 ' HB3' ' HA ' ' A' ' 62' ' ' PHE . 0.6 OUTLIER 179.95 178.47 0.59 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.799 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -160.44 167.37 27.43 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.007 -1.058 . . . . 0.0 109.909 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -115.93 153.63 48.24 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.303 -0.873 . . . . 0.0 109.308 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.73 56.44 5.62 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.531 2.154 . . . . 0.0 110.576 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.527 ' N ' ' HD3' ' A' ' 74' ' ' PRO . . . -169.45 61.35 0.42 Allowed Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.14 -0.975 . . . . 0.0 109.672 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.527 ' HD3' ' N ' ' A' ' 73' ' ' ALA . 36.3 Cg_endo -78.28 142.15 18.79 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.603 2.202 . . . . 0.0 110.328 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.429 ' HE3' ' O ' ' A' ' 73' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.461 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -107.36 -62.32 1.44 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.243 -0.91 . . . . 0.0 109.471 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.519 ' HB2' ' NE ' ' A' ' 18' ' ' ARG . 7.2 mm-40 -116.71 -88.7 0.59 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.239 -0.913 . . . . 0.0 109.605 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.455 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 5.9 m-20 -157.96 69.18 0.52 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.199 -0.938 . . . . 0.0 109.818 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.583 ' CE3' ' HB2' ' A' ' 18' ' ' ARG . 48.4 m95 -67.51 97.54 0.6 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.141 -0.974 . . . . 0.0 109.203 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 4' ' ' ASP . 28.6 mt -103.0 152.52 21.23 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.153 -0.967 . . . . 0.0 109.484 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.47 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 37.1 m-20 -47.43 129.57 13.19 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.211 -0.931 . . . . 0.0 109.133 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.519 ' CB ' ' HB2' ' A' ' 17' ' ' ARG . 54.1 t -79.9 114.05 43.06 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.302 -0.874 . . . . 0.0 109.653 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.47 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 36.4 Cg_endo -78.64 -46.1 0.12 Allowed 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.292 1.995 . . . . 0.0 110.195 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.575 ' CB ' ' CE1' ' A' ' 62' ' ' PHE . . . -46.57 -29.83 1.99 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.307 -0.871 . . . . 0.0 109.644 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.582 HD12 ' CD1' ' A' ' 15' ' ' TRP . 10.2 mt -115.54 -61.76 1.69 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.082 -1.011 . . . . 0.0 110.004 -179.772 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.47 ' O ' ' O ' ' A' ' 8' ' ' CYS . . . 158.79 -152.14 23.19 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.509 ' O ' ' N ' ' A' ' 15' ' ' TRP . 35.1 Cg_endo -77.79 179.32 6.62 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.633 2.222 . . . . 0.0 110.352 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.425 ' O ' ' HD3' ' A' ' 16' ' ' LYS . . . 67.2 -63.95 0.23 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 108.951 -1.66 . . . . 0.0 108.951 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.582 ' CD1' HD12 ' A' ' 11' ' ' LEU . 6.2 t-105 -53.09 126.95 22.41 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.385 -1.068 . . . . 0.0 109.089 179.356 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.425 ' HD3' ' O ' ' A' ' 14' ' ' GLY . 0.3 OUTLIER -100.33 114.71 28.42 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.061 -1.024 . . . . 0.0 109.761 -179.579 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.568 ' HG3' ' CE1' ' A' ' 35' ' ' TYR . 8.7 ttt-85 -95.93 102.99 14.85 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.361 -0.837 . . . . 0.0 109.174 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.583 ' HB2' ' CE3' ' A' ' 5' ' ' TRP . 8.4 ttt180 -99.94 151.41 21.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.154 -0.966 . . . . 0.0 109.973 -179.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -126.16 138.46 53.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.393 -0.817 . . . . 0.0 109.316 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.43 ' O ' ' HB2' ' A' ' 21' ' ' PHE . 11.4 t -136.18 152.66 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.242 -0.912 . . . . 0.0 109.359 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.534 ' CB ' ' HA ' ' A' ' 31' ' ' SER . 6.4 m-85 62.56 17.5 9.69 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.255 -0.903 . . . . 0.0 109.481 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.536 ' CA ' ' HB3' ' A' ' 31' ' ' SER . 0.0 OUTLIER -91.19 -53.01 4.54 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.286 -0.884 . . . . 0.0 109.726 -179.891 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.01 170.31 9.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.171 -0.956 . . . . 0.0 109.742 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.1 t 66.12 89.97 0.09 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.295 -0.878 . . . . 0.0 109.456 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 167.22 165.24 24.29 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.66 -79.38 0.17 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.247 -1.149 . . . . 0.0 109.444 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.5 t -146.81 74.94 1.37 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.249 -0.907 . . . . 0.0 109.432 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.7 t -89.96 -70.96 0.64 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.287 -0.883 . . . . 0.0 109.395 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.47 67.83 1.42 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.481 ' O ' ' O ' ' A' ' 31' ' ' SER . 0.0 OUTLIER -168.2 -62.64 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.294 -1.121 . . . . 0.0 109.3 179.892 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.536 ' HB3' ' CA ' ' A' ' 22' ' ' ARG . 0.1 OUTLIER 51.6 173.05 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.399 -0.813 . . . . 0.0 109.913 179.828 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.549 ' HB3' ' CZ ' ' A' ' 34' ' ' TYR . 7.8 m-20 -130.58 117.64 19.85 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.295 -0.878 . . . . 0.0 108.691 179.555 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.476 HG21 ' NH2' ' A' ' 17' ' ' ARG . 18.5 m -101.87 137.02 40.71 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.138 -0.976 . . . . 0.0 110.061 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.549 ' CZ ' ' HB3' ' A' ' 32' ' ' ASP . 46.5 m-85 -129.13 148.49 51.07 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.568 ' CE1' ' HG3' ' A' ' 17' ' ' ARG . 38.6 m-85 -110.81 137.64 48.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.079 -1.013 . . . . 0.0 109.897 -179.577 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.528 ' HB2' ' CZ3' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -116.38 116.86 28.49 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.273 -0.892 . . . . 0.0 109.257 179.536 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.464 ' CB ' ' HD2' ' A' ' 38' ' ' PRO . 0.6 OUTLIER -58.12 173.65 0.38 Allowed Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.303 -0.873 . . . . 0.0 109.309 -179.971 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.464 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 35.7 Cg_endo -78.72 0.67 9.77 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.621 2.214 . . . . 0.0 110.382 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.404 HG21 ' HB3' ' A' ' 37' ' ' SER . 5.5 t -111.88 -22.9 10.86 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.295 -0.878 . . . . 0.0 109.417 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.8 -2.37 5.22 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.417 ' CB ' ' HB2' ' A' ' 37' ' ' SER . 0.2 OUTLIER -65.31 171.09 4.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.188 -1.184 . . . . 0.0 109.427 179.952 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.456 ' HA ' ' O ' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -154.67 108.31 2.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.26 -0.9 . . . . 0.0 109.277 -179.962 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.48 HG22 ' CA ' ' A' ' 49' ' ' LEU . 2.4 mp -107.49 163.36 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.279 -0.888 . . . . 0.0 109.623 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.567 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 7.7 ttp180 -130.59 -32.51 1.71 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.316 -0.865 . . . . 0.0 109.851 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.572 ' CB ' ' HB2' ' A' ' 48' ' ' GLU . 0.6 OUTLIER -68.13 151.75 46.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.056 -1.027 . . . . 0.0 108.877 179.825 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.473 ' HA ' HD23 ' A' ' 49' ' ' LEU . 7.5 ttpm? -70.59 -68.78 0.4 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.272 -0.893 . . . . 0.0 111.185 -178.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.466 ' O ' ' CG ' ' A' ' 51' ' ' ARG . 54.5 t -71.9 -18.6 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.052 -1.03 . . . . 0.0 110.705 -178.53 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.572 ' HB2' ' CB ' ' A' ' 45' ' ' SER . 5.5 mt-10 -72.12 -42.74 65.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.656 -1.278 . . . . 0.0 108.745 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.484 ' O ' ' CD1' ' A' ' 53' ' ' LEU . 1.6 pp -69.42 -25.83 64.31 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 178.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.544 ' CG2' HD12 ' A' ' 59' ' ' LEU . 20.6 m -70.44 -62.7 1.29 Allowed 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.486 ' HG3' ' O ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -51.0 -22.56 2.36 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.477 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.479 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 59.2 t80 -64.03 -56.25 16.36 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.39 -0.819 . . . . 0.0 108.92 179.351 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.578 HD22 ' CE3' ' A' ' 15' ' ' TRP . 0.7 OUTLIER -61.87 -49.27 76.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.197 -0.94 . . . . 0.0 109.221 179.704 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 130.91 -156.03 21.53 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.79 3.42 6.95 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.536 2.157 . . . . 0.0 110.231 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -87.83 -12.89 43.62 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.384 -0.823 . . . . 0.0 109.325 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.46 ' O ' ' CG2' ' A' ' 50' ' ' THR . 52.9 m -139.02 131.68 28.95 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.233 -0.917 . . . . 0.0 109.703 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.48 ' HA ' HG23 ' A' ' 50' ' ' THR . 12.4 t70 -124.27 155.11 39.19 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.274 -0.891 . . . . 0.0 109.472 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.544 HD12 ' CG2' ' A' ' 50' ' ' THR . 5.5 mp -148.49 15.06 0.99 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.191 -0.943 . . . . 0.0 109.61 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.472 ' C ' ' CD2' ' A' ' 61' ' ' LEU . 12.7 m -46.01 -37.54 6.74 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.22 -0.925 . . . . 0.0 109.484 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.583 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 1.4 mm? -112.72 11.1 19.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.22 -0.925 . . . . 0.0 109.744 -179.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.575 ' CE1' ' CB ' ' A' ' 10' ' ' ALA . 51.5 t80 -69.3 151.05 46.7 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.329 -0.857 . . . . 0.0 110.317 -179.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -107.08 106.42 16.91 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.567 ' CE2' ' O ' ' A' ' 44' ' ' ARG . 0.2 OUTLIER -71.09 60.76 0.27 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.182 -0.949 . . . . 0.0 109.577 -179.224 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 15.5 ttpt -177.28 -35.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.196 -0.94 . . . . 0.0 109.585 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -101.08 -30.83 11.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.216 -0.928 . . . . 0.0 109.529 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.18 39.72 5.65 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.424 ' O ' ' CD1' ' A' ' 62' ' ' PHE . 2.2 pp -140.11 -178.64 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.168 -1.195 . . . . 0.0 109.967 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.5 ' HB3' ' HA ' ' A' ' 62' ' ' PHE . 0.8 OUTLIER -172.17 -175.97 1.54 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.36 -0.838 . . . . 0.0 108.99 -179.954 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.461 ' SG ' HD11 ' A' ' 61' ' ' LEU . 31.9 p -160.24 168.82 24.51 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.183 -0.948 . . . . 0.0 109.337 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -142.38 78.3 16.71 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.238 -0.914 . . . . 0.0 109.693 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.01 -169.18 0.71 Allowed 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.617 2.212 . . . . 0.0 110.06 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -167.05 83.43 0.87 Allowed Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.161 -0.962 . . . . 0.0 109.551 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.68 102.92 1.59 Allowed 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.695 2.263 . . . . 0.0 110.272 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.4 mttt . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.405 -179.906 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.9 tpt . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -168.66 54.75 0.05 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.223 -0.923 . . . . 0.0 109.578 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -140.55 124.96 17.74 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.266 -0.896 . . . . 0.0 109.453 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.473 ' O ' ' O ' ' A' ' 5' ' ' TRP . 61.0 t0 -144.69 24.08 1.55 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.268 -0.895 . . . . 0.0 109.379 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.57 ' CE2' ' HD2' ' A' ' 18' ' ' ARG . 62.5 m95 50.29 100.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.389 -0.82 . . . . 0.0 109.584 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.455 HD11 ' O ' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -107.58 150.26 27.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.234 -0.916 . . . . 0.0 109.596 179.984 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.52 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 0.4 OUTLIER -45.88 147.53 0.96 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.3 -0.875 . . . . 0.0 109.352 179.774 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.515 ' SG ' ' N ' ' A' ' 17' ' ' ARG . 52.3 m -93.8 109.81 43.67 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.329 -0.857 . . . . 0.0 109.77 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.52 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 35.8 Cg_endo -80.02 -29.43 2.66 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.26 1.973 . . . . 0.0 109.561 179.291 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.476 ' HB1' ' NH1' ' A' ' 17' ' ' ARG . . . -69.55 -34.77 74.68 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.376 -0.827 . . . . 0.0 109.357 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.541 HD11 ' CD1' ' A' ' 15' ' ' TRP . 10.4 mt -105.51 -50.27 3.25 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.208 -0.932 . . . . 0.0 109.509 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 139.08 -151.68 21.9 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -77.74 161.66 30.41 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.627 2.218 . . . . 0.0 110.268 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.94 -48.61 4.09 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.607 ' CZ2' ' HB2' ' A' ' 49' ' ' LEU . 11.4 t-105 -76.61 125.78 29.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.26 -1.141 . . . . 0.0 109.195 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.497 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 0.1 OUTLIER -102.21 127.53 49.11 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.386 -0.821 . . . . 0.0 109.448 -179.655 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.553 ' HG3' ' CE1' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -100.58 104.1 15.43 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.423 -0.798 . . . . 0.0 109.899 -179.311 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.57 ' HD2' ' CE2' ' A' ' 5' ' ' TRP . 1.0 OUTLIER -100.74 135.09 42.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.17 -0.956 . . . . 0.0 109.569 179.624 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -115.49 146.51 41.61 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.274 -0.891 . . . . 0.0 109.351 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.49 ' O ' ' N ' ' A' ' 32' ' ' ASP . 2.9 t -139.6 152.86 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.175 -0.953 . . . . 0.0 109.876 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 7.3 m-30 56.06 27.75 11.86 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.409 -0.807 . . . . 0.0 109.775 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.408 ' O ' ' CB ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -90.96 95.79 10.3 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.269 -0.894 . . . . 0.0 109.354 179.757 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.408 ' CB ' ' O ' ' A' ' 22' ' ' ARG . 0.6 OUTLIER 69.76 98.79 0.06 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.295 -0.878 . . . . 0.0 109.557 -179.936 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 17.5 m -153.91 -67.77 0.14 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.286 -0.884 . . . . 0.0 109.244 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.3 -59.4 0.84 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.469 ' O ' ' N ' ' A' ' 28' ' ' CYS . . . -92.31 20.17 6.34 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.25 -1.147 . . . . 0.0 109.33 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 48.67 -94.57 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.384 -0.822 . . . . 0.0 109.57 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . 0.469 ' N ' ' O ' ' A' ' 26' ' ' ALA . 1.7 m -85.92 89.8 7.89 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.127 -0.983 . . . . 0.0 109.493 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -133.49 -94.19 0.53 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 26.0 ttm-85 -146.68 121.05 9.61 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.184 -1.186 . . . . 0.0 109.645 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.425 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 1.6 p -110.22 135.45 50.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.251 -0.905 . . . . 0.0 109.312 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.529 ' HB3' ' CZ ' ' A' ' 34' ' ' TYR . 3.6 m-20 -86.31 103.86 15.29 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.163 -0.961 . . . . 0.0 109.24 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.438 ' OG1' ' HA ' ' A' ' 65' ' ' LYS . 1.5 m -100.65 120.26 39.8 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.278 -0.889 . . . . 0.0 109.841 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.564 ' CD1' ' HG2' ' A' ' 44' ' ' ARG . 15.2 m-85 -123.35 152.92 41.01 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.355 -0.84 . . . . 0.0 108.979 179.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.692 ' CE2' ' CE1' ' A' ' 64' ' ' PHE . 4.1 m-85 -118.57 145.16 45.59 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.117 -0.989 . . . . 0.0 109.593 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.491 ' NE2' ' O ' ' A' ' 37' ' ' SER . 0.0 OUTLIER -132.93 141.71 48.5 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.216 -0.928 . . . . 0.0 109.868 -179.802 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.491 ' O ' ' NE2' ' A' ' 36' ' ' GLN . 0.3 OUTLIER -81.26 173.4 7.75 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.45 -0.781 . . . . 0.0 109.183 179.616 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.45 ' CD ' ' CB ' ' A' ' 37' ' ' SER . 36.0 Cg_endo -78.89 7.2 4.43 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.605 2.203 . . . . 0.0 110.573 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.2 p -110.49 -13.59 14.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.212 -0.93 . . . . 0.0 109.502 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 110.59 24.3 5.64 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.469 ' OD2' ' CD1' ' A' ' 43' ' ' ILE . 9.5 t70 -97.42 123.23 41.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.279 -1.13 . . . . 0.0 109.393 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.26 124.84 50.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.29 -0.881 . . . . 0.0 109.645 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.584 ' CD1' ' N ' ' A' ' 43' ' ' ILE . 3.1 mp -128.05 150.43 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.255 -0.903 . . . . 0.0 109.447 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.564 ' HG2' ' CD1' ' A' ' 34' ' ' TYR . 11.9 mtt180 -144.92 9.68 1.31 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.253 -0.904 . . . . 0.0 110.235 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.545 ' CB ' ' HB2' ' A' ' 48' ' ' GLU . 0.3 OUTLIER -98.41 12.66 34.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.033 -1.042 . . . . 0.0 109.355 179.833 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.58 ' HA ' ' CE1' ' A' ' 64' ' ' PHE . 0.0 OUTLIER 63.22 -93.4 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.365 -0.834 . . . . 0.0 110.225 179.374 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.457 HG11 ' O ' ' A' ' 47' ' ' VAL . 75.5 t -55.35 -22.45 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.127 -0.983 . . . . 0.0 109.812 -179.161 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.545 ' HB2' ' CB ' ' A' ' 45' ' ' SER . 2.5 mt-10 -63.56 -47.83 79.96 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.038 -1.039 . . . . 0.0 108.766 179.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.607 ' HB2' ' CZ2' ' A' ' 15' ' ' TRP . 1.3 pp -67.56 -24.92 65.58 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 179.113 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.496 ' N ' ' HG ' ' A' ' 49' ' ' LEU . 4.9 m -66.95 -62.59 1.36 Allowed 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.496 ' HG3' ' O ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -52.4 -21.64 3.84 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.306 -0.957 . . . . 0.0 108.459 179.299 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.418 ' O ' ' C ' ' A' ' 53' ' ' LEU . 2.0 t80 -77.19 -64.51 1.12 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.463 -0.773 . . . . 0.0 108.989 179.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.514 HD21 ' CE3' ' A' ' 15' ' ' TRP . 2.2 mt -45.07 -63.64 0.88 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.18 -0.95 . . . . 0.0 109.047 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 143.8 -163.6 27.61 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.97 -7.26 16.32 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.604 2.203 . . . . 0.0 110.116 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -79.36 -11.3 59.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.341 -0.849 . . . . 0.0 109.453 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.413 ' SG ' ' HB3' ' A' ' 11' ' ' LEU . 1.0 OUTLIER -136.74 150.41 48.39 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.245 -0.909 . . . . 0.0 109.456 -179.986 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.475 ' C ' ' CD1' ' A' ' 59' ' ' LEU . 13.7 p-10 -139.97 156.15 46.79 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.234 -0.916 . . . . 0.0 109.43 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.48 HD13 HD12 ' A' ' 49' ' ' LEU . 6.0 mp -150.86 15.51 0.75 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.167 -0.958 . . . . 0.0 109.549 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.48 HG23 ' CD2' ' A' ' 61' ' ' LEU . 32.1 m -47.32 -41.03 18.45 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.277 -0.889 . . . . 0.0 109.336 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.598 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 2.4 mm? -109.27 -4.62 16.33 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.279 -0.888 . . . . 0.0 109.597 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.571 ' CE2' ' O ' ' A' ' 63' ' ' ASP . 33.4 t80 -56.93 136.48 56.0 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.273 -0.892 . . . . 0.0 109.73 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.571 ' O ' ' CE2' ' A' ' 62' ' ' PHE . 11.6 m-20 -85.13 129.23 34.84 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.361 -0.837 . . . . 0.0 109.11 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.692 ' CE1' ' CE2' ' A' ' 35' ' ' TYR . 0.6 OUTLIER -84.39 54.92 3.16 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.133 -0.98 . . . . 0.0 109.489 -179.61 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.438 ' HA ' ' OG1' ' A' ' 33' ' ' THR . 7.3 ttmt -175.91 -42.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.428 -0.795 . . . . 0.0 109.033 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 -83.25 -45.69 13.54 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.36 -0.838 . . . . 0.0 109.105 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.548 ' HA2' ' CE1' ' A' ' 62' ' ' PHE . . . 103.32 32.64 4.51 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.463 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 2.2 pp -140.52 162.21 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.108 -1.231 . . . . 0.0 109.692 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.454 ' HB3' ' HA ' ' A' ' 62' ' ' PHE . 1.1 pt? -143.6 164.16 31.19 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.301 -0.875 . . . . 0.0 108.982 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.56 ' O ' ' CB ' ' A' ' 71' ' ' TYR . 7.7 p -157.41 176.45 12.65 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.12 -0.987 . . . . 0.0 109.577 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.579 ' HB3' ' HD3' ' A' ' 72' ' ' PRO . 6.7 t80 158.98 -47.98 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.723 -0.61 . . . . 0.0 109.477 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.579 ' HD3' ' HB3' ' A' ' 71' ' ' TYR . 36.6 Cg_endo -79.57 93.43 1.08 Allowed 'Trans proline' 0 C--N 1.316 -1.179 0 C-N-CA 122.023 1.816 . . . . 0.0 110.212 179.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -174.62 145.75 0.99 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.103 -0.998 . . . . 0.0 109.525 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.35 110.01 2.77 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.573 2.182 . . . . 0.0 110.378 179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 117.949 -1.024 . . . . 0.0 109.42 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.408 ' O ' ' O ' ' A' ' 2' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 . . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.408 ' O ' ' O ' ' A' ' 1' ' ' MET . . . 62.1 118.45 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.277 -0.89 . . . . 0.0 109.475 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -85.14 179.9 7.15 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.295 -0.878 . . . . 0.0 109.531 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.413 ' O ' ' C ' ' A' ' 5' ' ' TRP . 0.3 OUTLIER -135.85 76.65 1.62 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.307 -0.871 . . . . 0.0 109.449 -179.973 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.577 ' CZ3' ' HB2' ' A' ' 18' ' ' ARG . 71.2 m95 -42.62 124.48 3.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.322 -0.862 . . . . 0.0 109.585 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.453 ' HG ' ' O ' ' A' ' 17' ' ' ARG . 0.2 OUTLIER -110.01 148.74 31.1 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.237 -0.914 . . . . 0.0 109.527 179.921 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.405 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 0.6 OUTLIER -47.43 147.32 1.71 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.203 -0.936 . . . . 0.0 109.49 -179.884 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.506 ' HB2' ' HB3' ' A' ' 15' ' ' TRP . 6.1 m -89.69 114.46 60.69 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.344 -0.848 . . . . 0.0 109.818 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.405 ' HD2' ' HD3' ' A' ' 17' ' ' ARG . 36.0 Cg_endo -79.04 -39.51 0.34 Allowed 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.362 2.041 . . . . 0.0 110.371 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.451 ' HB3' ' O ' ' A' ' 67' ' ' GLY . . . -64.58 -46.26 83.45 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.213 -0.93 . . . . 0.0 109.595 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.581 HD12 ' CD1' ' A' ' 15' ' ' TRP . 6.8 mt -90.12 -48.06 7.42 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.117 -0.989 . . . . 0.0 109.776 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 129.81 -153.26 19.93 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -77.41 155.81 32.44 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.732 2.288 . . . . 0.0 110.497 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.71 -26.66 8.0 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.229 -1.549 . . . . 0.0 109.229 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.592 ' CZ2' HD12 ' A' ' 49' ' ' LEU . 8.7 t-105 -101.74 132.8 47.26 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.345 -1.091 . . . . 0.0 108.9 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.423 ' C ' ' SG ' ' A' ' 8' ' ' CYS . 14.5 mptt -106.39 129.24 54.42 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.191 -0.943 . . . . 0.0 110.078 -179.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.577 ' HG3' ' CE2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -105.27 113.25 26.72 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.376 -0.828 . . . . 0.0 109.097 179.611 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.577 ' HB2' ' CZ3' ' A' ' 5' ' ' TRP . 0.1 OUTLIER -100.16 144.44 29.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.365 -0.834 . . . . 0.0 109.588 -179.728 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.449 ' OE1' HD22 ' A' ' 6' ' ' LEU . 5.2 pt-20 -130.83 131.06 44.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.341 -0.849 . . . . 0.0 109.197 179.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.474 ' O ' ' HB2' ' A' ' 31' ' ' SER . 14.5 t -138.34 161.57 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.205 -0.934 . . . . 0.0 109.514 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.454 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 0.5 OUTLIER 68.69 32.27 4.25 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.185 -0.947 . . . . 0.0 109.41 -179.994 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.454 ' HG3' ' HB3' ' A' ' 31' ' ' SER . 4.1 ttp180 -75.82 81.39 2.75 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.318 -0.864 . . . . 0.0 109.488 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 61.55 95.38 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.283 -0.886 . . . . 0.0 109.634 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -169.53 -66.16 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.288 -0.883 . . . . 0.0 109.606 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -84.56 -98.48 0.65 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -99.33 119.62 38.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.254 -1.145 . . . . 0.0 109.565 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -90.88 53.81 2.49 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.26 -0.9 . . . . 0.0 109.405 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 6.0 t -83.09 -15.75 49.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.336 -0.852 . . . . 0.0 109.641 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.455 ' O ' ' HG2' ' A' ' 30' ' ' ARG . . . -152.4 -88.76 0.07 OUTLIER Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.455 ' HG2' ' O ' ' A' ' 29' ' ' GLY . 0.0 OUTLIER -171.56 165.54 6.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.229 -1.159 . . . . 0.0 109.614 -179.837 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.474 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 0.3 OUTLIER -46.52 163.46 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.309 -0.869 . . . . 0.0 109.429 179.913 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.491 ' HB3' ' CE1' ' A' ' 34' ' ' TYR . 0.9 OUTLIER -89.6 170.1 10.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.214 -0.929 . . . . 0.0 109.154 179.751 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.6 m -137.82 109.28 6.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.11 -0.994 . . . . 0.0 109.829 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.582 ' CE1' ' HD2' ' A' ' 44' ' ' ARG . 8.8 m-30 -109.11 160.25 16.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.338 -0.851 . . . . 0.0 108.748 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.577 ' CE2' ' HG3' ' A' ' 17' ' ' ARG . 19.6 m-85 -131.76 145.56 51.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.047 -1.033 . . . . 0.0 109.776 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.427 ' HA ' ' O ' ' A' ' 41' ' ' ASP . 0.9 OUTLIER -133.17 130.44 39.15 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.286 -0.884 . . . . 0.0 109.248 179.931 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.421 ' HA ' ' CZ3' ' A' ' 15' ' ' TRP . 0.8 OUTLIER -71.54 170.42 12.04 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.247 -0.908 . . . . 0.0 109.386 -179.951 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.406 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 35.9 Cg_endo -78.27 5.61 5.32 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.592 2.195 . . . . 0.0 110.457 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.3 p -113.09 -23.03 10.24 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.251 -0.905 . . . . 0.0 109.227 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 125.47 23.36 1.72 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.836 -1.305 . . . . 0.0 109.836 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.573 ' OD2' ' CE1' ' A' ' 52' ' ' TYR . 2.8 t70 -87.73 136.16 33.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.153 -1.204 . . . . 0.0 109.07 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.96 100.71 7.74 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.219 -0.925 . . . . 0.0 109.844 -179.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.523 ' CG2' ' HB3' ' A' ' 49' ' ' LEU . 3.3 mt -112.87 154.09 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.404 -0.81 . . . . 0.0 109.146 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.582 ' HD2' ' CE1' ' A' ' 34' ' ' TYR . 8.1 ttp180 -129.02 -2.76 5.15 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.108 -0.995 . . . . 0.0 109.981 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.542 ' HB3' ' CB ' ' A' ' 48' ' ' GLU . 5.8 t -88.57 173.27 8.74 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.23 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.543 ' HA ' ' CE1' ' A' ' 64' ' ' PHE . 5.6 ttpm? -91.98 -60.49 1.84 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.894 -1.129 . . . . 0.0 110.113 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.443 ' O ' ' CG ' ' A' ' 51' ' ' ARG . 77.6 t -81.48 -22.04 10.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.01 -1.057 . . . . 0.0 109.33 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.542 ' CB ' ' HB3' ' A' ' 45' ' ' SER . 1.2 tt0 -66.21 -45.95 78.96 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 178.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.592 HD12 ' CZ2' ' A' ' 15' ' ' TRP . 1.7 pp -69.95 -22.53 63.16 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.525 ' CG2' HD12 ' A' ' 59' ' ' LEU . 25.5 m -69.09 -69.11 0.35 Allowed 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 178.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.449 ' HD2' ' HA ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -44.15 -28.45 0.5 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.494 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.573 ' CE1' ' OD2' ' A' ' 41' ' ' ASP . 87.5 t80 -59.23 -60.02 4.52 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.173 -0.954 . . . . 0.0 108.845 179.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.541 HD22 ' CE3' ' A' ' 15' ' ' TRP . 1.0 OUTLIER -52.7 -54.8 28.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.305 -0.872 . . . . 0.0 109.265 179.616 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 137.43 -162.74 25.44 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.44 -5.51 15.64 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.559 2.173 . . . . 0.0 110.192 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.19 -26.93 53.37 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.387 -0.82 . . . . 0.0 109.396 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 1.1 m -109.55 -171.61 1.88 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.302 -0.874 . . . . 0.0 109.323 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.456 ' C ' ' CD1' ' A' ' 59' ' ' LEU . 6.9 t0 -178.81 149.43 0.46 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.909 . . . . 0.0 109.655 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.559 HD22 ' CD2' ' A' ' 62' ' ' PHE . 5.5 mp -153.86 14.46 0.47 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.187 -0.945 . . . . 0.0 109.705 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.424 ' C ' HD23 ' A' ' 61' ' ' LEU . 98.4 m -47.94 -39.88 20.48 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.122 -0.987 . . . . 0.0 109.16 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.574 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 1.3 mm? -104.42 -14.05 15.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.396 -0.815 . . . . 0.0 109.229 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.559 ' CD2' HD22 ' A' ' 59' ' ' LEU . 64.6 t80 -44.96 156.19 0.09 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.441 -0.787 . . . . 0.0 109.811 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.499 ' O ' ' N ' ' A' ' 65' ' ' LYS . 5.1 m-20 -109.34 108.35 18.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.282 -0.887 . . . . 0.0 109.403 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.575 ' CZ ' ' O ' ' A' ' 44' ' ' ARG . 0.9 OUTLIER -67.48 61.72 0.06 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.405 -0.809 . . . . 0.0 109.03 179.964 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.499 ' N ' ' O ' ' A' ' 63' ' ' ASP . 0.7 OUTLIER 173.75 -28.11 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.319 -0.863 . . . . 0.0 109.69 -179.738 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -103.75 -26.45 12.73 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.125 -0.984 . . . . 0.0 110.11 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.502 ' CA ' ' NH2' ' A' ' 17' ' ' ARG . . . 85.53 30.26 24.9 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.686 -1.365 . . . . 0.0 109.686 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.494 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 1.9 pp -140.09 173.2 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.226 -1.161 . . . . 0.0 109.517 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.493 ' CB ' ' HA ' ' A' ' 62' ' ' PHE . 0.8 OUTLIER -150.38 -168.48 3.12 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.393 -0.817 . . . . 0.0 109.416 179.984 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -153.55 153.01 31.59 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.219 -0.926 . . . . 0.0 109.358 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.541 ' O ' ' CD2' ' A' ' 71' ' ' TYR . 12.9 p90 -134.55 96.4 15.21 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.129 -0.982 . . . . 0.0 109.688 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.66 104.36 1.86 Allowed 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.589 2.193 . . . . 0.0 110.43 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -146.32 162.03 36.36 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.349 -0.845 . . . . 0.0 109.217 179.822 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.419 ' O ' ' HB2' ' A' ' 75' ' ' LYS . 35.6 Cg_endo -78.44 -10.79 16.0 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.548 2.165 . . . . 0.0 110.489 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 74' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.462 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.5 mmt . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.22 143.12 30.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.302 -0.874 . . . . 0.0 109.468 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.437 ' HG3' ' NH1' ' A' ' 18' ' ' ARG . 13.9 mm-40 -119.18 -91.34 0.56 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.209 -0.932 . . . . 0.0 109.789 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -153.95 65.33 0.72 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.238 -0.914 . . . . 0.0 109.532 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.572 ' CE3' ' HB2' ' A' ' 18' ' ' ARG . 84.2 m95 -66.7 99.22 0.58 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.265 -0.897 . . . . 0.0 109.695 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 79.6 mt -112.69 154.05 26.72 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.27 -0.894 . . . . 0.0 109.366 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.482 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 0.4 OUTLIER -49.01 139.52 10.25 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.232 -0.918 . . . . 0.0 108.897 179.704 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.455 ' O ' ' O ' ' A' ' 12' ' ' GLY . 44.0 t -91.04 111.94 51.07 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.219 -0.925 . . . . 0.0 109.696 -179.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.482 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 36.7 Cg_endo -79.63 -48.68 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.255 1.97 . . . . 0.0 109.975 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.637 ' CB ' ' CE2' ' A' ' 62' ' ' PHE . . . -50.15 -35.44 26.03 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.398 -0.814 . . . . 0.0 109.476 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.598 ' CD1' ' CD1' ' A' ' 15' ' ' TRP . 14.5 mt -98.16 -64.98 0.99 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.262 -0.899 . . . . 0.0 109.555 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 8' ' ' CYS . . . 158.61 -158.88 29.72 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -76.77 159.91 34.63 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.551 2.167 . . . . 0.0 110.402 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.91 -68.15 3.54 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 -179.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.599 ' CE3' ' CD2' ' A' ' 53' ' ' LEU . 26.9 t-105 -49.87 128.64 18.82 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.296 -1.12 . . . . 0.0 108.82 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.3 mmtm -99.33 120.83 40.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.118 -0.989 . . . . 0.0 109.552 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.583 ' CZ ' ' CA ' ' A' ' 67' ' ' GLY . 23.7 ttt-85 -93.4 105.11 17.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.366 -0.834 . . . . 0.0 109.295 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.572 ' HB2' ' CE3' ' A' ' 5' ' ' TRP . 1.2 tmm_? -100.23 152.21 20.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.206 -0.934 . . . . 0.0 110.055 -179.572 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -137.98 155.13 49.18 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.454 ' O ' ' OG ' ' A' ' 31' ' ' SER . 1.0 OUTLIER -125.52 -179.28 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.983 -1.073 . . . . 0.0 109.735 -179.675 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 35.4 p90 -127.75 42.37 3.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.307 -0.871 . . . . 0.0 109.493 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.43 ' O ' ' CG ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -79.72 77.95 6.32 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.244 -0.91 . . . . 0.0 109.392 179.94 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.2 ptmt -170.26 51.35 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.215 -0.928 . . . . 0.0 109.411 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 34.5 t -108.75 15.54 23.53 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.277 -0.889 . . . . 0.0 109.44 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -131.56 -70.15 0.1 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -92.9 168.4 11.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.186 -1.185 . . . . 0.0 109.42 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.18 31.68 6.27 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.216 -0.927 . . . . 0.0 109.667 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.3 m -103.61 67.69 0.91 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.233 -0.917 . . . . 0.0 109.47 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 146.44 155.74 6.64 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.441 ' O ' ' HB3' ' A' ' 31' ' ' SER . 0.0 OUTLIER -120.63 64.72 0.85 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.238 -1.154 . . . . 0.0 109.56 -179.959 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.454 ' OG ' ' O ' ' A' ' 20' ' ' VAL . 0.1 OUTLIER 68.04 139.6 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.159 -0.963 . . . . 0.0 109.493 179.861 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.417 ' OD2' ' HB3' ' A' ' 22' ' ' ARG . 21.0 m-20 -80.85 160.63 24.73 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.262 -0.899 . . . . 0.0 109.251 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.44 ' O ' ' CD1' ' A' ' 34' ' ' TYR . 93.6 m -137.96 134.37 34.84 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.065 -1.022 . . . . 0.0 109.956 -179.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.44 ' CD1' ' O ' ' A' ' 33' ' ' THR . 18.1 m-85 -136.04 153.94 51.2 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.365 -0.834 . . . . 0.0 109.077 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.573 ' CE2' ' HG3' ' A' ' 17' ' ' ARG . 27.5 m-85 -121.02 161.51 21.53 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.996 -1.065 . . . . 0.0 109.752 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.559 ' HB2' ' CZ3' ' A' ' 5' ' ' TRP . 0.1 OUTLIER -128.13 115.29 18.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.289 -0.882 . . . . 0.0 109.287 179.723 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.529 ' CB ' ' HD2' ' A' ' 38' ' ' PRO . 0.8 OUTLIER -53.44 176.41 0.11 Allowed Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.354 -0.841 . . . . 0.0 109.24 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.529 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 35.4 Cg_endo -77.62 -8.88 17.18 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.442 2.095 . . . . 0.0 110.25 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.441 HG23 ' OG ' ' A' ' 37' ' ' SER . 12.9 t -110.17 -16.08 13.85 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.231 -0.918 . . . . 0.0 109.545 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 121.03 20.63 3.33 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.432 ' CB ' ' HB3' ' A' ' 37' ' ' SER . 0.2 OUTLIER -89.73 101.87 14.57 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.197 -1.178 . . . . 0.0 109.249 179.877 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.41 126.26 30.59 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.278 -0.889 . . . . 0.0 108.845 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.553 ' CG2' ' HB3' ' A' ' 49' ' ' LEU . 0.9 OUTLIER -116.47 162.61 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.148 -0.97 . . . . 0.0 110.348 -179.121 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.588 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 0.0 OUTLIER -131.83 -21.83 2.41 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.546 -0.721 . . . . 0.0 110.094 -179.909 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.459 ' HB2' ' HB2' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -99.9 119.2 37.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.886 -1.134 . . . . 0.0 109.269 179.865 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.48 ' O ' ' HG ' ' A' ' 49' ' ' LEU . 0.1 OUTLIER -46.89 -46.69 21.32 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.382 -0.824 . . . . 0.0 110.501 -179.442 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.427 ' HA ' ' HB ' ' A' ' 50' ' ' THR . 73.5 t -74.79 -41.7 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.851 -1.156 . . . . 0.0 109.317 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.481 ' O ' ' HG3' ' A' ' 51' ' ' ARG . 28.4 tt0 -48.53 -49.94 34.03 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.204 -0.935 . . . . 0.0 109.445 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.553 ' HB3' ' CG2' ' A' ' 43' ' ' ILE . 1.1 pp -72.67 -34.92 67.56 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.941 -1.1 . . . . 0.0 108.739 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.531 ' OG1' ' CD1' ' A' ' 59' ' ' LEU . 0.4 OUTLIER -54.63 -54.66 38.56 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.047 -1.033 . . . . 0.0 108.413 179.124 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.523 ' N ' ' CG2' ' A' ' 50' ' ' THR . 0.0 OUTLIER -67.97 -16.63 64.14 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.335 -0.853 . . . . 0.0 108.937 179.496 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.487 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 24.7 t80 -71.51 -56.15 6.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.278 -0.889 . . . . 0.0 109.058 179.409 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.599 ' CD2' ' CE3' ' A' ' 15' ' ' TRP . 0.4 OUTLIER -66.87 -48.84 67.55 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.199 -0.938 . . . . 0.0 108.983 179.523 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 138.64 -153.88 22.81 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.91 -26.9 6.28 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.55 2.167 . . . . 0.0 110.294 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.47 -27.28 65.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.346 -0.846 . . . . 0.0 109.357 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.487 ' CB ' HD13 ' A' ' 53' ' ' LEU . 6.0 m -121.0 104.54 9.88 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.276 -0.89 . . . . 0.0 109.308 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.465 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 0.4 OUTLIER -100.4 158.66 15.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.297 -0.877 . . . . 0.0 109.405 -179.903 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.592 HD21 ' CG ' ' A' ' 62' ' ' PHE . 0.7 OUTLIER -151.8 19.68 0.7 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.206 -0.934 . . . . 0.0 109.414 179.932 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.459 ' O ' HD23 ' A' ' 61' ' ' LEU . 28.6 m -49.95 -40.25 43.16 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.312 -0.867 . . . . 0.0 109.724 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.549 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 1.2 mm? -112.09 2.56 16.84 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.267 -0.896 . . . . 0.0 109.887 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.637 ' CE2' ' CB ' ' A' ' 10' ' ' ALA . 2.4 t80 -52.44 125.27 15.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.193 -0.942 . . . . 0.0 110.037 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.523 ' O ' ' N ' ' A' ' 65' ' ' LYS . 1.4 t0 -84.77 97.84 9.92 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.95 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.588 ' CE2' ' O ' ' A' ' 44' ' ' ARG . 0.7 OUTLIER -65.7 68.14 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.344 -0.848 . . . . 0.0 109.14 -179.243 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 63' ' ' ASP . 7.9 mtpt 174.82 -41.49 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.43 -0.794 . . . . 0.0 108.94 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -93.44 -39.65 10.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.358 -0.839 . . . . 0.0 109.092 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.583 ' CA ' ' CZ ' ' A' ' 17' ' ' ARG . . . 99.71 34.08 5.08 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 pp -140.52 151.04 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.053 -1.263 . . . . 0.0 110.059 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.48 ' HB3' ' HA ' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -139.59 160.52 39.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.326 -0.859 . . . . 0.0 109.179 179.305 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 1.7 p -150.27 169.01 22.38 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.15 -0.968 . . . . 0.0 109.602 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -95.04 149.12 35.78 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.273 -0.892 . . . . 0.0 109.376 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.72 139.04 17.51 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.61 2.207 . . . . 0.0 110.565 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -135.59 164.66 41.93 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.283 -0.886 . . . . 0.0 109.504 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -78.59 -9.85 15.93 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.71 2.273 . . . . 0.0 110.458 179.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 28.2 mttt . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 117.976 -1.012 . . . . 0.0 109.549 -179.939 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -129.18 3.94 5.23 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.298 -0.876 . . . . 0.0 109.639 -179.951 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.428 ' O ' ' OD1' ' A' ' 4' ' ' ASP . 4.6 pm0 -136.92 165.48 25.87 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.186 -0.947 . . . . 0.0 109.439 179.923 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.438 ' O ' ' C ' ' A' ' 5' ' ' TRP . 0.7 OUTLIER -160.65 88.49 0.78 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.252 -0.905 . . . . 0.0 109.596 -179.966 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.438 ' C ' ' O ' ' A' ' 4' ' ' ASP . 75.3 m95 -42.11 106.47 0.06 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.33 -0.856 . . . . 0.0 109.535 179.844 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 17' ' ' ARG . 0.7 OUTLIER -115.92 158.63 22.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.236 -0.915 . . . . 0.0 109.52 -179.801 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.404 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 12.5 m-20 -50.71 145.36 6.97 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.198 -0.938 . . . . 0.0 109.453 179.96 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.478 ' O ' ' O ' ' A' ' 12' ' ' GLY . 42.3 t -89.45 114.5 60.71 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.224 -0.923 . . . . 0.0 109.664 -179.869 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 35.8 Cg_endo -78.47 -55.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.284 1.99 . . . . 0.0 110.443 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.65 ' CB ' ' CE2' ' A' ' 62' ' ' PHE . . . -48.14 -39.21 19.94 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.315 -0.866 . . . . 0.0 109.937 -179.742 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.501 HD12 ' CG ' ' A' ' 15' ' ' TRP . 11.2 mt -94.18 -60.69 1.68 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.047 -1.033 . . . . 0.0 109.693 -179.996 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 8' ' ' CYS . . . 147.88 -148.76 20.57 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.854 -1.299 . . . . 0.0 109.854 -179.932 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.42 159.29 32.68 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.621 2.214 . . . . 0.0 110.845 -179.652 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.17 -70.27 3.14 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.825 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.565 ' CE3' HD23 ' A' ' 53' ' ' LEU . 14.2 t-105 -50.39 126.24 14.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.24 -1.153 . . . . 0.0 109.728 -179.861 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.0 mmtm -98.89 110.56 23.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.208 -0.932 . . . . 0.0 109.227 179.723 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.58 ' HG3' ' CE1' ' A' ' 35' ' ' TYR . 8.6 ttt-85 -89.13 105.02 17.52 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.389 -0.82 . . . . 0.0 109.863 -179.55 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.48 ' HB3' ' O ' ' A' ' 34' ' ' TYR . 11.9 ttt180 -94.94 138.54 32.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.924 . . . . 0.0 109.194 179.638 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -119.92 147.11 45.13 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.279 -0.888 . . . . 0.0 109.465 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.513 ' O ' ' N ' ' A' ' 22' ' ' ARG . 84.5 t -134.02 66.63 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.292 -0.88 . . . . 0.0 109.131 179.902 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -48.25 91.48 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.38 -0.825 . . . . 0.0 109.709 -179.697 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.513 ' N ' ' O ' ' A' ' 20' ' ' VAL . 12.2 mtt180 -74.79 -34.34 62.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.231 -0.918 . . . . 0.0 109.37 179.875 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.89 142.88 0.31 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.301 -0.875 . . . . 0.0 109.332 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.3 p -92.22 -26.42 18.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.209 -0.932 . . . . 0.0 109.488 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 55.44 -164.4 4.16 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.925 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.534 ' O ' ' CG2' ' A' ' 27' ' ' THR . . . -84.83 91.27 7.96 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.278 -1.13 . . . . 0.0 109.484 179.913 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.534 ' CG2' ' O ' ' A' ' 26' ' ' ALA . 10.2 t 40.98 35.01 0.32 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.553 -0.717 . . . . 0.0 109.973 179.947 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -147.8 24.99 1.06 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.232 -0.917 . . . . 0.0 109.246 179.702 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.44 -179.7 27.64 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.954 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.422 ' O ' ' HB2' ' A' ' 31' ' ' SER . 0.3 OUTLIER -141.22 -48.5 0.4 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.227 -1.16 . . . . 0.0 109.234 179.882 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.422 ' HB2' ' O ' ' A' ' 30' ' ' ARG . 14.6 m 64.56 144.02 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.24 -0.912 . . . . 0.0 109.552 179.773 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.56 ' HB3' ' CE1' ' A' ' 34' ' ' TYR . 7.5 m-20 -96.58 148.11 23.18 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.331 -0.855 . . . . 0.0 109.218 179.839 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.537 ' O ' ' CE1' ' A' ' 64' ' ' PHE . 0.0 OUTLIER -137.15 128.01 27.33 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.163 -0.96 . . . . 0.0 109.986 -179.658 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.56 ' CE1' ' HB3' ' A' ' 32' ' ' ASP . 1.1 m-85 -124.8 141.17 52.3 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.388 -0.82 . . . . 0.0 109.008 179.531 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.58 ' CE1' ' HG3' ' A' ' 17' ' ' ARG . 9.7 m-85 -118.17 143.9 46.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.004 -1.06 . . . . 0.0 109.751 -179.767 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.412 ' OE1' ' N ' ' A' ' 41' ' ' ASP . 8.7 tp-100 -117.86 134.43 54.94 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.371 -0.831 . . . . 0.0 109.474 179.931 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.441 ' OG ' ' HB3' ' A' ' 41' ' ' ASP . 0.0 OUTLIER -81.92 171.77 11.21 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.354 -0.841 . . . . 0.0 109.172 179.852 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.42 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 35.6 Cg_endo -78.01 6.13 4.85 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.486 2.124 . . . . 0.0 110.343 179.841 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.9 p -114.31 -9.92 12.75 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.185 -0.947 . . . . 0.0 109.409 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 102.82 17.3 19.29 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.894 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.567 ' OD2' ' CE1' ' A' ' 52' ' ' TYR . 19.5 t0 -96.61 111.0 23.31 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.135 -1.215 . . . . 0.0 109.327 179.805 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.88 121.63 31.43 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.277 -0.889 . . . . 0.0 109.778 -179.715 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.535 ' CG2' ' HB3' ' A' ' 49' ' ' LEU . 3.9 mt -121.72 150.02 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.344 -0.847 . . . . 0.0 109.202 179.74 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.569 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 1.8 ttp180 -128.51 -6.59 5.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.233 -0.917 . . . . 0.0 109.94 179.758 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.564 ' HB3' ' CB ' ' A' ' 48' ' ' GLU . 12.9 t -90.29 142.66 27.51 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.093 -1.005 . . . . 0.0 108.923 179.598 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.508 ' HG2' ' N ' ' A' ' 47' ' ' VAL . 21.0 ttpt -63.97 -74.79 0.09 Allowed 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.338 -0.851 . . . . 0.0 110.862 -178.692 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.508 ' N ' ' HG2' ' A' ' 46' ' ' LYS . 58.3 t -62.16 -26.81 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.218 -0.926 . . . . 0.0 110.604 -178.431 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.564 ' CB ' ' HB3' ' A' ' 45' ' ' SER . 1.7 tt0 -66.45 -52.14 49.47 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.697 -1.252 . . . . 0.0 109.059 179.861 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.535 ' HB3' ' CG2' ' A' ' 43' ' ' ILE . 1.3 pp -63.51 -23.3 67.33 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.331 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.531 ' CG2' ' HB2' ' A' ' 59' ' ' LEU . 25.2 m -67.86 -70.83 0.24 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.235 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.443 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 0.1 OUTLIER -46.95 -24.43 0.61 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.402 -0.811 . . . . 0.0 109.131 179.975 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.567 ' CE1' ' OD2' ' A' ' 41' ' ' ASP . 69.8 t80 -62.96 -55.8 22.66 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.279 -0.888 . . . . 0.0 109.439 179.761 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.565 HD23 ' CE3' ' A' ' 15' ' ' TRP . 0.3 OUTLIER -65.78 -50.0 66.29 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.178 -0.951 . . . . 0.0 109.344 179.996 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 121.23 -152.79 16.74 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 -179.697 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.9 -9.51 16.85 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.553 2.169 . . . . 0.0 110.462 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.96 -24.86 58.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.299 -0.875 . . . . 0.0 109.3 179.9 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.422 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 54.5 m -127.98 94.77 4.01 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.292 -0.88 . . . . 0.0 109.0 179.741 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.456 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 2.2 m-20 -76.91 157.26 31.47 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.347 -0.846 . . . . 0.0 110.168 -179.343 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.592 HD21 ' CD2' ' A' ' 62' ' ' PHE . 1.2 mp -152.09 39.56 0.6 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.538 -0.726 . . . . 0.0 109.062 -179.709 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.528 ' O ' ' CD2' ' A' ' 61' ' ' LEU . 0.1 OUTLIER -38.51 -44.72 0.97 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.669 -0.644 . . . . 0.0 110.421 -179.447 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.528 ' CD2' ' O ' ' A' ' 60' ' ' THR . 10.8 mt -142.35 33.41 1.49 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.096 -1.002 . . . . 0.0 109.759 -179.813 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.65 ' CE2' ' CB ' ' A' ' 10' ' ' ALA . 10.9 t80 -47.27 117.35 1.71 Allowed 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.283 -0.885 . . . . 0.0 109.617 179.907 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.476 ' O ' ' N ' ' A' ' 65' ' ' LYS . 1.5 m-20 -79.42 102.34 8.67 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.388 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.569 ' CE2' ' O ' ' A' ' 44' ' ' ARG . 0.1 OUTLIER -67.35 62.07 0.06 Allowed 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.292 -0.88 . . . . 0.0 109.568 -178.914 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.478 ' HA ' ' OG1' ' A' ' 33' ' ' THR . 0.0 OUTLIER 171.82 -30.48 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.285 -0.884 . . . . 0.0 109.51 179.895 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -99.58 -42.77 6.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.204 -0.935 . . . . 0.0 109.411 179.843 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.448 ' HA2' ' NE ' ' A' ' 17' ' ' ARG . . . 101.78 30.79 5.67 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.733 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.4 pp -140.21 178.45 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.246 -1.149 . . . . 0.0 109.573 179.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.522 ' HB3' ' HA ' ' A' ' 62' ' ' PHE . 0.8 OUTLIER -164.7 -176.79 4.44 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.334 -0.854 . . . . 0.0 109.427 179.809 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.523 ' O ' ' CG2' ' A' ' 60' ' ' THR . 0.3 OUTLIER -160.37 166.89 28.54 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.28 -0.888 . . . . 0.0 109.537 179.693 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.62 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 12.5 t80 -86.25 -45.02 0.58 Allowed Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.148 -0.97 . . . . 0.0 110.855 -179.734 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.62 ' CD ' ' N ' ' A' ' 71' ' ' TYR . 36.0 Cg_endo -80.55 -161.44 0.15 Allowed 'Trans proline' 0 C--N 1.313 -1.296 0 C-N-CA 122.282 1.988 . . . . 0.0 110.929 -179.106 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.529 ' N ' ' HD3' ' A' ' 74' ' ' PRO . . . 46.44 60.79 14.06 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.402 -0.811 . . . . 0.0 109.928 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.529 ' HD3' ' N ' ' A' ' 73' ' ' ALA . 36.3 Cg_endo -79.05 168.86 20.05 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.564 2.176 . . . . 0.0 110.316 179.699 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.3 mttt . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 118.003 -0.998 . . . . 0.0 109.399 179.783 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.28 156.68 38.88 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.119 -0.988 . . . . 0.0 109.918 -179.774 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.533 ' HG2' ' CD ' ' A' ' 18' ' ' ARG . 0.5 OUTLIER -80.63 -172.4 3.6 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.37 -0.831 . . . . 0.0 109.397 179.755 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -129.38 58.84 1.61 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.153 -0.967 . . . . 0.0 109.914 -179.919 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.573 ' CE3' ' HB2' ' A' ' 18' ' ' ARG . 73.7 m95 -51.4 101.27 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.178 -0.951 . . . . 0.0 109.115 179.599 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.425 ' O ' ' C ' ' A' ' 7' ' ' ASP . 0.5 OUTLIER -106.93 147.88 29.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.216 -0.927 . . . . 0.0 109.702 -179.757 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.483 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 12.3 m-20 -43.85 130.04 5.69 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.294 -0.879 . . . . 0.0 109.257 179.819 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.52 ' SG ' ' CZ ' ' A' ' 17' ' ' ARG . 12.2 t -86.56 113.37 52.4 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.294 -0.878 . . . . 0.0 109.583 -179.796 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.483 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 36.6 Cg_endo -80.62 -47.97 0.07 OUTLIER 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 122.411 2.074 . . . . 0.0 110.33 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 9' ' ' PRO . . . -41.66 -35.58 0.79 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.327 -0.858 . . . . 0.0 109.85 -179.716 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.562 HD11 ' CD1' ' A' ' 15' ' ' TRP . 14.7 mt -106.1 -65.94 1.03 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.176 -0.952 . . . . 0.0 109.659 -179.873 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 153.5 -150.91 22.7 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.7 153.55 30.02 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.651 2.234 . . . . 0.0 110.535 -179.9 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.455 ' O ' ' HD3' ' A' ' 38' ' ' PRO . . . 90.18 -24.98 13.49 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.854 -1.299 . . . . 0.0 109.854 179.667 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.582 ' CE3' HD21 ' A' ' 53' ' ' LEU . 10.9 t-105 -98.74 133.38 43.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.176 -1.191 . . . . 0.0 109.752 -179.749 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 26.1 mmtp -105.67 116.87 32.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.246 -0.909 . . . . 0.0 109.546 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.627 ' NH1' ' CE1' ' A' ' 62' ' ' PHE . 0.4 OUTLIER -89.97 103.82 16.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.156 -0.965 . . . . 0.0 109.228 179.869 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.573 ' HB2' ' CE3' ' A' ' 5' ' ' TRP . 2.0 ttm180 -97.12 140.62 31.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.244 -0.91 . . . . 0.0 110.006 -179.537 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.422 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 21.8 pt-20 -138.45 132.65 31.65 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.309 -0.869 . . . . 0.0 109.026 179.582 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.498 ' O ' ' N ' ' A' ' 22' ' ' ARG . 16.3 t -99.78 16.91 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.179 -0.951 . . . . 0.0 109.719 -179.681 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.437 ' O ' ' CB ' ' A' ' 31' ' ' SER . 0.1 OUTLIER 64.19 -66.87 0.11 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.607 -0.683 . . . . 0.0 110.188 179.524 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.498 ' N ' ' O ' ' A' ' 20' ' ' VAL . 0.0 OUTLIER 44.58 37.59 2.24 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.152 -0.967 . . . . 0.0 108.946 -179.298 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 15.9 tttp -102.16 77.0 1.63 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.469 -0.769 . . . . 0.0 109.649 -179.732 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.5 t -100.84 164.89 11.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.198 -0.939 . . . . 0.0 109.41 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.37 -40.69 98.98 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.937 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.92 167.74 0.55 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.312 -1.111 . . . . 0.0 109.482 179.96 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 39.6 p -100.73 23.42 10.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.225 -0.922 . . . . 0.0 109.301 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 58.9 m -53.92 -55.76 24.02 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.305 -0.872 . . . . 0.0 109.433 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -156.38 -178.34 30.42 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.888 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.446 ' O ' ' O ' ' A' ' 22' ' ' ARG . 11.9 tpp180 -105.87 -63.46 1.25 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.311 -1.111 . . . . 0.0 109.251 179.962 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.437 ' CB ' ' O ' ' A' ' 21' ' ' PHE . 22.5 p -169.39 130.27 1.09 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.398 -0.814 . . . . 0.0 108.927 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.553 ' HB3' ' CZ ' ' A' ' 34' ' ' TYR . 22.3 m-20 -79.3 142.36 36.2 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.105 -0.997 . . . . 0.0 109.557 -179.718 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.494 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 0.0 OUTLIER -127.61 90.92 3.2 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.276 -0.89 . . . . 0.0 109.595 -179.966 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.582 ' CD1' ' HG2' ' A' ' 44' ' ' ARG . 10.4 m-85 -99.68 140.66 33.55 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.309 -0.87 . . . . 0.0 109.086 179.758 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.58 ' CE2' ' CE1' ' A' ' 64' ' ' PHE . 4.8 m-85 -116.58 158.21 24.06 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.214 -0.929 . . . . 0.0 109.99 -179.324 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -138.88 121.74 16.57 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.477 -0.764 . . . . 0.0 109.229 179.904 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.478 ' HB2' ' HD2' ' A' ' 38' ' ' PRO . 1.1 p -73.68 173.61 6.04 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.331 -0.856 . . . . 0.0 109.253 179.911 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.478 ' HD2' ' HB2' ' A' ' 37' ' ' SER . 36.2 Cg_endo -79.38 9.7 3.31 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.664 2.242 . . . . 0.0 110.662 -179.871 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.4 p -120.24 12.53 11.8 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.097 -1.002 . . . . 0.0 109.83 -179.76 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 85.47 18.92 59.46 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.811 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.504 ' OD2' ' CE2' ' A' ' 52' ' ' TYR . 44.0 t0 -97.21 114.14 25.83 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.205 -1.174 . . . . 0.0 109.339 179.84 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.417 ' C ' HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -108.3 135.94 48.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.189 -0.944 . . . . 0.0 109.814 -179.726 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.493 ' CG2' ' HB3' ' A' ' 49' ' ' LEU . 2.4 mp -138.28 156.72 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.277 -0.889 . . . . 0.0 109.292 179.81 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.582 ' HG2' ' CD1' ' A' ' 34' ' ' TYR . 0.3 OUTLIER -140.69 17.6 2.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.132 -0.98 . . . . 0.0 109.739 -179.994 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.534 ' O ' ' CB ' ' A' ' 46' ' ' LYS . 0.6 OUTLIER -91.4 -87.21 0.21 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.202 -0.936 . . . . 0.0 108.805 179.445 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.534 ' CB ' ' O ' ' A' ' 45' ' ' SER . 4.9 ttpp 159.4 -60.49 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 179.632 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 26.9 t -87.71 -20.67 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.389 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -69.61 -42.92 73.73 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.802 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.533 ' O ' ' CD1' ' A' ' 53' ' ' LEU . 2.8 pp -75.99 -32.65 59.55 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.951 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.481 ' HB ' ' HB2' ' A' ' 59' ' ' LEU . 0.4 OUTLIER -64.01 -42.99 96.96 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 178.687 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 5.7 mmt85 -66.02 -26.61 67.6 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.18 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.504 ' CE2' ' OD2' ' A' ' 41' ' ' ASP . 28.8 t80 -68.53 -62.66 1.29 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.515 -0.741 . . . . 0.0 109.308 179.87 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.582 HD21 ' CE3' ' A' ' 15' ' ' TRP . 0.7 OUTLIER -53.74 -54.26 40.52 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.193 -0.942 . . . . 0.0 109.222 179.797 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 137.62 -156.33 23.55 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -179.807 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.35 -6.43 15.56 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.581 2.188 . . . . 0.0 110.442 179.915 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -78.44 -23.53 46.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.196 -0.94 . . . . 0.0 109.568 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 91.1 m -129.79 98.08 4.69 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.248 -0.908 . . . . 0.0 109.534 -179.911 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.19 148.05 22.36 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.214 -0.929 . . . . 0.0 109.49 -179.933 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.602 ' CD2' ' CD2' ' A' ' 62' ' ' PHE . 0.4 OUTLIER -138.78 16.94 2.68 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.374 -0.829 . . . . 0.0 109.18 -179.98 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.457 ' HB ' HD22 ' A' ' 61' ' ' LEU . 2.8 m -50.1 -50.32 48.69 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.429 -0.794 . . . . 0.0 109.579 -179.968 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.594 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 3.6 mm? -100.89 11.37 39.72 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.292 -0.88 . . . . 0.0 109.676 -179.704 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.627 ' CE1' ' NH1' ' A' ' 17' ' ' ARG . 70.9 t80 -68.86 129.68 40.62 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.233 -0.917 . . . . 0.0 109.826 -179.754 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.509 ' O ' ' N ' ' A' ' 65' ' ' LYS . 3.0 t0 -82.32 103.43 11.89 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.331 -0.855 . . . . 0.0 108.973 179.555 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.58 ' CE1' ' CE2' ' A' ' 35' ' ' TYR . 0.8 OUTLIER -67.44 67.74 0.09 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.126 -0.984 . . . . 0.0 109.126 -179.616 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.509 ' N ' ' O ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER 171.23 -32.43 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -179.899 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -95.15 -46.32 6.83 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.344 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.545 ' HA2' ' CE1' ' A' ' 62' ' ' PHE . . . 104.48 30.13 5.09 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 179.426 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.469 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 1.1 pp -141.01 162.02 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.898 -1.354 . . . . 0.0 110.106 179.845 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.489 ' HB3' ' HA ' ' A' ' 62' ' ' PHE . 1.5 pt? -151.83 164.78 36.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.327 -0.858 . . . . 0.0 109.364 179.973 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 6.1 p -155.2 110.19 3.01 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.204 -0.935 . . . . 0.0 109.269 179.704 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.414 ' O ' ' CG ' ' A' ' 71' ' ' TYR . 13.5 t80 -140.6 76.73 23.98 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.248 -0.908 . . . . 0.0 109.642 -179.692 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -79.04 164.46 24.86 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.598 2.199 . . . . 0.0 110.18 179.792 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -131.99 158.91 74.22 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.154 -0.966 . . . . 0.0 109.557 -179.915 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.2 -75.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.576 2.184 . . . . 0.0 110.093 179.759 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.556 179.795 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.4 -15.47 62.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.16 -0.962 . . . . 0.0 109.486 -179.926 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.447 ' CB ' ' HD2' ' A' ' 18' ' ' ARG . 1.2 mp0 -109.0 -146.41 0.4 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.282 -0.886 . . . . 0.0 109.414 -179.993 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.43 ' O ' HD23 ' A' ' 6' ' ' LEU . 20.8 m-20 -138.39 72.9 1.42 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.168 -0.958 . . . . 0.0 109.503 -179.918 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.567 ' CZ2' ' HD3' ' A' ' 18' ' ' ARG . 93.0 m95 -69.86 95.78 0.95 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.246 -0.909 . . . . 0.0 109.373 179.858 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.43 HD23 ' O ' ' A' ' 4' ' ' ASP . 2.4 mm? -99.36 166.39 11.22 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.239 -0.913 . . . . 0.0 109.488 -179.816 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.478 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 0.7 OUTLIER -66.72 145.27 55.73 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.242 -0.911 . . . . 0.0 109.1 179.711 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.507 ' SG ' ' N ' ' A' ' 17' ' ' ARG . 13.8 m -87.57 112.98 52.08 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.277 -0.89 . . . . 0.0 109.74 -179.595 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.478 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 36.3 Cg_endo -79.51 -40.87 0.23 Allowed 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.239 1.96 . . . . 0.0 109.749 179.441 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.469 ' HB2' ' NH1' ' A' ' 17' ' ' ARG . . . -61.4 -53.27 58.79 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.429 -0.794 . . . . 0.0 109.782 -179.951 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.636 ' CD1' ' CD1' ' A' ' 15' ' ' TRP . 6.6 mt -82.46 -47.94 11.65 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.164 -0.96 . . . . 0.0 109.676 -179.751 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 130.02 -148.18 18.39 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -76.71 155.59 35.2 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.624 2.216 . . . . 0.0 110.717 -179.879 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.91 -46.33 3.1 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.963 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.636 ' CD1' ' CD1' ' A' ' 11' ' ' LEU . 5.1 t-105 -80.31 131.14 35.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.259 -1.142 . . . . 0.0 110.074 -179.621 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.423 ' C ' ' SG ' ' A' ' 8' ' ' CYS . 17.5 mmtp -105.65 126.88 52.66 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.3 -0.875 . . . . 0.0 109.365 179.696 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.523 ' NH1' ' HG ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -99.12 107.47 19.85 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.294 -0.879 . . . . 0.0 109.587 -179.713 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.567 ' HD3' ' CZ2' ' A' ' 5' ' ' TRP . 25.1 ttp180 -100.54 143.72 30.38 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.247 -0.908 . . . . 0.0 109.853 -179.887 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -113.58 149.47 34.45 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.311 -0.868 . . . . 0.0 109.326 179.64 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 31' ' ' SER . 13.6 t -137.65 149.61 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.213 -0.93 . . . . 0.0 109.55 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.538 ' CB ' ' HA ' ' A' ' 31' ' ' SER . 1.7 m-85 64.67 15.45 9.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.268 -0.895 . . . . 0.0 109.623 179.973 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.483 ' HA ' ' HB3' ' A' ' 31' ' ' SER . 0.0 OUTLIER -84.26 2.01 42.07 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.243 -0.911 . . . . 0.0 109.518 179.795 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.24 56.92 1.67 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.181 -0.949 . . . . 0.0 109.664 -179.939 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.33 164.5 12.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.179 -0.95 . . . . 0.0 109.267 179.776 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -119.25 -63.38 0.28 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.88 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -85.07 -78.82 0.24 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.251 -1.146 . . . . 0.0 109.636 -179.747 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.74 98.29 3.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.277 -0.889 . . . . 0.0 109.871 -179.588 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -69.69 -75.65 0.11 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.233 -0.917 . . . . 0.0 109.228 179.59 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.79 -106.06 3.24 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.728 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.425 ' O ' ' C ' ' A' ' 31' ' ' SER . 0.5 OUTLIER -170.19 99.58 0.28 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.296 -1.12 . . . . 0.0 109.359 -179.761 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.538 ' HA ' ' CB ' ' A' ' 21' ' ' PHE . 1.8 p -43.48 123.54 3.09 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.228 -0.92 . . . . 0.0 109.572 180.0 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.459 ' HB2' ' OH ' ' A' ' 34' ' ' TYR . 4.7 m-20 -79.25 164.73 23.91 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.245 -0.91 . . . . 0.0 109.103 179.921 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.418 ' OG1' ' HA ' ' A' ' 65' ' ' LYS . 5.6 m -136.98 121.86 18.8 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.153 -0.967 . . . . 0.0 110.105 -179.444 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.459 ' OH ' ' HB2' ' A' ' 32' ' ' ASP . 1.4 m-85 -123.3 149.22 45.08 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.292 -0.88 . . . . 0.0 108.717 179.168 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.654 ' CE2' ' CE1' ' A' ' 64' ' ' PHE . 7.2 m-85 -113.91 150.87 33.08 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.933 -1.105 . . . . 0.0 109.809 -179.89 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.437 ' CB ' ' CZ3' ' A' ' 5' ' ' TRP . 12.4 tt0 -129.79 124.88 34.45 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.331 -0.856 . . . . 0.0 109.595 -179.835 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.474 ' HB3' ' HD2' ' A' ' 38' ' ' PRO . 0.9 OUTLIER -71.3 173.15 5.38 Favored Pre-proline 0 N--CA 1.488 1.437 0 O-C-N 121.347 -0.845 . . . . 0.0 109.04 179.785 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.474 ' HD2' ' HB3' ' A' ' 37' ' ' SER . 34.9 Cg_endo -78.34 8.82 3.4 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.55 2.167 . . . . 0.0 110.9 -179.895 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 15.3 t -115.55 -24.37 8.35 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.013 -1.054 . . . . 0.0 109.514 179.899 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 122.73 16.09 3.8 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.36 111.24 23.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.158 -1.201 . . . . 0.0 109.674 -179.924 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.69 148.59 22.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.191 -0.943 . . . . 0.0 109.34 179.79 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.552 ' CG2' ' HB3' ' A' ' 49' ' ' LEU . 4.5 mp -140.39 158.27 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.11 -0.994 . . . . 0.0 109.921 -179.825 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.495 ' HA ' ' CZ ' ' A' ' 64' ' ' PHE . 0.9 OUTLIER -137.05 -8.63 1.79 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.249 -0.907 . . . . 0.0 110.737 -179.778 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.527 ' CB ' ' HB2' ' A' ' 48' ' ' GLU . 0.6 OUTLIER -63.48 -86.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.782 -1.199 . . . . 0.0 109.334 179.905 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.5 ' NZ ' ' O ' ' A' ' 59' ' ' LEU . 42.7 tttm 161.97 -63.99 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 -179.769 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.417 HG23 ' HG2' ' A' ' 46' ' ' LYS . 75.0 t -87.94 -19.98 7.59 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 178.518 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.527 ' HB2' ' CB ' ' A' ' 45' ' ' SER . 2.8 mt-10 -66.83 -43.62 83.29 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.353 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.552 ' HB3' ' CG2' ' A' ' 43' ' ' ILE . 1.9 pp -70.07 -23.63 63.1 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 178.647 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.492 ' OG1' ' HB2' ' A' ' 59' ' ' LEU . 30.3 m -70.96 -64.48 0.9 Allowed 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.969 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.458 ' HG3' ' O ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -49.73 -29.46 7.66 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.361 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.419 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 86.2 t80 -57.82 -60.93 2.95 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.377 -0.827 . . . . 0.0 108.909 179.417 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.597 ' CD2' ' CE3' ' A' ' 15' ' ' TRP . 0.4 OUTLIER -58.17 -51.94 67.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.287 -0.883 . . . . 0.0 109.221 179.576 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 133.19 -154.1 21.05 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.394 -1.483 . . . . 0.0 109.394 -179.914 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.76 -17.93 13.72 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.614 2.209 . . . . 0.0 110.176 179.752 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.57 -24.47 66.35 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.31 -0.869 . . . . 0.0 109.507 179.925 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 1.7 m -117.13 156.15 28.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.242 -0.911 . . . . 0.0 109.517 179.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' A' ' 59' ' ' LEU . 62.0 t0 -149.22 147.95 29.02 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.334 -0.854 . . . . 0.0 109.291 179.937 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.513 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 5.7 mp -148.51 17.56 1.03 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.188 -0.945 . . . . 0.0 109.489 -179.64 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.484 ' C ' ' CD2' ' A' ' 61' ' ' LEU . 3.6 m -42.52 -49.25 5.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.422 -0.799 . . . . 0.0 109.29 -179.876 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.574 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 1.2 mm? -113.09 18.64 17.85 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.395 -0.816 . . . . 0.0 109.455 -179.92 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.569 ' CE1' ' O ' ' A' ' 63' ' ' ASP . 9.8 t80 -77.24 133.97 38.72 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.315 -0.866 . . . . 0.0 109.289 179.945 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.569 ' O ' ' CE1' ' A' ' 62' ' ' PHE . 0.9 OUTLIER -84.92 136.08 33.78 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.355 -0.84 . . . . 0.0 109.211 179.792 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.654 ' CE1' ' CE2' ' A' ' 35' ' ' TYR . 0.3 OUTLIER -86.79 43.61 1.1 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.141 -0.974 . . . . 0.0 109.2 179.957 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.418 ' HA ' ' OG1' ' A' ' 33' ' ' THR . 0.0 OUTLIER -165.12 -44.15 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.409 -0.807 . . . . 0.0 109.052 -179.898 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -81.59 -36.1 29.38 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.328 -0.858 . . . . 0.0 109.259 179.73 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.528 ' HA2' ' CE2' ' A' ' 62' ' ' PHE . . . 88.89 35.15 8.45 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.854 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.473 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 1.8 pp -140.04 155.97 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.172 -1.193 . . . . 0.0 109.781 -179.823 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.49 ' HB3' ' HA ' ' A' ' 62' ' ' PHE . 1.3 pt? -143.56 166.92 23.49 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.31 -0.869 . . . . 0.0 109.043 179.667 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.425 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 0.6 OUTLIER -155.07 -171.48 3.84 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.129 -0.982 . . . . 0.0 109.658 -179.987 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -118.49 162.12 32.05 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.288 -0.882 . . . . 0.0 109.41 179.919 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.74 55.64 5.3 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.622 2.215 . . . . 0.0 110.515 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -138.06 86.84 17.03 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.245 -0.909 . . . . 0.0 109.64 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.34 112.2 3.16 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.684 2.256 . . . . 0.0 110.207 179.957 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.516 -179.873 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 51.75 40.98 28.73 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.241 -0.912 . . . . 0.0 109.314 -179.92 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.78 -58.79 3.01 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.329 -0.857 . . . . 0.0 109.41 -179.972 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.438 ' CB ' ' HG2' ' A' ' 19' ' ' GLU . 1.8 m-20 -153.98 26.38 0.48 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.29 -0.881 . . . . 0.0 109.429 179.905 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.626 ' CH2' ' NH1' ' A' ' 18' ' ' ARG . 67.4 m95 -65.56 92.24 0.14 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.309 -0.869 . . . . 0.0 109.331 179.868 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.407 ' O ' ' C ' ' A' ' 7' ' ' ASP . 54.2 mt -109.75 153.24 24.61 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.149 -0.97 . . . . 0.0 109.63 -179.809 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.407 ' C ' ' O ' ' A' ' 6' ' ' LEU . 7.5 t70 -45.64 140.39 3.4 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.255 -0.903 . . . . 0.0 109.062 179.77 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.475 ' HB2' ' HB2' ' A' ' 17' ' ' ARG . 44.5 t -102.29 108.79 58.5 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.182 -0.949 . . . . 0.0 109.869 -179.599 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.408 ' HD2' ' CZ ' ' A' ' 17' ' ' ARG . 34.1 Cg_endo -77.01 -32.77 3.06 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.154 1.903 . . . . 0.0 109.767 179.194 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.474 ' CB ' ' CE1' ' A' ' 62' ' ' PHE . . . -50.55 -30.13 12.36 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.302 -0.874 . . . . 0.0 108.954 179.319 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.636 ' CD1' ' CD1' ' A' ' 15' ' ' TRP . 9.6 mt -117.25 -65.54 1.17 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.383 -0.823 . . . . 0.0 109.485 179.848 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.412 ' O ' ' O ' ' A' ' 8' ' ' CYS . . . 168.38 -147.42 11.39 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -179.885 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . 0.514 ' O ' ' N ' ' A' ' 15' ' ' TRP . 35.9 Cg_endo -78.08 175.39 11.2 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.681 2.254 . . . . 0.0 110.618 -179.701 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . 0.426 ' O ' ' C ' ' A' ' 15' ' ' TRP . . . 65.66 -68.39 0.11 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.97 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.636 ' CD1' ' CD1' ' A' ' 11' ' ' LEU . 4.5 t-105 -43.55 119.62 1.7 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.374 -1.074 . . . . 0.0 109.515 179.9 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.454 ' HD2' ' HB3' ' A' ' 5' ' ' TRP . 1.0 OUTLIER -101.7 114.91 29.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.185 -0.947 . . . . 0.0 109.659 -179.937 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.475 ' HB2' ' HB2' ' A' ' 8' ' ' CYS . 10.4 ttp85 -92.95 111.2 22.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.232 -0.917 . . . . 0.0 109.309 179.771 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.626 ' NH1' ' CH2' ' A' ' 5' ' ' TRP . 41.2 ttp180 -100.38 148.47 24.67 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.185 -0.947 . . . . 0.0 109.488 -179.933 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.438 ' HG2' ' CB ' ' A' ' 4' ' ' ASP . 17.1 pt-20 -102.98 145.15 30.3 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.221 -0.924 . . . . 0.0 109.369 179.924 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.437 HG21 ' CE2' ' A' ' 34' ' ' TYR . 2.9 t -117.76 155.01 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.187 -0.946 . . . . 0.0 109.547 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.529 ' CD1' ' N ' ' A' ' 21' ' ' PHE . 1.0 OUTLIER -116.25 41.35 2.64 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.263 -0.898 . . . . 0.0 109.346 179.95 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.448 ' O ' ' N ' ' A' ' 24' ' ' SER . 0.0 OUTLIER 45.09 28.51 0.4 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.282 -0.886 . . . . 0.0 109.405 -179.939 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.2 mttp 67.47 -70.71 0.11 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.234 -0.916 . . . . 0.0 109.495 179.889 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.448 ' N ' ' O ' ' A' ' 22' ' ' ARG . 25.3 p -108.82 10.91 26.5 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.31 -0.869 . . . . 0.0 109.482 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . 0.41 ' HA3' ' HA3' ' A' ' 29' ' ' GLY . . . -100.85 67.56 0.48 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.947 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.25 -46.92 21.54 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.305 -1.115 . . . . 0.0 109.598 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.2 t -133.7 35.49 3.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.208 -0.933 . . . . 0.0 109.475 -179.932 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.8 p -159.98 -38.62 0.05 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.333 -0.855 . . . . 0.0 109.478 179.959 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.41 ' HA3' ' HA3' ' A' ' 25' ' ' GLY . . . -85.01 143.2 20.32 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.953 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.412 ' HG3' ' N ' ' A' ' 31' ' ' SER . 0.2 OUTLIER -52.36 157.83 1.35 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.263 -1.139 . . . . 0.0 109.359 179.97 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.412 ' N ' ' HG3' ' A' ' 30' ' ' ARG . 0.6 OUTLIER -109.44 114.41 28.03 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.221 -0.924 . . . . 0.0 109.641 -179.943 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -88.95 166.06 14.18 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.221 -0.924 . . . . 0.0 109.388 179.944 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.528 ' O ' ' CE1' ' A' ' 64' ' ' PHE . 9.7 m -131.15 144.14 51.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.255 -0.903 . . . . 0.0 109.428 179.972 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.484 ' HB2' ' NH1' ' A' ' 18' ' ' ARG . 20.0 m-85 -124.75 164.94 18.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.383 -0.823 . . . . 0.0 109.142 179.819 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.585 ' OH ' ' CZ ' ' A' ' 62' ' ' PHE . 10.4 m-85 -121.27 147.99 44.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.058 -1.026 . . . . 0.0 110.483 -179.332 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.58 ' HB2' ' CZ3' ' A' ' 5' ' ' TRP . 0.1 OUTLIER -131.81 114.37 14.63 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.352 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.488 ' CB ' ' HD2' ' A' ' 38' ' ' PRO . 0.9 OUTLIER -72.4 173.79 5.17 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.354 -0.841 . . . . 0.0 109.455 -179.719 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.488 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 35.1 Cg_endo -76.89 -7.05 17.26 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.549 2.166 . . . . 0.0 110.246 179.939 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 p -105.07 -23.19 12.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.373 -0.829 . . . . 0.0 109.243 179.842 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 122.2 27.33 1.69 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -90.36 114.92 27.12 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.255 -1.144 . . . . 0.0 109.531 179.968 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.1 99.82 11.11 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.265 -0.897 . . . . 0.0 109.351 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.538 ' CG2' ' HB3' ' A' ' 49' ' ' LEU . 1.9 mp -114.44 146.95 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.2 -0.937 . . . . 0.0 109.661 -179.995 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.596 ' HA ' ' CZ ' ' A' ' 64' ' ' PHE . 7.5 ptt180 -140.28 3.41 1.95 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.37 -0.831 . . . . 0.0 109.995 179.962 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.529 ' O ' ' CB ' ' A' ' 46' ' ' LYS . 1.9 t -62.16 -82.39 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.049 -1.032 . . . . 0.0 109.292 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.529 ' CB ' ' O ' ' A' ' 45' ' ' SER . 6.6 ttmt 159.71 -61.74 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.477 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 21.5 t -96.19 -18.3 6.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.795 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.485 ' HB2' ' HB3' ' A' ' 45' ' ' SER . 40.2 mt-10 -73.54 -32.05 63.99 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.884 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.538 ' HB3' ' CG2' ' A' ' 43' ' ' ILE . 1.7 pp -78.81 -29.56 44.9 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.283 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.539 ' HA ' ' CD1' ' A' ' 53' ' ' LEU . 0.5 OUTLIER -70.16 -50.17 43.13 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.181 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.528 ' N ' ' CG2' ' A' ' 50' ' ' THR . 0.0 OUTLIER -59.62 -29.68 68.17 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.18 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.438 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 36.6 t80 -56.7 -57.15 13.65 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.327 -0.858 . . . . 0.0 108.702 179.252 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.568 HD21 ' CE3' ' A' ' 15' ' ' TRP . 0.5 OUTLIER -62.33 -40.7 97.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.228 -0.92 . . . . 0.0 109.077 179.536 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 127.17 -158.71 21.13 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 -179.689 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.91 -7.16 16.35 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.421 2.081 . . . . 0.0 110.304 179.852 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.79 -12.79 60.48 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.227 -0.921 . . . . 0.0 109.578 -179.985 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 69.6 m -138.77 132.06 30.07 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.263 -0.898 . . . . 0.0 109.514 -179.96 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -119.66 155.68 31.91 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.182 -0.949 . . . . 0.0 109.532 179.873 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.547 HD22 ' CD2' ' A' ' 62' ' ' PHE . 0.5 OUTLIER -148.83 16.78 0.98 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.204 -0.935 . . . . 0.0 109.779 -179.758 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.444 ' HB ' HD22 ' A' ' 61' ' ' LEU . 13.1 m -56.0 -37.41 69.08 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.257 -0.902 . . . . 0.0 109.415 -179.973 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.583 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 1.9 mm? -110.37 8.88 23.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.327 -0.858 . . . . 0.0 109.776 -179.653 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.585 ' CZ ' ' OH ' ' A' ' 35' ' ' TYR . 63.7 t80 -71.29 133.54 46.13 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.25 -0.906 . . . . 0.0 110.074 -179.617 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.51 ' O ' ' N ' ' A' ' 65' ' ' LYS . 15.9 t70 -86.98 100.72 12.81 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.248 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.596 ' CZ ' ' HA ' ' A' ' 44' ' ' ARG . 0.1 OUTLIER -66.22 67.87 0.05 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.299 -0.876 . . . . 0.0 109.391 -179.23 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.51 ' N ' ' O ' ' A' ' 63' ' ' ASP . 0.3 OUTLIER 176.01 -40.96 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.481 -0.762 . . . . 0.0 108.957 -179.917 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.72 -27.53 18.0 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.318 -0.864 . . . . 0.0 109.195 179.709 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . 0.455 ' HA3' ' NH2' ' A' ' 17' ' ' ARG . . . 90.55 33.52 8.5 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.851 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.469 ' CD1' ' C ' ' A' ' 68' ' ' ILE . 2.3 pp -140.42 174.84 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.086 -1.244 . . . . 0.0 109.76 179.967 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.536 ' CB ' ' HA ' ' A' ' 62' ' ' PHE . 0.6 OUTLIER -155.4 -167.97 2.69 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.373 -0.829 . . . . 0.0 109.277 179.676 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . 0.448 ' SG ' ' O ' ' A' ' 69' ' ' LEU . 7.8 m -159.97 -176.28 5.59 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.33 -0.856 . . . . 0.0 109.27 179.67 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.494 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 23.3 p90 -165.86 145.61 5.34 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.184 -0.948 . . . . 0.0 109.594 179.969 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.05 132.63 11.75 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.611 2.207 . . . . 0.0 110.124 179.659 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.459 ' N ' ' HD3' ' A' ' 74' ' ' PRO . . . -141.32 64.58 19.93 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.203 -0.936 . . . . 0.0 109.655 -179.838 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.459 ' HD3' ' N ' ' A' ' 73' ' ' ALA . 35.8 Cg_endo -78.41 126.57 7.66 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.635 2.223 . . . . 0.0 110.163 179.854 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 118.057 -0.973 . . . . 0.0 109.553 -179.817 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.415 ' O ' ' O ' ' A' ' 2' ' ' ALA . 56.8 mtm . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.415 ' O ' ' O ' ' A' ' 1' ' ' MET . . . 47.32 91.62 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.208 -0.933 . . . . 0.0 109.305 -179.976 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.536 ' HB3' ' CD ' ' A' ' 18' ' ' ARG . 1.5 mm-40 -103.19 -168.16 1.48 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.264 -0.897 . . . . 0.0 109.529 -179.893 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' ASP . . . . . 0.521 ' N ' ' HD3' ' A' ' 18' ' ' ARG . 0.3 OUTLIER -114.27 74.3 0.87 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.3 -0.875 . . . . 0.0 109.699 -179.849 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' TRP . . . . . 0.633 ' CE3' ' CB ' ' A' ' 18' ' ' ARG . 52.7 m95 -58.45 114.88 2.66 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.193 -0.942 . . . . 0.0 109.34 179.914 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 57.0 mt -100.51 159.59 15.03 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.327 -0.858 . . . . 0.0 109.585 -179.698 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.466 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 0.3 OUTLIER -49.83 132.71 22.37 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.256 -0.902 . . . . 0.0 109.319 179.792 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' CYS . . . . . 0.523 ' CB ' ' HB2' ' A' ' 17' ' ' ARG . 29.3 t -88.26 112.82 52.09 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.26 -0.9 . . . . 0.0 109.718 -179.74 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.466 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 36.5 Cg_endo -79.75 -59.41 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.46 2.107 . . . . 0.0 110.75 179.905 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.446 ' C ' ' O ' ' A' ' 9' ' ' PRO . . . -38.52 -39.66 0.49 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.59 -0.694 . . . . 0.0 110.424 -179.455 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.58 ' CD1' ' CD1' ' A' ' 15' ' ' TRP . 13.3 mt -95.34 -64.61 1.04 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.054 -1.029 . . . . 0.0 109.711 -179.931 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.404 ' O ' ' O ' ' A' ' 8' ' ' CYS . . . 152.98 -152.05 23.76 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -179.824 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.13 148.51 21.62 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.655 2.237 . . . . 0.0 110.399 -179.878 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.17 -51.82 1.64 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.893 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.635 ' CZ3' ' CD2' ' A' ' 53' ' ' LEU . 15.3 t-105 -69.24 126.68 30.53 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.307 -1.114 . . . . 0.0 109.504 -179.991 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.472 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -94.87 114.03 25.84 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.249 -0.907 . . . . 0.0 108.947 179.751 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.627 ' NH1' ' CZ ' ' A' ' 62' ' ' PHE . 2.9 ttm180 -94.67 96.71 9.58 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.161 -0.962 . . . . 0.0 109.844 -179.534 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.633 ' CB ' ' CE3' ' A' ' 5' ' ' TRP . 9.7 tpt180 -100.7 146.0 27.75 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.198 -0.939 . . . . 0.0 109.526 179.63 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.508 ' HG2' ' NH1' ' A' ' 18' ' ' ARG . 8.6 pt-20 -109.0 164.36 12.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.191 -0.943 . . . . 0.0 109.43 179.871 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . 0.495 ' O ' ' N ' ' A' ' 22' ' ' ARG . 96.7 t -137.02 66.78 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.216 -0.928 . . . . 0.0 109.463 -179.948 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.595 ' O ' ' CD2' ' A' ' 21' ' ' PHE . 30.4 p90 -41.54 95.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.453 -0.78 . . . . 0.0 109.803 -179.837 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' ARG . . . . . 0.495 ' N ' ' O ' ' A' ' 20' ' ' VAL . 5.3 mmt180 -60.19 -55.37 34.57 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.13 -0.981 . . . . 0.0 109.346 179.896 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.448 ' HB2' ' O ' ' A' ' 22' ' ' ARG . 36.3 ttmt 172.75 146.93 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.285 -0.885 . . . . 0.0 109.319 -179.986 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.96 124.28 49.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.129 -0.982 . . . . 0.0 109.647 -179.877 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -133.87 -141.52 4.53 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.962 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -91.61 -18.95 23.26 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.294 -1.121 . . . . 0.0 109.443 179.993 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.2 t -153.02 20.89 0.58 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.267 -0.896 . . . . 0.0 109.368 179.898 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.5 m -91.41 90.55 7.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.214 -0.929 . . . . 0.0 109.443 -179.985 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.463 ' O ' ' HB3' ' A' ' 30' ' ' ARG . . . -127.39 107.4 0.88 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.924 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.463 ' HB3' ' O ' ' A' ' 29' ' ' GLY . 0.0 OUTLIER 168.73 50.14 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.216 -1.167 . . . . 0.0 109.565 -179.949 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -53.82 149.1 9.13 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.257 -0.902 . . . . 0.0 109.264 179.921 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' ASP . . . . . 0.454 ' HB2' ' HB ' ' A' ' 20' ' ' VAL . 8.5 m-20 -90.03 121.94 32.57 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.177 -0.952 . . . . 0.0 109.351 -179.931 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.579 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 0.0 OUTLIER -103.94 110.1 22.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.165 -0.959 . . . . 0.0 109.637 -179.727 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.528 ' CD1' ' HB3' ' A' ' 44' ' ' ARG . 19.3 m-30 -106.26 143.1 34.87 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.138 -0.976 . . . . 0.0 109.164 179.803 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.573 ' CE1' ' HG3' ' A' ' 17' ' ' ARG . 5.0 m-85 -122.02 156.71 32.92 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.172 -0.955 . . . . 0.0 109.832 -179.507 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.425 ' OE1' ' HD2' ' A' ' 42' ' ' ARG . 44.5 tt0 -130.61 121.45 25.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.385 -0.822 . . . . 0.0 109.166 179.953 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.445 ' CB ' ' HD2' ' A' ' 38' ' ' PRO . 0.5 OUTLIER -76.37 171.56 11.88 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.154 -0.966 . . . . 0.0 109.746 -179.748 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.445 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 36.0 Cg_endo -77.93 -4.58 14.57 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.729 2.286 . . . . 0.0 110.437 179.994 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.475 ' CG2' ' OH ' ' A' ' 52' ' ' TYR . 12.3 t -100.11 -12.82 19.32 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.225 -0.922 . . . . 0.0 109.343 179.881 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 106.04 18.06 11.96 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.996 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.8 112.23 24.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -1.131 . . . . 0.0 109.354 -179.978 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' ARG . . . . . 0.425 ' HD2' ' OE1' ' A' ' 36' ' ' GLN . 2.2 mtp180 -99.1 121.04 40.47 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.179 -0.95 . . . . 0.0 109.503 -179.943 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.522 ' CG2' ' HB3' ' A' ' 49' ' ' LEU . 2.2 mp -118.46 168.03 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.251 -0.906 . . . . 0.0 109.472 179.98 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . 0.574 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 0.0 OUTLIER -153.74 14.99 0.49 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.338 -0.851 . . . . 0.0 109.845 -179.627 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.556 ' O ' ' CB ' ' A' ' 46' ' ' LYS . 7.5 t -95.67 -79.31 0.44 Allowed 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.028 -1.045 . . . . 0.0 108.452 179.346 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.584 ' HB2' ' CD1' ' A' ' 64' ' ' PHE . 4.6 ttpm? 153.45 -61.77 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 179.421 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.524 ' O ' ' CG ' ' A' ' 51' ' ' ARG . 50.0 t -82.93 -24.52 8.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 178.63 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.438 ' O ' ' HG3' ' A' ' 51' ' ' ARG . 23.3 tt0 -64.66 -48.21 75.6 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 179.012 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' LEU . . . . . 0.522 ' HB3' ' CG2' ' A' ' 43' ' ' ILE . 2.3 pp -68.8 -30.81 69.46 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 178.918 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' THR . . . . . 0.523 ' CG2' ' HA ' ' A' ' 58' ' ' ASP . 24.0 m -61.24 -67.96 0.36 Allowed 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.857 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.524 ' CG ' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -47.19 -31.13 3.39 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.375 -0.828 . . . . 0.0 108.934 179.456 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.475 ' OH ' ' CG2' ' A' ' 39' ' ' THR . 2.1 t80 -64.68 -62.56 1.5 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.287 -0.883 . . . . 0.0 108.95 179.422 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.635 ' CD2' ' CZ3' ' A' ' 15' ' ' TRP . 0.8 OUTLIER -49.82 -51.91 36.29 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.285 -0.884 . . . . 0.0 109.238 179.569 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 124.19 -151.23 17.13 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 -179.592 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.45 -12.74 16.91 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.562 2.174 . . . . 0.0 110.168 179.746 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.18 -3.18 31.5 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.337 -0.852 . . . . 0.0 109.358 179.749 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' CYS . . . . . 0.452 ' SG ' ' CB ' ' A' ' 53' ' ' LEU . 60.0 m -135.53 -176.2 4.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.196 -0.94 . . . . 0.0 109.5 -179.906 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.523 ' HA ' ' CG2' ' A' ' 50' ' ' THR . 12.1 t70 179.26 142.31 0.12 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.348 -0.845 . . . . 0.0 108.964 179.876 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.547 HD23 ' CD2' ' A' ' 62' ' ' PHE . 5.1 mp -152.89 16.77 0.58 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.135 -0.978 . . . . 0.0 109.55 -179.483 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.464 HG21 ' CD2' ' A' ' 61' ' ' LEU . 58.5 m -44.38 -40.23 5.24 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.377 -0.827 . . . . 0.0 109.412 -179.956 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' LEU . . . . . 0.543 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 1.4 mm? -111.57 -8.54 14.23 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.395 -0.815 . . . . 0.0 109.67 -179.834 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.627 ' CZ ' ' NH1' ' A' ' 17' ' ' ARG . 80.6 t80 -50.53 138.45 17.54 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.227 -0.921 . . . . 0.0 109.835 -179.368 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.525 ' OD1' ' CG ' ' A' ' 65' ' ' LYS . 3.9 t0 -89.44 113.52 24.88 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.447 -0.783 . . . . 0.0 109.158 179.714 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.584 ' CD1' ' HB2' ' A' ' 46' ' ' LYS . 1.1 t80 -72.06 63.78 0.51 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.126 -0.984 . . . . 0.0 109.728 -179.781 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.525 ' CG ' ' OD1' ' A' ' 63' ' ' ASP . 0.0 OUTLIER 167.82 -36.32 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.394 -0.816 . . . . 0.0 109.079 179.639 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -83.77 -41.57 17.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.142 -0.974 . . . . 0.0 108.948 179.411 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.84 28.0 8.07 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 179.666 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' ILE . . . . . 0.496 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 2.6 pp -140.52 179.47 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.114 -1.227 . . . . 0.0 109.668 179.938 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.505 ' HB3' ' HA ' ' A' ' 62' ' ' PHE . 0.6 OUTLIER -160.34 -175.78 5.24 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.409 -0.807 . . . . 0.0 109.111 179.934 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 32.1 p -160.12 170.98 20.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.237 -0.914 . . . . 0.0 109.444 179.587 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . 0.456 ' O ' ' HD2' ' A' ' 74' ' ' PRO . 27.1 m-85 -123.19 150.82 60.9 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.196 -0.94 . . . . 0.0 109.497 -179.891 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.78 74.08 5.37 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.684 2.256 . . . . 0.0 110.663 -179.821 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.586 ' CB ' ' HD3' ' A' ' 74' ' ' PRO . . . 178.34 -57.93 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.244 -0.91 . . . . 0.0 109.64 179.59 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' PRO . . . . . 0.586 ' HD3' ' CB ' ' A' ' 73' ' ' ALA . 35.6 Cg_endo -77.52 152.69 30.07 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.236 1.957 . . . . 0.0 110.176 179.531 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.4 pttt . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.5 -179.879 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.491 ' CE3' ' HB2' ' A' ' 18' ' ' ARG . 69.7 m95 . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.449 HD23 ' HA ' ' A' ' 6' ' ' LEU . 18.1 mt -109.28 160.87 15.78 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.215 -0.928 . . . . 0.0 109.615 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.438 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 0.2 OUTLIER -49.72 130.36 20.93 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.323 -0.861 . . . . 0.0 109.592 -179.885 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.522 ' SG ' ' CZ ' ' A' ' 17' ' ' ARG . 26.9 t -81.61 115.17 55.19 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.276 -0.89 . . . . 0.0 109.4 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.455 ' O ' ' C ' ' A' ' 10' ' ' ALA . 36.2 Cg_endo -78.57 -55.62 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.498 2.132 . . . . 0.0 111.088 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.646 ' HB3' ' NH1' ' A' ' 17' ' ' ARG . . . -39.69 -56.73 1.65 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.36 -0.838 . . . . 0.0 110.098 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.756 HD12 ' CD1' ' A' ' 15' ' ' TRP . 12.0 mt -83.31 -56.94 3.48 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.282 -0.886 . . . . 0.0 109.706 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 140.04 -146.48 17.96 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.57 158.15 32.26 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.62 2.214 . . . . 0.0 110.802 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.15 -38.89 3.14 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.774 -1.331 . . . . 0.0 109.774 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 0.983 ' CZ3' HD21 ' A' ' 53' ' ' LEU . 17.1 t-105 -89.0 130.0 35.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.268 -1.137 . . . . 0.0 109.585 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.462 ' HG2' ' HB3' ' A' ' 5' ' ' TRP . 0.1 OUTLIER -97.54 127.75 43.75 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.2 -0.937 . . . . 0.0 108.919 179.626 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.646 ' NH1' ' HB3' ' A' ' 10' ' ' ALA . 1.6 ttm180 -107.32 98.84 8.42 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.142 -0.974 . . . . 0.0 109.917 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.491 ' HB2' ' CE3' ' A' ' 5' ' ' TRP . 0.4 OUTLIER -100.24 145.65 27.82 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.316 -0.865 . . . . 0.0 109.201 179.601 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -121.91 158.33 29.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.11 -0.994 . . . . 0.0 109.802 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.463 HG22 HH11 ' A' ' 18' ' ' ARG . 2.3 t . . . . . 0 N--CA 1.489 1.515 0 O-C-N 121.396 -0.815 . . . . 0.0 109.205 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.444 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 0.3 OUTLIER -135.26 124.36 24.36 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.983 -1.073 . . . . 0.0 110.254 -179.456 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.561 ' CD1' ' HG2' ' A' ' 44' ' ' ARG . 16.7 m-85 -123.62 143.8 50.01 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 179.268 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.584 ' CE1' ' HG3' ' A' ' 17' ' ' ARG . 9.8 m-85 -116.01 154.42 29.89 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.107 -0.995 . . . . 0.0 110.204 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -122.41 120.41 33.87 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.507 ' HB3' ' HD2' ' A' ' 38' ' ' PRO . 0.7 OUTLIER -68.41 168.35 14.46 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 121.394 -0.816 . . . . 0.0 109.023 179.915 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.507 ' HD2' ' HB3' ' A' ' 37' ' ' SER . 34.7 Cg_endo -78.0 6.12 4.85 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.502 2.134 . . . . 0.0 110.577 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.3 t -116.56 -21.7 9.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.131 -0.981 . . . . 0.0 109.498 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 119.18 15.91 5.42 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.448 ' O ' ' OG ' ' A' ' 37' ' ' SER . 3.5 m-20 -96.81 107.03 19.44 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.248 -1.149 . . . . 0.0 109.297 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.26 132.29 33.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.132 -0.98 . . . . 0.0 109.658 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.729 HG21 ' N ' ' A' ' 49' ' ' LEU . 3.0 mp -130.04 149.93 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.325 -0.859 . . . . 0.0 109.239 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.561 ' HG2' ' CD1' ' A' ' 34' ' ' TYR . 51.5 mtm180 -142.17 9.35 1.88 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.091 -1.006 . . . . 0.0 110.058 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.529 ' HB3' ' CB ' ' A' ' 48' ' ' GLU . 0.5 OUTLIER -97.19 14.08 27.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.039 -1.038 . . . . 0.0 109.393 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.584 ' HA ' ' CE1' ' A' ' 64' ' ' PHE . 5.9 ttpp 62.73 -94.09 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.442 -0.786 . . . . 0.0 109.98 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.44 ' N ' ' HG2' ' A' ' 46' ' ' LYS . 48.6 t -52.87 -31.9 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.904 -1.122 . . . . 0.0 109.485 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.529 ' CB ' ' HB3' ' A' ' 45' ' ' SER . 67.4 tt0 -53.33 -45.54 69.1 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.067 -1.021 . . . . 0.0 108.784 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.832 ' O ' HD12 ' A' ' 53' ' ' LEU . 0.9 OUTLIER -71.88 -28.71 63.7 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.114 -0.991 . . . . 0.0 108.547 179.281 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.658 ' HG1' ' HB2' ' A' ' 59' ' ' LEU . 2.3 m -61.96 -65.28 0.71 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.0 -24.26 16.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.465 -0.772 . . . . 0.0 109.23 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.41 ' O ' ' C ' ' A' ' 53' ' ' LEU . 29.9 t80 -70.55 -68.11 0.45 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.227 -0.92 . . . . 0.0 108.992 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.983 HD21 ' CZ3' ' A' ' 15' ' ' TRP . 1.0 OUTLIER -45.17 -36.03 3.55 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.267 -0.896 . . . . 0.0 109.293 179.661 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 112.69 -157.6 14.84 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.81 6.13 4.77 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.567 2.178 . . . . 0.0 110.532 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -85.31 -21.45 28.95 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.216 -0.928 . . . . 0.0 109.614 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 50.9 m -135.89 164.38 28.08 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.037 -1.039 . . . . 0.0 109.663 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.593 ' HA ' HG23 ' A' ' 50' ' ' THR . 26.3 p30 -152.97 150.73 29.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.243 -0.91 . . . . 0.0 109.433 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 1.158 HD23 ' CD2' ' A' ' 62' ' ' PHE . 2.6 mp -143.71 12.09 1.67 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.242 -0.911 . . . . 0.0 109.593 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.55 ' C ' HD22 ' A' ' 61' ' ' LEU . 3.4 m -46.04 -46.08 16.47 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.174 -0.954 . . . . 0.0 109.401 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.585 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 2.4 mm? -101.58 0.53 36.55 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.272 -0.893 . . . . 0.0 109.512 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 1.158 ' CD2' HD23 ' A' ' 59' ' ' LEU . 65.1 t80 -66.36 137.48 56.92 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.364 -0.835 . . . . 0.0 109.944 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.454 ' O ' ' N ' ' A' ' 65' ' ' LYS . 0.4 OUTLIER -89.31 111.75 22.66 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.261 -0.899 . . . . 0.0 109.04 179.712 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.584 ' CE1' ' HA ' ' A' ' 46' ' ' LYS . 0.6 OUTLIER -70.26 59.33 0.18 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.207 -0.933 . . . . 0.0 109.11 -179.632 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.454 ' N ' ' O ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -179.52 -40.46 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.378 -0.826 . . . . 0.0 109.093 -179.825 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -90.4 -29.25 18.13 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.293 -0.88 . . . . 0.0 109.356 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.574 ' HA2' ' CE1' ' A' ' 62' ' ' PHE . . . 87.15 33.93 11.37 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.441 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 1.3 pt -140.98 155.39 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.065 -1.256 . . . . 0.0 110.004 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.603 ' N ' HD23 ' A' ' 69' ' ' LEU . 1.9 pt? -143.26 146.24 33.44 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.406 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.49 1.568 0 O-C-N 120.983 -1.073 . . . . 0.0 109.937 -179.636 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.595 ' CZ2' ' HD3' ' A' ' 18' ' ' ARG . 66.6 m95 . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -101.54 159.16 15.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.279 -0.888 . . . . 0.0 109.538 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.484 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 12.3 t70 -48.85 132.55 18.21 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.282 -0.886 . . . . 0.0 109.213 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.457 ' HB3' ' HB3' ' A' ' 15' ' ' TRP . 23.5 t -96.42 109.33 47.19 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.24 -0.912 . . . . 0.0 109.337 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 36.1 Cg_endo -78.43 -32.96 2.02 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.297 1.998 . . . . 0.0 110.552 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.417 ' CB ' ' CE1' ' A' ' 62' ' ' PHE . . . -49.1 -56.99 7.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.272 -0.892 . . . . 0.0 109.506 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.921 HD12 ' CD1' ' A' ' 15' ' ' TRP . 4.7 mt -87.28 -56.36 3.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.177 -0.952 . . . . 0.0 109.613 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 8' ' ' CYS . . . 155.2 -150.37 21.83 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.19 159.47 33.4 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.681 2.254 . . . . 0.0 110.409 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 83.54 -52.77 4.78 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 0.921 ' CD1' HD12 ' A' ' 11' ' ' LEU . 4.4 t-105 -64.62 126.15 26.99 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.213 -1.169 . . . . 0.0 109.505 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.512 ' CG ' ' HB3' ' A' ' 5' ' ' TRP . 5.5 tptt -107.28 112.75 25.75 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.135 -0.978 . . . . 0.0 109.316 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.58 ' HG3' ' CE2' ' A' ' 35' ' ' TYR . 1.0 OUTLIER -87.15 116.28 25.12 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.242 -0.911 . . . . 0.0 109.457 -179.964 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.671 ' CZ ' HG21 ' A' ' 20' ' ' VAL . 10.0 ttp180 -95.63 141.04 29.6 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.222 -0.924 . . . . 0.0 109.483 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.495 ' CG ' ' O ' ' A' ' 19' ' ' GLU . 3.4 pt-20 -115.05 119.47 36.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.229 -0.92 . . . . 0.0 109.472 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.671 HG21 ' CZ ' ' A' ' 18' ' ' ARG . 20.5 t . . . . . 0 N--CA 1.49 1.529 0 O-C-N 121.233 -0.917 . . . . 0.0 109.634 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 57.6 m -115.05 121.46 43.16 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.188 -0.945 . . . . 0.0 109.711 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.56 ' CD2' ' HG3' ' A' ' 44' ' ' ARG . 12.5 m-85 -103.8 157.25 17.21 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.258 -0.901 . . . . 0.0 109.179 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.58 ' CE2' ' HG3' ' A' ' 17' ' ' ARG . 11.5 m-85 -129.33 139.66 51.66 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.111 -0.993 . . . . 0.0 109.897 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.562 ' HB2' ' CZ3' ' A' ' 5' ' ' TRP . 22.0 tt0 -124.83 130.16 51.84 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.364 -0.835 . . . . 0.0 109.385 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.533 ' HA ' ' CZ3' ' A' ' 15' ' ' TRP . 0.5 OUTLIER -69.94 175.92 2.07 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.227 -0.92 . . . . 0.0 109.368 179.989 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.514 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 35.0 Cg_endo -78.11 -2.03 12.16 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.6 2.2 . . . . 0.0 110.283 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 p -109.38 -17.24 13.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.327 -0.858 . . . . 0.0 109.29 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 119.75 4.35 11.74 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.427 ' CB ' ' OG ' ' A' ' 37' ' ' SER . 0.1 OUTLIER -77.67 109.0 11.28 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.199 -1.177 . . . . 0.0 109.155 179.87 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.6 mtt180 -97.05 124.36 41.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.336 -0.852 . . . . 0.0 109.889 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.546 HG22 ' N ' ' A' ' 44' ' ' ARG . 3.0 mp -118.56 163.5 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.379 -0.826 . . . . 0.0 109.047 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.587 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 4.5 ttp180 -126.77 -23.82 3.63 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.126 -0.984 . . . . 0.0 110.327 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.842 ' O ' HD23 ' A' ' 49' ' ' LEU . 0.5 OUTLIER -75.24 166.47 23.58 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.76 -1.212 . . . . 0.0 108.615 179.543 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.673 ' HE3' HG23 ' A' ' 47' ' ' VAL . 7.6 ttpt -86.56 -63.77 1.26 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.123 -0.985 . . . . 0.0 110.529 -178.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.673 HG23 ' HE3' ' A' ' 46' ' ' LYS . 89.3 t -76.58 -16.8 14.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.11 -0.994 . . . . 0.0 109.773 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.585 ' HB2' ' CB ' ' A' ' 45' ' ' SER . 14.3 mt-10 -72.57 -46.86 52.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.965 -1.084 . . . . 0.0 108.495 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.86 HD13 ' CZ2' ' A' ' 15' ' ' TRP . 2.9 pp -66.76 -21.64 66.05 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 178.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.923 ' OG1' HD13 ' A' ' 59' ' ' LEU . 27.3 m -73.07 -64.49 0.96 Allowed 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.519 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -49.66 -23.73 1.88 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.224 -0.922 . . . . 0.0 108.611 179.665 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.48 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 63.9 t80 -62.68 -61.5 2.38 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.319 -0.863 . . . . 0.0 108.732 179.323 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.832 HD21 ' CE3' ' A' ' 15' ' ' TRP . 0.9 OUTLIER -53.36 -59.25 4.82 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.294 -0.879 . . . . 0.0 109.227 179.521 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 147.88 -162.55 28.75 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.72 -2.96 13.09 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.566 2.177 . . . . 0.0 110.144 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.87 -28.62 35.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.292 -0.88 . . . . 0.0 109.61 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 5.8 m -115.32 139.52 49.91 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.171 -0.955 . . . . 0.0 109.353 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.819 ' C ' HD12 ' A' ' 59' ' ' LEU . 2.0 p30 -132.76 153.26 51.38 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.078 -1.013 . . . . 0.0 109.905 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.923 HD13 ' OG1' ' A' ' 50' ' ' THR . 6.0 mp -146.35 12.04 1.18 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.412 -0.805 . . . . 0.0 109.223 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.611 ' C ' HD22 ' A' ' 61' ' ' LEU . 97.2 m -50.59 -31.55 16.23 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.237 -0.915 . . . . 0.0 109.093 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.611 HD22 ' C ' ' A' ' 60' ' ' THR . 1.2 mm? -111.11 -9.04 14.38 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.452 -0.78 . . . . 0.0 109.053 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.493 ' CZ ' ' HA2' ' A' ' 67' ' ' GLY . 61.7 t80 -56.08 129.68 40.95 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.412 -0.805 . . . . 0.0 109.168 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.525 ' O ' ' N ' ' A' ' 65' ' ' LYS . 19.2 t0 -79.04 104.01 9.38 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.246 -0.909 . . . . 0.0 109.141 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.587 ' CE2' ' O ' ' A' ' 44' ' ' ARG . 1.1 t80 -66.94 63.0 0.05 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.477 -0.764 . . . . 0.0 109.452 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.525 ' N ' ' O ' ' A' ' 63' ' ' ASP . 37.4 ttpt -179.65 -43.7 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.458 -0.776 . . . . 0.0 109.173 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -88.31 -45.57 9.92 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.314 -0.866 . . . . 0.0 109.315 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.493 ' HA2' ' CZ ' ' A' ' 62' ' ' PHE . . . 110.48 31.86 2.89 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.574 ' C ' HD12 ' A' ' 68' ' ' ILE . 2.8 pp -140.35 166.85 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.208 -1.172 . . . . 0.0 109.431 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.48 ' CB ' ' HA ' ' A' ' 62' ' ' PHE . 0.7 OUTLIER -145.54 177.63 8.72 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.202 -0.936 . . . . 0.0 109.482 -179.869 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.446 ' SG ' ' O ' ' A' ' 69' ' ' LEU . 72.2 m . . . . . 0 N--CA 1.49 1.533 0 O-C-N 121.366 -0.833 . . . . 0.0 109.292 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.568 ' CE3' ' HB2' ' A' ' 18' ' ' ARG . 73.3 m95 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.263 0.554 . . . . 0.0 109.534 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.476 HD23 ' HA ' ' A' ' 6' ' ' LEU . 51.8 mt -114.49 148.97 37.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.214 -0.929 . . . . 0.0 109.358 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.452 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 0.2 OUTLIER -43.63 133.74 4.45 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.297 -0.877 . . . . 0.0 109.424 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.521 ' HB3' ' HB3' ' A' ' 15' ' ' TRP . 39.7 t -88.37 113.38 55.03 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.298 -0.876 . . . . 0.0 109.563 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 34.8 Cg_endo -77.47 -40.02 0.48 Allowed 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 122.287 1.992 . . . . 0.0 110.003 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.673 ' HB3' ' NH1' ' A' ' 17' ' ' ARG . . . -47.04 -42.44 18.48 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.318 -0.864 . . . . 0.0 109.452 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.626 HD12 ' CG ' ' A' ' 15' ' ' TRP . 13.1 mt -101.15 -61.34 1.38 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.322 -0.861 . . . . 0.0 109.491 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 8' ' ' CYS . . . 156.7 -149.06 19.73 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -77.27 153.21 31.37 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.517 2.145 . . . . 0.0 110.327 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.408 ' O ' ' C ' ' A' ' 15' ' ' TRP . . . 93.76 -74.79 1.13 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 0.799 ' CE3' HD21 ' A' ' 53' ' ' LEU . 22.2 t-105 -44.24 122.6 3.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.275 -1.133 . . . . 0.0 109.304 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.3 mmtt -97.04 108.75 21.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.173 -0.954 . . . . 0.0 109.66 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.673 ' NH1' ' HB3' ' A' ' 10' ' ' ALA . 1.0 OUTLIER -87.1 106.33 17.79 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.199 -0.938 . . . . 0.0 109.389 179.863 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.568 ' HB2' ' CE3' ' A' ' 5' ' ' TRP . 5.1 ttt180 -100.02 147.52 25.52 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.235 -0.915 . . . . 0.0 109.749 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.468 ' HA ' HG23 ' A' ' 33' ' ' THR . 22.0 pt-20 -116.67 155.27 29.11 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.356 -0.84 . . . . 0.0 109.241 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.783 HG21 ' CE1' ' A' ' 34' ' ' TYR . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.165 -0.96 . . . . 0.0 109.407 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.487 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.512 ' CG2' ' O ' ' A' ' 18' ' ' ARG . 2.1 m -139.56 142.9 37.15 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.245 -0.909 . . . . 0.0 109.619 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.783 ' CE1' HG21 ' A' ' 20' ' ' VAL . 6.1 m-85 -135.58 151.86 50.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.337 -0.852 . . . . 0.0 109.243 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.895 ' HD2' HD22 ' A' ' 49' ' ' LEU . 9.8 m-85 -117.61 146.34 43.71 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.207 -0.933 . . . . 0.0 109.735 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.508 ' HB2' ' CZ3' ' A' ' 5' ' ' TRP . 35.7 tt0 -131.27 123.62 28.77 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.373 -0.83 . . . . 0.0 109.259 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.474 ' CB ' ' HD2' ' A' ' 38' ' ' PRO . 0.4 OUTLIER -66.15 173.07 2.41 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.263 -0.898 . . . . 0.0 108.965 179.823 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.474 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 36.1 Cg_endo -78.0 4.13 6.42 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.51 2.14 . . . . 0.0 110.291 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.4 p -111.62 -17.37 13.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.331 -0.855 . . . . 0.0 109.444 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 120.46 5.41 10.29 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.464 ' O ' ' HA ' ' A' ' 36' ' ' GLN . 6.7 t0 -74.9 136.78 41.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.199 -1.177 . . . . 0.0 109.364 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.4 mtp180 -121.07 116.46 25.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.196 -0.94 . . . . 0.0 109.277 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.64 HG21 ' CA ' ' A' ' 49' ' ' LEU . 4.4 mt -123.35 152.93 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.228 -0.92 . . . . 0.0 109.924 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.577 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 4.9 ttt-85 -128.49 -24.04 3.11 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.282 -0.886 . . . . 0.0 109.909 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.681 ' O ' HD23 ' A' ' 49' ' ' LEU . 1.7 m -73.56 147.89 43.5 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.979 -1.076 . . . . 0.0 108.909 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.639 ' HE2' HG23 ' A' ' 47' ' ' VAL . 24.4 ttpt -68.96 -71.84 0.2 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.287 -0.883 . . . . 0.0 110.811 -178.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.639 HG23 ' HE2' ' A' ' 46' ' ' LYS . 62.5 t -67.37 -14.96 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.031 -1.043 . . . . 0.0 110.274 -178.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.554 ' HB2' ' CB ' ' A' ' 45' ' ' SER . 2.4 tt0 -72.45 -51.97 17.9 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.884 -1.135 . . . . 0.0 108.502 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.895 HD22 ' HD2' ' A' ' 35' ' ' TYR . 1.9 pp -63.17 -28.7 70.24 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.021 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.84 ' HA ' HD12 ' A' ' 53' ' ' LEU . 0.2 OUTLIER -68.2 -55.41 12.38 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 178.376 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.429 ' HD3' ' HA ' ' A' ' 51' ' ' ARG . 48.6 mmt-85 -52.0 -24.3 6.39 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.053 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.477 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 44.4 t80 -73.3 -50.76 20.41 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.532 -0.73 . . . . 0.0 109.196 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.84 HD12 ' HA ' ' A' ' 50' ' ' THR . 0.4 OUTLIER -66.57 -53.0 39.33 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -0.909 . . . . 0.0 109.063 179.739 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 121.9 -146.42 17.01 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.62 -34.74 1.28 Allowed 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.512 2.141 . . . . 0.0 110.495 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -45.18 -33.95 2.52 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.302 -0.874 . . . . 0.0 109.837 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 67.2 m -122.07 148.51 44.77 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.165 -0.959 . . . . 0.0 109.767 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -126.82 146.27 50.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.276 -0.89 . . . . 0.0 109.422 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.833 HD23 ' CD2' ' A' ' 62' ' ' PHE . 0.2 OUTLIER -144.99 6.85 1.18 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.277 -0.889 . . . . 0.0 110.332 -179.157 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.581 ' C ' HD22 ' A' ' 61' ' ' LEU . 5.0 m -47.09 -41.88 17.95 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.062 -1.024 . . . . 0.0 109.861 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.581 HD22 ' C ' ' A' ' 60' ' ' THR . 1.4 mm? -110.1 13.2 23.3 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.166 -0.959 . . . . 0.0 110.113 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.833 ' CD2' HD23 ' A' ' 59' ' ' LEU . 51.5 t80 -69.5 136.1 51.01 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.201 -0.937 . . . . 0.0 109.549 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.429 ' O ' ' N ' ' A' ' 65' ' ' LYS . 0.3 OUTLIER -89.81 105.13 17.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.315 -0.866 . . . . 0.0 109.248 179.728 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.649 ' CZ ' ' CE2' ' A' ' 35' ' ' TYR . 0.4 OUTLIER -69.98 61.33 0.19 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.245 -0.909 . . . . 0.0 109.411 -179.594 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 63' ' ' ASP . 5.6 ttpt -174.46 -37.37 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.318 -0.864 . . . . 0.0 109.018 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -97.59 -38.74 9.43 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.419 -0.801 . . . . 0.0 109.111 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 103.67 32.36 4.51 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.695 ' C ' HD12 ' A' ' 68' ' ' ILE . 2.7 pp -139.87 173.38 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.162 -1.199 . . . . 0.0 109.58 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.504 ' CB ' ' HA ' ' A' ' 62' ' ' PHE . 0.6 OUTLIER -149.89 -165.07 2.17 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.243 -0.911 . . . . 0.0 109.385 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.44 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.488 1.459 0 O-C-N 121.334 -0.854 . . . . 0.0 109.344 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.575 ' CE3' ' HB2' ' A' ' 18' ' ' ARG . 84.1 m95 . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.487 HD21 ' OE1' ' A' ' 19' ' ' GLU . 0.5 OUTLIER -110.26 154.33 23.58 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.221 -0.924 . . . . 0.0 109.509 -179.947 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.419 ' C ' ' O ' ' A' ' 6' ' ' LEU . 2.0 m-20 -43.9 146.31 0.6 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.291 -0.881 . . . . 0.0 109.471 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.472 ' CB ' ' HB2' ' A' ' 17' ' ' ARG . 45.4 t -111.88 100.75 49.7 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.197 -0.94 . . . . 0.0 109.457 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.504 ' HD2' ' NH2' ' A' ' 17' ' ' ARG . 34.4 Cg_endo -76.6 -33.89 2.85 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.438 2.092 . . . . 0.0 110.569 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.47 ' C ' HD23 ' A' ' 11' ' ' LEU . . . -42.47 -48.43 5.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.308 -0.87 . . . . 0.0 109.609 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.824 HD12 ' CD1' ' A' ' 15' ' ' TRP . 3.1 mt -94.13 -61.99 1.42 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.247 -0.908 . . . . 0.0 109.457 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 8' ' ' CYS . . . 168.69 -158.67 31.45 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.94 145.92 20.11 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.592 2.195 . . . . 0.0 110.452 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.03 -49.83 1.22 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 0.824 ' CD1' HD12 ' A' ' 11' ' ' LEU . 15.7 t-105 -65.66 129.77 40.93 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.233 -1.157 . . . . 0.0 109.468 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.8 mmtp -100.99 123.02 44.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.172 -0.955 . . . . 0.0 109.394 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.504 ' NH2' ' HD2' ' A' ' 9' ' ' PRO . 7.7 ttp85 -94.19 110.65 22.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.16 -0.962 . . . . 0.0 109.588 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.575 ' HB2' ' CE3' ' A' ' 5' ' ' TRP . 0.5 OUTLIER -99.71 141.77 32.08 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.325 -0.859 . . . . 0.0 109.053 179.653 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.487 ' OE1' HD21 ' A' ' 6' ' ' LEU . 4.5 pt-20 -124.46 141.84 51.77 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.186 -0.947 . . . . 0.0 109.875 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 87.7 t . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.24 -0.913 . . . . 0.0 109.349 179.763 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.469 ' O ' ' CE1' ' A' ' 35' ' ' TYR . 4.5 m -139.34 98.52 3.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.298 -0.876 . . . . 0.0 109.542 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.54 ' CD1' ' HB3' ' A' ' 44' ' ' ARG . 13.0 m-85 -99.95 160.65 14.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.401 -0.812 . . . . 0.0 108.984 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.64 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 1.6 m-85 -131.78 156.46 45.94 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.977 -1.077 . . . . 0.0 109.912 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.559 ' HB2' ' CZ3' ' A' ' 5' ' ' TRP . 11.3 tt0 -129.66 129.97 44.97 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.441 -0.787 . . . . 0.0 109.047 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.46 ' CB ' ' HD2' ' A' ' 38' ' ' PRO . 0.6 OUTLIER -68.68 172.06 5.25 Favored Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 121.269 -0.894 . . . . 0.0 109.257 -179.976 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.46 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 35.1 Cg_endo -77.66 4.56 5.92 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.623 2.215 . . . . 0.0 110.408 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.6 t -122.13 -20.23 6.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.307 -0.871 . . . . 0.0 109.58 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 128.59 6.51 4.62 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.416 ' CB ' ' HB2' ' A' ' 37' ' ' SER . 0.5 OUTLIER -80.29 105.88 11.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.123 -1.222 . . . . 0.0 109.146 179.79 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.439 ' HG3' ' HG3' ' A' ' 36' ' ' GLN . 15.6 mtp180 -97.5 125.43 42.18 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.181 -0.95 . . . . 0.0 110.078 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.653 HG21 ' CA ' ' A' ' 49' ' ' LEU . 4.8 mt -127.65 163.91 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.54 ' HB3' ' CD1' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -160.31 18.17 0.14 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.894 -1.129 . . . . 0.0 110.654 -179.575 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.567 ' HB2' ' CB ' ' A' ' 48' ' ' GLU . 0.4 OUTLIER -99.98 18.13 19.24 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.856 -1.152 . . . . 0.0 109.397 179.761 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.586 ' HB2' ' CD1' ' A' ' 64' ' ' PHE . 12.7 tttt 64.36 -92.49 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.502 -0.749 . . . . 0.0 110.473 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.488 ' HA ' ' OG1' ' A' ' 50' ' ' THR . 74.8 t -62.33 -27.93 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.018 -1.051 . . . . 0.0 109.369 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.567 ' CB ' ' HB2' ' A' ' 45' ' ' SER . 23.9 tt0 -61.06 -49.28 77.99 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.025 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.683 HD12 HD11 ' A' ' 53' ' ' LEU . 0.8 OUTLIER -68.13 -23.72 64.93 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.814 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.544 ' OG1' ' CB ' ' A' ' 59' ' ' LEU . 26.9 m -65.65 -70.87 0.21 Allowed 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.425 ' C ' ' O ' ' A' ' 50' ' ' THR . 0.0 OUTLIER -43.57 -26.79 0.24 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.507 -0.746 . . . . 0.0 109.028 179.547 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.422 ' N ' ' O ' ' A' ' 50' ' ' THR . 37.1 t80 -64.16 -62.95 1.29 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.286 -0.884 . . . . 0.0 109.565 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.683 HD11 HD12 ' A' ' 49' ' ' LEU . 0.5 OUTLIER -55.57 -57.94 9.84 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.125 -0.984 . . . . 0.0 109.274 -179.92 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 131.06 -155.01 21.07 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.48 -9.5 16.11 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.623 2.216 . . . . 0.0 110.528 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -81.14 -13.99 58.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.302 -0.874 . . . . 0.0 109.638 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.47 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 88.1 m -134.07 79.27 1.8 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.191 -0.943 . . . . 0.0 109.596 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.54 137.23 56.64 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.145 -0.972 . . . . 0.0 109.133 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.775 HD23 ' HB3' ' A' ' 62' ' ' PHE . 0.1 OUTLIER -140.46 5.42 2.04 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.276 -0.89 . . . . 0.0 109.878 -179.288 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.629 ' C ' HD22 ' A' ' 61' ' ' LEU . 54.5 m -62.15 -21.36 64.98 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.215 -0.928 . . . . 0.0 109.156 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.629 HD22 ' C ' ' A' ' 60' ' ' THR . 1.7 mm? -107.31 -11.74 15.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.387 -0.821 . . . . 0.0 109.217 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.775 ' HB3' HD23 ' A' ' 59' ' ' LEU . 6.1 t80 -54.81 133.41 47.56 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.399 -0.813 . . . . 0.0 109.735 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.547 ' O ' ' CE1' ' A' ' 62' ' ' PHE . 2.4 t0 -80.57 104.74 11.31 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.283 -0.886 . . . . 0.0 108.882 179.458 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.586 ' CD1' ' HB2' ' A' ' 46' ' ' LYS . 0.6 OUTLIER -67.19 65.04 0.06 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.264 -0.898 . . . . 0.0 109.319 -179.426 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 63' ' ' ASP . 6.3 mtpt 171.48 -37.9 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.396 -0.815 . . . . 0.0 109.388 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 43.1 tt0 -88.16 -46.63 9.11 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.163 -0.961 . . . . 0.0 109.3 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.494 ' HA2' ' CZ ' ' A' ' 62' ' ' PHE . . . 111.77 25.69 4.75 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -140.72 171.43 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.011 -1.288 . . . . 0.0 109.69 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 62' ' ' PHE . 1.1 pt? -140.49 -174.3 3.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.22 -0.925 . . . . 0.0 109.337 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 23.0 m . . . . . 0 N--CA 1.491 1.582 0 O-C-N 121.187 -0.945 . . . . 0.0 109.592 -179.928 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.576 ' CZ3' ' HB2' ' A' ' 18' ' ' ARG . 97.9 m95 . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 81.4 mt -111.3 164.35 12.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.22 -0.925 . . . . 0.0 109.562 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 7' ' ' ASP . 0.5 OUTLIER -59.99 145.06 47.59 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.262 -0.898 . . . . 0.0 109.572 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.514 ' SG ' ' N ' ' A' ' 17' ' ' ARG . 7.1 m -91.24 113.89 59.85 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.258 -0.901 . . . . 0.0 109.886 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.415 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 36.3 Cg_endo -78.98 -27.35 4.66 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.344 2.029 . . . . 0.0 110.412 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.77 ' HB3' HH12 ' A' ' 17' ' ' ARG . . . -70.71 -37.34 73.54 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.106 -0.996 . . . . 0.0 109.839 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.813 HD12 ' CD1' ' A' ' 15' ' ' TRP . 6.5 mt -105.08 -46.37 4.28 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.134 -0.979 . . . . 0.0 109.635 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 135.06 -145.98 18.04 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.38 164.66 26.23 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.626 2.217 . . . . 0.0 110.405 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.8 -51.97 4.64 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 0.813 ' CD1' HD12 ' A' ' 11' ' ' LEU . 7.9 t-105 -75.72 125.75 29.66 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.292 -1.122 . . . . 0.0 109.346 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.427 ' C ' ' SG ' ' A' ' 8' ' ' CYS . 10.6 mmtp -103.14 132.4 49.43 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.213 -0.929 . . . . 0.0 109.526 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.77 HH12 ' HB3' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -99.22 111.43 23.81 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.507 -0.745 . . . . 0.0 109.413 -179.6 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.576 ' HB2' ' CZ3' ' A' ' 5' ' ' TRP . 1.6 ttt180 -100.11 131.76 45.87 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.174 -0.954 . . . . 0.0 109.61 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -112.35 142.79 44.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.299 -0.876 . . . . 0.0 109.328 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 39.3 t . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.139 -0.976 . . . . 0.0 109.778 -179.745 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.497 ' HB3' ' CZ ' ' A' ' 34' ' ' TYR . 3.7 m-20 . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.78 109.4 17.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.203 -0.936 . . . . 0.0 109.827 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.591 ' CD1' ' CD ' ' A' ' 44' ' ' ARG . 11.4 m-85 -112.49 138.07 49.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.256 -0.902 . . . . 0.0 108.992 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.638 ' HD2' HD22 ' A' ' 49' ' ' LEU . 5.3 m-85 -108.18 151.11 26.36 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.136 -0.977 . . . . 0.0 109.827 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -132.24 128.73 38.52 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.361 -0.837 . . . . 0.0 109.533 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.517 ' OG ' ' CB ' ' A' ' 41' ' ' ASP . 0.4 OUTLIER -71.94 174.68 3.77 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.28 -0.888 . . . . 0.0 109.511 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.509 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 35.9 Cg_endo -78.61 -4.49 14.15 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.722 2.282 . . . . 0.0 110.417 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.458 HG22 ' HB2' ' A' ' 37' ' ' SER . 2.4 t -103.92 -18.55 14.57 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.241 -0.912 . . . . 0.0 109.518 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 120.71 12.44 6.04 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.517 ' CB ' ' OG ' ' A' ' 37' ' ' SER . 0.4 OUTLIER -83.25 127.6 33.78 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -1.151 . . . . 0.0 109.571 -179.908 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.08 131.71 56.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.244 -0.91 . . . . 0.0 109.277 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.603 HG22 ' H ' ' A' ' 45' ' ' SER . 2.6 mp -137.64 161.49 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.225 -0.922 . . . . 0.0 109.611 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.591 ' CD ' ' CD1' ' A' ' 34' ' ' TYR . 34.8 mtm180 -143.79 18.42 1.81 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.316 -0.865 . . . . 0.0 109.557 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.603 ' H ' HG22 ' A' ' 43' ' ' ILE . 0.5 OUTLIER -91.88 -88.54 0.2 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.293 -0.879 . . . . 0.0 108.907 179.504 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.563 ' HB2' ' CD1' ' A' ' 64' ' ' PHE . 19.3 ttpt 159.52 -63.39 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.479 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 77.2 t -85.38 -21.54 7.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.489 ' O ' ' HG3' ' A' ' 51' ' ' ARG . 98.3 mt-10 -68.71 -44.81 73.13 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.638 HD22 ' HD2' ' A' ' 35' ' ' TYR . 3.4 pp -71.05 -25.07 62.49 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 178.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.856 ' OG1' HD13 ' A' ' 59' ' ' LEU . 20.5 m -68.59 -63.29 1.09 Allowed 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.489 ' HG3' ' O ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -49.45 -23.96 1.79 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.394 -0.816 . . . . 0.0 108.872 179.391 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.503 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 2.6 t80 -67.32 -64.64 0.81 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.303 -0.873 . . . . 0.0 109.159 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.676 HD21 ' CE3' ' A' ' 15' ' ' TRP . 0.6 OUTLIER -51.1 -57.85 7.63 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.04 -1.038 . . . . 0.0 109.257 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 141.16 -157.15 25.94 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.07 -9.7 16.62 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.592 2.195 . . . . 0.0 110.248 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.17 -13.56 59.93 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.297 -0.877 . . . . 0.0 109.438 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 73.3 m -132.99 130.23 39.23 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.356 -0.84 . . . . 0.0 109.19 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.685 ' C ' HD12 ' A' ' 59' ' ' LEU . 25.4 t0 -126.19 152.56 45.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.168 -0.958 . . . . 0.0 109.832 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.856 HD13 ' OG1' ' A' ' 50' ' ' THR . 5.2 mp -148.64 14.7 0.96 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.388 -0.82 . . . . 0.0 109.395 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.609 ' C ' HD22 ' A' ' 61' ' ' LEU . 22.3 m -46.35 -37.35 7.38 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.323 -0.861 . . . . 0.0 109.84 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.609 HD22 ' C ' ' A' ' 60' ' ' THR . 1.1 mm? -111.38 2.43 17.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.3 -0.875 . . . . 0.0 109.606 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.579 ' CE1' ' CB ' ' A' ' 10' ' ' ALA . 78.3 t80 -58.68 146.33 36.8 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.353 -0.842 . . . . 0.0 109.656 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.496 ' O ' ' N ' ' A' ' 65' ' ' LYS . 5.1 t0 -98.44 103.32 15.26 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.33 -0.856 . . . . 0.0 108.972 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.622 ' CE1' ' CE2' ' A' ' 35' ' ' TYR . 0.7 OUTLIER -66.61 69.64 0.07 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.149 -0.97 . . . . 0.0 109.426 -179.36 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.496 ' N ' ' O ' ' A' ' 63' ' ' ASP . 11.9 ttpp 177.07 -46.22 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.266 -0.896 . . . . 0.0 109.579 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -92.41 -39.35 11.48 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.24 -0.912 . . . . 0.0 109.728 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.481 ' HA2' ' CZ ' ' A' ' 62' ' ' PHE . . . 106.03 35.17 3.02 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.469 ' O ' ' N ' ' A' ' 63' ' ' ASP . 2.0 pp -140.52 173.41 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.16 -1.2 . . . . 0.0 109.628 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.471 ' HB3' ' HA ' ' A' ' 62' ' ' PHE . 0.7 OUTLIER -147.24 -164.83 2.09 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.78 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.451 ' SG ' ' O ' ' A' ' 69' ' ' LEU . 62.1 m . . . . . 0 N--CA 1.489 1.481 0 O-C-N 120.947 -1.096 . . . . 0.0 110.134 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.415 ' CE3' ' HB2' ' A' ' 18' ' ' ARG . 71.9 m95 . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.72 158.77 17.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.194 -0.941 . . . . 0.0 109.684 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.449 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 0.5 OUTLIER -53.16 138.93 30.35 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.222 -0.923 . . . . 0.0 109.126 179.695 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.455 ' HB2' ' HB2' ' A' ' 17' ' ' ARG . 40.3 t -98.99 109.17 52.99 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.101 -0.999 . . . . 0.0 109.878 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.463 ' HD2' ' CZ ' ' A' ' 17' ' ' ARG . 34.4 Cg_endo -77.23 -38.79 0.69 Allowed 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.205 1.937 . . . . 0.0 110.111 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.633 ' C ' HD23 ' A' ' 11' ' ' LEU . . . -42.97 -32.18 0.61 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.28 -0.887 . . . . 0.0 109.473 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.969 HD12 ' CD1' ' A' ' 15' ' ' TRP . 5.3 mt -115.93 -67.01 1.03 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.21 -0.931 . . . . 0.0 109.48 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 167.1 -149.1 14.17 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.88 169.21 20.99 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.688 2.259 . . . . 0.0 110.666 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.35 -56.18 2.84 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.634 -1.387 . . . . 0.0 109.634 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 0.969 ' CD1' HD12 ' A' ' 11' ' ' LEU . 10.0 t-105 -62.15 123.41 18.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.256 -1.143 . . . . 0.0 109.774 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -103.54 120.53 41.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.281 -0.887 . . . . 0.0 109.547 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.576 ' HG3' ' CE2' ' A' ' 35' ' ' TYR . 3.2 ttp85 -95.3 114.94 26.78 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.217 -0.927 . . . . 0.0 109.347 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.415 ' HB2' ' CE3' ' A' ' 5' ' ' TRP . 4.0 tmm_? -100.24 139.37 36.01 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.183 -0.948 . . . . 0.0 109.571 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -108.68 144.69 36.12 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.209 -0.932 . . . . 0.0 109.482 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 42.7 t . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.184 -0.947 . . . . 0.0 109.428 179.957 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.52 HG22 ' CZ ' ' A' ' 35' ' ' TYR . 31.2 m -128.72 126.06 39.26 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.22 -0.925 . . . . 0.0 109.778 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.615 ' CD1' ' N ' ' A' ' 34' ' ' TYR . 1.7 m-85 -115.14 167.18 11.05 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.301 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.64 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 2.5 m-85 -136.72 146.27 45.64 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.866 -1.146 . . . . 0.0 110.08 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -128.49 124.8 37.0 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.478 -0.763 . . . . 0.0 109.344 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.514 ' CB ' ' HD2' ' A' ' 38' ' ' PRO . 0.3 OUTLIER -68.19 174.98 2.02 Favored Pre-proline 0 N--CA 1.487 1.417 0 O-C-N 121.285 -0.884 . . . . 0.0 109.32 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.514 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 35.1 Cg_endo -78.14 5.35 5.46 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.65 2.234 . . . . 0.0 110.335 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.462 HG22 ' HB2' ' A' ' 37' ' ' SER . 15.3 t -114.6 -24.83 8.58 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.254 -0.904 . . . . 0.0 109.417 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 124.24 13.34 3.98 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.469 ' HB2' ' OH ' ' A' ' 52' ' ' TYR . 0.3 OUTLIER -90.95 112.53 24.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.132 -1.217 . . . . 0.0 109.24 179.882 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.485 ' CZ ' ' HB2' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -95.57 139.33 31.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -0.891 . . . . 0.0 109.618 -179.75 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.645 HD13 ' HA ' ' A' ' 49' ' ' LEU . 4.0 mt -135.98 161.21 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.187 -0.946 . . . . 0.0 109.566 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.591 ' HG3' ' CD2' ' A' ' 34' ' ' TYR . 0.1 OUTLIER -152.6 15.12 0.58 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.239 -0.913 . . . . 0.0 110.257 -179.37 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.579 ' CB ' ' HB3' ' A' ' 48' ' ' GLU . 0.3 OUTLIER -99.61 21.55 12.15 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.924 -1.11 . . . . 0.0 109.456 179.949 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.612 ' HA ' ' CE1' ' A' ' 64' ' ' PHE . 8.1 ttpt 59.3 -94.01 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.365 -0.834 . . . . 0.0 109.973 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.464 ' HA ' ' OG1' ' A' ' 50' ' ' THR . 26.3 t -59.0 -38.0 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.036 -1.04 . . . . 0.0 109.314 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.579 ' HB3' ' CB ' ' A' ' 45' ' ' SER . 71.3 tt0 -51.26 -43.44 61.56 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.002 -1.061 . . . . 0.0 108.356 179.164 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.693 HD21 HD22 ' A' ' 59' ' ' LEU . 0.5 OUTLIER -66.45 -27.86 68.15 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 179.393 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.526 ' N ' ' HG ' ' A' ' 49' ' ' LEU . 1.5 m -71.27 -66.22 0.65 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.07 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.467 ' CD ' ' HA ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -47.84 -24.33 0.97 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.357 -0.839 . . . . 0.0 108.778 179.321 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.479 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 62.4 t80 -63.34 -60.18 3.73 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.264 -0.898 . . . . 0.0 109.114 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.672 HD21 ' CE3' ' A' ' 15' ' ' TRP . 0.3 OUTLIER -60.74 -55.19 36.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.182 -0.949 . . . . 0.0 108.969 179.642 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 142.74 -155.33 25.78 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -78.02 -18.84 12.71 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.537 2.158 . . . . 0.0 110.366 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.22 -10.52 51.37 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.326 -0.859 . . . . 0.0 109.56 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.466 ' CB ' HD13 ' A' ' 53' ' ' LEU . 18.0 m -133.41 136.71 45.42 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.227 -0.921 . . . . 0.0 109.522 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.63 ' C ' HD12 ' A' ' 59' ' ' LEU . 18.3 t70 -130.95 148.59 52.73 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.272 -0.893 . . . . 0.0 109.49 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.693 HD22 HD21 ' A' ' 49' ' ' LEU . 4.1 mp -148.24 10.5 0.88 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.208 -0.932 . . . . 0.0 109.696 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.629 ' C ' HD22 ' A' ' 61' ' ' LEU . 94.5 m -49.92 -29.06 7.59 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.146 -0.971 . . . . 0.0 109.145 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.629 HD22 ' C ' ' A' ' 60' ' ' THR . 1.5 mm? -111.07 -8.42 14.44 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.322 -0.861 . . . . 0.0 109.381 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.618 ' CD2' HD23 ' A' ' 59' ' ' LEU . 48.0 t80 -59.18 131.1 50.01 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.378 -0.826 . . . . 0.0 109.337 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.63 117.49 20.6 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.192 -0.943 . . . . 0.0 109.261 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.612 ' CE1' ' HA ' ' A' ' 46' ' ' LYS . 0.4 OUTLIER -73.89 56.75 0.59 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.219 -0.926 . . . . 0.0 109.065 -179.94 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.14 -41.6 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.378 -0.826 . . . . 0.0 109.022 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -81.14 -46.66 14.58 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.267 -0.895 . . . . 0.0 109.113 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.503 ' HA3' ' NH1' ' A' ' 17' ' ' ARG . . . 104.22 28.63 5.74 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.469 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 1.1 pp -140.6 161.48 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.022 -1.281 . . . . 0.0 109.757 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.427 ' HB3' ' HA ' ' A' ' 62' ' ' PHE . 0.7 OUTLIER -143.74 173.84 11.33 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.339 -0.851 . . . . 0.0 108.935 179.74 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 21.6 p . . . . . 0 N--CA 1.489 1.511 0 O-C-N 121.118 -0.989 . . . . 0.0 109.767 179.802 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.555 ' CZ3' ' HB2' ' A' ' 36' ' ' GLN . 98.7 m95 . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -110.8 160.75 16.46 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.181 -0.949 . . . . 0.0 109.617 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -56.39 149.32 17.03 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.237 -0.914 . . . . 0.0 109.206 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.448 ' SG ' ' HG ' ' A' ' 11' ' ' LEU . 38.0 t -111.75 103.83 55.51 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.128 -0.983 . . . . 0.0 109.848 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.92 -26.21 6.88 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.373 2.049 . . . . 0.0 109.878 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.475 ' CB ' ' CE2' ' A' ' 62' ' ' PHE . . . -54.06 -34.63 60.56 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.406 -0.809 . . . . 0.0 109.314 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 1.03 HD12 ' CD1' ' A' ' 15' ' ' TRP . 12.2 mt -105.88 -66.79 0.97 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.292 -0.88 . . . . 0.0 109.358 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 157.98 -153.16 24.37 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.79 137.34 15.89 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.669 2.246 . . . . 0.0 110.353 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.29 23.25 17.35 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 1.03 ' CD1' HD12 ' A' ' 11' ' ' LEU . 27.6 t-105 -150.1 125.59 10.24 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.24 -1.153 . . . . 0.0 109.334 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.9 mmmt -105.9 134.66 48.67 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.15 -0.969 . . . . 0.0 109.538 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.508 ' HG3' ' CE2' ' A' ' 35' ' ' TYR . 3.7 ttp85 -103.6 111.68 24.26 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.311 -0.868 . . . . 0.0 109.643 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.548 ' HG3' ' CE2' ' A' ' 5' ' ' TRP . 0.3 OUTLIER -97.65 155.41 17.0 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.224 -0.923 . . . . 0.0 109.151 179.716 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -123.03 168.61 12.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.116 -0.99 . . . . 0.0 109.731 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.622 HG21 ' CE2' ' A' ' 34' ' ' TYR . 3.4 t . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.349 -0.845 . . . . 0.0 109.383 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.38 106.31 11.33 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.129 -0.982 . . . . 0.0 109.772 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.622 ' CE2' HG21 ' A' ' 20' ' ' VAL . 15.0 m-85 -101.99 167.27 10.15 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.275 -0.89 . . . . 0.0 109.054 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.578 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 3.9 m-85 -135.1 155.16 51.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.067 -1.02 . . . . 0.0 109.913 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.555 ' HB2' ' CZ3' ' A' ' 5' ' ' TRP . 4.4 tt0 -141.96 132.82 25.79 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.357 -0.839 . . . . 0.0 109.156 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.518 ' CB ' ' HD2' ' A' ' 38' ' ' PRO . 0.1 OUTLIER -70.78 176.13 2.18 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.238 -0.913 . . . . 0.0 109.213 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.518 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 35.7 Cg_endo -78.69 0.29 10.1 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.535 2.156 . . . . 0.0 110.289 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.475 HG22 ' HB2' ' A' ' 37' ' ' SER . 10.1 t -106.48 -21.58 13.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.338 -0.851 . . . . 0.0 109.575 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 122.51 10.95 5.76 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.437 ' CB ' ' OG ' ' A' ' 37' ' ' SER . 0.1 OUTLIER -79.76 102.97 9.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.232 -1.158 . . . . 0.0 109.472 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.3 mtp85 -90.48 117.3 29.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.281 -0.887 . . . . 0.0 109.477 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.647 HG21 ' N ' ' A' ' 49' ' ' LEU . 2.9 mp -121.63 153.04 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.277 -0.889 . . . . 0.0 109.494 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.47 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 8.7 mtm-85 -148.73 16.9 1.0 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.233 -0.917 . . . . 0.0 110.237 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.561 ' HB3' ' CB ' ' A' ' 48' ' ' GLU . 1.6 t -100.66 16.75 23.84 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.979 -1.076 . . . . 0.0 110.368 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.612 ' HA ' ' CE1' ' A' ' 64' ' ' PHE . 25.6 tttt 63.73 -94.18 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.221 -0.924 . . . . 0.0 110.92 178.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.448 ' HA ' ' OG1' ' A' ' 50' ' ' THR . 54.9 t -58.72 -27.88 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.906 -1.121 . . . . 0.0 109.656 -178.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.561 ' CB ' ' HB3' ' A' ' 45' ' ' SER . 14.7 tt0 -61.12 -47.79 84.65 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.093 -1.004 . . . . 0.0 108.525 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 1.012 HD13 ' CZ2' ' A' ' 15' ' ' TRP . 1.0 OUTLIER -67.75 -23.79 65.28 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.94 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.547 ' OG1' ' CB ' ' A' ' 59' ' ' LEU . 17.0 m -66.92 -68.76 0.35 Allowed 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.074 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.66 -20.41 2.04 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.533 -0.73 . . . . 0.0 109.23 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.485 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 44.5 t80 -66.76 -50.57 62.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.223 -0.923 . . . . 0.0 109.276 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.851 HD11 HD12 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -70.56 -48.52 55.0 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.19 -0.944 . . . . 0.0 109.093 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 121.6 -156.59 16.5 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -78.9 8.08 3.96 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.574 2.183 . . . . 0.0 110.552 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -88.53 -23.56 23.14 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.141 -0.974 . . . . 0.0 109.558 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.464 ' HB2' HD13 ' A' ' 53' ' ' LEU . 95.8 m -133.28 101.1 5.05 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.285 -0.884 . . . . 0.0 109.499 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -75.62 131.12 39.76 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.178 -0.951 . . . . 0.0 109.448 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.869 HD13 HD11 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -132.37 0.9 3.74 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.369 -0.832 . . . . 0.0 109.697 -179.689 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.434 ' O ' HD22 ' A' ' 61' ' ' LEU . 8.2 m -47.54 -34.35 7.53 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.335 -0.853 . . . . 0.0 110.24 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.499 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 0.7 OUTLIER -108.09 0.24 21.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.057 -1.027 . . . . 0.0 109.93 -179.321 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.748 ' CB ' HD23 ' A' ' 59' ' ' LEU . 3.4 t80 -51.61 131.55 29.8 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.17 -0.956 . . . . 0.0 109.358 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.486 ' O ' ' N ' ' A' ' 65' ' ' LYS . 99.0 m-20 -79.22 104.16 9.65 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.21 -0.931 . . . . 0.0 108.768 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.612 ' CE1' ' HA ' ' A' ' 46' ' ' LYS . 0.5 OUTLIER -68.62 58.86 0.09 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.337 -0.852 . . . . 0.0 109.658 -179.138 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.486 ' N ' ' O ' ' A' ' 63' ' ' ASP . 2.7 tmmt? 178.09 -33.63 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.272 -0.892 . . . . 0.0 109.432 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -92.12 -44.04 9.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.18 -0.95 . . . . 0.0 109.501 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.442 ' O ' ' HB2' ' A' ' 10' ' ' ALA . . . 110.95 25.31 5.16 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.567 HD12 ' N ' ' A' ' 69' ' ' LEU . 1.3 pp -140.31 -170.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.286 -1.126 . . . . 0.0 109.557 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.58 ' N ' HD23 ' A' ' 69' ' ' LEU . 1.1 pt? -153.42 178.53 9.69 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.378 -0.826 . . . . 0.0 109.0 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.497 0 O-C-N 121.139 -0.976 . . . . 0.0 109.24 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.598 ' CZ3' ' HB2' ' A' ' 36' ' ' GLN . 73.5 m95 . . . . . 0 N--CA 1.494 1.728 0 CA-C-O 121.344 0.592 . . . . 0.0 109.912 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.9 mt -102.78 152.62 21.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.117 -0.989 . . . . 0.0 109.685 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.474 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 5.3 m-20 -50.75 131.12 25.79 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.282 -0.886 . . . . 0.0 109.587 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.522 ' SG ' ' CZ ' ' A' ' 17' ' ' ARG . 12.1 t -82.06 113.94 47.11 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.33 -0.856 . . . . 0.0 109.629 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 36.5 Cg_endo -80.63 -55.61 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.282 0 C-N-CA 122.508 2.139 . . . . 0.0 110.909 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.64 ' HB3' ' NH1' ' A' ' 17' ' ' ARG . . . -37.99 -58.62 0.92 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.559 -0.713 . . . . 0.0 110.216 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.88 HD12 ' CD1' ' A' ' 15' ' ' TRP . 13.6 mt -79.38 -58.52 3.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.323 -0.861 . . . . 0.0 109.633 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 131.29 -140.82 12.11 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.81 138.0 16.44 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.509 2.139 . . . . 0.0 110.477 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.464 ' O ' ' HD3' ' A' ' 38' ' ' PRO . . . 99.3 14.14 36.63 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 1.028 ' CZ3' HD21 ' A' ' 53' ' ' LEU . 7.5 t-105 -148.36 137.06 21.59 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.229 -1.159 . . . . 0.0 109.532 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.76 129.22 55.64 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.261 -0.899 . . . . 0.0 109.313 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.64 ' NH1' ' HB3' ' A' ' 10' ' ' ALA . 0.6 OUTLIER -98.38 98.04 9.32 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.249 -0.907 . . . . 0.0 109.436 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.59 ' HB2' ' CE3' ' A' ' 5' ' ' TRP . 1.5 ttm180 -100.45 134.81 42.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.253 -0.904 . . . . 0.0 109.337 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -115.14 156.91 24.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.19 -0.944 . . . . 0.0 109.379 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.6 t . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.153 -0.967 . . . . 0.0 109.434 -179.902 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 . . . . . 0 N--CA 1.488 1.474 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.477 ' HB ' ' O ' ' A' ' 64' ' ' PHE . 87.2 m -114.9 132.96 56.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.171 -0.956 . . . . 0.0 109.525 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.44 ' CD1' ' HB3' ' A' ' 44' ' ' ARG . 27.9 m-85 -129.68 149.27 51.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.293 -0.88 . . . . 0.0 109.409 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.689 ' CD2' ' CZ ' ' A' ' 64' ' ' PHE . 12.3 m-85 -113.81 154.2 27.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.254 -0.904 . . . . 0.0 109.178 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.598 ' HB2' ' CZ3' ' A' ' 5' ' ' TRP . 0.7 OUTLIER -131.11 126.45 35.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.188 -0.945 . . . . 0.0 109.613 -179.877 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.534 ' HB3' HG22 ' A' ' 39' ' ' THR . 0.4 OUTLIER -62.97 170.97 2.15 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.356 -0.84 . . . . 0.0 109.364 179.864 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 14' ' ' GLY . 35.6 Cg_endo -78.41 5.99 5.1 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.577 2.185 . . . . 0.0 110.472 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.534 HG22 ' HB3' ' A' ' 37' ' ' SER . 1.7 t -115.14 -16.13 11.61 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.247 -0.908 . . . . 0.0 109.524 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 124.55 3.52 7.82 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.462 ' O ' ' HA ' ' A' ' 36' ' ' GLN . 0.7 OUTLIER -76.87 157.0 31.74 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.276 -1.132 . . . . 0.0 109.325 -179.988 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.441 ' O ' ' HG2' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -143.32 122.75 13.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.224 -0.922 . . . . 0.0 109.618 -179.874 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.517 HD13 ' CB ' ' A' ' 49' ' ' LEU . 2.6 mp -128.95 153.44 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.277 -0.89 . . . . 0.0 109.559 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.589 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 8.5 ptt85 -117.3 -15.14 10.41 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.273 -0.892 . . . . 0.0 109.242 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.579 ' CB ' ' HB2' ' A' ' 48' ' ' GLU . 1.1 m -91.02 124.82 35.55 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.217 -0.927 . . . . 0.0 108.813 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.551 ' CG ' ' N ' ' A' ' 47' ' ' VAL . 33.6 pttt -60.46 -48.18 82.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.268 -0.895 . . . . 0.0 110.442 -178.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.551 ' N ' ' CG ' ' A' ' 46' ' ' LYS . 86.6 t -77.22 -31.49 18.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.067 -1.021 . . . . 0.0 109.668 -179.369 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.579 ' HB2' ' CB ' ' A' ' 45' ' ' SER . 39.1 tt0 -59.25 -51.71 68.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.96 -1.087 . . . . 0.0 108.604 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.731 ' O ' HD12 ' A' ' 53' ' ' LEU . 3.2 pp -69.22 -33.62 73.59 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 178.742 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.645 ' OG1' HD13 ' A' ' 59' ' ' LEU . 22.8 m -52.33 -67.27 0.26 Allowed 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.472 ' HG3' ' O ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -50.05 -30.88 11.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.416 -0.803 . . . . 0.0 109.213 179.801 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.516 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 28.5 t80 -64.41 -63.01 1.25 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.122 -0.986 . . . . 0.0 108.861 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 1.028 HD21 ' CZ3' ' A' ' 15' ' ' TRP . 0.5 OUTLIER -55.27 -48.49 73.94 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.989 -1.069 . . . . 0.0 108.898 179.391 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.84 -159.26 20.27 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.23 -2.34 12.55 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.541 2.161 . . . . 0.0 110.225 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.98 -25.15 55.53 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.287 -0.883 . . . . 0.0 109.348 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.401 ' O ' HG23 ' A' ' 50' ' ' THR . 59.7 m -135.11 103.03 5.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.242 -0.911 . . . . 0.0 109.231 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.839 ' C ' HD12 ' A' ' 59' ' ' LEU . 10.0 p30 -95.41 161.43 14.08 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.177 -0.952 . . . . 0.0 109.869 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.911 HD23 ' CD2' ' A' ' 62' ' ' PHE . 5.0 mp -154.6 20.02 0.47 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.441 -0.787 . . . . 0.0 109.282 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.566 ' C ' HD22 ' A' ' 61' ' ' LEU . 21.0 m -47.24 -40.3 16.12 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.326 -0.859 . . . . 0.0 109.75 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.585 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 0.8 OUTLIER -110.78 5.22 20.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.206 -0.934 . . . . 0.0 109.873 -179.387 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.911 ' CD2' HD23 ' A' ' 59' ' ' LEU . 54.7 t80 -71.88 136.07 46.79 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.192 -0.943 . . . . 0.0 109.418 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.481 ' HB2' ' HB2' ' A' ' 66' ' ' GLN . 2.4 m-20 -95.94 120.09 35.59 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.34 -0.85 . . . . 0.0 108.977 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.689 ' CZ ' ' CD2' ' A' ' 35' ' ' TYR . 0.6 OUTLIER -66.61 -11.72 54.75 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.278 -0.888 . . . . 0.0 109.512 -179.55 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -101.92 -41.71 6.38 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.208 -0.933 . . . . 0.0 110.112 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.481 ' HB2' ' HB2' ' A' ' 63' ' ' ASP . 5.9 mt-30 -83.22 -37.8 23.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.101 -1.0 . . . . 0.0 109.856 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.584 ' HA2' ' CZ ' ' A' ' 62' ' ' PHE . . . 89.31 29.65 16.37 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -139.58 160.26 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.202 -1.176 . . . . 0.0 109.367 179.914 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.617 ' N ' HD23 ' A' ' 69' ' ' LEU . 1.3 pt? -143.25 172.26 12.98 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.233 -0.917 . . . . 0.0 109.377 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.489 1.507 0 O-C-N 121.345 -0.847 . . . . 0.0 109.274 179.816 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.594 ' CE3' ' HB2' ' A' ' 18' ' ' ARG . 62.6 m95 . . . . . 0 N--CA 1.487 1.4 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.485 HD23 ' O ' ' A' ' 5' ' ' TRP . 17.9 mt -119.28 165.44 14.25 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.2 -0.937 . . . . 0.0 109.429 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -55.58 131.87 47.35 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.11 -0.994 . . . . 0.0 109.483 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.532 ' CB ' ' HB2' ' A' ' 17' ' ' ARG . 53.9 t -82.03 117.43 68.32 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.275 -0.891 . . . . 0.0 109.642 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.95 -51.24 0.06 OUTLIER 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.418 2.079 . . . . 0.0 110.698 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -49.69 -38.05 31.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.177 -0.952 . . . . 0.0 109.929 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 1.032 HD12 ' CD1' ' A' ' 15' ' ' TRP . 13.1 mt -98.73 -54.87 2.89 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.139 -0.976 . . . . 0.0 109.656 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 134.45 -152.54 20.68 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.769 -1.333 . . . . 0.0 109.769 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.77 159.36 31.43 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.695 2.263 . . . . 0.0 110.533 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 83.71 -10.13 60.57 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 1.032 ' CD1' HD12 ' A' ' 11' ' ' LEU . 15.6 t-105 -118.06 131.42 56.45 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.313 -1.11 . . . . 0.0 109.264 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.469 ' HB3' ' HB3' ' A' ' 5' ' ' TRP . 21.4 mmtt -95.71 116.6 29.11 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.185 -0.947 . . . . 0.0 109.316 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.617 ' CZ ' HG21 ' A' ' 33' ' ' THR . 3.2 ttt-85 -104.45 100.04 9.74 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.255 -0.903 . . . . 0.0 109.294 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.77 ' O ' HG23 ' A' ' 33' ' ' THR . 1.4 tpt180 -100.7 144.18 29.99 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.149 -0.97 . . . . 0.0 110.052 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.445 ' HG2' ' CZ ' ' A' ' 18' ' ' ARG . 15.0 pt-20 -113.83 144.94 42.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.349 -0.844 . . . . 0.0 109.258 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.526 HG21 ' CE2' ' A' ' 34' ' ' TYR . 20.8 t . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.112 -0.993 . . . . 0.0 109.72 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.77 HG23 ' O ' ' A' ' 18' ' ' ARG . 56.5 m -125.4 122.0 35.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.084 -1.01 . . . . 0.0 110.126 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.526 ' CE2' HG21 ' A' ' 20' ' ' VAL . 3.3 m-85 -100.76 159.68 14.98 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.071 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.528 ' HB3' ' NE1' ' A' ' 15' ' ' TRP . 16.4 m-85 -130.49 137.08 49.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.943 -1.098 . . . . 0.0 110.114 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -118.99 116.18 25.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.489 -0.757 . . . . 0.0 109.327 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.839 ' OG ' HG22 ' A' ' 39' ' ' THR . 0.7 OUTLIER -57.07 168.86 0.78 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.327 -0.858 . . . . 0.0 109.448 -179.943 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.38 5.39 5.52 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.641 2.227 . . . . 0.0 110.379 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.839 HG22 ' OG ' ' A' ' 37' ' ' SER . 6.5 t -115.61 -11.63 11.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.155 -0.966 . . . . 0.0 109.648 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 116.98 3.86 17.26 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.81 142.45 40.3 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.163 -1.199 . . . . 0.0 109.108 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.0 117.5 24.15 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.227 -0.92 . . . . 0.0 109.707 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.61 HG21 ' HB3' ' A' ' 49' ' ' LEU . 3.4 mp -123.19 162.53 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.347 -0.845 . . . . 0.0 109.332 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.513 ' N ' HG22 ' A' ' 43' ' ' ILE . 34.6 mtp180 -149.1 15.57 0.93 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.141 -0.975 . . . . 0.0 109.805 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.546 ' O ' ' CB ' ' A' ' 46' ' ' LYS . 0.6 OUTLIER -85.34 -85.45 0.14 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.212 -0.93 . . . . 0.0 109.119 179.609 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.546 ' CB ' ' O ' ' A' ' 45' ' ' SER . 12.4 ttpt 157.92 -62.82 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.458 HG23 ' HE2' ' A' ' 46' ' ' LYS . 61.0 t -88.52 -21.83 6.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 178.5 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.483 ' O ' ' HG3' ' A' ' 51' ' ' ARG . 18.0 mt-10 -69.05 -41.78 77.18 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.757 ' O ' HD12 ' A' ' 53' ' ' LEU . 3.0 pp -71.87 -25.16 61.83 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 178.487 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.54 ' OG1' ' HB2' ' A' ' 59' ' ' LEU . 8.8 m -69.75 -61.5 1.75 Allowed 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.483 ' HG3' ' O ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -51.11 -23.21 2.98 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 179.297 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.481 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 65.2 t80 -69.63 -65.99 0.64 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.334 -0.854 . . . . 0.0 108.982 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.906 HD21 ' CE3' ' A' ' 15' ' ' TRP . 0.9 OUTLIER -49.9 -58.68 4.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.163 -0.961 . . . . 0.0 109.124 179.611 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 132.04 -146.89 18.47 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.71 -29.35 3.61 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.599 2.2 . . . . 0.0 110.139 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -54.63 -26.3 32.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.33 -0.856 . . . . 0.0 109.287 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 11.7 m -121.71 170.58 9.6 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.323 -0.861 . . . . 0.0 109.22 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.669 ' C ' HD12 ' A' ' 59' ' ' LEU . 17.6 p-10 -165.19 148.57 8.33 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.164 -0.96 . . . . 0.0 109.441 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 1.028 HD23 ' CD2' ' A' ' 62' ' ' PHE . 4.1 mp -153.0 21.02 0.58 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.206 -0.934 . . . . 0.0 109.716 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.45 ' C ' HD22 ' A' ' 61' ' ' LEU . 1.9 m -43.59 -49.59 7.52 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.268 -0.895 . . . . 0.0 109.647 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.506 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 1.5 mm? -106.97 9.8 30.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.324 -0.86 . . . . 0.0 109.755 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 1.028 ' CD2' HD23 ' A' ' 59' ' ' LEU . 72.0 t80 -55.87 139.94 44.2 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.402 -0.811 . . . . 0.0 109.999 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.528 ' O ' ' N ' ' A' ' 65' ' ' LYS . 0.7 OUTLIER -95.08 96.86 9.52 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.973 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.479 ' CE2' ' O ' ' A' ' 44' ' ' ARG . 0.5 OUTLIER -63.0 73.67 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.369 -0.832 . . . . 0.0 109.311 -179.119 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.528 ' N ' ' O ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER 168.35 -32.37 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.457 -0.777 . . . . 0.0 109.057 -179.757 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -103.57 -27.31 12.42 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.296 -0.878 . . . . 0.0 109.389 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.479 ' HA2' ' CZ ' ' A' ' 62' ' ' PHE . . . 89.42 33.16 9.57 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.472 ' O ' ' N ' ' A' ' 63' ' ' ASP . 1.0 OUTLIER -140.43 169.67 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.197 -1.178 . . . . 0.0 109.914 -179.833 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.725 ' N ' HD23 ' A' ' 69' ' ' LEU . 0.7 OUTLIER -145.11 -165.94 2.29 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.376 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.303 -1.454 0 O-C-N 121.094 -1.004 . . . . 0.0 109.897 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.594 ' CE3' ' HB2' ' A' ' 18' ' ' ARG . 72.6 m95 . . . . . 0 N--CA 1.489 1.486 0 CA-C-O 121.21 0.528 . . . . 0.0 109.658 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.451 HD23 ' HA ' ' A' ' 6' ' ' LEU . 69.2 mt -114.05 151.17 32.89 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.22 -0.925 . . . . 0.0 109.328 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.471 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 7.7 m-20 -44.42 139.23 2.83 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.188 -0.945 . . . . 0.0 109.484 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.494 ' HB2' ' N ' ' A' ' 17' ' ' ARG . 38.3 t -103.65 104.78 44.16 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.302 -0.874 . . . . 0.0 109.639 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 35.1 Cg_endo -76.87 -35.26 1.96 Allowed 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 122.441 2.094 . . . . 0.0 110.415 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 9' ' ' PRO . . . -43.89 -45.57 7.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.264 -0.897 . . . . 0.0 109.401 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 1.034 HD12 ' CD1' ' A' ' 15' ' ' TRP . 11.5 mt -97.67 -60.63 1.53 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.201 -0.937 . . . . 0.0 109.404 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 154.3 -153.15 24.61 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.07 145.0 21.67 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.71 2.273 . . . . 0.0 110.323 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.94 -24.44 31.19 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 1.034 ' CD1' HD12 ' A' ' 11' ' ' LEU . 5.5 t-105 -98.61 132.64 43.86 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.41 -1.053 . . . . 0.0 109.264 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.442 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -111.08 120.48 42.47 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.108 -0.995 . . . . 0.0 109.888 -179.793 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.494 ' N ' ' HB2' ' A' ' 8' ' ' CYS . 1.3 ttp85 -93.35 115.97 28.53 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.346 -0.846 . . . . 0.0 108.891 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.594 ' HB2' ' CE3' ' A' ' 5' ' ' TRP . 12.0 ttt180 -100.15 147.33 25.8 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.291 -0.88 . . . . 0.0 110.28 -179.234 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.481 ' O ' ' HG3' ' A' ' 19' ' ' GLU . 6.1 pt-20 -125.11 144.16 50.56 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.581 HG22 ' HE ' ' A' ' 18' ' ' ARG . 2.5 t . . . . . 0 N--CA 1.489 1.502 0 O-C-N 121.076 -1.015 . . . . 0.0 109.843 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.593 ' HB3' ' CE1' ' A' ' 34' ' ' TYR . 2.2 m-20 . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 8.7 m -131.74 108.59 9.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.249 -0.907 . . . . 0.0 109.656 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.597 ' CD1' ' CG ' ' A' ' 44' ' ' ARG . 6.5 m-85 -105.69 165.2 11.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.232 -0.918 . . . . 0.0 109.345 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.605 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 4.3 m-85 -133.66 140.24 46.95 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.102 -0.999 . . . . 0.0 109.921 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -123.0 128.25 49.94 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.425 -0.797 . . . . 0.0 109.246 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.49 ' HB2' ' HD2' ' A' ' 38' ' ' PRO . 1.7 p -80.17 167.99 29.15 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.301 -0.874 . . . . 0.0 109.42 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.49 ' HD2' ' HB2' ' A' ' 37' ' ' SER . 35.6 Cg_endo -78.37 5.85 5.19 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.647 2.231 . . . . 0.0 110.414 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.9 p -113.21 -24.93 9.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.217 -0.927 . . . . 0.0 109.479 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 123.38 16.18 3.53 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.17 105.35 17.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.148 -1.207 . . . . 0.0 109.254 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.75 105.1 17.59 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.318 -0.864 . . . . 0.0 109.689 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.718 HG21 ' CA ' ' A' ' 49' ' ' LEU . 3.2 mt -110.09 151.77 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.307 -0.87 . . . . 0.0 109.092 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.597 ' CG ' ' CD1' ' A' ' 34' ' ' TYR . 7.5 ttp180 -126.85 -0.25 6.65 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.133 -0.979 . . . . 0.0 110.04 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.887 ' O ' HD23 ' A' ' 49' ' ' LEU . 1.1 m -93.73 172.05 8.49 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.142 -0.974 . . . . 0.0 108.525 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.568 ' HB2' ' CD1' ' A' ' 64' ' ' PHE . 22.8 ttpt -91.12 -63.27 1.29 Allowed 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.034 -1.042 . . . . 0.0 110.146 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.401 ' O ' HG12 ' A' ' 47' ' ' VAL . 61.9 t -80.8 -10.82 12.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.048 -1.033 . . . . 0.0 109.316 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.568 ' HB2' ' CB ' ' A' ' 45' ' ' SER . 0.1 OUTLIER -77.3 -46.52 22.72 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 178.485 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.887 HD23 ' O ' ' A' ' 45' ' ' SER . 2.5 pp -68.84 -25.89 64.88 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 178.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.899 ' OG1' HD13 ' A' ' 59' ' ' LEU . 8.5 m -72.86 -49.28 31.02 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.294 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.23 -25.99 49.58 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.413 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 40.9 t80 -65.8 -60.46 2.86 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.54 -0.725 . . . . 0.0 109.288 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.851 HD21 ' CZ3' ' A' ' 15' ' ' TRP . 0.5 OUTLIER -58.44 -56.3 23.93 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.194 -0.941 . . . . 0.0 109.3 179.908 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 131.42 -149.44 19.26 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.5 -11.85 17.08 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.556 2.171 . . . . 0.0 110.302 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.21 -19.11 63.18 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.211 -0.93 . . . . 0.0 109.205 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 53.0 m -135.42 146.95 48.79 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.352 -0.842 . . . . 0.0 109.194 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.656 ' C ' HD12 ' A' ' 59' ' ' LEU . 0.6 OUTLIER -138.04 152.66 49.06 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.144 -0.972 . . . . 0.0 109.872 -179.754 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.899 HD13 ' OG1' ' A' ' 50' ' ' THR . 4.5 mp -148.47 9.88 0.84 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.266 -0.897 . . . . 0.0 109.541 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.673 HG22 ' CD2' ' A' ' 61' ' ' LEU . 23.2 m -48.93 -28.05 3.56 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.175 -0.953 . . . . 0.0 109.007 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.673 ' CD2' HG22 ' A' ' 60' ' ' THR . 1.3 mm? -111.74 -13.75 13.68 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.437 -0.79 . . . . 0.0 109.164 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.543 ' CD1' ' C ' ' A' ' 62' ' ' PHE . 7.8 t80 -49.37 131.71 20.38 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.401 -0.812 . . . . 0.0 109.517 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.539 ' O ' ' N ' ' A' ' 65' ' ' LYS . 2.3 m-20 -79.72 100.57 7.96 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.223 -0.923 . . . . 0.0 108.811 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.568 ' CD1' ' HB2' ' A' ' 46' ' ' LYS . 1.1 t80 -66.63 61.12 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.405 -0.809 . . . . 0.0 109.519 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.539 ' N ' ' O ' ' A' ' 63' ' ' ASP . 20.0 ttpt 177.22 -38.55 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.464 -0.772 . . . . 0.0 108.963 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -86.8 -47.8 8.76 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.313 -0.867 . . . . 0.0 109.203 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 115.21 23.05 4.66 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.569 ' C ' HD12 ' A' ' 68' ' ' ILE . 2.4 pp -140.11 -173.3 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.079 -1.247 . . . . 0.0 109.576 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.514 ' CB ' ' HA ' ' A' ' 62' ' ' PHE . 0.7 OUTLIER -151.43 -166.64 2.57 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.282 -0.886 . . . . 0.0 109.124 -179.874 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.439 ' O ' ' HG ' ' A' ' 61' ' ' LEU . 2.7 t . . . . . 0 N--CA 1.489 1.496 0 O-C-N 121.179 -0.951 . . . . 0.0 109.72 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.583 ' CE2' ' HG3' ' A' ' 18' ' ' ARG . 89.1 m95 . . . . . 0 N--CA 1.489 1.476 0 CA-C-O 121.304 0.573 . . . . 0.0 109.671 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.21 151.18 38.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.238 -0.913 . . . . 0.0 109.394 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.415 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 16.9 t70 -45.04 145.43 1.0 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.336 -0.853 . . . . 0.0 109.33 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.468 ' HB3' ' HB3' ' A' ' 15' ' ' TRP . 26.8 t -105.55 105.56 53.02 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.198 -0.939 . . . . 0.0 109.678 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.5 ' HD2' ' CZ ' ' A' ' 17' ' ' ARG . 35.2 Cg_endo -76.97 -33.57 2.69 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.441 2.094 . . . . 0.0 110.129 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.414 ' C ' HD23 ' A' ' 11' ' ' LEU . . . -47.33 -42.23 20.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.226 -0.921 . . . . 0.0 109.329 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.97 HD12 ' CD1' ' A' ' 15' ' ' TRP . 8.8 mt -99.98 -62.41 1.24 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.306 -0.871 . . . . 0.0 109.349 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.432 ' O ' ' O ' ' A' ' 8' ' ' CYS . . . 165.5 -153.03 22.82 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.44 150.31 25.01 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.643 2.229 . . . . 0.0 110.361 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.55 -65.85 1.76 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 0.97 ' CD1' HD12 ' A' ' 11' ' ' LEU . 6.4 t-105 -48.98 130.5 18.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.264 -1.139 . . . . 0.0 109.409 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -107.85 118.67 37.35 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.119 -0.988 . . . . 0.0 109.406 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.5 ' CZ ' ' HD2' ' A' ' 9' ' ' PRO . 1.2 ttp85 -93.16 116.76 29.34 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.275 -0.891 . . . . 0.0 109.368 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.583 ' HG3' ' CE2' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -96.99 142.36 29.04 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.341 -0.85 . . . . 0.0 109.437 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.434 ' CG ' ' O ' ' A' ' 19' ' ' GLU . 17.9 pt-20 -127.24 116.68 20.95 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.231 -0.918 . . . . 0.0 109.306 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 82.0 t . . . . . 0 N--CA 1.491 1.578 0 O-C-N 121.166 -0.958 . . . . 0.0 109.683 -179.771 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.468 ' OD2' ' CZ ' ' A' ' 34' ' ' TYR . 3.0 t70 . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 70.0 m -110.62 125.4 53.38 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.191 -0.943 . . . . 0.0 109.868 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.572 ' CD1' ' N ' ' A' ' 34' ' ' TYR . 3.7 m-85 -112.9 155.41 24.76 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.29 -0.881 . . . . 0.0 108.888 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.634 ' CD1' HD22 ' A' ' 49' ' ' LEU . 39.4 m-85 -126.03 131.07 52.26 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.019 -1.05 . . . . 0.0 109.905 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -122.42 128.19 50.61 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.465 -0.772 . . . . 0.0 109.151 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.498 ' CB ' ' HD2' ' A' ' 38' ' ' PRO . 0.9 OUTLIER -73.54 173.58 6.02 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.309 -0.869 . . . . 0.0 109.675 -179.73 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.498 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 34.5 Cg_endo -77.35 1.23 8.97 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.668 2.245 . . . . 0.0 110.297 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 p -111.04 -24.13 10.52 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.255 -0.903 . . . . 0.0 109.147 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 125.3 18.29 2.54 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.669 ' OD2' HD11 ' A' ' 43' ' ' ILE . 5.1 t70 -79.64 119.28 22.37 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.086 -1.244 . . . . 0.0 109.35 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.412 ' O ' ' HG2' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -103.4 107.74 18.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.285 -0.884 . . . . 0.0 109.737 -179.717 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.685 HG21 ' CA ' ' A' ' 49' ' ' LEU . 3.3 mt -120.33 151.38 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.321 -0.862 . . . . 0.0 109.133 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.591 ' O ' ' CZ ' ' A' ' 64' ' ' PHE . 10.6 ttm180 -126.81 -1.13 6.66 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.087 -1.008 . . . . 0.0 109.884 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.862 ' O ' HD23 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -88.84 179.26 6.24 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.073 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.559 ' HA ' ' CE1' ' A' ' 64' ' ' PHE . 28.7 ttpt -97.87 -59.68 1.72 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.977 -1.077 . . . . 0.0 109.657 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 99.2 t -84.24 -16.66 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.108 -0.995 . . . . 0.0 108.889 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.568 ' HB2' ' CB ' ' A' ' 45' ' ' SER . 1.9 tt0 -70.05 -45.36 67.28 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.59 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.862 HD23 ' O ' ' A' ' 45' ' ' SER . 2.0 pp -71.36 -27.12 63.13 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 178.394 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.957 ' OG1' HD13 ' A' ' 59' ' ' LEU . 27.7 m -67.36 -47.08 71.49 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.32 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.519 ' NH1' ' HG3' ' A' ' 51' ' ' ARG . 7.2 mmt85 -55.34 -31.33 61.63 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.542 ' CZ ' ' HB2' ' A' ' 41' ' ' ASP . 86.0 t80 -63.71 -51.24 65.89 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.934 -0.706 . . . . 0.0 109.431 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.86 HD21 ' CE3' ' A' ' 15' ' ' TRP . 1.5 mt -59.63 -58.86 6.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.305 -0.872 . . . . 0.0 109.536 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 135.71 -155.27 22.18 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -79.41 -10.17 14.79 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.621 2.214 . . . . 0.0 110.494 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.22 -15.81 56.18 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.228 -0.92 . . . . 0.0 109.711 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.4 ' CB ' HD13 ' A' ' 53' ' ' LEU . 72.7 m -128.45 139.77 52.17 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.254 -0.904 . . . . 0.0 109.39 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.897 ' C ' HD12 ' A' ' 59' ' ' LEU . 2.8 p30 -137.02 151.73 49.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.257 -0.902 . . . . 0.0 109.523 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.957 HD13 ' OG1' ' A' ' 50' ' ' THR . 6.6 mp -142.53 -0.2 1.24 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.22 -0.925 . . . . 0.0 110.076 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.573 ' C ' HD22 ' A' ' 61' ' ' LEU . 17.1 m -48.16 -27.44 2.39 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 120.996 -1.065 . . . . 0.0 108.521 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.602 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 1.3 mm? -105.53 -21.08 13.28 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.542 ' CE1' ' HA2' ' A' ' 67' ' ' GLY . 51.2 t80 -55.85 140.62 41.86 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.64 -0.662 . . . . 0.0 109.267 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.519 ' O ' ' N ' ' A' ' 65' ' ' LYS . 4.9 m-20 -88.32 108.64 19.44 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.189 -0.945 . . . . 0.0 109.578 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.591 ' CZ ' ' O ' ' A' ' 44' ' ' ARG . 1.7 t80 -66.62 66.9 0.06 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.288 -0.882 . . . . 0.0 109.214 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 63' ' ' ASP . 1.2 ttpm? 166.92 -36.55 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -88.18 -40.45 13.7 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.413 -0.804 . . . . 0.0 109.46 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.542 ' HA2' ' CE1' ' A' ' 62' ' ' PHE . . . 98.56 25.22 10.16 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.46 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 1.6 pp -140.47 160.31 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.201 -1.176 . . . . 0.0 109.812 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.478 ' CA ' ' HA ' ' A' ' 62' ' ' PHE . 0.6 OUTLIER -137.45 -167.57 2.14 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.338 -0.852 . . . . 0.0 108.875 179.481 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 37.7 t . . . . . 0 N--CA 1.489 1.498 0 O-C-N 121.085 -1.01 . . . . 0.0 109.61 179.955 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.591 ' CE3' ' HB2' ' A' ' 18' ' ' ARG . 64.3 m95 . . . . . 0 N--CA 1.489 1.491 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.3 mt -106.06 169.31 8.57 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.13 -0.981 . . . . 0.0 109.855 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.474 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 0.7 OUTLIER -56.85 132.25 51.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.338 -0.851 . . . . 0.0 109.474 -179.853 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.519 ' SG ' ' CZ ' ' A' ' 17' ' ' ARG . 18.9 t -89.02 112.76 52.89 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.224 -0.922 . . . . 0.0 109.398 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 35.9 Cg_endo -77.72 -52.86 0.07 OUTLIER 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.366 2.044 . . . . 0.0 110.822 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.646 ' HB3' ' NH1' ' A' ' 17' ' ' ARG . . . -39.81 -46.77 2.01 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.427 -0.795 . . . . 0.0 110.045 -179.641 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 1.023 HD12 ' CD1' ' A' ' 15' ' ' TRP . 11.6 mt -94.16 -60.63 1.69 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.169 -0.957 . . . . 0.0 109.467 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.443 ' O ' ' O ' ' A' ' 8' ' ' CYS . . . 148.36 -145.4 13.81 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.04 156.48 30.29 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.608 2.205 . . . . 0.0 110.342 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.99 -57.82 4.31 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.299 -1.521 . . . . 0.0 109.299 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 1.023 ' CD1' HD12 ' A' ' 11' ' ' LEU . 4.8 t-105 -65.49 129.27 39.17 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.298 -1.119 . . . . 0.0 109.526 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.47 123.08 46.84 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.305 -0.872 . . . . 0.0 109.59 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.646 ' NH1' ' HB3' ' A' ' 10' ' ' ALA . 0.2 OUTLIER -93.48 106.03 18.04 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.273 -0.892 . . . . 0.0 109.365 179.881 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.591 ' HB2' ' CE3' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -100.35 142.68 31.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.239 -0.913 . . . . 0.0 109.524 -179.891 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.525 ' N ' ' HG2' ' A' ' 18' ' ' ARG . 6.1 pt-20 -99.95 159.09 15.35 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.292 -0.88 . . . . 0.0 109.825 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.511 ' HB ' ' CB ' ' A' ' 32' ' ' ASP . 98.9 t . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.325 -0.86 . . . . 0.0 109.038 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.511 ' CB ' ' HB ' ' A' ' 20' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.28 0.562 . . . . 0.0 109.495 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -134.81 116.0 14.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.239 -0.913 . . . . 0.0 109.585 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.503 ' CE1' ' HD3' ' A' ' 44' ' ' ARG . 20.8 m-30 -116.22 140.06 49.71 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.245 -0.91 . . . . 0.0 109.247 179.699 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.551 ' CE2' ' CE1' ' A' ' 64' ' ' PHE . 4.3 m-85 -112.02 147.05 36.8 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.199 -0.938 . . . . 0.0 109.636 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.454 ' HA ' ' O ' ' A' ' 41' ' ' ASP . 26.1 tt0 -131.24 128.17 39.34 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.334 -0.854 . . . . 0.0 109.342 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.508 ' HB3' ' HD2' ' A' ' 38' ' ' PRO . 0.9 OUTLIER -69.72 173.9 3.64 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.249 -0.907 . . . . 0.0 109.304 179.999 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.508 ' HD2' ' HB3' ' A' ' 37' ' ' SER . 36.3 Cg_endo -78.12 -3.79 13.76 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.597 2.198 . . . . 0.0 110.602 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.477 HG22 ' HB2' ' A' ' 37' ' ' SER . 10.7 t -101.42 -9.78 20.8 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.2 -0.938 . . . . 0.0 109.594 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 111.46 9.68 21.06 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.494 ' HB2' ' OG ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -78.76 141.56 37.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.186 -1.185 . . . . 0.0 109.424 179.889 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.467 ' O ' ' HG2' ' A' ' 42' ' ' ARG . 0.1 OUTLIER -128.37 120.41 26.92 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.154 -0.966 . . . . 0.0 109.703 -179.753 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.642 HG21 ' HB3' ' A' ' 49' ' ' LEU . 2.4 mp -126.73 162.23 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.19 -0.944 . . . . 0.0 109.328 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.576 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 29.3 mtt85 -147.35 20.07 1.21 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.217 -0.927 . . . . 0.0 109.756 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.585 ' H ' HG22 ' A' ' 43' ' ' ILE . 0.5 OUTLIER -95.06 -86.78 0.29 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.386 -0.821 . . . . 0.0 108.821 179.433 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.549 ' HB2' ' CD1' ' A' ' 64' ' ' PHE . 24.2 ttmt 159.72 -64.96 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 43.7 t -87.25 -19.58 7.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.501 ' HB2' ' HB2' ' A' ' 45' ' ' SER . 16.2 mt-10 -69.89 -41.44 74.73 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.642 ' HB3' HG21 ' A' ' 43' ' ' ILE . 3.0 pp -72.39 -33.09 66.94 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.714 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.86 ' HA ' HD12 ' A' ' 53' ' ' LEU . 1.4 m -63.91 -48.62 75.87 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.402 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.22 -28.13 57.28 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.487 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 41.6 t80 -72.58 -56.98 4.51 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.624 -0.672 . . . . 0.0 109.353 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.915 HD21 ' CE3' ' A' ' 15' ' ' TRP . 0.5 OUTLIER -55.03 -57.09 13.13 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.098 -1.001 . . . . 0.0 109.139 179.681 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 134.28 -157.98 23.16 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.1 3.17 7.29 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.559 2.173 . . . . 0.0 110.343 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -84.87 -27.27 26.81 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.228 -0.92 . . . . 0.0 109.465 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.525 ' O ' ' CG2' ' A' ' 50' ' ' THR . 54.3 m -122.33 138.48 54.5 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.303 -0.873 . . . . 0.0 109.245 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.553 ' HA ' HG21 ' A' ' 50' ' ' THR . 29.0 t70 -127.05 142.83 51.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.165 -0.96 . . . . 0.0 109.511 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.747 HD23 ' CD2' ' A' ' 62' ' ' PHE . 3.6 mp -141.3 8.89 2.04 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.191 -0.943 . . . . 0.0 109.803 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.443 ' C ' HD22 ' A' ' 61' ' ' LEU . 4.0 m -47.43 -42.78 23.02 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.113 -0.992 . . . . 0.0 109.282 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.58 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 1.7 mm? -99.66 -3.08 33.87 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.333 -0.854 . . . . 0.0 109.56 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.747 ' CD2' HD23 ' A' ' 59' ' ' LEU . 83.3 t80 -61.51 139.37 58.25 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.354 -0.841 . . . . 0.0 109.744 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.434 ' O ' ' N ' ' A' ' 65' ' ' LYS . 3.4 m-20 -92.24 104.65 16.99 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.443 -0.786 . . . . 0.0 108.967 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.576 ' CE2' ' O ' ' A' ' 44' ' ' ARG . 0.8 OUTLIER -68.51 65.11 0.11 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.239 -0.913 . . . . 0.0 109.479 -179.526 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 63' ' ' ASP . 1.7 ttpt -178.41 -33.36 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.17 -0.956 . . . . 0.0 109.625 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -107.23 -32.85 7.62 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.264 -0.898 . . . . 0.0 109.704 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.571 ' HA2' ' CZ ' ' A' ' 62' ' ' PHE . . . 97.92 38.63 4.06 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.479 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 1.9 pp -139.88 165.84 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.246 -1.15 . . . . 0.0 109.581 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.513 ' CB ' ' HA ' ' A' ' 62' ' ' PHE . 0.5 OUTLIER -153.79 -176.04 5.65 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.276 -0.89 . . . . 0.0 109.589 179.946 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.474 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.361 -0.837 . . . . 0.0 109.355 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.544 ' CE3' ' HB2' ' A' ' 18' ' ' ARG . 76.7 m95 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.351 0.596 . . . . 0.0 109.45 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.2 mt -107.18 161.32 14.88 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.148 -0.97 . . . . 0.0 109.739 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -53.91 149.28 9.15 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.394 -0.816 . . . . 0.0 109.519 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.467 ' HB3' ' HB3' ' A' ' 15' ' ' TRP . 50.2 t -111.18 103.42 54.89 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.369 -0.832 . . . . 0.0 109.331 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -77.03 -23.85 10.23 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.354 2.036 . . . . 0.0 110.31 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.436 ' C ' HD23 ' A' ' 11' ' ' LEU . . . -52.65 -48.66 66.28 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.189 -0.944 . . . . 0.0 109.173 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.715 HD12 ' CD1' ' A' ' 15' ' ' TRP . 0.7 OUTLIER -96.64 -59.86 1.72 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.375 -0.828 . . . . 0.0 109.245 179.882 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 158.82 -153.69 24.81 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.35 154.41 28.17 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.614 2.209 . . . . 0.0 110.596 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.18 -12.32 68.24 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 0.715 ' CD1' HD12 ' A' ' 11' ' ' LEU . 16.5 t-105 -111.7 126.21 54.8 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.175 -1.191 . . . . 0.0 109.52 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 18.3 mmtp -101.27 119.58 38.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.282 -0.887 . . . . 0.0 109.581 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.519 ' HG3' ' CE2' ' A' ' 35' ' ' TYR . 5.8 ttp85 -94.89 114.69 26.57 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.224 -0.922 . . . . 0.0 109.359 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.544 ' HB2' ' CE3' ' A' ' 5' ' ' TRP . 0.2 OUTLIER -100.29 128.47 46.35 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.351 -0.843 . . . . 0.0 109.321 179.997 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -118.24 134.06 55.35 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.263 -0.898 . . . . 0.0 109.248 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 32' ' ' ASP . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 O-C-N 121.246 -0.909 . . . . 0.0 109.474 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.506 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 46.2 m -128.78 108.94 10.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.087 -1.008 . . . . 0.0 110.042 -179.564 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.535 ' CD1' ' N ' ' A' ' 34' ' ' TYR . 2.7 m-30 -99.66 151.73 20.88 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.333 -0.854 . . . . 0.0 108.922 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.603 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 3.8 m-85 -123.68 148.77 46.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.962 -1.086 . . . . 0.0 109.914 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.521 ' HB2' ' CZ3' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -128.32 119.59 25.39 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.497 -0.752 . . . . 0.0 109.01 179.753 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.417 ' HB3' ' HD2' ' A' ' 38' ' ' PRO . 0.6 OUTLIER -63.99 170.32 3.52 Favored Pre-proline 0 N--CA 1.488 1.437 0 O-C-N 121.317 -0.865 . . . . 0.0 109.374 -179.918 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.417 ' HD2' ' HB3' ' A' ' 37' ' ' SER . 35.1 Cg_endo -78.26 -2.58 12.64 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.619 2.213 . . . . 0.0 110.161 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.8 p -102.75 -23.8 13.78 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.269 -0.895 . . . . 0.0 109.645 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 123.81 9.44 5.76 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.471 ' HB2' ' OH ' ' A' ' 52' ' ' TYR . 0.7 OUTLIER -92.07 112.3 24.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.19 -1.182 . . . . 0.0 109.362 179.951 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.462 ' HB3' ' HG3' ' A' ' 36' ' ' GLN . 0.0 OUTLIER -99.43 122.36 42.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.343 -0.848 . . . . 0.0 109.808 -179.738 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.613 HG22 ' H ' ' A' ' 45' ' ' SER . 2.7 mp -117.68 154.04 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.346 -0.846 . . . . 0.0 109.169 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.583 ' O ' ' CZ ' ' A' ' 64' ' ' PHE . 5.6 ttp180 -123.46 -0.21 8.75 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.001 -1.062 . . . . 0.0 109.956 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.752 ' O ' HD23 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -96.61 154.54 17.22 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.231 -0.918 . . . . 0.0 108.558 179.228 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.551 ' HB2' ' CD1' ' A' ' 64' ' ' PHE . 17.4 ttpt -72.85 -67.36 0.57 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.069 -1.019 . . . . 0.0 110.402 -178.968 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.483 ' O ' ' CG ' ' A' ' 51' ' ' ARG . 53.5 t -72.1 -25.69 24.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 120.862 -1.149 . . . . 0.0 109.956 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.553 ' HB2' ' CB ' ' A' ' 45' ' ' SER . 6.9 tt0 -62.72 -49.03 76.68 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.759 -1.213 . . . . 0.0 108.278 179.021 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.752 HD23 ' O ' ' A' ' 45' ' ' SER . 1.8 pp -70.26 -23.85 62.96 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.636 HG23 ' HB2' ' A' ' 59' ' ' LEU . 33.0 m -65.5 -68.55 0.36 Allowed 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.611 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.485 ' HG3' ' O ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -42.9 -31.56 0.52 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 179.269 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.494 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 51.4 t80 -55.09 -56.88 14.81 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.326 -0.859 . . . . 0.0 108.74 179.169 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.574 HD12 ' HA ' ' A' ' 50' ' ' THR . 0.3 OUTLIER -65.07 -43.14 93.17 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.214 -0.929 . . . . 0.0 109.16 179.379 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 110.26 -152.7 17.28 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.284 -1.527 . . . . 0.0 109.284 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.43 -10.92 15.99 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.545 2.163 . . . . 0.0 110.205 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.1 -32.15 66.73 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.296 -0.878 . . . . 0.0 109.371 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.512 ' HB2' ' CB ' ' A' ' 53' ' ' LEU . 4.0 m -121.86 97.84 5.68 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 0.0 109.251 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -74.99 137.42 41.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.255 -0.903 . . . . 0.0 109.731 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.798 HD23 ' CB ' ' A' ' 62' ' ' PHE . 0.1 OUTLIER -142.21 7.91 1.8 Allowed 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.37 -0.831 . . . . 0.0 109.54 -179.731 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.673 ' C ' HD22 ' A' ' 61' ' ' LEU . 97.9 m -56.69 -28.39 60.73 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.348 -0.845 . . . . 0.0 109.645 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.673 HD22 ' C ' ' A' ' 60' ' ' THR . 2.4 mm? -107.33 -10.47 15.78 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.261 -0.899 . . . . 0.0 109.485 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.798 ' CB ' HD23 ' A' ' 59' ' ' LEU . 38.5 t80 -45.27 128.83 7.9 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.361 -0.837 . . . . 0.0 109.53 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.495 ' O ' ' N ' ' A' ' 65' ' ' LYS . 11.1 m-20 -79.67 100.99 8.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.326 -0.859 . . . . 0.0 109.194 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.583 ' CZ ' ' O ' ' A' ' 44' ' ' ARG . 0.7 OUTLIER -65.55 72.95 0.06 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.374 -0.829 . . . . 0.0 109.333 -179.672 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.495 ' N ' ' O ' ' A' ' 63' ' ' ASP . 0.6 OUTLIER 166.5 -43.6 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.824 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.433 ' HG3' ' HD3' ' A' ' 65' ' ' LYS . 8.5 mt-30 -86.33 -44.67 11.9 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.373 -0.829 . . . . 0.0 109.305 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.408 ' HA2' ' CZ ' ' A' ' 62' ' ' PHE . . . 108.77 25.18 5.78 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.891 -1.283 . . . . 0.0 109.891 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.464 HG13 ' OD2' ' A' ' 63' ' ' ASP . 1.1 pt -140.23 162.58 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.199 -1.177 . . . . 0.0 109.48 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.624 ' H ' HD23 ' A' ' 69' ' ' LEU . 1.7 pt? -133.0 146.38 51.72 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.125 -0.984 . . . . 0.0 109.472 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.418 ' H ' ' HB3' ' A' ' 61' ' ' LEU . 40.7 m . . . . . 0 C--N 1.301 -1.504 0 O-C-N 121.325 -0.859 . . . . 0.0 108.824 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 73.3 m95 . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.245 0.545 . . . . 0.0 109.773 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.417 ' O ' ' C ' ' A' ' 7' ' ' ASP . 0.4 OUTLIER -130.92 147.97 52.63 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.29 -0.881 . . . . 0.0 109.487 179.839 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.484 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 48.4 t0 -44.02 138.07 3.03 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.348 -0.845 . . . . 0.0 109.104 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.462 ' SG ' ' HD3' ' A' ' 17' ' ' ARG . 32.6 t -102.77 105.67 46.02 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.198 -0.939 . . . . 0.0 109.505 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 34.4 Cg_endo -77.33 -27.49 6.46 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.297 1.998 . . . . 0.0 109.991 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.658 ' O ' HD21 ' A' ' 69' ' ' LEU . . . -45.5 -57.95 3.74 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.347 -0.846 . . . . 0.0 109.41 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.651 ' N ' HD23 ' A' ' 11' ' ' LEU . 0.9 OUTLIER -89.34 -58.44 2.53 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.321 -0.862 . . . . 0.0 109.327 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 159.02 -152.88 23.99 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.84 164.1 28.06 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.557 2.172 . . . . 0.0 110.351 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.447 ' O ' ' HD3' ' A' ' 38' ' ' PRO . . . 75.49 8.81 84.36 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 0.918 ' CE3' HD21 ' A' ' 53' ' ' LEU . 9.2 t-105 -130.6 126.08 35.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.171 -1.194 . . . . 0.0 109.46 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 12.5 mmtt -106.4 120.32 41.57 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.225 -0.922 . . . . 0.0 109.579 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.462 ' HD3' ' SG ' ' A' ' 8' ' ' CYS . 1.4 ttp85 -88.38 115.86 26.19 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.474 -0.766 . . . . 0.0 109.325 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.429 ' HD2' ' CG2' ' A' ' 20' ' ' VAL . 3.8 ttm180 -99.53 131.14 45.73 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.173 -0.955 . . . . 0.0 109.371 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.5 ' CG ' ' O ' ' A' ' 19' ' ' GLU . 1.7 pp20? -116.39 117.38 29.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.209 -0.932 . . . . 0.0 109.352 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.429 ' CG2' ' HD2' ' A' ' 18' ' ' ARG . 8.5 t . . . . . 0 C--N 1.303 -1.423 0 O-C-N 121.229 -0.92 . . . . 0.0 109.172 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 42.0 m -127.49 111.51 13.89 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.122 -0.987 . . . . 0.0 109.953 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.477 ' CD1' ' N ' ' A' ' 34' ' ' TYR . 19.8 m-85 -99.76 152.98 19.48 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.295 -0.878 . . . . 0.0 108.806 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.622 ' CE1' ' CE1' ' A' ' 64' ' ' PHE . 7.5 m-85 -124.5 142.74 51.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.983 -1.073 . . . . 0.0 109.934 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -126.63 138.98 53.5 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.375 -0.828 . . . . 0.0 109.402 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.924 ' OG ' HG22 ' A' ' 39' ' ' THR . 0.9 OUTLIER -77.89 172.52 9.59 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.287 -0.883 . . . . 0.0 109.506 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.451 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 35.0 Cg_endo -79.29 13.4 2.04 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.77 2.313 . . . . 0.0 110.98 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.924 HG22 ' OG ' ' A' ' 37' ' ' SER . 14.6 t -123.34 -21.62 5.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.981 -1.074 . . . . 0.0 109.852 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 127.27 8.23 4.59 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.456 ' OD2' ' OH ' ' A' ' 52' ' ' TYR . 6.0 m-20 -88.86 133.3 34.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.083 -1.245 . . . . 0.0 109.324 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.41 ' O ' ' HG2' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -116.37 137.06 52.46 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.263 -0.898 . . . . 0.0 109.432 -179.734 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.747 HD13 ' HA ' ' A' ' 49' ' ' LEU . 4.5 mt -132.7 156.21 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.264 -0.897 . . . . 0.0 109.922 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.592 ' O ' ' CZ ' ' A' ' 64' ' ' PHE . 13.3 ttp180 -123.5 -45.72 2.06 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.581 -0.699 . . . . 0.0 110.067 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.578 ' HB2' ' CB ' ' A' ' 48' ' ' GLU . 0.6 OUTLIER -59.28 122.7 14.54 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.915 -1.115 . . . . 0.0 108.831 -179.965 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.575 ' HA ' ' CE1' ' A' ' 64' ' ' PHE . 4.9 ttpm? -40.34 -83.17 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.543 -0.723 . . . . 0.0 110.724 -179.022 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.499 ' HA ' ' OG1' ' A' ' 50' ' ' THR . 42.7 t -55.64 -30.4 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.205 -0.935 . . . . 0.0 110.641 -178.581 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.578 ' CB ' ' HB2' ' A' ' 45' ' ' SER . 14.2 tt0 -54.8 -45.88 74.4 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.663 -1.273 . . . . 0.0 108.813 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.747 ' HA ' HD13 ' A' ' 43' ' ' ILE . 1.4 pp -69.83 -20.67 63.42 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.038 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.78 ' OG1' HD13 ' A' ' 59' ' ' LEU . 17.0 m -71.95 -67.21 0.55 Allowed 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.646 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.46 ' HG3' ' O ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -44.58 -26.96 0.42 Allowed 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.795 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.456 ' OH ' ' OD2' ' A' ' 41' ' ' ASP . 76.5 t80 -67.75 -64.68 0.81 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.455 -0.778 . . . . 0.0 109.191 179.516 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.918 HD21 ' CE3' ' A' ' 15' ' ' TRP . 1.3 mt -44.5 -57.27 3.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.189 -0.945 . . . . 0.0 109.04 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 141.01 -162.16 26.75 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.95 -16.17 14.45 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.648 2.232 . . . . 0.0 110.218 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.29 -8.19 56.54 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.307 -0.871 . . . . 0.0 109.585 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 39.8 m -124.98 168.17 13.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.242 -0.911 . . . . 0.0 109.553 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.928 ' C ' HD12 ' A' ' 59' ' ' LEU . 9.3 p-10 -165.46 141.95 5.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.273 -0.892 . . . . 0.0 109.44 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.928 HD12 ' C ' ' A' ' 58' ' ' ASP . 6.7 mp -139.43 1.28 1.95 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.097 -1.002 . . . . 0.0 109.955 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.619 ' C ' HD22 ' A' ' 61' ' ' LEU . 67.5 m -47.25 -31.28 3.62 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.044 -1.035 . . . . 0.0 108.876 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.813 HD22 ' N ' ' A' ' 61' ' ' LEU . 2.7 mm? -103.43 -15.95 15.74 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.538 ' CZ ' ' HA2' ' A' ' 67' ' ' GLY . 64.9 t80 -57.61 132.87 54.53 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.551 -0.718 . . . . 0.0 109.702 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.497 ' O ' ' N ' ' A' ' 65' ' ' LYS . 1.1 m-20 -79.71 104.79 10.54 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.331 -0.856 . . . . 0.0 108.915 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.622 ' CE1' ' CE1' ' A' ' 35' ' ' TYR . 0.4 OUTLIER -67.74 63.81 0.08 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.183 -0.948 . . . . 0.0 109.424 -179.584 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.497 ' N ' ' O ' ' A' ' 63' ' ' ASP . 1.4 ttmm 173.61 -32.62 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -94.01 -46.45 7.14 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.374 -0.829 . . . . 0.0 109.012 179.529 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.538 ' HA2' ' CZ ' ' A' ' 62' ' ' PHE . . . 108.45 28.54 4.55 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 1.3 pp -140.74 159.13 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.017 -1.284 . . . . 0.0 109.909 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.695 ' N ' HD23 ' A' ' 69' ' ' LEU . 1.1 pt? -141.54 -176.09 4.61 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.037 -1.04 . . . . 0.0 109.828 179.794 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.592 ' CZ3' ' HB2' ' A' ' 36' ' ' GLN . 65.3 m95 . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.444 HD11 ' OE2' ' A' ' 19' ' ' GLU . 3.0 mt -103.86 176.48 5.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.37 -0.831 . . . . 0.0 109.644 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 7' ' ' ASP . 6.6 p-10 -62.17 137.27 58.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.391 -0.818 . . . . 0.0 109.422 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.528 ' SG ' ' CZ ' ' A' ' 17' ' ' ARG . 13.4 t -95.5 109.99 48.48 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.259 -0.901 . . . . 0.0 109.231 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 36.2 Cg_endo -79.45 -46.7 0.1 OUTLIER 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.446 2.097 . . . . 0.0 110.795 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.646 ' HB3' ' NH1' ' A' ' 17' ' ' ARG . . . -43.21 -44.03 5.02 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.162 -0.962 . . . . 0.0 109.935 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.785 HD12 ' CD1' ' A' ' 15' ' ' TRP . 10.7 mt -97.23 -61.53 1.39 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.203 -0.936 . . . . 0.0 109.777 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 8' ' ' CYS . . . 155.74 -155.02 25.97 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.95 158.63 30.92 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.582 2.188 . . . . 0.0 110.335 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.4 -43.01 3.09 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 0.88 ' CE3' HD21 ' A' ' 53' ' ' LEU . 15.9 t-105 -79.35 130.66 35.65 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.221 -1.164 . . . . 0.0 109.424 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.3 mmtm -97.97 124.04 42.25 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.256 -0.903 . . . . 0.0 109.235 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.646 ' NH1' ' HB3' ' A' ' 10' ' ' ALA . 0.7 OUTLIER -99.63 108.92 21.42 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.256 -0.902 . . . . 0.0 109.318 -179.944 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.426 ' HD2' ' CE2' ' A' ' 5' ' ' TRP . 0.2 OUTLIER -99.85 137.78 37.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.175 -0.953 . . . . 0.0 109.744 -179.779 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.444 ' OE2' HD11 ' A' ' 6' ' ' LEU . 1.5 pt-20 -123.83 152.93 41.74 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.37 -0.831 . . . . 0.0 109.272 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 32' ' ' ASP . 1.9 t . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.22 -0.925 . . . . 0.0 109.467 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.595 ' HB3' ' CZ ' ' A' ' 34' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.412 HG23 ' O ' ' A' ' 18' ' ' ARG . 2.7 m -139.79 123.61 17.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.184 -0.948 . . . . 0.0 109.546 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.595 ' CZ ' ' HB3' ' A' ' 32' ' ' ASP . 0.7 OUTLIER -120.63 163.06 18.61 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.258 -0.901 . . . . 0.0 109.474 179.911 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.813 ' HD2' HD22 ' A' ' 49' ' ' LEU . 8.8 m-85 -130.45 156.99 43.83 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.182 -0.949 . . . . 0.0 109.834 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.592 ' HB2' ' CZ3' ' A' ' 5' ' ' TRP . 12.4 tt0 -139.18 114.33 9.55 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.398 -0.814 . . . . 0.0 109.001 179.472 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.584 ' HB2' HG22 ' A' ' 39' ' ' THR . 0.8 OUTLIER -63.2 163.05 19.53 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.291 -0.88 . . . . 0.0 109.615 -179.686 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.58 3.08 7.15 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.625 2.217 . . . . 0.0 110.241 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.584 HG22 ' HB2' ' A' ' 37' ' ' SER . 2.8 t -103.56 -16.77 15.43 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.334 -0.854 . . . . 0.0 109.233 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.0 14.8 8.96 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.513 ' OD2' ' CE1' ' A' ' 52' ' ' TYR . 0.8 OUTLIER -95.39 115.93 28.1 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.221 -1.164 . . . . 0.0 109.504 179.947 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.428 ' O ' ' HG2' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -99.51 121.35 41.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.184 -0.948 . . . . 0.0 109.541 179.961 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.502 ' CG2' ' HB3' ' A' ' 49' ' ' LEU . 2.7 mp -126.36 156.53 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.337 -0.852 . . . . 0.0 109.207 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.584 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 2.2 ttm180 -133.37 -8.68 2.92 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.088 -1.007 . . . . 0.0 110.773 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.986 ' O ' HD23 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -79.71 -178.27 6.3 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.73 -1.231 . . . . 0.0 108.391 179.296 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.557 ' HA ' ' CE1' ' A' ' 64' ' ' PHE . 29.4 ttpt -102.15 -57.32 2.09 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.988 -1.07 . . . . 0.0 109.845 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 57.4 t -84.57 -14.8 11.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.12 -0.988 . . . . 0.0 109.387 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.574 ' HB2' ' CB ' ' A' ' 45' ' ' SER . 1.9 mt-10 -74.7 -42.21 58.78 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.066 -1.021 . . . . 0.0 108.389 179.083 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.986 HD23 ' O ' ' A' ' 45' ' ' SER . 1.5 pp -70.96 -29.13 65.05 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.023 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.886 ' OG1' HD12 ' A' ' 59' ' ' LEU . 0.4 OUTLIER -71.86 -43.8 64.87 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.301 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.421 ' N ' HG22 ' A' ' 50' ' ' THR . 0.3 OUTLIER -61.24 -21.81 64.22 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.993 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.513 ' CE1' ' OD2' ' A' ' 41' ' ' ASP . 90.2 t80 -75.81 -60.21 2.42 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.558 -0.714 . . . . 0.0 109.448 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.88 HD21 ' CE3' ' A' ' 15' ' ' TRP . 1.0 OUTLIER -56.02 -46.28 78.87 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.155 -0.965 . . . . 0.0 109.254 179.726 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 128.63 -151.34 18.92 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -79.08 -24.31 6.94 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.638 2.225 . . . . 0.0 110.504 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.7 -20.47 66.34 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.269 -0.894 . . . . 0.0 109.854 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 49.3 m -133.52 103.48 5.94 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.179 -0.95 . . . . 0.0 109.687 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.49 150.82 24.25 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.226 -0.921 . . . . 0.0 109.044 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 1.007 HD23 ' CD2' ' A' ' 62' ' ' PHE . 0.6 OUTLIER -134.42 9.11 3.69 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.236 -0.915 . . . . 0.0 109.466 -179.876 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.572 ' C ' HD22 ' A' ' 61' ' ' LEU . 2.5 m -47.76 -46.8 30.51 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.326 -0.858 . . . . 0.0 109.303 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.63 HD22 ' N ' ' A' ' 61' ' ' LEU . 3.5 mm? -99.26 -2.15 37.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.353 -0.842 . . . . 0.0 109.528 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 1.007 ' CD2' HD23 ' A' ' 59' ' ' LEU . 69.2 t80 -60.1 129.04 39.81 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.264 -0.898 . . . . 0.0 109.488 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.503 ' O ' ' N ' ' A' ' 65' ' ' LYS . 3.2 m-20 -79.3 101.05 7.84 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.242 -0.911 . . . . 0.0 108.931 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.584 ' CE2' ' O ' ' A' ' 44' ' ' ARG . 0.9 OUTLIER -67.32 61.21 0.06 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.35 -0.844 . . . . 0.0 109.435 -179.494 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.503 ' N ' ' O ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -174.08 -38.54 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.312 -0.868 . . . . 0.0 109.449 -179.819 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -100.37 -39.87 7.77 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.288 -0.882 . . . . 0.0 109.511 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.437 ' HA2' ' CZ ' ' A' ' 62' ' ' PHE . . . 107.22 35.96 2.6 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.0 pp -140.64 163.73 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.129 -1.218 . . . . 0.0 109.726 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.482 ' HB3' ' HA ' ' A' ' 62' ' ' PHE . 0.7 OUTLIER -145.59 173.66 11.86 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.271 -0.893 . . . . 0.0 109.032 179.76 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.468 ' O ' ' HG ' ' A' ' 61' ' ' LEU . 1.6 p . . . . . 0 N--CA 1.489 1.513 0 O-C-N 121.184 -0.948 . . . . 0.0 109.362 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 67.7 m95 . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.425 ' O ' ' C ' ' A' ' 7' ' ' ASP . 89.9 mt -113.62 145.9 40.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.24 -0.912 . . . . 0.0 109.284 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.484 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 12.5 t0 -43.21 129.07 4.76 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.183 -0.948 . . . . 0.0 109.469 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 15' ' ' TRP . 14.8 t -80.36 113.25 37.64 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.408 -0.808 . . . . 0.0 109.505 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 36.5 Cg_endo -80.14 -53.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.353 2.036 . . . . 0.0 110.461 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.52 ' CB ' ' CE1' ' A' ' 62' ' ' PHE . . . -42.66 -33.4 0.71 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.38 -0.825 . . . . 0.0 109.867 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 1.14 HD12 ' CD1' ' A' ' 15' ' ' TRP . 16.8 mt -105.89 -63.78 1.22 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.189 -0.944 . . . . 0.0 109.299 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 146.8 -151.5 23.77 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.66 155.04 31.18 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.639 2.226 . . . . 0.0 110.26 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.423 ' O ' ' HD3' ' A' ' 38' ' ' PRO . . . 90.57 -33.55 4.54 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 1.14 ' CD1' HD12 ' A' ' 11' ' ' LEU . 13.7 t-105 -94.91 122.85 37.97 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.394 -1.062 . . . . 0.0 108.958 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.6 121.52 39.6 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.142 -0.973 . . . . 0.0 109.172 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.598 ' CG ' ' CE1' ' A' ' 35' ' ' TYR . 0.2 OUTLIER -90.56 104.91 17.44 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.365 -0.834 . . . . 0.0 109.772 -179.774 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.802 ' O ' HG23 ' A' ' 33' ' ' THR . 0.7 OUTLIER -97.55 143.34 28.34 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.397 -0.815 . . . . 0.0 109.028 179.584 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -137.35 141.97 41.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.014 -1.054 . . . . 0.0 109.92 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.2 t . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.348 -0.845 . . . . 0.0 109.24 179.677 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.571 ' HB3' ' CE1' ' A' ' 34' ' ' TYR . 60.9 m-20 . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.802 HG23 ' O ' ' A' ' 18' ' ' ARG . 6.1 m -113.35 138.29 50.27 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.23 -0.919 . . . . 0.0 109.385 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.571 ' CE1' ' HB3' ' A' ' 32' ' ' ASP . 13.1 m-85 -131.13 151.18 51.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.235 -0.916 . . . . 0.0 109.393 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.682 ' CZ ' ' CE1' ' A' ' 64' ' ' PHE . 14.7 m-85 -122.17 133.93 54.73 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.291 -0.881 . . . . 0.0 109.224 179.648 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.444 ' HG3' ' HG3' ' A' ' 42' ' ' ARG . 39.6 tt0 -115.85 124.73 51.39 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.215 -0.928 . . . . 0.0 109.606 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.534 ' CB ' ' HD2' ' A' ' 38' ' ' PRO . 0.1 OUTLIER -75.48 175.66 3.91 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.234 -0.916 . . . . 0.0 109.368 179.888 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.534 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 35.2 Cg_endo -77.63 -4.75 14.89 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.64 2.227 . . . . 0.0 110.55 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.488 HG22 ' HB2' ' A' ' 37' ' ' SER . 8.1 t -101.85 -0.43 34.13 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.212 -0.93 . . . . 0.0 109.536 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 94.99 19.6 30.64 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.457 ' HB2' ' OG ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -84.77 118.02 24.19 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.291 -1.123 . . . . 0.0 109.335 -179.996 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.444 ' HG3' ' HG3' ' A' ' 36' ' ' GLN . 0.0 OUTLIER -105.58 107.08 17.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.362 -0.836 . . . . 0.0 109.535 -179.839 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.529 HG21 ' HB3' ' A' ' 49' ' ' LEU . 1.8 mp -120.5 153.53 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.289 -0.882 . . . . 0.0 109.448 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.586 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 13.6 ptt180 -122.11 -26.16 4.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.135 -0.978 . . . . 0.0 109.466 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.5 ' CB ' ' HB2' ' A' ' 48' ' ' GLU . 0.3 OUTLIER -83.2 139.9 32.87 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.217 -0.927 . . . . 0.0 109.022 179.751 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.582 ' HG3' HG23 ' A' ' 47' ' ' VAL . 9.0 pttt -66.91 -52.01 48.32 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.304 -0.872 . . . . 0.0 110.932 -178.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.582 HG23 ' HG3' ' A' ' 46' ' ' LYS . 48.4 t -74.92 -23.25 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.818 -1.176 . . . . 0.0 109.958 -179.17 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.5 ' HB2' ' CB ' ' A' ' 45' ' ' SER . 28.8 mt-10 -65.28 -50.49 65.55 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.895 -1.128 . . . . 0.0 108.297 179.207 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.655 ' O ' HD12 ' A' ' 53' ' ' LEU . 3.7 pp -72.58 -35.81 68.03 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.289 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.623 ' OG1' HD12 ' A' ' 59' ' ' LEU . 0.5 OUTLIER -59.29 -39.66 83.68 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.025 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.1 mmt180 -69.38 -25.11 64.0 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.038 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.485 ' OH ' HG21 ' A' ' 39' ' ' THR . 5.6 t80 -71.32 -57.66 4.26 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.658 -0.651 . . . . 0.0 109.326 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.998 HD21 ' CZ3' ' A' ' 15' ' ' TRP . 0.2 OUTLIER -65.95 -40.21 91.12 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.094 -1.004 . . . . 0.0 109.248 179.724 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 122.44 -153.86 16.89 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.422 ' O ' ' C ' ' A' ' 56' ' ' ALA . 34.8 Cg_endo -77.57 -36.23 1.3 Allowed 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.534 2.156 . . . . 0.0 110.331 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 55' ' ' PRO . . . -44.86 -39.86 5.73 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.213 -0.93 . . . . 0.0 109.227 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.419 ' O ' ' OG1' ' A' ' 50' ' ' THR . 1.3 m -114.48 84.0 1.98 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.32 -0.862 . . . . 0.0 109.05 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -77.86 163.97 25.58 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.224 -0.922 . . . . 0.0 109.883 -179.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.975 HD23 ' CD2' ' A' ' 62' ' ' PHE . 0.5 OUTLIER -160.01 23.23 0.17 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.444 -0.785 . . . . 0.0 109.27 179.964 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.491 ' C ' HD22 ' A' ' 61' ' ' LEU . 3.6 m -55.35 -48.2 74.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.331 -0.856 . . . . 0.0 109.95 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.535 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 2.2 mm? -103.98 4.07 34.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.28 -0.887 . . . . 0.0 109.95 -179.36 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.975 ' CD2' HD23 ' A' ' 59' ' ' LEU . 54.3 t80 -63.64 136.75 57.73 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.205 -0.934 . . . . 0.0 109.909 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.98 114.95 27.25 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.501 -0.749 . . . . 0.0 108.995 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.711 ' HE1' HG22 ' A' ' 33' ' ' THR . 0.3 OUTLIER -74.58 62.27 1.02 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.222 -0.924 . . . . 0.0 109.797 -179.458 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.443 ' HB3' ' O ' ' A' ' 64' ' ' PHE . 17.5 pttt 178.91 -38.41 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.273 -0.892 . . . . 0.0 109.178 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.402 ' N ' ' CG ' ' A' ' 65' ' ' LYS . 1.3 mt-30 -94.23 -18.46 21.67 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.285 -0.884 . . . . 0.0 108.991 179.407 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.58 ' CA ' ' CZ ' ' A' ' 17' ' ' ARG . . . 73.32 43.08 39.83 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 1.4 pp -140.48 -167.47 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.152 -1.205 . . . . 0.0 109.511 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.578 ' HB3' ' HA ' ' A' ' 62' ' ' PHE . 0.6 OUTLIER 179.95 178.47 0.59 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.799 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.494 0 O-C-N 121.007 -1.058 . . . . 0.0 109.909 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.602 ' CE3' ' HB2' ' A' ' 18' ' ' ARG . 48.4 m95 . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 28.6 mt -103.0 152.52 21.23 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.153 -0.967 . . . . 0.0 109.484 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.471 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 37.1 m-20 -47.43 129.57 13.19 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.211 -0.931 . . . . 0.0 109.133 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.531 ' CB ' ' HB2' ' A' ' 17' ' ' ARG . 54.1 t -79.9 114.05 43.06 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.302 -0.874 . . . . 0.0 109.653 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 36.4 Cg_endo -78.64 -46.1 0.12 Allowed 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.292 1.995 . . . . 0.0 110.195 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.657 ' O ' HD23 ' A' ' 11' ' ' LEU . . . -46.57 -29.83 1.99 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.307 -0.871 . . . . 0.0 109.644 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.934 HD12 ' CD1' ' A' ' 15' ' ' TRP . 10.2 mt -115.54 -61.76 1.69 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.082 -1.011 . . . . 0.0 110.004 -179.772 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.47 ' O ' ' O ' ' A' ' 8' ' ' CYS . . . 158.79 -152.14 23.19 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.52 ' O ' ' N ' ' A' ' 15' ' ' TRP . 35.1 Cg_endo -77.79 179.32 6.62 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.633 2.222 . . . . 0.0 110.352 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.45 ' O ' ' HD3' ' A' ' 16' ' ' LYS . . . 67.2 -63.95 0.23 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 108.951 -1.66 . . . . 0.0 108.951 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 0.934 ' CD1' HD12 ' A' ' 11' ' ' LEU . 6.2 t-105 -53.09 126.95 22.41 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.385 -1.068 . . . . 0.0 109.089 179.356 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.45 ' HD3' ' O ' ' A' ' 14' ' ' GLY . 0.3 OUTLIER -100.33 114.71 28.42 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.061 -1.024 . . . . 0.0 109.761 -179.579 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 1.008 ' NH2' HG21 ' A' ' 33' ' ' THR . 8.7 ttt-85 -95.93 102.99 14.85 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.361 -0.837 . . . . 0.0 109.174 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.602 ' HB2' ' CE3' ' A' ' 5' ' ' TRP . 8.4 ttt180 -99.94 151.41 21.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.154 -0.966 . . . . 0.0 109.973 -179.619 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -126.16 138.46 53.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.393 -0.817 . . . . 0.0 109.316 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.469 ' O ' ' N ' ' A' ' 32' ' ' ASP . 11.4 t . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.242 -0.912 . . . . 0.0 109.359 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.566 ' HB3' ' CE1' ' A' ' 34' ' ' TYR . 7.8 m-20 . . . . . 0 N--CA 1.488 1.467 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' THR . . . . . 1.008 HG21 ' NH2' ' A' ' 17' ' ' ARG . 18.5 m -101.87 137.02 40.71 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.138 -0.976 . . . . 0.0 110.061 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.566 ' CE1' ' HB3' ' A' ' 32' ' ' ASP . 46.5 m-85 -129.13 148.49 51.07 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.784 ' HD2' HD22 ' A' ' 49' ' ' LEU . 38.6 m-85 -110.81 137.64 48.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.079 -1.013 . . . . 0.0 109.897 -179.577 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.545 ' HB2' ' CZ3' ' A' ' 5' ' ' TRP . 3.4 tt0 -116.38 116.86 28.49 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.273 -0.892 . . . . 0.0 109.257 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.478 ' CB ' ' HD2' ' A' ' 38' ' ' PRO . 0.6 OUTLIER -58.12 173.65 0.38 Allowed Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.303 -0.873 . . . . 0.0 109.309 -179.971 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.478 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 35.7 Cg_endo -78.72 0.67 9.77 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.621 2.214 . . . . 0.0 110.382 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.444 HG22 ' HB3' ' A' ' 37' ' ' SER . 5.5 t -111.88 -22.9 10.86 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.295 -0.878 . . . . 0.0 109.417 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.8 -2.37 5.22 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.433 ' CB ' ' HB2' ' A' ' 37' ' ' SER . 0.2 OUTLIER -65.31 171.09 4.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.188 -1.184 . . . . 0.0 109.427 179.952 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.465 ' HA ' ' O ' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -154.67 108.31 2.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.26 -0.9 . . . . 0.0 109.277 -179.962 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.63 HG21 ' CA ' ' A' ' 49' ' ' LEU . 2.4 mp -107.49 163.36 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.279 -0.888 . . . . 0.0 109.623 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.567 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 7.7 ttp180 -130.59 -32.51 1.71 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.316 -0.865 . . . . 0.0 109.851 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.842 ' O ' HD23 ' A' ' 49' ' ' LEU . 0.6 OUTLIER -68.13 151.75 46.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.056 -1.027 . . . . 0.0 108.877 179.825 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.441 ' HD2' ' O ' ' A' ' 59' ' ' LEU . 7.5 ttpm? -70.59 -68.78 0.4 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.272 -0.893 . . . . 0.0 111.185 -178.642 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.477 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 54.5 t -71.9 -18.6 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.052 -1.03 . . . . 0.0 110.705 -178.53 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.576 ' HB2' ' CB ' ' A' ' 45' ' ' SER . 5.5 mt-10 -72.12 -42.74 65.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.656 -1.278 . . . . 0.0 108.745 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.842 HD23 ' O ' ' A' ' 45' ' ' SER . 1.6 pp -69.42 -25.83 64.31 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 178.523 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.891 ' OG1' HD13 ' A' ' 59' ' ' LEU . 20.6 m -70.44 -62.7 1.29 Allowed 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.696 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.49 ' HG3' ' O ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -51.0 -22.56 2.36 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.477 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.496 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 59.2 t80 -64.03 -56.25 16.36 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.39 -0.819 . . . . 0.0 108.92 179.351 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.756 HD21 ' CE3' ' A' ' 15' ' ' TRP . 0.7 OUTLIER -61.87 -49.27 76.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.197 -0.94 . . . . 0.0 109.221 179.704 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 130.91 -156.03 21.53 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.79 3.42 6.95 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.536 2.157 . . . . 0.0 110.231 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -87.83 -12.89 43.62 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.384 -0.823 . . . . 0.0 109.325 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.46 ' O ' ' CG2' ' A' ' 50' ' ' THR . 52.9 m -139.02 131.68 28.95 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.233 -0.917 . . . . 0.0 109.703 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.84 ' C ' HD12 ' A' ' 59' ' ' LEU . 12.4 t70 -124.27 155.11 39.19 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.274 -0.891 . . . . 0.0 109.472 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.891 HD13 ' OG1' ' A' ' 50' ' ' THR . 5.5 mp -148.49 15.06 0.99 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.191 -0.943 . . . . 0.0 109.61 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.645 ' C ' HD22 ' A' ' 61' ' ' LEU . 12.7 m -46.01 -37.54 6.74 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.22 -0.925 . . . . 0.0 109.484 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.645 HD22 ' C ' ' A' ' 60' ' ' THR . 1.4 mm? -112.72 11.1 19.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.22 -0.925 . . . . 0.0 109.744 -179.41 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.804 ' CD2' HD23 ' A' ' 59' ' ' LEU . 51.5 t80 -69.3 151.05 46.7 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.329 -0.857 . . . . 0.0 110.317 -179.475 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -107.08 106.42 16.91 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.268 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.567 ' CE2' ' O ' ' A' ' 44' ' ' ARG . 0.2 OUTLIER -71.09 60.76 0.27 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.182 -0.949 . . . . 0.0 109.577 -179.224 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 15.5 ttpt -177.28 -35.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.196 -0.94 . . . . 0.0 109.585 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -101.08 -30.83 11.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.216 -0.928 . . . . 0.0 109.529 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.18 39.72 5.65 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.424 ' O ' ' CD1' ' A' ' 62' ' ' PHE . 2.2 pp -140.11 -178.64 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.168 -1.195 . . . . 0.0 109.967 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.524 ' HB3' ' HA ' ' A' ' 62' ' ' PHE . 0.8 OUTLIER -172.17 -175.97 1.54 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.36 -0.838 . . . . 0.0 108.99 -179.954 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.477 ' SG ' HD12 ' A' ' 61' ' ' LEU . 31.9 p . . . . . 0 C--N 1.303 -1.452 0 O-C-N 121.183 -0.948 . . . . 0.0 109.337 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.588 ' CE2' ' HD2' ' A' ' 18' ' ' ARG . 62.5 m95 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.266 0.555 . . . . 0.0 109.584 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.658 HD12 ' O ' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -107.58 150.26 27.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.234 -0.916 . . . . 0.0 109.596 179.984 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.537 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 0.4 OUTLIER -45.88 147.53 0.96 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.3 -0.875 . . . . 0.0 109.352 179.774 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.529 ' HB2' ' HB3' ' A' ' 15' ' ' TRP . 52.3 m -93.8 109.81 43.67 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.329 -0.857 . . . . 0.0 109.77 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.537 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 35.8 Cg_endo -80.02 -29.43 2.66 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.26 1.973 . . . . 0.0 109.561 179.291 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.968 ' HB3' ' NH1' ' A' ' 17' ' ' ARG . . . -69.55 -34.77 74.68 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.376 -0.827 . . . . 0.0 109.357 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.952 HD12 ' CD1' ' A' ' 15' ' ' TRP . 10.4 mt -105.51 -50.27 3.25 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.208 -0.932 . . . . 0.0 109.509 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 139.08 -151.68 21.9 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -77.74 161.66 30.41 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.627 2.218 . . . . 0.0 110.268 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.94 -48.61 4.09 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 1.001 ' CZ2' HD13 ' A' ' 49' ' ' LEU . 11.4 t-105 -76.61 125.78 29.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.26 -1.141 . . . . 0.0 109.195 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.491 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 0.1 OUTLIER -102.21 127.53 49.11 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.386 -0.821 . . . . 0.0 109.448 -179.655 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.968 ' NH1' ' HB3' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -100.58 104.1 15.43 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.423 -0.798 . . . . 0.0 109.899 -179.311 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.588 ' HD2' ' CE2' ' A' ' 5' ' ' TRP . 1.0 OUTLIER -100.74 135.09 42.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.17 -0.956 . . . . 0.0 109.569 179.624 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -115.49 146.51 41.61 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.274 -0.891 . . . . 0.0 109.351 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.49 ' O ' ' N ' ' A' ' 32' ' ' ASP . 2.9 t . . . . . 0 N--CA 1.491 1.614 0 O-C-N 121.175 -0.953 . . . . 0.0 109.876 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.526 ' HB3' ' CZ ' ' A' ' 34' ' ' TYR . 3.6 m-20 . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.545 HG22 ' HE1' ' A' ' 35' ' ' TYR . 1.5 m -100.65 120.26 39.8 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.278 -0.889 . . . . 0.0 109.841 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.554 ' CG ' ' HD3' ' A' ' 44' ' ' ARG . 15.2 m-85 -123.35 152.92 41.01 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.355 -0.84 . . . . 0.0 108.979 179.645 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.692 ' CE2' ' CE1' ' A' ' 64' ' ' PHE . 4.1 m-85 -118.57 145.16 45.59 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.117 -0.989 . . . . 0.0 109.593 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.419 ' HA ' ' O ' ' A' ' 41' ' ' ASP . 3.8 tt0 -132.93 141.71 48.5 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.216 -0.928 . . . . 0.0 109.868 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.534 ' HG ' ' HZ3' ' A' ' 15' ' ' TRP . 0.3 OUTLIER -81.26 173.4 7.75 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.45 -0.781 . . . . 0.0 109.183 179.616 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.463 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 36.0 Cg_endo -78.89 7.2 4.43 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.605 2.203 . . . . 0.0 110.573 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.2 p -110.49 -13.59 14.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.212 -0.93 . . . . 0.0 109.502 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 110.59 24.3 5.64 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.877 ' OD2' HD11 ' A' ' 43' ' ' ILE . 9.5 t70 -97.42 123.23 41.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.279 -1.13 . . . . 0.0 109.393 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.689 ' C ' HD12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -107.26 124.84 50.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.29 -0.881 . . . . 0.0 109.645 -179.912 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.877 HD11 ' OD2' ' A' ' 41' ' ' ASP . 3.1 mp -128.05 150.43 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.255 -0.903 . . . . 0.0 109.447 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.572 ' HA ' ' CZ ' ' A' ' 64' ' ' PHE . 11.9 mtt180 -144.92 9.68 1.31 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.253 -0.904 . . . . 0.0 110.235 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.549 ' CB ' ' HB2' ' A' ' 48' ' ' GLU . 0.3 OUTLIER -98.41 12.66 34.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.033 -1.042 . . . . 0.0 109.355 179.833 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.584 ' HA ' ' CE1' ' A' ' 64' ' ' PHE . 0.0 OUTLIER 63.22 -93.4 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.365 -0.834 . . . . 0.0 110.225 179.374 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.459 ' HA ' ' OG1' ' A' ' 50' ' ' THR . 75.5 t -55.35 -22.45 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.127 -0.983 . . . . 0.0 109.812 -179.161 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.549 ' HB2' ' CB ' ' A' ' 45' ' ' SER . 2.5 mt-10 -63.56 -47.83 79.96 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.038 -1.039 . . . . 0.0 108.766 179.264 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 1.076 HD12 HD11 ' A' ' 53' ' ' LEU . 1.3 pp -67.56 -24.92 65.58 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 179.113 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.526 ' HA ' HD12 ' A' ' 53' ' ' LEU . 4.9 m -66.95 -62.59 1.36 Allowed 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.501 ' HG3' ' O ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -52.4 -21.64 3.84 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.306 -0.957 . . . . 0.0 108.459 179.299 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.418 ' O ' ' C ' ' A' ' 53' ' ' LEU . 2.0 t80 -77.19 -64.51 1.12 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.463 -0.773 . . . . 0.0 108.989 179.303 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 1.076 HD11 HD12 ' A' ' 49' ' ' LEU . 2.2 mt -45.07 -63.64 0.88 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.18 -0.95 . . . . 0.0 109.047 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 143.8 -163.6 27.61 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.97 -7.26 16.32 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.604 2.203 . . . . 0.0 110.116 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -79.36 -11.3 59.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.341 -0.849 . . . . 0.0 109.453 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.409 ' SG ' ' HB3' ' A' ' 11' ' ' LEU . 1.0 OUTLIER -136.74 150.41 48.39 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.245 -0.909 . . . . 0.0 109.456 -179.986 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.924 ' C ' HD12 ' A' ' 59' ' ' LEU . 13.7 p-10 -139.97 156.15 46.79 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.234 -0.916 . . . . 0.0 109.43 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.924 HD12 ' C ' ' A' ' 58' ' ' ASP . 6.0 mp -150.86 15.51 0.75 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.167 -0.958 . . . . 0.0 109.549 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.695 ' C ' HD22 ' A' ' 61' ' ' LEU . 32.1 m -47.32 -41.03 18.45 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.277 -0.889 . . . . 0.0 109.336 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.695 HD22 ' C ' ' A' ' 60' ' ' THR . 2.4 mm? -109.27 -4.62 16.33 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.279 -0.888 . . . . 0.0 109.597 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.577 ' CD2' HD23 ' A' ' 59' ' ' LEU . 33.4 t80 -56.93 136.48 56.0 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.273 -0.892 . . . . 0.0 109.73 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.571 ' O ' ' CE2' ' A' ' 62' ' ' PHE . 11.6 m-20 -85.13 129.23 34.84 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.361 -0.837 . . . . 0.0 109.11 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.692 ' CE1' ' CE2' ' A' ' 35' ' ' TYR . 0.6 OUTLIER -84.39 54.92 3.16 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.133 -0.98 . . . . 0.0 109.489 -179.61 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.449 ' HA ' ' OG1' ' A' ' 33' ' ' THR . 7.3 ttmt -175.91 -42.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.428 -0.795 . . . . 0.0 109.033 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 -83.25 -45.69 13.54 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.36 -0.838 . . . . 0.0 109.105 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.553 ' O ' ' HB2' ' A' ' 10' ' ' ALA . . . 103.32 32.64 4.51 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.477 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 2.2 pp -140.52 162.21 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.108 -1.231 . . . . 0.0 109.692 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.465 ' HB3' ' HA ' ' A' ' 62' ' ' PHE . 1.1 pt? -143.6 164.16 31.19 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.301 -0.875 . . . . 0.0 108.982 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.496 ' O ' ' HG ' ' A' ' 61' ' ' LEU . 7.7 p . . . . . 0 N--CA 1.489 1.509 0 O-C-N 121.12 -0.987 . . . . 0.0 109.577 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.59 ' CZ3' ' HB2' ' A' ' 18' ' ' ARG . 71.2 m95 . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 17' ' ' ARG . 0.2 OUTLIER -110.01 148.74 31.1 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.237 -0.914 . . . . 0.0 109.527 179.921 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.413 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 0.6 OUTLIER -47.43 147.32 1.71 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.203 -0.936 . . . . 0.0 109.49 -179.884 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.532 ' HB2' ' HB3' ' A' ' 15' ' ' TRP . 6.1 m -89.69 114.46 60.69 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.344 -0.848 . . . . 0.0 109.818 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.451 ' HD2' ' HD3' ' A' ' 17' ' ' ARG . 36.0 Cg_endo -79.04 -39.51 0.34 Allowed 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.362 2.041 . . . . 0.0 110.371 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.499 ' HB2' ' O ' ' A' ' 67' ' ' GLY . . . -64.58 -46.26 83.45 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.213 -0.93 . . . . 0.0 109.595 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 1.01 HD12 ' CD1' ' A' ' 15' ' ' TRP . 6.8 mt -90.12 -48.06 7.42 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.117 -0.989 . . . . 0.0 109.776 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 129.81 -153.26 19.93 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -77.41 155.81 32.44 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.732 2.288 . . . . 0.0 110.497 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.71 -26.66 8.0 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.229 -1.549 . . . . 0.0 109.229 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 1.01 ' CD1' HD12 ' A' ' 11' ' ' LEU . 8.7 t-105 -101.74 132.8 47.26 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.345 -1.091 . . . . 0.0 108.9 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.423 ' C ' ' SG ' ' A' ' 8' ' ' CYS . 14.5 mptt -106.39 129.24 54.42 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.191 -0.943 . . . . 0.0 110.078 -179.243 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.601 ' HG3' ' CE2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -105.27 113.25 26.72 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.376 -0.828 . . . . 0.0 109.097 179.611 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.59 ' HB2' ' CZ3' ' A' ' 5' ' ' TRP . 0.1 OUTLIER -100.16 144.44 29.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.365 -0.834 . . . . 0.0 109.588 -179.728 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -130.83 131.06 44.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.341 -0.849 . . . . 0.0 109.197 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.519 ' O ' ' N ' ' A' ' 32' ' ' ASP . 14.5 t . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.205 -0.934 . . . . 0.0 109.514 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.519 ' N ' ' O ' ' A' ' 20' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.6 m -137.82 109.28 6.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.11 -0.994 . . . . 0.0 109.829 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.575 ' CE1' ' HD2' ' A' ' 44' ' ' ARG . 8.8 m-30 -109.11 160.25 16.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.338 -0.851 . . . . 0.0 108.748 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.601 ' CE2' ' HG3' ' A' ' 17' ' ' ARG . 19.6 m-85 -131.76 145.56 51.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.047 -1.033 . . . . 0.0 109.776 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.436 ' HA ' ' O ' ' A' ' 41' ' ' ASP . 0.9 OUTLIER -133.17 130.44 39.15 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.286 -0.884 . . . . 0.0 109.248 179.931 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.427 ' HA ' ' CZ3' ' A' ' 15' ' ' TRP . 0.8 OUTLIER -71.54 170.42 12.04 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.247 -0.908 . . . . 0.0 109.386 -179.951 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.422 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 35.9 Cg_endo -78.27 5.61 5.32 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.592 2.195 . . . . 0.0 110.457 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.3 p -113.09 -23.03 10.24 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.251 -0.905 . . . . 0.0 109.227 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 125.47 23.36 1.72 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.836 -1.305 . . . . 0.0 109.836 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.573 ' OD2' ' CE1' ' A' ' 52' ' ' TYR . 2.8 t70 -87.73 136.16 33.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.153 -1.204 . . . . 0.0 109.07 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.96 100.71 7.74 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.219 -0.925 . . . . 0.0 109.844 -179.573 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.626 HG21 ' CA ' ' A' ' 49' ' ' LEU . 3.3 mt -112.87 154.09 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.404 -0.81 . . . . 0.0 109.146 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.575 ' HD2' ' CE1' ' A' ' 34' ' ' TYR . 8.1 ttp180 -129.02 -2.76 5.15 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.108 -0.995 . . . . 0.0 109.981 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.753 ' O ' HD23 ' A' ' 49' ' ' LEU . 5.8 t -88.57 173.27 8.74 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.23 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.553 ' HA ' ' CE1' ' A' ' 64' ' ' PHE . 5.6 ttpm? -91.98 -60.49 1.84 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.894 -1.129 . . . . 0.0 110.113 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.443 ' O ' ' CG ' ' A' ' 51' ' ' ARG . 77.6 t -81.48 -22.04 10.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.01 -1.057 . . . . 0.0 109.33 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.554 ' HB2' ' CB ' ' A' ' 45' ' ' SER . 1.2 tt0 -66.21 -45.95 78.96 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 178.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.824 HD13 ' CZ2' ' A' ' 15' ' ' TRP . 1.7 pp -69.95 -22.53 63.16 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.606 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.705 ' OG1' HD13 ' A' ' 59' ' ' LEU . 25.5 m -69.09 -69.11 0.35 Allowed 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 178.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.443 ' CG ' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -44.15 -28.45 0.5 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.494 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.573 ' CE1' ' OD2' ' A' ' 41' ' ' ASP . 87.5 t80 -59.23 -60.02 4.52 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.173 -0.954 . . . . 0.0 108.845 179.365 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.871 HD21 ' CE3' ' A' ' 15' ' ' TRP . 1.0 OUTLIER -52.7 -54.8 28.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.305 -0.872 . . . . 0.0 109.265 179.616 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 137.43 -162.74 25.44 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.44 -5.51 15.64 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.559 2.173 . . . . 0.0 110.192 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.19 -26.93 53.37 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.387 -0.82 . . . . 0.0 109.396 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 1.1 m -109.55 -171.61 1.88 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.302 -0.874 . . . . 0.0 109.323 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.886 ' C ' HD12 ' A' ' 59' ' ' LEU . 6.9 t0 -178.81 149.43 0.46 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.909 . . . . 0.0 109.655 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.886 HD12 ' C ' ' A' ' 58' ' ' ASP . 5.5 mp -153.86 14.46 0.47 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.187 -0.945 . . . . 0.0 109.705 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.521 HG22 ' CD2' ' A' ' 61' ' ' LEU . 98.4 m -47.94 -39.88 20.48 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.122 -0.987 . . . . 0.0 109.16 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.574 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 1.3 mm? -104.42 -14.05 15.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.396 -0.815 . . . . 0.0 109.229 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.761 ' CD2' HD23 ' A' ' 59' ' ' LEU . 64.6 t80 -44.96 156.19 0.09 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.441 -0.787 . . . . 0.0 109.811 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.499 ' O ' ' N ' ' A' ' 65' ' ' LYS . 5.1 m-20 -109.34 108.35 18.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.282 -0.887 . . . . 0.0 109.403 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.575 ' CZ ' ' O ' ' A' ' 44' ' ' ARG . 0.9 OUTLIER -67.48 61.72 0.06 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.405 -0.809 . . . . 0.0 109.03 179.964 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.499 ' N ' ' O ' ' A' ' 63' ' ' ASP . 0.7 OUTLIER 173.75 -28.11 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.319 -0.863 . . . . 0.0 109.69 -179.738 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -103.75 -26.45 12.73 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.125 -0.984 . . . . 0.0 110.11 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.502 ' CA ' ' NH2' ' A' ' 17' ' ' ARG . . . 85.53 30.26 24.9 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.686 -1.365 . . . . 0.0 109.686 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.511 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 1.9 pp -140.09 173.2 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.226 -1.161 . . . . 0.0 109.517 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.498 ' HB3' ' HA ' ' A' ' 62' ' ' PHE . 0.8 OUTLIER -150.38 -168.48 3.12 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.393 -0.817 . . . . 0.0 109.416 179.984 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.219 -0.926 . . . . 0.0 109.358 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.584 ' CE3' ' HB2' ' A' ' 18' ' ' ARG . 84.2 m95 . . . . . 0 N--CA 1.489 1.486 0 CA-C-O 121.253 0.549 . . . . 0.0 109.695 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 79.6 mt -112.69 154.05 26.72 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.27 -0.894 . . . . 0.0 109.366 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.495 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 0.4 OUTLIER -49.01 139.52 10.25 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.232 -0.918 . . . . 0.0 108.897 179.704 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.484 ' HG ' ' HE2' ' A' ' 35' ' ' TYR . 44.0 t -91.04 111.94 51.07 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.219 -0.925 . . . . 0.0 109.696 -179.597 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.495 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 36.7 Cg_endo -79.63 -48.68 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.255 1.97 . . . . 0.0 109.975 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.647 ' HB3' ' CE2' ' A' ' 62' ' ' PHE . . . -50.15 -35.44 26.03 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.398 -0.814 . . . . 0.0 109.476 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 1.138 HD12 ' CD1' ' A' ' 15' ' ' TRP . 14.5 mt -98.16 -64.98 0.99 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.262 -0.899 . . . . 0.0 109.555 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 8' ' ' CYS . . . 158.61 -158.88 29.72 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -76.77 159.91 34.63 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.551 2.167 . . . . 0.0 110.402 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.91 -68.15 3.54 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 -179.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 1.138 ' CD1' HD12 ' A' ' 11' ' ' LEU . 26.9 t-105 -49.87 128.64 18.82 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.296 -1.12 . . . . 0.0 108.82 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.3 mmtm -99.33 120.83 40.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.118 -0.989 . . . . 0.0 109.552 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.583 ' CZ ' ' CA ' ' A' ' 67' ' ' GLY . 23.7 ttt-85 -93.4 105.11 17.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.366 -0.834 . . . . 0.0 109.295 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.792 HH11 HG22 ' A' ' 20' ' ' VAL . 1.2 tmm_? -100.23 152.21 20.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.206 -0.934 . . . . 0.0 110.055 -179.572 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -137.98 155.13 49.18 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.471 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.792 HG22 HH11 ' A' ' 18' ' ' ARG . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.642 0 O-C-N 120.983 -1.073 . . . . 0.0 109.735 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.505 HG23 ' O ' ' A' ' 18' ' ' ARG . 93.6 m -137.96 134.37 34.84 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.065 -1.022 . . . . 0.0 109.956 -179.745 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.44 ' CD1' ' O ' ' A' ' 33' ' ' THR . 18.1 m-85 -136.04 153.94 51.2 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.365 -0.834 . . . . 0.0 109.077 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.559 ' CE2' ' HG3' ' A' ' 17' ' ' ARG . 27.5 m-85 -121.02 161.51 21.53 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.996 -1.065 . . . . 0.0 109.752 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.58 ' HB2' ' CZ3' ' A' ' 5' ' ' TRP . 0.1 OUTLIER -128.13 115.29 18.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.289 -0.882 . . . . 0.0 109.287 179.723 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.805 ' HG ' HG22 ' A' ' 39' ' ' THR . 0.8 OUTLIER -53.44 176.41 0.11 Allowed Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.354 -0.841 . . . . 0.0 109.24 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.546 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 35.4 Cg_endo -77.62 -8.88 17.18 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.442 2.095 . . . . 0.0 110.25 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.805 HG22 ' HG ' ' A' ' 37' ' ' SER . 12.9 t -110.17 -16.08 13.85 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.231 -0.918 . . . . 0.0 109.545 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 121.03 20.63 3.33 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.444 ' CB ' ' HB3' ' A' ' 37' ' ' SER . 0.2 OUTLIER -89.73 101.87 14.57 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.197 -1.178 . . . . 0.0 109.249 179.877 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.41 126.26 30.59 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.278 -0.889 . . . . 0.0 108.845 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.701 HG21 ' HB3' ' A' ' 49' ' ' LEU . 0.9 OUTLIER -116.47 162.61 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.148 -0.97 . . . . 0.0 110.348 -179.121 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.588 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 0.0 OUTLIER -131.83 -21.83 2.41 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.546 -0.721 . . . . 0.0 110.094 -179.909 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.477 ' HB2' ' HB2' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -99.9 119.2 37.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.886 -1.134 . . . . 0.0 109.269 179.865 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.567 ' HA ' HD21 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -46.89 -46.69 21.32 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.382 -0.824 . . . . 0.0 110.501 -179.442 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.439 ' HA ' ' HB ' ' A' ' 50' ' ' THR . 73.5 t -74.79 -41.7 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.851 -1.156 . . . . 0.0 109.317 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.488 ' O ' ' HG3' ' A' ' 51' ' ' ARG . 28.4 tt0 -48.53 -49.94 34.03 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.204 -0.935 . . . . 0.0 109.445 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.729 ' O ' HD12 ' A' ' 53' ' ' LEU . 1.1 pp -72.67 -34.92 67.56 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.941 -1.1 . . . . 0.0 108.739 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.766 ' OG1' HD12 ' A' ' 59' ' ' LEU . 0.4 OUTLIER -54.63 -54.66 38.56 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.047 -1.033 . . . . 0.0 108.413 179.124 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.576 ' N ' HG22 ' A' ' 50' ' ' THR . 0.0 OUTLIER -67.97 -16.63 64.14 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.335 -0.853 . . . . 0.0 108.937 179.496 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.495 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 24.7 t80 -71.51 -56.15 6.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.278 -0.889 . . . . 0.0 109.058 179.409 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.97 HD21 ' CE3' ' A' ' 15' ' ' TRP . 0.4 OUTLIER -66.87 -48.84 67.55 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.199 -0.938 . . . . 0.0 108.983 179.523 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 138.64 -153.88 22.81 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.91 -26.9 6.28 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.55 2.167 . . . . 0.0 110.294 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.47 -27.28 65.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.346 -0.846 . . . . 0.0 109.357 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.693 ' CB ' HD13 ' A' ' 53' ' ' LEU . 6.0 m -121.0 104.54 9.88 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.276 -0.89 . . . . 0.0 109.308 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.465 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 0.4 OUTLIER -100.4 158.66 15.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.297 -0.877 . . . . 0.0 109.405 -179.903 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.766 HD12 ' OG1' ' A' ' 50' ' ' THR . 0.7 OUTLIER -151.8 19.68 0.7 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.206 -0.934 . . . . 0.0 109.414 179.932 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.601 ' C ' HD22 ' A' ' 61' ' ' LEU . 28.6 m -49.95 -40.25 43.16 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.312 -0.867 . . . . 0.0 109.724 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.601 HD22 ' C ' ' A' ' 60' ' ' THR . 1.2 mm? -112.09 2.56 16.84 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.267 -0.896 . . . . 0.0 109.887 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.717 ' CG ' HD23 ' A' ' 59' ' ' LEU . 2.4 t80 -52.44 125.27 15.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.193 -0.942 . . . . 0.0 110.037 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.523 ' O ' ' N ' ' A' ' 65' ' ' LYS . 1.4 t0 -84.77 97.84 9.92 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.588 ' CE2' ' O ' ' A' ' 44' ' ' ARG . 0.7 OUTLIER -65.7 68.14 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.344 -0.848 . . . . 0.0 109.14 -179.243 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 63' ' ' ASP . 7.9 mtpt 174.82 -41.49 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.43 -0.794 . . . . 0.0 108.94 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -93.44 -39.65 10.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.358 -0.839 . . . . 0.0 109.092 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.583 ' CA ' ' CZ ' ' A' ' 17' ' ' ARG . . . 99.71 34.08 5.08 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 pp -140.52 151.04 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.053 -1.263 . . . . 0.0 110.059 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.503 ' HB3' ' HA ' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -139.59 160.52 39.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.326 -0.859 . . . . 0.0 109.179 179.305 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 1.7 p . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.15 -0.968 . . . . 0.0 109.602 179.995 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.432 ' CZ3' ' HB2' ' A' ' 36' ' ' GLN . 75.3 m95 . . . . . 0 N--CA 1.488 1.472 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 17' ' ' ARG . 0.7 OUTLIER -115.92 158.63 22.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.236 -0.915 . . . . 0.0 109.52 -179.801 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.408 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 12.5 m-20 -50.71 145.36 6.97 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.198 -0.938 . . . . 0.0 109.453 179.96 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.482 ' HA ' ' HB2' ' A' ' 17' ' ' ARG . 42.3 t -89.45 114.5 60.71 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.224 -0.923 . . . . 0.0 109.664 -179.869 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 35.8 Cg_endo -78.47 -55.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.284 1.99 . . . . 0.0 110.443 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.837 ' HB3' ' CE2' ' A' ' 62' ' ' PHE . . . -48.14 -39.21 19.94 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.315 -0.866 . . . . 0.0 109.937 -179.742 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.899 HD12 ' CD1' ' A' ' 15' ' ' TRP . 11.2 mt -94.18 -60.69 1.68 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.047 -1.033 . . . . 0.0 109.693 -179.996 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 8' ' ' CYS . . . 147.88 -148.76 20.57 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.854 -1.299 . . . . 0.0 109.854 -179.932 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.42 159.29 32.68 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.621 2.214 . . . . 0.0 110.845 -179.652 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.17 -70.27 3.14 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.825 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 0.899 ' CD1' HD12 ' A' ' 11' ' ' LEU . 14.2 t-105 -50.39 126.24 14.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.24 -1.153 . . . . 0.0 109.728 -179.861 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.0 mmtm -98.89 110.56 23.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.208 -0.932 . . . . 0.0 109.227 179.723 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.608 ' HG3' ' CE1' ' A' ' 35' ' ' TYR . 8.6 ttt-85 -89.13 105.02 17.52 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.389 -0.82 . . . . 0.0 109.863 -179.55 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.49 ' HB3' ' O ' ' A' ' 34' ' ' TYR . 11.9 ttt180 -94.94 138.54 32.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.924 . . . . 0.0 109.194 179.638 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -119.92 147.11 45.13 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.279 -0.888 . . . . 0.0 109.465 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.538 HG12 ' O ' ' A' ' 20' ' ' VAL . 84.5 t . . . . . 0 N--CA 1.489 1.511 0 O-C-N 121.292 -0.88 . . . . 0.0 109.131 179.902 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.577 ' HB3' ' CE1' ' A' ' 34' ' ' TYR . 7.5 m-20 . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.537 ' O ' ' CE1' ' A' ' 64' ' ' PHE . 0.0 OUTLIER -137.15 128.01 27.33 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.163 -0.96 . . . . 0.0 109.986 -179.658 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.577 ' CE1' ' HB3' ' A' ' 32' ' ' ASP . 1.1 m-85 -124.8 141.17 52.3 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.388 -0.82 . . . . 0.0 109.008 179.531 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.643 ' HD2' HD22 ' A' ' 49' ' ' LEU . 9.7 m-85 -118.17 143.9 46.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.004 -1.06 . . . . 0.0 109.751 -179.767 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.432 ' HB2' ' CZ3' ' A' ' 5' ' ' TRP . 8.7 tp-100 -117.86 134.43 54.94 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.371 -0.831 . . . . 0.0 109.474 179.931 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.454 ' OG ' ' HB3' ' A' ' 41' ' ' ASP . 0.0 OUTLIER -81.92 171.77 11.21 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.354 -0.841 . . . . 0.0 109.172 179.852 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.435 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 35.6 Cg_endo -78.01 6.13 4.85 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.486 2.124 . . . . 0.0 110.343 179.841 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.9 p -114.31 -9.92 12.75 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.185 -0.947 . . . . 0.0 109.409 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 102.82 17.3 19.29 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.894 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.567 ' OD2' ' CE1' ' A' ' 52' ' ' TYR . 19.5 t0 -96.61 111.0 23.31 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.135 -1.215 . . . . 0.0 109.327 179.805 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.88 121.63 31.43 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.277 -0.889 . . . . 0.0 109.778 -179.715 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.578 HG21 ' CA ' ' A' ' 49' ' ' LEU . 3.9 mt -121.72 150.02 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.344 -0.847 . . . . 0.0 109.202 179.74 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.569 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 1.8 ttp180 -128.51 -6.59 5.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.233 -0.917 . . . . 0.0 109.94 179.758 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.572 ' HB3' ' CB ' ' A' ' 48' ' ' GLU . 12.9 t -90.29 142.66 27.51 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.093 -1.005 . . . . 0.0 108.923 179.598 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.504 ' HG2' ' N ' ' A' ' 47' ' ' VAL . 21.0 ttpt -63.97 -74.79 0.09 Allowed 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.338 -0.851 . . . . 0.0 110.862 -178.692 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.504 ' N ' ' HG2' ' A' ' 46' ' ' LYS . 58.3 t -62.16 -26.81 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.218 -0.926 . . . . 0.0 110.604 -178.431 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.572 ' CB ' ' HB3' ' A' ' 45' ' ' SER . 1.7 tt0 -66.45 -52.14 49.47 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.697 -1.252 . . . . 0.0 109.059 179.861 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.752 HD12 HD11 ' A' ' 53' ' ' LEU . 1.3 pp -63.51 -23.3 67.33 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.331 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.539 ' CG2' ' HB2' ' A' ' 59' ' ' LEU . 25.2 m -67.86 -70.83 0.24 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.235 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.469 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 0.1 OUTLIER -46.95 -24.43 0.61 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.402 -0.811 . . . . 0.0 109.131 179.975 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.567 ' CE1' ' OD2' ' A' ' 41' ' ' ASP . 69.8 t80 -62.96 -55.8 22.66 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.279 -0.888 . . . . 0.0 109.439 179.761 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.752 HD11 HD12 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -65.78 -50.0 66.29 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.178 -0.951 . . . . 0.0 109.344 179.996 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 121.23 -152.79 16.74 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 -179.697 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.9 -9.51 16.85 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.553 2.169 . . . . 0.0 110.462 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.96 -24.86 58.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.299 -0.875 . . . . 0.0 109.3 179.9 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.442 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 54.5 m -127.98 94.77 4.01 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.292 -0.88 . . . . 0.0 109.0 179.741 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.456 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 2.2 m-20 -76.91 157.26 31.47 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.347 -0.846 . . . . 0.0 110.168 -179.343 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.932 HD23 ' CB ' ' A' ' 62' ' ' PHE . 1.2 mp -152.09 39.56 0.6 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.538 -0.726 . . . . 0.0 109.062 -179.709 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.947 ' O ' HD23 ' A' ' 61' ' ' LEU . 0.1 OUTLIER -38.51 -44.72 0.97 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.669 -0.644 . . . . 0.0 110.421 -179.447 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.947 HD23 ' O ' ' A' ' 60' ' ' THR . 10.8 mt -142.35 33.41 1.49 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.096 -1.002 . . . . 0.0 109.759 -179.813 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.932 ' CB ' HD23 ' A' ' 59' ' ' LEU . 10.9 t80 -47.27 117.35 1.71 Allowed 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.283 -0.885 . . . . 0.0 109.617 179.907 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.511 ' O ' ' N ' ' A' ' 65' ' ' LYS . 1.5 m-20 -79.42 102.34 8.67 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.388 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.569 ' CE2' ' O ' ' A' ' 44' ' ' ARG . 0.1 OUTLIER -67.35 62.07 0.06 Allowed 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.292 -0.88 . . . . 0.0 109.568 -178.914 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.511 ' N ' ' O ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER 171.82 -30.48 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.285 -0.884 . . . . 0.0 109.51 179.895 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -99.58 -42.77 6.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.204 -0.935 . . . . 0.0 109.411 179.843 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.469 ' HA2' ' NE ' ' A' ' 17' ' ' ARG . . . 101.78 30.79 5.67 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.733 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.459 HD11 ' OD2' ' A' ' 63' ' ' ASP . 2.4 pp -140.21 178.45 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.246 -1.149 . . . . 0.0 109.573 179.994 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.549 ' HB3' ' HA ' ' A' ' 62' ' ' PHE . 0.8 OUTLIER -164.7 -176.79 4.44 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.334 -0.854 . . . . 0.0 109.427 179.809 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.64 ' HB3' HD12 ' A' ' 61' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.28 -0.888 . . . . 0.0 109.537 179.693 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.579 ' CE3' ' HB2' ' A' ' 18' ' ' ARG . 73.7 m95 . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.425 ' O ' ' C ' ' A' ' 7' ' ' ASP . 0.5 OUTLIER -106.93 147.88 29.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.216 -0.927 . . . . 0.0 109.702 -179.757 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.484 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 12.3 m-20 -43.85 130.04 5.69 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.294 -0.879 . . . . 0.0 109.257 179.819 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.52 ' SG ' ' CZ ' ' A' ' 17' ' ' ARG . 12.2 t -86.56 113.37 52.4 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.294 -0.878 . . . . 0.0 109.583 -179.796 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 36.6 Cg_endo -80.62 -47.97 0.07 OUTLIER 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 122.411 2.074 . . . . 0.0 110.33 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.645 ' HB3' ' NH1' ' A' ' 17' ' ' ARG . . . -41.66 -35.58 0.79 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.327 -0.858 . . . . 0.0 109.85 -179.716 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.863 HD12 ' CD1' ' A' ' 15' ' ' TRP . 14.7 mt -106.1 -65.94 1.03 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.176 -0.952 . . . . 0.0 109.659 -179.873 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 153.5 -150.91 22.7 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.949 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.7 153.55 30.02 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.651 2.234 . . . . 0.0 110.535 -179.9 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.436 ' O ' ' HD3' ' A' ' 38' ' ' PRO . . . 90.18 -24.98 13.49 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.854 -1.299 . . . . 0.0 109.854 179.667 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 0.863 ' CD1' HD12 ' A' ' 11' ' ' LEU . 10.9 t-105 -98.74 133.38 43.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.176 -1.191 . . . . 0.0 109.752 -179.749 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.458 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 26.1 mmtp -105.67 116.87 32.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.246 -0.909 . . . . 0.0 109.546 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.645 ' NH1' ' HB3' ' A' ' 10' ' ' ALA . 0.4 OUTLIER -89.97 103.82 16.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.156 -0.965 . . . . 0.0 109.228 179.869 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.579 ' HB2' ' CE3' ' A' ' 5' ' ' TRP . 2.0 ttm180 -97.12 140.62 31.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.244 -0.91 . . . . 0.0 110.006 -179.537 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 21.8 pt-20 -138.45 132.65 31.65 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.309 -0.869 . . . . 0.0 109.026 179.582 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.531 HG12 ' O ' ' A' ' 20' ' ' VAL . 16.3 t . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.179 -0.951 . . . . 0.0 109.719 -179.681 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.564 ' HB3' ' CZ ' ' A' ' 34' ' ' TYR . 22.3 m-20 . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.339 0.59 . . . . 0.0 109.557 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.494 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 0.0 OUTLIER -127.61 90.92 3.2 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.276 -0.89 . . . . 0.0 109.595 -179.966 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.567 ' CD1' ' HG2' ' A' ' 44' ' ' ARG . 10.4 m-85 -99.68 140.66 33.55 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.309 -0.87 . . . . 0.0 109.086 179.758 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.598 ' HD2' HD22 ' A' ' 49' ' ' LEU . 4.8 m-85 -116.58 158.21 24.06 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.214 -0.929 . . . . 0.0 109.99 -179.324 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -138.88 121.74 16.57 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.477 -0.764 . . . . 0.0 109.229 179.904 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.486 ' HB2' ' HD2' ' A' ' 38' ' ' PRO . 1.1 p -73.68 173.61 6.04 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.331 -0.856 . . . . 0.0 109.253 179.911 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.486 ' HD2' ' HB2' ' A' ' 37' ' ' SER . 36.2 Cg_endo -79.38 9.7 3.31 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.664 2.242 . . . . 0.0 110.662 -179.871 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.4 p -120.24 12.53 11.8 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.097 -1.002 . . . . 0.0 109.83 -179.76 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 85.47 18.92 59.46 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.811 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.504 ' OD2' ' CE2' ' A' ' 52' ' ' TYR . 44.0 t0 -97.21 114.14 25.83 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.205 -1.174 . . . . 0.0 109.339 179.84 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.406 ' C ' HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -108.3 135.94 48.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.189 -0.944 . . . . 0.0 109.814 -179.726 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.62 HD13 ' HB2' ' A' ' 49' ' ' LEU . 2.4 mp -138.28 156.72 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.277 -0.889 . . . . 0.0 109.292 179.81 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.58 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 0.3 OUTLIER -140.69 17.6 2.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.132 -0.98 . . . . 0.0 109.739 -179.994 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.541 ' H ' HG22 ' A' ' 43' ' ' ILE . 0.6 OUTLIER -91.4 -87.21 0.21 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.202 -0.936 . . . . 0.0 108.805 179.445 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.534 ' CB ' ' O ' ' A' ' 45' ' ' SER . 4.9 ttpp 159.4 -60.49 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 179.632 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.41 HG23 ' HE3' ' A' ' 46' ' ' LYS . 26.9 t -87.71 -20.67 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.389 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -69.61 -42.92 73.73 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.802 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.726 ' O ' HD12 ' A' ' 53' ' ' LEU . 2.8 pp -75.99 -32.65 59.55 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.951 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.694 ' OG1' HD12 ' A' ' 59' ' ' LEU . 0.4 OUTLIER -64.01 -42.99 96.96 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 178.687 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.42 ' N ' HG22 ' A' ' 50' ' ' THR . 5.7 mmt85 -66.02 -26.61 67.6 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.18 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.504 ' CE2' ' OD2' ' A' ' 41' ' ' ASP . 28.8 t80 -68.53 -62.66 1.29 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.515 -0.741 . . . . 0.0 109.308 179.87 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.729 HD21 ' CE3' ' A' ' 15' ' ' TRP . 0.7 OUTLIER -53.74 -54.26 40.52 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.193 -0.942 . . . . 0.0 109.222 179.797 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 137.62 -156.33 23.55 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -179.807 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.35 -6.43 15.56 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.581 2.188 . . . . 0.0 110.442 179.915 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -78.44 -23.53 46.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.196 -0.94 . . . . 0.0 109.568 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.459 ' HB2' HD13 ' A' ' 53' ' ' LEU . 91.1 m -129.79 98.08 4.69 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.248 -0.908 . . . . 0.0 109.534 -179.911 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.19 148.05 22.36 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.214 -0.929 . . . . 0.0 109.49 -179.933 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 1.025 HD23 ' CD2' ' A' ' 62' ' ' PHE . 0.4 OUTLIER -138.78 16.94 2.68 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.374 -0.829 . . . . 0.0 109.18 -179.98 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.602 ' C ' HD22 ' A' ' 61' ' ' LEU . 2.8 m -50.1 -50.32 48.69 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.429 -0.794 . . . . 0.0 109.579 -179.968 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.666 HD22 ' N ' ' A' ' 61' ' ' LEU . 3.6 mm? -100.89 11.37 39.72 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.292 -0.88 . . . . 0.0 109.676 -179.704 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 1.025 ' CD2' HD23 ' A' ' 59' ' ' LEU . 70.9 t80 -68.86 129.68 40.62 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.233 -0.917 . . . . 0.0 109.826 -179.754 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.509 ' O ' ' N ' ' A' ' 65' ' ' LYS . 3.0 t0 -82.32 103.43 11.89 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.331 -0.855 . . . . 0.0 108.973 179.555 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.58 ' CE1' ' CE2' ' A' ' 35' ' ' TYR . 0.8 OUTLIER -67.44 67.74 0.09 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.126 -0.984 . . . . 0.0 109.126 -179.616 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.509 ' N ' ' O ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER 171.23 -32.43 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -179.899 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -95.15 -46.32 6.83 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.344 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.538 ' HA2' ' CE1' ' A' ' 62' ' ' PHE . . . 104.48 30.13 5.09 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 179.426 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.478 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 1.1 pp -141.01 162.02 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.898 -1.354 . . . . 0.0 110.106 179.845 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.551 ' N ' HD23 ' A' ' 69' ' ' LEU . 1.5 pt? -151.83 164.78 36.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.327 -0.858 . . . . 0.0 109.364 179.973 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 6.1 p . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.204 -0.935 . . . . 0.0 109.269 179.704 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.586 ' CZ2' ' HD3' ' A' ' 18' ' ' ARG . 93.0 m95 . . . . . 0 N--CA 1.488 1.467 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -99.36 166.39 11.22 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.239 -0.913 . . . . 0.0 109.488 -179.816 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.48 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 0.7 OUTLIER -66.72 145.27 55.73 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.242 -0.911 . . . . 0.0 109.1 179.711 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.507 ' SG ' ' N ' ' A' ' 17' ' ' ARG . 13.8 m -87.57 112.98 52.08 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.277 -0.89 . . . . 0.0 109.74 -179.595 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.48 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 36.3 Cg_endo -79.51 -40.87 0.23 Allowed 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.239 1.96 . . . . 0.0 109.749 179.441 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.904 ' HB3' ' NH1' ' A' ' 17' ' ' ARG . . . -61.4 -53.27 58.79 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.429 -0.794 . . . . 0.0 109.782 -179.951 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 1.031 HD12 ' CD1' ' A' ' 15' ' ' TRP . 6.6 mt -82.46 -47.94 11.65 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.164 -0.96 . . . . 0.0 109.676 -179.751 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 130.02 -148.18 18.39 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -76.71 155.59 35.2 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.624 2.216 . . . . 0.0 110.717 -179.879 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.91 -46.33 3.1 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.963 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 1.031 ' CD1' HD12 ' A' ' 11' ' ' LEU . 5.1 t-105 -80.31 131.14 35.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.259 -1.142 . . . . 0.0 110.074 -179.621 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.423 ' C ' ' SG ' ' A' ' 8' ' ' CYS . 17.5 mmtp -105.65 126.88 52.66 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.3 -0.875 . . . . 0.0 109.365 179.696 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.904 ' NH1' ' HB3' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -99.12 107.47 19.85 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.294 -0.879 . . . . 0.0 109.587 -179.713 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.586 ' HD3' ' CZ2' ' A' ' 5' ' ' TRP . 25.1 ttp180 -100.54 143.72 30.38 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.247 -0.908 . . . . 0.0 109.853 -179.887 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -113.58 149.47 34.45 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.311 -0.868 . . . . 0.0 109.326 179.64 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.821 HG21 ' CE2' ' A' ' 34' ' ' TYR . 13.6 t . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.213 -0.93 . . . . 0.0 109.55 -179.981 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.476 ' HB2' ' CZ ' ' A' ' 34' ' ' TYR . 4.7 m-20 . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.448 HG22 ' CE1' ' A' ' 35' ' ' TYR . 5.6 m -136.98 121.86 18.8 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.153 -0.967 . . . . 0.0 110.105 -179.444 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.821 ' CE2' HG21 ' A' ' 20' ' ' VAL . 1.4 m-85 -123.3 149.22 45.08 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.292 -0.88 . . . . 0.0 108.717 179.168 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.677 ' HD2' HD22 ' A' ' 49' ' ' LEU . 7.2 m-85 -113.91 150.87 33.08 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.933 -1.105 . . . . 0.0 109.809 -179.89 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.46 ' HB2' ' CZ3' ' A' ' 5' ' ' TRP . 2.3 tt0 -129.79 124.88 34.45 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.331 -0.856 . . . . 0.0 109.595 -179.835 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.508 ' HB3' ' HD2' ' A' ' 38' ' ' PRO . 0.9 OUTLIER -71.3 173.15 5.38 Favored Pre-proline 0 N--CA 1.488 1.437 0 O-C-N 121.347 -0.845 . . . . 0.0 109.04 179.785 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.508 ' HD2' ' HB3' ' A' ' 37' ' ' SER . 34.9 Cg_endo -78.34 8.82 3.4 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.55 2.167 . . . . 0.0 110.9 -179.895 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.417 HG22 ' HB2' ' A' ' 37' ' ' SER . 15.3 t -115.55 -24.37 8.35 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.013 -1.054 . . . . 0.0 109.514 179.899 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 122.73 16.09 3.8 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.36 111.24 23.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.158 -1.201 . . . . 0.0 109.674 -179.924 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.69 148.59 22.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.191 -0.943 . . . . 0.0 109.34 179.79 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.562 ' CG2' ' HB3' ' A' ' 49' ' ' LEU . 4.5 mp -140.39 158.27 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.11 -0.994 . . . . 0.0 109.921 -179.825 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.514 ' HA ' ' CZ ' ' A' ' 64' ' ' PHE . 0.9 OUTLIER -137.05 -8.63 1.79 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.249 -0.907 . . . . 0.0 110.737 -179.778 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.543 ' CB ' ' HB2' ' A' ' 48' ' ' GLU . 0.6 OUTLIER -63.48 -86.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.782 -1.199 . . . . 0.0 109.334 179.905 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.502 ' HB2' ' O ' ' A' ' 45' ' ' SER . 42.7 tttm 161.97 -63.99 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 -179.769 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 75.0 t -87.94 -19.98 7.59 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 178.518 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.543 ' HB2' ' CB ' ' A' ' 45' ' ' SER . 2.8 mt-10 -66.83 -43.62 83.29 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.353 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.677 HD22 ' HD2' ' A' ' 35' ' ' TYR . 1.9 pp -70.07 -23.63 63.1 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 178.647 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.861 ' OG1' HD13 ' A' ' 59' ' ' LEU . 30.3 m -70.96 -64.48 0.9 Allowed 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.969 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -49.73 -29.46 7.66 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.361 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.431 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 86.2 t80 -57.82 -60.93 2.95 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.377 -0.827 . . . . 0.0 108.909 179.417 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 1.007 HD21 ' CE3' ' A' ' 15' ' ' TRP . 0.4 OUTLIER -58.17 -51.94 67.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.287 -0.883 . . . . 0.0 109.221 179.576 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 133.19 -154.1 21.05 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.394 -1.483 . . . . 0.0 109.394 -179.914 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.76 -17.93 13.72 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.614 2.209 . . . . 0.0 110.176 179.752 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.57 -24.47 66.35 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.31 -0.869 . . . . 0.0 109.507 179.925 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.485 ' CB ' HD13 ' A' ' 53' ' ' LEU . 1.7 m -117.13 156.15 28.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.242 -0.911 . . . . 0.0 109.517 179.991 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.793 ' C ' HD12 ' A' ' 59' ' ' LEU . 62.0 t0 -149.22 147.95 29.02 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.334 -0.854 . . . . 0.0 109.291 179.937 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.889 HD23 ' CD1' ' A' ' 62' ' ' PHE . 5.7 mp -148.51 17.56 1.03 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.188 -0.945 . . . . 0.0 109.489 -179.64 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.632 ' C ' HD22 ' A' ' 61' ' ' LEU . 3.6 m -42.52 -49.25 5.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.422 -0.799 . . . . 0.0 109.29 -179.876 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.632 HD22 ' C ' ' A' ' 60' ' ' THR . 1.2 mm? -113.09 18.64 17.85 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.395 -0.816 . . . . 0.0 109.455 -179.92 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.889 ' CD1' HD23 ' A' ' 59' ' ' LEU . 9.8 t80 -77.24 133.97 38.72 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.315 -0.866 . . . . 0.0 109.289 179.945 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.569 ' O ' ' CE1' ' A' ' 62' ' ' PHE . 0.9 OUTLIER -84.92 136.08 33.78 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.355 -0.84 . . . . 0.0 109.211 179.792 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.654 ' CE1' ' CE2' ' A' ' 35' ' ' TYR . 0.3 OUTLIER -86.79 43.61 1.1 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.141 -0.974 . . . . 0.0 109.2 179.957 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.429 ' HA ' ' OG1' ' A' ' 33' ' ' THR . 0.0 OUTLIER -165.12 -44.15 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.409 -0.807 . . . . 0.0 109.052 -179.898 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -81.59 -36.1 29.38 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.328 -0.858 . . . . 0.0 109.259 179.73 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.526 ' HA2' ' CE2' ' A' ' 62' ' ' PHE . . . 88.89 35.15 8.45 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.854 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.484 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 1.8 pp -140.04 155.97 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.172 -1.193 . . . . 0.0 109.781 -179.823 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.544 ' N ' HD23 ' A' ' 69' ' ' LEU . 1.3 pt? -143.56 166.92 23.49 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.31 -0.869 . . . . 0.0 109.043 179.667 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.437 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.483 0 O-C-N 121.129 -0.982 . . . . 0.0 109.658 -179.987 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.626 ' CH2' ' NH1' ' A' ' 18' ' ' ARG . 67.4 m95 . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 6' ' ' LEU . 54.2 mt -109.75 153.24 24.61 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.149 -0.97 . . . . 0.0 109.63 -179.809 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.407 ' C ' ' O ' ' A' ' 6' ' ' LEU . 7.5 t70 -45.64 140.39 3.4 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.255 -0.903 . . . . 0.0 109.062 179.77 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.524 ' HG ' ' HE1' ' A' ' 35' ' ' TYR . 44.5 t -102.29 108.79 58.5 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.182 -0.949 . . . . 0.0 109.869 -179.599 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.423 ' HD2' ' CZ ' ' A' ' 17' ' ' ARG . 34.1 Cg_endo -77.01 -32.77 3.06 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.154 1.903 . . . . 0.0 109.767 179.194 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.679 ' O ' HD23 ' A' ' 11' ' ' LEU . . . -50.55 -30.13 12.36 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.302 -0.874 . . . . 0.0 108.954 179.319 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 1.053 HD12 ' CD1' ' A' ' 15' ' ' TRP . 9.6 mt -117.25 -65.54 1.17 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.383 -0.823 . . . . 0.0 109.485 179.848 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.412 ' O ' ' O ' ' A' ' 8' ' ' CYS . . . 168.38 -147.42 11.39 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -179.885 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 13' ' ' PRO . . . . . 0.514 ' O ' ' N ' ' A' ' 15' ' ' TRP . 35.9 Cg_endo -78.08 175.39 11.2 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.681 2.254 . . . . 0.0 110.618 -179.701 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 14' ' ' GLY . . . . . 0.426 ' O ' ' C ' ' A' ' 15' ' ' TRP . . . 65.66 -68.39 0.11 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.97 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 1.053 ' CD1' HD12 ' A' ' 11' ' ' LEU . 4.5 t-105 -43.55 119.62 1.7 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.374 -1.074 . . . . 0.0 109.515 179.9 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.451 ' HD2' ' HB3' ' A' ' 5' ' ' TRP . 1.0 OUTLIER -101.7 114.91 29.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.185 -0.947 . . . . 0.0 109.659 -179.937 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.486 ' HD3' ' OH ' ' A' ' 35' ' ' TYR . 10.4 ttp85 -92.95 111.2 22.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.232 -0.917 . . . . 0.0 109.309 179.771 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.626 ' NH1' ' CH2' ' A' ' 5' ' ' TRP . 41.2 ttp180 -100.38 148.47 24.67 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.185 -0.947 . . . . 0.0 109.488 -179.933 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -102.98 145.15 30.3 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.221 -0.924 . . . . 0.0 109.369 179.924 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.691 HG21 ' CE2' ' A' ' 34' ' ' TYR . 2.9 t . . . . . 0 N--CA 1.489 1.521 0 O-C-N 121.187 -0.946 . . . . 0.0 109.547 -179.918 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.528 ' O ' ' CE1' ' A' ' 64' ' ' PHE . 9.7 m -131.15 144.14 51.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.255 -0.903 . . . . 0.0 109.428 179.972 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.691 ' CE2' HG21 ' A' ' 20' ' ' VAL . 20.0 m-85 -124.75 164.94 18.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.383 -0.823 . . . . 0.0 109.142 179.819 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.893 ' HD2' HD22 ' A' ' 49' ' ' LEU . 10.4 m-85 -121.27 147.99 44.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.058 -1.026 . . . . 0.0 110.483 -179.332 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.606 ' HB2' ' CZ3' ' A' ' 5' ' ' TRP . 0.1 OUTLIER -131.81 114.37 14.63 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.352 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.505 ' CB ' ' HD2' ' A' ' 38' ' ' PRO . 0.9 OUTLIER -72.4 173.79 5.17 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.354 -0.841 . . . . 0.0 109.455 -179.719 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.505 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 35.1 Cg_endo -76.89 -7.05 17.26 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.549 2.166 . . . . 0.0 110.246 179.939 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 p -105.07 -23.19 12.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.373 -0.829 . . . . 0.0 109.243 179.842 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 122.2 27.33 1.69 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -90.36 114.92 27.12 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.255 -1.144 . . . . 0.0 109.531 179.968 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.1 99.82 11.11 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.265 -0.897 . . . . 0.0 109.351 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.554 ' CG2' ' HB3' ' A' ' 49' ' ' LEU . 1.9 mp -114.44 146.95 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.2 -0.937 . . . . 0.0 109.661 -179.995 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.608 ' HA ' ' CZ ' ' A' ' 64' ' ' PHE . 7.5 ptt180 -140.28 3.41 1.95 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.37 -0.831 . . . . 0.0 109.995 179.962 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.529 ' O ' ' CB ' ' A' ' 46' ' ' LYS . 1.9 t -62.16 -82.39 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.049 -1.032 . . . . 0.0 109.292 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.529 ' CB ' ' O ' ' A' ' 45' ' ' SER . 6.6 ttmt 159.71 -61.74 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.502 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 21.5 t -96.19 -18.3 6.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.795 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.501 ' HB2' ' HB3' ' A' ' 45' ' ' SER . 40.2 mt-10 -73.54 -32.05 63.99 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.884 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.893 HD22 ' HD2' ' A' ' 35' ' ' TYR . 1.7 pp -78.81 -29.56 44.9 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.283 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.748 ' OG1' HD12 ' A' ' 59' ' ' LEU . 0.5 OUTLIER -70.16 -50.17 43.13 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.181 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.528 ' N ' ' CG2' ' A' ' 50' ' ' THR . 0.0 OUTLIER -59.62 -29.68 68.17 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.18 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.448 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 36.6 t80 -56.7 -57.15 13.65 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.327 -0.858 . . . . 0.0 108.702 179.252 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.825 HD21 ' CE3' ' A' ' 15' ' ' TRP . 0.5 OUTLIER -62.33 -40.7 97.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.228 -0.92 . . . . 0.0 109.077 179.536 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 127.17 -158.71 21.13 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 -179.689 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.91 -7.16 16.35 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.421 2.081 . . . . 0.0 110.304 179.852 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.79 -12.79 60.48 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.227 -0.921 . . . . 0.0 109.578 -179.985 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.444 ' HB2' HD13 ' A' ' 53' ' ' LEU . 69.6 m -138.77 132.06 30.07 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.263 -0.898 . . . . 0.0 109.514 -179.96 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -119.66 155.68 31.91 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.182 -0.949 . . . . 0.0 109.532 179.873 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.93 HD23 ' CD2' ' A' ' 62' ' ' PHE . 0.5 OUTLIER -148.83 16.78 0.98 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.204 -0.935 . . . . 0.0 109.779 -179.758 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.638 ' C ' HD22 ' A' ' 61' ' ' LEU . 13.1 m -56.0 -37.41 69.08 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.257 -0.902 . . . . 0.0 109.415 -179.973 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.638 HD22 ' C ' ' A' ' 60' ' ' THR . 1.9 mm? -110.37 8.88 23.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.327 -0.858 . . . . 0.0 109.776 -179.653 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.93 ' CD2' HD23 ' A' ' 59' ' ' LEU . 63.7 t80 -71.29 133.54 46.13 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.25 -0.906 . . . . 0.0 110.074 -179.617 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.519 ' O ' ' N ' ' A' ' 65' ' ' LYS . 15.9 t70 -86.98 100.72 12.81 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.248 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.608 ' CZ ' ' HA ' ' A' ' 44' ' ' ARG . 0.1 OUTLIER -66.22 67.87 0.05 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.299 -0.876 . . . . 0.0 109.391 -179.23 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 63' ' ' ASP . 0.3 OUTLIER 176.01 -40.96 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.481 -0.762 . . . . 0.0 108.957 -179.917 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.72 -27.53 18.0 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.318 -0.864 . . . . 0.0 109.195 179.709 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 67' ' ' GLY . . . . . 0.469 ' HA3' ' NH2' ' A' ' 17' ' ' ARG . . . 90.55 33.52 8.5 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.851 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.722 ' C ' HD12 ' A' ' 68' ' ' ILE . 2.3 pp -140.42 174.84 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.086 -1.244 . . . . 0.0 109.76 179.967 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.611 ' N ' HD12 ' A' ' 68' ' ' ILE . 0.6 OUTLIER -155.4 -167.97 2.69 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.373 -0.829 . . . . 0.0 109.277 179.676 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.443 ' SG ' ' O ' ' A' ' 69' ' ' LEU . 7.8 m . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.33 -0.856 . . . . 0.0 109.27 179.67 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 5' ' ' TRP . . . . . 0.633 ' CE3' ' CB ' ' A' ' 18' ' ' ARG . 52.7 m95 . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 57.0 mt -100.51 159.59 15.03 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.327 -0.858 . . . . 0.0 109.585 -179.698 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' ASP . . . . . 0.473 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 0.3 OUTLIER -49.83 132.71 22.37 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.256 -0.902 . . . . 0.0 109.319 179.792 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 8' ' ' CYS . . . . . 0.533 ' CB ' ' HB2' ' A' ' 17' ' ' ARG . 29.3 t -88.26 112.82 52.09 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.26 -0.9 . . . . 0.0 109.718 -179.74 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 36.5 Cg_endo -79.75 -59.41 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.46 2.107 . . . . 0.0 110.75 179.905 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.785 ' HB3' ' NH1' ' A' ' 17' ' ' ARG . . . -38.52 -39.66 0.49 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.59 -0.694 . . . . 0.0 110.424 -179.455 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 1.044 HD12 ' CD1' ' A' ' 15' ' ' TRP . 13.3 mt -95.34 -64.61 1.04 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.054 -1.029 . . . . 0.0 109.711 -179.931 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.404 ' O ' ' O ' ' A' ' 8' ' ' CYS . . . 152.98 -152.05 23.76 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -179.824 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.13 148.51 21.62 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.655 2.237 . . . . 0.0 110.399 -179.878 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.17 -51.82 1.64 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.893 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 1.044 ' CD1' HD12 ' A' ' 11' ' ' LEU . 15.3 t-105 -69.24 126.68 30.53 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.307 -1.114 . . . . 0.0 109.504 -179.991 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -94.87 114.03 25.84 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.249 -0.907 . . . . 0.0 108.947 179.751 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.785 ' NH1' ' HB3' ' A' ' 10' ' ' ALA . 2.9 ttm180 -94.67 96.71 9.58 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.161 -0.962 . . . . 0.0 109.844 -179.534 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.633 ' CB ' ' CE3' ' A' ' 5' ' ' TRP . 9.7 tpt180 -100.7 146.0 27.75 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.198 -0.939 . . . . 0.0 109.526 179.63 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.531 ' HG2' ' NH1' ' A' ' 18' ' ' ARG . 8.6 pt-20 -109.0 164.36 12.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.191 -0.943 . . . . 0.0 109.43 179.871 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.591 HG12 ' O ' ' A' ' 20' ' ' VAL . 96.7 t . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.216 -0.928 . . . . 0.0 109.463 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' ASP . . . . . 0.469 ' HB2' ' HB ' ' A' ' 20' ' ' VAL . 8.5 m-20 . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.579 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 0.0 OUTLIER -103.94 110.1 22.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.165 -0.959 . . . . 0.0 109.637 -179.727 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.55 ' CD1' ' HB3' ' A' ' 44' ' ' ARG . 19.3 m-30 -106.26 143.1 34.87 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.138 -0.976 . . . . 0.0 109.164 179.803 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.573 ' CE1' ' HG3' ' A' ' 17' ' ' ARG . 5.0 m-85 -122.02 156.71 32.92 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.172 -0.955 . . . . 0.0 109.832 -179.507 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.437 ' OE1' ' HD2' ' A' ' 42' ' ' ARG . 44.5 tt0 -130.61 121.45 25.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.385 -0.822 . . . . 0.0 109.166 179.953 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.493 ' HB2' HG22 ' A' ' 39' ' ' THR . 0.5 OUTLIER -76.37 171.56 11.88 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.154 -0.966 . . . . 0.0 109.746 -179.748 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.46 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 36.0 Cg_endo -77.93 -4.58 14.57 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.729 2.286 . . . . 0.0 110.437 179.994 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.903 HG21 ' OH ' ' A' ' 52' ' ' TYR . 12.3 t -100.11 -12.82 19.32 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.225 -0.922 . . . . 0.0 109.343 179.881 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 106.04 18.06 11.96 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.996 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.8 112.23 24.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -1.131 . . . . 0.0 109.354 -179.978 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 42' ' ' ARG . . . . . 0.437 ' HD2' ' OE1' ' A' ' 36' ' ' GLN . 2.2 mtp180 -99.1 121.04 40.47 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.179 -0.95 . . . . 0.0 109.503 -179.943 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.8 HD13 ' HB2' ' A' ' 49' ' ' LEU . 2.2 mp -118.46 168.03 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.251 -0.906 . . . . 0.0 109.472 179.98 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 44' ' ' ARG . . . . . 0.574 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 0.0 OUTLIER -153.74 14.99 0.49 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.338 -0.851 . . . . 0.0 109.845 -179.627 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.558 ' H ' HG22 ' A' ' 43' ' ' ILE . 7.5 t -95.67 -79.31 0.44 Allowed 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.028 -1.045 . . . . 0.0 108.452 179.346 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.576 ' HB2' ' CD1' ' A' ' 64' ' ' PHE . 4.6 ttpm? 153.45 -61.77 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 179.421 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.524 ' O ' ' CG ' ' A' ' 51' ' ' ARG . 50.0 t -82.93 -24.52 8.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 178.63 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.439 ' O ' ' HG3' ' A' ' 51' ' ' ARG . 23.3 tt0 -64.66 -48.21 75.6 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 179.012 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' LEU . . . . . 0.8 ' HB2' HD13 ' A' ' 43' ' ' ILE . 2.3 pp -68.8 -30.81 69.46 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 178.918 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 50' ' ' THR . . . . . 0.67 ' OG1' HD13 ' A' ' 59' ' ' LEU . 24.0 m -61.24 -67.96 0.36 Allowed 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.857 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.524 ' CG ' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -47.19 -31.13 3.39 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.375 -0.828 . . . . 0.0 108.934 179.456 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 52' ' ' TYR . . . . . 0.903 ' OH ' HG21 ' A' ' 39' ' ' THR . 2.1 t80 -64.68 -62.56 1.5 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.287 -0.883 . . . . 0.0 108.95 179.422 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 1.002 HD21 ' CZ3' ' A' ' 15' ' ' TRP . 0.8 OUTLIER -49.82 -51.91 36.29 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.285 -0.884 . . . . 0.0 109.238 179.569 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 124.19 -151.23 17.13 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 -179.592 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.45 -12.74 16.91 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.562 2.174 . . . . 0.0 110.168 179.746 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.18 -3.18 31.5 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.337 -0.852 . . . . 0.0 109.358 179.749 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' CYS . . . . . 0.478 ' CB ' HD13 ' A' ' 53' ' ' LEU . 60.0 m -135.53 -176.2 4.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.196 -0.94 . . . . 0.0 109.5 -179.906 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.817 ' C ' HD12 ' A' ' 59' ' ' LEU . 12.1 t70 179.26 142.31 0.12 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.348 -0.845 . . . . 0.0 108.964 179.876 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.824 HD23 ' CD2' ' A' ' 62' ' ' PHE . 5.1 mp -152.89 16.77 0.58 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.135 -0.978 . . . . 0.0 109.55 -179.483 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.575 ' C ' HD22 ' A' ' 61' ' ' LEU . 58.5 m -44.38 -40.23 5.24 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.377 -0.827 . . . . 0.0 109.412 -179.956 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 61' ' ' LEU . . . . . 0.575 HD22 ' C ' ' A' ' 60' ' ' THR . 1.4 mm? -111.57 -8.54 14.23 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.395 -0.815 . . . . 0.0 109.67 -179.834 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.824 ' CD2' HD23 ' A' ' 59' ' ' LEU . 80.6 t80 -50.53 138.45 17.54 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.227 -0.921 . . . . 0.0 109.835 -179.368 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.525 ' OD1' ' CG ' ' A' ' 65' ' ' LYS . 3.9 t0 -89.44 113.52 24.88 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.447 -0.783 . . . . 0.0 109.158 179.714 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.579 ' CE2' ' O ' ' A' ' 33' ' ' THR . 1.1 t80 -72.06 63.78 0.51 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.126 -0.984 . . . . 0.0 109.728 -179.781 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.525 ' CG ' ' OD1' ' A' ' 63' ' ' ASP . 0.0 OUTLIER 167.82 -36.32 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.394 -0.816 . . . . 0.0 109.079 179.639 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -83.77 -41.57 17.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.142 -0.974 . . . . 0.0 108.948 179.411 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.84 28.0 8.07 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 179.666 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' ILE . . . . . 0.5 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 2.6 pp -140.52 179.47 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.114 -1.227 . . . . 0.0 109.668 179.938 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 69' ' ' LEU . . . . . 0.533 ' HB3' ' HA ' ' A' ' 62' ' ' PHE . 0.6 OUTLIER -160.34 -175.78 5.24 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.409 -0.807 . . . . 0.0 109.111 179.934 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 70' ' ' CYS . . . . . 0.418 ' SG ' HD12 ' A' ' 61' ' ' LEU . 32.1 p . . . . . 0 N--CA 1.489 1.513 0 O-C-N 121.237 -0.914 . . . . 0.0 109.444 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.471 ' O ' ' HB2' ' A' ' 2' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.471 ' HB2' ' O ' ' A' ' 1' ' ' MET . . . 176.54 -175.54 0.12 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.317 -0.864 . . . . 0.0 109.276 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.415 ' HG2' ' HD3' ' A' ' 18' ' ' ARG . 0.5 OUTLIER -127.67 -92.16 0.48 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.229 -0.919 . . . . 0.0 109.587 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.458 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 1.2 t0 -139.32 35.45 2.07 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.173 -0.954 . . . . 0.0 109.585 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.491 ' CE3' ' HB2' ' A' ' 18' ' ' ARG . 69.7 m95 -54.68 94.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.2 -0.938 . . . . 0.0 109.431 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 4' ' ' ASP . 18.1 mt -109.28 160.87 15.78 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.215 -0.928 . . . . 0.0 109.615 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.438 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 0.2 OUTLIER -49.72 130.36 20.93 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.323 -0.861 . . . . 0.0 109.592 -179.885 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.522 ' SG ' ' CZ ' ' A' ' 17' ' ' ARG . 26.9 t -81.61 115.17 55.19 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.276 -0.89 . . . . 0.0 109.4 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.455 ' O ' ' C ' ' A' ' 10' ' ' ALA . 36.2 Cg_endo -78.57 -55.62 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.498 2.132 . . . . 0.0 111.088 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.646 ' HB3' ' NH1' ' A' ' 17' ' ' ARG . . . -39.69 -56.73 1.65 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.36 -0.838 . . . . 0.0 110.098 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.756 HD12 ' CD1' ' A' ' 15' ' ' TRP . 12.0 mt -83.31 -56.94 3.48 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.282 -0.886 . . . . 0.0 109.706 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 140.04 -146.48 17.96 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.57 158.15 32.26 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.62 2.214 . . . . 0.0 110.802 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.15 -38.89 3.14 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.774 -1.331 . . . . 0.0 109.774 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.983 ' CZ3' HD21 ' A' ' 53' ' ' LEU . 17.1 t-105 -89.0 130.0 35.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.268 -1.137 . . . . 0.0 109.585 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.462 ' HG2' ' HB3' ' A' ' 5' ' ' TRP . 0.1 OUTLIER -97.54 127.75 43.75 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.2 -0.937 . . . . 0.0 108.919 179.626 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.646 ' NH1' ' HB3' ' A' ' 10' ' ' ALA . 1.6 ttm180 -107.32 98.84 8.42 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.142 -0.974 . . . . 0.0 109.917 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.491 ' HB2' ' CE3' ' A' ' 5' ' ' TRP . 0.4 OUTLIER -100.24 145.65 27.82 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.316 -0.865 . . . . 0.0 109.201 179.601 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -121.91 158.33 29.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.11 -0.994 . . . . 0.0 109.802 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.463 HG22 HH11 ' A' ' 18' ' ' ARG . 2.3 t -139.9 161.13 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.396 -0.815 . . . . 0.0 109.205 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.402 ' HB2' ' HA ' ' A' ' 31' ' ' SER . 9.8 m-85 48.59 27.95 1.63 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.141 -0.974 . . . . 0.0 109.328 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.41 ' HG2' ' CB ' ' A' ' 31' ' ' SER . 0.0 OUTLIER -103.23 -40.07 6.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.258 -0.901 . . . . 0.0 109.65 -179.821 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.67 -83.92 0.09 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.224 -0.922 . . . . 0.0 109.422 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.2 t -64.54 133.85 53.21 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.238 -0.914 . . . . 0.0 109.459 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 142.21 153.6 5.95 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.92 172.55 0.08 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.314 -1.109 . . . . 0.0 109.463 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 6.2 m -59.96 -14.84 17.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 0.0 109.485 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 37.1 t -119.38 31.59 6.52 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.195 -0.94 . . . . 0.0 109.385 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.86 99.88 0.88 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 -46.66 116.42 1.31 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.24 -1.153 . . . . 0.0 109.361 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.453 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 2.2 p -96.95 122.44 39.94 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.903 . . . . 0.0 109.486 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -79.42 157.14 27.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.21 -0.931 . . . . 0.0 108.652 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.444 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 0.3 OUTLIER -135.26 124.36 24.36 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.983 -1.073 . . . . 0.0 110.254 -179.456 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.561 ' CD1' ' HG2' ' A' ' 44' ' ' ARG . 16.7 m-85 -123.62 143.8 50.01 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 179.268 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.584 ' CE1' ' HG3' ' A' ' 17' ' ' ARG . 9.8 m-85 -116.01 154.42 29.89 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.107 -0.995 . . . . 0.0 110.204 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -122.41 120.41 33.87 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.507 ' HB3' ' HD2' ' A' ' 38' ' ' PRO . 0.7 OUTLIER -68.41 168.35 14.46 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 121.394 -0.816 . . . . 0.0 109.023 179.915 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.507 ' HD2' ' HB3' ' A' ' 37' ' ' SER . 34.7 Cg_endo -78.0 6.12 4.85 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.502 2.134 . . . . 0.0 110.577 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.3 t -116.56 -21.7 9.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.131 -0.981 . . . . 0.0 109.498 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 119.18 15.91 5.42 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.448 ' O ' ' OG ' ' A' ' 37' ' ' SER . 3.5 m-20 -96.81 107.03 19.44 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.248 -1.149 . . . . 0.0 109.297 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.26 132.29 33.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.132 -0.98 . . . . 0.0 109.658 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.729 HG21 ' N ' ' A' ' 49' ' ' LEU . 3.0 mp -130.04 149.93 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.325 -0.859 . . . . 0.0 109.239 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.561 ' HG2' ' CD1' ' A' ' 34' ' ' TYR . 51.5 mtm180 -142.17 9.35 1.88 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.091 -1.006 . . . . 0.0 110.058 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.529 ' HB3' ' CB ' ' A' ' 48' ' ' GLU . 0.5 OUTLIER -97.19 14.08 27.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.039 -1.038 . . . . 0.0 109.393 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.584 ' HA ' ' CE1' ' A' ' 64' ' ' PHE . 5.9 ttpp 62.73 -94.09 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.442 -0.786 . . . . 0.0 109.98 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.44 ' N ' ' HG2' ' A' ' 46' ' ' LYS . 48.6 t -52.87 -31.9 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.904 -1.122 . . . . 0.0 109.485 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.529 ' CB ' ' HB3' ' A' ' 45' ' ' SER . 67.4 tt0 -53.33 -45.54 69.1 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.067 -1.021 . . . . 0.0 108.784 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.832 ' O ' HD12 ' A' ' 53' ' ' LEU . 0.9 OUTLIER -71.88 -28.71 63.7 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.114 -0.991 . . . . 0.0 108.547 179.281 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.658 ' HG1' ' HB2' ' A' ' 59' ' ' LEU . 2.3 m -61.96 -65.28 0.71 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.0 -24.26 16.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.465 -0.772 . . . . 0.0 109.23 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.41 ' O ' ' C ' ' A' ' 53' ' ' LEU . 29.9 t80 -70.55 -68.11 0.45 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.227 -0.92 . . . . 0.0 108.992 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.983 HD21 ' CZ3' ' A' ' 15' ' ' TRP . 1.0 OUTLIER -45.17 -36.03 3.55 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.267 -0.896 . . . . 0.0 109.293 179.661 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 112.69 -157.6 14.84 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.81 6.13 4.77 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.567 2.178 . . . . 0.0 110.532 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -85.31 -21.45 28.95 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.216 -0.928 . . . . 0.0 109.614 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 50.9 m -135.89 164.38 28.08 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.037 -1.039 . . . . 0.0 109.663 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.593 ' HA ' HG23 ' A' ' 50' ' ' THR . 26.3 p30 -152.97 150.73 29.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.243 -0.91 . . . . 0.0 109.433 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 1.158 HD23 ' CD2' ' A' ' 62' ' ' PHE . 2.6 mp -143.71 12.09 1.67 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.242 -0.911 . . . . 0.0 109.593 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.55 ' C ' HD22 ' A' ' 61' ' ' LEU . 3.4 m -46.04 -46.08 16.47 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.174 -0.954 . . . . 0.0 109.401 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.585 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 2.4 mm? -101.58 0.53 36.55 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.272 -0.893 . . . . 0.0 109.512 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 1.158 ' CD2' HD23 ' A' ' 59' ' ' LEU . 65.1 t80 -66.36 137.48 56.92 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.364 -0.835 . . . . 0.0 109.944 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.454 ' O ' ' N ' ' A' ' 65' ' ' LYS . 0.4 OUTLIER -89.31 111.75 22.66 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.261 -0.899 . . . . 0.0 109.04 179.712 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.584 ' CE1' ' HA ' ' A' ' 46' ' ' LYS . 0.6 OUTLIER -70.26 59.33 0.18 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.207 -0.933 . . . . 0.0 109.11 -179.632 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.454 ' N ' ' O ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -179.52 -40.46 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.378 -0.826 . . . . 0.0 109.093 -179.825 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -90.4 -29.25 18.13 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.293 -0.88 . . . . 0.0 109.356 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.574 ' HA2' ' CE1' ' A' ' 62' ' ' PHE . . . 87.15 33.93 11.37 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.441 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 1.3 pt -140.98 155.39 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.065 -1.256 . . . . 0.0 110.004 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.603 ' N ' HD23 ' A' ' 69' ' ' LEU . 1.9 pt? -143.26 146.24 33.44 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 3.5 m -121.49 156.79 32.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.983 -1.073 . . . . 0.0 109.937 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.571 ' CG ' ' O ' ' A' ' 71' ' ' TYR . 5.0 p90 -146.11 98.84 4.33 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.407 -0.808 . . . . 0.0 109.251 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -76.74 91.12 1.17 Allowed 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.46 2.107 . . . . 0.0 110.367 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 48.22 91.24 0.07 OUTLIER Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.243 -0.911 . . . . 0.0 109.401 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.4 69.88 7.03 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.581 2.187 . . . . 0.0 110.277 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.6 mttt . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 117.978 -1.01 . . . . 0.0 109.527 -179.902 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.436 ' HG2' ' O ' ' A' ' 1' ' ' MET . 17.4 ttt . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.15 0.5 . . . . 0.0 109.671 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -55.75 133.24 50.79 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.247 -0.908 . . . . 0.0 109.278 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.542 ' OE1' HG22 ' A' ' 20' ' ' VAL . 1.0 OUTLIER -97.66 -71.63 0.68 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.224 -0.922 . . . . 0.0 109.554 -179.808 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.579 ' O ' HD23 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -148.06 27.12 0.96 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.183 -0.948 . . . . 0.0 109.479 -179.921 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.595 ' CZ2' ' HD3' ' A' ' 18' ' ' ARG . 66.6 m95 -49.54 92.24 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.309 -0.869 . . . . 0.0 109.338 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.579 HD23 ' O ' ' A' ' 4' ' ' ASP . 0.6 OUTLIER -101.54 159.16 15.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.279 -0.888 . . . . 0.0 109.538 -179.82 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.484 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 12.3 t70 -48.85 132.55 18.21 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.282 -0.886 . . . . 0.0 109.213 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.457 ' HB3' ' HB3' ' A' ' 15' ' ' TRP . 23.5 t -96.42 109.33 47.19 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.24 -0.912 . . . . 0.0 109.337 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 36.1 Cg_endo -78.43 -32.96 2.02 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.297 1.998 . . . . 0.0 110.552 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.417 ' CB ' ' CE1' ' A' ' 62' ' ' PHE . . . -49.1 -56.99 7.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.272 -0.892 . . . . 0.0 109.506 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.921 HD12 ' CD1' ' A' ' 15' ' ' TRP . 4.7 mt -87.28 -56.36 3.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.177 -0.952 . . . . 0.0 109.613 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 8' ' ' CYS . . . 155.2 -150.37 21.83 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.19 159.47 33.4 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.681 2.254 . . . . 0.0 110.409 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 83.54 -52.77 4.78 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.921 ' CD1' HD12 ' A' ' 11' ' ' LEU . 4.4 t-105 -64.62 126.15 26.99 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.213 -1.169 . . . . 0.0 109.505 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.512 ' CG ' ' HB3' ' A' ' 5' ' ' TRP . 5.5 tptt -107.28 112.75 25.75 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.135 -0.978 . . . . 0.0 109.316 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.58 ' HG3' ' CE2' ' A' ' 35' ' ' TYR . 1.0 OUTLIER -87.15 116.28 25.12 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.242 -0.911 . . . . 0.0 109.457 -179.964 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.671 ' CZ ' HG21 ' A' ' 20' ' ' VAL . 10.0 ttp180 -95.63 141.04 29.6 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.222 -0.924 . . . . 0.0 109.483 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.495 ' CG ' ' O ' ' A' ' 19' ' ' GLU . 3.4 pt-20 -115.05 119.47 36.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.229 -0.92 . . . . 0.0 109.472 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.671 HG21 ' CZ ' ' A' ' 18' ' ' ARG . 20.5 t -126.36 156.89 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.233 -0.917 . . . . 0.0 109.634 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.49 ' CB ' ' HA ' ' A' ' 31' ' ' SER . 7.5 m-85 56.57 16.36 2.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.337 -0.852 . . . . 0.0 109.61 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.478 ' HA ' ' CB ' ' A' ' 31' ' ' SER . 0.0 OUTLIER -80.99 -20.37 41.98 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.121 -0.987 . . . . 0.0 108.882 179.619 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 25' ' ' GLY . 25.9 mttt -119.79 -76.26 0.58 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.429 -0.795 . . . . 0.0 109.299 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.471 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 13.3 t 63.2 -70.89 0.06 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.436 -0.79 . . . . 0.0 109.67 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . -158.52 -107.18 0.24 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.16 -159.11 0.11 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.284 -1.127 . . . . 0.0 109.109 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -96.96 84.45 3.56 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.096 -1.003 . . . . 0.0 109.288 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 7.7 p -158.18 64.64 0.45 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.348 -0.845 . . . . 0.0 109.572 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -168.5 113.54 0.53 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.421 ' HD3' ' O ' ' A' ' 31' ' ' SER . 0.0 OUTLIER -54.3 -20.42 7.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.199 -1.177 . . . . 0.0 109.591 -179.94 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.49 ' HA ' ' CB ' ' A' ' 21' ' ' PHE . 3.6 p 63.81 123.52 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.28 -0.887 . . . . 0.0 109.664 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -94.84 144.31 25.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.357 -0.84 . . . . 0.0 109.317 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 57.6 m -115.05 121.46 43.16 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.188 -0.945 . . . . 0.0 109.711 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.56 ' CD2' ' HG3' ' A' ' 44' ' ' ARG . 12.5 m-85 -103.8 157.25 17.21 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.258 -0.901 . . . . 0.0 109.179 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.58 ' CE2' ' HG3' ' A' ' 17' ' ' ARG . 11.5 m-85 -129.33 139.66 51.66 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.111 -0.993 . . . . 0.0 109.897 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.562 ' HB2' ' CZ3' ' A' ' 5' ' ' TRP . 22.0 tt0 -124.83 130.16 51.84 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.364 -0.835 . . . . 0.0 109.385 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.533 ' HA ' ' CZ3' ' A' ' 15' ' ' TRP . 0.5 OUTLIER -69.94 175.92 2.07 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.227 -0.92 . . . . 0.0 109.368 179.989 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.514 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 35.0 Cg_endo -78.11 -2.03 12.16 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.6 2.2 . . . . 0.0 110.283 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 p -109.38 -17.24 13.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.327 -0.858 . . . . 0.0 109.29 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 119.75 4.35 11.74 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.427 ' CB ' ' OG ' ' A' ' 37' ' ' SER . 0.1 OUTLIER -77.67 109.0 11.28 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.199 -1.177 . . . . 0.0 109.155 179.87 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.6 mtt180 -97.05 124.36 41.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.336 -0.852 . . . . 0.0 109.889 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.546 HG22 ' N ' ' A' ' 44' ' ' ARG . 3.0 mp -118.56 163.5 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.379 -0.826 . . . . 0.0 109.047 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.587 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 4.5 ttp180 -126.77 -23.82 3.63 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.126 -0.984 . . . . 0.0 110.327 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.842 ' O ' HD23 ' A' ' 49' ' ' LEU . 0.5 OUTLIER -75.24 166.47 23.58 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.76 -1.212 . . . . 0.0 108.615 179.543 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.673 ' HE3' HG23 ' A' ' 47' ' ' VAL . 7.6 ttpt -86.56 -63.77 1.26 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.123 -0.985 . . . . 0.0 110.529 -178.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.673 HG23 ' HE3' ' A' ' 46' ' ' LYS . 89.3 t -76.58 -16.8 14.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.11 -0.994 . . . . 0.0 109.773 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.585 ' HB2' ' CB ' ' A' ' 45' ' ' SER . 14.3 mt-10 -72.57 -46.86 52.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.965 -1.084 . . . . 0.0 108.495 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.86 HD13 ' CZ2' ' A' ' 15' ' ' TRP . 2.9 pp -66.76 -21.64 66.05 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 178.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.923 ' OG1' HD13 ' A' ' 59' ' ' LEU . 27.3 m -73.07 -64.49 0.96 Allowed 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.519 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -49.66 -23.73 1.88 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.224 -0.922 . . . . 0.0 108.611 179.665 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.48 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 63.9 t80 -62.68 -61.5 2.38 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.319 -0.863 . . . . 0.0 108.732 179.323 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.832 HD21 ' CE3' ' A' ' 15' ' ' TRP . 0.9 OUTLIER -53.36 -59.25 4.82 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.294 -0.879 . . . . 0.0 109.227 179.521 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 147.88 -162.55 28.75 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.72 -2.96 13.09 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.566 2.177 . . . . 0.0 110.144 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.87 -28.62 35.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.292 -0.88 . . . . 0.0 109.61 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 5.8 m -115.32 139.52 49.91 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.171 -0.955 . . . . 0.0 109.353 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.819 ' C ' HD12 ' A' ' 59' ' ' LEU . 2.0 p30 -132.76 153.26 51.38 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.078 -1.013 . . . . 0.0 109.905 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.923 HD13 ' OG1' ' A' ' 50' ' ' THR . 6.0 mp -146.35 12.04 1.18 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.412 -0.805 . . . . 0.0 109.223 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.611 ' C ' HD22 ' A' ' 61' ' ' LEU . 97.2 m -50.59 -31.55 16.23 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.237 -0.915 . . . . 0.0 109.093 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.611 HD22 ' C ' ' A' ' 60' ' ' THR . 1.2 mm? -111.11 -9.04 14.38 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.452 -0.78 . . . . 0.0 109.053 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.493 ' CZ ' ' HA2' ' A' ' 67' ' ' GLY . 61.7 t80 -56.08 129.68 40.95 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.412 -0.805 . . . . 0.0 109.168 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.525 ' O ' ' N ' ' A' ' 65' ' ' LYS . 19.2 t0 -79.04 104.01 9.38 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.246 -0.909 . . . . 0.0 109.141 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.587 ' CE2' ' O ' ' A' ' 44' ' ' ARG . 1.1 t80 -66.94 63.0 0.05 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.477 -0.764 . . . . 0.0 109.452 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.525 ' N ' ' O ' ' A' ' 63' ' ' ASP . 37.4 ttpt -179.65 -43.7 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.458 -0.776 . . . . 0.0 109.173 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -88.31 -45.57 9.92 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.314 -0.866 . . . . 0.0 109.315 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.493 ' HA2' ' CZ ' ' A' ' 62' ' ' PHE . . . 110.48 31.86 2.89 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.574 ' C ' HD12 ' A' ' 68' ' ' ILE . 2.8 pp -140.35 166.85 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.208 -1.172 . . . . 0.0 109.431 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.48 ' CB ' ' HA ' ' A' ' 62' ' ' PHE . 0.7 OUTLIER -145.54 177.63 8.72 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.202 -0.936 . . . . 0.0 109.482 -179.869 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.446 ' SG ' ' O ' ' A' ' 69' ' ' LEU . 72.2 m -153.11 -179.33 7.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.366 -0.833 . . . . 0.0 109.292 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.519 ' CD1' ' N ' ' A' ' 71' ' ' TYR . 7.4 m-85 -117.02 154.35 49.74 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.151 -0.968 . . . . 0.0 109.497 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.71 -161.02 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.559 2.173 . . . . 0.0 110.18 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 56.79 78.73 0.36 Allowed Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.203 -0.935 . . . . 0.0 109.428 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.91 -174.11 2.1 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.657 2.238 . . . . 0.0 110.37 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.541 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -54.59 134.58 46.74 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.284 -0.885 . . . . 0.0 109.553 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -92.69 -147.25 0.23 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.289 -0.882 . . . . 0.0 109.411 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -104.45 40.38 1.49 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.157 -0.965 . . . . 0.0 109.664 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.568 ' CE3' ' HB2' ' A' ' 18' ' ' ARG . 73.3 m95 -57.88 104.89 0.22 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.243 -0.911 . . . . 0.0 109.534 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.476 HD23 ' HA ' ' A' ' 6' ' ' LEU . 51.8 mt -114.49 148.97 37.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.214 -0.929 . . . . 0.0 109.358 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.452 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 0.2 OUTLIER -43.63 133.74 4.45 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.297 -0.877 . . . . 0.0 109.424 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.521 ' HB3' ' HB3' ' A' ' 15' ' ' TRP . 39.7 t -88.37 113.38 55.03 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.298 -0.876 . . . . 0.0 109.563 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 34.8 Cg_endo -77.47 -40.02 0.48 Allowed 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 122.287 1.992 . . . . 0.0 110.003 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.673 ' HB3' ' NH1' ' A' ' 17' ' ' ARG . . . -47.04 -42.44 18.48 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.318 -0.864 . . . . 0.0 109.452 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.626 HD12 ' CG ' ' A' ' 15' ' ' TRP . 13.1 mt -101.15 -61.34 1.38 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.322 -0.861 . . . . 0.0 109.491 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 8' ' ' CYS . . . 156.7 -149.06 19.73 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -77.27 153.21 31.37 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.517 2.145 . . . . 0.0 110.327 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.408 ' O ' ' C ' ' A' ' 15' ' ' TRP . . . 93.76 -74.79 1.13 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.799 ' CE3' HD21 ' A' ' 53' ' ' LEU . 22.2 t-105 -44.24 122.6 3.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.275 -1.133 . . . . 0.0 109.304 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.3 mmtt -97.04 108.75 21.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.173 -0.954 . . . . 0.0 109.66 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.673 ' NH1' ' HB3' ' A' ' 10' ' ' ALA . 1.0 OUTLIER -87.1 106.33 17.79 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.199 -0.938 . . . . 0.0 109.389 179.863 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.568 ' HB2' ' CE3' ' A' ' 5' ' ' TRP . 5.1 ttt180 -100.02 147.52 25.52 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.235 -0.915 . . . . 0.0 109.749 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.468 ' HA ' HG23 ' A' ' 33' ' ' THR . 22.0 pt-20 -116.67 155.27 29.11 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.356 -0.84 . . . . 0.0 109.241 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.783 HG21 ' CE1' ' A' ' 34' ' ' TYR . 0.9 OUTLIER -140.28 143.35 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.165 -0.96 . . . . 0.0 109.407 -179.972 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.515 ' O ' ' N ' ' A' ' 23' ' ' LYS . 2.3 p90 -110.91 40.56 2.0 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.273 -0.892 . . . . 0.0 109.469 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.439 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 29.4 mtp180 60.68 -79.8 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.312 -0.867 . . . . 0.0 109.329 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.515 ' N ' ' O ' ' A' ' 21' ' ' PHE . 1.3 mttt -153.57 -169.23 3.23 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.278 -0.889 . . . . 0.0 109.396 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.8 p -80.3 124.48 28.88 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.253 -0.904 . . . . 0.0 109.398 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 123.35 103.14 1.62 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -88.82 137.74 32.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.245 -1.15 . . . . 0.0 109.684 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.05 -46.16 0.78 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.292 -0.88 . . . . 0.0 109.399 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 6.4 m -138.89 47.72 1.92 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.277 -0.89 . . . . 0.0 109.388 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.461 ' O ' ' HB3' ' A' ' 30' ' ' ARG . . . 49.88 -131.77 27.83 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.462 ' HG3' ' N ' ' A' ' 31' ' ' SER . 2.5 tpt85 65.07 153.99 0.07 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.276 -1.132 . . . . 0.0 109.611 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.462 ' N ' ' HG3' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -177.77 133.01 0.16 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.298 -0.876 . . . . 0.0 109.363 -179.991 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.74 157.91 27.03 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.225 -0.922 . . . . 0.0 109.291 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.512 ' CG2' ' O ' ' A' ' 18' ' ' ARG . 2.1 m -139.56 142.9 37.15 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.245 -0.909 . . . . 0.0 109.619 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.783 ' CE1' HG21 ' A' ' 20' ' ' VAL . 6.1 m-85 -135.58 151.86 50.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.337 -0.852 . . . . 0.0 109.243 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.895 ' HD2' HD22 ' A' ' 49' ' ' LEU . 9.8 m-85 -117.61 146.34 43.71 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.207 -0.933 . . . . 0.0 109.735 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.508 ' HB2' ' CZ3' ' A' ' 5' ' ' TRP . 35.7 tt0 -131.27 123.62 28.77 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.373 -0.83 . . . . 0.0 109.259 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.474 ' CB ' ' HD2' ' A' ' 38' ' ' PRO . 0.4 OUTLIER -66.15 173.07 2.41 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.263 -0.898 . . . . 0.0 108.965 179.823 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.474 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 36.1 Cg_endo -78.0 4.13 6.42 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.51 2.14 . . . . 0.0 110.291 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.4 p -111.62 -17.37 13.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.331 -0.855 . . . . 0.0 109.444 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 120.46 5.41 10.29 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.464 ' O ' ' HA ' ' A' ' 36' ' ' GLN . 6.7 t0 -74.9 136.78 41.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.199 -1.177 . . . . 0.0 109.364 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.4 mtp180 -121.07 116.46 25.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.196 -0.94 . . . . 0.0 109.277 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.64 HG21 ' CA ' ' A' ' 49' ' ' LEU . 4.4 mt -123.35 152.93 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.228 -0.92 . . . . 0.0 109.924 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.577 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 4.9 ttt-85 -128.49 -24.04 3.11 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.282 -0.886 . . . . 0.0 109.909 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.681 ' O ' HD23 ' A' ' 49' ' ' LEU . 1.7 m -73.56 147.89 43.5 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.979 -1.076 . . . . 0.0 108.909 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.639 ' HE2' HG23 ' A' ' 47' ' ' VAL . 24.4 ttpt -68.96 -71.84 0.2 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.287 -0.883 . . . . 0.0 110.811 -178.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.639 HG23 ' HE2' ' A' ' 46' ' ' LYS . 62.5 t -67.37 -14.96 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.031 -1.043 . . . . 0.0 110.274 -178.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.554 ' HB2' ' CB ' ' A' ' 45' ' ' SER . 2.4 tt0 -72.45 -51.97 17.9 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.884 -1.135 . . . . 0.0 108.502 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.895 HD22 ' HD2' ' A' ' 35' ' ' TYR . 1.9 pp -63.17 -28.7 70.24 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.021 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.84 ' HA ' HD12 ' A' ' 53' ' ' LEU . 0.2 OUTLIER -68.2 -55.41 12.38 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 178.376 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.429 ' HD3' ' HA ' ' A' ' 51' ' ' ARG . 48.6 mmt-85 -52.0 -24.3 6.39 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.053 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.477 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 44.4 t80 -73.3 -50.76 20.41 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.532 -0.73 . . . . 0.0 109.196 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.84 HD12 ' HA ' ' A' ' 50' ' ' THR . 0.4 OUTLIER -66.57 -53.0 39.33 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -0.909 . . . . 0.0 109.063 179.739 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 121.9 -146.42 17.01 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.62 -34.74 1.28 Allowed 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.512 2.141 . . . . 0.0 110.495 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -45.18 -33.95 2.52 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.302 -0.874 . . . . 0.0 109.837 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 67.2 m -122.07 148.51 44.77 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.165 -0.959 . . . . 0.0 109.767 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -126.82 146.27 50.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.276 -0.89 . . . . 0.0 109.422 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.833 HD23 ' CD2' ' A' ' 62' ' ' PHE . 0.2 OUTLIER -144.99 6.85 1.18 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.277 -0.889 . . . . 0.0 110.332 -179.157 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.581 ' C ' HD22 ' A' ' 61' ' ' LEU . 5.0 m -47.09 -41.88 17.95 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.062 -1.024 . . . . 0.0 109.861 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.581 HD22 ' C ' ' A' ' 60' ' ' THR . 1.4 mm? -110.1 13.2 23.3 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.166 -0.959 . . . . 0.0 110.113 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.833 ' CD2' HD23 ' A' ' 59' ' ' LEU . 51.5 t80 -69.5 136.1 51.01 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.201 -0.937 . . . . 0.0 109.549 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.429 ' O ' ' N ' ' A' ' 65' ' ' LYS . 0.3 OUTLIER -89.81 105.13 17.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.315 -0.866 . . . . 0.0 109.248 179.728 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.649 ' CZ ' ' CE2' ' A' ' 35' ' ' TYR . 0.4 OUTLIER -69.98 61.33 0.19 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.245 -0.909 . . . . 0.0 109.411 -179.594 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 63' ' ' ASP . 5.6 ttpt -174.46 -37.37 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.318 -0.864 . . . . 0.0 109.018 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 33.7 tt0 -97.59 -38.74 9.43 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.419 -0.801 . . . . 0.0 109.111 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 103.67 32.36 4.51 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.695 ' C ' HD12 ' A' ' 68' ' ' ILE . 2.7 pp -139.87 173.38 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.162 -1.199 . . . . 0.0 109.58 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.504 ' CB ' ' HA ' ' A' ' 62' ' ' PHE . 0.6 OUTLIER -149.89 -165.07 2.17 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.243 -0.911 . . . . 0.0 109.385 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.44 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 0.5 OUTLIER -160.36 168.46 25.19 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.334 -0.854 . . . . 0.0 109.344 179.628 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -138.71 77.42 33.28 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.179 -0.95 . . . . 0.0 109.408 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.717 ' O ' ' HB2' ' A' ' 73' ' ' ALA . 35.1 Cg_endo -77.75 -159.67 0.1 Allowed 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.603 2.202 . . . . 0.0 110.187 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.947 ' HB3' ' HD3' ' A' ' 74' ' ' PRO . . . 164.07 -52.97 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.171 -0.956 . . . . 0.0 109.989 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.947 ' HD3' ' HB3' ' A' ' 73' ' ' ALA . 35.8 Cg_endo -77.75 -61.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.435 2.09 . . . . 0.0 110.46 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 118.007 -0.996 . . . . 0.0 109.486 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 tpt . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -54.72 178.1 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.285 -0.884 . . . . 0.0 109.608 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.449 ' O ' ' OD1' ' A' ' 4' ' ' ASP . 82.3 mt-10 -95.6 156.29 16.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.282 -0.886 . . . . 0.0 109.392 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.668 ' O ' HD23 ' A' ' 6' ' ' LEU . 47.2 m-20 -150.63 67.86 0.95 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.182 -0.949 . . . . 0.0 109.647 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.575 ' CE3' ' HB2' ' A' ' 18' ' ' ARG . 84.1 m95 -44.14 102.73 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.234 -0.916 . . . . 0.0 109.416 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.668 HD23 ' O ' ' A' ' 4' ' ' ASP . 0.5 OUTLIER -110.26 154.33 23.58 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.221 -0.924 . . . . 0.0 109.509 -179.947 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.419 ' C ' ' O ' ' A' ' 6' ' ' LEU . 2.0 m-20 -43.9 146.31 0.6 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.291 -0.881 . . . . 0.0 109.471 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.472 ' CB ' ' HB2' ' A' ' 17' ' ' ARG . 45.4 t -111.88 100.75 49.7 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.197 -0.94 . . . . 0.0 109.457 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.504 ' HD2' ' NH2' ' A' ' 17' ' ' ARG . 34.4 Cg_endo -76.6 -33.89 2.85 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.438 2.092 . . . . 0.0 110.569 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.47 ' C ' HD23 ' A' ' 11' ' ' LEU . . . -42.47 -48.43 5.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.308 -0.87 . . . . 0.0 109.609 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.824 HD12 ' CD1' ' A' ' 15' ' ' TRP . 3.1 mt -94.13 -61.99 1.42 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.247 -0.908 . . . . 0.0 109.457 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 8' ' ' CYS . . . 168.69 -158.67 31.45 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.94 145.92 20.11 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.592 2.195 . . . . 0.0 110.452 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.03 -49.83 1.22 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.824 ' CD1' HD12 ' A' ' 11' ' ' LEU . 15.7 t-105 -65.66 129.77 40.93 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.233 -1.157 . . . . 0.0 109.468 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.8 mmtp -100.99 123.02 44.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.172 -0.955 . . . . 0.0 109.394 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.504 ' NH2' ' HD2' ' A' ' 9' ' ' PRO . 7.7 ttp85 -94.19 110.65 22.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.16 -0.962 . . . . 0.0 109.588 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.575 ' HB2' ' CE3' ' A' ' 5' ' ' TRP . 0.5 OUTLIER -99.71 141.77 32.08 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.325 -0.859 . . . . 0.0 109.053 179.653 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.487 ' OE1' HD21 ' A' ' 6' ' ' LEU . 4.5 pt-20 -124.46 141.84 51.77 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.186 -0.947 . . . . 0.0 109.875 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 87.7 t -132.64 146.82 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.24 -0.913 . . . . 0.0 109.349 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -98.59 71.26 1.97 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.286 -0.884 . . . . 0.0 109.592 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.408 ' O ' ' C ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -72.46 81.89 1.07 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.263 -0.898 . . . . 0.0 109.391 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.408 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -45.82 138.75 4.6 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.225 -0.922 . . . . 0.0 109.162 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.1 t -125.24 -47.57 1.75 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.212 -0.93 . . . . 0.0 109.641 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -126.84 -144.99 6.16 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -69.77 -71.45 0.23 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.285 -1.126 . . . . 0.0 109.57 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.404 ' O ' ' C ' ' A' ' 28' ' ' CYS . 21.1 p -135.65 27.56 3.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.215 -0.928 . . . . 0.0 109.596 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.404 ' C ' ' O ' ' A' ' 27' ' ' THR . 35.9 m -46.09 -76.98 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.169 -0.957 . . . . 0.0 109.27 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.85 41.08 0.8 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.75 -69.14 0.4 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.263 -1.14 . . . . 0.0 109.571 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.1 m 65.86 175.01 0.22 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.26 -0.9 . . . . 0.0 109.22 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -136.09 164.36 28.21 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.179 -0.951 . . . . 0.0 109.406 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.469 ' O ' ' CE1' ' A' ' 35' ' ' TYR . 4.5 m -139.34 98.52 3.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.298 -0.876 . . . . 0.0 109.542 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.54 ' CD1' ' HB3' ' A' ' 44' ' ' ARG . 13.0 m-85 -99.95 160.65 14.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.401 -0.812 . . . . 0.0 108.984 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.64 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 1.6 m-85 -131.78 156.46 45.94 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.977 -1.077 . . . . 0.0 109.912 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.559 ' HB2' ' CZ3' ' A' ' 5' ' ' TRP . 11.3 tt0 -129.66 129.97 44.97 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.441 -0.787 . . . . 0.0 109.047 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.46 ' CB ' ' HD2' ' A' ' 38' ' ' PRO . 0.6 OUTLIER -68.68 172.06 5.25 Favored Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 121.269 -0.894 . . . . 0.0 109.257 -179.976 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.46 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 35.1 Cg_endo -77.66 4.56 5.92 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.623 2.215 . . . . 0.0 110.408 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.6 t -122.13 -20.23 6.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.307 -0.871 . . . . 0.0 109.58 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 128.59 6.51 4.62 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.416 ' CB ' ' HB2' ' A' ' 37' ' ' SER . 0.5 OUTLIER -80.29 105.88 11.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.123 -1.222 . . . . 0.0 109.146 179.79 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.439 ' HG3' ' HG3' ' A' ' 36' ' ' GLN . 15.6 mtp180 -97.5 125.43 42.18 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.181 -0.95 . . . . 0.0 110.078 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.653 HG21 ' CA ' ' A' ' 49' ' ' LEU . 4.8 mt -127.65 163.91 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.54 ' HB3' ' CD1' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -160.31 18.17 0.14 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.894 -1.129 . . . . 0.0 110.654 -179.575 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.567 ' HB2' ' CB ' ' A' ' 48' ' ' GLU . 0.4 OUTLIER -99.98 18.13 19.24 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.856 -1.152 . . . . 0.0 109.397 179.761 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.586 ' HB2' ' CD1' ' A' ' 64' ' ' PHE . 12.7 tttt 64.36 -92.49 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.502 -0.749 . . . . 0.0 110.473 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.488 ' HA ' ' OG1' ' A' ' 50' ' ' THR . 74.8 t -62.33 -27.93 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.018 -1.051 . . . . 0.0 109.369 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.567 ' CB ' ' HB2' ' A' ' 45' ' ' SER . 23.9 tt0 -61.06 -49.28 77.99 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.025 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.683 HD12 HD11 ' A' ' 53' ' ' LEU . 0.8 OUTLIER -68.13 -23.72 64.93 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.814 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.544 ' OG1' ' CB ' ' A' ' 59' ' ' LEU . 26.9 m -65.65 -70.87 0.21 Allowed 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.425 ' C ' ' O ' ' A' ' 50' ' ' THR . 0.0 OUTLIER -43.57 -26.79 0.24 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.507 -0.746 . . . . 0.0 109.028 179.547 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.422 ' N ' ' O ' ' A' ' 50' ' ' THR . 37.1 t80 -64.16 -62.95 1.29 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.286 -0.884 . . . . 0.0 109.565 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.683 HD11 HD12 ' A' ' 49' ' ' LEU . 0.5 OUTLIER -55.57 -57.94 9.84 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.125 -0.984 . . . . 0.0 109.274 -179.92 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 131.06 -155.01 21.07 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.48 -9.5 16.11 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.623 2.216 . . . . 0.0 110.528 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -81.14 -13.99 58.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.302 -0.874 . . . . 0.0 109.638 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.47 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 88.1 m -134.07 79.27 1.8 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.191 -0.943 . . . . 0.0 109.596 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.54 137.23 56.64 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.145 -0.972 . . . . 0.0 109.133 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.775 HD23 ' HB3' ' A' ' 62' ' ' PHE . 0.1 OUTLIER -140.46 5.42 2.04 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.276 -0.89 . . . . 0.0 109.878 -179.288 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.629 ' C ' HD22 ' A' ' 61' ' ' LEU . 54.5 m -62.15 -21.36 64.98 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.215 -0.928 . . . . 0.0 109.156 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.629 HD22 ' C ' ' A' ' 60' ' ' THR . 1.7 mm? -107.31 -11.74 15.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.387 -0.821 . . . . 0.0 109.217 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.775 ' HB3' HD23 ' A' ' 59' ' ' LEU . 6.1 t80 -54.81 133.41 47.56 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.399 -0.813 . . . . 0.0 109.735 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.547 ' O ' ' CE1' ' A' ' 62' ' ' PHE . 2.4 t0 -80.57 104.74 11.31 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.283 -0.886 . . . . 0.0 108.882 179.458 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.586 ' CD1' ' HB2' ' A' ' 46' ' ' LYS . 0.6 OUTLIER -67.19 65.04 0.06 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.264 -0.898 . . . . 0.0 109.319 -179.426 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 63' ' ' ASP . 6.3 mtpt 171.48 -37.9 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.396 -0.815 . . . . 0.0 109.388 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 43.1 tt0 -88.16 -46.63 9.11 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.163 -0.961 . . . . 0.0 109.3 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.494 ' HA2' ' CZ ' ' A' ' 62' ' ' PHE . . . 111.77 25.69 4.75 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -140.72 171.43 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.011 -1.288 . . . . 0.0 109.69 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 62' ' ' PHE . 1.1 pt? -140.49 -174.3 3.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.22 -0.925 . . . . 0.0 109.337 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 23.0 m -147.09 146.24 29.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.187 -0.945 . . . . 0.0 109.592 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.452 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 56.4 m-85 -97.35 161.31 26.47 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.253 -0.905 . . . . 0.0 109.4 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.452 ' HD2' ' HB3' ' A' ' 71' ' ' TYR . 35.7 Cg_endo -78.2 173.11 14.36 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.655 2.237 . . . . 0.0 110.664 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -144.11 79.76 12.81 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.3 -0.875 . . . . 0.0 109.277 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.25 116.74 3.95 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.674 2.249 . . . . 0.0 110.374 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.487 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ttt . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.17 -166.98 1.66 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.278 -0.889 . . . . 0.0 109.403 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.54 ' HG2' ' CZ ' ' A' ' 18' ' ' ARG . 23.4 mp0 -86.07 -171.81 3.76 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.222 -0.924 . . . . 0.0 109.428 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -102.85 55.98 0.77 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.3 -0.875 . . . . 0.0 109.42 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.576 ' CZ3' ' HB2' ' A' ' 18' ' ' ARG . 97.9 m95 -64.86 97.93 0.25 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.202 -0.936 . . . . 0.0 109.398 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 81.4 mt -111.3 164.35 12.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.22 -0.925 . . . . 0.0 109.562 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 7' ' ' ASP . 0.5 OUTLIER -59.99 145.06 47.59 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.262 -0.898 . . . . 0.0 109.572 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.514 ' SG ' ' N ' ' A' ' 17' ' ' ARG . 7.1 m -91.24 113.89 59.85 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.258 -0.901 . . . . 0.0 109.886 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.415 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 36.3 Cg_endo -78.98 -27.35 4.66 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.344 2.029 . . . . 0.0 110.412 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.77 ' HB3' HH12 ' A' ' 17' ' ' ARG . . . -70.71 -37.34 73.54 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.106 -0.996 . . . . 0.0 109.839 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.813 HD12 ' CD1' ' A' ' 15' ' ' TRP . 6.5 mt -105.08 -46.37 4.28 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.134 -0.979 . . . . 0.0 109.635 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 135.06 -145.98 18.04 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.38 164.66 26.23 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.626 2.217 . . . . 0.0 110.405 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.8 -51.97 4.64 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.813 ' CD1' HD12 ' A' ' 11' ' ' LEU . 7.9 t-105 -75.72 125.75 29.66 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.292 -1.122 . . . . 0.0 109.346 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.427 ' C ' ' SG ' ' A' ' 8' ' ' CYS . 10.6 mmtp -103.14 132.4 49.43 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.213 -0.929 . . . . 0.0 109.526 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.77 HH12 ' HB3' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -99.22 111.43 23.81 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.507 -0.745 . . . . 0.0 109.413 -179.6 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.576 ' HB2' ' CZ3' ' A' ' 5' ' ' TRP . 1.6 ttt180 -100.11 131.76 45.87 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.174 -0.954 . . . . 0.0 109.61 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -112.35 142.79 44.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.299 -0.876 . . . . 0.0 109.328 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.407 ' O ' ' C ' ' A' ' 21' ' ' PHE . 39.3 t -140.34 91.66 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.139 -0.976 . . . . 0.0 109.778 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.407 ' C ' ' O ' ' A' ' 20' ' ' VAL . 0.7 OUTLIER -44.71 102.16 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.205 -0.934 . . . . 0.0 109.193 179.736 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.484 ' CG ' ' OD2' ' A' ' 32' ' ' ASP . 0.5 OUTLIER -75.05 -69.06 0.49 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.348 -0.845 . . . . 0.0 110.026 -179.596 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.509 ' O ' ' CB ' ' A' ' 24' ' ' SER . 4.7 mttm -73.46 -58.86 3.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.224 -0.923 . . . . 0.0 109.906 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.509 ' CB ' ' O ' ' A' ' 23' ' ' LYS . 5.2 t 75.39 111.74 0.07 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.164 -0.96 . . . . 0.0 109.417 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 129.83 -30.95 3.46 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.58 65.8 0.69 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.213 -1.169 . . . . 0.0 109.523 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.415 ' O ' ' C ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER 45.09 53.69 7.59 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.29 -0.881 . . . . 0.0 109.546 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.415 ' C ' ' O ' ' A' ' 27' ' ' THR . 1.2 m 43.77 50.34 6.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.278 -0.889 . . . . 0.0 109.414 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -131.47 156.28 21.77 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 67.63 133.41 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.248 -1.148 . . . . 0.0 109.53 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.3 p -178.43 165.86 1.79 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.302 -0.874 . . . . 0.0 109.38 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.497 ' HB3' ' CZ ' ' A' ' 34' ' ' TYR . 3.7 m-20 -87.84 123.75 32.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.243 -0.911 . . . . 0.0 109.225 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.78 109.4 17.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.203 -0.936 . . . . 0.0 109.827 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.591 ' CD1' ' CD ' ' A' ' 44' ' ' ARG . 11.4 m-85 -112.49 138.07 49.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.256 -0.902 . . . . 0.0 108.992 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.638 ' HD2' HD22 ' A' ' 49' ' ' LEU . 5.3 m-85 -108.18 151.11 26.36 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.136 -0.977 . . . . 0.0 109.827 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -132.24 128.73 38.52 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.361 -0.837 . . . . 0.0 109.533 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.517 ' OG ' ' CB ' ' A' ' 41' ' ' ASP . 0.4 OUTLIER -71.94 174.68 3.77 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.28 -0.888 . . . . 0.0 109.511 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.509 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 35.9 Cg_endo -78.61 -4.49 14.15 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.722 2.282 . . . . 0.0 110.417 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.458 HG22 ' HB2' ' A' ' 37' ' ' SER . 2.4 t -103.92 -18.55 14.57 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.241 -0.912 . . . . 0.0 109.518 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 120.71 12.44 6.04 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.517 ' CB ' ' OG ' ' A' ' 37' ' ' SER . 0.4 OUTLIER -83.25 127.6 33.78 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -1.151 . . . . 0.0 109.571 -179.908 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.08 131.71 56.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.244 -0.91 . . . . 0.0 109.277 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.603 HG22 ' H ' ' A' ' 45' ' ' SER . 2.6 mp -137.64 161.49 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.225 -0.922 . . . . 0.0 109.611 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.591 ' CD ' ' CD1' ' A' ' 34' ' ' TYR . 34.8 mtm180 -143.79 18.42 1.81 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.316 -0.865 . . . . 0.0 109.557 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.603 ' H ' HG22 ' A' ' 43' ' ' ILE . 0.5 OUTLIER -91.88 -88.54 0.2 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.293 -0.879 . . . . 0.0 108.907 179.504 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.563 ' HB2' ' CD1' ' A' ' 64' ' ' PHE . 19.3 ttpt 159.52 -63.39 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.479 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 77.2 t -85.38 -21.54 7.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.489 ' O ' ' HG3' ' A' ' 51' ' ' ARG . 98.3 mt-10 -68.71 -44.81 73.13 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.638 HD22 ' HD2' ' A' ' 35' ' ' TYR . 3.4 pp -71.05 -25.07 62.49 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 178.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.856 ' OG1' HD13 ' A' ' 59' ' ' LEU . 20.5 m -68.59 -63.29 1.09 Allowed 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.489 ' HG3' ' O ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -49.45 -23.96 1.79 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.394 -0.816 . . . . 0.0 108.872 179.391 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.503 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 2.6 t80 -67.32 -64.64 0.81 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.303 -0.873 . . . . 0.0 109.159 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.676 HD21 ' CE3' ' A' ' 15' ' ' TRP . 0.6 OUTLIER -51.1 -57.85 7.63 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.04 -1.038 . . . . 0.0 109.257 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 141.16 -157.15 25.94 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.07 -9.7 16.62 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.592 2.195 . . . . 0.0 110.248 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.17 -13.56 59.93 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.297 -0.877 . . . . 0.0 109.438 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 73.3 m -132.99 130.23 39.23 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.356 -0.84 . . . . 0.0 109.19 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.685 ' C ' HD12 ' A' ' 59' ' ' LEU . 25.4 t0 -126.19 152.56 45.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.168 -0.958 . . . . 0.0 109.832 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.856 HD13 ' OG1' ' A' ' 50' ' ' THR . 5.2 mp -148.64 14.7 0.96 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.388 -0.82 . . . . 0.0 109.395 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.609 ' C ' HD22 ' A' ' 61' ' ' LEU . 22.3 m -46.35 -37.35 7.38 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.323 -0.861 . . . . 0.0 109.84 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.609 HD22 ' C ' ' A' ' 60' ' ' THR . 1.1 mm? -111.38 2.43 17.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.3 -0.875 . . . . 0.0 109.606 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.579 ' CE1' ' CB ' ' A' ' 10' ' ' ALA . 78.3 t80 -58.68 146.33 36.8 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.353 -0.842 . . . . 0.0 109.656 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.496 ' O ' ' N ' ' A' ' 65' ' ' LYS . 5.1 t0 -98.44 103.32 15.26 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.33 -0.856 . . . . 0.0 108.972 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.622 ' CE1' ' CE2' ' A' ' 35' ' ' TYR . 0.7 OUTLIER -66.61 69.64 0.07 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.149 -0.97 . . . . 0.0 109.426 -179.36 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.496 ' N ' ' O ' ' A' ' 63' ' ' ASP . 11.9 ttpp 177.07 -46.22 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.266 -0.896 . . . . 0.0 109.579 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -92.41 -39.35 11.48 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.24 -0.912 . . . . 0.0 109.728 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.481 ' HA2' ' CZ ' ' A' ' 62' ' ' PHE . . . 106.03 35.17 3.02 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.469 ' O ' ' N ' ' A' ' 63' ' ' ASP . 2.0 pp -140.52 173.41 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.16 -1.2 . . . . 0.0 109.628 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.471 ' HB3' ' HA ' ' A' ' 62' ' ' PHE . 0.7 OUTLIER -147.24 -164.83 2.09 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.78 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.451 ' SG ' ' O ' ' A' ' 69' ' ' LEU . 62.1 m -151.71 -162.23 1.48 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.947 -1.096 . . . . 0.0 110.134 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.536 ' CD1' ' N ' ' A' ' 71' ' ' TYR . 1.7 p90 -147.82 164.37 22.8 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.432 -0.792 . . . . 0.0 109.424 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.486 ' HD2' ' HB2' ' A' ' 71' ' ' TYR . 35.1 Cg_endo -77.41 -175.02 2.45 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.486 2.124 . . . . 0.0 110.348 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -139.72 154.75 71.35 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.282 -0.886 . . . . 0.0 109.514 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.53 140.66 17.08 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.683 2.255 . . . . 0.0 110.296 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.565 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.523 ' O ' ' HB3' ' A' ' 2' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.523 ' HB3' ' O ' ' A' ' 1' ' ' MET . . . 65.53 17.9 11.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.292 -0.88 . . . . 0.0 109.546 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.456 ' OE1' ' NE ' ' A' ' 18' ' ' ARG . 48.0 mt-10 -151.92 145.05 24.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.272 -0.892 . . . . 0.0 109.413 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.436 ' O ' ' C ' ' A' ' 5' ' ' TRP . 0.7 OUTLIER -123.15 66.62 0.98 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.245 -0.909 . . . . 0.0 109.597 -179.933 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.436 ' C ' ' O ' ' A' ' 4' ' ' ASP . 71.9 m95 -43.4 108.39 0.11 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.301 -0.874 . . . . 0.0 109.316 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.72 158.77 17.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.194 -0.941 . . . . 0.0 109.684 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.449 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 0.5 OUTLIER -53.16 138.93 30.35 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.222 -0.923 . . . . 0.0 109.126 179.695 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.455 ' HB2' ' HB2' ' A' ' 17' ' ' ARG . 40.3 t -98.99 109.17 52.99 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.101 -0.999 . . . . 0.0 109.878 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.463 ' HD2' ' CZ ' ' A' ' 17' ' ' ARG . 34.4 Cg_endo -77.23 -38.79 0.69 Allowed 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.205 1.937 . . . . 0.0 110.111 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.633 ' C ' HD23 ' A' ' 11' ' ' LEU . . . -42.97 -32.18 0.61 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.28 -0.887 . . . . 0.0 109.473 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.969 HD12 ' CD1' ' A' ' 15' ' ' TRP . 5.3 mt -115.93 -67.01 1.03 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.21 -0.931 . . . . 0.0 109.48 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 167.1 -149.1 14.17 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.88 169.21 20.99 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.688 2.259 . . . . 0.0 110.666 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.35 -56.18 2.84 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.634 -1.387 . . . . 0.0 109.634 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.969 ' CD1' HD12 ' A' ' 11' ' ' LEU . 10.0 t-105 -62.15 123.41 18.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.256 -1.143 . . . . 0.0 109.774 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -103.54 120.53 41.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.281 -0.887 . . . . 0.0 109.547 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.576 ' HG3' ' CE2' ' A' ' 35' ' ' TYR . 3.2 ttp85 -95.3 114.94 26.78 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.217 -0.927 . . . . 0.0 109.347 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.456 ' NE ' ' OE1' ' A' ' 3' ' ' GLU . 4.0 tmm_? -100.24 139.37 36.01 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.183 -0.948 . . . . 0.0 109.571 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -108.68 144.69 36.12 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.209 -0.932 . . . . 0.0 109.482 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.48 HG12 ' N ' ' A' ' 21' ' ' PHE . 42.7 t -128.14 159.89 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.184 -0.947 . . . . 0.0 109.428 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.517 ' O ' ' N ' ' A' ' 23' ' ' LYS . 13.1 p90 -116.09 66.28 0.71 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.318 -0.864 . . . . 0.0 109.192 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.459 ' CG ' ' O ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -52.15 88.85 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.439 -0.788 . . . . 0.0 109.613 -179.886 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.517 ' N ' ' O ' ' A' ' 21' ' ' PHE . 7.7 mtmt 60.22 168.1 0.08 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.277 -0.889 . . . . 0.0 109.467 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 t -120.05 158.03 27.67 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.267 -0.895 . . . . 0.0 109.531 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -168.53 -117.8 0.42 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.7 169.0 0.16 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.129 -1.218 . . . . 0.0 109.12 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.726 ' O ' HG23 ' A' ' 27' ' ' THR . 7.9 t -61.88 96.92 0.07 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.134 -0.979 . . . . 0.0 109.401 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 48.89 52.06 14.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.199 -0.938 . . . . 0.0 109.279 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.51 -60.55 8.32 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -152.64 155.97 38.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.201 -1.176 . . . . 0.0 109.672 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.0 p -141.17 148.81 40.6 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.357 -0.839 . . . . 0.0 109.201 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.439 ' OD2' ' HB3' ' A' ' 22' ' ' ARG . 9.8 m-20 -79.81 139.85 37.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.193 -0.942 . . . . 0.0 109.245 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.52 HG22 ' CZ ' ' A' ' 35' ' ' TYR . 31.2 m -128.72 126.06 39.26 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.22 -0.925 . . . . 0.0 109.778 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.615 ' CD1' ' N ' ' A' ' 34' ' ' TYR . 1.7 m-85 -115.14 167.18 11.05 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.64 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 2.5 m-85 -136.72 146.27 45.64 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.866 -1.146 . . . . 0.0 110.08 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -128.49 124.8 37.0 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.478 -0.763 . . . . 0.0 109.344 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.514 ' CB ' ' HD2' ' A' ' 38' ' ' PRO . 0.3 OUTLIER -68.19 174.98 2.02 Favored Pre-proline 0 N--CA 1.487 1.417 0 O-C-N 121.285 -0.884 . . . . 0.0 109.32 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.514 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 35.1 Cg_endo -78.14 5.35 5.46 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.65 2.234 . . . . 0.0 110.335 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.462 HG22 ' HB2' ' A' ' 37' ' ' SER . 15.3 t -114.6 -24.83 8.58 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.254 -0.904 . . . . 0.0 109.417 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 124.24 13.34 3.98 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.469 ' HB2' ' OH ' ' A' ' 52' ' ' TYR . 0.3 OUTLIER -90.95 112.53 24.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.132 -1.217 . . . . 0.0 109.24 179.882 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.485 ' CZ ' ' HB2' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -95.57 139.33 31.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -0.891 . . . . 0.0 109.618 -179.75 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.645 HD13 ' HA ' ' A' ' 49' ' ' LEU . 4.0 mt -135.98 161.21 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.187 -0.946 . . . . 0.0 109.566 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.591 ' HG3' ' CD2' ' A' ' 34' ' ' TYR . 0.1 OUTLIER -152.6 15.12 0.58 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.239 -0.913 . . . . 0.0 110.257 -179.37 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.579 ' CB ' ' HB3' ' A' ' 48' ' ' GLU . 0.3 OUTLIER -99.61 21.55 12.15 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.924 -1.11 . . . . 0.0 109.456 179.949 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.612 ' HA ' ' CE1' ' A' ' 64' ' ' PHE . 8.1 ttpt 59.3 -94.01 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.365 -0.834 . . . . 0.0 109.973 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.464 ' HA ' ' OG1' ' A' ' 50' ' ' THR . 26.3 t -59.0 -38.0 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.036 -1.04 . . . . 0.0 109.314 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.579 ' HB3' ' CB ' ' A' ' 45' ' ' SER . 71.3 tt0 -51.26 -43.44 61.56 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.002 -1.061 . . . . 0.0 108.356 179.164 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.693 HD21 HD22 ' A' ' 59' ' ' LEU . 0.5 OUTLIER -66.45 -27.86 68.15 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 179.393 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.526 ' N ' ' HG ' ' A' ' 49' ' ' LEU . 1.5 m -71.27 -66.22 0.65 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.07 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.467 ' CD ' ' HA ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -47.84 -24.33 0.97 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.357 -0.839 . . . . 0.0 108.778 179.321 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.479 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 62.4 t80 -63.34 -60.18 3.73 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.264 -0.898 . . . . 0.0 109.114 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.672 HD21 ' CE3' ' A' ' 15' ' ' TRP . 0.3 OUTLIER -60.74 -55.19 36.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.182 -0.949 . . . . 0.0 108.969 179.642 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 142.74 -155.33 25.78 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -78.02 -18.84 12.71 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.537 2.158 . . . . 0.0 110.366 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.22 -10.52 51.37 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.326 -0.859 . . . . 0.0 109.56 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.466 ' CB ' HD13 ' A' ' 53' ' ' LEU . 18.0 m -133.41 136.71 45.42 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.227 -0.921 . . . . 0.0 109.522 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.63 ' C ' HD12 ' A' ' 59' ' ' LEU . 18.3 t70 -130.95 148.59 52.73 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.272 -0.893 . . . . 0.0 109.49 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.693 HD22 HD21 ' A' ' 49' ' ' LEU . 4.1 mp -148.24 10.5 0.88 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.208 -0.932 . . . . 0.0 109.696 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.629 ' C ' HD22 ' A' ' 61' ' ' LEU . 94.5 m -49.92 -29.06 7.59 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.146 -0.971 . . . . 0.0 109.145 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.629 HD22 ' C ' ' A' ' 60' ' ' THR . 1.5 mm? -111.07 -8.42 14.44 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.322 -0.861 . . . . 0.0 109.381 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.618 ' CD2' HD23 ' A' ' 59' ' ' LEU . 48.0 t80 -59.18 131.1 50.01 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.378 -0.826 . . . . 0.0 109.337 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.63 117.49 20.6 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.192 -0.943 . . . . 0.0 109.261 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.612 ' CE1' ' HA ' ' A' ' 46' ' ' LYS . 0.4 OUTLIER -73.89 56.75 0.59 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.219 -0.926 . . . . 0.0 109.065 -179.94 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.14 -41.6 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.378 -0.826 . . . . 0.0 109.022 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -81.14 -46.66 14.58 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.267 -0.895 . . . . 0.0 109.113 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.503 ' HA3' ' NH1' ' A' ' 17' ' ' ARG . . . 104.22 28.63 5.74 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.469 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 1.1 pp -140.6 161.48 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.022 -1.281 . . . . 0.0 109.757 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.427 ' HB3' ' HA ' ' A' ' 62' ' ' PHE . 0.7 OUTLIER -143.74 173.84 11.33 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.339 -0.851 . . . . 0.0 108.935 179.74 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 21.6 p -159.85 -169.08 2.42 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.118 -0.989 . . . . 0.0 109.767 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -162.92 88.54 1.3 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.331 -0.856 . . . . 0.0 109.4 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.695 ' O ' ' HB2' ' A' ' 73' ' ' ALA . 35.5 Cg_endo -78.27 147.47 23.2 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.663 2.242 . . . . 0.0 110.544 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.934 ' HB3' ' HD3' ' A' ' 74' ' ' PRO . . . 163.41 -53.28 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.362 -0.837 . . . . 0.0 109.48 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.934 ' HD3' ' HB3' ' A' ' 73' ' ' ALA . 36.2 Cg_endo -78.7 -27.51 4.87 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.48 2.12 . . . . 0.0 110.394 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.6 mttt . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.414 -179.905 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.9 ptt? . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -112.1 154.7 25.05 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.301 -0.874 . . . . 0.0 109.453 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.429 ' HG2' ' HD3' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -116.37 -149.56 0.45 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.292 -0.88 . . . . 0.0 109.578 -179.877 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.401 ' O ' HD23 ' A' ' 6' ' ' LEU . 3.2 m-20 -95.81 30.42 2.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.248 -0.908 . . . . 0.0 109.644 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.555 ' CZ3' ' HB2' ' A' ' 36' ' ' GLN . 98.7 m95 -48.77 104.06 0.05 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.221 -0.924 . . . . 0.0 109.212 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.401 HD23 ' O ' ' A' ' 4' ' ' ASP . 0.6 OUTLIER -110.8 160.75 16.46 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.181 -0.949 . . . . 0.0 109.617 -179.78 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -56.39 149.32 17.03 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.237 -0.914 . . . . 0.0 109.206 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.448 ' SG ' ' HG ' ' A' ' 11' ' ' LEU . 38.0 t -111.75 103.83 55.51 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.128 -0.983 . . . . 0.0 109.848 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.92 -26.21 6.88 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.373 2.049 . . . . 0.0 109.878 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.475 ' CB ' ' CE2' ' A' ' 62' ' ' PHE . . . -54.06 -34.63 60.56 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.406 -0.809 . . . . 0.0 109.314 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 1.03 HD12 ' CD1' ' A' ' 15' ' ' TRP . 12.2 mt -105.88 -66.79 0.97 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.292 -0.88 . . . . 0.0 109.358 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 157.98 -153.16 24.37 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.79 137.34 15.89 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.669 2.246 . . . . 0.0 110.353 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.29 23.25 17.35 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 1.03 ' CD1' HD12 ' A' ' 11' ' ' LEU . 27.6 t-105 -150.1 125.59 10.24 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.24 -1.153 . . . . 0.0 109.334 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.9 mmmt -105.9 134.66 48.67 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.15 -0.969 . . . . 0.0 109.538 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.508 ' HG3' ' CE2' ' A' ' 35' ' ' TYR . 3.7 ttp85 -103.6 111.68 24.26 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.311 -0.868 . . . . 0.0 109.643 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.548 ' HG3' ' CE2' ' A' ' 5' ' ' TRP . 0.3 OUTLIER -97.65 155.41 17.0 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.224 -0.923 . . . . 0.0 109.151 179.716 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -123.03 168.61 12.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.116 -0.99 . . . . 0.0 109.731 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.622 HG21 ' CE2' ' A' ' 34' ' ' TYR . 3.4 t -140.03 103.2 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.349 -0.845 . . . . 0.0 109.383 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -89.13 54.32 2.94 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.151 -0.968 . . . . 0.0 109.531 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.94 -25.37 3.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.332 -0.855 . . . . 0.0 109.489 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 47.0 25.19 0.45 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.156 -0.965 . . . . 0.0 109.362 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.24 90.74 3.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.304 -0.873 . . . . 0.0 109.443 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 175.03 135.21 2.03 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.29 -165.3 0.18 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.287 -1.125 . . . . 0.0 109.497 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.98 72.17 0.56 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.209 -0.932 . . . . 0.0 109.492 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 25.2 p -150.13 18.97 0.87 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.22 -0.925 . . . . 0.0 109.485 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 161.68 -159.47 31.38 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.491 ' CB ' ' HD3' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -161.46 -163.99 1.07 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.296 -1.12 . . . . 0.0 109.241 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.3 p -51.35 167.71 0.08 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.188 -0.945 . . . . 0.0 109.27 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -110.43 150.21 29.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.223 -0.923 . . . . 0.0 109.33 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.38 106.31 11.33 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.129 -0.982 . . . . 0.0 109.772 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.622 ' CE2' HG21 ' A' ' 20' ' ' VAL . 15.0 m-85 -101.99 167.27 10.15 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.275 -0.89 . . . . 0.0 109.054 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.578 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 3.9 m-85 -135.1 155.16 51.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.067 -1.02 . . . . 0.0 109.913 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.555 ' HB2' ' CZ3' ' A' ' 5' ' ' TRP . 4.4 tt0 -141.96 132.82 25.79 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.357 -0.839 . . . . 0.0 109.156 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.518 ' CB ' ' HD2' ' A' ' 38' ' ' PRO . 0.1 OUTLIER -70.78 176.13 2.18 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.238 -0.913 . . . . 0.0 109.213 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.518 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 35.7 Cg_endo -78.69 0.29 10.1 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.535 2.156 . . . . 0.0 110.289 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.475 HG22 ' HB2' ' A' ' 37' ' ' SER . 10.1 t -106.48 -21.58 13.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.338 -0.851 . . . . 0.0 109.575 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 122.51 10.95 5.76 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.437 ' CB ' ' OG ' ' A' ' 37' ' ' SER . 0.1 OUTLIER -79.76 102.97 9.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.232 -1.158 . . . . 0.0 109.472 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.3 mtp85 -90.48 117.3 29.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.281 -0.887 . . . . 0.0 109.477 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.647 HG21 ' N ' ' A' ' 49' ' ' LEU . 2.9 mp -121.63 153.04 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.277 -0.889 . . . . 0.0 109.494 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.47 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 8.7 mtm-85 -148.73 16.9 1.0 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.233 -0.917 . . . . 0.0 110.237 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.561 ' HB3' ' CB ' ' A' ' 48' ' ' GLU . 1.6 t -100.66 16.75 23.84 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.979 -1.076 . . . . 0.0 110.368 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.612 ' HA ' ' CE1' ' A' ' 64' ' ' PHE . 25.6 tttt 63.73 -94.18 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.221 -0.924 . . . . 0.0 110.92 178.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.448 ' HA ' ' OG1' ' A' ' 50' ' ' THR . 54.9 t -58.72 -27.88 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.906 -1.121 . . . . 0.0 109.656 -178.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.561 ' CB ' ' HB3' ' A' ' 45' ' ' SER . 14.7 tt0 -61.12 -47.79 84.65 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.093 -1.004 . . . . 0.0 108.525 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 1.012 HD13 ' CZ2' ' A' ' 15' ' ' TRP . 1.0 OUTLIER -67.75 -23.79 65.28 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.94 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.547 ' OG1' ' CB ' ' A' ' 59' ' ' LEU . 17.0 m -66.92 -68.76 0.35 Allowed 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.074 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.66 -20.41 2.04 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.533 -0.73 . . . . 0.0 109.23 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.485 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 44.5 t80 -66.76 -50.57 62.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.223 -0.923 . . . . 0.0 109.276 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.851 HD11 HD12 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -70.56 -48.52 55.0 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.19 -0.944 . . . . 0.0 109.093 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 121.6 -156.59 16.5 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -78.9 8.08 3.96 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.574 2.183 . . . . 0.0 110.552 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -88.53 -23.56 23.14 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.141 -0.974 . . . . 0.0 109.558 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.464 ' HB2' HD13 ' A' ' 53' ' ' LEU . 95.8 m -133.28 101.1 5.05 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.285 -0.884 . . . . 0.0 109.499 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -75.62 131.12 39.76 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.178 -0.951 . . . . 0.0 109.448 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.869 HD13 HD11 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -132.37 0.9 3.74 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.369 -0.832 . . . . 0.0 109.697 -179.689 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.434 ' O ' HD22 ' A' ' 61' ' ' LEU . 8.2 m -47.54 -34.35 7.53 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.335 -0.853 . . . . 0.0 110.24 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.499 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 0.7 OUTLIER -108.09 0.24 21.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.057 -1.027 . . . . 0.0 109.93 -179.321 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.748 ' CB ' HD23 ' A' ' 59' ' ' LEU . 3.4 t80 -51.61 131.55 29.8 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.17 -0.956 . . . . 0.0 109.358 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.486 ' O ' ' N ' ' A' ' 65' ' ' LYS . 99.0 m-20 -79.22 104.16 9.65 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.21 -0.931 . . . . 0.0 108.768 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.612 ' CE1' ' HA ' ' A' ' 46' ' ' LYS . 0.5 OUTLIER -68.62 58.86 0.09 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.337 -0.852 . . . . 0.0 109.658 -179.138 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.491 ' HD3' ' CB ' ' A' ' 30' ' ' ARG . 2.7 tmmt? 178.09 -33.63 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.272 -0.892 . . . . 0.0 109.432 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -92.12 -44.04 9.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.18 -0.95 . . . . 0.0 109.501 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.442 ' O ' ' HB2' ' A' ' 10' ' ' ALA . . . 110.95 25.31 5.16 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.567 HD12 ' N ' ' A' ' 69' ' ' LEU . 1.3 pp -140.31 -170.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.286 -1.126 . . . . 0.0 109.557 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.58 ' N ' HD23 ' A' ' 69' ' ' LEU . 1.1 pt? -153.42 178.53 9.69 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.378 -0.826 . . . . 0.0 109.0 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 0.8 OUTLIER -155.24 -165.16 1.94 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.139 -0.976 . . . . 0.0 109.24 179.635 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.489 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.3 OUTLIER -177.76 63.02 0.18 Allowed Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.166 -0.959 . . . . 0.0 109.909 -179.896 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.489 ' HD3' ' N ' ' A' ' 71' ' ' TYR . 35.0 Cg_endo -77.99 177.91 8.22 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.526 2.151 . . . . 0.0 110.123 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.422 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . . . -80.49 139.67 51.57 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.076 -1.015 . . . . 0.0 109.436 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 73' ' ' ALA . 36.2 Cg_endo -78.83 61.75 8.18 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.548 2.165 . . . . 0.0 110.621 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 36.1 tttt . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.435 179.921 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.681 ' O ' ' HB3' ' A' ' 2' ' ' ALA . 1.4 mpt? . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.253 0.549 . . . . 0.0 109.565 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.681 ' HB3' ' O ' ' A' ' 1' ' ' MET . . . 75.89 179.49 0.17 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.362 -0.836 . . . . 0.0 109.377 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.4 105.0 17.02 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.232 -0.918 . . . . 0.0 109.588 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.482 ' O ' ' O ' ' A' ' 5' ' ' TRP . 11.5 m-20 -143.71 15.39 1.77 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.221 -0.925 . . . . 0.0 109.578 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.598 ' CZ3' ' HB2' ' A' ' 36' ' ' GLN . 73.5 m95 48.41 102.38 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.656 -0.653 . . . . 0.0 109.912 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.9 mt -102.78 152.62 21.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.117 -0.989 . . . . 0.0 109.685 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.474 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 5.3 m-20 -50.75 131.12 25.79 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.282 -0.886 . . . . 0.0 109.587 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.522 ' SG ' ' CZ ' ' A' ' 17' ' ' ARG . 12.1 t -82.06 113.94 47.11 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.33 -0.856 . . . . 0.0 109.629 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 36.5 Cg_endo -80.63 -55.61 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.282 0 C-N-CA 122.508 2.139 . . . . 0.0 110.909 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.64 ' HB3' ' NH1' ' A' ' 17' ' ' ARG . . . -37.99 -58.62 0.92 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.559 -0.713 . . . . 0.0 110.216 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.88 HD12 ' CD1' ' A' ' 15' ' ' TRP . 13.6 mt -79.38 -58.52 3.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.323 -0.861 . . . . 0.0 109.633 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 131.29 -140.82 12.11 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.81 138.0 16.44 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.509 2.139 . . . . 0.0 110.477 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.464 ' O ' ' HD3' ' A' ' 38' ' ' PRO . . . 99.3 14.14 36.63 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 1.028 ' CZ3' HD21 ' A' ' 53' ' ' LEU . 7.5 t-105 -148.36 137.06 21.59 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.229 -1.159 . . . . 0.0 109.532 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.76 129.22 55.64 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.261 -0.899 . . . . 0.0 109.313 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.64 ' NH1' ' HB3' ' A' ' 10' ' ' ALA . 0.6 OUTLIER -98.38 98.04 9.32 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.249 -0.907 . . . . 0.0 109.436 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.59 ' HB2' ' CE3' ' A' ' 5' ' ' TRP . 1.5 ttm180 -100.45 134.81 42.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.253 -0.904 . . . . 0.0 109.337 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -115.14 156.91 24.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.19 -0.944 . . . . 0.0 109.379 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.639 HG12 ' H ' ' A' ' 21' ' ' PHE . 3.6 t -130.71 175.27 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.153 -0.967 . . . . 0.0 109.434 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.639 ' H ' HG12 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -116.46 80.81 1.52 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.189 -0.944 . . . . 0.0 109.635 -179.869 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 -46.53 -59.37 3.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.28 -0.888 . . . . 0.0 109.379 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.6 83.97 0.15 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.286 -0.884 . . . . 0.0 109.371 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.2 p -129.74 61.02 1.57 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.226 -0.921 . . . . 0.0 109.471 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.88 -162.37 13.09 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -91.73 65.99 5.14 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.2 -1.176 . . . . 0.0 109.496 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 90.8 m -129.9 85.04 2.26 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.25 -0.906 . . . . 0.0 109.435 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 12.4 t -72.29 87.29 1.12 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.268 -0.895 . . . . 0.0 109.458 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 169.84 -34.46 0.17 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.48 149.55 47.08 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.298 -1.119 . . . . 0.0 109.343 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -179.14 138.24 0.14 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.185 -0.947 . . . . 0.0 109.7 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -80.26 127.66 32.62 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.374 -0.829 . . . . 0.0 109.079 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.477 ' HB ' ' O ' ' A' ' 64' ' ' PHE . 87.2 m -114.9 132.96 56.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.171 -0.956 . . . . 0.0 109.525 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.44 ' CD1' ' HB3' ' A' ' 44' ' ' ARG . 27.9 m-85 -129.68 149.27 51.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.293 -0.88 . . . . 0.0 109.409 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.689 ' CD2' ' CZ ' ' A' ' 64' ' ' PHE . 12.3 m-85 -113.81 154.2 27.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.254 -0.904 . . . . 0.0 109.178 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.598 ' HB2' ' CZ3' ' A' ' 5' ' ' TRP . 0.7 OUTLIER -131.11 126.45 35.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.188 -0.945 . . . . 0.0 109.613 -179.877 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.534 ' HB3' HG22 ' A' ' 39' ' ' THR . 0.4 OUTLIER -62.97 170.97 2.15 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.356 -0.84 . . . . 0.0 109.364 179.864 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 14' ' ' GLY . 35.6 Cg_endo -78.41 5.99 5.1 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.577 2.185 . . . . 0.0 110.472 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.534 HG22 ' HB3' ' A' ' 37' ' ' SER . 1.7 t -115.14 -16.13 11.61 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.247 -0.908 . . . . 0.0 109.524 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 124.55 3.52 7.82 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.462 ' O ' ' HA ' ' A' ' 36' ' ' GLN . 0.7 OUTLIER -76.87 157.0 31.74 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.276 -1.132 . . . . 0.0 109.325 -179.988 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.441 ' O ' ' HG2' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -143.32 122.75 13.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.224 -0.922 . . . . 0.0 109.618 -179.874 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.517 HD13 ' CB ' ' A' ' 49' ' ' LEU . 2.6 mp -128.95 153.44 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.277 -0.89 . . . . 0.0 109.559 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.589 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 8.5 ptt85 -117.3 -15.14 10.41 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.273 -0.892 . . . . 0.0 109.242 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.579 ' CB ' ' HB2' ' A' ' 48' ' ' GLU . 1.1 m -91.02 124.82 35.55 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.217 -0.927 . . . . 0.0 108.813 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.551 ' CG ' ' N ' ' A' ' 47' ' ' VAL . 33.6 pttt -60.46 -48.18 82.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.268 -0.895 . . . . 0.0 110.442 -178.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.551 ' N ' ' CG ' ' A' ' 46' ' ' LYS . 86.6 t -77.22 -31.49 18.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.067 -1.021 . . . . 0.0 109.668 -179.369 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.579 ' HB2' ' CB ' ' A' ' 45' ' ' SER . 39.1 tt0 -59.25 -51.71 68.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.96 -1.087 . . . . 0.0 108.604 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.731 ' O ' HD12 ' A' ' 53' ' ' LEU . 3.2 pp -69.22 -33.62 73.59 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 178.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.645 ' OG1' HD13 ' A' ' 59' ' ' LEU . 22.8 m -52.33 -67.27 0.26 Allowed 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.472 ' HG3' ' O ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -50.05 -30.88 11.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.416 -0.803 . . . . 0.0 109.213 179.801 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.516 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 28.5 t80 -64.41 -63.01 1.25 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.122 -0.986 . . . . 0.0 108.861 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 1.028 HD21 ' CZ3' ' A' ' 15' ' ' TRP . 0.5 OUTLIER -55.27 -48.49 73.94 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.989 -1.069 . . . . 0.0 108.898 179.391 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.84 -159.26 20.27 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.23 -2.34 12.55 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.541 2.161 . . . . 0.0 110.225 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.98 -25.15 55.53 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.287 -0.883 . . . . 0.0 109.348 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.401 ' O ' HG23 ' A' ' 50' ' ' THR . 59.7 m -135.11 103.03 5.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.242 -0.911 . . . . 0.0 109.231 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.839 ' C ' HD12 ' A' ' 59' ' ' LEU . 10.0 p30 -95.41 161.43 14.08 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.177 -0.952 . . . . 0.0 109.869 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.911 HD23 ' CD2' ' A' ' 62' ' ' PHE . 5.0 mp -154.6 20.02 0.47 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.441 -0.787 . . . . 0.0 109.282 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.566 ' C ' HD22 ' A' ' 61' ' ' LEU . 21.0 m -47.24 -40.3 16.12 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.326 -0.859 . . . . 0.0 109.75 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.585 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 0.8 OUTLIER -110.78 5.22 20.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.206 -0.934 . . . . 0.0 109.873 -179.387 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.911 ' CD2' HD23 ' A' ' 59' ' ' LEU . 54.7 t80 -71.88 136.07 46.79 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.192 -0.943 . . . . 0.0 109.418 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.481 ' HB2' ' HB2' ' A' ' 66' ' ' GLN . 2.4 m-20 -95.94 120.09 35.59 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.34 -0.85 . . . . 0.0 108.977 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.689 ' CZ ' ' CD2' ' A' ' 35' ' ' TYR . 0.6 OUTLIER -66.61 -11.72 54.75 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.278 -0.888 . . . . 0.0 109.512 -179.55 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -101.92 -41.71 6.38 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.208 -0.933 . . . . 0.0 110.112 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.481 ' HB2' ' HB2' ' A' ' 63' ' ' ASP . 5.9 mt-30 -83.22 -37.8 23.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.101 -1.0 . . . . 0.0 109.856 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.584 ' HA2' ' CZ ' ' A' ' 62' ' ' PHE . . . 89.31 29.65 16.37 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -139.58 160.26 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.202 -1.176 . . . . 0.0 109.367 179.914 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.617 ' N ' HD23 ' A' ' 69' ' ' LEU . 1.3 pt? -143.25 172.26 12.98 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.233 -0.917 . . . . 0.0 109.377 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 1.3 m -160.2 156.25 26.29 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.345 -0.847 . . . . 0.0 109.274 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -160.07 144.6 10.88 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.162 -0.961 . . . . 0.0 109.577 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.428 ' O ' ' O ' ' A' ' 73' ' ' ALA . 35.8 Cg_endo -78.59 108.75 2.5 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.647 2.231 . . . . 0.0 110.466 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.428 ' O ' ' O ' ' A' ' 72' ' ' PRO . . . 60.04 154.98 0.1 Allowed Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.294 -0.879 . . . . 0.0 109.408 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.09 102.99 1.63 Allowed 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.624 2.216 . . . . 0.0 110.457 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.536 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.477 ' O ' ' N ' ' A' ' 3' ' ' GLU . 5.7 ttt . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.256 0.551 . . . . 0.0 109.578 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' A' ' 1' ' ' MET . . . 61.77 -81.71 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.249 -0.907 . . . . 0.0 109.468 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.477 ' N ' ' O ' ' A' ' 1' ' ' MET . 19.8 mm-40 -124.72 -178.03 4.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.216 -0.927 . . . . 0.0 109.307 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.456 ' N ' ' HD3' ' A' ' 18' ' ' ARG . 1.5 t0 -129.74 84.86 2.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.157 -0.964 . . . . 0.0 109.647 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.594 ' CE3' ' HB2' ' A' ' 18' ' ' ARG . 62.6 m95 -54.87 132.33 46.22 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.383 -0.823 . . . . 0.0 109.468 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.485 HD23 ' O ' ' A' ' 5' ' ' TRP . 17.9 mt -119.28 165.44 14.25 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.2 -0.937 . . . . 0.0 109.429 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -55.58 131.87 47.35 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.11 -0.994 . . . . 0.0 109.483 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.532 ' CB ' ' HB2' ' A' ' 17' ' ' ARG . 53.9 t -82.03 117.43 68.32 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.275 -0.891 . . . . 0.0 109.642 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.95 -51.24 0.06 OUTLIER 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.418 2.079 . . . . 0.0 110.698 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -49.69 -38.05 31.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.177 -0.952 . . . . 0.0 109.929 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 1.032 HD12 ' CD1' ' A' ' 15' ' ' TRP . 13.1 mt -98.73 -54.87 2.89 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.139 -0.976 . . . . 0.0 109.656 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 134.45 -152.54 20.68 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.769 -1.333 . . . . 0.0 109.769 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.77 159.36 31.43 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.695 2.263 . . . . 0.0 110.533 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 83.71 -10.13 60.57 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 1.032 ' CD1' HD12 ' A' ' 11' ' ' LEU . 15.6 t-105 -118.06 131.42 56.45 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.313 -1.11 . . . . 0.0 109.264 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.469 ' HB3' ' HB3' ' A' ' 5' ' ' TRP . 21.4 mmtt -95.71 116.6 29.11 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.185 -0.947 . . . . 0.0 109.316 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.617 ' CZ ' HG21 ' A' ' 33' ' ' THR . 3.2 ttt-85 -104.45 100.04 9.74 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.255 -0.903 . . . . 0.0 109.294 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.77 ' O ' HG23 ' A' ' 33' ' ' THR . 1.4 tpt180 -100.7 144.18 29.99 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.149 -0.97 . . . . 0.0 110.052 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.449 ' O ' ' OE1' ' A' ' 3' ' ' GLU . 15.0 pt-20 -113.83 144.94 42.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.349 -0.844 . . . . 0.0 109.258 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.526 HG21 ' CE2' ' A' ' 34' ' ' TYR . 20.8 t -134.7 144.27 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.112 -0.993 . . . . 0.0 109.72 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -88.64 49.04 1.72 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.316 -0.865 . . . . 0.0 109.423 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 48.64 35.22 5.87 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.145 -0.972 . . . . 0.0 109.233 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 49.44 39.49 16.67 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.269 -0.894 . . . . 0.0 109.393 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 69.3 m -142.69 -61.27 0.44 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.206 -0.934 . . . . 0.0 109.669 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 124.92 11.43 4.36 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.52 127.95 34.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.229 -1.159 . . . . 0.0 109.391 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.8 t -113.42 27.01 9.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.226 -0.921 . . . . 0.0 109.575 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 98.3 m -60.91 -67.2 0.43 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.234 -0.916 . . . . 0.0 109.363 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 175.09 76.14 0.05 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.511 ' HG2' ' N ' ' A' ' 31' ' ' SER . 2.7 ttm180 -168.31 -92.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.272 -1.134 . . . . 0.0 109.257 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.511 ' N ' ' HG2' ' A' ' 30' ' ' ARG . 1.4 p 65.21 152.94 0.06 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.19 -0.944 . . . . 0.0 109.957 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -114.49 145.01 42.42 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.459 -0.776 . . . . 0.0 108.939 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.77 HG23 ' O ' ' A' ' 18' ' ' ARG . 56.5 m -125.4 122.0 35.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.084 -1.01 . . . . 0.0 110.126 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.526 ' CE2' HG21 ' A' ' 20' ' ' VAL . 3.3 m-85 -100.76 159.68 14.98 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.071 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.528 ' HB3' ' NE1' ' A' ' 15' ' ' TRP . 16.4 m-85 -130.49 137.08 49.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.943 -1.098 . . . . 0.0 110.114 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -118.99 116.18 25.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.489 -0.757 . . . . 0.0 109.327 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.839 ' OG ' HG22 ' A' ' 39' ' ' THR . 0.7 OUTLIER -57.07 168.86 0.78 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.327 -0.858 . . . . 0.0 109.448 -179.943 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.38 5.39 5.52 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.641 2.227 . . . . 0.0 110.379 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.839 HG22 ' OG ' ' A' ' 37' ' ' SER . 6.5 t -115.61 -11.63 11.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.155 -0.966 . . . . 0.0 109.648 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 116.98 3.86 17.26 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.81 142.45 40.3 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.163 -1.199 . . . . 0.0 109.108 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.0 117.5 24.15 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.227 -0.92 . . . . 0.0 109.707 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.61 HG21 ' HB3' ' A' ' 49' ' ' LEU . 3.4 mp -123.19 162.53 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.347 -0.845 . . . . 0.0 109.332 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.513 ' N ' HG22 ' A' ' 43' ' ' ILE . 34.6 mtp180 -149.1 15.57 0.93 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.141 -0.975 . . . . 0.0 109.805 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.546 ' O ' ' CB ' ' A' ' 46' ' ' LYS . 0.6 OUTLIER -85.34 -85.45 0.14 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.212 -0.93 . . . . 0.0 109.119 179.609 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.546 ' CB ' ' O ' ' A' ' 45' ' ' SER . 12.4 ttpt 157.92 -62.82 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.458 HG23 ' HE2' ' A' ' 46' ' ' LYS . 61.0 t -88.52 -21.83 6.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 178.5 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.483 ' O ' ' HG3' ' A' ' 51' ' ' ARG . 18.0 mt-10 -69.05 -41.78 77.18 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.757 ' O ' HD12 ' A' ' 53' ' ' LEU . 3.0 pp -71.87 -25.16 61.83 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 178.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.54 ' OG1' ' HB2' ' A' ' 59' ' ' LEU . 8.8 m -69.75 -61.5 1.75 Allowed 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.483 ' HG3' ' O ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -51.11 -23.21 2.98 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 179.297 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.481 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 65.2 t80 -69.63 -65.99 0.64 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.334 -0.854 . . . . 0.0 108.982 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.906 HD21 ' CE3' ' A' ' 15' ' ' TRP . 0.9 OUTLIER -49.9 -58.68 4.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.163 -0.961 . . . . 0.0 109.124 179.611 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 132.04 -146.89 18.47 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.71 -29.35 3.61 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.599 2.2 . . . . 0.0 110.139 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -54.63 -26.3 32.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.33 -0.856 . . . . 0.0 109.287 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 11.7 m -121.71 170.58 9.6 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.323 -0.861 . . . . 0.0 109.22 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.669 ' C ' HD12 ' A' ' 59' ' ' LEU . 17.6 p-10 -165.19 148.57 8.33 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.164 -0.96 . . . . 0.0 109.441 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 1.028 HD23 ' CD2' ' A' ' 62' ' ' PHE . 4.1 mp -153.0 21.02 0.58 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.206 -0.934 . . . . 0.0 109.716 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.45 ' C ' HD22 ' A' ' 61' ' ' LEU . 1.9 m -43.59 -49.59 7.52 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.268 -0.895 . . . . 0.0 109.647 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.506 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 1.5 mm? -106.97 9.8 30.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.324 -0.86 . . . . 0.0 109.755 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 1.028 ' CD2' HD23 ' A' ' 59' ' ' LEU . 72.0 t80 -55.87 139.94 44.2 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.402 -0.811 . . . . 0.0 109.999 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.528 ' O ' ' N ' ' A' ' 65' ' ' LYS . 0.7 OUTLIER -95.08 96.86 9.52 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.973 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.479 ' CE2' ' O ' ' A' ' 44' ' ' ARG . 0.5 OUTLIER -63.0 73.67 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.369 -0.832 . . . . 0.0 109.311 -179.119 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.528 ' N ' ' O ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER 168.35 -32.37 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.457 -0.777 . . . . 0.0 109.057 -179.757 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -103.57 -27.31 12.42 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.296 -0.878 . . . . 0.0 109.389 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.479 ' HA2' ' CZ ' ' A' ' 62' ' ' PHE . . . 89.42 33.16 9.57 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.472 ' O ' ' N ' ' A' ' 63' ' ' ASP . 1.0 OUTLIER -140.43 169.67 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.197 -1.178 . . . . 0.0 109.914 -179.833 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.725 ' N ' HD23 ' A' ' 69' ' ' LEU . 0.7 OUTLIER -145.11 -165.94 2.29 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.376 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.454 ' C ' ' CD2' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -160.05 169.98 22.24 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.094 -1.004 . . . . 0.0 109.897 179.766 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.549 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 2.9 p90 -177.58 60.87 0.16 Allowed Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.421 -0.8 . . . . 0.0 109.283 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.549 ' HD3' ' N ' ' A' ' 71' ' ' TYR . 35.2 Cg_endo -78.04 65.86 8.31 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.639 2.226 . . . . 0.0 110.482 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -104.14 156.42 35.76 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.222 -0.924 . . . . 0.0 109.394 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.47 149.05 26.98 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.576 2.184 . . . . 0.0 110.426 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.422 -179.931 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.54 -170.58 0.54 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.318 -0.864 . . . . 0.0 109.529 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.491 ' HG3' ' CZ ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -132.96 -169.3 2.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.186 -0.946 . . . . 0.0 109.487 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.49 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 1.4 m-20 -87.51 46.92 1.43 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.258 -0.902 . . . . 0.0 109.523 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.594 ' CE3' ' HB2' ' A' ' 18' ' ' ARG . 72.6 m95 -55.44 111.66 0.93 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.255 -0.903 . . . . 0.0 109.658 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' A' ' 4' ' ' ASP . 69.2 mt -114.05 151.17 32.89 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.22 -0.925 . . . . 0.0 109.328 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.471 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 7.7 m-20 -44.42 139.23 2.83 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.188 -0.945 . . . . 0.0 109.484 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.494 ' HB2' ' N ' ' A' ' 17' ' ' ARG . 38.3 t -103.65 104.78 44.16 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.302 -0.874 . . . . 0.0 109.639 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 35.1 Cg_endo -76.87 -35.26 1.96 Allowed 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 122.441 2.094 . . . . 0.0 110.415 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 9' ' ' PRO . . . -43.89 -45.57 7.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.264 -0.897 . . . . 0.0 109.401 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 1.034 HD12 ' CD1' ' A' ' 15' ' ' TRP . 11.5 mt -97.67 -60.63 1.53 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.201 -0.937 . . . . 0.0 109.404 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 154.3 -153.15 24.61 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.07 145.0 21.67 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.71 2.273 . . . . 0.0 110.323 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.94 -24.44 31.19 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 1.034 ' CD1' HD12 ' A' ' 11' ' ' LEU . 5.5 t-105 -98.61 132.64 43.86 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.41 -1.053 . . . . 0.0 109.264 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.442 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -111.08 120.48 42.47 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.108 -0.995 . . . . 0.0 109.888 -179.793 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.494 ' N ' ' HB2' ' A' ' 8' ' ' CYS . 1.3 ttp85 -93.35 115.97 28.53 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.346 -0.846 . . . . 0.0 108.891 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.594 ' HB2' ' CE3' ' A' ' 5' ' ' TRP . 12.0 ttt180 -100.15 147.33 25.8 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.291 -0.88 . . . . 0.0 110.28 -179.234 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.481 ' O ' ' HG3' ' A' ' 19' ' ' GLU . 6.1 pt-20 -125.11 144.16 50.56 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.581 HG22 ' HE ' ' A' ' 18' ' ' ARG . 2.5 t -131.12 159.08 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.076 -1.015 . . . . 0.0 109.843 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.444 ' O ' ' CB ' ' A' ' 22' ' ' ARG . 1.6 m-30 -95.41 10.03 37.84 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.324 -0.86 . . . . 0.0 109.211 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.444 ' CB ' ' O ' ' A' ' 21' ' ' PHE . 0.0 OUTLIER 73.11 -70.26 0.17 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.32 -0.863 . . . . 0.0 109.349 -179.868 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.79 -57.62 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.269 -0.894 . . . . 0.0 109.435 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 17.1 m -87.79 176.94 7.15 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.245 -0.909 . . . . 0.0 109.425 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -122.24 28.17 5.89 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.66 170.42 9.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.25 -1.147 . . . . 0.0 109.509 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.6 p -92.51 15.13 14.82 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.255 -0.903 . . . . 0.0 109.628 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 4.3 t -121.34 -26.92 4.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.159 -0.963 . . . . 0.0 109.622 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.54 154.08 35.34 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.76 178.29 4.74 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.2 -1.176 . . . . 0.0 109.41 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.9 m -119.94 166.37 13.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.183 -0.948 . . . . 0.0 109.61 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.593 ' HB3' ' CE1' ' A' ' 34' ' ' TYR . 2.2 m-20 -112.81 155.47 24.55 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.3 -0.875 . . . . 0.0 109.419 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 8.7 m -131.74 108.59 9.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.249 -0.907 . . . . 0.0 109.656 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.597 ' CD1' ' CG ' ' A' ' 44' ' ' ARG . 6.5 m-85 -105.69 165.2 11.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.232 -0.918 . . . . 0.0 109.345 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.605 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 4.3 m-85 -133.66 140.24 46.95 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.102 -0.999 . . . . 0.0 109.921 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -123.0 128.25 49.94 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.425 -0.797 . . . . 0.0 109.246 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.49 ' HB2' ' HD2' ' A' ' 38' ' ' PRO . 1.7 p -80.17 167.99 29.15 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.301 -0.874 . . . . 0.0 109.42 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.49 ' HD2' ' HB2' ' A' ' 37' ' ' SER . 35.6 Cg_endo -78.37 5.85 5.19 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.647 2.231 . . . . 0.0 110.414 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.9 p -113.21 -24.93 9.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.217 -0.927 . . . . 0.0 109.479 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 123.38 16.18 3.53 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.17 105.35 17.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.148 -1.207 . . . . 0.0 109.254 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.75 105.1 17.59 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.318 -0.864 . . . . 0.0 109.689 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.718 HG21 ' CA ' ' A' ' 49' ' ' LEU . 3.2 mt -110.09 151.77 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.307 -0.87 . . . . 0.0 109.092 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.597 ' CG ' ' CD1' ' A' ' 34' ' ' TYR . 7.5 ttp180 -126.85 -0.25 6.65 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.133 -0.979 . . . . 0.0 110.04 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.887 ' O ' HD23 ' A' ' 49' ' ' LEU . 1.1 m -93.73 172.05 8.49 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.142 -0.974 . . . . 0.0 108.525 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.568 ' HB2' ' CD1' ' A' ' 64' ' ' PHE . 22.8 ttpt -91.12 -63.27 1.29 Allowed 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.034 -1.042 . . . . 0.0 110.146 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.401 ' O ' HG12 ' A' ' 47' ' ' VAL . 61.9 t -80.8 -10.82 12.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.048 -1.033 . . . . 0.0 109.316 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.568 ' HB2' ' CB ' ' A' ' 45' ' ' SER . 0.1 OUTLIER -77.3 -46.52 22.72 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 178.485 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.887 HD23 ' O ' ' A' ' 45' ' ' SER . 2.5 pp -68.84 -25.89 64.88 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 178.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.899 ' OG1' HD13 ' A' ' 59' ' ' LEU . 8.5 m -72.86 -49.28 31.02 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.294 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.23 -25.99 49.58 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.413 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 40.9 t80 -65.8 -60.46 2.86 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.54 -0.725 . . . . 0.0 109.288 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.851 HD21 ' CZ3' ' A' ' 15' ' ' TRP . 0.5 OUTLIER -58.44 -56.3 23.93 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.194 -0.941 . . . . 0.0 109.3 179.908 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 131.42 -149.44 19.26 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.5 -11.85 17.08 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.556 2.171 . . . . 0.0 110.302 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.21 -19.11 63.18 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.211 -0.93 . . . . 0.0 109.205 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 53.0 m -135.42 146.95 48.79 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.352 -0.842 . . . . 0.0 109.194 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.656 ' C ' HD12 ' A' ' 59' ' ' LEU . 0.6 OUTLIER -138.04 152.66 49.06 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.144 -0.972 . . . . 0.0 109.872 -179.754 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.899 HD13 ' OG1' ' A' ' 50' ' ' THR . 4.5 mp -148.47 9.88 0.84 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.266 -0.897 . . . . 0.0 109.541 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.673 HG22 ' CD2' ' A' ' 61' ' ' LEU . 23.2 m -48.93 -28.05 3.56 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.175 -0.953 . . . . 0.0 109.007 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.673 ' CD2' HG22 ' A' ' 60' ' ' THR . 1.3 mm? -111.74 -13.75 13.68 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.437 -0.79 . . . . 0.0 109.164 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.543 ' CD1' ' C ' ' A' ' 62' ' ' PHE . 7.8 t80 -49.37 131.71 20.38 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.401 -0.812 . . . . 0.0 109.517 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.539 ' O ' ' N ' ' A' ' 65' ' ' LYS . 2.3 m-20 -79.72 100.57 7.96 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.223 -0.923 . . . . 0.0 108.811 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.568 ' CD1' ' HB2' ' A' ' 46' ' ' LYS . 1.1 t80 -66.63 61.12 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.405 -0.809 . . . . 0.0 109.519 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.539 ' N ' ' O ' ' A' ' 63' ' ' ASP . 20.0 ttpt 177.22 -38.55 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.464 -0.772 . . . . 0.0 108.963 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -86.8 -47.8 8.76 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.313 -0.867 . . . . 0.0 109.203 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 115.21 23.05 4.66 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.569 ' C ' HD12 ' A' ' 68' ' ' ILE . 2.4 pp -140.11 -173.3 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.079 -1.247 . . . . 0.0 109.576 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.514 ' CB ' ' HA ' ' A' ' 62' ' ' PHE . 0.7 OUTLIER -151.43 -166.64 2.57 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.282 -0.886 . . . . 0.0 109.124 -179.874 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.483 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 2.7 t -160.44 137.39 9.11 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.179 -0.951 . . . . 0.0 109.72 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -110.63 96.71 29.31 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.184 -0.948 . . . . 0.0 109.009 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.688 ' O ' ' HB2' ' A' ' 73' ' ' ALA . 35.1 Cg_endo -77.06 156.47 34.01 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.518 2.146 . . . . 0.0 110.497 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.924 ' HB3' ' HD3' ' A' ' 74' ' ' PRO . . . 162.92 -52.89 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.387 -0.82 . . . . 0.0 109.305 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.924 ' HD3' ' HB3' ' A' ' 73' ' ' ALA . 35.1 Cg_endo -78.24 -37.72 0.71 Allowed 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.408 2.072 . . . . 0.0 110.328 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.8 pttp . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 117.999 -1.001 . . . . 0.0 109.498 179.938 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.1 ttt . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.296 0.569 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -133.2 -143.29 0.22 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.273 -0.892 . . . . 0.0 109.251 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.2 pm0 -103.37 97.98 7.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.039 -1.038 . . . . 0.0 109.543 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.469 ' O ' ' O ' ' A' ' 5' ' ' TRP . 75.4 m-20 -128.93 23.53 5.7 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.268 -0.895 . . . . 0.0 109.345 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.583 ' CE2' ' HG3' ' A' ' 18' ' ' ARG . 89.1 m95 55.72 109.32 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.422 -0.799 . . . . 0.0 109.671 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.21 151.18 38.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.238 -0.913 . . . . 0.0 109.394 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.415 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 16.9 t70 -45.04 145.43 1.0 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.336 -0.853 . . . . 0.0 109.33 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.468 ' HB3' ' HB3' ' A' ' 15' ' ' TRP . 26.8 t -105.55 105.56 53.02 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.198 -0.939 . . . . 0.0 109.678 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.5 ' HD2' ' CZ ' ' A' ' 17' ' ' ARG . 35.2 Cg_endo -76.97 -33.57 2.69 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.441 2.094 . . . . 0.0 110.129 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.414 ' C ' HD23 ' A' ' 11' ' ' LEU . . . -47.33 -42.23 20.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.226 -0.921 . . . . 0.0 109.329 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.97 HD12 ' CD1' ' A' ' 15' ' ' TRP . 8.8 mt -99.98 -62.41 1.24 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.306 -0.871 . . . . 0.0 109.349 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.432 ' O ' ' O ' ' A' ' 8' ' ' CYS . . . 165.5 -153.03 22.82 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.44 150.31 25.01 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.643 2.229 . . . . 0.0 110.361 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.55 -65.85 1.76 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.97 ' CD1' HD12 ' A' ' 11' ' ' LEU . 6.4 t-105 -48.98 130.5 18.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.264 -1.139 . . . . 0.0 109.409 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -107.85 118.67 37.35 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.119 -0.988 . . . . 0.0 109.406 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.5 ' CZ ' ' HD2' ' A' ' 9' ' ' PRO . 1.2 ttp85 -93.16 116.76 29.34 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.275 -0.891 . . . . 0.0 109.368 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.583 ' HG3' ' CE2' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -96.99 142.36 29.04 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.341 -0.85 . . . . 0.0 109.437 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.434 ' CG ' ' O ' ' A' ' 19' ' ' GLU . 17.9 pt-20 -127.24 116.68 20.95 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.231 -0.918 . . . . 0.0 109.306 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.466 ' O ' ' HB3' ' A' ' 31' ' ' SER . 82.0 t -108.35 136.26 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.166 -0.958 . . . . 0.0 109.683 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -85.18 75.27 10.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.339 -0.85 . . . . 0.0 109.491 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -49.67 -62.34 1.61 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.364 -0.835 . . . . 0.0 109.438 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.461 ' O ' ' HG3' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -167.3 29.46 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.28 -0.888 . . . . 0.0 109.574 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -177.63 82.31 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.142 -0.974 . . . . 0.0 109.553 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -124.0 33.4 3.89 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.43 -68.95 0.57 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.341 -1.094 . . . . 0.0 109.664 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 48.8 p -122.67 73.46 1.13 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.184 -0.948 . . . . 0.0 109.707 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 62.21 40.91 11.11 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.329 -0.857 . . . . 0.0 109.756 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.79 -138.59 0.02 OUTLIER Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.464 ' HA ' ' HD2' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -87.28 -79.86 0.27 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.244 -1.15 . . . . 0.0 109.227 179.727 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.466 ' HB3' ' O ' ' A' ' 20' ' ' VAL . 5.8 m 61.4 166.61 0.1 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.177 -0.952 . . . . 0.0 109.673 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.468 ' OD2' ' CZ ' ' A' ' 34' ' ' TYR . 3.0 t70 -118.99 129.8 55.35 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.272 -0.892 . . . . 0.0 109.206 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 70.0 m -110.62 125.4 53.38 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.191 -0.943 . . . . 0.0 109.868 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.572 ' CD1' ' N ' ' A' ' 34' ' ' TYR . 3.7 m-85 -112.9 155.41 24.76 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.29 -0.881 . . . . 0.0 108.888 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.634 ' CD1' HD22 ' A' ' 49' ' ' LEU . 39.4 m-85 -126.03 131.07 52.26 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.019 -1.05 . . . . 0.0 109.905 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -122.42 128.19 50.61 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.465 -0.772 . . . . 0.0 109.151 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.498 ' CB ' ' HD2' ' A' ' 38' ' ' PRO . 0.9 OUTLIER -73.54 173.58 6.02 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.309 -0.869 . . . . 0.0 109.675 -179.73 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.498 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 34.5 Cg_endo -77.35 1.23 8.97 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.668 2.245 . . . . 0.0 110.297 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 p -111.04 -24.13 10.52 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.255 -0.903 . . . . 0.0 109.147 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 125.3 18.29 2.54 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.669 ' OD2' HD11 ' A' ' 43' ' ' ILE . 5.1 t70 -79.64 119.28 22.37 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.086 -1.244 . . . . 0.0 109.35 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.412 ' O ' ' HG2' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -103.4 107.74 18.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.285 -0.884 . . . . 0.0 109.737 -179.717 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.685 HG21 ' CA ' ' A' ' 49' ' ' LEU . 3.3 mt -120.33 151.38 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.321 -0.862 . . . . 0.0 109.133 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.591 ' O ' ' CZ ' ' A' ' 64' ' ' PHE . 10.6 ttm180 -126.81 -1.13 6.66 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.087 -1.008 . . . . 0.0 109.884 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.862 ' O ' HD23 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -88.84 179.26 6.24 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.073 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.559 ' HA ' ' CE1' ' A' ' 64' ' ' PHE . 28.7 ttpt -97.87 -59.68 1.72 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.977 -1.077 . . . . 0.0 109.657 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 99.2 t -84.24 -16.66 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.108 -0.995 . . . . 0.0 108.889 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.568 ' HB2' ' CB ' ' A' ' 45' ' ' SER . 1.9 tt0 -70.05 -45.36 67.28 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.59 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.862 HD23 ' O ' ' A' ' 45' ' ' SER . 2.0 pp -71.36 -27.12 63.13 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 178.394 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.957 ' OG1' HD13 ' A' ' 59' ' ' LEU . 27.7 m -67.36 -47.08 71.49 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.32 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.519 ' NH1' ' HG3' ' A' ' 51' ' ' ARG . 7.2 mmt85 -55.34 -31.33 61.63 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.542 ' CZ ' ' HB2' ' A' ' 41' ' ' ASP . 86.0 t80 -63.71 -51.24 65.89 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.934 -0.706 . . . . 0.0 109.431 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.86 HD21 ' CE3' ' A' ' 15' ' ' TRP . 1.5 mt -59.63 -58.86 6.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.305 -0.872 . . . . 0.0 109.536 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 135.71 -155.27 22.18 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -79.41 -10.17 14.79 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.621 2.214 . . . . 0.0 110.494 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.22 -15.81 56.18 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.228 -0.92 . . . . 0.0 109.711 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.4 ' CB ' HD13 ' A' ' 53' ' ' LEU . 72.7 m -128.45 139.77 52.17 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.254 -0.904 . . . . 0.0 109.39 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.897 ' C ' HD12 ' A' ' 59' ' ' LEU . 2.8 p30 -137.02 151.73 49.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.257 -0.902 . . . . 0.0 109.523 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.957 HD13 ' OG1' ' A' ' 50' ' ' THR . 6.6 mp -142.53 -0.2 1.24 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.22 -0.925 . . . . 0.0 110.076 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.573 ' C ' HD22 ' A' ' 61' ' ' LEU . 17.1 m -48.16 -27.44 2.39 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 120.996 -1.065 . . . . 0.0 108.521 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.602 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 1.3 mm? -105.53 -21.08 13.28 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.542 ' CE1' ' HA2' ' A' ' 67' ' ' GLY . 51.2 t80 -55.85 140.62 41.86 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.64 -0.662 . . . . 0.0 109.267 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.519 ' O ' ' N ' ' A' ' 65' ' ' LYS . 4.9 m-20 -88.32 108.64 19.44 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.189 -0.945 . . . . 0.0 109.578 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.591 ' CZ ' ' O ' ' A' ' 44' ' ' ARG . 1.7 t80 -66.62 66.9 0.06 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.288 -0.882 . . . . 0.0 109.214 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 63' ' ' ASP . 1.2 ttpm? 166.92 -36.55 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -88.18 -40.45 13.7 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.413 -0.804 . . . . 0.0 109.46 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.542 ' HA2' ' CE1' ' A' ' 62' ' ' PHE . . . 98.56 25.22 10.16 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.46 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 1.6 pp -140.47 160.31 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.201 -1.176 . . . . 0.0 109.812 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.478 ' CA ' ' HA ' ' A' ' 62' ' ' PHE . 0.6 OUTLIER -137.45 -167.57 2.14 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.338 -0.852 . . . . 0.0 108.875 179.481 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 37.7 t -153.11 148.92 27.53 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.085 -1.01 . . . . 0.0 109.61 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -133.48 87.54 37.14 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.309 -0.87 . . . . 0.0 109.353 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.29 137.36 15.02 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.682 2.255 . . . . 0.0 110.365 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.805 ' HB1' ' HD2' ' A' ' 74' ' ' PRO . . . -163.02 169.9 8.27 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.274 -0.891 . . . . 0.0 109.419 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.805 ' HD2' ' HB1' ' A' ' 73' ' ' ALA . 35.7 Cg_endo -77.85 -5.57 15.39 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.591 2.194 . . . . 0.0 110.286 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.418 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.9 mmm . . . . . 0 N--CA 1.488 1.465 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -128.04 0.55 5.89 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.269 -0.894 . . . . 0.0 109.509 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -133.87 137.37 44.95 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.259 -0.901 . . . . 0.0 109.012 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.461 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 0.6 OUTLIER -145.83 76.4 1.46 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.136 -0.978 . . . . 0.0 110.081 -179.601 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.591 ' CE3' ' HB2' ' A' ' 18' ' ' ARG . 64.3 m95 -66.14 96.58 0.34 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.272 -0.892 . . . . 0.0 108.78 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 4' ' ' ASP . 1.3 mt -106.06 169.31 8.57 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.13 -0.981 . . . . 0.0 109.855 -179.282 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.474 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 0.7 OUTLIER -56.85 132.25 51.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.338 -0.851 . . . . 0.0 109.474 -179.853 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.519 ' SG ' ' CZ ' ' A' ' 17' ' ' ARG . 18.9 t -89.02 112.76 52.89 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.224 -0.922 . . . . 0.0 109.398 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 35.9 Cg_endo -77.72 -52.86 0.07 OUTLIER 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.366 2.044 . . . . 0.0 110.822 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.646 ' HB3' ' NH1' ' A' ' 17' ' ' ARG . . . -39.81 -46.77 2.01 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.427 -0.795 . . . . 0.0 110.045 -179.641 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 1.023 HD12 ' CD1' ' A' ' 15' ' ' TRP . 11.6 mt -94.16 -60.63 1.69 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.169 -0.957 . . . . 0.0 109.467 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.443 ' O ' ' O ' ' A' ' 8' ' ' CYS . . . 148.36 -145.4 13.81 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.04 156.48 30.29 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.608 2.205 . . . . 0.0 110.342 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.99 -57.82 4.31 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.299 -1.521 . . . . 0.0 109.299 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 1.023 ' CD1' HD12 ' A' ' 11' ' ' LEU . 4.8 t-105 -65.49 129.27 39.17 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.298 -1.119 . . . . 0.0 109.526 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.47 123.08 46.84 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.305 -0.872 . . . . 0.0 109.59 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.646 ' NH1' ' HB3' ' A' ' 10' ' ' ALA . 0.2 OUTLIER -93.48 106.03 18.04 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.273 -0.892 . . . . 0.0 109.365 179.881 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.591 ' HB2' ' CE3' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -100.35 142.68 31.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.239 -0.913 . . . . 0.0 109.524 -179.891 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.525 ' N ' ' HG2' ' A' ' 18' ' ' ARG . 6.1 pt-20 -99.95 159.09 15.35 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.292 -0.88 . . . . 0.0 109.825 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.511 ' HB ' ' CB ' ' A' ' 32' ' ' ASP . 98.9 t -128.94 158.68 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.325 -0.86 . . . . 0.0 109.038 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.449 ' N ' HG12 ' A' ' 20' ' ' VAL . 0.3 OUTLIER -104.5 45.28 0.97 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.105 -0.997 . . . . 0.0 109.799 -179.821 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.435 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 0.0 OUTLIER 65.59 50.15 1.68 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.22 -0.925 . . . . 0.0 109.665 179.757 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.435 ' HG2' ' O ' ' A' ' 22' ' ' ARG . 0.9 OUTLIER -139.7 112.17 7.76 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.131 -0.98 . . . . 0.0 109.668 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.448 ' HB2' ' OH ' ' A' ' 34' ' ' TYR . 1.6 t -176.86 -81.45 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.303 -0.873 . . . . 0.0 109.327 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -143.43 -141.22 3.78 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -83.07 55.94 3.3 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.299 -1.118 . . . . 0.0 109.509 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -104.93 95.34 5.8 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.297 -0.877 . . . . 0.0 109.496 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -86.42 76.26 9.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.304 -0.873 . . . . 0.0 109.506 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -133.0 -163.45 10.55 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.424 ' O ' ' OG ' ' A' ' 31' ' ' SER . 2.2 tpt180 -102.65 95.94 6.55 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.246 -1.149 . . . . 0.0 109.438 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.424 ' OG ' ' O ' ' A' ' 30' ' ' ARG . 4.2 p 63.3 128.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.25 -0.907 . . . . 0.0 109.534 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.511 ' CB ' ' HB ' ' A' ' 20' ' ' VAL . 0.9 OUTLIER -83.91 158.43 21.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.21 -0.931 . . . . 0.0 109.495 -179.892 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -134.81 116.0 14.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.239 -0.913 . . . . 0.0 109.585 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.503 ' CE1' ' HD3' ' A' ' 44' ' ' ARG . 20.8 m-30 -116.22 140.06 49.71 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.245 -0.91 . . . . 0.0 109.247 179.699 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.551 ' CE2' ' CE1' ' A' ' 64' ' ' PHE . 4.3 m-85 -112.02 147.05 36.8 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.199 -0.938 . . . . 0.0 109.636 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.454 ' HA ' ' O ' ' A' ' 41' ' ' ASP . 26.1 tt0 -131.24 128.17 39.34 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.334 -0.854 . . . . 0.0 109.342 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.508 ' HB3' ' HD2' ' A' ' 38' ' ' PRO . 0.9 OUTLIER -69.72 173.9 3.64 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.249 -0.907 . . . . 0.0 109.304 179.999 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.508 ' HD2' ' HB3' ' A' ' 37' ' ' SER . 36.3 Cg_endo -78.12 -3.79 13.76 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.597 2.198 . . . . 0.0 110.602 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.477 HG22 ' HB2' ' A' ' 37' ' ' SER . 10.7 t -101.42 -9.78 20.8 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.2 -0.938 . . . . 0.0 109.594 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 111.46 9.68 21.06 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.494 ' HB2' ' OG ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -78.76 141.56 37.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.186 -1.185 . . . . 0.0 109.424 179.889 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.467 ' O ' ' HG2' ' A' ' 42' ' ' ARG . 0.1 OUTLIER -128.37 120.41 26.92 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.154 -0.966 . . . . 0.0 109.703 -179.753 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.642 HG21 ' HB3' ' A' ' 49' ' ' LEU . 2.4 mp -126.73 162.23 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.19 -0.944 . . . . 0.0 109.328 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.576 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 29.3 mtt85 -147.35 20.07 1.21 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.217 -0.927 . . . . 0.0 109.756 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.585 ' H ' HG22 ' A' ' 43' ' ' ILE . 0.5 OUTLIER -95.06 -86.78 0.29 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.386 -0.821 . . . . 0.0 108.821 179.433 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.549 ' HB2' ' CD1' ' A' ' 64' ' ' PHE . 24.2 ttmt 159.72 -64.96 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 43.7 t -87.25 -19.58 7.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.501 ' HB2' ' HB2' ' A' ' 45' ' ' SER . 16.2 mt-10 -69.89 -41.44 74.73 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.642 ' HB3' HG21 ' A' ' 43' ' ' ILE . 3.0 pp -72.39 -33.09 66.94 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.86 ' HA ' HD12 ' A' ' 53' ' ' LEU . 1.4 m -63.91 -48.62 75.87 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.402 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.22 -28.13 57.28 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.487 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 41.6 t80 -72.58 -56.98 4.51 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.624 -0.672 . . . . 0.0 109.353 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.915 HD21 ' CE3' ' A' ' 15' ' ' TRP . 0.5 OUTLIER -55.03 -57.09 13.13 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.098 -1.001 . . . . 0.0 109.139 179.681 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 134.28 -157.98 23.16 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.1 3.17 7.29 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.559 2.173 . . . . 0.0 110.343 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -84.87 -27.27 26.81 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.228 -0.92 . . . . 0.0 109.465 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.525 ' O ' ' CG2' ' A' ' 50' ' ' THR . 54.3 m -122.33 138.48 54.5 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.303 -0.873 . . . . 0.0 109.245 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.553 ' HA ' HG21 ' A' ' 50' ' ' THR . 29.0 t70 -127.05 142.83 51.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.165 -0.96 . . . . 0.0 109.511 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.747 HD23 ' CD2' ' A' ' 62' ' ' PHE . 3.6 mp -141.3 8.89 2.04 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.191 -0.943 . . . . 0.0 109.803 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.443 ' C ' HD22 ' A' ' 61' ' ' LEU . 4.0 m -47.43 -42.78 23.02 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.113 -0.992 . . . . 0.0 109.282 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.58 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 1.7 mm? -99.66 -3.08 33.87 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.333 -0.854 . . . . 0.0 109.56 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.747 ' CD2' HD23 ' A' ' 59' ' ' LEU . 83.3 t80 -61.51 139.37 58.25 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.354 -0.841 . . . . 0.0 109.744 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.434 ' O ' ' N ' ' A' ' 65' ' ' LYS . 3.4 m-20 -92.24 104.65 16.99 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.443 -0.786 . . . . 0.0 108.967 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.576 ' CE2' ' O ' ' A' ' 44' ' ' ARG . 0.8 OUTLIER -68.51 65.11 0.11 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.239 -0.913 . . . . 0.0 109.479 -179.526 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 63' ' ' ASP . 1.7 ttpt -178.41 -33.36 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.17 -0.956 . . . . 0.0 109.625 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -107.23 -32.85 7.62 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.264 -0.898 . . . . 0.0 109.704 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.571 ' HA2' ' CZ ' ' A' ' 62' ' ' PHE . . . 97.92 38.63 4.06 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.479 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 1.9 pp -139.88 165.84 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.246 -1.15 . . . . 0.0 109.581 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.513 ' CB ' ' HA ' ' A' ' 62' ' ' PHE . 0.5 OUTLIER -153.79 -176.04 5.65 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.276 -0.89 . . . . 0.0 109.589 179.946 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.474 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 0.1 OUTLIER -157.27 152.63 26.33 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.361 -0.837 . . . . 0.0 109.355 179.797 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.6 t80 178.82 99.23 0.16 Allowed Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.107 -0.996 . . . . 0.0 109.653 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.456 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 36.3 Cg_endo -79.39 174.19 12.24 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.65 2.233 . . . . 0.0 110.615 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 72' ' ' PRO . . . 62.48 71.53 0.69 Allowed Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.326 -0.859 . . . . 0.0 109.602 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.51 54.56 5.08 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.655 2.237 . . . . 0.0 110.432 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.02 -0.991 . . . . 0.0 109.561 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.401 ' O ' ' HB3' ' A' ' 2' ' ' ALA . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 1' ' ' MET . . . 59.31 -170.19 0.13 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.151 -0.968 . . . . 0.0 108.993 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.483 ' HG2' ' HG2' ' A' ' 18' ' ' ARG . 13.8 tp10 -117.59 156.78 27.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.024 -1.047 . . . . 0.0 109.532 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.474 ' O ' ' O ' ' A' ' 5' ' ' TRP . 0.4 OUTLIER -148.99 26.29 0.89 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.214 -0.929 . . . . 0.0 109.358 179.884 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.544 ' CE3' ' HB2' ' A' ' 18' ' ' ARG . 76.7 m95 55.03 107.38 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.375 -0.828 . . . . 0.0 109.45 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.2 mt -107.18 161.32 14.88 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.148 -0.97 . . . . 0.0 109.739 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -53.91 149.28 9.15 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.394 -0.816 . . . . 0.0 109.519 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.467 ' HB3' ' HB3' ' A' ' 15' ' ' TRP . 50.2 t -111.18 103.42 54.89 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.369 -0.832 . . . . 0.0 109.331 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -77.03 -23.85 10.23 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.354 2.036 . . . . 0.0 110.31 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.436 ' C ' HD23 ' A' ' 11' ' ' LEU . . . -52.65 -48.66 66.28 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.189 -0.944 . . . . 0.0 109.173 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.715 HD12 ' CD1' ' A' ' 15' ' ' TRP . 0.7 OUTLIER -96.64 -59.86 1.72 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.375 -0.828 . . . . 0.0 109.245 179.882 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 158.82 -153.69 24.81 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.35 154.41 28.17 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.614 2.209 . . . . 0.0 110.596 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.18 -12.32 68.24 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.715 ' CD1' HD12 ' A' ' 11' ' ' LEU . 16.5 t-105 -111.7 126.21 54.8 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.175 -1.191 . . . . 0.0 109.52 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 18.3 mmtp -101.27 119.58 38.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.282 -0.887 . . . . 0.0 109.581 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.519 ' HG3' ' CE2' ' A' ' 35' ' ' TYR . 5.8 ttp85 -94.89 114.69 26.57 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.224 -0.922 . . . . 0.0 109.359 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.544 ' HB2' ' CE3' ' A' ' 5' ' ' TRP . 0.2 OUTLIER -100.29 128.47 46.35 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.351 -0.843 . . . . 0.0 109.321 179.997 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.448 ' HG2' ' OE2' ' A' ' 3' ' ' GLU . 9.3 pt-20 -118.24 134.06 55.35 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.263 -0.898 . . . . 0.0 109.248 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 32' ' ' ASP . 0.2 OUTLIER -111.51 -178.51 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.246 -0.909 . . . . 0.0 109.474 -179.834 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.456 ' O ' ' HB2' ' A' ' 22' ' ' ARG . 28.1 m-85 -124.95 44.21 2.84 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.281 -0.887 . . . . 0.0 109.186 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.486 ' O ' ' CB ' ' A' ' 23' ' ' LYS . 0.8 OUTLIER 69.25 -60.83 0.45 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.325 -0.859 . . . . 0.0 109.532 -179.944 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.486 ' CB ' ' O ' ' A' ' 22' ' ' ARG . 1.3 tmtt? 74.98 -56.98 0.62 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.267 -0.896 . . . . 0.0 109.458 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.438 ' OG ' ' N ' ' A' ' 25' ' ' GLY . 9.9 t -161.91 179.79 7.77 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.184 -0.947 . . . . 0.0 109.435 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.438 ' N ' ' OG ' ' A' ' 24' ' ' SER . . . 119.4 -132.58 9.62 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -97.03 -175.89 3.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.256 -1.144 . . . . 0.0 109.518 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 20.2 p -92.44 27.65 2.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.267 -0.896 . . . . 0.0 109.375 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 85.9 m -48.05 -68.03 0.22 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.263 -0.898 . . . . 0.0 109.57 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 107.01 35.02 2.84 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.9 ptt85 -127.79 144.19 51.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.197 -1.178 . . . . 0.0 109.4 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.5 p -97.23 133.79 41.39 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.297 -0.877 . . . . 0.0 109.612 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 32' ' ' ASP . 0.3 OUTLIER -80.04 149.4 30.72 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.291 -0.881 . . . . 0.0 109.108 179.774 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 46.2 m -128.78 108.94 10.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.087 -1.008 . . . . 0.0 110.042 -179.564 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.535 ' CD1' ' N ' ' A' ' 34' ' ' TYR . 2.7 m-30 -99.66 151.73 20.88 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.333 -0.854 . . . . 0.0 108.922 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.603 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 3.8 m-85 -123.68 148.77 46.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.962 -1.086 . . . . 0.0 109.914 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.521 ' HB2' ' CZ3' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -128.32 119.59 25.39 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.497 -0.752 . . . . 0.0 109.01 179.753 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.417 ' HB3' ' HD2' ' A' ' 38' ' ' PRO . 0.6 OUTLIER -63.99 170.32 3.52 Favored Pre-proline 0 N--CA 1.488 1.437 0 O-C-N 121.317 -0.865 . . . . 0.0 109.374 -179.918 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.417 ' HD2' ' HB3' ' A' ' 37' ' ' SER . 35.1 Cg_endo -78.26 -2.58 12.64 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.619 2.213 . . . . 0.0 110.161 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.8 p -102.75 -23.8 13.78 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.269 -0.895 . . . . 0.0 109.645 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 123.81 9.44 5.76 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.471 ' HB2' ' OH ' ' A' ' 52' ' ' TYR . 0.7 OUTLIER -92.07 112.3 24.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.19 -1.182 . . . . 0.0 109.362 179.951 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.462 ' HB3' ' HG3' ' A' ' 36' ' ' GLN . 0.0 OUTLIER -99.43 122.36 42.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.343 -0.848 . . . . 0.0 109.808 -179.738 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.613 HG22 ' H ' ' A' ' 45' ' ' SER . 2.7 mp -117.68 154.04 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.346 -0.846 . . . . 0.0 109.169 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.583 ' O ' ' CZ ' ' A' ' 64' ' ' PHE . 5.6 ttp180 -123.46 -0.21 8.75 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.001 -1.062 . . . . 0.0 109.956 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.752 ' O ' HD23 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -96.61 154.54 17.22 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.231 -0.918 . . . . 0.0 108.558 179.228 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.551 ' HB2' ' CD1' ' A' ' 64' ' ' PHE . 17.4 ttpt -72.85 -67.36 0.57 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.069 -1.019 . . . . 0.0 110.402 -178.968 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.483 ' O ' ' CG ' ' A' ' 51' ' ' ARG . 53.5 t -72.1 -25.69 24.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 120.862 -1.149 . . . . 0.0 109.956 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.553 ' HB2' ' CB ' ' A' ' 45' ' ' SER . 6.9 tt0 -62.72 -49.03 76.68 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.759 -1.213 . . . . 0.0 108.278 179.021 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.752 HD23 ' O ' ' A' ' 45' ' ' SER . 1.8 pp -70.26 -23.85 62.96 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.636 HG23 ' HB2' ' A' ' 59' ' ' LEU . 33.0 m -65.5 -68.55 0.36 Allowed 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.611 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.485 ' HG3' ' O ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -42.9 -31.56 0.52 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 179.269 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.494 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 51.4 t80 -55.09 -56.88 14.81 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.326 -0.859 . . . . 0.0 108.74 179.169 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.574 HD12 ' HA ' ' A' ' 50' ' ' THR . 0.3 OUTLIER -65.07 -43.14 93.17 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.214 -0.929 . . . . 0.0 109.16 179.379 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 110.26 -152.7 17.28 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.284 -1.527 . . . . 0.0 109.284 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.43 -10.92 15.99 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.545 2.163 . . . . 0.0 110.205 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.1 -32.15 66.73 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.296 -0.878 . . . . 0.0 109.371 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.512 ' HB2' ' CB ' ' A' ' 53' ' ' LEU . 4.0 m -121.86 97.84 5.68 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 0.0 109.251 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -74.99 137.42 41.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.255 -0.903 . . . . 0.0 109.731 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.798 HD23 ' CB ' ' A' ' 62' ' ' PHE . 0.1 OUTLIER -142.21 7.91 1.8 Allowed 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.37 -0.831 . . . . 0.0 109.54 -179.731 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.673 ' C ' HD22 ' A' ' 61' ' ' LEU . 97.9 m -56.69 -28.39 60.73 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.348 -0.845 . . . . 0.0 109.645 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.673 HD22 ' C ' ' A' ' 60' ' ' THR . 2.4 mm? -107.33 -10.47 15.78 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.261 -0.899 . . . . 0.0 109.485 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.798 ' CB ' HD23 ' A' ' 59' ' ' LEU . 38.5 t80 -45.27 128.83 7.9 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.361 -0.837 . . . . 0.0 109.53 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.495 ' O ' ' N ' ' A' ' 65' ' ' LYS . 11.1 m-20 -79.67 100.99 8.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.326 -0.859 . . . . 0.0 109.194 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.583 ' CZ ' ' O ' ' A' ' 44' ' ' ARG . 0.7 OUTLIER -65.55 72.95 0.06 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.374 -0.829 . . . . 0.0 109.333 -179.672 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.495 ' N ' ' O ' ' A' ' 63' ' ' ASP . 0.6 OUTLIER 166.5 -43.6 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.824 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.433 ' HG3' ' HD3' ' A' ' 65' ' ' LYS . 8.5 mt-30 -86.33 -44.67 11.9 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.373 -0.829 . . . . 0.0 109.305 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.408 ' HA2' ' CZ ' ' A' ' 62' ' ' PHE . . . 108.77 25.18 5.78 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.891 -1.283 . . . . 0.0 109.891 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.464 HG13 ' OD2' ' A' ' 63' ' ' ASP . 1.1 pt -140.23 162.58 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.199 -1.177 . . . . 0.0 109.48 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.624 ' H ' HD23 ' A' ' 69' ' ' LEU . 1.7 pt? -133.0 146.38 51.72 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.125 -0.984 . . . . 0.0 109.472 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.418 ' H ' ' HB3' ' A' ' 61' ' ' LEU . 40.7 m -129.33 -148.94 0.39 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.325 -0.859 . . . . 0.0 108.824 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.463 ' HA ' ' HG ' ' A' ' 61' ' ' LEU . 1.3 m-85 -123.71 165.39 23.59 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.08 -1.013 . . . . 0.0 109.394 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.453 ' HD2' ' CD2' ' A' ' 71' ' ' TYR . 35.1 Cg_endo -77.99 122.91 5.98 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.72 2.28 . . . . 0.0 110.623 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -135.39 93.33 16.61 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.326 -0.859 . . . . 0.0 109.296 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.418 ' O ' ' CB ' ' A' ' 75' ' ' LYS . 35.2 Cg_endo -77.12 139.91 19.45 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.579 2.186 . . . . 0.0 110.422 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.418 ' CB ' ' O ' ' A' ' 74' ' ' PRO . 11.8 mttm . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.997 -1.002 . . . . 0.0 109.442 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.7 mtm . . . . . 0 N--CA 1.489 1.492 0 CA-C-O 121.246 0.546 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.523 ' O ' ' CZ ' ' A' ' 21' ' ' PHE . . . -156.0 32.82 0.34 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.236 -0.915 . . . . 0.0 109.392 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.418 ' HB2' ' HG2' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -116.94 -178.75 3.51 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.26 -0.9 . . . . 0.0 109.567 -179.949 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.929 ' O ' HD23 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -154.18 80.34 1.12 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.385 -0.822 . . . . 0.0 108.9 179.844 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.412 ' C ' ' O ' ' A' ' 4' ' ' ASP . 73.3 m95 -42.42 119.31 1.38 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.469 -0.769 . . . . 0.0 109.773 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.929 HD23 ' O ' ' A' ' 4' ' ' ASP . 0.4 OUTLIER -130.92 147.97 52.63 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.29 -0.881 . . . . 0.0 109.487 179.839 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.484 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 48.4 t0 -44.02 138.07 3.03 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.348 -0.845 . . . . 0.0 109.104 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.462 ' SG ' ' HD3' ' A' ' 17' ' ' ARG . 32.6 t -102.77 105.67 46.02 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.198 -0.939 . . . . 0.0 109.505 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 34.4 Cg_endo -77.33 -27.49 6.46 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.297 1.998 . . . . 0.0 109.991 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.658 ' O ' HD21 ' A' ' 69' ' ' LEU . . . -45.5 -57.95 3.74 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.347 -0.846 . . . . 0.0 109.41 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.651 ' N ' HD23 ' A' ' 11' ' ' LEU . 0.9 OUTLIER -89.34 -58.44 2.53 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.321 -0.862 . . . . 0.0 109.327 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 159.02 -152.88 23.99 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.84 164.1 28.06 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.557 2.172 . . . . 0.0 110.351 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.447 ' O ' ' HD3' ' A' ' 38' ' ' PRO . . . 75.49 8.81 84.36 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.918 ' CE3' HD21 ' A' ' 53' ' ' LEU . 9.2 t-105 -130.6 126.08 35.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.171 -1.194 . . . . 0.0 109.46 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 12.5 mmtt -106.4 120.32 41.57 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.225 -0.922 . . . . 0.0 109.579 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.462 ' HD3' ' SG ' ' A' ' 8' ' ' CYS . 1.4 ttp85 -88.38 115.86 26.19 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.474 -0.766 . . . . 0.0 109.325 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.429 ' HD2' ' CG2' ' A' ' 20' ' ' VAL . 3.8 ttm180 -99.53 131.14 45.73 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.173 -0.955 . . . . 0.0 109.371 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.5 ' CG ' ' O ' ' A' ' 19' ' ' GLU . 1.7 pp20? -116.39 117.38 29.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.209 -0.932 . . . . 0.0 109.352 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.53 ' O ' ' N ' ' A' ' 22' ' ' ARG . 8.5 t -113.71 83.73 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.229 -0.92 . . . . 0.0 109.172 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.523 ' CZ ' ' O ' ' A' ' 2' ' ' ALA . 1.1 p90 -45.95 91.75 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.413 -0.805 . . . . 0.0 109.878 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.53 ' N ' ' O ' ' A' ' 20' ' ' VAL . 0.2 OUTLIER -56.07 -35.27 66.79 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.254 -0.904 . . . . 0.0 109.138 179.784 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -176.01 42.07 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.394 -0.816 . . . . 0.0 109.21 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.9 p -57.31 105.86 0.27 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.216 -0.928 . . . . 0.0 109.338 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -86.42 -120.18 1.19 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.81 -89.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.281 -1.129 . . . . 0.0 109.485 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.416 ' O ' ' OG1' ' A' ' 27' ' ' THR . 0.3 OUTLIER -142.97 19.57 1.96 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.254 -0.904 . . . . 0.0 109.401 -179.96 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.5 m -126.35 45.28 2.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.191 -0.943 . . . . 0.0 109.403 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -99.81 -154.85 28.05 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.407 ' O ' ' O ' ' A' ' 31' ' ' SER . 0.0 OUTLIER -134.22 -50.28 0.81 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.252 -1.146 . . . . 0.0 109.417 179.957 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.407 ' O ' ' O ' ' A' ' 30' ' ' ARG . 1.9 m 60.95 116.39 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.37 -0.832 . . . . 0.0 109.657 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -81.49 149.61 28.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.263 -0.898 . . . . 0.0 109.152 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 42.0 m -127.49 111.51 13.89 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.122 -0.987 . . . . 0.0 109.953 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.477 ' CD1' ' N ' ' A' ' 34' ' ' TYR . 19.8 m-85 -99.76 152.98 19.48 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.295 -0.878 . . . . 0.0 108.806 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.622 ' CE1' ' CE1' ' A' ' 64' ' ' PHE . 7.5 m-85 -124.5 142.74 51.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.983 -1.073 . . . . 0.0 109.934 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -126.63 138.98 53.5 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.375 -0.828 . . . . 0.0 109.402 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.924 ' OG ' HG22 ' A' ' 39' ' ' THR . 0.9 OUTLIER -77.89 172.52 9.59 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.287 -0.883 . . . . 0.0 109.506 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.451 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 35.0 Cg_endo -79.29 13.4 2.04 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.77 2.313 . . . . 0.0 110.98 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.924 HG22 ' OG ' ' A' ' 37' ' ' SER . 14.6 t -123.34 -21.62 5.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.981 -1.074 . . . . 0.0 109.852 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 127.27 8.23 4.59 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.456 ' OD2' ' OH ' ' A' ' 52' ' ' TYR . 6.0 m-20 -88.86 133.3 34.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.083 -1.245 . . . . 0.0 109.324 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.41 ' O ' ' HG2' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -116.37 137.06 52.46 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.263 -0.898 . . . . 0.0 109.432 -179.734 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.747 HD13 ' HA ' ' A' ' 49' ' ' LEU . 4.5 mt -132.7 156.21 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.264 -0.897 . . . . 0.0 109.922 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.592 ' O ' ' CZ ' ' A' ' 64' ' ' PHE . 13.3 ttp180 -123.5 -45.72 2.06 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.581 -0.699 . . . . 0.0 110.067 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.578 ' HB2' ' CB ' ' A' ' 48' ' ' GLU . 0.6 OUTLIER -59.28 122.7 14.54 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.915 -1.115 . . . . 0.0 108.831 -179.965 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.575 ' HA ' ' CE1' ' A' ' 64' ' ' PHE . 4.9 ttpm? -40.34 -83.17 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.543 -0.723 . . . . 0.0 110.724 -179.022 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.499 ' HA ' ' OG1' ' A' ' 50' ' ' THR . 42.7 t -55.64 -30.4 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.205 -0.935 . . . . 0.0 110.641 -178.581 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.578 ' CB ' ' HB2' ' A' ' 45' ' ' SER . 14.2 tt0 -54.8 -45.88 74.4 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.663 -1.273 . . . . 0.0 108.813 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.747 ' HA ' HD13 ' A' ' 43' ' ' ILE . 1.4 pp -69.83 -20.67 63.42 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.038 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.78 ' OG1' HD13 ' A' ' 59' ' ' LEU . 17.0 m -71.95 -67.21 0.55 Allowed 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.646 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.46 ' HG3' ' O ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -44.58 -26.96 0.42 Allowed 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.795 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.456 ' OH ' ' OD2' ' A' ' 41' ' ' ASP . 76.5 t80 -67.75 -64.68 0.81 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.455 -0.778 . . . . 0.0 109.191 179.516 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.918 HD21 ' CE3' ' A' ' 15' ' ' TRP . 1.3 mt -44.5 -57.27 3.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.189 -0.945 . . . . 0.0 109.04 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 141.01 -162.16 26.75 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.95 -16.17 14.45 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.648 2.232 . . . . 0.0 110.218 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.29 -8.19 56.54 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.307 -0.871 . . . . 0.0 109.585 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 39.8 m -124.98 168.17 13.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.242 -0.911 . . . . 0.0 109.553 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.928 ' C ' HD12 ' A' ' 59' ' ' LEU . 9.3 p-10 -165.46 141.95 5.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.273 -0.892 . . . . 0.0 109.44 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.928 HD12 ' C ' ' A' ' 58' ' ' ASP . 6.7 mp -139.43 1.28 1.95 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.097 -1.002 . . . . 0.0 109.955 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.619 ' C ' HD22 ' A' ' 61' ' ' LEU . 67.5 m -47.25 -31.28 3.62 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.044 -1.035 . . . . 0.0 108.876 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.813 HD22 ' N ' ' A' ' 61' ' ' LEU . 2.7 mm? -103.43 -15.95 15.74 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.538 ' CZ ' ' HA2' ' A' ' 67' ' ' GLY . 64.9 t80 -57.61 132.87 54.53 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.551 -0.718 . . . . 0.0 109.702 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.497 ' O ' ' N ' ' A' ' 65' ' ' LYS . 1.1 m-20 -79.71 104.79 10.54 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.331 -0.856 . . . . 0.0 108.915 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.622 ' CE1' ' CE1' ' A' ' 35' ' ' TYR . 0.4 OUTLIER -67.74 63.81 0.08 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.183 -0.948 . . . . 0.0 109.424 -179.584 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.497 ' N ' ' O ' ' A' ' 63' ' ' ASP . 1.4 ttmm 173.61 -32.62 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -94.01 -46.45 7.14 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.374 -0.829 . . . . 0.0 109.012 179.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.538 ' HA2' ' CZ ' ' A' ' 62' ' ' PHE . . . 108.45 28.54 4.55 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 1.3 pp -140.74 159.13 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.017 -1.284 . . . . 0.0 109.909 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.695 ' N ' HD23 ' A' ' 69' ' ' LEU . 1.1 pt? -141.54 -176.09 4.61 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 1.2 m -157.16 173.92 16.25 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.037 -1.04 . . . . 0.0 109.828 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -151.78 77.63 7.02 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.409 -0.807 . . . . 0.0 109.307 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.69 69.05 7.49 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.618 2.212 . . . . 0.0 110.346 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.932 ' HB3' ' HD3' ' A' ' 74' ' ' PRO . . . -63.84 -52.39 57.79 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.319 -0.863 . . . . 0.0 109.911 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.932 ' HD3' ' HB3' ' A' ' 73' ' ' ALA . 35.4 Cg_endo -78.13 -176.75 3.41 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.39 2.06 . . . . 0.0 110.611 -179.658 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.6 pttm . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.336 -179.862 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -169.54 -61.52 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.344 -0.848 . . . . 0.0 109.405 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.526 ' HB2' ' CZ ' ' A' ' 18' ' ' ARG . 1.7 pm0 -103.28 73.09 1.19 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.202 -0.936 . . . . 0.0 109.481 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.45 ' O ' ' O ' ' A' ' 5' ' ' TRP . 12.3 m-20 -110.16 27.2 9.85 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.292 -0.88 . . . . 0.0 109.287 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.592 ' CZ3' ' HB2' ' A' ' 36' ' ' GLN . 65.3 m95 47.01 93.24 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.258 -0.901 . . . . 0.0 109.241 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.444 HD11 ' OE2' ' A' ' 19' ' ' GLU . 3.0 mt -103.86 176.48 5.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.37 -0.831 . . . . 0.0 109.644 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 7' ' ' ASP . 6.6 p-10 -62.17 137.27 58.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.391 -0.818 . . . . 0.0 109.422 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.528 ' SG ' ' CZ ' ' A' ' 17' ' ' ARG . 13.4 t -95.5 109.99 48.48 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.259 -0.901 . . . . 0.0 109.231 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 36.2 Cg_endo -79.45 -46.7 0.1 OUTLIER 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.446 2.097 . . . . 0.0 110.795 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.646 ' HB3' ' NH1' ' A' ' 17' ' ' ARG . . . -43.21 -44.03 5.02 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.162 -0.962 . . . . 0.0 109.935 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.785 HD12 ' CD1' ' A' ' 15' ' ' TRP . 10.7 mt -97.23 -61.53 1.39 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.203 -0.936 . . . . 0.0 109.777 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 8' ' ' CYS . . . 155.74 -155.02 25.97 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.95 158.63 30.92 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.582 2.188 . . . . 0.0 110.335 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.4 -43.01 3.09 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.88 ' CE3' HD21 ' A' ' 53' ' ' LEU . 15.9 t-105 -79.35 130.66 35.65 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.221 -1.164 . . . . 0.0 109.424 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.3 mmtm -97.97 124.04 42.25 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.256 -0.903 . . . . 0.0 109.235 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.646 ' NH1' ' HB3' ' A' ' 10' ' ' ALA . 0.7 OUTLIER -99.63 108.92 21.42 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.256 -0.902 . . . . 0.0 109.318 -179.944 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.526 ' CZ ' ' HB2' ' A' ' 3' ' ' GLU . 0.2 OUTLIER -99.85 137.78 37.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.175 -0.953 . . . . 0.0 109.744 -179.779 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.444 ' OE2' HD11 ' A' ' 6' ' ' LEU . 1.5 pt-20 -123.83 152.93 41.74 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.37 -0.831 . . . . 0.0 109.272 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.542 HG12 ' H ' ' A' ' 21' ' ' PHE . 1.9 t -129.05 175.26 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.22 -0.925 . . . . 0.0 109.467 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.542 ' H ' HG12 ' A' ' 20' ' ' VAL . 15.5 m-85 -129.16 60.01 1.56 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.316 -0.865 . . . . 0.0 109.094 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.1 mtt85 -73.02 90.29 1.49 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.388 -0.82 . . . . 0.0 109.779 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -58.5 -47.67 83.35 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.095 -1.003 . . . . 0.0 108.974 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 47.93 -167.08 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.297 -0.877 . . . . 0.0 109.595 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -128.49 -57.33 0.11 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.11 162.14 0.52 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.213 -1.169 . . . . 0.0 109.42 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -100.91 56.74 0.87 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.288 -0.882 . . . . 0.0 109.516 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.9 m -125.65 84.37 2.27 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.253 -0.905 . . . . 0.0 109.449 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.43 124.65 5.43 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.48 ' O ' ' CB ' ' A' ' 31' ' ' SER . 4.9 tpt180 -109.75 94.62 5.12 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.223 -1.163 . . . . 0.0 109.338 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.48 ' CB ' ' O ' ' A' ' 30' ' ' ARG . 0.9 OUTLIER 72.91 136.12 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.246 -0.909 . . . . 0.0 109.27 -179.887 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.595 ' HB3' ' CZ ' ' A' ' 34' ' ' TYR . 0.4 OUTLIER -95.66 157.6 15.83 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.215 -0.928 . . . . 0.0 109.454 -179.896 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.412 HG23 ' O ' ' A' ' 18' ' ' ARG . 2.7 m -139.79 123.61 17.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.184 -0.948 . . . . 0.0 109.546 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.595 ' CZ ' ' HB3' ' A' ' 32' ' ' ASP . 0.7 OUTLIER -120.63 163.06 18.61 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.258 -0.901 . . . . 0.0 109.474 179.911 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.813 ' HD2' HD22 ' A' ' 49' ' ' LEU . 8.8 m-85 -130.45 156.99 43.83 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.182 -0.949 . . . . 0.0 109.834 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.592 ' HB2' ' CZ3' ' A' ' 5' ' ' TRP . 12.4 tt0 -139.18 114.33 9.55 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.398 -0.814 . . . . 0.0 109.001 179.472 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.584 ' HB2' HG22 ' A' ' 39' ' ' THR . 0.8 OUTLIER -63.2 163.05 19.53 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.291 -0.88 . . . . 0.0 109.615 -179.686 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.58 3.08 7.15 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.625 2.217 . . . . 0.0 110.241 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.584 HG22 ' HB2' ' A' ' 37' ' ' SER . 2.8 t -103.56 -16.77 15.43 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.334 -0.854 . . . . 0.0 109.233 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.0 14.8 8.96 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.513 ' OD2' ' CE1' ' A' ' 52' ' ' TYR . 0.8 OUTLIER -95.39 115.93 28.1 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.221 -1.164 . . . . 0.0 109.504 179.947 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.428 ' O ' ' HG2' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -99.51 121.35 41.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.184 -0.948 . . . . 0.0 109.541 179.961 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.502 ' CG2' ' HB3' ' A' ' 49' ' ' LEU . 2.7 mp -126.36 156.53 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.337 -0.852 . . . . 0.0 109.207 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.584 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 2.2 ttm180 -133.37 -8.68 2.92 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.088 -1.007 . . . . 0.0 110.773 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.986 ' O ' HD23 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -79.71 -178.27 6.3 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.73 -1.231 . . . . 0.0 108.391 179.296 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.557 ' HA ' ' CE1' ' A' ' 64' ' ' PHE . 29.4 ttpt -102.15 -57.32 2.09 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.988 -1.07 . . . . 0.0 109.845 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 57.4 t -84.57 -14.8 11.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.12 -0.988 . . . . 0.0 109.387 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.574 ' HB2' ' CB ' ' A' ' 45' ' ' SER . 1.9 mt-10 -74.7 -42.21 58.78 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.066 -1.021 . . . . 0.0 108.389 179.083 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.986 HD23 ' O ' ' A' ' 45' ' ' SER . 1.5 pp -70.96 -29.13 65.05 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.023 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.886 ' OG1' HD12 ' A' ' 59' ' ' LEU . 0.4 OUTLIER -71.86 -43.8 64.87 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.301 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.421 ' N ' HG22 ' A' ' 50' ' ' THR . 0.3 OUTLIER -61.24 -21.81 64.22 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.993 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.513 ' CE1' ' OD2' ' A' ' 41' ' ' ASP . 90.2 t80 -75.81 -60.21 2.42 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.558 -0.714 . . . . 0.0 109.448 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.88 HD21 ' CE3' ' A' ' 15' ' ' TRP . 1.0 OUTLIER -56.02 -46.28 78.87 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.155 -0.965 . . . . 0.0 109.254 179.726 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 128.63 -151.34 18.92 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -79.08 -24.31 6.94 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.638 2.225 . . . . 0.0 110.504 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.7 -20.47 66.34 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.269 -0.894 . . . . 0.0 109.854 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 49.3 m -133.52 103.48 5.94 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.179 -0.95 . . . . 0.0 109.687 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.49 150.82 24.25 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.226 -0.921 . . . . 0.0 109.044 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 1.007 HD23 ' CD2' ' A' ' 62' ' ' PHE . 0.6 OUTLIER -134.42 9.11 3.69 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.236 -0.915 . . . . 0.0 109.466 -179.876 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.572 ' C ' HD22 ' A' ' 61' ' ' LEU . 2.5 m -47.76 -46.8 30.51 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.326 -0.858 . . . . 0.0 109.303 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.63 HD22 ' N ' ' A' ' 61' ' ' LEU . 3.5 mm? -99.26 -2.15 37.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.353 -0.842 . . . . 0.0 109.528 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 1.007 ' CD2' HD23 ' A' ' 59' ' ' LEU . 69.2 t80 -60.1 129.04 39.81 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.264 -0.898 . . . . 0.0 109.488 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.503 ' O ' ' N ' ' A' ' 65' ' ' LYS . 3.2 m-20 -79.3 101.05 7.84 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.242 -0.911 . . . . 0.0 108.931 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.584 ' CE2' ' O ' ' A' ' 44' ' ' ARG . 0.9 OUTLIER -67.32 61.21 0.06 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.35 -0.844 . . . . 0.0 109.435 -179.494 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.503 ' N ' ' O ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -174.08 -38.54 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.312 -0.868 . . . . 0.0 109.449 -179.819 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 32.1 mt-30 -100.37 -39.87 7.77 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.288 -0.882 . . . . 0.0 109.511 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.437 ' HA2' ' CZ ' ' A' ' 62' ' ' PHE . . . 107.22 35.96 2.6 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.0 pp -140.64 163.73 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.129 -1.218 . . . . 0.0 109.726 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.482 ' HB3' ' HA ' ' A' ' 62' ' ' PHE . 0.7 OUTLIER -145.59 173.66 11.86 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.271 -0.893 . . . . 0.0 109.032 179.76 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.468 ' O ' ' HG ' ' A' ' 61' ' ' LEU . 1.6 p -151.9 139.23 19.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.184 -0.948 . . . . 0.0 109.362 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -129.7 154.3 80.93 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.235 -0.916 . . . . 0.0 109.635 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.439 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 35.2 Cg_endo -77.49 -160.38 0.12 Allowed 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.671 2.248 . . . . 0.0 110.441 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 72' ' ' PRO . . . 61.32 79.05 0.29 Allowed Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.211 -0.93 . . . . 0.0 109.472 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -77.81 -85.57 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.644 2.229 . . . . 0.0 110.463 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.9 pttm . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.477 179.978 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.238 0.542 . . . . 0.0 109.605 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.41 144.42 31.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.264 -0.897 . . . . 0.0 109.494 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.5 ' OE2' HG22 ' A' ' 20' ' ' VAL . 0.3 OUTLIER -86.03 -158.44 0.4 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.187 -0.946 . . . . 0.0 109.373 179.913 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -102.46 50.12 0.83 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.127 -0.983 . . . . 0.0 109.642 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 67.7 m95 -62.05 99.11 0.12 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.159 -0.963 . . . . 0.0 109.42 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.425 ' O ' ' C ' ' A' ' 7' ' ' ASP . 89.9 mt -113.62 145.9 40.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.24 -0.912 . . . . 0.0 109.284 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.484 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 12.5 t0 -43.21 129.07 4.76 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.183 -0.948 . . . . 0.0 109.469 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 15' ' ' TRP . 14.8 t -80.36 113.25 37.64 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.408 -0.808 . . . . 0.0 109.505 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 36.5 Cg_endo -80.14 -53.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.353 2.036 . . . . 0.0 110.461 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.52 ' CB ' ' CE1' ' A' ' 62' ' ' PHE . . . -42.66 -33.4 0.71 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.38 -0.825 . . . . 0.0 109.867 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 1.14 HD12 ' CD1' ' A' ' 15' ' ' TRP . 16.8 mt -105.89 -63.78 1.22 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.189 -0.944 . . . . 0.0 109.299 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 146.8 -151.5 23.77 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.66 155.04 31.18 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.639 2.226 . . . . 0.0 110.26 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.423 ' O ' ' HD3' ' A' ' 38' ' ' PRO . . . 90.57 -33.55 4.54 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 1.14 ' CD1' HD12 ' A' ' 11' ' ' LEU . 13.7 t-105 -94.91 122.85 37.97 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.394 -1.062 . . . . 0.0 108.958 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.6 121.52 39.6 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.142 -0.973 . . . . 0.0 109.172 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.598 ' CG ' ' CE1' ' A' ' 35' ' ' TYR . 0.2 OUTLIER -90.56 104.91 17.44 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.365 -0.834 . . . . 0.0 109.772 -179.774 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.802 ' O ' HG23 ' A' ' 33' ' ' THR . 0.7 OUTLIER -97.55 143.34 28.34 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.397 -0.815 . . . . 0.0 109.028 179.584 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -137.35 141.97 41.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.014 -1.054 . . . . 0.0 109.92 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.638 HG12 ' H ' ' A' ' 21' ' ' PHE . 2.2 t -127.11 178.57 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.348 -0.845 . . . . 0.0 109.24 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.638 ' H ' HG12 ' A' ' 20' ' ' VAL . 0.2 OUTLIER -116.08 3.6 13.58 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.191 -0.943 . . . . 0.0 109.739 -179.849 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.471 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 1.6 tmt_? 67.68 -73.6 0.08 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.19 -0.943 . . . . 0.0 109.748 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 22' ' ' ARG . 0.2 OUTLIER 177.36 -35.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.301 -0.875 . . . . 0.0 109.083 -179.916 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.6 m -151.01 178.01 9.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.292 -0.88 . . . . 0.0 109.384 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 171.83 81.39 0.05 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.23 -85.61 0.09 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.243 -1.151 . . . . 0.0 109.391 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.98 7.08 16.75 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.283 -0.885 . . . . 0.0 109.396 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.6 t -142.63 52.59 1.42 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.32 -0.862 . . . . 0.0 109.272 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -97.18 -177.15 34.68 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.97 -36.55 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.498 -1.001 . . . . 0.0 109.079 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.44 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 0.0 OUTLIER 68.82 132.59 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.271 -0.893 . . . . 0.0 109.73 179.55 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.571 ' HB3' ' CE1' ' A' ' 34' ' ' TYR . 60.9 m-20 -87.88 124.55 33.77 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.333 -0.854 . . . . 0.0 109.068 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.802 HG23 ' O ' ' A' ' 18' ' ' ARG . 6.1 m -113.35 138.29 50.27 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.23 -0.919 . . . . 0.0 109.385 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.571 ' CE1' ' HB3' ' A' ' 32' ' ' ASP . 13.1 m-85 -131.13 151.18 51.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.235 -0.916 . . . . 0.0 109.393 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.682 ' CZ ' ' CE1' ' A' ' 64' ' ' PHE . 14.7 m-85 -122.17 133.93 54.73 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.291 -0.881 . . . . 0.0 109.224 179.648 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.444 ' HG3' ' HG3' ' A' ' 42' ' ' ARG . 39.6 tt0 -115.85 124.73 51.39 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.215 -0.928 . . . . 0.0 109.606 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.534 ' CB ' ' HD2' ' A' ' 38' ' ' PRO . 0.1 OUTLIER -75.48 175.66 3.91 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.234 -0.916 . . . . 0.0 109.368 179.888 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.534 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 35.2 Cg_endo -77.63 -4.75 14.89 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.64 2.227 . . . . 0.0 110.55 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.488 HG22 ' HB2' ' A' ' 37' ' ' SER . 8.1 t -101.85 -0.43 34.13 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.212 -0.93 . . . . 0.0 109.536 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 94.99 19.6 30.64 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.457 ' HB2' ' OG ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -84.77 118.02 24.19 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.291 -1.123 . . . . 0.0 109.335 -179.996 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.444 ' HG3' ' HG3' ' A' ' 36' ' ' GLN . 0.0 OUTLIER -105.58 107.08 17.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.362 -0.836 . . . . 0.0 109.535 -179.839 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.529 HG21 ' HB3' ' A' ' 49' ' ' LEU . 1.8 mp -120.5 153.53 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.289 -0.882 . . . . 0.0 109.448 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.586 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 13.6 ptt180 -122.11 -26.16 4.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.135 -0.978 . . . . 0.0 109.466 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.5 ' CB ' ' HB2' ' A' ' 48' ' ' GLU . 0.3 OUTLIER -83.2 139.9 32.87 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.217 -0.927 . . . . 0.0 109.022 179.751 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.582 ' HG3' HG23 ' A' ' 47' ' ' VAL . 9.0 pttt -66.91 -52.01 48.32 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.304 -0.872 . . . . 0.0 110.932 -178.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.582 HG23 ' HG3' ' A' ' 46' ' ' LYS . 48.4 t -74.92 -23.25 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.818 -1.176 . . . . 0.0 109.958 -179.17 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.5 ' HB2' ' CB ' ' A' ' 45' ' ' SER . 28.8 mt-10 -65.28 -50.49 65.55 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.895 -1.128 . . . . 0.0 108.297 179.207 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.655 ' O ' HD12 ' A' ' 53' ' ' LEU . 3.7 pp -72.58 -35.81 68.03 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.289 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.623 ' OG1' HD12 ' A' ' 59' ' ' LEU . 0.5 OUTLIER -59.29 -39.66 83.68 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.025 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.1 mmt180 -69.38 -25.11 64.0 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.038 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.485 ' OH ' HG21 ' A' ' 39' ' ' THR . 5.6 t80 -71.32 -57.66 4.26 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.658 -0.651 . . . . 0.0 109.326 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.998 HD21 ' CZ3' ' A' ' 15' ' ' TRP . 0.2 OUTLIER -65.95 -40.21 91.12 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.094 -1.004 . . . . 0.0 109.248 179.724 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 122.44 -153.86 16.89 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.422 ' O ' ' C ' ' A' ' 56' ' ' ALA . 34.8 Cg_endo -77.57 -36.23 1.3 Allowed 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.534 2.156 . . . . 0.0 110.331 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 55' ' ' PRO . . . -44.86 -39.86 5.73 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.213 -0.93 . . . . 0.0 109.227 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.419 ' O ' ' OG1' ' A' ' 50' ' ' THR . 1.3 m -114.48 84.0 1.98 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.32 -0.862 . . . . 0.0 109.05 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -77.86 163.97 25.58 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.224 -0.922 . . . . 0.0 109.883 -179.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.975 HD23 ' CD2' ' A' ' 62' ' ' PHE . 0.5 OUTLIER -160.01 23.23 0.17 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.444 -0.785 . . . . 0.0 109.27 179.964 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.491 ' C ' HD22 ' A' ' 61' ' ' LEU . 3.6 m -55.35 -48.2 74.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.331 -0.856 . . . . 0.0 109.95 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.535 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 2.2 mm? -103.98 4.07 34.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.28 -0.887 . . . . 0.0 109.95 -179.36 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.975 ' CD2' HD23 ' A' ' 59' ' ' LEU . 54.3 t80 -63.64 136.75 57.73 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.205 -0.934 . . . . 0.0 109.909 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.98 114.95 27.25 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.501 -0.749 . . . . 0.0 108.995 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.711 ' HE1' HG22 ' A' ' 33' ' ' THR . 0.3 OUTLIER -74.58 62.27 1.02 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.222 -0.924 . . . . 0.0 109.797 -179.458 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.443 ' HB3' ' O ' ' A' ' 64' ' ' PHE . 17.5 pttt 178.91 -38.41 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.273 -0.892 . . . . 0.0 109.178 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.402 ' N ' ' CG ' ' A' ' 65' ' ' LYS . 1.3 mt-30 -94.23 -18.46 21.67 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.285 -0.884 . . . . 0.0 108.991 179.407 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.58 ' CA ' ' CZ ' ' A' ' 17' ' ' ARG . . . 73.32 43.08 39.83 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 1.4 pp -140.48 -167.47 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.152 -1.205 . . . . 0.0 109.511 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.578 ' HB3' ' HA ' ' A' ' 62' ' ' PHE . 0.6 OUTLIER 179.95 178.47 0.59 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.799 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -160.44 167.37 27.43 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.007 -1.058 . . . . 0.0 109.909 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -115.93 153.63 48.24 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.303 -0.873 . . . . 0.0 109.308 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.73 56.44 5.62 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.531 2.154 . . . . 0.0 110.576 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.535 ' N ' ' HD3' ' A' ' 74' ' ' PRO . . . -169.45 61.35 0.42 Allowed Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.14 -0.975 . . . . 0.0 109.672 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.535 ' HD3' ' N ' ' A' ' 73' ' ' ALA . 36.3 Cg_endo -78.28 142.15 18.79 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.603 2.202 . . . . 0.0 110.328 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.422 ' HE3' ' O ' ' A' ' 73' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.461 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -107.36 -62.32 1.44 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.243 -0.91 . . . . 0.0 109.471 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.531 ' HB2' ' NE ' ' A' ' 18' ' ' ARG . 7.2 mm-40 -116.71 -88.7 0.59 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.239 -0.913 . . . . 0.0 109.605 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.464 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 5.9 m-20 -157.96 69.18 0.52 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.199 -0.938 . . . . 0.0 109.818 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.602 ' CE3' ' HB2' ' A' ' 18' ' ' ARG . 48.4 m95 -67.51 97.54 0.6 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.141 -0.974 . . . . 0.0 109.203 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 4' ' ' ASP . 28.6 mt -103.0 152.52 21.23 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.153 -0.967 . . . . 0.0 109.484 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.471 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 37.1 m-20 -47.43 129.57 13.19 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.211 -0.931 . . . . 0.0 109.133 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.531 ' CB ' ' HB2' ' A' ' 17' ' ' ARG . 54.1 t -79.9 114.05 43.06 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.302 -0.874 . . . . 0.0 109.653 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 36.4 Cg_endo -78.64 -46.1 0.12 Allowed 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.292 1.995 . . . . 0.0 110.195 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.657 ' O ' HD23 ' A' ' 11' ' ' LEU . . . -46.57 -29.83 1.99 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.307 -0.871 . . . . 0.0 109.644 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.934 HD12 ' CD1' ' A' ' 15' ' ' TRP . 10.2 mt -115.54 -61.76 1.69 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.082 -1.011 . . . . 0.0 110.004 -179.772 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.47 ' O ' ' O ' ' A' ' 8' ' ' CYS . . . 158.79 -152.14 23.19 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.52 ' O ' ' N ' ' A' ' 15' ' ' TRP . 35.1 Cg_endo -77.79 179.32 6.62 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.633 2.222 . . . . 0.0 110.352 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.45 ' O ' ' HD3' ' A' ' 16' ' ' LYS . . . 67.2 -63.95 0.23 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 108.951 -1.66 . . . . 0.0 108.951 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.934 ' CD1' HD12 ' A' ' 11' ' ' LEU . 6.2 t-105 -53.09 126.95 22.41 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.385 -1.068 . . . . 0.0 109.089 179.356 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.45 ' HD3' ' O ' ' A' ' 14' ' ' GLY . 0.3 OUTLIER -100.33 114.71 28.42 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.061 -1.024 . . . . 0.0 109.761 -179.579 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 1.008 ' NH2' HG21 ' A' ' 33' ' ' THR . 8.7 ttt-85 -95.93 102.99 14.85 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.361 -0.837 . . . . 0.0 109.174 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.602 ' HB2' ' CE3' ' A' ' 5' ' ' TRP . 8.4 ttt180 -99.94 151.41 21.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.154 -0.966 . . . . 0.0 109.973 -179.619 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -126.16 138.46 53.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.393 -0.817 . . . . 0.0 109.316 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.44 HG22 ' HE ' ' A' ' 18' ' ' ARG . 11.4 t -136.18 152.66 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.242 -0.912 . . . . 0.0 109.359 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.544 ' CB ' ' HA ' ' A' ' 31' ' ' SER . 6.4 m-85 62.56 17.5 9.69 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.255 -0.903 . . . . 0.0 109.481 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.549 ' CA ' ' HB3' ' A' ' 31' ' ' SER . 0.0 OUTLIER -91.19 -53.01 4.54 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.286 -0.884 . . . . 0.0 109.726 -179.891 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.01 170.31 9.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.171 -0.956 . . . . 0.0 109.742 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.1 t 66.12 89.97 0.09 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.295 -0.878 . . . . 0.0 109.456 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 167.22 165.24 24.29 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.66 -79.38 0.17 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.247 -1.149 . . . . 0.0 109.444 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.5 t -146.81 74.94 1.37 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.249 -0.907 . . . . 0.0 109.432 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.7 t -89.96 -70.96 0.64 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.287 -0.883 . . . . 0.0 109.395 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.47 67.83 1.42 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.481 ' O ' ' O ' ' A' ' 31' ' ' SER . 0.0 OUTLIER -168.2 -62.64 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.294 -1.121 . . . . 0.0 109.3 179.892 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.549 ' HB3' ' CA ' ' A' ' 22' ' ' ARG . 0.1 OUTLIER 51.6 173.05 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.399 -0.813 . . . . 0.0 109.913 179.828 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.566 ' HB3' ' CE1' ' A' ' 34' ' ' TYR . 7.8 m-20 -130.58 117.64 19.85 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.295 -0.878 . . . . 0.0 108.691 179.555 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' THR . . . . . 1.008 HG21 ' NH2' ' A' ' 17' ' ' ARG . 18.5 m -101.87 137.02 40.71 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.138 -0.976 . . . . 0.0 110.061 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.566 ' CE1' ' HB3' ' A' ' 32' ' ' ASP . 46.5 m-85 -129.13 148.49 51.07 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.784 ' HD2' HD22 ' A' ' 49' ' ' LEU . 38.6 m-85 -110.81 137.64 48.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.079 -1.013 . . . . 0.0 109.897 -179.577 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.545 ' HB2' ' CZ3' ' A' ' 5' ' ' TRP . 3.4 tt0 -116.38 116.86 28.49 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.273 -0.892 . . . . 0.0 109.257 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.478 ' CB ' ' HD2' ' A' ' 38' ' ' PRO . 0.6 OUTLIER -58.12 173.65 0.38 Allowed Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.303 -0.873 . . . . 0.0 109.309 -179.971 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.478 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 35.7 Cg_endo -78.72 0.67 9.77 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.621 2.214 . . . . 0.0 110.382 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.444 HG22 ' HB3' ' A' ' 37' ' ' SER . 5.5 t -111.88 -22.9 10.86 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.295 -0.878 . . . . 0.0 109.417 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.8 -2.37 5.22 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.433 ' CB ' ' HB2' ' A' ' 37' ' ' SER . 0.2 OUTLIER -65.31 171.09 4.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.188 -1.184 . . . . 0.0 109.427 179.952 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.465 ' HA ' ' O ' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -154.67 108.31 2.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.26 -0.9 . . . . 0.0 109.277 -179.962 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.63 HG21 ' CA ' ' A' ' 49' ' ' LEU . 2.4 mp -107.49 163.36 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.279 -0.888 . . . . 0.0 109.623 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.567 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 7.7 ttp180 -130.59 -32.51 1.71 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.316 -0.865 . . . . 0.0 109.851 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.842 ' O ' HD23 ' A' ' 49' ' ' LEU . 0.6 OUTLIER -68.13 151.75 46.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.056 -1.027 . . . . 0.0 108.877 179.825 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.441 ' HD2' ' O ' ' A' ' 59' ' ' LEU . 7.5 ttpm? -70.59 -68.78 0.4 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.272 -0.893 . . . . 0.0 111.185 -178.642 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.477 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 54.5 t -71.9 -18.6 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.052 -1.03 . . . . 0.0 110.705 -178.53 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.576 ' HB2' ' CB ' ' A' ' 45' ' ' SER . 5.5 mt-10 -72.12 -42.74 65.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.656 -1.278 . . . . 0.0 108.745 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.842 HD23 ' O ' ' A' ' 45' ' ' SER . 1.6 pp -69.42 -25.83 64.31 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 178.523 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.891 ' OG1' HD13 ' A' ' 59' ' ' LEU . 20.6 m -70.44 -62.7 1.29 Allowed 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.696 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.49 ' HG3' ' O ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -51.0 -22.56 2.36 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.477 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.496 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 59.2 t80 -64.03 -56.25 16.36 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.39 -0.819 . . . . 0.0 108.92 179.351 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.756 HD21 ' CE3' ' A' ' 15' ' ' TRP . 0.7 OUTLIER -61.87 -49.27 76.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.197 -0.94 . . . . 0.0 109.221 179.704 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 130.91 -156.03 21.53 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.79 3.42 6.95 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.536 2.157 . . . . 0.0 110.231 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -87.83 -12.89 43.62 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.384 -0.823 . . . . 0.0 109.325 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.46 ' O ' ' CG2' ' A' ' 50' ' ' THR . 52.9 m -139.02 131.68 28.95 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.233 -0.917 . . . . 0.0 109.703 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.84 ' C ' HD12 ' A' ' 59' ' ' LEU . 12.4 t70 -124.27 155.11 39.19 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.274 -0.891 . . . . 0.0 109.472 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.891 HD13 ' OG1' ' A' ' 50' ' ' THR . 5.5 mp -148.49 15.06 0.99 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.191 -0.943 . . . . 0.0 109.61 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.645 ' C ' HD22 ' A' ' 61' ' ' LEU . 12.7 m -46.01 -37.54 6.74 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.22 -0.925 . . . . 0.0 109.484 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.645 HD22 ' C ' ' A' ' 60' ' ' THR . 1.4 mm? -112.72 11.1 19.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.22 -0.925 . . . . 0.0 109.744 -179.41 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.804 ' CD2' HD23 ' A' ' 59' ' ' LEU . 51.5 t80 -69.3 151.05 46.7 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.329 -0.857 . . . . 0.0 110.317 -179.475 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -107.08 106.42 16.91 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.567 ' CE2' ' O ' ' A' ' 44' ' ' ARG . 0.2 OUTLIER -71.09 60.76 0.27 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.182 -0.949 . . . . 0.0 109.577 -179.224 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 15.5 ttpt -177.28 -35.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.196 -0.94 . . . . 0.0 109.585 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -101.08 -30.83 11.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.216 -0.928 . . . . 0.0 109.529 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.18 39.72 5.65 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.424 ' O ' ' CD1' ' A' ' 62' ' ' PHE . 2.2 pp -140.11 -178.64 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.168 -1.195 . . . . 0.0 109.967 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.524 ' HB3' ' HA ' ' A' ' 62' ' ' PHE . 0.8 OUTLIER -172.17 -175.97 1.54 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.36 -0.838 . . . . 0.0 108.99 -179.954 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.477 ' SG ' HD12 ' A' ' 61' ' ' LEU . 31.9 p -160.24 168.82 24.51 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.183 -0.948 . . . . 0.0 109.337 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -142.38 78.3 16.71 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.238 -0.914 . . . . 0.0 109.693 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.01 -169.18 0.71 Allowed 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.617 2.212 . . . . 0.0 110.06 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -167.05 83.43 0.87 Allowed Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.161 -0.962 . . . . 0.0 109.551 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.68 102.92 1.59 Allowed 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.695 2.263 . . . . 0.0 110.272 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.4 mttt . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.405 -179.906 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.9 tpt . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -168.66 54.75 0.05 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.223 -0.923 . . . . 0.0 109.578 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -140.55 124.96 17.74 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.266 -0.896 . . . . 0.0 109.453 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.473 ' O ' ' O ' ' A' ' 5' ' ' TRP . 61.0 t0 -144.69 24.08 1.55 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.268 -0.895 . . . . 0.0 109.379 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.588 ' CE2' ' HD2' ' A' ' 18' ' ' ARG . 62.5 m95 50.29 100.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.389 -0.82 . . . . 0.0 109.584 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.658 HD12 ' O ' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -107.58 150.26 27.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.234 -0.916 . . . . 0.0 109.596 179.984 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.537 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 0.4 OUTLIER -45.88 147.53 0.96 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.3 -0.875 . . . . 0.0 109.352 179.774 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.529 ' HB2' ' HB3' ' A' ' 15' ' ' TRP . 52.3 m -93.8 109.81 43.67 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.329 -0.857 . . . . 0.0 109.77 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.537 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 35.8 Cg_endo -80.02 -29.43 2.66 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.26 1.973 . . . . 0.0 109.561 179.291 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.968 ' HB3' ' NH1' ' A' ' 17' ' ' ARG . . . -69.55 -34.77 74.68 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.376 -0.827 . . . . 0.0 109.357 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.952 HD12 ' CD1' ' A' ' 15' ' ' TRP . 10.4 mt -105.51 -50.27 3.25 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.208 -0.932 . . . . 0.0 109.509 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 139.08 -151.68 21.9 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -77.74 161.66 30.41 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.627 2.218 . . . . 0.0 110.268 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.94 -48.61 4.09 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 1.001 ' CZ2' HD13 ' A' ' 49' ' ' LEU . 11.4 t-105 -76.61 125.78 29.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.26 -1.141 . . . . 0.0 109.195 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.491 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 0.1 OUTLIER -102.21 127.53 49.11 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.386 -0.821 . . . . 0.0 109.448 -179.655 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.968 ' NH1' ' HB3' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -100.58 104.1 15.43 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.423 -0.798 . . . . 0.0 109.899 -179.311 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.588 ' HD2' ' CE2' ' A' ' 5' ' ' TRP . 1.0 OUTLIER -100.74 135.09 42.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.17 -0.956 . . . . 0.0 109.569 179.624 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -115.49 146.51 41.61 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.274 -0.891 . . . . 0.0 109.351 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.49 ' O ' ' N ' ' A' ' 32' ' ' ASP . 2.9 t -139.6 152.86 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.175 -0.953 . . . . 0.0 109.876 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 7.3 m-30 56.06 27.75 11.86 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.409 -0.807 . . . . 0.0 109.775 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.408 ' O ' ' CB ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -90.96 95.79 10.3 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.269 -0.894 . . . . 0.0 109.354 179.757 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.408 ' CB ' ' O ' ' A' ' 22' ' ' ARG . 0.6 OUTLIER 69.76 98.79 0.06 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.295 -0.878 . . . . 0.0 109.557 -179.936 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 17.5 m -153.91 -67.77 0.14 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.286 -0.884 . . . . 0.0 109.244 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.3 -59.4 0.84 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.469 ' O ' ' N ' ' A' ' 28' ' ' CYS . . . -92.31 20.17 6.34 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.25 -1.147 . . . . 0.0 109.33 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 48.67 -94.57 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.384 -0.822 . . . . 0.0 109.57 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' CYS . . . . . 0.469 ' N ' ' O ' ' A' ' 26' ' ' ALA . 1.7 m -85.92 89.8 7.89 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.127 -0.983 . . . . 0.0 109.493 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -133.49 -94.19 0.53 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 26.0 ttm-85 -146.68 121.05 9.61 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.184 -1.186 . . . . 0.0 109.645 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.415 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 1.6 p -110.22 135.45 50.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.251 -0.905 . . . . 0.0 109.312 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.526 ' HB3' ' CZ ' ' A' ' 34' ' ' TYR . 3.6 m-20 -86.31 103.86 15.29 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.163 -0.961 . . . . 0.0 109.24 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.545 HG22 ' HE1' ' A' ' 35' ' ' TYR . 1.5 m -100.65 120.26 39.8 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.278 -0.889 . . . . 0.0 109.841 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.554 ' CG ' ' HD3' ' A' ' 44' ' ' ARG . 15.2 m-85 -123.35 152.92 41.01 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.355 -0.84 . . . . 0.0 108.979 179.645 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.692 ' CE2' ' CE1' ' A' ' 64' ' ' PHE . 4.1 m-85 -118.57 145.16 45.59 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.117 -0.989 . . . . 0.0 109.593 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.419 ' HA ' ' O ' ' A' ' 41' ' ' ASP . 3.8 tt0 -132.93 141.71 48.5 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.216 -0.928 . . . . 0.0 109.868 -179.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.534 ' HG ' ' HZ3' ' A' ' 15' ' ' TRP . 0.3 OUTLIER -81.26 173.4 7.75 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.45 -0.781 . . . . 0.0 109.183 179.616 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.463 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 36.0 Cg_endo -78.89 7.2 4.43 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.605 2.203 . . . . 0.0 110.573 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.2 p -110.49 -13.59 14.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.212 -0.93 . . . . 0.0 109.502 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 110.59 24.3 5.64 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.877 ' OD2' HD11 ' A' ' 43' ' ' ILE . 9.5 t70 -97.42 123.23 41.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.279 -1.13 . . . . 0.0 109.393 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.689 ' C ' HD12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -107.26 124.84 50.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.29 -0.881 . . . . 0.0 109.645 -179.912 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.877 HD11 ' OD2' ' A' ' 41' ' ' ASP . 3.1 mp -128.05 150.43 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.255 -0.903 . . . . 0.0 109.447 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.572 ' HA ' ' CZ ' ' A' ' 64' ' ' PHE . 11.9 mtt180 -144.92 9.68 1.31 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.253 -0.904 . . . . 0.0 110.235 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.549 ' CB ' ' HB2' ' A' ' 48' ' ' GLU . 0.3 OUTLIER -98.41 12.66 34.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.033 -1.042 . . . . 0.0 109.355 179.833 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.584 ' HA ' ' CE1' ' A' ' 64' ' ' PHE . 0.0 OUTLIER 63.22 -93.4 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.365 -0.834 . . . . 0.0 110.225 179.374 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.459 ' HA ' ' OG1' ' A' ' 50' ' ' THR . 75.5 t -55.35 -22.45 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.127 -0.983 . . . . 0.0 109.812 -179.161 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.549 ' HB2' ' CB ' ' A' ' 45' ' ' SER . 2.5 mt-10 -63.56 -47.83 79.96 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.038 -1.039 . . . . 0.0 108.766 179.264 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 1.076 HD12 HD11 ' A' ' 53' ' ' LEU . 1.3 pp -67.56 -24.92 65.58 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 179.113 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.526 ' HA ' HD12 ' A' ' 53' ' ' LEU . 4.9 m -66.95 -62.59 1.36 Allowed 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.501 ' HG3' ' O ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -52.4 -21.64 3.84 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.306 -0.957 . . . . 0.0 108.459 179.299 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.418 ' O ' ' C ' ' A' ' 53' ' ' LEU . 2.0 t80 -77.19 -64.51 1.12 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.463 -0.773 . . . . 0.0 108.989 179.303 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 1.076 HD11 HD12 ' A' ' 49' ' ' LEU . 2.2 mt -45.07 -63.64 0.88 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.18 -0.95 . . . . 0.0 109.047 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 143.8 -163.6 27.61 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.97 -7.26 16.32 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.604 2.203 . . . . 0.0 110.116 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -79.36 -11.3 59.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.341 -0.849 . . . . 0.0 109.453 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.409 ' SG ' ' HB3' ' A' ' 11' ' ' LEU . 1.0 OUTLIER -136.74 150.41 48.39 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.245 -0.909 . . . . 0.0 109.456 -179.986 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.924 ' C ' HD12 ' A' ' 59' ' ' LEU . 13.7 p-10 -139.97 156.15 46.79 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.234 -0.916 . . . . 0.0 109.43 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.924 HD12 ' C ' ' A' ' 58' ' ' ASP . 6.0 mp -150.86 15.51 0.75 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.167 -0.958 . . . . 0.0 109.549 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.695 ' C ' HD22 ' A' ' 61' ' ' LEU . 32.1 m -47.32 -41.03 18.45 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.277 -0.889 . . . . 0.0 109.336 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.695 HD22 ' C ' ' A' ' 60' ' ' THR . 2.4 mm? -109.27 -4.62 16.33 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.279 -0.888 . . . . 0.0 109.597 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.577 ' CD2' HD23 ' A' ' 59' ' ' LEU . 33.4 t80 -56.93 136.48 56.0 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.273 -0.892 . . . . 0.0 109.73 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.571 ' O ' ' CE2' ' A' ' 62' ' ' PHE . 11.6 m-20 -85.13 129.23 34.84 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.361 -0.837 . . . . 0.0 109.11 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.692 ' CE1' ' CE2' ' A' ' 35' ' ' TYR . 0.6 OUTLIER -84.39 54.92 3.16 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.133 -0.98 . . . . 0.0 109.489 -179.61 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.449 ' HA ' ' OG1' ' A' ' 33' ' ' THR . 7.3 ttmt -175.91 -42.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.428 -0.795 . . . . 0.0 109.033 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 -83.25 -45.69 13.54 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.36 -0.838 . . . . 0.0 109.105 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.553 ' O ' ' HB2' ' A' ' 10' ' ' ALA . . . 103.32 32.64 4.51 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.477 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 2.2 pp -140.52 162.21 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.108 -1.231 . . . . 0.0 109.692 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.465 ' HB3' ' HA ' ' A' ' 62' ' ' PHE . 1.1 pt? -143.6 164.16 31.19 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.301 -0.875 . . . . 0.0 108.982 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.56 ' O ' ' CB ' ' A' ' 71' ' ' TYR . 7.7 p -157.41 176.45 12.65 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.12 -0.987 . . . . 0.0 109.577 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.607 ' HB3' ' HD3' ' A' ' 72' ' ' PRO . 6.7 t80 158.98 -47.98 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.723 -0.61 . . . . 0.0 109.477 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.607 ' HD3' ' HB3' ' A' ' 71' ' ' TYR . 36.6 Cg_endo -79.57 93.43 1.08 Allowed 'Trans proline' 0 C--N 1.316 -1.179 0 C-N-CA 122.023 1.816 . . . . 0.0 110.212 179.498 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.415 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . . . -174.62 145.75 0.99 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.103 -0.998 . . . . 0.0 109.525 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 73' ' ' ALA . 36.2 Cg_endo -78.35 110.01 2.77 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.573 2.182 . . . . 0.0 110.378 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 117.949 -1.024 . . . . 0.0 109.42 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.449 ' O ' ' HB3' ' A' ' 2' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 . . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 1' ' ' MET . . . 62.1 118.45 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.277 -0.89 . . . . 0.0 109.475 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -85.14 179.9 7.15 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.295 -0.878 . . . . 0.0 109.531 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.413 ' O ' ' C ' ' A' ' 5' ' ' TRP . 0.3 OUTLIER -135.85 76.65 1.62 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.307 -0.871 . . . . 0.0 109.449 -179.973 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.59 ' CZ3' ' HB2' ' A' ' 18' ' ' ARG . 71.2 m95 -42.62 124.48 3.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.322 -0.862 . . . . 0.0 109.585 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 17' ' ' ARG . 0.2 OUTLIER -110.01 148.74 31.1 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.237 -0.914 . . . . 0.0 109.527 179.921 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.413 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 0.6 OUTLIER -47.43 147.32 1.71 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.203 -0.936 . . . . 0.0 109.49 -179.884 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.532 ' HB2' ' HB3' ' A' ' 15' ' ' TRP . 6.1 m -89.69 114.46 60.69 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.344 -0.848 . . . . 0.0 109.818 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.451 ' HD2' ' HD3' ' A' ' 17' ' ' ARG . 36.0 Cg_endo -79.04 -39.51 0.34 Allowed 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.362 2.041 . . . . 0.0 110.371 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.499 ' HB2' ' O ' ' A' ' 67' ' ' GLY . . . -64.58 -46.26 83.45 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.213 -0.93 . . . . 0.0 109.595 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 1.01 HD12 ' CD1' ' A' ' 15' ' ' TRP . 6.8 mt -90.12 -48.06 7.42 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.117 -0.989 . . . . 0.0 109.776 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 129.81 -153.26 19.93 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -77.41 155.81 32.44 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.732 2.288 . . . . 0.0 110.497 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.71 -26.66 8.0 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.229 -1.549 . . . . 0.0 109.229 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 1.01 ' CD1' HD12 ' A' ' 11' ' ' LEU . 8.7 t-105 -101.74 132.8 47.26 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.345 -1.091 . . . . 0.0 108.9 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.423 ' C ' ' SG ' ' A' ' 8' ' ' CYS . 14.5 mptt -106.39 129.24 54.42 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.191 -0.943 . . . . 0.0 110.078 -179.243 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.601 ' HG3' ' CE2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -105.27 113.25 26.72 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.376 -0.828 . . . . 0.0 109.097 179.611 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.59 ' HB2' ' CZ3' ' A' ' 5' ' ' TRP . 0.1 OUTLIER -100.16 144.44 29.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.365 -0.834 . . . . 0.0 109.588 -179.728 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -130.83 131.06 44.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.341 -0.849 . . . . 0.0 109.197 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.516 ' O ' ' N ' ' A' ' 32' ' ' ASP . 14.5 t -138.34 161.57 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.205 -0.934 . . . . 0.0 109.514 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.461 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 0.5 OUTLIER 68.69 32.27 4.25 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.185 -0.947 . . . . 0.0 109.41 -179.994 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.485 ' HG3' ' HB3' ' A' ' 31' ' ' SER . 4.1 ttp180 -75.82 81.39 2.75 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.318 -0.864 . . . . 0.0 109.488 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 61.55 95.38 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.283 -0.886 . . . . 0.0 109.634 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -169.53 -66.16 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.288 -0.883 . . . . 0.0 109.606 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -84.56 -98.48 0.65 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -99.33 119.62 38.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.254 -1.145 . . . . 0.0 109.565 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -90.88 53.81 2.49 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.26 -0.9 . . . . 0.0 109.405 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 6.0 t -83.09 -15.75 49.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.336 -0.852 . . . . 0.0 109.641 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.469 ' O ' ' HG2' ' A' ' 30' ' ' ARG . . . -152.4 -88.76 0.07 OUTLIER Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.469 ' HG2' ' O ' ' A' ' 29' ' ' GLY . 0.0 OUTLIER -171.56 165.54 6.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.229 -1.159 . . . . 0.0 109.614 -179.837 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.485 ' HB3' ' HG3' ' A' ' 22' ' ' ARG . 0.3 OUTLIER -46.52 163.46 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.309 -0.869 . . . . 0.0 109.429 179.913 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 20' ' ' VAL . 0.9 OUTLIER -89.6 170.1 10.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.214 -0.929 . . . . 0.0 109.154 179.751 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.6 m -137.82 109.28 6.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.11 -0.994 . . . . 0.0 109.829 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.575 ' CE1' ' HD2' ' A' ' 44' ' ' ARG . 8.8 m-30 -109.11 160.25 16.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.338 -0.851 . . . . 0.0 108.748 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.601 ' CE2' ' HG3' ' A' ' 17' ' ' ARG . 19.6 m-85 -131.76 145.56 51.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.047 -1.033 . . . . 0.0 109.776 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.436 ' HA ' ' O ' ' A' ' 41' ' ' ASP . 0.9 OUTLIER -133.17 130.44 39.15 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.286 -0.884 . . . . 0.0 109.248 179.931 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.427 ' HA ' ' CZ3' ' A' ' 15' ' ' TRP . 0.8 OUTLIER -71.54 170.42 12.04 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.247 -0.908 . . . . 0.0 109.386 -179.951 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.422 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 35.9 Cg_endo -78.27 5.61 5.32 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.592 2.195 . . . . 0.0 110.457 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.3 p -113.09 -23.03 10.24 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.251 -0.905 . . . . 0.0 109.227 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 125.47 23.36 1.72 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.836 -1.305 . . . . 0.0 109.836 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.573 ' OD2' ' CE1' ' A' ' 52' ' ' TYR . 2.8 t70 -87.73 136.16 33.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.153 -1.204 . . . . 0.0 109.07 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.96 100.71 7.74 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.219 -0.925 . . . . 0.0 109.844 -179.573 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.626 HG21 ' CA ' ' A' ' 49' ' ' LEU . 3.3 mt -112.87 154.09 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.404 -0.81 . . . . 0.0 109.146 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.575 ' HD2' ' CE1' ' A' ' 34' ' ' TYR . 8.1 ttp180 -129.02 -2.76 5.15 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.108 -0.995 . . . . 0.0 109.981 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.753 ' O ' HD23 ' A' ' 49' ' ' LEU . 5.8 t -88.57 173.27 8.74 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.23 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.553 ' HA ' ' CE1' ' A' ' 64' ' ' PHE . 5.6 ttpm? -91.98 -60.49 1.84 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.894 -1.129 . . . . 0.0 110.113 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.443 ' O ' ' CG ' ' A' ' 51' ' ' ARG . 77.6 t -81.48 -22.04 10.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.01 -1.057 . . . . 0.0 109.33 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.554 ' HB2' ' CB ' ' A' ' 45' ' ' SER . 1.2 tt0 -66.21 -45.95 78.96 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 178.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.824 HD13 ' CZ2' ' A' ' 15' ' ' TRP . 1.7 pp -69.95 -22.53 63.16 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.606 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.705 ' OG1' HD13 ' A' ' 59' ' ' LEU . 25.5 m -69.09 -69.11 0.35 Allowed 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 178.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.443 ' CG ' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -44.15 -28.45 0.5 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.494 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.573 ' CE1' ' OD2' ' A' ' 41' ' ' ASP . 87.5 t80 -59.23 -60.02 4.52 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.173 -0.954 . . . . 0.0 108.845 179.365 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.871 HD21 ' CE3' ' A' ' 15' ' ' TRP . 1.0 OUTLIER -52.7 -54.8 28.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.305 -0.872 . . . . 0.0 109.265 179.616 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 137.43 -162.74 25.44 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.44 -5.51 15.64 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.559 2.173 . . . . 0.0 110.192 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.19 -26.93 53.37 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.387 -0.82 . . . . 0.0 109.396 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 1.1 m -109.55 -171.61 1.88 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.302 -0.874 . . . . 0.0 109.323 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.886 ' C ' HD12 ' A' ' 59' ' ' LEU . 6.9 t0 -178.81 149.43 0.46 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.909 . . . . 0.0 109.655 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.886 HD12 ' C ' ' A' ' 58' ' ' ASP . 5.5 mp -153.86 14.46 0.47 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.187 -0.945 . . . . 0.0 109.705 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.521 HG22 ' CD2' ' A' ' 61' ' ' LEU . 98.4 m -47.94 -39.88 20.48 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.122 -0.987 . . . . 0.0 109.16 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.574 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 1.3 mm? -104.42 -14.05 15.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.396 -0.815 . . . . 0.0 109.229 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.761 ' CD2' HD23 ' A' ' 59' ' ' LEU . 64.6 t80 -44.96 156.19 0.09 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.441 -0.787 . . . . 0.0 109.811 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.499 ' O ' ' N ' ' A' ' 65' ' ' LYS . 5.1 m-20 -109.34 108.35 18.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.282 -0.887 . . . . 0.0 109.403 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.575 ' CZ ' ' O ' ' A' ' 44' ' ' ARG . 0.9 OUTLIER -67.48 61.72 0.06 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.405 -0.809 . . . . 0.0 109.03 179.964 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.499 ' N ' ' O ' ' A' ' 63' ' ' ASP . 0.7 OUTLIER 173.75 -28.11 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.319 -0.863 . . . . 0.0 109.69 -179.738 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -103.75 -26.45 12.73 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.125 -0.984 . . . . 0.0 110.11 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.502 ' CA ' ' NH2' ' A' ' 17' ' ' ARG . . . 85.53 30.26 24.9 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.686 -1.365 . . . . 0.0 109.686 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.511 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 1.9 pp -140.09 173.2 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.226 -1.161 . . . . 0.0 109.517 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.498 ' HB3' ' HA ' ' A' ' 62' ' ' PHE . 0.8 OUTLIER -150.38 -168.48 3.12 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.393 -0.817 . . . . 0.0 109.416 179.984 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -153.55 153.01 31.59 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.219 -0.926 . . . . 0.0 109.358 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.541 ' O ' ' CD2' ' A' ' 71' ' ' TYR . 12.9 p90 -134.55 96.4 15.21 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.129 -0.982 . . . . 0.0 109.688 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.66 104.36 1.86 Allowed 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.589 2.193 . . . . 0.0 110.43 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.543 ' HB1' ' HD2' ' A' ' 74' ' ' PRO . . . -146.32 162.03 36.36 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.349 -0.845 . . . . 0.0 109.217 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.543 ' HD2' ' HB1' ' A' ' 73' ' ' ALA . 35.6 Cg_endo -78.44 -10.79 16.0 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.548 2.165 . . . . 0.0 110.489 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LYS . . . . . 0.407 ' HB2' ' O ' ' A' ' 74' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.462 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.5 mmt . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.22 143.12 30.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.302 -0.874 . . . . 0.0 109.468 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.454 ' HG3' ' NH1' ' A' ' 18' ' ' ARG . 13.9 mm-40 -119.18 -91.34 0.56 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.209 -0.932 . . . . 0.0 109.789 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -153.95 65.33 0.72 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.238 -0.914 . . . . 0.0 109.532 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.584 ' CE3' ' HB2' ' A' ' 18' ' ' ARG . 84.2 m95 -66.7 99.22 0.58 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.265 -0.897 . . . . 0.0 109.695 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 79.6 mt -112.69 154.05 26.72 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.27 -0.894 . . . . 0.0 109.366 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.495 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 0.4 OUTLIER -49.01 139.52 10.25 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.232 -0.918 . . . . 0.0 108.897 179.704 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.484 ' HG ' ' HE2' ' A' ' 35' ' ' TYR . 44.0 t -91.04 111.94 51.07 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.219 -0.925 . . . . 0.0 109.696 -179.597 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.495 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 36.7 Cg_endo -79.63 -48.68 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.255 1.97 . . . . 0.0 109.975 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.647 ' HB3' ' CE2' ' A' ' 62' ' ' PHE . . . -50.15 -35.44 26.03 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.398 -0.814 . . . . 0.0 109.476 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 1.138 HD12 ' CD1' ' A' ' 15' ' ' TRP . 14.5 mt -98.16 -64.98 0.99 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.262 -0.899 . . . . 0.0 109.555 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 8' ' ' CYS . . . 158.61 -158.88 29.72 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -76.77 159.91 34.63 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.551 2.167 . . . . 0.0 110.402 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.91 -68.15 3.54 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 -179.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 1.138 ' CD1' HD12 ' A' ' 11' ' ' LEU . 26.9 t-105 -49.87 128.64 18.82 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.296 -1.12 . . . . 0.0 108.82 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.3 mmtm -99.33 120.83 40.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.118 -0.989 . . . . 0.0 109.552 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.583 ' CZ ' ' CA ' ' A' ' 67' ' ' GLY . 23.7 ttt-85 -93.4 105.11 17.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.366 -0.834 . . . . 0.0 109.295 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.792 HH11 HG22 ' A' ' 20' ' ' VAL . 1.2 tmm_? -100.23 152.21 20.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.206 -0.934 . . . . 0.0 110.055 -179.572 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -137.98 155.13 49.18 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.471 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.792 HG22 HH11 ' A' ' 18' ' ' ARG . 1.0 OUTLIER -125.52 -179.28 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.983 -1.073 . . . . 0.0 109.735 -179.675 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.551 ' H ' HG12 ' A' ' 20' ' ' VAL . 35.4 p90 -127.75 42.37 3.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.307 -0.871 . . . . 0.0 109.493 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.433 ' HB3' ' OD2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -79.72 77.95 6.32 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.244 -0.91 . . . . 0.0 109.392 179.94 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.2 ptmt -170.26 51.35 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.215 -0.928 . . . . 0.0 109.411 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 34.5 t -108.75 15.54 23.53 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.277 -0.889 . . . . 0.0 109.44 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -131.56 -70.15 0.1 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -92.9 168.4 11.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.186 -1.185 . . . . 0.0 109.42 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.18 31.68 6.27 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.216 -0.927 . . . . 0.0 109.667 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.3 m -103.61 67.69 0.91 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.233 -0.917 . . . . 0.0 109.47 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 146.44 155.74 6.64 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.425 ' O ' ' HB3' ' A' ' 31' ' ' SER . 0.0 OUTLIER -120.63 64.72 0.85 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.238 -1.154 . . . . 0.0 109.56 -179.959 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.426 ' OG ' ' O ' ' A' ' 20' ' ' VAL . 0.1 OUTLIER 68.04 139.6 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.159 -0.963 . . . . 0.0 109.493 179.861 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.433 ' OD2' ' HB3' ' A' ' 22' ' ' ARG . 21.0 m-20 -80.85 160.63 24.73 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.262 -0.899 . . . . 0.0 109.251 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.505 HG23 ' O ' ' A' ' 18' ' ' ARG . 93.6 m -137.96 134.37 34.84 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.065 -1.022 . . . . 0.0 109.956 -179.745 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.44 ' CD1' ' O ' ' A' ' 33' ' ' THR . 18.1 m-85 -136.04 153.94 51.2 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.365 -0.834 . . . . 0.0 109.077 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.559 ' CE2' ' HG3' ' A' ' 17' ' ' ARG . 27.5 m-85 -121.02 161.51 21.53 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.996 -1.065 . . . . 0.0 109.752 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.58 ' HB2' ' CZ3' ' A' ' 5' ' ' TRP . 0.1 OUTLIER -128.13 115.29 18.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.289 -0.882 . . . . 0.0 109.287 179.723 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.805 ' HG ' HG22 ' A' ' 39' ' ' THR . 0.8 OUTLIER -53.44 176.41 0.11 Allowed Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.354 -0.841 . . . . 0.0 109.24 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.546 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 35.4 Cg_endo -77.62 -8.88 17.18 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.442 2.095 . . . . 0.0 110.25 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.805 HG22 ' HG ' ' A' ' 37' ' ' SER . 12.9 t -110.17 -16.08 13.85 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.231 -0.918 . . . . 0.0 109.545 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 121.03 20.63 3.33 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.444 ' CB ' ' HB3' ' A' ' 37' ' ' SER . 0.2 OUTLIER -89.73 101.87 14.57 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.197 -1.178 . . . . 0.0 109.249 179.877 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.41 126.26 30.59 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.278 -0.889 . . . . 0.0 108.845 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.701 HG21 ' HB3' ' A' ' 49' ' ' LEU . 0.9 OUTLIER -116.47 162.61 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.148 -0.97 . . . . 0.0 110.348 -179.121 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.588 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 0.0 OUTLIER -131.83 -21.83 2.41 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.546 -0.721 . . . . 0.0 110.094 -179.909 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.477 ' HB2' ' HB2' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -99.9 119.2 37.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.886 -1.134 . . . . 0.0 109.269 179.865 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.567 ' HA ' HD21 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -46.89 -46.69 21.32 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.382 -0.824 . . . . 0.0 110.501 -179.442 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.439 ' HA ' ' HB ' ' A' ' 50' ' ' THR . 73.5 t -74.79 -41.7 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.851 -1.156 . . . . 0.0 109.317 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.488 ' O ' ' HG3' ' A' ' 51' ' ' ARG . 28.4 tt0 -48.53 -49.94 34.03 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.204 -0.935 . . . . 0.0 109.445 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.729 ' O ' HD12 ' A' ' 53' ' ' LEU . 1.1 pp -72.67 -34.92 67.56 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.941 -1.1 . . . . 0.0 108.739 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.766 ' OG1' HD12 ' A' ' 59' ' ' LEU . 0.4 OUTLIER -54.63 -54.66 38.56 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.047 -1.033 . . . . 0.0 108.413 179.124 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.576 ' N ' HG22 ' A' ' 50' ' ' THR . 0.0 OUTLIER -67.97 -16.63 64.14 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.335 -0.853 . . . . 0.0 108.937 179.496 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.495 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 24.7 t80 -71.51 -56.15 6.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.278 -0.889 . . . . 0.0 109.058 179.409 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.97 HD21 ' CE3' ' A' ' 15' ' ' TRP . 0.4 OUTLIER -66.87 -48.84 67.55 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.199 -0.938 . . . . 0.0 108.983 179.523 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 138.64 -153.88 22.81 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.91 -26.9 6.28 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.55 2.167 . . . . 0.0 110.294 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.47 -27.28 65.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.346 -0.846 . . . . 0.0 109.357 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.693 ' CB ' HD13 ' A' ' 53' ' ' LEU . 6.0 m -121.0 104.54 9.88 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.276 -0.89 . . . . 0.0 109.308 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.465 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 0.4 OUTLIER -100.4 158.66 15.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.297 -0.877 . . . . 0.0 109.405 -179.903 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.766 HD12 ' OG1' ' A' ' 50' ' ' THR . 0.7 OUTLIER -151.8 19.68 0.7 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.206 -0.934 . . . . 0.0 109.414 179.932 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.601 ' C ' HD22 ' A' ' 61' ' ' LEU . 28.6 m -49.95 -40.25 43.16 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.312 -0.867 . . . . 0.0 109.724 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.601 HD22 ' C ' ' A' ' 60' ' ' THR . 1.2 mm? -112.09 2.56 16.84 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.267 -0.896 . . . . 0.0 109.887 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.717 ' CG ' HD23 ' A' ' 59' ' ' LEU . 2.4 t80 -52.44 125.27 15.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.193 -0.942 . . . . 0.0 110.037 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.523 ' O ' ' N ' ' A' ' 65' ' ' LYS . 1.4 t0 -84.77 97.84 9.92 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.588 ' CE2' ' O ' ' A' ' 44' ' ' ARG . 0.7 OUTLIER -65.7 68.14 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.344 -0.848 . . . . 0.0 109.14 -179.243 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 63' ' ' ASP . 7.9 mtpt 174.82 -41.49 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.43 -0.794 . . . . 0.0 108.94 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -93.44 -39.65 10.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.358 -0.839 . . . . 0.0 109.092 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.583 ' CA ' ' CZ ' ' A' ' 17' ' ' ARG . . . 99.71 34.08 5.08 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 pp -140.52 151.04 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.053 -1.263 . . . . 0.0 110.059 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.503 ' HB3' ' HA ' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -139.59 160.52 39.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.326 -0.859 . . . . 0.0 109.179 179.305 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 1.7 p -150.27 169.01 22.38 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.15 -0.968 . . . . 0.0 109.602 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -95.04 149.12 35.78 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.273 -0.892 . . . . 0.0 109.376 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.72 139.04 17.51 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.61 2.207 . . . . 0.0 110.565 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.634 ' HB1' ' HD2' ' A' ' 74' ' ' PRO . . . -135.59 164.66 41.93 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.283 -0.886 . . . . 0.0 109.504 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.634 ' HD2' ' HB1' ' A' ' 73' ' ' ALA . 35.9 Cg_endo -78.59 -9.85 15.93 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.71 2.273 . . . . 0.0 110.458 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 28.2 mttt . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 117.976 -1.012 . . . . 0.0 109.549 -179.939 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -129.18 3.94 5.23 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.298 -0.876 . . . . 0.0 109.639 -179.951 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.508 ' HB3' HG22 ' A' ' 20' ' ' VAL . 4.6 pm0 -136.92 165.48 25.87 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.186 -0.947 . . . . 0.0 109.439 179.923 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.438 ' O ' ' C ' ' A' ' 5' ' ' TRP . 0.7 OUTLIER -160.65 88.49 0.78 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.252 -0.905 . . . . 0.0 109.596 -179.966 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.438 ' C ' ' O ' ' A' ' 4' ' ' ASP . 75.3 m95 -42.11 106.47 0.06 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.33 -0.856 . . . . 0.0 109.535 179.844 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 17' ' ' ARG . 0.7 OUTLIER -115.92 158.63 22.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.236 -0.915 . . . . 0.0 109.52 -179.801 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.408 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 12.5 m-20 -50.71 145.36 6.97 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.198 -0.938 . . . . 0.0 109.453 179.96 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.482 ' HA ' ' HB2' ' A' ' 17' ' ' ARG . 42.3 t -89.45 114.5 60.71 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.224 -0.923 . . . . 0.0 109.664 -179.869 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 35.8 Cg_endo -78.47 -55.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.284 1.99 . . . . 0.0 110.443 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.837 ' HB3' ' CE2' ' A' ' 62' ' ' PHE . . . -48.14 -39.21 19.94 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.315 -0.866 . . . . 0.0 109.937 -179.742 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.899 HD12 ' CD1' ' A' ' 15' ' ' TRP . 11.2 mt -94.18 -60.69 1.68 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.047 -1.033 . . . . 0.0 109.693 -179.996 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 8' ' ' CYS . . . 147.88 -148.76 20.57 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.854 -1.299 . . . . 0.0 109.854 -179.932 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.42 159.29 32.68 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.621 2.214 . . . . 0.0 110.845 -179.652 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.17 -70.27 3.14 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.825 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.899 ' CD1' HD12 ' A' ' 11' ' ' LEU . 14.2 t-105 -50.39 126.24 14.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.24 -1.153 . . . . 0.0 109.728 -179.861 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.0 mmtm -98.89 110.56 23.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.208 -0.932 . . . . 0.0 109.227 179.723 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.608 ' HG3' ' CE1' ' A' ' 35' ' ' TYR . 8.6 ttt-85 -89.13 105.02 17.52 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.389 -0.82 . . . . 0.0 109.863 -179.55 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.49 ' HB3' ' O ' ' A' ' 34' ' ' TYR . 11.9 ttt180 -94.94 138.54 32.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.924 . . . . 0.0 109.194 179.638 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -119.92 147.11 45.13 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.279 -0.888 . . . . 0.0 109.465 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.538 HG12 ' O ' ' A' ' 20' ' ' VAL . 84.5 t -134.02 66.63 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.292 -0.88 . . . . 0.0 109.131 179.902 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -48.25 91.48 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.38 -0.825 . . . . 0.0 109.709 -179.697 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.513 ' N ' ' O ' ' A' ' 20' ' ' VAL . 12.2 mtt180 -74.79 -34.34 62.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.231 -0.918 . . . . 0.0 109.37 179.875 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.89 142.88 0.31 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.301 -0.875 . . . . 0.0 109.332 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.3 p -92.22 -26.42 18.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.209 -0.932 . . . . 0.0 109.488 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 55.44 -164.4 4.16 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.925 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.534 ' O ' ' CG2' ' A' ' 27' ' ' THR . . . -84.83 91.27 7.96 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.278 -1.13 . . . . 0.0 109.484 179.913 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' THR . . . . . 0.534 ' CG2' ' O ' ' A' ' 26' ' ' ALA . 10.2 t 40.98 35.01 0.32 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.553 -0.717 . . . . 0.0 109.973 179.947 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -147.8 24.99 1.06 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.232 -0.917 . . . . 0.0 109.246 179.702 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.44 -179.7 27.64 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.954 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.408 ' O ' ' HB2' ' A' ' 31' ' ' SER . 0.3 OUTLIER -141.22 -48.5 0.4 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.227 -1.16 . . . . 0.0 109.234 179.882 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.408 ' HB2' ' O ' ' A' ' 30' ' ' ARG . 14.6 m 64.56 144.02 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.24 -0.912 . . . . 0.0 109.552 179.773 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.577 ' HB3' ' CE1' ' A' ' 34' ' ' TYR . 7.5 m-20 -96.58 148.11 23.18 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.331 -0.855 . . . . 0.0 109.218 179.839 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.537 ' O ' ' CE1' ' A' ' 64' ' ' PHE . 0.0 OUTLIER -137.15 128.01 27.33 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.163 -0.96 . . . . 0.0 109.986 -179.658 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.577 ' CE1' ' HB3' ' A' ' 32' ' ' ASP . 1.1 m-85 -124.8 141.17 52.3 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.388 -0.82 . . . . 0.0 109.008 179.531 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.643 ' HD2' HD22 ' A' ' 49' ' ' LEU . 9.7 m-85 -118.17 143.9 46.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.004 -1.06 . . . . 0.0 109.751 -179.767 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.432 ' HB2' ' CZ3' ' A' ' 5' ' ' TRP . 8.7 tp-100 -117.86 134.43 54.94 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.371 -0.831 . . . . 0.0 109.474 179.931 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.454 ' OG ' ' HB3' ' A' ' 41' ' ' ASP . 0.0 OUTLIER -81.92 171.77 11.21 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.354 -0.841 . . . . 0.0 109.172 179.852 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.435 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 35.6 Cg_endo -78.01 6.13 4.85 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.486 2.124 . . . . 0.0 110.343 179.841 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.9 p -114.31 -9.92 12.75 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.185 -0.947 . . . . 0.0 109.409 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 102.82 17.3 19.29 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.894 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.567 ' OD2' ' CE1' ' A' ' 52' ' ' TYR . 19.5 t0 -96.61 111.0 23.31 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.135 -1.215 . . . . 0.0 109.327 179.805 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.88 121.63 31.43 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.277 -0.889 . . . . 0.0 109.778 -179.715 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.578 HG21 ' CA ' ' A' ' 49' ' ' LEU . 3.9 mt -121.72 150.02 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.344 -0.847 . . . . 0.0 109.202 179.74 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.569 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 1.8 ttp180 -128.51 -6.59 5.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.233 -0.917 . . . . 0.0 109.94 179.758 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.572 ' HB3' ' CB ' ' A' ' 48' ' ' GLU . 12.9 t -90.29 142.66 27.51 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.093 -1.005 . . . . 0.0 108.923 179.598 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.504 ' HG2' ' N ' ' A' ' 47' ' ' VAL . 21.0 ttpt -63.97 -74.79 0.09 Allowed 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.338 -0.851 . . . . 0.0 110.862 -178.692 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.504 ' N ' ' HG2' ' A' ' 46' ' ' LYS . 58.3 t -62.16 -26.81 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.218 -0.926 . . . . 0.0 110.604 -178.431 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.572 ' CB ' ' HB3' ' A' ' 45' ' ' SER . 1.7 tt0 -66.45 -52.14 49.47 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.697 -1.252 . . . . 0.0 109.059 179.861 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.752 HD12 HD11 ' A' ' 53' ' ' LEU . 1.3 pp -63.51 -23.3 67.33 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.331 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.539 ' CG2' ' HB2' ' A' ' 59' ' ' LEU . 25.2 m -67.86 -70.83 0.24 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.235 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.469 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 0.1 OUTLIER -46.95 -24.43 0.61 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.402 -0.811 . . . . 0.0 109.131 179.975 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.567 ' CE1' ' OD2' ' A' ' 41' ' ' ASP . 69.8 t80 -62.96 -55.8 22.66 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.279 -0.888 . . . . 0.0 109.439 179.761 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.752 HD11 HD12 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -65.78 -50.0 66.29 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.178 -0.951 . . . . 0.0 109.344 179.996 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 121.23 -152.79 16.74 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 -179.697 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.9 -9.51 16.85 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.553 2.169 . . . . 0.0 110.462 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.96 -24.86 58.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.299 -0.875 . . . . 0.0 109.3 179.9 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.442 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 54.5 m -127.98 94.77 4.01 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.292 -0.88 . . . . 0.0 109.0 179.741 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.456 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 2.2 m-20 -76.91 157.26 31.47 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.347 -0.846 . . . . 0.0 110.168 -179.343 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.932 HD23 ' CB ' ' A' ' 62' ' ' PHE . 1.2 mp -152.09 39.56 0.6 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.538 -0.726 . . . . 0.0 109.062 -179.709 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.947 ' O ' HD23 ' A' ' 61' ' ' LEU . 0.1 OUTLIER -38.51 -44.72 0.97 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.669 -0.644 . . . . 0.0 110.421 -179.447 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.947 HD23 ' O ' ' A' ' 60' ' ' THR . 10.8 mt -142.35 33.41 1.49 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.096 -1.002 . . . . 0.0 109.759 -179.813 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.932 ' CB ' HD23 ' A' ' 59' ' ' LEU . 10.9 t80 -47.27 117.35 1.71 Allowed 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.283 -0.885 . . . . 0.0 109.617 179.907 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.511 ' O ' ' N ' ' A' ' 65' ' ' LYS . 1.5 m-20 -79.42 102.34 8.67 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.388 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.569 ' CE2' ' O ' ' A' ' 44' ' ' ARG . 0.1 OUTLIER -67.35 62.07 0.06 Allowed 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.292 -0.88 . . . . 0.0 109.568 -178.914 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.511 ' N ' ' O ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER 171.82 -30.48 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.285 -0.884 . . . . 0.0 109.51 179.895 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -99.58 -42.77 6.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.204 -0.935 . . . . 0.0 109.411 179.843 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.469 ' HA2' ' NE ' ' A' ' 17' ' ' ARG . . . 101.78 30.79 5.67 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.733 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.459 HD11 ' OD2' ' A' ' 63' ' ' ASP . 2.4 pp -140.21 178.45 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.246 -1.149 . . . . 0.0 109.573 179.994 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.549 ' HB3' ' HA ' ' A' ' 62' ' ' PHE . 0.8 OUTLIER -164.7 -176.79 4.44 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.334 -0.854 . . . . 0.0 109.427 179.809 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.64 ' HB3' HD12 ' A' ' 61' ' ' LEU . 0.3 OUTLIER -160.37 166.89 28.54 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.28 -0.888 . . . . 0.0 109.537 179.693 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.62 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 12.5 t80 -86.25 -45.02 0.58 Allowed Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.148 -0.97 . . . . 0.0 110.855 -179.734 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.859 ' O ' HD11 ' A' ' 61' ' ' LEU . 36.0 Cg_endo -80.55 -161.44 0.15 Allowed 'Trans proline' 0 C--N 1.313 -1.296 0 C-N-CA 122.282 1.988 . . . . 0.0 110.929 -179.106 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.539 ' N ' ' HD3' ' A' ' 74' ' ' PRO . . . 46.44 60.79 14.06 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.402 -0.811 . . . . 0.0 109.928 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.539 ' HD3' ' N ' ' A' ' 73' ' ' ALA . 36.3 Cg_endo -79.05 168.86 20.05 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.564 2.176 . . . . 0.0 110.316 179.699 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.3 mttt . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 118.003 -0.998 . . . . 0.0 109.399 179.783 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.28 156.68 38.88 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.119 -0.988 . . . . 0.0 109.918 -179.774 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.541 ' HG2' ' CD ' ' A' ' 18' ' ' ARG . 0.5 OUTLIER -80.63 -172.4 3.6 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.37 -0.831 . . . . 0.0 109.397 179.755 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.443 ' O ' HD23 ' A' ' 6' ' ' LEU . 3.6 t70 -129.38 58.84 1.61 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.153 -0.967 . . . . 0.0 109.914 -179.919 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.579 ' CE3' ' HB2' ' A' ' 18' ' ' ARG . 73.7 m95 -51.4 101.27 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.178 -0.951 . . . . 0.0 109.115 179.599 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.443 HD23 ' O ' ' A' ' 4' ' ' ASP . 0.5 OUTLIER -106.93 147.88 29.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.216 -0.927 . . . . 0.0 109.702 -179.757 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.484 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 12.3 m-20 -43.85 130.04 5.69 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.294 -0.879 . . . . 0.0 109.257 179.819 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.52 ' SG ' ' CZ ' ' A' ' 17' ' ' ARG . 12.2 t -86.56 113.37 52.4 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.294 -0.878 . . . . 0.0 109.583 -179.796 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 36.6 Cg_endo -80.62 -47.97 0.07 OUTLIER 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 122.411 2.074 . . . . 0.0 110.33 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.645 ' HB3' ' NH1' ' A' ' 17' ' ' ARG . . . -41.66 -35.58 0.79 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.327 -0.858 . . . . 0.0 109.85 -179.716 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.863 HD12 ' CD1' ' A' ' 15' ' ' TRP . 14.7 mt -106.1 -65.94 1.03 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.176 -0.952 . . . . 0.0 109.659 -179.873 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 153.5 -150.91 22.7 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.949 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.7 153.55 30.02 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.651 2.234 . . . . 0.0 110.535 -179.9 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.436 ' O ' ' HD3' ' A' ' 38' ' ' PRO . . . 90.18 -24.98 13.49 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.854 -1.299 . . . . 0.0 109.854 179.667 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.863 ' CD1' HD12 ' A' ' 11' ' ' LEU . 10.9 t-105 -98.74 133.38 43.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.176 -1.191 . . . . 0.0 109.752 -179.749 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.458 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 26.1 mmtp -105.67 116.87 32.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.246 -0.909 . . . . 0.0 109.546 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.645 ' NH1' ' HB3' ' A' ' 10' ' ' ALA . 0.4 OUTLIER -89.97 103.82 16.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.156 -0.965 . . . . 0.0 109.228 179.869 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.579 ' HB2' ' CE3' ' A' ' 5' ' ' TRP . 2.0 ttm180 -97.12 140.62 31.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.244 -0.91 . . . . 0.0 110.006 -179.537 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 21.8 pt-20 -138.45 132.65 31.65 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.309 -0.869 . . . . 0.0 109.026 179.582 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.531 HG12 ' O ' ' A' ' 20' ' ' VAL . 16.3 t -99.78 16.91 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.179 -0.951 . . . . 0.0 109.719 -179.681 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.437 ' O ' ' CB ' ' A' ' 31' ' ' SER . 0.1 OUTLIER 64.19 -66.87 0.11 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.607 -0.683 . . . . 0.0 110.188 179.524 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.498 ' N ' ' O ' ' A' ' 20' ' ' VAL . 0.0 OUTLIER 44.58 37.59 2.24 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.152 -0.967 . . . . 0.0 108.946 -179.298 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 15.9 tttp -102.16 77.0 1.63 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.469 -0.769 . . . . 0.0 109.649 -179.732 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.5 t -100.84 164.89 11.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.198 -0.939 . . . . 0.0 109.41 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.37 -40.69 98.98 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.937 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.92 167.74 0.55 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.312 -1.111 . . . . 0.0 109.482 179.96 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 39.6 p -100.73 23.42 10.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.225 -0.922 . . . . 0.0 109.301 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 58.9 m -53.92 -55.76 24.02 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.305 -0.872 . . . . 0.0 109.433 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -156.38 -178.34 30.42 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.888 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.446 ' O ' ' O ' ' A' ' 22' ' ' ARG . 11.9 tpp180 -105.87 -63.46 1.25 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.311 -1.111 . . . . 0.0 109.251 179.962 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.437 ' CB ' ' O ' ' A' ' 21' ' ' PHE . 22.5 p -169.39 130.27 1.09 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.398 -0.814 . . . . 0.0 108.927 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.564 ' HB3' ' CZ ' ' A' ' 34' ' ' TYR . 22.3 m-20 -79.3 142.36 36.2 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.105 -0.997 . . . . 0.0 109.557 -179.718 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.494 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 0.0 OUTLIER -127.61 90.92 3.2 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.276 -0.89 . . . . 0.0 109.595 -179.966 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.567 ' CD1' ' HG2' ' A' ' 44' ' ' ARG . 10.4 m-85 -99.68 140.66 33.55 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.309 -0.87 . . . . 0.0 109.086 179.758 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.598 ' HD2' HD22 ' A' ' 49' ' ' LEU . 4.8 m-85 -116.58 158.21 24.06 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.214 -0.929 . . . . 0.0 109.99 -179.324 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -138.88 121.74 16.57 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.477 -0.764 . . . . 0.0 109.229 179.904 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.486 ' HB2' ' HD2' ' A' ' 38' ' ' PRO . 1.1 p -73.68 173.61 6.04 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.331 -0.856 . . . . 0.0 109.253 179.911 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.486 ' HD2' ' HB2' ' A' ' 37' ' ' SER . 36.2 Cg_endo -79.38 9.7 3.31 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.664 2.242 . . . . 0.0 110.662 -179.871 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.4 p -120.24 12.53 11.8 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.097 -1.002 . . . . 0.0 109.83 -179.76 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 85.47 18.92 59.46 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.811 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.504 ' OD2' ' CE2' ' A' ' 52' ' ' TYR . 44.0 t0 -97.21 114.14 25.83 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.205 -1.174 . . . . 0.0 109.339 179.84 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.406 ' C ' HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -108.3 135.94 48.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.189 -0.944 . . . . 0.0 109.814 -179.726 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.62 HD13 ' HB2' ' A' ' 49' ' ' LEU . 2.4 mp -138.28 156.72 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.277 -0.889 . . . . 0.0 109.292 179.81 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.58 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 0.3 OUTLIER -140.69 17.6 2.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.132 -0.98 . . . . 0.0 109.739 -179.994 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.541 ' H ' HG22 ' A' ' 43' ' ' ILE . 0.6 OUTLIER -91.4 -87.21 0.21 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.202 -0.936 . . . . 0.0 108.805 179.445 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.534 ' CB ' ' O ' ' A' ' 45' ' ' SER . 4.9 ttpp 159.4 -60.49 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 179.632 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.41 HG23 ' HE3' ' A' ' 46' ' ' LYS . 26.9 t -87.71 -20.67 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.389 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -69.61 -42.92 73.73 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.802 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.726 ' O ' HD12 ' A' ' 53' ' ' LEU . 2.8 pp -75.99 -32.65 59.55 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.951 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.694 ' OG1' HD12 ' A' ' 59' ' ' LEU . 0.4 OUTLIER -64.01 -42.99 96.96 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 178.687 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.42 ' N ' HG22 ' A' ' 50' ' ' THR . 5.7 mmt85 -66.02 -26.61 67.6 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.18 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.504 ' CE2' ' OD2' ' A' ' 41' ' ' ASP . 28.8 t80 -68.53 -62.66 1.29 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.515 -0.741 . . . . 0.0 109.308 179.87 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.729 HD21 ' CE3' ' A' ' 15' ' ' TRP . 0.7 OUTLIER -53.74 -54.26 40.52 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.193 -0.942 . . . . 0.0 109.222 179.797 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 137.62 -156.33 23.55 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -179.807 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.35 -6.43 15.56 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.581 2.188 . . . . 0.0 110.442 179.915 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -78.44 -23.53 46.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.196 -0.94 . . . . 0.0 109.568 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.459 ' HB2' HD13 ' A' ' 53' ' ' LEU . 91.1 m -129.79 98.08 4.69 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.248 -0.908 . . . . 0.0 109.534 -179.911 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.19 148.05 22.36 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.214 -0.929 . . . . 0.0 109.49 -179.933 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 1.025 HD23 ' CD2' ' A' ' 62' ' ' PHE . 0.4 OUTLIER -138.78 16.94 2.68 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.374 -0.829 . . . . 0.0 109.18 -179.98 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.602 ' C ' HD22 ' A' ' 61' ' ' LEU . 2.8 m -50.1 -50.32 48.69 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.429 -0.794 . . . . 0.0 109.579 -179.968 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.666 HD22 ' N ' ' A' ' 61' ' ' LEU . 3.6 mm? -100.89 11.37 39.72 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.292 -0.88 . . . . 0.0 109.676 -179.704 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 1.025 ' CD2' HD23 ' A' ' 59' ' ' LEU . 70.9 t80 -68.86 129.68 40.62 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.233 -0.917 . . . . 0.0 109.826 -179.754 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.509 ' O ' ' N ' ' A' ' 65' ' ' LYS . 3.0 t0 -82.32 103.43 11.89 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.331 -0.855 . . . . 0.0 108.973 179.555 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.58 ' CE1' ' CE2' ' A' ' 35' ' ' TYR . 0.8 OUTLIER -67.44 67.74 0.09 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.126 -0.984 . . . . 0.0 109.126 -179.616 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.509 ' N ' ' O ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER 171.23 -32.43 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -179.899 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -95.15 -46.32 6.83 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.344 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.538 ' HA2' ' CE1' ' A' ' 62' ' ' PHE . . . 104.48 30.13 5.09 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 179.426 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.478 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 1.1 pp -141.01 162.02 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.898 -1.354 . . . . 0.0 110.106 179.845 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.551 ' N ' HD23 ' A' ' 69' ' ' LEU . 1.5 pt? -151.83 164.78 36.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.327 -0.858 . . . . 0.0 109.364 179.973 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 6.1 p -155.2 110.19 3.01 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.204 -0.935 . . . . 0.0 109.269 179.704 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.414 ' O ' ' CG ' ' A' ' 71' ' ' TYR . 13.5 t80 -140.6 76.73 23.98 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.248 -0.908 . . . . 0.0 109.642 -179.692 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -79.04 164.46 24.86 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.598 2.199 . . . . 0.0 110.18 179.792 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.476 ' HB1' ' HD2' ' A' ' 74' ' ' PRO . . . -131.99 158.91 74.22 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.154 -0.966 . . . . 0.0 109.557 -179.915 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.476 ' HD2' ' HB1' ' A' ' 73' ' ' ALA . 35.8 Cg_endo -78.2 -75.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.576 2.184 . . . . 0.0 110.093 179.759 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.556 179.795 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.4 -15.47 62.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.16 -0.962 . . . . 0.0 109.486 -179.926 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.46 ' CB ' ' HD2' ' A' ' 18' ' ' ARG . 1.2 mp0 -109.0 -146.41 0.4 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.282 -0.886 . . . . 0.0 109.414 -179.993 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.46 ' O ' HD23 ' A' ' 6' ' ' LEU . 20.8 m-20 -138.39 72.9 1.42 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.168 -0.958 . . . . 0.0 109.503 -179.918 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.586 ' CZ2' ' HD3' ' A' ' 18' ' ' ARG . 93.0 m95 -69.86 95.78 0.95 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.246 -0.909 . . . . 0.0 109.373 179.858 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.46 HD23 ' O ' ' A' ' 4' ' ' ASP . 2.4 mm? -99.36 166.39 11.22 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.239 -0.913 . . . . 0.0 109.488 -179.816 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.48 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 0.7 OUTLIER -66.72 145.27 55.73 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.242 -0.911 . . . . 0.0 109.1 179.711 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.507 ' SG ' ' N ' ' A' ' 17' ' ' ARG . 13.8 m -87.57 112.98 52.08 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.277 -0.89 . . . . 0.0 109.74 -179.595 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.48 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 36.3 Cg_endo -79.51 -40.87 0.23 Allowed 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.239 1.96 . . . . 0.0 109.749 179.441 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.904 ' HB3' ' NH1' ' A' ' 17' ' ' ARG . . . -61.4 -53.27 58.79 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.429 -0.794 . . . . 0.0 109.782 -179.951 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 1.031 HD12 ' CD1' ' A' ' 15' ' ' TRP . 6.6 mt -82.46 -47.94 11.65 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.164 -0.96 . . . . 0.0 109.676 -179.751 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 130.02 -148.18 18.39 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -76.71 155.59 35.2 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.624 2.216 . . . . 0.0 110.717 -179.879 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.91 -46.33 3.1 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.963 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 1.031 ' CD1' HD12 ' A' ' 11' ' ' LEU . 5.1 t-105 -80.31 131.14 35.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.259 -1.142 . . . . 0.0 110.074 -179.621 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.423 ' C ' ' SG ' ' A' ' 8' ' ' CYS . 17.5 mmtp -105.65 126.88 52.66 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.3 -0.875 . . . . 0.0 109.365 179.696 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.904 ' NH1' ' HB3' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -99.12 107.47 19.85 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.294 -0.879 . . . . 0.0 109.587 -179.713 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.586 ' HD3' ' CZ2' ' A' ' 5' ' ' TRP . 25.1 ttp180 -100.54 143.72 30.38 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.247 -0.908 . . . . 0.0 109.853 -179.887 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -113.58 149.47 34.45 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.311 -0.868 . . . . 0.0 109.326 179.64 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.821 HG21 ' CE2' ' A' ' 34' ' ' TYR . 13.6 t -137.65 149.61 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.213 -0.93 . . . . 0.0 109.55 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.547 ' CB ' ' HA ' ' A' ' 31' ' ' SER . 1.7 m-85 64.67 15.45 9.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.268 -0.895 . . . . 0.0 109.623 179.973 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.506 ' HA ' ' HB3' ' A' ' 31' ' ' SER . 0.0 OUTLIER -84.26 2.01 42.07 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.243 -0.911 . . . . 0.0 109.518 179.795 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.24 56.92 1.67 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.181 -0.949 . . . . 0.0 109.664 -179.939 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.33 164.5 12.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.179 -0.95 . . . . 0.0 109.267 179.776 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -119.25 -63.38 0.28 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.88 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -85.07 -78.82 0.24 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.251 -1.146 . . . . 0.0 109.636 -179.747 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.74 98.29 3.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.277 -0.889 . . . . 0.0 109.871 -179.588 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -69.69 -75.65 0.11 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.233 -0.917 . . . . 0.0 109.228 179.59 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.79 -106.06 3.24 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.728 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.425 ' O ' ' C ' ' A' ' 31' ' ' SER . 0.5 OUTLIER -170.19 99.58 0.28 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.296 -1.12 . . . . 0.0 109.359 -179.761 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.547 ' HA ' ' CB ' ' A' ' 21' ' ' PHE . 1.8 p -43.48 123.54 3.09 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.228 -0.92 . . . . 0.0 109.572 180.0 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.476 ' HB2' ' CZ ' ' A' ' 34' ' ' TYR . 4.7 m-20 -79.25 164.73 23.91 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.245 -0.91 . . . . 0.0 109.103 179.921 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.448 HG22 ' CE1' ' A' ' 35' ' ' TYR . 5.6 m -136.98 121.86 18.8 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.153 -0.967 . . . . 0.0 110.105 -179.444 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.821 ' CE2' HG21 ' A' ' 20' ' ' VAL . 1.4 m-85 -123.3 149.22 45.08 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.292 -0.88 . . . . 0.0 108.717 179.168 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.677 ' HD2' HD22 ' A' ' 49' ' ' LEU . 7.2 m-85 -113.91 150.87 33.08 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.933 -1.105 . . . . 0.0 109.809 -179.89 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.46 ' HB2' ' CZ3' ' A' ' 5' ' ' TRP . 2.3 tt0 -129.79 124.88 34.45 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.331 -0.856 . . . . 0.0 109.595 -179.835 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.508 ' HB3' ' HD2' ' A' ' 38' ' ' PRO . 0.9 OUTLIER -71.3 173.15 5.38 Favored Pre-proline 0 N--CA 1.488 1.437 0 O-C-N 121.347 -0.845 . . . . 0.0 109.04 179.785 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.508 ' HD2' ' HB3' ' A' ' 37' ' ' SER . 34.9 Cg_endo -78.34 8.82 3.4 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.55 2.167 . . . . 0.0 110.9 -179.895 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.417 HG22 ' HB2' ' A' ' 37' ' ' SER . 15.3 t -115.55 -24.37 8.35 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.013 -1.054 . . . . 0.0 109.514 179.899 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 122.73 16.09 3.8 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.36 111.24 23.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.158 -1.201 . . . . 0.0 109.674 -179.924 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.69 148.59 22.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.191 -0.943 . . . . 0.0 109.34 179.79 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.562 ' CG2' ' HB3' ' A' ' 49' ' ' LEU . 4.5 mp -140.39 158.27 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.11 -0.994 . . . . 0.0 109.921 -179.825 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.514 ' HA ' ' CZ ' ' A' ' 64' ' ' PHE . 0.9 OUTLIER -137.05 -8.63 1.79 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.249 -0.907 . . . . 0.0 110.737 -179.778 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.543 ' CB ' ' HB2' ' A' ' 48' ' ' GLU . 0.6 OUTLIER -63.48 -86.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.782 -1.199 . . . . 0.0 109.334 179.905 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.502 ' HB2' ' O ' ' A' ' 45' ' ' SER . 42.7 tttm 161.97 -63.99 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 -179.769 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 75.0 t -87.94 -19.98 7.59 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 178.518 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.543 ' HB2' ' CB ' ' A' ' 45' ' ' SER . 2.8 mt-10 -66.83 -43.62 83.29 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.353 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.677 HD22 ' HD2' ' A' ' 35' ' ' TYR . 1.9 pp -70.07 -23.63 63.1 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 178.647 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.861 ' OG1' HD13 ' A' ' 59' ' ' LEU . 30.3 m -70.96 -64.48 0.9 Allowed 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.969 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -49.73 -29.46 7.66 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.361 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.431 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 86.2 t80 -57.82 -60.93 2.95 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.377 -0.827 . . . . 0.0 108.909 179.417 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 1.007 HD21 ' CE3' ' A' ' 15' ' ' TRP . 0.4 OUTLIER -58.17 -51.94 67.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.287 -0.883 . . . . 0.0 109.221 179.576 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 133.19 -154.1 21.05 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.394 -1.483 . . . . 0.0 109.394 -179.914 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.76 -17.93 13.72 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.614 2.209 . . . . 0.0 110.176 179.752 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.57 -24.47 66.35 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.31 -0.869 . . . . 0.0 109.507 179.925 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.485 ' CB ' HD13 ' A' ' 53' ' ' LEU . 1.7 m -117.13 156.15 28.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.242 -0.911 . . . . 0.0 109.517 179.991 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.793 ' C ' HD12 ' A' ' 59' ' ' LEU . 62.0 t0 -149.22 147.95 29.02 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.334 -0.854 . . . . 0.0 109.291 179.937 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.889 HD23 ' CD1' ' A' ' 62' ' ' PHE . 5.7 mp -148.51 17.56 1.03 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.188 -0.945 . . . . 0.0 109.489 -179.64 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.632 ' C ' HD22 ' A' ' 61' ' ' LEU . 3.6 m -42.52 -49.25 5.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.422 -0.799 . . . . 0.0 109.29 -179.876 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.632 HD22 ' C ' ' A' ' 60' ' ' THR . 1.2 mm? -113.09 18.64 17.85 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.395 -0.816 . . . . 0.0 109.455 -179.92 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.889 ' CD1' HD23 ' A' ' 59' ' ' LEU . 9.8 t80 -77.24 133.97 38.72 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.315 -0.866 . . . . 0.0 109.289 179.945 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.569 ' O ' ' CE1' ' A' ' 62' ' ' PHE . 0.9 OUTLIER -84.92 136.08 33.78 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.355 -0.84 . . . . 0.0 109.211 179.792 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.654 ' CE1' ' CE2' ' A' ' 35' ' ' TYR . 0.3 OUTLIER -86.79 43.61 1.1 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.141 -0.974 . . . . 0.0 109.2 179.957 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.429 ' HA ' ' OG1' ' A' ' 33' ' ' THR . 0.0 OUTLIER -165.12 -44.15 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.409 -0.807 . . . . 0.0 109.052 -179.898 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -81.59 -36.1 29.38 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.328 -0.858 . . . . 0.0 109.259 179.73 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.526 ' HA2' ' CE2' ' A' ' 62' ' ' PHE . . . 88.89 35.15 8.45 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.854 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.484 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 1.8 pp -140.04 155.97 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.172 -1.193 . . . . 0.0 109.781 -179.823 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.544 ' N ' HD23 ' A' ' 69' ' ' LEU . 1.3 pt? -143.56 166.92 23.49 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.31 -0.869 . . . . 0.0 109.043 179.667 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.437 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 0.6 OUTLIER -155.07 -171.48 3.84 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.129 -0.982 . . . . 0.0 109.658 -179.987 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -118.49 162.12 32.05 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.288 -0.882 . . . . 0.0 109.41 179.919 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.74 55.64 5.3 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.622 2.215 . . . . 0.0 110.515 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -138.06 86.84 17.03 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.245 -0.909 . . . . 0.0 109.64 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.34 112.2 3.16 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.684 2.256 . . . . 0.0 110.207 179.957 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.516 -179.873 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 51.75 40.98 28.73 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.241 -0.912 . . . . 0.0 109.314 -179.92 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.78 -58.79 3.01 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.329 -0.857 . . . . 0.0 109.41 -179.972 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.454 ' CB ' ' HG2' ' A' ' 19' ' ' GLU . 1.8 m-20 -153.98 26.38 0.48 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.29 -0.881 . . . . 0.0 109.429 179.905 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.626 ' CH2' ' NH1' ' A' ' 18' ' ' ARG . 67.4 m95 -65.56 92.24 0.14 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.309 -0.869 . . . . 0.0 109.331 179.868 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 6' ' ' LEU . 54.2 mt -109.75 153.24 24.61 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.149 -0.97 . . . . 0.0 109.63 -179.809 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.407 ' C ' ' O ' ' A' ' 6' ' ' LEU . 7.5 t70 -45.64 140.39 3.4 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.255 -0.903 . . . . 0.0 109.062 179.77 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.524 ' HG ' ' HE1' ' A' ' 35' ' ' TYR . 44.5 t -102.29 108.79 58.5 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.182 -0.949 . . . . 0.0 109.869 -179.599 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.423 ' HD2' ' CZ ' ' A' ' 17' ' ' ARG . 34.1 Cg_endo -77.01 -32.77 3.06 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.154 1.903 . . . . 0.0 109.767 179.194 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.679 ' O ' HD23 ' A' ' 11' ' ' LEU . . . -50.55 -30.13 12.36 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.302 -0.874 . . . . 0.0 108.954 179.319 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 1.053 HD12 ' CD1' ' A' ' 15' ' ' TRP . 9.6 mt -117.25 -65.54 1.17 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.383 -0.823 . . . . 0.0 109.485 179.848 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.412 ' O ' ' O ' ' A' ' 8' ' ' CYS . . . 168.38 -147.42 11.39 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -179.885 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' PRO . . . . . 0.514 ' O ' ' N ' ' A' ' 15' ' ' TRP . 35.9 Cg_endo -78.08 175.39 11.2 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.681 2.254 . . . . 0.0 110.618 -179.701 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' GLY . . . . . 0.426 ' O ' ' C ' ' A' ' 15' ' ' TRP . . . 65.66 -68.39 0.11 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.97 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 1.053 ' CD1' HD12 ' A' ' 11' ' ' LEU . 4.5 t-105 -43.55 119.62 1.7 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.374 -1.074 . . . . 0.0 109.515 179.9 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.451 ' HD2' ' HB3' ' A' ' 5' ' ' TRP . 1.0 OUTLIER -101.7 114.91 29.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.185 -0.947 . . . . 0.0 109.659 -179.937 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.486 ' HD3' ' OH ' ' A' ' 35' ' ' TYR . 10.4 ttp85 -92.95 111.2 22.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.232 -0.917 . . . . 0.0 109.309 179.771 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.626 ' NH1' ' CH2' ' A' ' 5' ' ' TRP . 41.2 ttp180 -100.38 148.47 24.67 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.185 -0.947 . . . . 0.0 109.488 -179.933 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.454 ' HG2' ' CB ' ' A' ' 4' ' ' ASP . 17.1 pt-20 -102.98 145.15 30.3 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.221 -0.924 . . . . 0.0 109.369 179.924 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.691 HG21 ' CE2' ' A' ' 34' ' ' TYR . 2.9 t -117.76 155.01 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.187 -0.946 . . . . 0.0 109.547 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.529 ' CD1' ' N ' ' A' ' 21' ' ' PHE . 1.0 OUTLIER -116.25 41.35 2.64 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.263 -0.898 . . . . 0.0 109.346 179.95 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.448 ' O ' ' N ' ' A' ' 24' ' ' SER . 0.0 OUTLIER 45.09 28.51 0.4 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.282 -0.886 . . . . 0.0 109.405 -179.939 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.2 mttp 67.47 -70.71 0.11 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.234 -0.916 . . . . 0.0 109.495 179.889 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.448 ' N ' ' O ' ' A' ' 22' ' ' ARG . 25.3 p -108.82 10.91 26.5 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.31 -0.869 . . . . 0.0 109.482 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' GLY . . . . . 0.422 ' HA3' ' HA3' ' A' ' 29' ' ' GLY . . . -100.85 67.56 0.48 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.947 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.25 -46.92 21.54 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.305 -1.115 . . . . 0.0 109.598 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.2 t -133.7 35.49 3.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.208 -0.933 . . . . 0.0 109.475 -179.932 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.8 p -159.98 -38.62 0.05 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.333 -0.855 . . . . 0.0 109.478 179.959 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.422 ' HA3' ' HA3' ' A' ' 25' ' ' GLY . . . -85.01 143.2 20.32 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.953 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.402 ' HG3' ' N ' ' A' ' 31' ' ' SER . 0.2 OUTLIER -52.36 157.83 1.35 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.263 -1.139 . . . . 0.0 109.359 179.97 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.402 ' N ' ' HG3' ' A' ' 30' ' ' ARG . 0.6 OUTLIER -109.44 114.41 28.03 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.221 -0.924 . . . . 0.0 109.641 -179.943 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -88.95 166.06 14.18 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.221 -0.924 . . . . 0.0 109.388 179.944 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.528 ' O ' ' CE1' ' A' ' 64' ' ' PHE . 9.7 m -131.15 144.14 51.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.255 -0.903 . . . . 0.0 109.428 179.972 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.691 ' CE2' HG21 ' A' ' 20' ' ' VAL . 20.0 m-85 -124.75 164.94 18.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.383 -0.823 . . . . 0.0 109.142 179.819 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.893 ' HD2' HD22 ' A' ' 49' ' ' LEU . 10.4 m-85 -121.27 147.99 44.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.058 -1.026 . . . . 0.0 110.483 -179.332 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.606 ' HB2' ' CZ3' ' A' ' 5' ' ' TRP . 0.1 OUTLIER -131.81 114.37 14.63 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.352 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.505 ' CB ' ' HD2' ' A' ' 38' ' ' PRO . 0.9 OUTLIER -72.4 173.79 5.17 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.354 -0.841 . . . . 0.0 109.455 -179.719 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.505 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 35.1 Cg_endo -76.89 -7.05 17.26 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.549 2.166 . . . . 0.0 110.246 179.939 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 p -105.07 -23.19 12.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.373 -0.829 . . . . 0.0 109.243 179.842 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 122.2 27.33 1.69 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -90.36 114.92 27.12 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.255 -1.144 . . . . 0.0 109.531 179.968 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.1 99.82 11.11 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.265 -0.897 . . . . 0.0 109.351 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.554 ' CG2' ' HB3' ' A' ' 49' ' ' LEU . 1.9 mp -114.44 146.95 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.2 -0.937 . . . . 0.0 109.661 -179.995 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.608 ' HA ' ' CZ ' ' A' ' 64' ' ' PHE . 7.5 ptt180 -140.28 3.41 1.95 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.37 -0.831 . . . . 0.0 109.995 179.962 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.529 ' O ' ' CB ' ' A' ' 46' ' ' LYS . 1.9 t -62.16 -82.39 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.049 -1.032 . . . . 0.0 109.292 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.529 ' CB ' ' O ' ' A' ' 45' ' ' SER . 6.6 ttmt 159.71 -61.74 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.502 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 21.5 t -96.19 -18.3 6.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.795 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.501 ' HB2' ' HB3' ' A' ' 45' ' ' SER . 40.2 mt-10 -73.54 -32.05 63.99 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.884 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.893 HD22 ' HD2' ' A' ' 35' ' ' TYR . 1.7 pp -78.81 -29.56 44.9 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.283 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.748 ' OG1' HD12 ' A' ' 59' ' ' LEU . 0.5 OUTLIER -70.16 -50.17 43.13 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.181 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.528 ' N ' ' CG2' ' A' ' 50' ' ' THR . 0.0 OUTLIER -59.62 -29.68 68.17 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.18 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.448 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 36.6 t80 -56.7 -57.15 13.65 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.327 -0.858 . . . . 0.0 108.702 179.252 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.825 HD21 ' CE3' ' A' ' 15' ' ' TRP . 0.5 OUTLIER -62.33 -40.7 97.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.228 -0.92 . . . . 0.0 109.077 179.536 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 127.17 -158.71 21.13 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 -179.689 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.91 -7.16 16.35 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.421 2.081 . . . . 0.0 110.304 179.852 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.79 -12.79 60.48 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.227 -0.921 . . . . 0.0 109.578 -179.985 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.444 ' HB2' HD13 ' A' ' 53' ' ' LEU . 69.6 m -138.77 132.06 30.07 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.263 -0.898 . . . . 0.0 109.514 -179.96 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -119.66 155.68 31.91 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.182 -0.949 . . . . 0.0 109.532 179.873 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.93 HD23 ' CD2' ' A' ' 62' ' ' PHE . 0.5 OUTLIER -148.83 16.78 0.98 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.204 -0.935 . . . . 0.0 109.779 -179.758 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.638 ' C ' HD22 ' A' ' 61' ' ' LEU . 13.1 m -56.0 -37.41 69.08 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.257 -0.902 . . . . 0.0 109.415 -179.973 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.638 HD22 ' C ' ' A' ' 60' ' ' THR . 1.9 mm? -110.37 8.88 23.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.327 -0.858 . . . . 0.0 109.776 -179.653 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.93 ' CD2' HD23 ' A' ' 59' ' ' LEU . 63.7 t80 -71.29 133.54 46.13 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.25 -0.906 . . . . 0.0 110.074 -179.617 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.519 ' O ' ' N ' ' A' ' 65' ' ' LYS . 15.9 t70 -86.98 100.72 12.81 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.248 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.608 ' CZ ' ' HA ' ' A' ' 44' ' ' ARG . 0.1 OUTLIER -66.22 67.87 0.05 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.299 -0.876 . . . . 0.0 109.391 -179.23 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 63' ' ' ASP . 0.3 OUTLIER 176.01 -40.96 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.481 -0.762 . . . . 0.0 108.957 -179.917 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.72 -27.53 18.0 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.318 -0.864 . . . . 0.0 109.195 179.709 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' GLY . . . . . 0.469 ' HA3' ' NH2' ' A' ' 17' ' ' ARG . . . 90.55 33.52 8.5 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.851 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.722 ' C ' HD12 ' A' ' 68' ' ' ILE . 2.3 pp -140.42 174.84 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.086 -1.244 . . . . 0.0 109.76 179.967 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.611 ' N ' HD12 ' A' ' 68' ' ' ILE . 0.6 OUTLIER -155.4 -167.97 2.69 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.373 -0.829 . . . . 0.0 109.277 179.676 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.443 ' SG ' ' O ' ' A' ' 69' ' ' LEU . 7.8 m -159.97 -176.28 5.59 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.33 -0.856 . . . . 0.0 109.27 179.67 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.494 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 23.3 p90 -165.86 145.61 5.34 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.184 -0.948 . . . . 0.0 109.594 179.969 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.05 132.63 11.75 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.611 2.207 . . . . 0.0 110.124 179.659 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.466 ' N ' ' HD3' ' A' ' 74' ' ' PRO . . . -141.32 64.58 19.93 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.203 -0.936 . . . . 0.0 109.655 -179.838 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 0.466 ' HD3' ' N ' ' A' ' 73' ' ' ALA . 35.8 Cg_endo -78.41 126.57 7.66 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.635 2.223 . . . . 0.0 110.163 179.854 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 118.057 -0.973 . . . . 0.0 109.553 -179.817 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.415 ' O ' ' O ' ' A' ' 2' ' ' ALA . 56.8 mtm . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.415 ' O ' ' O ' ' A' ' 1' ' ' MET . . . 47.32 91.62 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.208 -0.933 . . . . 0.0 109.305 -179.976 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.551 ' HB3' ' CD ' ' A' ' 18' ' ' ARG . 1.5 mm-40 -103.19 -168.16 1.48 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.264 -0.897 . . . . 0.0 109.529 -179.893 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 4' ' ' ASP . . . . . 0.528 ' N ' ' HD3' ' A' ' 18' ' ' ARG . 0.3 OUTLIER -114.27 74.3 0.87 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.3 -0.875 . . . . 0.0 109.699 -179.849 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 5' ' ' TRP . . . . . 0.633 ' CE3' ' CB ' ' A' ' 18' ' ' ARG . 52.7 m95 -58.45 114.88 2.66 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.193 -0.942 . . . . 0.0 109.34 179.914 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 57.0 mt -100.51 159.59 15.03 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.327 -0.858 . . . . 0.0 109.585 -179.698 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.473 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 0.3 OUTLIER -49.83 132.71 22.37 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.256 -0.902 . . . . 0.0 109.319 179.792 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 8' ' ' CYS . . . . . 0.533 ' CB ' ' HB2' ' A' ' 17' ' ' ARG . 29.3 t -88.26 112.82 52.09 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.26 -0.9 . . . . 0.0 109.718 -179.74 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 36.5 Cg_endo -79.75 -59.41 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.46 2.107 . . . . 0.0 110.75 179.905 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.785 ' HB3' ' NH1' ' A' ' 17' ' ' ARG . . . -38.52 -39.66 0.49 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.59 -0.694 . . . . 0.0 110.424 -179.455 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 1.044 HD12 ' CD1' ' A' ' 15' ' ' TRP . 13.3 mt -95.34 -64.61 1.04 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.054 -1.029 . . . . 0.0 109.711 -179.931 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.404 ' O ' ' O ' ' A' ' 8' ' ' CYS . . . 152.98 -152.05 23.76 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -179.824 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.13 148.51 21.62 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.655 2.237 . . . . 0.0 110.399 -179.878 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.17 -51.82 1.64 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.893 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 1.044 ' CD1' HD12 ' A' ' 11' ' ' LEU . 15.3 t-105 -69.24 126.68 30.53 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.307 -1.114 . . . . 0.0 109.504 -179.991 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -94.87 114.03 25.84 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.249 -0.907 . . . . 0.0 108.947 179.751 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.785 ' NH1' ' HB3' ' A' ' 10' ' ' ALA . 2.9 ttm180 -94.67 96.71 9.58 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.161 -0.962 . . . . 0.0 109.844 -179.534 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.633 ' CB ' ' CE3' ' A' ' 5' ' ' TRP . 9.7 tpt180 -100.7 146.0 27.75 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.198 -0.939 . . . . 0.0 109.526 179.63 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.531 ' HG2' ' NH1' ' A' ' 18' ' ' ARG . 8.6 pt-20 -109.0 164.36 12.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.191 -0.943 . . . . 0.0 109.43 179.871 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.591 HG12 ' O ' ' A' ' 20' ' ' VAL . 96.7 t -137.02 66.78 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.216 -0.928 . . . . 0.0 109.463 -179.948 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.595 ' O ' ' CD2' ' A' ' 21' ' ' PHE . 30.4 p90 -41.54 95.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.453 -0.78 . . . . 0.0 109.803 -179.837 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' ARG . . . . . 0.495 ' N ' ' O ' ' A' ' 20' ' ' VAL . 5.3 mmt180 -60.19 -55.37 34.57 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.13 -0.981 . . . . 0.0 109.346 179.896 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 22' ' ' ARG . 36.3 ttmt 172.75 146.93 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.285 -0.885 . . . . 0.0 109.319 -179.986 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.96 124.28 49.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.129 -0.982 . . . . 0.0 109.647 -179.877 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -133.87 -141.52 4.53 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.962 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -91.61 -18.95 23.26 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.294 -1.121 . . . . 0.0 109.443 179.993 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.2 t -153.02 20.89 0.58 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.267 -0.896 . . . . 0.0 109.368 179.898 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.5 m -91.41 90.55 7.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.214 -0.929 . . . . 0.0 109.443 -179.985 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.443 ' O ' ' HB3' ' A' ' 30' ' ' ARG . . . -127.39 107.4 0.88 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.924 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.443 ' HB3' ' O ' ' A' ' 29' ' ' GLY . 0.0 OUTLIER 168.73 50.14 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.216 -1.167 . . . . 0.0 109.565 -179.949 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -53.82 149.1 9.13 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.257 -0.902 . . . . 0.0 109.264 179.921 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' ASP . . . . . 0.469 ' HB2' ' HB ' ' A' ' 20' ' ' VAL . 8.5 m-20 -90.03 121.94 32.57 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.177 -0.952 . . . . 0.0 109.351 -179.931 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.579 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 0.0 OUTLIER -103.94 110.1 22.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.165 -0.959 . . . . 0.0 109.637 -179.727 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.55 ' CD1' ' HB3' ' A' ' 44' ' ' ARG . 19.3 m-30 -106.26 143.1 34.87 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.138 -0.976 . . . . 0.0 109.164 179.803 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.573 ' CE1' ' HG3' ' A' ' 17' ' ' ARG . 5.0 m-85 -122.02 156.71 32.92 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.172 -0.955 . . . . 0.0 109.832 -179.507 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.437 ' OE1' ' HD2' ' A' ' 42' ' ' ARG . 44.5 tt0 -130.61 121.45 25.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.385 -0.822 . . . . 0.0 109.166 179.953 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.493 ' HB2' HG22 ' A' ' 39' ' ' THR . 0.5 OUTLIER -76.37 171.56 11.88 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.154 -0.966 . . . . 0.0 109.746 -179.748 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.46 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 36.0 Cg_endo -77.93 -4.58 14.57 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.729 2.286 . . . . 0.0 110.437 179.994 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.903 HG21 ' OH ' ' A' ' 52' ' ' TYR . 12.3 t -100.11 -12.82 19.32 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.225 -0.922 . . . . 0.0 109.343 179.881 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 106.04 18.06 11.96 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.996 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.8 112.23 24.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -1.131 . . . . 0.0 109.354 -179.978 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' ARG . . . . . 0.437 ' HD2' ' OE1' ' A' ' 36' ' ' GLN . 2.2 mtp180 -99.1 121.04 40.47 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.179 -0.95 . . . . 0.0 109.503 -179.943 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.8 HD13 ' HB2' ' A' ' 49' ' ' LEU . 2.2 mp -118.46 168.03 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.251 -0.906 . . . . 0.0 109.472 179.98 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 44' ' ' ARG . . . . . 0.574 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 0.0 OUTLIER -153.74 14.99 0.49 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.338 -0.851 . . . . 0.0 109.845 -179.627 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.558 ' H ' HG22 ' A' ' 43' ' ' ILE . 7.5 t -95.67 -79.31 0.44 Allowed 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.028 -1.045 . . . . 0.0 108.452 179.346 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.576 ' HB2' ' CD1' ' A' ' 64' ' ' PHE . 4.6 ttpm? 153.45 -61.77 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 179.421 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.524 ' O ' ' CG ' ' A' ' 51' ' ' ARG . 50.0 t -82.93 -24.52 8.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 178.63 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.439 ' O ' ' HG3' ' A' ' 51' ' ' ARG . 23.3 tt0 -64.66 -48.21 75.6 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 179.012 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' LEU . . . . . 0.8 ' HB2' HD13 ' A' ' 43' ' ' ILE . 2.3 pp -68.8 -30.81 69.46 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 178.918 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' THR . . . . . 0.67 ' OG1' HD13 ' A' ' 59' ' ' LEU . 24.0 m -61.24 -67.96 0.36 Allowed 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.857 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.524 ' CG ' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -47.19 -31.13 3.39 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.375 -0.828 . . . . 0.0 108.934 179.456 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 52' ' ' TYR . . . . . 0.903 ' OH ' HG21 ' A' ' 39' ' ' THR . 2.1 t80 -64.68 -62.56 1.5 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.287 -0.883 . . . . 0.0 108.95 179.422 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 1.002 HD21 ' CZ3' ' A' ' 15' ' ' TRP . 0.8 OUTLIER -49.82 -51.91 36.29 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.285 -0.884 . . . . 0.0 109.238 179.569 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 124.19 -151.23 17.13 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 -179.592 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.45 -12.74 16.91 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.562 2.174 . . . . 0.0 110.168 179.746 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.18 -3.18 31.5 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.337 -0.852 . . . . 0.0 109.358 179.749 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' CYS . . . . . 0.478 ' CB ' HD13 ' A' ' 53' ' ' LEU . 60.0 m -135.53 -176.2 4.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.196 -0.94 . . . . 0.0 109.5 -179.906 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.817 ' C ' HD12 ' A' ' 59' ' ' LEU . 12.1 t70 179.26 142.31 0.12 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.348 -0.845 . . . . 0.0 108.964 179.876 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.824 HD23 ' CD2' ' A' ' 62' ' ' PHE . 5.1 mp -152.89 16.77 0.58 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.135 -0.978 . . . . 0.0 109.55 -179.483 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.575 ' C ' HD22 ' A' ' 61' ' ' LEU . 58.5 m -44.38 -40.23 5.24 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.377 -0.827 . . . . 0.0 109.412 -179.956 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 61' ' ' LEU . . . . . 0.575 HD22 ' C ' ' A' ' 60' ' ' THR . 1.4 mm? -111.57 -8.54 14.23 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.395 -0.815 . . . . 0.0 109.67 -179.834 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.824 ' CD2' HD23 ' A' ' 59' ' ' LEU . 80.6 t80 -50.53 138.45 17.54 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.227 -0.921 . . . . 0.0 109.835 -179.368 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.525 ' OD1' ' CG ' ' A' ' 65' ' ' LYS . 3.9 t0 -89.44 113.52 24.88 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.447 -0.783 . . . . 0.0 109.158 179.714 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.579 ' CE2' ' O ' ' A' ' 33' ' ' THR . 1.1 t80 -72.06 63.78 0.51 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.126 -0.984 . . . . 0.0 109.728 -179.781 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.525 ' CG ' ' OD1' ' A' ' 63' ' ' ASP . 0.0 OUTLIER 167.82 -36.32 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.394 -0.816 . . . . 0.0 109.079 179.639 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -83.77 -41.57 17.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.142 -0.974 . . . . 0.0 108.948 179.411 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.84 28.0 8.07 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 179.666 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' ILE . . . . . 0.5 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 2.6 pp -140.52 179.47 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.114 -1.227 . . . . 0.0 109.668 179.938 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.533 ' HB3' ' HA ' ' A' ' 62' ' ' PHE . 0.6 OUTLIER -160.34 -175.78 5.24 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.409 -0.807 . . . . 0.0 109.111 179.934 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 70' ' ' CYS . . . . . 0.418 ' SG ' HD12 ' A' ' 61' ' ' LEU . 32.1 p -160.12 170.98 20.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.237 -0.914 . . . . 0.0 109.444 179.587 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 71' ' ' TYR . . . . . 0.458 ' O ' ' HD2' ' A' ' 74' ' ' PRO . 27.1 m-85 -123.19 150.82 60.9 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.196 -0.94 . . . . 0.0 109.497 -179.891 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.449 ' O ' ' HB2' ' A' ' 73' ' ' ALA . 35.2 Cg_endo -77.78 74.08 5.37 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.684 2.256 . . . . 0.0 110.663 -179.821 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 1.004 ' HB3' ' HD3' ' A' ' 74' ' ' PRO . . . 178.34 -57.93 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.244 -0.91 . . . . 0.0 109.64 179.59 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' PRO . . . . . 1.004 ' HD3' ' HB3' ' A' ' 73' ' ' ALA . 35.6 Cg_endo -77.52 152.69 30.07 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.236 1.957 . . . . 0.0 110.176 179.531 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.4 pttt . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.5 -179.879 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.491 ' CE3' ' HB2' ' A' ' 18' ' ' ARG . 69.7 m95 . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.449 HD23 ' HA ' ' A' ' 6' ' ' LEU . 18.1 mt -109.28 160.87 15.78 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.215 -0.928 . . . . 0.0 109.615 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.438 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 0.2 OUTLIER -49.72 130.36 20.93 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.323 -0.861 . . . . 0.0 109.592 -179.885 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.522 ' SG ' ' CZ ' ' A' ' 17' ' ' ARG . 26.9 t -81.61 115.17 55.19 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.276 -0.89 . . . . 0.0 109.4 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.455 ' O ' ' C ' ' A' ' 10' ' ' ALA . 36.2 Cg_endo -78.57 -55.62 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.498 2.132 . . . . 0.0 111.088 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.646 ' HB3' ' NH1' ' A' ' 17' ' ' ARG . . . -39.69 -56.73 1.65 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.36 -0.838 . . . . 0.0 110.098 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.756 HD12 ' CD1' ' A' ' 15' ' ' TRP . 12.0 mt -83.31 -56.94 3.48 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.282 -0.886 . . . . 0.0 109.706 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 140.04 -146.48 17.96 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.57 158.15 32.26 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.62 2.214 . . . . 0.0 110.802 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.15 -38.89 3.14 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.774 -1.331 . . . . 0.0 109.774 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 0.983 ' CZ3' HD21 ' A' ' 53' ' ' LEU . 17.1 t-105 -89.0 130.0 35.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.268 -1.137 . . . . 0.0 109.585 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.462 ' HG2' ' HB3' ' A' ' 5' ' ' TRP . 0.1 OUTLIER -97.54 127.75 43.75 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.2 -0.937 . . . . 0.0 108.919 179.626 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.646 ' NH1' ' HB3' ' A' ' 10' ' ' ALA . 1.6 ttm180 -107.32 98.84 8.42 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.142 -0.974 . . . . 0.0 109.917 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.491 ' HB2' ' CE3' ' A' ' 5' ' ' TRP . 0.4 OUTLIER -100.24 145.65 27.82 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.316 -0.865 . . . . 0.0 109.201 179.601 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -121.91 158.33 29.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.11 -0.994 . . . . 0.0 109.802 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.463 HG22 HH11 ' A' ' 18' ' ' ARG . 2.3 t . . . . . 0 N--CA 1.489 1.515 0 O-C-N 121.396 -0.815 . . . . 0.0 109.205 179.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.444 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 0.3 OUTLIER -135.26 124.36 24.36 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.983 -1.073 . . . . 0.0 110.254 -179.456 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.561 ' CD1' ' HG2' ' A' ' 44' ' ' ARG . 16.7 m-85 -123.62 143.8 50.01 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 179.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.584 ' CE1' ' HG3' ' A' ' 17' ' ' ARG . 9.8 m-85 -116.01 154.42 29.89 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.107 -0.995 . . . . 0.0 110.204 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -122.41 120.41 33.87 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.507 ' HB3' ' HD2' ' A' ' 38' ' ' PRO . 0.7 OUTLIER -68.41 168.35 14.46 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 121.394 -0.816 . . . . 0.0 109.023 179.915 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.507 ' HD2' ' HB3' ' A' ' 37' ' ' SER . 34.7 Cg_endo -78.0 6.12 4.85 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.502 2.134 . . . . 0.0 110.577 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.3 t -116.56 -21.7 9.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.131 -0.981 . . . . 0.0 109.498 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 119.18 15.91 5.42 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.448 ' O ' ' OG ' ' A' ' 37' ' ' SER . 3.5 m-20 -96.81 107.03 19.44 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.248 -1.149 . . . . 0.0 109.297 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.26 132.29 33.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.132 -0.98 . . . . 0.0 109.658 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.729 HG21 ' N ' ' A' ' 49' ' ' LEU . 3.0 mp -130.04 149.93 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.325 -0.859 . . . . 0.0 109.239 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.561 ' HG2' ' CD1' ' A' ' 34' ' ' TYR . 51.5 mtm180 -142.17 9.35 1.88 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.091 -1.006 . . . . 0.0 110.058 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.529 ' HB3' ' CB ' ' A' ' 48' ' ' GLU . 0.5 OUTLIER -97.19 14.08 27.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.039 -1.038 . . . . 0.0 109.393 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.584 ' HA ' ' CE1' ' A' ' 64' ' ' PHE . 5.9 ttpp 62.73 -94.09 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.442 -0.786 . . . . 0.0 109.98 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.44 ' N ' ' HG2' ' A' ' 46' ' ' LYS . 48.6 t -52.87 -31.9 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.904 -1.122 . . . . 0.0 109.485 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.529 ' CB ' ' HB3' ' A' ' 45' ' ' SER . 67.4 tt0 -53.33 -45.54 69.1 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.067 -1.021 . . . . 0.0 108.784 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.832 ' O ' HD12 ' A' ' 53' ' ' LEU . 0.9 OUTLIER -71.88 -28.71 63.7 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.114 -0.991 . . . . 0.0 108.547 179.281 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.658 ' HG1' ' HB2' ' A' ' 59' ' ' LEU . 2.3 m -61.96 -65.28 0.71 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.0 -24.26 16.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.465 -0.772 . . . . 0.0 109.23 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.41 ' O ' ' C ' ' A' ' 53' ' ' LEU . 29.9 t80 -70.55 -68.11 0.45 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.227 -0.92 . . . . 0.0 108.992 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.983 HD21 ' CZ3' ' A' ' 15' ' ' TRP . 1.0 OUTLIER -45.17 -36.03 3.55 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.267 -0.896 . . . . 0.0 109.293 179.661 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 112.69 -157.6 14.84 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.81 6.13 4.77 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.567 2.178 . . . . 0.0 110.532 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -85.31 -21.45 28.95 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.216 -0.928 . . . . 0.0 109.614 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 50.9 m -135.89 164.38 28.08 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.037 -1.039 . . . . 0.0 109.663 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.593 ' HA ' HG23 ' A' ' 50' ' ' THR . 26.3 p30 -152.97 150.73 29.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.243 -0.91 . . . . 0.0 109.433 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 1.158 HD23 ' CD2' ' A' ' 62' ' ' PHE . 2.6 mp -143.71 12.09 1.67 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.242 -0.911 . . . . 0.0 109.593 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.55 ' C ' HD22 ' A' ' 61' ' ' LEU . 3.4 m -46.04 -46.08 16.47 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.174 -0.954 . . . . 0.0 109.401 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.585 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 2.4 mm? -101.58 0.53 36.55 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.272 -0.893 . . . . 0.0 109.512 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 1.158 ' CD2' HD23 ' A' ' 59' ' ' LEU . 65.1 t80 -66.36 137.48 56.92 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.364 -0.835 . . . . 0.0 109.944 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.454 ' O ' ' N ' ' A' ' 65' ' ' LYS . 0.4 OUTLIER -89.31 111.75 22.66 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.261 -0.899 . . . . 0.0 109.04 179.712 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.584 ' CE1' ' HA ' ' A' ' 46' ' ' LYS . 0.6 OUTLIER -70.26 59.33 0.18 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.207 -0.933 . . . . 0.0 109.11 -179.632 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.454 ' N ' ' O ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -179.52 -40.46 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.378 -0.826 . . . . 0.0 109.093 -179.825 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -90.4 -29.25 18.13 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.293 -0.88 . . . . 0.0 109.356 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.574 ' HA2' ' CE1' ' A' ' 62' ' ' PHE . . . 87.15 33.93 11.37 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.441 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 1.3 pt -140.98 155.39 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.065 -1.256 . . . . 0.0 110.004 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.603 ' N ' HD23 ' A' ' 69' ' ' LEU . 1.9 pt? -143.26 146.24 33.44 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 3.5 m . . . . . 0 N--CA 1.49 1.568 0 O-C-N 120.983 -1.073 . . . . 0.0 109.937 -179.636 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.595 ' CZ2' ' HD3' ' A' ' 18' ' ' ARG . 66.6 m95 . . . . . 0 N--CA 1.49 1.531 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -101.54 159.16 15.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.279 -0.888 . . . . 0.0 109.538 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.484 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 12.3 t70 -48.85 132.55 18.21 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.282 -0.886 . . . . 0.0 109.213 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.457 ' HB3' ' HB3' ' A' ' 15' ' ' TRP . 23.5 t -96.42 109.33 47.19 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.24 -0.912 . . . . 0.0 109.337 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 36.1 Cg_endo -78.43 -32.96 2.02 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.297 1.998 . . . . 0.0 110.552 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.417 ' CB ' ' CE1' ' A' ' 62' ' ' PHE . . . -49.1 -56.99 7.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.272 -0.892 . . . . 0.0 109.506 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.921 HD12 ' CD1' ' A' ' 15' ' ' TRP . 4.7 mt -87.28 -56.36 3.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.177 -0.952 . . . . 0.0 109.613 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 8' ' ' CYS . . . 155.2 -150.37 21.83 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.19 159.47 33.4 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.681 2.254 . . . . 0.0 110.409 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 83.54 -52.77 4.78 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 0.921 ' CD1' HD12 ' A' ' 11' ' ' LEU . 4.4 t-105 -64.62 126.15 26.99 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.213 -1.169 . . . . 0.0 109.505 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.512 ' CG ' ' HB3' ' A' ' 5' ' ' TRP . 5.5 tptt -107.28 112.75 25.75 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.135 -0.978 . . . . 0.0 109.316 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.58 ' HG3' ' CE2' ' A' ' 35' ' ' TYR . 1.0 OUTLIER -87.15 116.28 25.12 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.242 -0.911 . . . . 0.0 109.457 -179.964 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.671 ' CZ ' HG21 ' A' ' 20' ' ' VAL . 10.0 ttp180 -95.63 141.04 29.6 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.222 -0.924 . . . . 0.0 109.483 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.495 ' CG ' ' O ' ' A' ' 19' ' ' GLU . 3.4 pt-20 -115.05 119.47 36.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.229 -0.92 . . . . 0.0 109.472 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.671 HG21 ' CZ ' ' A' ' 18' ' ' ARG . 20.5 t . . . . . 0 N--CA 1.49 1.529 0 O-C-N 121.233 -0.917 . . . . 0.0 109.634 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 57.6 m -115.05 121.46 43.16 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.188 -0.945 . . . . 0.0 109.711 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.56 ' CD2' ' HG3' ' A' ' 44' ' ' ARG . 12.5 m-85 -103.8 157.25 17.21 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.258 -0.901 . . . . 0.0 109.179 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.58 ' CE2' ' HG3' ' A' ' 17' ' ' ARG . 11.5 m-85 -129.33 139.66 51.66 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.111 -0.993 . . . . 0.0 109.897 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.562 ' HB2' ' CZ3' ' A' ' 5' ' ' TRP . 22.0 tt0 -124.83 130.16 51.84 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.364 -0.835 . . . . 0.0 109.385 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.533 ' HA ' ' CZ3' ' A' ' 15' ' ' TRP . 0.5 OUTLIER -69.94 175.92 2.07 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.227 -0.92 . . . . 0.0 109.368 179.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.514 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 35.0 Cg_endo -78.11 -2.03 12.16 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.6 2.2 . . . . 0.0 110.283 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 p -109.38 -17.24 13.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.327 -0.858 . . . . 0.0 109.29 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 119.75 4.35 11.74 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.427 ' CB ' ' OG ' ' A' ' 37' ' ' SER . 0.1 OUTLIER -77.67 109.0 11.28 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.199 -1.177 . . . . 0.0 109.155 179.87 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.6 mtt180 -97.05 124.36 41.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.336 -0.852 . . . . 0.0 109.889 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.546 HG22 ' N ' ' A' ' 44' ' ' ARG . 3.0 mp -118.56 163.5 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.379 -0.826 . . . . 0.0 109.047 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.587 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 4.5 ttp180 -126.77 -23.82 3.63 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.126 -0.984 . . . . 0.0 110.327 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.842 ' O ' HD23 ' A' ' 49' ' ' LEU . 0.5 OUTLIER -75.24 166.47 23.58 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.76 -1.212 . . . . 0.0 108.615 179.543 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.673 ' HE3' HG23 ' A' ' 47' ' ' VAL . 7.6 ttpt -86.56 -63.77 1.26 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.123 -0.985 . . . . 0.0 110.529 -178.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.673 HG23 ' HE3' ' A' ' 46' ' ' LYS . 89.3 t -76.58 -16.8 14.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.11 -0.994 . . . . 0.0 109.773 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.585 ' HB2' ' CB ' ' A' ' 45' ' ' SER . 14.3 mt-10 -72.57 -46.86 52.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.965 -1.084 . . . . 0.0 108.495 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.86 HD13 ' CZ2' ' A' ' 15' ' ' TRP . 2.9 pp -66.76 -21.64 66.05 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 178.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.923 ' OG1' HD13 ' A' ' 59' ' ' LEU . 27.3 m -73.07 -64.49 0.96 Allowed 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.519 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -49.66 -23.73 1.88 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.224 -0.922 . . . . 0.0 108.611 179.665 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.48 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 63.9 t80 -62.68 -61.5 2.38 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.319 -0.863 . . . . 0.0 108.732 179.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.832 HD21 ' CE3' ' A' ' 15' ' ' TRP . 0.9 OUTLIER -53.36 -59.25 4.82 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.294 -0.879 . . . . 0.0 109.227 179.521 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 147.88 -162.55 28.75 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.72 -2.96 13.09 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.566 2.177 . . . . 0.0 110.144 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.87 -28.62 35.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.292 -0.88 . . . . 0.0 109.61 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 5.8 m -115.32 139.52 49.91 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.171 -0.955 . . . . 0.0 109.353 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.819 ' C ' HD12 ' A' ' 59' ' ' LEU . 2.0 p30 -132.76 153.26 51.38 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.078 -1.013 . . . . 0.0 109.905 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.923 HD13 ' OG1' ' A' ' 50' ' ' THR . 6.0 mp -146.35 12.04 1.18 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.412 -0.805 . . . . 0.0 109.223 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.611 ' C ' HD22 ' A' ' 61' ' ' LEU . 97.2 m -50.59 -31.55 16.23 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.237 -0.915 . . . . 0.0 109.093 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.611 HD22 ' C ' ' A' ' 60' ' ' THR . 1.2 mm? -111.11 -9.04 14.38 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.452 -0.78 . . . . 0.0 109.053 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.493 ' CZ ' ' HA2' ' A' ' 67' ' ' GLY . 61.7 t80 -56.08 129.68 40.95 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.412 -0.805 . . . . 0.0 109.168 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.525 ' O ' ' N ' ' A' ' 65' ' ' LYS . 19.2 t0 -79.04 104.01 9.38 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.246 -0.909 . . . . 0.0 109.141 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.587 ' CE2' ' O ' ' A' ' 44' ' ' ARG . 1.1 t80 -66.94 63.0 0.05 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.477 -0.764 . . . . 0.0 109.452 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.525 ' N ' ' O ' ' A' ' 63' ' ' ASP . 37.4 ttpt -179.65 -43.7 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.458 -0.776 . . . . 0.0 109.173 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -88.31 -45.57 9.92 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.314 -0.866 . . . . 0.0 109.315 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.493 ' HA2' ' CZ ' ' A' ' 62' ' ' PHE . . . 110.48 31.86 2.89 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.574 ' C ' HD12 ' A' ' 68' ' ' ILE . 2.8 pp -140.35 166.85 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.208 -1.172 . . . . 0.0 109.431 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.48 ' CB ' ' HA ' ' A' ' 62' ' ' PHE . 0.7 OUTLIER -145.54 177.63 8.72 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.202 -0.936 . . . . 0.0 109.482 -179.869 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.446 ' SG ' ' O ' ' A' ' 69' ' ' LEU . 72.2 m . . . . . 0 N--CA 1.49 1.533 0 O-C-N 121.366 -0.833 . . . . 0.0 109.292 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.568 ' CE3' ' HB2' ' A' ' 18' ' ' ARG . 73.3 m95 . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.263 0.554 . . . . 0.0 109.534 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.476 HD23 ' HA ' ' A' ' 6' ' ' LEU . 51.8 mt -114.49 148.97 37.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.214 -0.929 . . . . 0.0 109.358 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.452 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 0.2 OUTLIER -43.63 133.74 4.45 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.297 -0.877 . . . . 0.0 109.424 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.521 ' HB3' ' HB3' ' A' ' 15' ' ' TRP . 39.7 t -88.37 113.38 55.03 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.298 -0.876 . . . . 0.0 109.563 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 34.8 Cg_endo -77.47 -40.02 0.48 Allowed 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 122.287 1.992 . . . . 0.0 110.003 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.673 ' HB3' ' NH1' ' A' ' 17' ' ' ARG . . . -47.04 -42.44 18.48 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.318 -0.864 . . . . 0.0 109.452 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.626 HD12 ' CG ' ' A' ' 15' ' ' TRP . 13.1 mt -101.15 -61.34 1.38 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.322 -0.861 . . . . 0.0 109.491 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 8' ' ' CYS . . . 156.7 -149.06 19.73 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -77.27 153.21 31.37 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.517 2.145 . . . . 0.0 110.327 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.408 ' O ' ' C ' ' A' ' 15' ' ' TRP . . . 93.76 -74.79 1.13 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 0.799 ' CE3' HD21 ' A' ' 53' ' ' LEU . 22.2 t-105 -44.24 122.6 3.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.275 -1.133 . . . . 0.0 109.304 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.3 mmtt -97.04 108.75 21.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.173 -0.954 . . . . 0.0 109.66 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.673 ' NH1' ' HB3' ' A' ' 10' ' ' ALA . 1.0 OUTLIER -87.1 106.33 17.79 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.199 -0.938 . . . . 0.0 109.389 179.863 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.568 ' HB2' ' CE3' ' A' ' 5' ' ' TRP . 5.1 ttt180 -100.02 147.52 25.52 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.235 -0.915 . . . . 0.0 109.749 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.468 ' HA ' HG23 ' A' ' 33' ' ' THR . 22.0 pt-20 -116.67 155.27 29.11 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.356 -0.84 . . . . 0.0 109.241 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.783 HG21 ' CE1' ' A' ' 34' ' ' TYR . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.165 -0.96 . . . . 0.0 109.407 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.487 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.512 ' CG2' ' O ' ' A' ' 18' ' ' ARG . 2.1 m -139.56 142.9 37.15 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.245 -0.909 . . . . 0.0 109.619 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.783 ' CE1' HG21 ' A' ' 20' ' ' VAL . 6.1 m-85 -135.58 151.86 50.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.337 -0.852 . . . . 0.0 109.243 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.895 ' HD2' HD22 ' A' ' 49' ' ' LEU . 9.8 m-85 -117.61 146.34 43.71 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.207 -0.933 . . . . 0.0 109.735 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.508 ' HB2' ' CZ3' ' A' ' 5' ' ' TRP . 35.7 tt0 -131.27 123.62 28.77 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.373 -0.83 . . . . 0.0 109.259 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.474 ' CB ' ' HD2' ' A' ' 38' ' ' PRO . 0.4 OUTLIER -66.15 173.07 2.41 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.263 -0.898 . . . . 0.0 108.965 179.823 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.474 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 36.1 Cg_endo -78.0 4.13 6.42 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.51 2.14 . . . . 0.0 110.291 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.4 p -111.62 -17.37 13.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.331 -0.855 . . . . 0.0 109.444 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 120.46 5.41 10.29 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.464 ' O ' ' HA ' ' A' ' 36' ' ' GLN . 6.7 t0 -74.9 136.78 41.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.199 -1.177 . . . . 0.0 109.364 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.4 mtp180 -121.07 116.46 25.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.196 -0.94 . . . . 0.0 109.277 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.64 HG21 ' CA ' ' A' ' 49' ' ' LEU . 4.4 mt -123.35 152.93 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.228 -0.92 . . . . 0.0 109.924 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.577 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 4.9 ttt-85 -128.49 -24.04 3.11 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.282 -0.886 . . . . 0.0 109.909 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.681 ' O ' HD23 ' A' ' 49' ' ' LEU . 1.7 m -73.56 147.89 43.5 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.979 -1.076 . . . . 0.0 108.909 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.639 ' HE2' HG23 ' A' ' 47' ' ' VAL . 24.4 ttpt -68.96 -71.84 0.2 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.287 -0.883 . . . . 0.0 110.811 -178.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.639 HG23 ' HE2' ' A' ' 46' ' ' LYS . 62.5 t -67.37 -14.96 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.031 -1.043 . . . . 0.0 110.274 -178.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.554 ' HB2' ' CB ' ' A' ' 45' ' ' SER . 2.4 tt0 -72.45 -51.97 17.9 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.884 -1.135 . . . . 0.0 108.502 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.895 HD22 ' HD2' ' A' ' 35' ' ' TYR . 1.9 pp -63.17 -28.7 70.24 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.84 ' HA ' HD12 ' A' ' 53' ' ' LEU . 0.2 OUTLIER -68.2 -55.41 12.38 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 178.376 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.429 ' HD3' ' HA ' ' A' ' 51' ' ' ARG . 48.6 mmt-85 -52.0 -24.3 6.39 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.477 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 44.4 t80 -73.3 -50.76 20.41 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.532 -0.73 . . . . 0.0 109.196 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.84 HD12 ' HA ' ' A' ' 50' ' ' THR . 0.4 OUTLIER -66.57 -53.0 39.33 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -0.909 . . . . 0.0 109.063 179.739 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 121.9 -146.42 17.01 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.62 -34.74 1.28 Allowed 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.512 2.141 . . . . 0.0 110.495 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -45.18 -33.95 2.52 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.302 -0.874 . . . . 0.0 109.837 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 67.2 m -122.07 148.51 44.77 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.165 -0.959 . . . . 0.0 109.767 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -126.82 146.27 50.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.276 -0.89 . . . . 0.0 109.422 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.833 HD23 ' CD2' ' A' ' 62' ' ' PHE . 0.2 OUTLIER -144.99 6.85 1.18 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.277 -0.889 . . . . 0.0 110.332 -179.157 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.581 ' C ' HD22 ' A' ' 61' ' ' LEU . 5.0 m -47.09 -41.88 17.95 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.062 -1.024 . . . . 0.0 109.861 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.581 HD22 ' C ' ' A' ' 60' ' ' THR . 1.4 mm? -110.1 13.2 23.3 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.166 -0.959 . . . . 0.0 110.113 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.833 ' CD2' HD23 ' A' ' 59' ' ' LEU . 51.5 t80 -69.5 136.1 51.01 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.201 -0.937 . . . . 0.0 109.549 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.429 ' O ' ' N ' ' A' ' 65' ' ' LYS . 0.3 OUTLIER -89.81 105.13 17.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.315 -0.866 . . . . 0.0 109.248 179.728 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.649 ' CZ ' ' CE2' ' A' ' 35' ' ' TYR . 0.4 OUTLIER -69.98 61.33 0.19 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.245 -0.909 . . . . 0.0 109.411 -179.594 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 63' ' ' ASP . 5.6 ttpt -174.46 -37.37 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.318 -0.864 . . . . 0.0 109.018 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -97.59 -38.74 9.43 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.419 -0.801 . . . . 0.0 109.111 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 103.67 32.36 4.51 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.695 ' C ' HD12 ' A' ' 68' ' ' ILE . 2.7 pp -139.87 173.38 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.162 -1.199 . . . . 0.0 109.58 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.504 ' CB ' ' HA ' ' A' ' 62' ' ' PHE . 0.6 OUTLIER -149.89 -165.07 2.17 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.243 -0.911 . . . . 0.0 109.385 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.44 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.488 1.459 0 O-C-N 121.334 -0.854 . . . . 0.0 109.344 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.575 ' CE3' ' HB2' ' A' ' 18' ' ' ARG . 84.1 m95 . . . . . 0 N--CA 1.489 1.515 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.487 HD21 ' OE1' ' A' ' 19' ' ' GLU . 0.5 OUTLIER -110.26 154.33 23.58 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.221 -0.924 . . . . 0.0 109.509 -179.947 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.419 ' C ' ' O ' ' A' ' 6' ' ' LEU . 2.0 m-20 -43.9 146.31 0.6 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.291 -0.881 . . . . 0.0 109.471 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.472 ' CB ' ' HB2' ' A' ' 17' ' ' ARG . 45.4 t -111.88 100.75 49.7 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.197 -0.94 . . . . 0.0 109.457 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.504 ' HD2' ' NH2' ' A' ' 17' ' ' ARG . 34.4 Cg_endo -76.6 -33.89 2.85 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.438 2.092 . . . . 0.0 110.569 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.47 ' C ' HD23 ' A' ' 11' ' ' LEU . . . -42.47 -48.43 5.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.308 -0.87 . . . . 0.0 109.609 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.824 HD12 ' CD1' ' A' ' 15' ' ' TRP . 3.1 mt -94.13 -61.99 1.42 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.247 -0.908 . . . . 0.0 109.457 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 8' ' ' CYS . . . 168.69 -158.67 31.45 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.94 145.92 20.11 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.592 2.195 . . . . 0.0 110.452 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.03 -49.83 1.22 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 0.824 ' CD1' HD12 ' A' ' 11' ' ' LEU . 15.7 t-105 -65.66 129.77 40.93 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.233 -1.157 . . . . 0.0 109.468 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.8 mmtp -100.99 123.02 44.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.172 -0.955 . . . . 0.0 109.394 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.504 ' NH2' ' HD2' ' A' ' 9' ' ' PRO . 7.7 ttp85 -94.19 110.65 22.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.16 -0.962 . . . . 0.0 109.588 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.575 ' HB2' ' CE3' ' A' ' 5' ' ' TRP . 0.5 OUTLIER -99.71 141.77 32.08 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.325 -0.859 . . . . 0.0 109.053 179.653 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.487 ' OE1' HD21 ' A' ' 6' ' ' LEU . 4.5 pt-20 -124.46 141.84 51.77 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.186 -0.947 . . . . 0.0 109.875 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 87.7 t . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.24 -0.913 . . . . 0.0 109.349 179.763 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.469 ' O ' ' CE1' ' A' ' 35' ' ' TYR . 4.5 m -139.34 98.52 3.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.298 -0.876 . . . . 0.0 109.542 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.54 ' CD1' ' HB3' ' A' ' 44' ' ' ARG . 13.0 m-85 -99.95 160.65 14.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.401 -0.812 . . . . 0.0 108.984 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.64 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 1.6 m-85 -131.78 156.46 45.94 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.977 -1.077 . . . . 0.0 109.912 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.559 ' HB2' ' CZ3' ' A' ' 5' ' ' TRP . 11.3 tt0 -129.66 129.97 44.97 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.441 -0.787 . . . . 0.0 109.047 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.46 ' CB ' ' HD2' ' A' ' 38' ' ' PRO . 0.6 OUTLIER -68.68 172.06 5.25 Favored Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 121.269 -0.894 . . . . 0.0 109.257 -179.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.46 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 35.1 Cg_endo -77.66 4.56 5.92 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.623 2.215 . . . . 0.0 110.408 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.6 t -122.13 -20.23 6.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.307 -0.871 . . . . 0.0 109.58 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 128.59 6.51 4.62 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.416 ' CB ' ' HB2' ' A' ' 37' ' ' SER . 0.5 OUTLIER -80.29 105.88 11.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.123 -1.222 . . . . 0.0 109.146 179.79 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.439 ' HG3' ' HG3' ' A' ' 36' ' ' GLN . 15.6 mtp180 -97.5 125.43 42.18 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.181 -0.95 . . . . 0.0 110.078 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.653 HG21 ' CA ' ' A' ' 49' ' ' LEU . 4.8 mt -127.65 163.91 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.54 ' HB3' ' CD1' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -160.31 18.17 0.14 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.894 -1.129 . . . . 0.0 110.654 -179.575 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.567 ' HB2' ' CB ' ' A' ' 48' ' ' GLU . 0.4 OUTLIER -99.98 18.13 19.24 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.856 -1.152 . . . . 0.0 109.397 179.761 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.586 ' HB2' ' CD1' ' A' ' 64' ' ' PHE . 12.7 tttt 64.36 -92.49 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.502 -0.749 . . . . 0.0 110.473 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.488 ' HA ' ' OG1' ' A' ' 50' ' ' THR . 74.8 t -62.33 -27.93 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.018 -1.051 . . . . 0.0 109.369 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.567 ' CB ' ' HB2' ' A' ' 45' ' ' SER . 23.9 tt0 -61.06 -49.28 77.99 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.683 HD12 HD11 ' A' ' 53' ' ' LEU . 0.8 OUTLIER -68.13 -23.72 64.93 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.814 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.544 ' OG1' ' CB ' ' A' ' 59' ' ' LEU . 26.9 m -65.65 -70.87 0.21 Allowed 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.425 ' C ' ' O ' ' A' ' 50' ' ' THR . 0.0 OUTLIER -43.57 -26.79 0.24 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.507 -0.746 . . . . 0.0 109.028 179.547 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.422 ' N ' ' O ' ' A' ' 50' ' ' THR . 37.1 t80 -64.16 -62.95 1.29 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.286 -0.884 . . . . 0.0 109.565 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.683 HD11 HD12 ' A' ' 49' ' ' LEU . 0.5 OUTLIER -55.57 -57.94 9.84 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.125 -0.984 . . . . 0.0 109.274 -179.92 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 131.06 -155.01 21.07 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.48 -9.5 16.11 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.623 2.216 . . . . 0.0 110.528 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -81.14 -13.99 58.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.302 -0.874 . . . . 0.0 109.638 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.47 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 88.1 m -134.07 79.27 1.8 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.191 -0.943 . . . . 0.0 109.596 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.54 137.23 56.64 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.145 -0.972 . . . . 0.0 109.133 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.775 HD23 ' HB3' ' A' ' 62' ' ' PHE . 0.1 OUTLIER -140.46 5.42 2.04 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.276 -0.89 . . . . 0.0 109.878 -179.288 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.629 ' C ' HD22 ' A' ' 61' ' ' LEU . 54.5 m -62.15 -21.36 64.98 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.215 -0.928 . . . . 0.0 109.156 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.629 HD22 ' C ' ' A' ' 60' ' ' THR . 1.7 mm? -107.31 -11.74 15.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.387 -0.821 . . . . 0.0 109.217 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.775 ' HB3' HD23 ' A' ' 59' ' ' LEU . 6.1 t80 -54.81 133.41 47.56 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.399 -0.813 . . . . 0.0 109.735 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.547 ' O ' ' CE1' ' A' ' 62' ' ' PHE . 2.4 t0 -80.57 104.74 11.31 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.283 -0.886 . . . . 0.0 108.882 179.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.586 ' CD1' ' HB2' ' A' ' 46' ' ' LYS . 0.6 OUTLIER -67.19 65.04 0.06 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.264 -0.898 . . . . 0.0 109.319 -179.426 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 63' ' ' ASP . 6.3 mtpt 171.48 -37.9 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.396 -0.815 . . . . 0.0 109.388 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -88.16 -46.63 9.11 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.163 -0.961 . . . . 0.0 109.3 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.494 ' HA2' ' CZ ' ' A' ' 62' ' ' PHE . . . 111.77 25.69 4.75 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -140.72 171.43 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.011 -1.288 . . . . 0.0 109.69 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 62' ' ' PHE . 1.1 pt? -140.49 -174.3 3.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.22 -0.925 . . . . 0.0 109.337 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 23.0 m . . . . . 0 N--CA 1.491 1.582 0 O-C-N 121.187 -0.945 . . . . 0.0 109.592 -179.928 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.576 ' CZ3' ' HB2' ' A' ' 18' ' ' ARG . 97.9 m95 . . . . . 0 N--CA 1.49 1.562 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 81.4 mt -111.3 164.35 12.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.22 -0.925 . . . . 0.0 109.562 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 7' ' ' ASP . 0.5 OUTLIER -59.99 145.06 47.59 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.262 -0.898 . . . . 0.0 109.572 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.514 ' SG ' ' N ' ' A' ' 17' ' ' ARG . 7.1 m -91.24 113.89 59.85 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.258 -0.901 . . . . 0.0 109.886 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.415 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 36.3 Cg_endo -78.98 -27.35 4.66 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.344 2.029 . . . . 0.0 110.412 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.77 ' HB3' HH12 ' A' ' 17' ' ' ARG . . . -70.71 -37.34 73.54 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.106 -0.996 . . . . 0.0 109.839 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.813 HD12 ' CD1' ' A' ' 15' ' ' TRP . 6.5 mt -105.08 -46.37 4.28 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.134 -0.979 . . . . 0.0 109.635 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 135.06 -145.98 18.04 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.38 164.66 26.23 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.626 2.217 . . . . 0.0 110.405 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.8 -51.97 4.64 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 0.813 ' CD1' HD12 ' A' ' 11' ' ' LEU . 7.9 t-105 -75.72 125.75 29.66 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.292 -1.122 . . . . 0.0 109.346 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.427 ' C ' ' SG ' ' A' ' 8' ' ' CYS . 10.6 mmtp -103.14 132.4 49.43 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.213 -0.929 . . . . 0.0 109.526 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.77 HH12 ' HB3' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -99.22 111.43 23.81 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.507 -0.745 . . . . 0.0 109.413 -179.6 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.576 ' HB2' ' CZ3' ' A' ' 5' ' ' TRP . 1.6 ttt180 -100.11 131.76 45.87 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.174 -0.954 . . . . 0.0 109.61 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -112.35 142.79 44.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.299 -0.876 . . . . 0.0 109.328 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 39.3 t . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.139 -0.976 . . . . 0.0 109.778 -179.745 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.497 ' HB3' ' CZ ' ' A' ' 34' ' ' TYR . 3.7 m-20 . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.78 109.4 17.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.203 -0.936 . . . . 0.0 109.827 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.591 ' CD1' ' CD ' ' A' ' 44' ' ' ARG . 11.4 m-85 -112.49 138.07 49.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.256 -0.902 . . . . 0.0 108.992 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.638 ' HD2' HD22 ' A' ' 49' ' ' LEU . 5.3 m-85 -108.18 151.11 26.36 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.136 -0.977 . . . . 0.0 109.827 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -132.24 128.73 38.52 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.361 -0.837 . . . . 0.0 109.533 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.517 ' OG ' ' CB ' ' A' ' 41' ' ' ASP . 0.4 OUTLIER -71.94 174.68 3.77 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.28 -0.888 . . . . 0.0 109.511 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.509 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 35.9 Cg_endo -78.61 -4.49 14.15 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.722 2.282 . . . . 0.0 110.417 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.458 HG22 ' HB2' ' A' ' 37' ' ' SER . 2.4 t -103.92 -18.55 14.57 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.241 -0.912 . . . . 0.0 109.518 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 120.71 12.44 6.04 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.517 ' CB ' ' OG ' ' A' ' 37' ' ' SER . 0.4 OUTLIER -83.25 127.6 33.78 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -1.151 . . . . 0.0 109.571 -179.908 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.08 131.71 56.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.244 -0.91 . . . . 0.0 109.277 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.603 HG22 ' H ' ' A' ' 45' ' ' SER . 2.6 mp -137.64 161.49 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.225 -0.922 . . . . 0.0 109.611 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.591 ' CD ' ' CD1' ' A' ' 34' ' ' TYR . 34.8 mtm180 -143.79 18.42 1.81 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.316 -0.865 . . . . 0.0 109.557 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.603 ' H ' HG22 ' A' ' 43' ' ' ILE . 0.5 OUTLIER -91.88 -88.54 0.2 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.293 -0.879 . . . . 0.0 108.907 179.504 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.563 ' HB2' ' CD1' ' A' ' 64' ' ' PHE . 19.3 ttpt 159.52 -63.39 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.479 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 77.2 t -85.38 -21.54 7.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.489 ' O ' ' HG3' ' A' ' 51' ' ' ARG . 98.3 mt-10 -68.71 -44.81 73.13 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.638 HD22 ' HD2' ' A' ' 35' ' ' TYR . 3.4 pp -71.05 -25.07 62.49 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 178.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.856 ' OG1' HD13 ' A' ' 59' ' ' LEU . 20.5 m -68.59 -63.29 1.09 Allowed 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.489 ' HG3' ' O ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -49.45 -23.96 1.79 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.394 -0.816 . . . . 0.0 108.872 179.391 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.503 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 2.6 t80 -67.32 -64.64 0.81 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.303 -0.873 . . . . 0.0 109.159 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.676 HD21 ' CE3' ' A' ' 15' ' ' TRP . 0.6 OUTLIER -51.1 -57.85 7.63 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.04 -1.038 . . . . 0.0 109.257 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 141.16 -157.15 25.94 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.07 -9.7 16.62 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.592 2.195 . . . . 0.0 110.248 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.17 -13.56 59.93 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.297 -0.877 . . . . 0.0 109.438 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 73.3 m -132.99 130.23 39.23 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.356 -0.84 . . . . 0.0 109.19 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.685 ' C ' HD12 ' A' ' 59' ' ' LEU . 25.4 t0 -126.19 152.56 45.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.168 -0.958 . . . . 0.0 109.832 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.856 HD13 ' OG1' ' A' ' 50' ' ' THR . 5.2 mp -148.64 14.7 0.96 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.388 -0.82 . . . . 0.0 109.395 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.609 ' C ' HD22 ' A' ' 61' ' ' LEU . 22.3 m -46.35 -37.35 7.38 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.323 -0.861 . . . . 0.0 109.84 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.609 HD22 ' C ' ' A' ' 60' ' ' THR . 1.1 mm? -111.38 2.43 17.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.3 -0.875 . . . . 0.0 109.606 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.579 ' CE1' ' CB ' ' A' ' 10' ' ' ALA . 78.3 t80 -58.68 146.33 36.8 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.353 -0.842 . . . . 0.0 109.656 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.496 ' O ' ' N ' ' A' ' 65' ' ' LYS . 5.1 t0 -98.44 103.32 15.26 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.33 -0.856 . . . . 0.0 108.972 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.622 ' CE1' ' CE2' ' A' ' 35' ' ' TYR . 0.7 OUTLIER -66.61 69.64 0.07 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.149 -0.97 . . . . 0.0 109.426 -179.36 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.496 ' N ' ' O ' ' A' ' 63' ' ' ASP . 11.9 ttpp 177.07 -46.22 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.266 -0.896 . . . . 0.0 109.579 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -92.41 -39.35 11.48 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.24 -0.912 . . . . 0.0 109.728 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.481 ' HA2' ' CZ ' ' A' ' 62' ' ' PHE . . . 106.03 35.17 3.02 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.469 ' O ' ' N ' ' A' ' 63' ' ' ASP . 2.0 pp -140.52 173.41 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.16 -1.2 . . . . 0.0 109.628 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.471 ' HB3' ' HA ' ' A' ' 62' ' ' PHE . 0.7 OUTLIER -147.24 -164.83 2.09 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.78 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.451 ' SG ' ' O ' ' A' ' 69' ' ' LEU . 62.1 m . . . . . 0 N--CA 1.489 1.481 0 O-C-N 120.947 -1.096 . . . . 0.0 110.134 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.415 ' CE3' ' HB2' ' A' ' 18' ' ' ARG . 71.9 m95 . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.72 158.77 17.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.194 -0.941 . . . . 0.0 109.684 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.449 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 0.5 OUTLIER -53.16 138.93 30.35 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.222 -0.923 . . . . 0.0 109.126 179.695 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.455 ' HB2' ' HB2' ' A' ' 17' ' ' ARG . 40.3 t -98.99 109.17 52.99 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.101 -0.999 . . . . 0.0 109.878 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.463 ' HD2' ' CZ ' ' A' ' 17' ' ' ARG . 34.4 Cg_endo -77.23 -38.79 0.69 Allowed 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.205 1.937 . . . . 0.0 110.111 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.633 ' C ' HD23 ' A' ' 11' ' ' LEU . . . -42.97 -32.18 0.61 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.28 -0.887 . . . . 0.0 109.473 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.969 HD12 ' CD1' ' A' ' 15' ' ' TRP . 5.3 mt -115.93 -67.01 1.03 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.21 -0.931 . . . . 0.0 109.48 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 167.1 -149.1 14.17 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.88 169.21 20.99 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.688 2.259 . . . . 0.0 110.666 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.35 -56.18 2.84 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.634 -1.387 . . . . 0.0 109.634 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 0.969 ' CD1' HD12 ' A' ' 11' ' ' LEU . 10.0 t-105 -62.15 123.41 18.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.256 -1.143 . . . . 0.0 109.774 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -103.54 120.53 41.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.281 -0.887 . . . . 0.0 109.547 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.576 ' HG3' ' CE2' ' A' ' 35' ' ' TYR . 3.2 ttp85 -95.3 114.94 26.78 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.217 -0.927 . . . . 0.0 109.347 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.415 ' HB2' ' CE3' ' A' ' 5' ' ' TRP . 4.0 tmm_? -100.24 139.37 36.01 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.183 -0.948 . . . . 0.0 109.571 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -108.68 144.69 36.12 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.209 -0.932 . . . . 0.0 109.482 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 42.7 t . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.184 -0.947 . . . . 0.0 109.428 179.957 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 . . . . . 0 N--CA 1.49 1.554 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.52 HG22 ' CZ ' ' A' ' 35' ' ' TYR . 31.2 m -128.72 126.06 39.26 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.22 -0.925 . . . . 0.0 109.778 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.615 ' CD1' ' N ' ' A' ' 34' ' ' TYR . 1.7 m-85 -115.14 167.18 11.05 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.64 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 2.5 m-85 -136.72 146.27 45.64 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.866 -1.146 . . . . 0.0 110.08 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -128.49 124.8 37.0 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.478 -0.763 . . . . 0.0 109.344 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.514 ' CB ' ' HD2' ' A' ' 38' ' ' PRO . 0.3 OUTLIER -68.19 174.98 2.02 Favored Pre-proline 0 N--CA 1.487 1.417 0 O-C-N 121.285 -0.884 . . . . 0.0 109.32 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.514 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 35.1 Cg_endo -78.14 5.35 5.46 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.65 2.234 . . . . 0.0 110.335 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.462 HG22 ' HB2' ' A' ' 37' ' ' SER . 15.3 t -114.6 -24.83 8.58 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.254 -0.904 . . . . 0.0 109.417 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 124.24 13.34 3.98 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.469 ' HB2' ' OH ' ' A' ' 52' ' ' TYR . 0.3 OUTLIER -90.95 112.53 24.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.132 -1.217 . . . . 0.0 109.24 179.882 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.485 ' CZ ' ' HB2' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -95.57 139.33 31.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -0.891 . . . . 0.0 109.618 -179.75 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.645 HD13 ' HA ' ' A' ' 49' ' ' LEU . 4.0 mt -135.98 161.21 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.187 -0.946 . . . . 0.0 109.566 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.591 ' HG3' ' CD2' ' A' ' 34' ' ' TYR . 0.1 OUTLIER -152.6 15.12 0.58 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.239 -0.913 . . . . 0.0 110.257 -179.37 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.579 ' CB ' ' HB3' ' A' ' 48' ' ' GLU . 0.3 OUTLIER -99.61 21.55 12.15 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.924 -1.11 . . . . 0.0 109.456 179.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.612 ' HA ' ' CE1' ' A' ' 64' ' ' PHE . 8.1 ttpt 59.3 -94.01 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.365 -0.834 . . . . 0.0 109.973 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.464 ' HA ' ' OG1' ' A' ' 50' ' ' THR . 26.3 t -59.0 -38.0 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.036 -1.04 . . . . 0.0 109.314 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.579 ' HB3' ' CB ' ' A' ' 45' ' ' SER . 71.3 tt0 -51.26 -43.44 61.56 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.002 -1.061 . . . . 0.0 108.356 179.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.693 HD21 HD22 ' A' ' 59' ' ' LEU . 0.5 OUTLIER -66.45 -27.86 68.15 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 179.393 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.526 ' N ' ' HG ' ' A' ' 49' ' ' LEU . 1.5 m -71.27 -66.22 0.65 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.467 ' CD ' ' HA ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -47.84 -24.33 0.97 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.357 -0.839 . . . . 0.0 108.778 179.321 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.479 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 62.4 t80 -63.34 -60.18 3.73 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.264 -0.898 . . . . 0.0 109.114 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.672 HD21 ' CE3' ' A' ' 15' ' ' TRP . 0.3 OUTLIER -60.74 -55.19 36.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.182 -0.949 . . . . 0.0 108.969 179.642 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 142.74 -155.33 25.78 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -78.02 -18.84 12.71 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.537 2.158 . . . . 0.0 110.366 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.22 -10.52 51.37 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.326 -0.859 . . . . 0.0 109.56 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.466 ' CB ' HD13 ' A' ' 53' ' ' LEU . 18.0 m -133.41 136.71 45.42 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.227 -0.921 . . . . 0.0 109.522 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.63 ' C ' HD12 ' A' ' 59' ' ' LEU . 18.3 t70 -130.95 148.59 52.73 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.272 -0.893 . . . . 0.0 109.49 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.693 HD22 HD21 ' A' ' 49' ' ' LEU . 4.1 mp -148.24 10.5 0.88 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.208 -0.932 . . . . 0.0 109.696 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.629 ' C ' HD22 ' A' ' 61' ' ' LEU . 94.5 m -49.92 -29.06 7.59 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.146 -0.971 . . . . 0.0 109.145 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.629 HD22 ' C ' ' A' ' 60' ' ' THR . 1.5 mm? -111.07 -8.42 14.44 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.322 -0.861 . . . . 0.0 109.381 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.618 ' CD2' HD23 ' A' ' 59' ' ' LEU . 48.0 t80 -59.18 131.1 50.01 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.378 -0.826 . . . . 0.0 109.337 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.63 117.49 20.6 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.192 -0.943 . . . . 0.0 109.261 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.612 ' CE1' ' HA ' ' A' ' 46' ' ' LYS . 0.4 OUTLIER -73.89 56.75 0.59 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.219 -0.926 . . . . 0.0 109.065 -179.94 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.14 -41.6 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.378 -0.826 . . . . 0.0 109.022 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -81.14 -46.66 14.58 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.267 -0.895 . . . . 0.0 109.113 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.503 ' HA3' ' NH1' ' A' ' 17' ' ' ARG . . . 104.22 28.63 5.74 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.469 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 1.1 pp -140.6 161.48 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.022 -1.281 . . . . 0.0 109.757 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.427 ' HB3' ' HA ' ' A' ' 62' ' ' PHE . 0.7 OUTLIER -143.74 173.84 11.33 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.339 -0.851 . . . . 0.0 108.935 179.74 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 21.6 p . . . . . 0 N--CA 1.489 1.511 0 O-C-N 121.118 -0.989 . . . . 0.0 109.767 179.802 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.555 ' CZ3' ' HB2' ' A' ' 36' ' ' GLN . 98.7 m95 . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.212 -0.662 . . . . 0.0 109.212 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -110.8 160.75 16.46 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.181 -0.949 . . . . 0.0 109.617 -179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -56.39 149.32 17.03 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.237 -0.914 . . . . 0.0 109.206 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.448 ' SG ' ' HG ' ' A' ' 11' ' ' LEU . 38.0 t -111.75 103.83 55.51 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.128 -0.983 . . . . 0.0 109.848 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.92 -26.21 6.88 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.373 2.049 . . . . 0.0 109.878 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.475 ' CB ' ' CE2' ' A' ' 62' ' ' PHE . . . -54.06 -34.63 60.56 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.406 -0.809 . . . . 0.0 109.314 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 1.03 HD12 ' CD1' ' A' ' 15' ' ' TRP . 12.2 mt -105.88 -66.79 0.97 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.292 -0.88 . . . . 0.0 109.358 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 157.98 -153.16 24.37 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.79 137.34 15.89 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.669 2.246 . . . . 0.0 110.353 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.29 23.25 17.35 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 1.03 ' CD1' HD12 ' A' ' 11' ' ' LEU . 27.6 t-105 -150.1 125.59 10.24 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.24 -1.153 . . . . 0.0 109.334 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.9 mmmt -105.9 134.66 48.67 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.15 -0.969 . . . . 0.0 109.538 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.508 ' HG3' ' CE2' ' A' ' 35' ' ' TYR . 3.7 ttp85 -103.6 111.68 24.26 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.311 -0.868 . . . . 0.0 109.643 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.548 ' HG3' ' CE2' ' A' ' 5' ' ' TRP . 0.3 OUTLIER -97.65 155.41 17.0 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.224 -0.923 . . . . 0.0 109.151 179.716 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -123.03 168.61 12.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.116 -0.99 . . . . 0.0 109.731 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.622 HG21 ' CE2' ' A' ' 34' ' ' TYR . 3.4 t . . . . . 0 N--CA 1.49 1.539 0 O-C-N 121.349 -0.845 . . . . 0.0 109.383 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 . . . . . 0 N--CA 1.491 1.611 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.38 106.31 11.33 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.129 -0.982 . . . . 0.0 109.772 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.622 ' CE2' HG21 ' A' ' 20' ' ' VAL . 15.0 m-85 -101.99 167.27 10.15 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.275 -0.89 . . . . 0.0 109.054 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.578 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 3.9 m-85 -135.1 155.16 51.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.067 -1.02 . . . . 0.0 109.913 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.555 ' HB2' ' CZ3' ' A' ' 5' ' ' TRP . 4.4 tt0 -141.96 132.82 25.79 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.357 -0.839 . . . . 0.0 109.156 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.518 ' CB ' ' HD2' ' A' ' 38' ' ' PRO . 0.1 OUTLIER -70.78 176.13 2.18 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.238 -0.913 . . . . 0.0 109.213 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.518 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 35.7 Cg_endo -78.69 0.29 10.1 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.535 2.156 . . . . 0.0 110.289 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.475 HG22 ' HB2' ' A' ' 37' ' ' SER . 10.1 t -106.48 -21.58 13.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.338 -0.851 . . . . 0.0 109.575 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 122.51 10.95 5.76 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.437 ' CB ' ' OG ' ' A' ' 37' ' ' SER . 0.1 OUTLIER -79.76 102.97 9.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.232 -1.158 . . . . 0.0 109.472 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.3 mtp85 -90.48 117.3 29.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.281 -0.887 . . . . 0.0 109.477 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.647 HG21 ' N ' ' A' ' 49' ' ' LEU . 2.9 mp -121.63 153.04 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.277 -0.889 . . . . 0.0 109.494 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.47 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 8.7 mtm-85 -148.73 16.9 1.0 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.233 -0.917 . . . . 0.0 110.237 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.561 ' HB3' ' CB ' ' A' ' 48' ' ' GLU . 1.6 t -100.66 16.75 23.84 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.979 -1.076 . . . . 0.0 110.368 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.612 ' HA ' ' CE1' ' A' ' 64' ' ' PHE . 25.6 tttt 63.73 -94.18 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.221 -0.924 . . . . 0.0 110.92 178.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.448 ' HA ' ' OG1' ' A' ' 50' ' ' THR . 54.9 t -58.72 -27.88 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.906 -1.121 . . . . 0.0 109.656 -178.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.561 ' CB ' ' HB3' ' A' ' 45' ' ' SER . 14.7 tt0 -61.12 -47.79 84.65 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.093 -1.004 . . . . 0.0 108.525 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 1.012 HD13 ' CZ2' ' A' ' 15' ' ' TRP . 1.0 OUTLIER -67.75 -23.79 65.28 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.94 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.547 ' OG1' ' CB ' ' A' ' 59' ' ' LEU . 17.0 m -66.92 -68.76 0.35 Allowed 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.66 -20.41 2.04 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.533 -0.73 . . . . 0.0 109.23 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.485 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 44.5 t80 -66.76 -50.57 62.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.223 -0.923 . . . . 0.0 109.276 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.851 HD11 HD12 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -70.56 -48.52 55.0 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.19 -0.944 . . . . 0.0 109.093 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 121.6 -156.59 16.5 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -78.9 8.08 3.96 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.574 2.183 . . . . 0.0 110.552 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -88.53 -23.56 23.14 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.141 -0.974 . . . . 0.0 109.558 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.464 ' HB2' HD13 ' A' ' 53' ' ' LEU . 95.8 m -133.28 101.1 5.05 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.285 -0.884 . . . . 0.0 109.499 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -75.62 131.12 39.76 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.178 -0.951 . . . . 0.0 109.448 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.869 HD13 HD11 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -132.37 0.9 3.74 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.369 -0.832 . . . . 0.0 109.697 -179.689 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.434 ' O ' HD22 ' A' ' 61' ' ' LEU . 8.2 m -47.54 -34.35 7.53 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.335 -0.853 . . . . 0.0 110.24 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.499 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 0.7 OUTLIER -108.09 0.24 21.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.057 -1.027 . . . . 0.0 109.93 -179.321 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.748 ' CB ' HD23 ' A' ' 59' ' ' LEU . 3.4 t80 -51.61 131.55 29.8 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.17 -0.956 . . . . 0.0 109.358 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.486 ' O ' ' N ' ' A' ' 65' ' ' LYS . 99.0 m-20 -79.22 104.16 9.65 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.21 -0.931 . . . . 0.0 108.768 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.612 ' CE1' ' HA ' ' A' ' 46' ' ' LYS . 0.5 OUTLIER -68.62 58.86 0.09 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.337 -0.852 . . . . 0.0 109.658 -179.138 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.486 ' N ' ' O ' ' A' ' 63' ' ' ASP . 2.7 tmmt? 178.09 -33.63 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.272 -0.892 . . . . 0.0 109.432 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -92.12 -44.04 9.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.18 -0.95 . . . . 0.0 109.501 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.442 ' O ' ' HB2' ' A' ' 10' ' ' ALA . . . 110.95 25.31 5.16 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.567 HD12 ' N ' ' A' ' 69' ' ' LEU . 1.3 pp -140.31 -170.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.286 -1.126 . . . . 0.0 109.557 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.58 ' N ' HD23 ' A' ' 69' ' ' LEU . 1.1 pt? -153.42 178.53 9.69 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.378 -0.826 . . . . 0.0 109.0 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.489 1.497 0 O-C-N 121.139 -0.976 . . . . 0.0 109.24 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.598 ' CZ3' ' HB2' ' A' ' 36' ' ' GLN . 73.5 m95 . . . . . 0 N--CA 1.494 1.728 0 CA-C-O 121.344 0.592 . . . . 0.0 109.912 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.9 mt -102.78 152.62 21.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.117 -0.989 . . . . 0.0 109.685 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.474 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 5.3 m-20 -50.75 131.12 25.79 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.282 -0.886 . . . . 0.0 109.587 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.522 ' SG ' ' CZ ' ' A' ' 17' ' ' ARG . 12.1 t -82.06 113.94 47.11 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.33 -0.856 . . . . 0.0 109.629 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 36.5 Cg_endo -80.63 -55.61 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.282 0 C-N-CA 122.508 2.139 . . . . 0.0 110.909 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.64 ' HB3' ' NH1' ' A' ' 17' ' ' ARG . . . -37.99 -58.62 0.92 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.559 -0.713 . . . . 0.0 110.216 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.88 HD12 ' CD1' ' A' ' 15' ' ' TRP . 13.6 mt -79.38 -58.52 3.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.323 -0.861 . . . . 0.0 109.633 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 131.29 -140.82 12.11 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.81 138.0 16.44 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.509 2.139 . . . . 0.0 110.477 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.464 ' O ' ' HD3' ' A' ' 38' ' ' PRO . . . 99.3 14.14 36.63 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 1.028 ' CZ3' HD21 ' A' ' 53' ' ' LEU . 7.5 t-105 -148.36 137.06 21.59 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.229 -1.159 . . . . 0.0 109.532 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.76 129.22 55.64 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.261 -0.899 . . . . 0.0 109.313 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.64 ' NH1' ' HB3' ' A' ' 10' ' ' ALA . 0.6 OUTLIER -98.38 98.04 9.32 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.249 -0.907 . . . . 0.0 109.436 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.59 ' HB2' ' CE3' ' A' ' 5' ' ' TRP . 1.5 ttm180 -100.45 134.81 42.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.253 -0.904 . . . . 0.0 109.337 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -115.14 156.91 24.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.19 -0.944 . . . . 0.0 109.379 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 3.6 t . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.153 -0.967 . . . . 0.0 109.434 -179.902 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 . . . . . 0 N--CA 1.488 1.474 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.477 ' HB ' ' O ' ' A' ' 64' ' ' PHE . 87.2 m -114.9 132.96 56.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.171 -0.956 . . . . 0.0 109.525 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.44 ' CD1' ' HB3' ' A' ' 44' ' ' ARG . 27.9 m-85 -129.68 149.27 51.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.293 -0.88 . . . . 0.0 109.409 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.689 ' CD2' ' CZ ' ' A' ' 64' ' ' PHE . 12.3 m-85 -113.81 154.2 27.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.254 -0.904 . . . . 0.0 109.178 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.598 ' HB2' ' CZ3' ' A' ' 5' ' ' TRP . 0.7 OUTLIER -131.11 126.45 35.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.188 -0.945 . . . . 0.0 109.613 -179.877 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.534 ' HB3' HG22 ' A' ' 39' ' ' THR . 0.4 OUTLIER -62.97 170.97 2.15 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.356 -0.84 . . . . 0.0 109.364 179.864 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 14' ' ' GLY . 35.6 Cg_endo -78.41 5.99 5.1 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.577 2.185 . . . . 0.0 110.472 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.534 HG22 ' HB3' ' A' ' 37' ' ' SER . 1.7 t -115.14 -16.13 11.61 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.247 -0.908 . . . . 0.0 109.524 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 124.55 3.52 7.82 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.462 ' O ' ' HA ' ' A' ' 36' ' ' GLN . 0.7 OUTLIER -76.87 157.0 31.74 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.276 -1.132 . . . . 0.0 109.325 -179.988 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.441 ' O ' ' HG2' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -143.32 122.75 13.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.224 -0.922 . . . . 0.0 109.618 -179.874 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.517 HD13 ' CB ' ' A' ' 49' ' ' LEU . 2.6 mp -128.95 153.44 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.277 -0.89 . . . . 0.0 109.559 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.589 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 8.5 ptt85 -117.3 -15.14 10.41 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.273 -0.892 . . . . 0.0 109.242 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.579 ' CB ' ' HB2' ' A' ' 48' ' ' GLU . 1.1 m -91.02 124.82 35.55 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.217 -0.927 . . . . 0.0 108.813 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.551 ' CG ' ' N ' ' A' ' 47' ' ' VAL . 33.6 pttt -60.46 -48.18 82.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.268 -0.895 . . . . 0.0 110.442 -178.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.551 ' N ' ' CG ' ' A' ' 46' ' ' LYS . 86.6 t -77.22 -31.49 18.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.067 -1.021 . . . . 0.0 109.668 -179.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.579 ' HB2' ' CB ' ' A' ' 45' ' ' SER . 39.1 tt0 -59.25 -51.71 68.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.96 -1.087 . . . . 0.0 108.604 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.731 ' O ' HD12 ' A' ' 53' ' ' LEU . 3.2 pp -69.22 -33.62 73.59 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 178.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.645 ' OG1' HD13 ' A' ' 59' ' ' LEU . 22.8 m -52.33 -67.27 0.26 Allowed 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.472 ' HG3' ' O ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -50.05 -30.88 11.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.416 -0.803 . . . . 0.0 109.213 179.801 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.516 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 28.5 t80 -64.41 -63.01 1.25 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.122 -0.986 . . . . 0.0 108.861 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 1.028 HD21 ' CZ3' ' A' ' 15' ' ' TRP . 0.5 OUTLIER -55.27 -48.49 73.94 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.989 -1.069 . . . . 0.0 108.898 179.391 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.84 -159.26 20.27 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.23 -2.34 12.55 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.541 2.161 . . . . 0.0 110.225 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.98 -25.15 55.53 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.287 -0.883 . . . . 0.0 109.348 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.401 ' O ' HG23 ' A' ' 50' ' ' THR . 59.7 m -135.11 103.03 5.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.242 -0.911 . . . . 0.0 109.231 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.839 ' C ' HD12 ' A' ' 59' ' ' LEU . 10.0 p30 -95.41 161.43 14.08 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.177 -0.952 . . . . 0.0 109.869 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.911 HD23 ' CD2' ' A' ' 62' ' ' PHE . 5.0 mp -154.6 20.02 0.47 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.441 -0.787 . . . . 0.0 109.282 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.566 ' C ' HD22 ' A' ' 61' ' ' LEU . 21.0 m -47.24 -40.3 16.12 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.326 -0.859 . . . . 0.0 109.75 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.585 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 0.8 OUTLIER -110.78 5.22 20.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.206 -0.934 . . . . 0.0 109.873 -179.387 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.911 ' CD2' HD23 ' A' ' 59' ' ' LEU . 54.7 t80 -71.88 136.07 46.79 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.192 -0.943 . . . . 0.0 109.418 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.481 ' HB2' ' HB2' ' A' ' 66' ' ' GLN . 2.4 m-20 -95.94 120.09 35.59 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.34 -0.85 . . . . 0.0 108.977 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.689 ' CZ ' ' CD2' ' A' ' 35' ' ' TYR . 0.6 OUTLIER -66.61 -11.72 54.75 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.278 -0.888 . . . . 0.0 109.512 -179.55 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -101.92 -41.71 6.38 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.208 -0.933 . . . . 0.0 110.112 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.481 ' HB2' ' HB2' ' A' ' 63' ' ' ASP . 5.9 mt-30 -83.22 -37.8 23.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.101 -1.0 . . . . 0.0 109.856 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.584 ' HA2' ' CZ ' ' A' ' 62' ' ' PHE . . . 89.31 29.65 16.37 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -139.58 160.26 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.202 -1.176 . . . . 0.0 109.367 179.914 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.617 ' N ' HD23 ' A' ' 69' ' ' LEU . 1.3 pt? -143.25 172.26 12.98 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.233 -0.917 . . . . 0.0 109.377 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.489 1.507 0 O-C-N 121.345 -0.847 . . . . 0.0 109.274 179.816 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.594 ' CE3' ' HB2' ' A' ' 18' ' ' ARG . 62.6 m95 . . . . . 0 N--CA 1.487 1.4 0 N-CA-C 109.468 -0.567 . . . . 0.0 109.468 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.485 HD23 ' O ' ' A' ' 5' ' ' TRP . 17.9 mt -119.28 165.44 14.25 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.2 -0.937 . . . . 0.0 109.429 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -55.58 131.87 47.35 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.11 -0.994 . . . . 0.0 109.483 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.532 ' CB ' ' HB2' ' A' ' 17' ' ' ARG . 53.9 t -82.03 117.43 68.32 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.275 -0.891 . . . . 0.0 109.642 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.95 -51.24 0.06 OUTLIER 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.418 2.079 . . . . 0.0 110.698 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -49.69 -38.05 31.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.177 -0.952 . . . . 0.0 109.929 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 1.032 HD12 ' CD1' ' A' ' 15' ' ' TRP . 13.1 mt -98.73 -54.87 2.89 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.139 -0.976 . . . . 0.0 109.656 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 134.45 -152.54 20.68 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.769 -1.333 . . . . 0.0 109.769 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.77 159.36 31.43 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.695 2.263 . . . . 0.0 110.533 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 83.71 -10.13 60.57 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 1.032 ' CD1' HD12 ' A' ' 11' ' ' LEU . 15.6 t-105 -118.06 131.42 56.45 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.313 -1.11 . . . . 0.0 109.264 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.469 ' HB3' ' HB3' ' A' ' 5' ' ' TRP . 21.4 mmtt -95.71 116.6 29.11 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.185 -0.947 . . . . 0.0 109.316 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.617 ' CZ ' HG21 ' A' ' 33' ' ' THR . 3.2 ttt-85 -104.45 100.04 9.74 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.255 -0.903 . . . . 0.0 109.294 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.77 ' O ' HG23 ' A' ' 33' ' ' THR . 1.4 tpt180 -100.7 144.18 29.99 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.149 -0.97 . . . . 0.0 110.052 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.445 ' HG2' ' CZ ' ' A' ' 18' ' ' ARG . 15.0 pt-20 -113.83 144.94 42.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.349 -0.844 . . . . 0.0 109.258 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.526 HG21 ' CE2' ' A' ' 34' ' ' TYR . 20.8 t . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.112 -0.993 . . . . 0.0 109.72 -179.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 N--CA 1.49 1.54 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.77 HG23 ' O ' ' A' ' 18' ' ' ARG . 56.5 m -125.4 122.0 35.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.084 -1.01 . . . . 0.0 110.126 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.526 ' CE2' HG21 ' A' ' 20' ' ' VAL . 3.3 m-85 -100.76 159.68 14.98 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.528 ' HB3' ' NE1' ' A' ' 15' ' ' TRP . 16.4 m-85 -130.49 137.08 49.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.943 -1.098 . . . . 0.0 110.114 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -118.99 116.18 25.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.489 -0.757 . . . . 0.0 109.327 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.839 ' OG ' HG22 ' A' ' 39' ' ' THR . 0.7 OUTLIER -57.07 168.86 0.78 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.327 -0.858 . . . . 0.0 109.448 -179.943 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.38 5.39 5.52 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.641 2.227 . . . . 0.0 110.379 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.839 HG22 ' OG ' ' A' ' 37' ' ' SER . 6.5 t -115.61 -11.63 11.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.155 -0.966 . . . . 0.0 109.648 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 116.98 3.86 17.26 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.81 142.45 40.3 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.163 -1.199 . . . . 0.0 109.108 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.0 117.5 24.15 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.227 -0.92 . . . . 0.0 109.707 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.61 HG21 ' HB3' ' A' ' 49' ' ' LEU . 3.4 mp -123.19 162.53 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.347 -0.845 . . . . 0.0 109.332 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.513 ' N ' HG22 ' A' ' 43' ' ' ILE . 34.6 mtp180 -149.1 15.57 0.93 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.141 -0.975 . . . . 0.0 109.805 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.546 ' O ' ' CB ' ' A' ' 46' ' ' LYS . 0.6 OUTLIER -85.34 -85.45 0.14 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.212 -0.93 . . . . 0.0 109.119 179.609 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.546 ' CB ' ' O ' ' A' ' 45' ' ' SER . 12.4 ttpt 157.92 -62.82 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.458 HG23 ' HE2' ' A' ' 46' ' ' LYS . 61.0 t -88.52 -21.83 6.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 178.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.483 ' O ' ' HG3' ' A' ' 51' ' ' ARG . 18.0 mt-10 -69.05 -41.78 77.18 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.757 ' O ' HD12 ' A' ' 53' ' ' LEU . 3.0 pp -71.87 -25.16 61.83 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 178.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.54 ' OG1' ' HB2' ' A' ' 59' ' ' LEU . 8.8 m -69.75 -61.5 1.75 Allowed 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.483 ' HG3' ' O ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -51.11 -23.21 2.98 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 179.297 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.481 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 65.2 t80 -69.63 -65.99 0.64 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.334 -0.854 . . . . 0.0 108.982 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.906 HD21 ' CE3' ' A' ' 15' ' ' TRP . 0.9 OUTLIER -49.9 -58.68 4.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.163 -0.961 . . . . 0.0 109.124 179.611 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 132.04 -146.89 18.47 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.71 -29.35 3.61 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.599 2.2 . . . . 0.0 110.139 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -54.63 -26.3 32.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.33 -0.856 . . . . 0.0 109.287 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 11.7 m -121.71 170.58 9.6 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.323 -0.861 . . . . 0.0 109.22 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.669 ' C ' HD12 ' A' ' 59' ' ' LEU . 17.6 p-10 -165.19 148.57 8.33 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.164 -0.96 . . . . 0.0 109.441 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 1.028 HD23 ' CD2' ' A' ' 62' ' ' PHE . 4.1 mp -153.0 21.02 0.58 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.206 -0.934 . . . . 0.0 109.716 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.45 ' C ' HD22 ' A' ' 61' ' ' LEU . 1.9 m -43.59 -49.59 7.52 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.268 -0.895 . . . . 0.0 109.647 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.506 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 1.5 mm? -106.97 9.8 30.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.324 -0.86 . . . . 0.0 109.755 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 1.028 ' CD2' HD23 ' A' ' 59' ' ' LEU . 72.0 t80 -55.87 139.94 44.2 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.402 -0.811 . . . . 0.0 109.999 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.528 ' O ' ' N ' ' A' ' 65' ' ' LYS . 0.7 OUTLIER -95.08 96.86 9.52 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.973 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.479 ' CE2' ' O ' ' A' ' 44' ' ' ARG . 0.5 OUTLIER -63.0 73.67 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.369 -0.832 . . . . 0.0 109.311 -179.119 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.528 ' N ' ' O ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER 168.35 -32.37 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.457 -0.777 . . . . 0.0 109.057 -179.757 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -103.57 -27.31 12.42 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.296 -0.878 . . . . 0.0 109.389 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.479 ' HA2' ' CZ ' ' A' ' 62' ' ' PHE . . . 89.42 33.16 9.57 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.472 ' O ' ' N ' ' A' ' 63' ' ' ASP . 1.0 OUTLIER -140.43 169.67 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.197 -1.178 . . . . 0.0 109.914 -179.833 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.725 ' N ' HD23 ' A' ' 69' ' ' LEU . 0.7 OUTLIER -145.11 -165.94 2.29 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.376 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.303 -1.454 0 O-C-N 121.094 -1.004 . . . . 0.0 109.897 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.594 ' CE3' ' HB2' ' A' ' 18' ' ' ARG . 72.6 m95 . . . . . 0 N--CA 1.489 1.486 0 CA-C-O 121.21 0.528 . . . . 0.0 109.658 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.451 HD23 ' HA ' ' A' ' 6' ' ' LEU . 69.2 mt -114.05 151.17 32.89 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.22 -0.925 . . . . 0.0 109.328 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.471 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 7.7 m-20 -44.42 139.23 2.83 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.188 -0.945 . . . . 0.0 109.484 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.494 ' HB2' ' N ' ' A' ' 17' ' ' ARG . 38.3 t -103.65 104.78 44.16 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.302 -0.874 . . . . 0.0 109.639 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 35.1 Cg_endo -76.87 -35.26 1.96 Allowed 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 122.441 2.094 . . . . 0.0 110.415 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 9' ' ' PRO . . . -43.89 -45.57 7.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.264 -0.897 . . . . 0.0 109.401 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 1.034 HD12 ' CD1' ' A' ' 15' ' ' TRP . 11.5 mt -97.67 -60.63 1.53 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.201 -0.937 . . . . 0.0 109.404 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 154.3 -153.15 24.61 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.07 145.0 21.67 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.71 2.273 . . . . 0.0 110.323 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.94 -24.44 31.19 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 1.034 ' CD1' HD12 ' A' ' 11' ' ' LEU . 5.5 t-105 -98.61 132.64 43.86 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.41 -1.053 . . . . 0.0 109.264 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.442 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -111.08 120.48 42.47 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.108 -0.995 . . . . 0.0 109.888 -179.793 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.494 ' N ' ' HB2' ' A' ' 8' ' ' CYS . 1.3 ttp85 -93.35 115.97 28.53 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.346 -0.846 . . . . 0.0 108.891 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.594 ' HB2' ' CE3' ' A' ' 5' ' ' TRP . 12.0 ttt180 -100.15 147.33 25.8 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.291 -0.88 . . . . 0.0 110.28 -179.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.481 ' O ' ' HG3' ' A' ' 19' ' ' GLU . 6.1 pt-20 -125.11 144.16 50.56 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.581 HG22 ' HE ' ' A' ' 18' ' ' ARG . 2.5 t . . . . . 0 N--CA 1.489 1.502 0 O-C-N 121.076 -1.015 . . . . 0.0 109.843 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.593 ' HB3' ' CE1' ' A' ' 34' ' ' TYR . 2.2 m-20 . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 109.419 -0.585 . . . . 0.0 109.419 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 8.7 m -131.74 108.59 9.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.249 -0.907 . . . . 0.0 109.656 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.597 ' CD1' ' CG ' ' A' ' 44' ' ' ARG . 6.5 m-85 -105.69 165.2 11.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.232 -0.918 . . . . 0.0 109.345 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.605 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 4.3 m-85 -133.66 140.24 46.95 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.102 -0.999 . . . . 0.0 109.921 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -123.0 128.25 49.94 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.425 -0.797 . . . . 0.0 109.246 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.49 ' HB2' ' HD2' ' A' ' 38' ' ' PRO . 1.7 p -80.17 167.99 29.15 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.301 -0.874 . . . . 0.0 109.42 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.49 ' HD2' ' HB2' ' A' ' 37' ' ' SER . 35.6 Cg_endo -78.37 5.85 5.19 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.647 2.231 . . . . 0.0 110.414 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.9 p -113.21 -24.93 9.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.217 -0.927 . . . . 0.0 109.479 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 123.38 16.18 3.53 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.17 105.35 17.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.148 -1.207 . . . . 0.0 109.254 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.75 105.1 17.59 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.318 -0.864 . . . . 0.0 109.689 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.718 HG21 ' CA ' ' A' ' 49' ' ' LEU . 3.2 mt -110.09 151.77 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.307 -0.87 . . . . 0.0 109.092 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.597 ' CG ' ' CD1' ' A' ' 34' ' ' TYR . 7.5 ttp180 -126.85 -0.25 6.65 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.133 -0.979 . . . . 0.0 110.04 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.887 ' O ' HD23 ' A' ' 49' ' ' LEU . 1.1 m -93.73 172.05 8.49 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.142 -0.974 . . . . 0.0 108.525 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.568 ' HB2' ' CD1' ' A' ' 64' ' ' PHE . 22.8 ttpt -91.12 -63.27 1.29 Allowed 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.034 -1.042 . . . . 0.0 110.146 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.401 ' O ' HG12 ' A' ' 47' ' ' VAL . 61.9 t -80.8 -10.82 12.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.048 -1.033 . . . . 0.0 109.316 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.568 ' HB2' ' CB ' ' A' ' 45' ' ' SER . 0.1 OUTLIER -77.3 -46.52 22.72 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 178.485 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.887 HD23 ' O ' ' A' ' 45' ' ' SER . 2.5 pp -68.84 -25.89 64.88 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 178.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.899 ' OG1' HD13 ' A' ' 59' ' ' LEU . 8.5 m -72.86 -49.28 31.02 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.23 -25.99 49.58 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.413 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 40.9 t80 -65.8 -60.46 2.86 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.54 -0.725 . . . . 0.0 109.288 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.851 HD21 ' CZ3' ' A' ' 15' ' ' TRP . 0.5 OUTLIER -58.44 -56.3 23.93 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.194 -0.941 . . . . 0.0 109.3 179.908 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 131.42 -149.44 19.26 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.5 -11.85 17.08 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.556 2.171 . . . . 0.0 110.302 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.21 -19.11 63.18 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.211 -0.93 . . . . 0.0 109.205 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 53.0 m -135.42 146.95 48.79 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.352 -0.842 . . . . 0.0 109.194 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.656 ' C ' HD12 ' A' ' 59' ' ' LEU . 0.6 OUTLIER -138.04 152.66 49.06 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.144 -0.972 . . . . 0.0 109.872 -179.754 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.899 HD13 ' OG1' ' A' ' 50' ' ' THR . 4.5 mp -148.47 9.88 0.84 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.266 -0.897 . . . . 0.0 109.541 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.673 HG22 ' CD2' ' A' ' 61' ' ' LEU . 23.2 m -48.93 -28.05 3.56 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.175 -0.953 . . . . 0.0 109.007 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.673 ' CD2' HG22 ' A' ' 60' ' ' THR . 1.3 mm? -111.74 -13.75 13.68 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.437 -0.79 . . . . 0.0 109.164 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.543 ' CD1' ' C ' ' A' ' 62' ' ' PHE . 7.8 t80 -49.37 131.71 20.38 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.401 -0.812 . . . . 0.0 109.517 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.539 ' O ' ' N ' ' A' ' 65' ' ' LYS . 2.3 m-20 -79.72 100.57 7.96 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.223 -0.923 . . . . 0.0 108.811 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.568 ' CD1' ' HB2' ' A' ' 46' ' ' LYS . 1.1 t80 -66.63 61.12 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.405 -0.809 . . . . 0.0 109.519 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.539 ' N ' ' O ' ' A' ' 63' ' ' ASP . 20.0 ttpt 177.22 -38.55 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.464 -0.772 . . . . 0.0 108.963 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -86.8 -47.8 8.76 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.313 -0.867 . . . . 0.0 109.203 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 115.21 23.05 4.66 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.569 ' C ' HD12 ' A' ' 68' ' ' ILE . 2.4 pp -140.11 -173.3 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.079 -1.247 . . . . 0.0 109.576 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.514 ' CB ' ' HA ' ' A' ' 62' ' ' PHE . 0.7 OUTLIER -151.43 -166.64 2.57 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.282 -0.886 . . . . 0.0 109.124 -179.874 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.439 ' O ' ' HG ' ' A' ' 61' ' ' LEU . 2.7 t . . . . . 0 N--CA 1.489 1.496 0 O-C-N 121.179 -0.951 . . . . 0.0 109.72 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.583 ' CE2' ' HG3' ' A' ' 18' ' ' ARG . 89.1 m95 . . . . . 0 N--CA 1.489 1.476 0 CA-C-O 121.304 0.573 . . . . 0.0 109.671 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.21 151.18 38.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.238 -0.913 . . . . 0.0 109.394 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.415 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 16.9 t70 -45.04 145.43 1.0 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.336 -0.853 . . . . 0.0 109.33 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.468 ' HB3' ' HB3' ' A' ' 15' ' ' TRP . 26.8 t -105.55 105.56 53.02 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.198 -0.939 . . . . 0.0 109.678 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.5 ' HD2' ' CZ ' ' A' ' 17' ' ' ARG . 35.2 Cg_endo -76.97 -33.57 2.69 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.441 2.094 . . . . 0.0 110.129 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.414 ' C ' HD23 ' A' ' 11' ' ' LEU . . . -47.33 -42.23 20.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.226 -0.921 . . . . 0.0 109.329 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.97 HD12 ' CD1' ' A' ' 15' ' ' TRP . 8.8 mt -99.98 -62.41 1.24 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.306 -0.871 . . . . 0.0 109.349 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.432 ' O ' ' O ' ' A' ' 8' ' ' CYS . . . 165.5 -153.03 22.82 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.44 150.31 25.01 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.643 2.229 . . . . 0.0 110.361 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.55 -65.85 1.76 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 0.97 ' CD1' HD12 ' A' ' 11' ' ' LEU . 6.4 t-105 -48.98 130.5 18.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.264 -1.139 . . . . 0.0 109.409 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -107.85 118.67 37.35 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.119 -0.988 . . . . 0.0 109.406 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.5 ' CZ ' ' HD2' ' A' ' 9' ' ' PRO . 1.2 ttp85 -93.16 116.76 29.34 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.275 -0.891 . . . . 0.0 109.368 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.583 ' HG3' ' CE2' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -96.99 142.36 29.04 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.341 -0.85 . . . . 0.0 109.437 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.434 ' CG ' ' O ' ' A' ' 19' ' ' GLU . 17.9 pt-20 -127.24 116.68 20.95 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.231 -0.918 . . . . 0.0 109.306 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 82.0 t . . . . . 0 N--CA 1.491 1.578 0 O-C-N 121.166 -0.958 . . . . 0.0 109.683 -179.771 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.468 ' OD2' ' CZ ' ' A' ' 34' ' ' TYR . 3.0 t70 . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 70.0 m -110.62 125.4 53.38 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.191 -0.943 . . . . 0.0 109.868 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.572 ' CD1' ' N ' ' A' ' 34' ' ' TYR . 3.7 m-85 -112.9 155.41 24.76 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.29 -0.881 . . . . 0.0 108.888 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.634 ' CD1' HD22 ' A' ' 49' ' ' LEU . 39.4 m-85 -126.03 131.07 52.26 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.019 -1.05 . . . . 0.0 109.905 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -122.42 128.19 50.61 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.465 -0.772 . . . . 0.0 109.151 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.498 ' CB ' ' HD2' ' A' ' 38' ' ' PRO . 0.9 OUTLIER -73.54 173.58 6.02 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.309 -0.869 . . . . 0.0 109.675 -179.73 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.498 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 34.5 Cg_endo -77.35 1.23 8.97 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.668 2.245 . . . . 0.0 110.297 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 p -111.04 -24.13 10.52 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.255 -0.903 . . . . 0.0 109.147 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 125.3 18.29 2.54 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.669 ' OD2' HD11 ' A' ' 43' ' ' ILE . 5.1 t70 -79.64 119.28 22.37 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.086 -1.244 . . . . 0.0 109.35 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.412 ' O ' ' HG2' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -103.4 107.74 18.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.285 -0.884 . . . . 0.0 109.737 -179.717 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.685 HG21 ' CA ' ' A' ' 49' ' ' LEU . 3.3 mt -120.33 151.38 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.321 -0.862 . . . . 0.0 109.133 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.591 ' O ' ' CZ ' ' A' ' 64' ' ' PHE . 10.6 ttm180 -126.81 -1.13 6.66 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.087 -1.008 . . . . 0.0 109.884 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.862 ' O ' HD23 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -88.84 179.26 6.24 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.073 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.559 ' HA ' ' CE1' ' A' ' 64' ' ' PHE . 28.7 ttpt -97.87 -59.68 1.72 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.977 -1.077 . . . . 0.0 109.657 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 99.2 t -84.24 -16.66 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.108 -0.995 . . . . 0.0 108.889 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.568 ' HB2' ' CB ' ' A' ' 45' ' ' SER . 1.9 tt0 -70.05 -45.36 67.28 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.862 HD23 ' O ' ' A' ' 45' ' ' SER . 2.0 pp -71.36 -27.12 63.13 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 178.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.957 ' OG1' HD13 ' A' ' 59' ' ' LEU . 27.7 m -67.36 -47.08 71.49 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.519 ' NH1' ' HG3' ' A' ' 51' ' ' ARG . 7.2 mmt85 -55.34 -31.33 61.63 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.542 ' CZ ' ' HB2' ' A' ' 41' ' ' ASP . 86.0 t80 -63.71 -51.24 65.89 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.934 -0.706 . . . . 0.0 109.431 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.86 HD21 ' CE3' ' A' ' 15' ' ' TRP . 1.5 mt -59.63 -58.86 6.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.305 -0.872 . . . . 0.0 109.536 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 135.71 -155.27 22.18 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -79.41 -10.17 14.79 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.621 2.214 . . . . 0.0 110.494 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.22 -15.81 56.18 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.228 -0.92 . . . . 0.0 109.711 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.4 ' CB ' HD13 ' A' ' 53' ' ' LEU . 72.7 m -128.45 139.77 52.17 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.254 -0.904 . . . . 0.0 109.39 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.897 ' C ' HD12 ' A' ' 59' ' ' LEU . 2.8 p30 -137.02 151.73 49.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.257 -0.902 . . . . 0.0 109.523 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.957 HD13 ' OG1' ' A' ' 50' ' ' THR . 6.6 mp -142.53 -0.2 1.24 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.22 -0.925 . . . . 0.0 110.076 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.573 ' C ' HD22 ' A' ' 61' ' ' LEU . 17.1 m -48.16 -27.44 2.39 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 120.996 -1.065 . . . . 0.0 108.521 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.602 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 1.3 mm? -105.53 -21.08 13.28 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.542 ' CE1' ' HA2' ' A' ' 67' ' ' GLY . 51.2 t80 -55.85 140.62 41.86 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.64 -0.662 . . . . 0.0 109.267 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.519 ' O ' ' N ' ' A' ' 65' ' ' LYS . 4.9 m-20 -88.32 108.64 19.44 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.189 -0.945 . . . . 0.0 109.578 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.591 ' CZ ' ' O ' ' A' ' 44' ' ' ARG . 1.7 t80 -66.62 66.9 0.06 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.288 -0.882 . . . . 0.0 109.214 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 63' ' ' ASP . 1.2 ttpm? 166.92 -36.55 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -88.18 -40.45 13.7 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.413 -0.804 . . . . 0.0 109.46 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.542 ' HA2' ' CE1' ' A' ' 62' ' ' PHE . . . 98.56 25.22 10.16 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.46 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 1.6 pp -140.47 160.31 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.201 -1.176 . . . . 0.0 109.812 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.478 ' CA ' ' HA ' ' A' ' 62' ' ' PHE . 0.6 OUTLIER -137.45 -167.57 2.14 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.338 -0.852 . . . . 0.0 108.875 179.481 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 37.7 t . . . . . 0 N--CA 1.489 1.498 0 O-C-N 121.085 -1.01 . . . . 0.0 109.61 179.955 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.591 ' CE3' ' HB2' ' A' ' 18' ' ' ARG . 64.3 m95 . . . . . 0 N--CA 1.489 1.491 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.3 mt -106.06 169.31 8.57 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.13 -0.981 . . . . 0.0 109.855 -179.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.474 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 0.7 OUTLIER -56.85 132.25 51.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.338 -0.851 . . . . 0.0 109.474 -179.853 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.519 ' SG ' ' CZ ' ' A' ' 17' ' ' ARG . 18.9 t -89.02 112.76 52.89 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.224 -0.922 . . . . 0.0 109.398 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 35.9 Cg_endo -77.72 -52.86 0.07 OUTLIER 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.366 2.044 . . . . 0.0 110.822 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.646 ' HB3' ' NH1' ' A' ' 17' ' ' ARG . . . -39.81 -46.77 2.01 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.427 -0.795 . . . . 0.0 110.045 -179.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 1.023 HD12 ' CD1' ' A' ' 15' ' ' TRP . 11.6 mt -94.16 -60.63 1.69 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.169 -0.957 . . . . 0.0 109.467 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.443 ' O ' ' O ' ' A' ' 8' ' ' CYS . . . 148.36 -145.4 13.81 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.04 156.48 30.29 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.608 2.205 . . . . 0.0 110.342 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.99 -57.82 4.31 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.299 -1.521 . . . . 0.0 109.299 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 1.023 ' CD1' HD12 ' A' ' 11' ' ' LEU . 4.8 t-105 -65.49 129.27 39.17 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.298 -1.119 . . . . 0.0 109.526 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.47 123.08 46.84 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.305 -0.872 . . . . 0.0 109.59 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.646 ' NH1' ' HB3' ' A' ' 10' ' ' ALA . 0.2 OUTLIER -93.48 106.03 18.04 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.273 -0.892 . . . . 0.0 109.365 179.881 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.591 ' HB2' ' CE3' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -100.35 142.68 31.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.239 -0.913 . . . . 0.0 109.524 -179.891 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.525 ' N ' ' HG2' ' A' ' 18' ' ' ARG . 6.1 pt-20 -99.95 159.09 15.35 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.292 -0.88 . . . . 0.0 109.825 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.511 ' HB ' ' CB ' ' A' ' 32' ' ' ASP . 98.9 t . . . . . 0 N--CA 1.49 1.552 0 O-C-N 121.325 -0.86 . . . . 0.0 109.038 179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.511 ' CB ' ' HB ' ' A' ' 20' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.28 0.562 . . . . 0.0 109.495 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -134.81 116.0 14.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.239 -0.913 . . . . 0.0 109.585 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.503 ' CE1' ' HD3' ' A' ' 44' ' ' ARG . 20.8 m-30 -116.22 140.06 49.71 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.245 -0.91 . . . . 0.0 109.247 179.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.551 ' CE2' ' CE1' ' A' ' 64' ' ' PHE . 4.3 m-85 -112.02 147.05 36.8 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.199 -0.938 . . . . 0.0 109.636 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.454 ' HA ' ' O ' ' A' ' 41' ' ' ASP . 26.1 tt0 -131.24 128.17 39.34 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.334 -0.854 . . . . 0.0 109.342 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.508 ' HB3' ' HD2' ' A' ' 38' ' ' PRO . 0.9 OUTLIER -69.72 173.9 3.64 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.249 -0.907 . . . . 0.0 109.304 179.999 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.508 ' HD2' ' HB3' ' A' ' 37' ' ' SER . 36.3 Cg_endo -78.12 -3.79 13.76 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.597 2.198 . . . . 0.0 110.602 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.477 HG22 ' HB2' ' A' ' 37' ' ' SER . 10.7 t -101.42 -9.78 20.8 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.2 -0.938 . . . . 0.0 109.594 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 111.46 9.68 21.06 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.494 ' HB2' ' OG ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -78.76 141.56 37.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.186 -1.185 . . . . 0.0 109.424 179.889 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.467 ' O ' ' HG2' ' A' ' 42' ' ' ARG . 0.1 OUTLIER -128.37 120.41 26.92 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.154 -0.966 . . . . 0.0 109.703 -179.753 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.642 HG21 ' HB3' ' A' ' 49' ' ' LEU . 2.4 mp -126.73 162.23 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.19 -0.944 . . . . 0.0 109.328 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.576 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 29.3 mtt85 -147.35 20.07 1.21 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.217 -0.927 . . . . 0.0 109.756 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.585 ' H ' HG22 ' A' ' 43' ' ' ILE . 0.5 OUTLIER -95.06 -86.78 0.29 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.386 -0.821 . . . . 0.0 108.821 179.433 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.549 ' HB2' ' CD1' ' A' ' 64' ' ' PHE . 24.2 ttmt 159.72 -64.96 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 43.7 t -87.25 -19.58 7.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.501 ' HB2' ' HB2' ' A' ' 45' ' ' SER . 16.2 mt-10 -69.89 -41.44 74.73 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.642 ' HB3' HG21 ' A' ' 43' ' ' ILE . 3.0 pp -72.39 -33.09 66.94 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.86 ' HA ' HD12 ' A' ' 53' ' ' LEU . 1.4 m -63.91 -48.62 75.87 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.22 -28.13 57.28 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.487 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 41.6 t80 -72.58 -56.98 4.51 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.624 -0.672 . . . . 0.0 109.353 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.915 HD21 ' CE3' ' A' ' 15' ' ' TRP . 0.5 OUTLIER -55.03 -57.09 13.13 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.098 -1.001 . . . . 0.0 109.139 179.681 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 134.28 -157.98 23.16 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.1 3.17 7.29 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.559 2.173 . . . . 0.0 110.343 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -84.87 -27.27 26.81 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.228 -0.92 . . . . 0.0 109.465 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.525 ' O ' ' CG2' ' A' ' 50' ' ' THR . 54.3 m -122.33 138.48 54.5 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.303 -0.873 . . . . 0.0 109.245 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.553 ' HA ' HG21 ' A' ' 50' ' ' THR . 29.0 t70 -127.05 142.83 51.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.165 -0.96 . . . . 0.0 109.511 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.747 HD23 ' CD2' ' A' ' 62' ' ' PHE . 3.6 mp -141.3 8.89 2.04 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.191 -0.943 . . . . 0.0 109.803 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.443 ' C ' HD22 ' A' ' 61' ' ' LEU . 4.0 m -47.43 -42.78 23.02 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.113 -0.992 . . . . 0.0 109.282 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.58 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 1.7 mm? -99.66 -3.08 33.87 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.333 -0.854 . . . . 0.0 109.56 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.747 ' CD2' HD23 ' A' ' 59' ' ' LEU . 83.3 t80 -61.51 139.37 58.25 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.354 -0.841 . . . . 0.0 109.744 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.434 ' O ' ' N ' ' A' ' 65' ' ' LYS . 3.4 m-20 -92.24 104.65 16.99 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.443 -0.786 . . . . 0.0 108.967 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.576 ' CE2' ' O ' ' A' ' 44' ' ' ARG . 0.8 OUTLIER -68.51 65.11 0.11 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.239 -0.913 . . . . 0.0 109.479 -179.526 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 63' ' ' ASP . 1.7 ttpt -178.41 -33.36 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.17 -0.956 . . . . 0.0 109.625 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -107.23 -32.85 7.62 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.264 -0.898 . . . . 0.0 109.704 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.571 ' HA2' ' CZ ' ' A' ' 62' ' ' PHE . . . 97.92 38.63 4.06 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.479 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 1.9 pp -139.88 165.84 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.246 -1.15 . . . . 0.0 109.581 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.513 ' CB ' ' HA ' ' A' ' 62' ' ' PHE . 0.5 OUTLIER -153.79 -176.04 5.65 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.276 -0.89 . . . . 0.0 109.589 179.946 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.474 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.361 -0.837 . . . . 0.0 109.355 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.544 ' CE3' ' HB2' ' A' ' 18' ' ' ARG . 76.7 m95 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 121.351 0.596 . . . . 0.0 109.45 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.2 mt -107.18 161.32 14.88 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.148 -0.97 . . . . 0.0 109.739 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -53.91 149.28 9.15 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.394 -0.816 . . . . 0.0 109.519 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.467 ' HB3' ' HB3' ' A' ' 15' ' ' TRP . 50.2 t -111.18 103.42 54.89 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.369 -0.832 . . . . 0.0 109.331 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -77.03 -23.85 10.23 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.354 2.036 . . . . 0.0 110.31 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.436 ' C ' HD23 ' A' ' 11' ' ' LEU . . . -52.65 -48.66 66.28 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.189 -0.944 . . . . 0.0 109.173 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.715 HD12 ' CD1' ' A' ' 15' ' ' TRP . 0.7 OUTLIER -96.64 -59.86 1.72 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.375 -0.828 . . . . 0.0 109.245 179.882 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 158.82 -153.69 24.81 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.35 154.41 28.17 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.614 2.209 . . . . 0.0 110.596 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.18 -12.32 68.24 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 0.715 ' CD1' HD12 ' A' ' 11' ' ' LEU . 16.5 t-105 -111.7 126.21 54.8 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.175 -1.191 . . . . 0.0 109.52 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 18.3 mmtp -101.27 119.58 38.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.282 -0.887 . . . . 0.0 109.581 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.519 ' HG3' ' CE2' ' A' ' 35' ' ' TYR . 5.8 ttp85 -94.89 114.69 26.57 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.224 -0.922 . . . . 0.0 109.359 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.544 ' HB2' ' CE3' ' A' ' 5' ' ' TRP . 0.2 OUTLIER -100.29 128.47 46.35 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.351 -0.843 . . . . 0.0 109.321 179.997 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -118.24 134.06 55.35 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.263 -0.898 . . . . 0.0 109.248 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 32' ' ' ASP . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 O-C-N 121.246 -0.909 . . . . 0.0 109.474 -179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.506 ' N ' ' OD1' ' A' ' 32' ' ' ASP . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 46.2 m -128.78 108.94 10.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.087 -1.008 . . . . 0.0 110.042 -179.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.535 ' CD1' ' N ' ' A' ' 34' ' ' TYR . 2.7 m-30 -99.66 151.73 20.88 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.333 -0.854 . . . . 0.0 108.922 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.603 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 3.8 m-85 -123.68 148.77 46.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.962 -1.086 . . . . 0.0 109.914 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.521 ' HB2' ' CZ3' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -128.32 119.59 25.39 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.497 -0.752 . . . . 0.0 109.01 179.753 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.417 ' HB3' ' HD2' ' A' ' 38' ' ' PRO . 0.6 OUTLIER -63.99 170.32 3.52 Favored Pre-proline 0 N--CA 1.488 1.437 0 O-C-N 121.317 -0.865 . . . . 0.0 109.374 -179.918 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.417 ' HD2' ' HB3' ' A' ' 37' ' ' SER . 35.1 Cg_endo -78.26 -2.58 12.64 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.619 2.213 . . . . 0.0 110.161 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.8 p -102.75 -23.8 13.78 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.269 -0.895 . . . . 0.0 109.645 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 123.81 9.44 5.76 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.471 ' HB2' ' OH ' ' A' ' 52' ' ' TYR . 0.7 OUTLIER -92.07 112.3 24.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.19 -1.182 . . . . 0.0 109.362 179.951 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.462 ' HB3' ' HG3' ' A' ' 36' ' ' GLN . 0.0 OUTLIER -99.43 122.36 42.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.343 -0.848 . . . . 0.0 109.808 -179.738 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.613 HG22 ' H ' ' A' ' 45' ' ' SER . 2.7 mp -117.68 154.04 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.346 -0.846 . . . . 0.0 109.169 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.583 ' O ' ' CZ ' ' A' ' 64' ' ' PHE . 5.6 ttp180 -123.46 -0.21 8.75 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.001 -1.062 . . . . 0.0 109.956 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.752 ' O ' HD23 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -96.61 154.54 17.22 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.231 -0.918 . . . . 0.0 108.558 179.228 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.551 ' HB2' ' CD1' ' A' ' 64' ' ' PHE . 17.4 ttpt -72.85 -67.36 0.57 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.069 -1.019 . . . . 0.0 110.402 -178.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.483 ' O ' ' CG ' ' A' ' 51' ' ' ARG . 53.5 t -72.1 -25.69 24.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 120.862 -1.149 . . . . 0.0 109.956 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.553 ' HB2' ' CB ' ' A' ' 45' ' ' SER . 6.9 tt0 -62.72 -49.03 76.68 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.759 -1.213 . . . . 0.0 108.278 179.021 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.752 HD23 ' O ' ' A' ' 45' ' ' SER . 1.8 pp -70.26 -23.85 62.96 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.636 HG23 ' HB2' ' A' ' 59' ' ' LEU . 33.0 m -65.5 -68.55 0.36 Allowed 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.485 ' HG3' ' O ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -42.9 -31.56 0.52 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 179.269 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.494 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 51.4 t80 -55.09 -56.88 14.81 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.326 -0.859 . . . . 0.0 108.74 179.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.574 HD12 ' HA ' ' A' ' 50' ' ' THR . 0.3 OUTLIER -65.07 -43.14 93.17 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.214 -0.929 . . . . 0.0 109.16 179.379 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 110.26 -152.7 17.28 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.284 -1.527 . . . . 0.0 109.284 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.43 -10.92 15.99 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.545 2.163 . . . . 0.0 110.205 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.1 -32.15 66.73 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.296 -0.878 . . . . 0.0 109.371 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.512 ' HB2' ' CB ' ' A' ' 53' ' ' LEU . 4.0 m -121.86 97.84 5.68 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 0.0 109.251 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -74.99 137.42 41.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.255 -0.903 . . . . 0.0 109.731 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.798 HD23 ' CB ' ' A' ' 62' ' ' PHE . 0.1 OUTLIER -142.21 7.91 1.8 Allowed 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.37 -0.831 . . . . 0.0 109.54 -179.731 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.673 ' C ' HD22 ' A' ' 61' ' ' LEU . 97.9 m -56.69 -28.39 60.73 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.348 -0.845 . . . . 0.0 109.645 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.673 HD22 ' C ' ' A' ' 60' ' ' THR . 2.4 mm? -107.33 -10.47 15.78 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.261 -0.899 . . . . 0.0 109.485 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.798 ' CB ' HD23 ' A' ' 59' ' ' LEU . 38.5 t80 -45.27 128.83 7.9 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.361 -0.837 . . . . 0.0 109.53 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.495 ' O ' ' N ' ' A' ' 65' ' ' LYS . 11.1 m-20 -79.67 100.99 8.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.326 -0.859 . . . . 0.0 109.194 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.583 ' CZ ' ' O ' ' A' ' 44' ' ' ARG . 0.7 OUTLIER -65.55 72.95 0.06 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.374 -0.829 . . . . 0.0 109.333 -179.672 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.495 ' N ' ' O ' ' A' ' 63' ' ' ASP . 0.6 OUTLIER 166.5 -43.6 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.824 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.433 ' HG3' ' HD3' ' A' ' 65' ' ' LYS . 3.8 mt-30 -86.33 -44.67 11.9 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.373 -0.829 . . . . 0.0 109.305 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.408 ' HA2' ' CZ ' ' A' ' 62' ' ' PHE . . . 108.77 25.18 5.78 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.891 -1.283 . . . . 0.0 109.891 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.464 HG13 ' OD2' ' A' ' 63' ' ' ASP . 1.1 pt -140.23 162.58 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.199 -1.177 . . . . 0.0 109.48 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.624 ' H ' HD23 ' A' ' 69' ' ' LEU . 1.7 pt? -133.0 146.38 51.72 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.125 -0.984 . . . . 0.0 109.472 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.418 ' H ' ' HB3' ' A' ' 61' ' ' LEU . 40.7 m . . . . . 0 C--N 1.301 -1.504 0 O-C-N 121.325 -0.859 . . . . 0.0 108.824 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 73.3 m95 . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.245 0.545 . . . . 0.0 109.773 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.417 ' O ' ' C ' ' A' ' 7' ' ' ASP . 0.4 OUTLIER -130.92 147.97 52.63 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.29 -0.881 . . . . 0.0 109.487 179.839 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.484 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 48.4 t0 -44.02 138.07 3.03 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.348 -0.845 . . . . 0.0 109.104 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.462 ' SG ' ' HD3' ' A' ' 17' ' ' ARG . 32.6 t -102.77 105.67 46.02 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.198 -0.939 . . . . 0.0 109.505 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 34.4 Cg_endo -77.33 -27.49 6.46 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.297 1.998 . . . . 0.0 109.991 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.658 ' O ' HD21 ' A' ' 69' ' ' LEU . . . -45.5 -57.95 3.74 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.347 -0.846 . . . . 0.0 109.41 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.651 ' N ' HD23 ' A' ' 11' ' ' LEU . 0.9 OUTLIER -89.34 -58.44 2.53 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.321 -0.862 . . . . 0.0 109.327 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 159.02 -152.88 23.99 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.84 164.1 28.06 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.557 2.172 . . . . 0.0 110.351 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.447 ' O ' ' HD3' ' A' ' 38' ' ' PRO . . . 75.49 8.81 84.36 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 0.918 ' CE3' HD21 ' A' ' 53' ' ' LEU . 9.2 t-105 -130.6 126.08 35.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.171 -1.194 . . . . 0.0 109.46 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 12.5 mmtt -106.4 120.32 41.57 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.225 -0.922 . . . . 0.0 109.579 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.462 ' HD3' ' SG ' ' A' ' 8' ' ' CYS . 1.4 ttp85 -88.38 115.86 26.19 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.474 -0.766 . . . . 0.0 109.325 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.429 ' HD2' ' CG2' ' A' ' 20' ' ' VAL . 3.8 ttm180 -99.53 131.14 45.73 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.173 -0.955 . . . . 0.0 109.371 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.5 ' CG ' ' O ' ' A' ' 19' ' ' GLU . 1.7 pp20? -116.39 117.38 29.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.209 -0.932 . . . . 0.0 109.352 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.429 ' CG2' ' HD2' ' A' ' 18' ' ' ARG . 8.5 t . . . . . 0 C--N 1.303 -1.423 0 O-C-N 121.229 -0.92 . . . . 0.0 109.172 179.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 42.0 m -127.49 111.51 13.89 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.122 -0.987 . . . . 0.0 109.953 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.477 ' CD1' ' N ' ' A' ' 34' ' ' TYR . 19.8 m-85 -99.76 152.98 19.48 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.295 -0.878 . . . . 0.0 108.806 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.622 ' CE1' ' CE1' ' A' ' 64' ' ' PHE . 7.5 m-85 -124.5 142.74 51.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.983 -1.073 . . . . 0.0 109.934 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -126.63 138.98 53.5 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.375 -0.828 . . . . 0.0 109.402 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.924 ' OG ' HG22 ' A' ' 39' ' ' THR . 0.9 OUTLIER -77.89 172.52 9.59 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.287 -0.883 . . . . 0.0 109.506 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.451 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 35.0 Cg_endo -79.29 13.4 2.04 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.77 2.313 . . . . 0.0 110.98 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.924 HG22 ' OG ' ' A' ' 37' ' ' SER . 14.6 t -123.34 -21.62 5.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.981 -1.074 . . . . 0.0 109.852 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 127.27 8.23 4.59 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.456 ' OD2' ' OH ' ' A' ' 52' ' ' TYR . 6.0 m-20 -88.86 133.3 34.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.083 -1.245 . . . . 0.0 109.324 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.41 ' O ' ' HG2' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -116.37 137.06 52.46 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.263 -0.898 . . . . 0.0 109.432 -179.734 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.747 HD13 ' HA ' ' A' ' 49' ' ' LEU . 4.5 mt -132.7 156.21 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.264 -0.897 . . . . 0.0 109.922 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.592 ' O ' ' CZ ' ' A' ' 64' ' ' PHE . 13.3 ttp180 -123.5 -45.72 2.06 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.581 -0.699 . . . . 0.0 110.067 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.578 ' HB2' ' CB ' ' A' ' 48' ' ' GLU . 0.6 OUTLIER -59.28 122.7 14.54 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.915 -1.115 . . . . 0.0 108.831 -179.965 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.575 ' HA ' ' CE1' ' A' ' 64' ' ' PHE . 4.9 ttpm? -40.34 -83.17 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.543 -0.723 . . . . 0.0 110.724 -179.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.499 ' HA ' ' OG1' ' A' ' 50' ' ' THR . 42.7 t -55.64 -30.4 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.205 -0.935 . . . . 0.0 110.641 -178.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.578 ' CB ' ' HB2' ' A' ' 45' ' ' SER . 14.2 tt0 -54.8 -45.88 74.4 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.663 -1.273 . . . . 0.0 108.813 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.747 ' HA ' HD13 ' A' ' 43' ' ' ILE . 1.4 pp -69.83 -20.67 63.42 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.78 ' OG1' HD13 ' A' ' 59' ' ' LEU . 17.0 m -71.95 -67.21 0.55 Allowed 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.46 ' HG3' ' O ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -44.58 -26.96 0.42 Allowed 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.795 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.456 ' OH ' ' OD2' ' A' ' 41' ' ' ASP . 76.5 t80 -67.75 -64.68 0.81 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.455 -0.778 . . . . 0.0 109.191 179.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.918 HD21 ' CE3' ' A' ' 15' ' ' TRP . 1.3 mt -44.5 -57.27 3.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.189 -0.945 . . . . 0.0 109.04 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 141.01 -162.16 26.75 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.95 -16.17 14.45 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.648 2.232 . . . . 0.0 110.218 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.29 -8.19 56.54 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.307 -0.871 . . . . 0.0 109.585 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 39.8 m -124.98 168.17 13.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.242 -0.911 . . . . 0.0 109.553 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.928 ' C ' HD12 ' A' ' 59' ' ' LEU . 9.3 p-10 -165.46 141.95 5.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.273 -0.892 . . . . 0.0 109.44 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.928 HD12 ' C ' ' A' ' 58' ' ' ASP . 6.7 mp -139.43 1.28 1.95 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.097 -1.002 . . . . 0.0 109.955 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.619 ' C ' HD22 ' A' ' 61' ' ' LEU . 67.5 m -47.25 -31.28 3.62 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.044 -1.035 . . . . 0.0 108.876 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.813 HD22 ' N ' ' A' ' 61' ' ' LEU . 2.7 mm? -103.43 -15.95 15.74 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.538 ' CZ ' ' HA2' ' A' ' 67' ' ' GLY . 64.9 t80 -57.61 132.87 54.53 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.551 -0.718 . . . . 0.0 109.702 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.497 ' O ' ' N ' ' A' ' 65' ' ' LYS . 1.1 m-20 -79.71 104.79 10.54 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.331 -0.856 . . . . 0.0 108.915 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.622 ' CE1' ' CE1' ' A' ' 35' ' ' TYR . 0.4 OUTLIER -67.74 63.81 0.08 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.183 -0.948 . . . . 0.0 109.424 -179.584 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.497 ' N ' ' O ' ' A' ' 63' ' ' ASP . 1.4 ttmm 173.61 -32.62 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -94.01 -46.45 7.14 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.374 -0.829 . . . . 0.0 109.012 179.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.538 ' HA2' ' CZ ' ' A' ' 62' ' ' PHE . . . 108.45 28.54 4.55 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 1.3 pp -140.74 159.13 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.017 -1.284 . . . . 0.0 109.909 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.695 ' N ' HD23 ' A' ' 69' ' ' LEU . 1.1 pt? -141.54 -176.09 4.61 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.49 1.538 0 O-C-N 121.037 -1.04 . . . . 0.0 109.828 179.794 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.592 ' CZ3' ' HB2' ' A' ' 36' ' ' GLN . 65.3 m95 . . . . . 0 N--CA 1.489 1.493 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.444 HD11 ' OE2' ' A' ' 19' ' ' GLU . 3.0 mt -103.86 176.48 5.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.37 -0.831 . . . . 0.0 109.644 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 7' ' ' ASP . 6.6 p-10 -62.17 137.27 58.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.391 -0.818 . . . . 0.0 109.422 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.528 ' SG ' ' CZ ' ' A' ' 17' ' ' ARG . 13.4 t -95.5 109.99 48.48 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.259 -0.901 . . . . 0.0 109.231 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 36.2 Cg_endo -79.45 -46.7 0.1 OUTLIER 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.446 2.097 . . . . 0.0 110.795 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.646 ' HB3' ' NH1' ' A' ' 17' ' ' ARG . . . -43.21 -44.03 5.02 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.162 -0.962 . . . . 0.0 109.935 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.785 HD12 ' CD1' ' A' ' 15' ' ' TRP . 10.7 mt -97.23 -61.53 1.39 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.203 -0.936 . . . . 0.0 109.777 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 8' ' ' CYS . . . 155.74 -155.02 25.97 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.95 158.63 30.92 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.582 2.188 . . . . 0.0 110.335 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.4 -43.01 3.09 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 0.88 ' CE3' HD21 ' A' ' 53' ' ' LEU . 15.9 t-105 -79.35 130.66 35.65 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.221 -1.164 . . . . 0.0 109.424 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.3 mmtm -97.97 124.04 42.25 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.256 -0.903 . . . . 0.0 109.235 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.646 ' NH1' ' HB3' ' A' ' 10' ' ' ALA . 0.7 OUTLIER -99.63 108.92 21.42 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.256 -0.902 . . . . 0.0 109.318 -179.944 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.426 ' HD2' ' CE2' ' A' ' 5' ' ' TRP . 0.2 OUTLIER -99.85 137.78 37.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.175 -0.953 . . . . 0.0 109.744 -179.779 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.444 ' OE2' HD11 ' A' ' 6' ' ' LEU . 1.5 pt-20 -123.83 152.93 41.74 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.37 -0.831 . . . . 0.0 109.272 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 32' ' ' ASP . 1.9 t . . . . . 0 N--CA 1.49 1.572 0 O-C-N 121.22 -0.925 . . . . 0.0 109.467 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.595 ' HB3' ' CZ ' ' A' ' 34' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.412 HG23 ' O ' ' A' ' 18' ' ' ARG . 2.7 m -139.79 123.61 17.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.184 -0.948 . . . . 0.0 109.546 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.595 ' CZ ' ' HB3' ' A' ' 32' ' ' ASP . 0.7 OUTLIER -120.63 163.06 18.61 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.258 -0.901 . . . . 0.0 109.474 179.911 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.813 ' HD2' HD22 ' A' ' 49' ' ' LEU . 8.8 m-85 -130.45 156.99 43.83 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.182 -0.949 . . . . 0.0 109.834 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.592 ' HB2' ' CZ3' ' A' ' 5' ' ' TRP . 12.4 tt0 -139.18 114.33 9.55 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.398 -0.814 . . . . 0.0 109.001 179.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.584 ' HB2' HG22 ' A' ' 39' ' ' THR . 0.8 OUTLIER -63.2 163.05 19.53 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.291 -0.88 . . . . 0.0 109.615 -179.686 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.58 3.08 7.15 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.625 2.217 . . . . 0.0 110.241 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.584 HG22 ' HB2' ' A' ' 37' ' ' SER . 2.8 t -103.56 -16.77 15.43 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.334 -0.854 . . . . 0.0 109.233 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.0 14.8 8.96 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.513 ' OD2' ' CE1' ' A' ' 52' ' ' TYR . 0.8 OUTLIER -95.39 115.93 28.1 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.221 -1.164 . . . . 0.0 109.504 179.947 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.428 ' O ' ' HG2' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -99.51 121.35 41.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.184 -0.948 . . . . 0.0 109.541 179.961 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.502 ' CG2' ' HB3' ' A' ' 49' ' ' LEU . 2.7 mp -126.36 156.53 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.337 -0.852 . . . . 0.0 109.207 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.584 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 2.2 ttm180 -133.37 -8.68 2.92 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.088 -1.007 . . . . 0.0 110.773 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.986 ' O ' HD23 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -79.71 -178.27 6.3 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.73 -1.231 . . . . 0.0 108.391 179.296 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.557 ' HA ' ' CE1' ' A' ' 64' ' ' PHE . 29.4 ttpt -102.15 -57.32 2.09 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.988 -1.07 . . . . 0.0 109.845 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 57.4 t -84.57 -14.8 11.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.12 -0.988 . . . . 0.0 109.387 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.574 ' HB2' ' CB ' ' A' ' 45' ' ' SER . 1.9 mt-10 -74.7 -42.21 58.78 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.066 -1.021 . . . . 0.0 108.389 179.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.986 HD23 ' O ' ' A' ' 45' ' ' SER . 1.5 pp -70.96 -29.13 65.05 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.023 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.886 ' OG1' HD12 ' A' ' 59' ' ' LEU . 0.4 OUTLIER -71.86 -43.8 64.87 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.301 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.421 ' N ' HG22 ' A' ' 50' ' ' THR . 0.3 OUTLIER -61.24 -21.81 64.22 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.993 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.513 ' CE1' ' OD2' ' A' ' 41' ' ' ASP . 90.2 t80 -75.81 -60.21 2.42 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.558 -0.714 . . . . 0.0 109.448 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.88 HD21 ' CE3' ' A' ' 15' ' ' TRP . 1.0 OUTLIER -56.02 -46.28 78.87 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.155 -0.965 . . . . 0.0 109.254 179.726 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 128.63 -151.34 18.92 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -79.08 -24.31 6.94 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.638 2.225 . . . . 0.0 110.504 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.7 -20.47 66.34 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.269 -0.894 . . . . 0.0 109.854 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 49.3 m -133.52 103.48 5.94 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.179 -0.95 . . . . 0.0 109.687 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.49 150.82 24.25 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.226 -0.921 . . . . 0.0 109.044 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 1.007 HD23 ' CD2' ' A' ' 62' ' ' PHE . 0.6 OUTLIER -134.42 9.11 3.69 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.236 -0.915 . . . . 0.0 109.466 -179.876 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.572 ' C ' HD22 ' A' ' 61' ' ' LEU . 2.5 m -47.76 -46.8 30.51 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.326 -0.858 . . . . 0.0 109.303 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.63 HD22 ' N ' ' A' ' 61' ' ' LEU . 3.5 mm? -99.26 -2.15 37.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.353 -0.842 . . . . 0.0 109.528 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 1.007 ' CD2' HD23 ' A' ' 59' ' ' LEU . 69.2 t80 -60.1 129.04 39.81 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.264 -0.898 . . . . 0.0 109.488 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.503 ' O ' ' N ' ' A' ' 65' ' ' LYS . 3.2 m-20 -79.3 101.05 7.84 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.242 -0.911 . . . . 0.0 108.931 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.584 ' CE2' ' O ' ' A' ' 44' ' ' ARG . 0.9 OUTLIER -67.32 61.21 0.06 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.35 -0.844 . . . . 0.0 109.435 -179.494 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.503 ' N ' ' O ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -174.08 -38.54 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.312 -0.868 . . . . 0.0 109.449 -179.819 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -100.37 -39.87 7.77 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.288 -0.882 . . . . 0.0 109.511 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.437 ' HA2' ' CZ ' ' A' ' 62' ' ' PHE . . . 107.22 35.96 2.6 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.0 pp -140.64 163.73 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.129 -1.218 . . . . 0.0 109.726 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.482 ' HB3' ' HA ' ' A' ' 62' ' ' PHE . 0.7 OUTLIER -145.59 173.66 11.86 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.271 -0.893 . . . . 0.0 109.032 179.76 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.468 ' O ' ' HG ' ' A' ' 61' ' ' LEU . 1.6 p . . . . . 0 N--CA 1.489 1.513 0 O-C-N 121.184 -0.948 . . . . 0.0 109.362 179.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 67.7 m95 . . . . . 0 N--CA 1.489 1.509 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.425 ' O ' ' C ' ' A' ' 7' ' ' ASP . 89.9 mt -113.62 145.9 40.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.24 -0.912 . . . . 0.0 109.284 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.484 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 12.5 t0 -43.21 129.07 4.76 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.183 -0.948 . . . . 0.0 109.469 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 15' ' ' TRP . 14.8 t -80.36 113.25 37.64 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.408 -0.808 . . . . 0.0 109.505 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 36.5 Cg_endo -80.14 -53.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.353 2.036 . . . . 0.0 110.461 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.52 ' CB ' ' CE1' ' A' ' 62' ' ' PHE . . . -42.66 -33.4 0.71 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.38 -0.825 . . . . 0.0 109.867 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 1.14 HD12 ' CD1' ' A' ' 15' ' ' TRP . 16.8 mt -105.89 -63.78 1.22 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.189 -0.944 . . . . 0.0 109.299 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 146.8 -151.5 23.77 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.66 155.04 31.18 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.639 2.226 . . . . 0.0 110.26 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.423 ' O ' ' HD3' ' A' ' 38' ' ' PRO . . . 90.57 -33.55 4.54 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 1.14 ' CD1' HD12 ' A' ' 11' ' ' LEU . 13.7 t-105 -94.91 122.85 37.97 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.394 -1.062 . . . . 0.0 108.958 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.6 121.52 39.6 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.142 -0.973 . . . . 0.0 109.172 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.598 ' CG ' ' CE1' ' A' ' 35' ' ' TYR . 0.2 OUTLIER -90.56 104.91 17.44 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.365 -0.834 . . . . 0.0 109.772 -179.774 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.802 ' O ' HG23 ' A' ' 33' ' ' THR . 0.7 OUTLIER -97.55 143.34 28.34 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.397 -0.815 . . . . 0.0 109.028 179.584 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -137.35 141.97 41.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.014 -1.054 . . . . 0.0 109.92 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 2.2 t . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.348 -0.845 . . . . 0.0 109.24 179.677 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.571 ' HB3' ' CE1' ' A' ' 34' ' ' TYR . 60.9 m-20 . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.802 HG23 ' O ' ' A' ' 18' ' ' ARG . 6.1 m -113.35 138.29 50.27 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.23 -0.919 . . . . 0.0 109.385 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.571 ' CE1' ' HB3' ' A' ' 32' ' ' ASP . 13.1 m-85 -131.13 151.18 51.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.235 -0.916 . . . . 0.0 109.393 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.682 ' CZ ' ' CE1' ' A' ' 64' ' ' PHE . 14.7 m-85 -122.17 133.93 54.73 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.291 -0.881 . . . . 0.0 109.224 179.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.444 ' HG3' ' HG3' ' A' ' 42' ' ' ARG . 39.6 tt0 -115.85 124.73 51.39 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.215 -0.928 . . . . 0.0 109.606 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.534 ' CB ' ' HD2' ' A' ' 38' ' ' PRO . 0.1 OUTLIER -75.48 175.66 3.91 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.234 -0.916 . . . . 0.0 109.368 179.888 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.534 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 35.2 Cg_endo -77.63 -4.75 14.89 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.64 2.227 . . . . 0.0 110.55 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.488 HG22 ' HB2' ' A' ' 37' ' ' SER . 8.1 t -101.85 -0.43 34.13 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.212 -0.93 . . . . 0.0 109.536 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 94.99 19.6 30.64 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.457 ' HB2' ' OG ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -84.77 118.02 24.19 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.291 -1.123 . . . . 0.0 109.335 -179.996 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.444 ' HG3' ' HG3' ' A' ' 36' ' ' GLN . 0.0 OUTLIER -105.58 107.08 17.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.362 -0.836 . . . . 0.0 109.535 -179.839 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.529 HG21 ' HB3' ' A' ' 49' ' ' LEU . 1.8 mp -120.5 153.53 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.289 -0.882 . . . . 0.0 109.448 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.586 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 13.6 ptt180 -122.11 -26.16 4.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.135 -0.978 . . . . 0.0 109.466 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.5 ' CB ' ' HB2' ' A' ' 48' ' ' GLU . 0.3 OUTLIER -83.2 139.9 32.87 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.217 -0.927 . . . . 0.0 109.022 179.751 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.582 ' HG3' HG23 ' A' ' 47' ' ' VAL . 9.0 pttt -66.91 -52.01 48.32 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.304 -0.872 . . . . 0.0 110.932 -178.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.582 HG23 ' HG3' ' A' ' 46' ' ' LYS . 48.4 t -74.92 -23.25 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.818 -1.176 . . . . 0.0 109.958 -179.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.5 ' HB2' ' CB ' ' A' ' 45' ' ' SER . 28.8 mt-10 -65.28 -50.49 65.55 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.895 -1.128 . . . . 0.0 108.297 179.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.655 ' O ' HD12 ' A' ' 53' ' ' LEU . 3.7 pp -72.58 -35.81 68.03 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.623 ' OG1' HD12 ' A' ' 59' ' ' LEU . 0.5 OUTLIER -59.29 -39.66 83.68 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.025 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.1 mmt180 -69.38 -25.11 64.0 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.485 ' OH ' HG21 ' A' ' 39' ' ' THR . 5.6 t80 -71.32 -57.66 4.26 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.658 -0.651 . . . . 0.0 109.326 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.998 HD21 ' CZ3' ' A' ' 15' ' ' TRP . 0.2 OUTLIER -65.95 -40.21 91.12 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.094 -1.004 . . . . 0.0 109.248 179.724 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 122.44 -153.86 16.89 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.422 ' O ' ' C ' ' A' ' 56' ' ' ALA . 34.8 Cg_endo -77.57 -36.23 1.3 Allowed 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.534 2.156 . . . . 0.0 110.331 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 55' ' ' PRO . . . -44.86 -39.86 5.73 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.213 -0.93 . . . . 0.0 109.227 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.419 ' O ' ' OG1' ' A' ' 50' ' ' THR . 1.3 m -114.48 84.0 1.98 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.32 -0.862 . . . . 0.0 109.05 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -77.86 163.97 25.58 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.224 -0.922 . . . . 0.0 109.883 -179.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.975 HD23 ' CD2' ' A' ' 62' ' ' PHE . 0.5 OUTLIER -160.01 23.23 0.17 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.444 -0.785 . . . . 0.0 109.27 179.964 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.491 ' C ' HD22 ' A' ' 61' ' ' LEU . 3.6 m -55.35 -48.2 74.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.331 -0.856 . . . . 0.0 109.95 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.535 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 2.2 mm? -103.98 4.07 34.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.28 -0.887 . . . . 0.0 109.95 -179.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.975 ' CD2' HD23 ' A' ' 59' ' ' LEU . 54.3 t80 -63.64 136.75 57.73 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.205 -0.934 . . . . 0.0 109.909 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.98 114.95 27.25 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.501 -0.749 . . . . 0.0 108.995 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.711 ' HE1' HG22 ' A' ' 33' ' ' THR . 0.3 OUTLIER -74.58 62.27 1.02 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.222 -0.924 . . . . 0.0 109.797 -179.458 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.443 ' HB3' ' O ' ' A' ' 64' ' ' PHE . 17.5 pttt 178.91 -38.41 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.273 -0.892 . . . . 0.0 109.178 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.402 ' N ' ' CG ' ' A' ' 65' ' ' LYS . 0.4 OUTLIER -94.23 -18.46 21.67 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.285 -0.884 . . . . 0.0 108.991 179.407 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.58 ' CA ' ' CZ ' ' A' ' 17' ' ' ARG . . . 73.32 43.08 39.83 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 1.4 pp -140.48 -167.47 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.152 -1.205 . . . . 0.0 109.511 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.578 ' HB3' ' HA ' ' A' ' 62' ' ' PHE . 0.6 OUTLIER 179.95 178.47 0.59 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.799 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.494 0 O-C-N 121.007 -1.058 . . . . 0.0 109.909 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.602 ' CE3' ' HB2' ' A' ' 18' ' ' ARG . 48.4 m95 . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.203 -0.666 . . . . 0.0 109.203 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 28.6 mt -103.0 152.52 21.23 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.153 -0.967 . . . . 0.0 109.484 -179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.471 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 37.1 m-20 -47.43 129.57 13.19 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.211 -0.931 . . . . 0.0 109.133 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.531 ' CB ' ' HB2' ' A' ' 17' ' ' ARG . 54.1 t -79.9 114.05 43.06 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.302 -0.874 . . . . 0.0 109.653 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 36.4 Cg_endo -78.64 -46.1 0.12 Allowed 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.292 1.995 . . . . 0.0 110.195 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.657 ' O ' HD23 ' A' ' 11' ' ' LEU . . . -46.57 -29.83 1.99 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.307 -0.871 . . . . 0.0 109.644 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.934 HD12 ' CD1' ' A' ' 15' ' ' TRP . 10.2 mt -115.54 -61.76 1.69 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.082 -1.011 . . . . 0.0 110.004 -179.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.47 ' O ' ' O ' ' A' ' 8' ' ' CYS . . . 158.79 -152.14 23.19 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.52 ' O ' ' N ' ' A' ' 15' ' ' TRP . 35.1 Cg_endo -77.79 179.32 6.62 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.633 2.222 . . . . 0.0 110.352 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.45 ' O ' ' HD3' ' A' ' 16' ' ' LYS . . . 67.2 -63.95 0.23 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 108.951 -1.66 . . . . 0.0 108.951 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 0.934 ' CD1' HD12 ' A' ' 11' ' ' LEU . 6.2 t-105 -53.09 126.95 22.41 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.385 -1.068 . . . . 0.0 109.089 179.356 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.45 ' HD3' ' O ' ' A' ' 14' ' ' GLY . 0.3 OUTLIER -100.33 114.71 28.42 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.061 -1.024 . . . . 0.0 109.761 -179.579 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 1.008 ' NH2' HG21 ' A' ' 33' ' ' THR . 8.7 ttt-85 -95.93 102.99 14.85 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.361 -0.837 . . . . 0.0 109.174 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.602 ' HB2' ' CE3' ' A' ' 5' ' ' TRP . 8.4 ttt180 -99.94 151.41 21.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.154 -0.966 . . . . 0.0 109.973 -179.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -126.16 138.46 53.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.393 -0.817 . . . . 0.0 109.316 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.469 ' O ' ' N ' ' A' ' 32' ' ' ASP . 11.4 t . . . . . 0 N--CA 1.49 1.563 0 O-C-N 121.242 -0.912 . . . . 0.0 109.359 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.566 ' HB3' ' CE1' ' A' ' 34' ' ' TYR . 7.8 m-20 . . . . . 0 N--CA 1.488 1.467 0 N-CA-C 108.691 -0.855 . . . . 0.0 108.691 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 1.008 HG21 ' NH2' ' A' ' 17' ' ' ARG . 18.5 m -101.87 137.02 40.71 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.138 -0.976 . . . . 0.0 110.061 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.566 ' CE1' ' HB3' ' A' ' 32' ' ' ASP . 46.5 m-85 -129.13 148.49 51.07 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.784 ' HD2' HD22 ' A' ' 49' ' ' LEU . 38.6 m-85 -110.81 137.64 48.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.079 -1.013 . . . . 0.0 109.897 -179.577 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.545 ' HB2' ' CZ3' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -116.38 116.86 28.49 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.273 -0.892 . . . . 0.0 109.257 179.536 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.478 ' CB ' ' HD2' ' A' ' 38' ' ' PRO . 0.6 OUTLIER -58.12 173.65 0.38 Allowed Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.303 -0.873 . . . . 0.0 109.309 -179.971 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.478 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 35.7 Cg_endo -78.72 0.67 9.77 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.621 2.214 . . . . 0.0 110.382 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.444 HG22 ' HB3' ' A' ' 37' ' ' SER . 5.5 t -111.88 -22.9 10.86 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.295 -0.878 . . . . 0.0 109.417 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.8 -2.37 5.22 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.433 ' CB ' ' HB2' ' A' ' 37' ' ' SER . 0.2 OUTLIER -65.31 171.09 4.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.188 -1.184 . . . . 0.0 109.427 179.952 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.465 ' HA ' ' O ' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -154.67 108.31 2.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.26 -0.9 . . . . 0.0 109.277 -179.962 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.63 HG21 ' CA ' ' A' ' 49' ' ' LEU . 2.4 mp -107.49 163.36 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.279 -0.888 . . . . 0.0 109.623 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.567 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 7.7 ttp180 -130.59 -32.51 1.71 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.316 -0.865 . . . . 0.0 109.851 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.842 ' O ' HD23 ' A' ' 49' ' ' LEU . 0.6 OUTLIER -68.13 151.75 46.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.056 -1.027 . . . . 0.0 108.877 179.825 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.441 ' HD2' ' O ' ' A' ' 59' ' ' LEU . 7.5 ttpm? -70.59 -68.78 0.4 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.272 -0.893 . . . . 0.0 111.185 -178.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.477 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 54.5 t -71.9 -18.6 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.052 -1.03 . . . . 0.0 110.705 -178.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.576 ' HB2' ' CB ' ' A' ' 45' ' ' SER . 5.5 mt-10 -72.12 -42.74 65.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.656 -1.278 . . . . 0.0 108.745 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.842 HD23 ' O ' ' A' ' 45' ' ' SER . 1.6 pp -69.42 -25.83 64.31 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 178.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.891 ' OG1' HD13 ' A' ' 59' ' ' LEU . 20.6 m -70.44 -62.7 1.29 Allowed 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.49 ' HG3' ' O ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -51.0 -22.56 2.36 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.477 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.496 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 59.2 t80 -64.03 -56.25 16.36 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.39 -0.819 . . . . 0.0 108.92 179.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.756 HD21 ' CE3' ' A' ' 15' ' ' TRP . 0.7 OUTLIER -61.87 -49.27 76.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.197 -0.94 . . . . 0.0 109.221 179.704 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 130.91 -156.03 21.53 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.79 3.42 6.95 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.536 2.157 . . . . 0.0 110.231 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -87.83 -12.89 43.62 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.384 -0.823 . . . . 0.0 109.325 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.46 ' O ' ' CG2' ' A' ' 50' ' ' THR . 52.9 m -139.02 131.68 28.95 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.233 -0.917 . . . . 0.0 109.703 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.84 ' C ' HD12 ' A' ' 59' ' ' LEU . 12.4 t70 -124.27 155.11 39.19 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.274 -0.891 . . . . 0.0 109.472 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.891 HD13 ' OG1' ' A' ' 50' ' ' THR . 5.5 mp -148.49 15.06 0.99 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.191 -0.943 . . . . 0.0 109.61 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.645 ' C ' HD22 ' A' ' 61' ' ' LEU . 12.7 m -46.01 -37.54 6.74 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.22 -0.925 . . . . 0.0 109.484 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.645 HD22 ' C ' ' A' ' 60' ' ' THR . 1.4 mm? -112.72 11.1 19.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.22 -0.925 . . . . 0.0 109.744 -179.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.804 ' CD2' HD23 ' A' ' 59' ' ' LEU . 51.5 t80 -69.3 151.05 46.7 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.329 -0.857 . . . . 0.0 110.317 -179.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -107.08 106.42 16.91 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.567 ' CE2' ' O ' ' A' ' 44' ' ' ARG . 0.2 OUTLIER -71.09 60.76 0.27 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.182 -0.949 . . . . 0.0 109.577 -179.224 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 15.5 ttpt -177.28 -35.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.196 -0.94 . . . . 0.0 109.585 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -101.08 -30.83 11.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.216 -0.928 . . . . 0.0 109.529 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.18 39.72 5.65 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.424 ' O ' ' CD1' ' A' ' 62' ' ' PHE . 2.2 pp -140.11 -178.64 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.168 -1.195 . . . . 0.0 109.967 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.524 ' HB3' ' HA ' ' A' ' 62' ' ' PHE . 0.8 OUTLIER -172.17 -175.97 1.54 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.36 -0.838 . . . . 0.0 108.99 -179.954 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.477 ' SG ' HD12 ' A' ' 61' ' ' LEU . 31.9 p . . . . . 0 C--N 1.303 -1.452 0 O-C-N 121.183 -0.948 . . . . 0.0 109.337 179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.588 ' CE2' ' HD2' ' A' ' 18' ' ' ARG . 62.5 m95 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.266 0.555 . . . . 0.0 109.584 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.658 HD12 ' O ' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -107.58 150.26 27.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.234 -0.916 . . . . 0.0 109.596 179.984 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.537 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 0.4 OUTLIER -45.88 147.53 0.96 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.3 -0.875 . . . . 0.0 109.352 179.774 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.529 ' HB2' ' HB3' ' A' ' 15' ' ' TRP . 52.3 m -93.8 109.81 43.67 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.329 -0.857 . . . . 0.0 109.77 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.537 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 35.8 Cg_endo -80.02 -29.43 2.66 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.26 1.973 . . . . 0.0 109.561 179.291 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.968 ' HB3' ' NH1' ' A' ' 17' ' ' ARG . . . -69.55 -34.77 74.68 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.376 -0.827 . . . . 0.0 109.357 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.952 HD12 ' CD1' ' A' ' 15' ' ' TRP . 10.4 mt -105.51 -50.27 3.25 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.208 -0.932 . . . . 0.0 109.509 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 139.08 -151.68 21.9 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -77.74 161.66 30.41 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.627 2.218 . . . . 0.0 110.268 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.94 -48.61 4.09 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 1.001 ' CZ2' HD13 ' A' ' 49' ' ' LEU . 11.4 t-105 -76.61 125.78 29.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.26 -1.141 . . . . 0.0 109.195 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.491 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 0.1 OUTLIER -102.21 127.53 49.11 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.386 -0.821 . . . . 0.0 109.448 -179.655 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.968 ' NH1' ' HB3' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -100.58 104.1 15.43 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.423 -0.798 . . . . 0.0 109.899 -179.311 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.588 ' HD2' ' CE2' ' A' ' 5' ' ' TRP . 1.0 OUTLIER -100.74 135.09 42.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.17 -0.956 . . . . 0.0 109.569 179.624 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -115.49 146.51 41.61 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.274 -0.891 . . . . 0.0 109.351 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.49 ' O ' ' N ' ' A' ' 32' ' ' ASP . 2.9 t . . . . . 0 N--CA 1.491 1.614 0 O-C-N 121.175 -0.953 . . . . 0.0 109.876 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.526 ' HB3' ' CZ ' ' A' ' 34' ' ' TYR . 3.6 m-20 . . . . . 0 N--CA 1.489 1.494 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.545 HG22 ' HE1' ' A' ' 35' ' ' TYR . 1.5 m -100.65 120.26 39.8 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.278 -0.889 . . . . 0.0 109.841 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.554 ' CG ' ' HD3' ' A' ' 44' ' ' ARG . 15.2 m-85 -123.35 152.92 41.01 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.355 -0.84 . . . . 0.0 108.979 179.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.692 ' CE2' ' CE1' ' A' ' 64' ' ' PHE . 4.1 m-85 -118.57 145.16 45.59 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.117 -0.989 . . . . 0.0 109.593 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.491 ' NE2' ' O ' ' A' ' 37' ' ' SER . 0.0 OUTLIER -132.93 141.71 48.5 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.216 -0.928 . . . . 0.0 109.868 -179.802 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.534 ' HG ' ' HZ3' ' A' ' 15' ' ' TRP . 0.3 OUTLIER -81.26 173.4 7.75 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.45 -0.781 . . . . 0.0 109.183 179.616 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.463 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 36.0 Cg_endo -78.89 7.2 4.43 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.605 2.203 . . . . 0.0 110.573 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.2 p -110.49 -13.59 14.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.212 -0.93 . . . . 0.0 109.502 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 110.59 24.3 5.64 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.877 ' OD2' HD11 ' A' ' 43' ' ' ILE . 9.5 t70 -97.42 123.23 41.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.279 -1.13 . . . . 0.0 109.393 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.689 ' C ' HD12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -107.26 124.84 50.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.29 -0.881 . . . . 0.0 109.645 -179.912 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.877 HD11 ' OD2' ' A' ' 41' ' ' ASP . 3.1 mp -128.05 150.43 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.255 -0.903 . . . . 0.0 109.447 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.572 ' HA ' ' CZ ' ' A' ' 64' ' ' PHE . 11.9 mtt180 -144.92 9.68 1.31 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.253 -0.904 . . . . 0.0 110.235 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.549 ' CB ' ' HB2' ' A' ' 48' ' ' GLU . 0.3 OUTLIER -98.41 12.66 34.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.033 -1.042 . . . . 0.0 109.355 179.833 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.584 ' HA ' ' CE1' ' A' ' 64' ' ' PHE . 0.0 OUTLIER 63.22 -93.4 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.365 -0.834 . . . . 0.0 110.225 179.374 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.459 ' HA ' ' OG1' ' A' ' 50' ' ' THR . 75.5 t -55.35 -22.45 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.127 -0.983 . . . . 0.0 109.812 -179.161 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.549 ' HB2' ' CB ' ' A' ' 45' ' ' SER . 2.5 mt-10 -63.56 -47.83 79.96 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.038 -1.039 . . . . 0.0 108.766 179.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 1.076 HD12 HD11 ' A' ' 53' ' ' LEU . 1.3 pp -67.56 -24.92 65.58 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 179.113 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.526 ' HA ' HD12 ' A' ' 53' ' ' LEU . 4.9 m -66.95 -62.59 1.36 Allowed 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.501 ' HG3' ' O ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -52.4 -21.64 3.84 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.306 -0.957 . . . . 0.0 108.459 179.299 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.418 ' O ' ' C ' ' A' ' 53' ' ' LEU . 2.0 t80 -77.19 -64.51 1.12 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.463 -0.773 . . . . 0.0 108.989 179.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 1.076 HD11 HD12 ' A' ' 49' ' ' LEU . 2.2 mt -45.07 -63.64 0.88 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.18 -0.95 . . . . 0.0 109.047 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 143.8 -163.6 27.61 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.97 -7.26 16.32 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.604 2.203 . . . . 0.0 110.116 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -79.36 -11.3 59.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.341 -0.849 . . . . 0.0 109.453 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.409 ' SG ' ' HB3' ' A' ' 11' ' ' LEU . 1.0 OUTLIER -136.74 150.41 48.39 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.245 -0.909 . . . . 0.0 109.456 -179.986 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.924 ' C ' HD12 ' A' ' 59' ' ' LEU . 13.7 p-10 -139.97 156.15 46.79 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.234 -0.916 . . . . 0.0 109.43 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.924 HD12 ' C ' ' A' ' 58' ' ' ASP . 6.0 mp -150.86 15.51 0.75 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.167 -0.958 . . . . 0.0 109.549 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.695 ' C ' HD22 ' A' ' 61' ' ' LEU . 32.1 m -47.32 -41.03 18.45 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.277 -0.889 . . . . 0.0 109.336 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.695 HD22 ' C ' ' A' ' 60' ' ' THR . 2.4 mm? -109.27 -4.62 16.33 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.279 -0.888 . . . . 0.0 109.597 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.577 ' CD2' HD23 ' A' ' 59' ' ' LEU . 33.4 t80 -56.93 136.48 56.0 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.273 -0.892 . . . . 0.0 109.73 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.571 ' O ' ' CE2' ' A' ' 62' ' ' PHE . 11.6 m-20 -85.13 129.23 34.84 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.361 -0.837 . . . . 0.0 109.11 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.692 ' CE1' ' CE2' ' A' ' 35' ' ' TYR . 0.6 OUTLIER -84.39 54.92 3.16 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.133 -0.98 . . . . 0.0 109.489 -179.61 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.449 ' HA ' ' OG1' ' A' ' 33' ' ' THR . 7.3 ttmt -175.91 -42.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.428 -0.795 . . . . 0.0 109.033 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 -83.25 -45.69 13.54 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.36 -0.838 . . . . 0.0 109.105 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.553 ' O ' ' HB2' ' A' ' 10' ' ' ALA . . . 103.32 32.64 4.51 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.477 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 2.2 pp -140.52 162.21 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.108 -1.231 . . . . 0.0 109.692 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.465 ' HB3' ' HA ' ' A' ' 62' ' ' PHE . 1.1 pt? -143.6 164.16 31.19 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.301 -0.875 . . . . 0.0 108.982 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.496 ' O ' ' HG ' ' A' ' 61' ' ' LEU . 7.7 p . . . . . 0 N--CA 1.489 1.509 0 O-C-N 121.12 -0.987 . . . . 0.0 109.577 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.59 ' CZ3' ' HB2' ' A' ' 18' ' ' ARG . 71.2 m95 . . . . . 0 N--CA 1.49 1.536 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 17' ' ' ARG . 0.2 OUTLIER -110.01 148.74 31.1 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.237 -0.914 . . . . 0.0 109.527 179.921 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.413 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 0.6 OUTLIER -47.43 147.32 1.71 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.203 -0.936 . . . . 0.0 109.49 -179.884 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.532 ' HB2' ' HB3' ' A' ' 15' ' ' TRP . 6.1 m -89.69 114.46 60.69 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.344 -0.848 . . . . 0.0 109.818 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.451 ' HD2' ' HD3' ' A' ' 17' ' ' ARG . 36.0 Cg_endo -79.04 -39.51 0.34 Allowed 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.362 2.041 . . . . 0.0 110.371 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.499 ' HB2' ' O ' ' A' ' 67' ' ' GLY . . . -64.58 -46.26 83.45 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.213 -0.93 . . . . 0.0 109.595 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 1.01 HD12 ' CD1' ' A' ' 15' ' ' TRP . 6.8 mt -90.12 -48.06 7.42 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.117 -0.989 . . . . 0.0 109.776 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 129.81 -153.26 19.93 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -77.41 155.81 32.44 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.732 2.288 . . . . 0.0 110.497 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.71 -26.66 8.0 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.229 -1.549 . . . . 0.0 109.229 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 1.01 ' CD1' HD12 ' A' ' 11' ' ' LEU . 8.7 t-105 -101.74 132.8 47.26 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.345 -1.091 . . . . 0.0 108.9 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.423 ' C ' ' SG ' ' A' ' 8' ' ' CYS . 14.5 mptt -106.39 129.24 54.42 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.191 -0.943 . . . . 0.0 110.078 -179.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.601 ' HG3' ' CE2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -105.27 113.25 26.72 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.376 -0.828 . . . . 0.0 109.097 179.611 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.59 ' HB2' ' CZ3' ' A' ' 5' ' ' TRP . 0.1 OUTLIER -100.16 144.44 29.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.365 -0.834 . . . . 0.0 109.588 -179.728 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -130.83 131.06 44.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.341 -0.849 . . . . 0.0 109.197 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.519 ' O ' ' N ' ' A' ' 32' ' ' ASP . 14.5 t . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.205 -0.934 . . . . 0.0 109.514 -179.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.519 ' N ' ' O ' ' A' ' 20' ' ' VAL . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.6 m -137.82 109.28 6.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.11 -0.994 . . . . 0.0 109.829 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.575 ' CE1' ' HD2' ' A' ' 44' ' ' ARG . 8.8 m-30 -109.11 160.25 16.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.338 -0.851 . . . . 0.0 108.748 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.601 ' CE2' ' HG3' ' A' ' 17' ' ' ARG . 19.6 m-85 -131.76 145.56 51.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.047 -1.033 . . . . 0.0 109.776 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.436 ' HA ' ' O ' ' A' ' 41' ' ' ASP . 0.9 OUTLIER -133.17 130.44 39.15 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.286 -0.884 . . . . 0.0 109.248 179.931 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.427 ' HA ' ' CZ3' ' A' ' 15' ' ' TRP . 0.8 OUTLIER -71.54 170.42 12.04 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.247 -0.908 . . . . 0.0 109.386 -179.951 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.422 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 35.9 Cg_endo -78.27 5.61 5.32 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.592 2.195 . . . . 0.0 110.457 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.3 p -113.09 -23.03 10.24 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.251 -0.905 . . . . 0.0 109.227 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 125.47 23.36 1.72 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.836 -1.305 . . . . 0.0 109.836 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.573 ' OD2' ' CE1' ' A' ' 52' ' ' TYR . 2.8 t70 -87.73 136.16 33.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.153 -1.204 . . . . 0.0 109.07 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.96 100.71 7.74 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.219 -0.925 . . . . 0.0 109.844 -179.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.626 HG21 ' CA ' ' A' ' 49' ' ' LEU . 3.3 mt -112.87 154.09 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.404 -0.81 . . . . 0.0 109.146 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.575 ' HD2' ' CE1' ' A' ' 34' ' ' TYR . 8.1 ttp180 -129.02 -2.76 5.15 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.108 -0.995 . . . . 0.0 109.981 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.753 ' O ' HD23 ' A' ' 49' ' ' LEU . 5.8 t -88.57 173.27 8.74 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.23 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.553 ' HA ' ' CE1' ' A' ' 64' ' ' PHE . 5.6 ttpm? -91.98 -60.49 1.84 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.894 -1.129 . . . . 0.0 110.113 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.443 ' O ' ' CG ' ' A' ' 51' ' ' ARG . 77.6 t -81.48 -22.04 10.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.01 -1.057 . . . . 0.0 109.33 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.554 ' HB2' ' CB ' ' A' ' 45' ' ' SER . 1.2 tt0 -66.21 -45.95 78.96 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 178.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.824 HD13 ' CZ2' ' A' ' 15' ' ' TRP . 1.7 pp -69.95 -22.53 63.16 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.705 ' OG1' HD13 ' A' ' 59' ' ' LEU . 25.5 m -69.09 -69.11 0.35 Allowed 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 178.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.443 ' CG ' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -44.15 -28.45 0.5 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.494 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.573 ' CE1' ' OD2' ' A' ' 41' ' ' ASP . 87.5 t80 -59.23 -60.02 4.52 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.173 -0.954 . . . . 0.0 108.845 179.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.871 HD21 ' CE3' ' A' ' 15' ' ' TRP . 1.0 OUTLIER -52.7 -54.8 28.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.305 -0.872 . . . . 0.0 109.265 179.616 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 137.43 -162.74 25.44 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.44 -5.51 15.64 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.559 2.173 . . . . 0.0 110.192 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.19 -26.93 53.37 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.387 -0.82 . . . . 0.0 109.396 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 1.1 m -109.55 -171.61 1.88 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.302 -0.874 . . . . 0.0 109.323 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.886 ' C ' HD12 ' A' ' 59' ' ' LEU . 6.9 t0 -178.81 149.43 0.46 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.909 . . . . 0.0 109.655 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.886 HD12 ' C ' ' A' ' 58' ' ' ASP . 5.5 mp -153.86 14.46 0.47 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.187 -0.945 . . . . 0.0 109.705 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.521 HG22 ' CD2' ' A' ' 61' ' ' LEU . 98.4 m -47.94 -39.88 20.48 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.122 -0.987 . . . . 0.0 109.16 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.574 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 1.3 mm? -104.42 -14.05 15.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.396 -0.815 . . . . 0.0 109.229 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.761 ' CD2' HD23 ' A' ' 59' ' ' LEU . 64.6 t80 -44.96 156.19 0.09 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.441 -0.787 . . . . 0.0 109.811 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.499 ' O ' ' N ' ' A' ' 65' ' ' LYS . 5.1 m-20 -109.34 108.35 18.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.282 -0.887 . . . . 0.0 109.403 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.575 ' CZ ' ' O ' ' A' ' 44' ' ' ARG . 0.9 OUTLIER -67.48 61.72 0.06 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.405 -0.809 . . . . 0.0 109.03 179.964 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.499 ' N ' ' O ' ' A' ' 63' ' ' ASP . 0.7 OUTLIER 173.75 -28.11 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.319 -0.863 . . . . 0.0 109.69 -179.738 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -103.75 -26.45 12.73 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.125 -0.984 . . . . 0.0 110.11 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.502 ' CA ' ' NH2' ' A' ' 17' ' ' ARG . . . 85.53 30.26 24.9 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.686 -1.365 . . . . 0.0 109.686 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.511 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 1.9 pp -140.09 173.2 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.226 -1.161 . . . . 0.0 109.517 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.498 ' HB3' ' HA ' ' A' ' 62' ' ' PHE . 0.8 OUTLIER -150.38 -168.48 3.12 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.393 -0.817 . . . . 0.0 109.416 179.984 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.219 -0.926 . . . . 0.0 109.358 179.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.584 ' CE3' ' HB2' ' A' ' 18' ' ' ARG . 84.2 m95 . . . . . 0 N--CA 1.489 1.486 0 CA-C-O 121.253 0.549 . . . . 0.0 109.695 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 79.6 mt -112.69 154.05 26.72 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.27 -0.894 . . . . 0.0 109.366 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.495 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 0.4 OUTLIER -49.01 139.52 10.25 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.232 -0.918 . . . . 0.0 108.897 179.704 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.484 ' HG ' ' HE2' ' A' ' 35' ' ' TYR . 44.0 t -91.04 111.94 51.07 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.219 -0.925 . . . . 0.0 109.696 -179.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.495 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 36.7 Cg_endo -79.63 -48.68 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.255 1.97 . . . . 0.0 109.975 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.647 ' HB3' ' CE2' ' A' ' 62' ' ' PHE . . . -50.15 -35.44 26.03 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.398 -0.814 . . . . 0.0 109.476 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 1.138 HD12 ' CD1' ' A' ' 15' ' ' TRP . 14.5 mt -98.16 -64.98 0.99 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.262 -0.899 . . . . 0.0 109.555 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 8' ' ' CYS . . . 158.61 -158.88 29.72 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -76.77 159.91 34.63 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.551 2.167 . . . . 0.0 110.402 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.91 -68.15 3.54 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 -179.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 1.138 ' CD1' HD12 ' A' ' 11' ' ' LEU . 26.9 t-105 -49.87 128.64 18.82 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.296 -1.12 . . . . 0.0 108.82 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.3 mmtm -99.33 120.83 40.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.118 -0.989 . . . . 0.0 109.552 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.583 ' CZ ' ' CA ' ' A' ' 67' ' ' GLY . 23.7 ttt-85 -93.4 105.11 17.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.366 -0.834 . . . . 0.0 109.295 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.792 HH11 HG22 ' A' ' 20' ' ' VAL . 1.2 tmm_? -100.23 152.21 20.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.206 -0.934 . . . . 0.0 110.055 -179.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -137.98 155.13 49.18 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.792 HG22 HH11 ' A' ' 18' ' ' ARG . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.642 0 O-C-N 120.983 -1.073 . . . . 0.0 109.735 -179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.505 HG23 ' O ' ' A' ' 18' ' ' ARG . 93.6 m -137.96 134.37 34.84 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.065 -1.022 . . . . 0.0 109.956 -179.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.44 ' CD1' ' O ' ' A' ' 33' ' ' THR . 18.1 m-85 -136.04 153.94 51.2 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.365 -0.834 . . . . 0.0 109.077 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.559 ' CE2' ' HG3' ' A' ' 17' ' ' ARG . 27.5 m-85 -121.02 161.51 21.53 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.996 -1.065 . . . . 0.0 109.752 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.58 ' HB2' ' CZ3' ' A' ' 5' ' ' TRP . 0.1 OUTLIER -128.13 115.29 18.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.289 -0.882 . . . . 0.0 109.287 179.723 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.805 ' HG ' HG22 ' A' ' 39' ' ' THR . 0.8 OUTLIER -53.44 176.41 0.11 Allowed Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.354 -0.841 . . . . 0.0 109.24 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.546 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 35.4 Cg_endo -77.62 -8.88 17.18 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.442 2.095 . . . . 0.0 110.25 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.805 HG22 ' HG ' ' A' ' 37' ' ' SER . 12.9 t -110.17 -16.08 13.85 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.231 -0.918 . . . . 0.0 109.545 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 121.03 20.63 3.33 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.444 ' CB ' ' HB3' ' A' ' 37' ' ' SER . 0.2 OUTLIER -89.73 101.87 14.57 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.197 -1.178 . . . . 0.0 109.249 179.877 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.41 126.26 30.59 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.278 -0.889 . . . . 0.0 108.845 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.701 HG21 ' HB3' ' A' ' 49' ' ' LEU . 0.9 OUTLIER -116.47 162.61 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.148 -0.97 . . . . 0.0 110.348 -179.121 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.588 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 0.0 OUTLIER -131.83 -21.83 2.41 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.546 -0.721 . . . . 0.0 110.094 -179.909 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.477 ' HB2' ' HB2' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -99.9 119.2 37.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.886 -1.134 . . . . 0.0 109.269 179.865 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.567 ' HA ' HD21 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -46.89 -46.69 21.32 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.382 -0.824 . . . . 0.0 110.501 -179.442 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.439 ' HA ' ' HB ' ' A' ' 50' ' ' THR . 73.5 t -74.79 -41.7 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.851 -1.156 . . . . 0.0 109.317 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.488 ' O ' ' HG3' ' A' ' 51' ' ' ARG . 28.4 tt0 -48.53 -49.94 34.03 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.204 -0.935 . . . . 0.0 109.445 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.729 ' O ' HD12 ' A' ' 53' ' ' LEU . 1.1 pp -72.67 -34.92 67.56 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.941 -1.1 . . . . 0.0 108.739 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.766 ' OG1' HD12 ' A' ' 59' ' ' LEU . 0.4 OUTLIER -54.63 -54.66 38.56 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.047 -1.033 . . . . 0.0 108.413 179.124 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.576 ' N ' HG22 ' A' ' 50' ' ' THR . 0.0 OUTLIER -67.97 -16.63 64.14 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.335 -0.853 . . . . 0.0 108.937 179.496 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.495 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 24.7 t80 -71.51 -56.15 6.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.278 -0.889 . . . . 0.0 109.058 179.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.97 HD21 ' CE3' ' A' ' 15' ' ' TRP . 0.4 OUTLIER -66.87 -48.84 67.55 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.199 -0.938 . . . . 0.0 108.983 179.523 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 138.64 -153.88 22.81 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.91 -26.9 6.28 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.55 2.167 . . . . 0.0 110.294 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.47 -27.28 65.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.346 -0.846 . . . . 0.0 109.357 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.693 ' CB ' HD13 ' A' ' 53' ' ' LEU . 6.0 m -121.0 104.54 9.88 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.276 -0.89 . . . . 0.0 109.308 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.465 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 0.4 OUTLIER -100.4 158.66 15.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.297 -0.877 . . . . 0.0 109.405 -179.903 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.766 HD12 ' OG1' ' A' ' 50' ' ' THR . 0.7 OUTLIER -151.8 19.68 0.7 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.206 -0.934 . . . . 0.0 109.414 179.932 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.601 ' C ' HD22 ' A' ' 61' ' ' LEU . 28.6 m -49.95 -40.25 43.16 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.312 -0.867 . . . . 0.0 109.724 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.601 HD22 ' C ' ' A' ' 60' ' ' THR . 1.2 mm? -112.09 2.56 16.84 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.267 -0.896 . . . . 0.0 109.887 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.717 ' CG ' HD23 ' A' ' 59' ' ' LEU . 2.4 t80 -52.44 125.27 15.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.193 -0.942 . . . . 0.0 110.037 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.523 ' O ' ' N ' ' A' ' 65' ' ' LYS . 1.4 t0 -84.77 97.84 9.92 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.588 ' CE2' ' O ' ' A' ' 44' ' ' ARG . 0.7 OUTLIER -65.7 68.14 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.344 -0.848 . . . . 0.0 109.14 -179.243 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 63' ' ' ASP . 7.9 mtpt 174.82 -41.49 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.43 -0.794 . . . . 0.0 108.94 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -93.44 -39.65 10.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.358 -0.839 . . . . 0.0 109.092 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.583 ' CA ' ' CZ ' ' A' ' 17' ' ' ARG . . . 99.71 34.08 5.08 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 pp -140.52 151.04 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.053 -1.263 . . . . 0.0 110.059 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.503 ' HB3' ' HA ' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -139.59 160.52 39.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.326 -0.859 . . . . 0.0 109.179 179.305 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 1.7 p . . . . . 0 N--CA 1.49 1.568 0 O-C-N 121.15 -0.968 . . . . 0.0 109.602 179.995 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.432 ' CZ3' ' HB2' ' A' ' 36' ' ' GLN . 75.3 m95 . . . . . 0 N--CA 1.488 1.472 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 17' ' ' ARG . 0.7 OUTLIER -115.92 158.63 22.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.236 -0.915 . . . . 0.0 109.52 -179.801 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.408 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 12.5 m-20 -50.71 145.36 6.97 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.198 -0.938 . . . . 0.0 109.453 179.96 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.482 ' HA ' ' HB2' ' A' ' 17' ' ' ARG . 42.3 t -89.45 114.5 60.71 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.224 -0.923 . . . . 0.0 109.664 -179.869 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 35.8 Cg_endo -78.47 -55.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.284 1.99 . . . . 0.0 110.443 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.837 ' HB3' ' CE2' ' A' ' 62' ' ' PHE . . . -48.14 -39.21 19.94 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.315 -0.866 . . . . 0.0 109.937 -179.742 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.899 HD12 ' CD1' ' A' ' 15' ' ' TRP . 11.2 mt -94.18 -60.69 1.68 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.047 -1.033 . . . . 0.0 109.693 -179.996 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 8' ' ' CYS . . . 147.88 -148.76 20.57 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.854 -1.299 . . . . 0.0 109.854 -179.932 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.42 159.29 32.68 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.621 2.214 . . . . 0.0 110.845 -179.652 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.17 -70.27 3.14 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.825 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 0.899 ' CD1' HD12 ' A' ' 11' ' ' LEU . 14.2 t-105 -50.39 126.24 14.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.24 -1.153 . . . . 0.0 109.728 -179.861 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.0 mmtm -98.89 110.56 23.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.208 -0.932 . . . . 0.0 109.227 179.723 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.608 ' HG3' ' CE1' ' A' ' 35' ' ' TYR . 8.6 ttt-85 -89.13 105.02 17.52 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.389 -0.82 . . . . 0.0 109.863 -179.55 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.49 ' HB3' ' O ' ' A' ' 34' ' ' TYR . 11.9 ttt180 -94.94 138.54 32.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.924 . . . . 0.0 109.194 179.638 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -119.92 147.11 45.13 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.279 -0.888 . . . . 0.0 109.465 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.538 HG12 ' O ' ' A' ' 20' ' ' VAL . 84.5 t . . . . . 0 N--CA 1.489 1.511 0 O-C-N 121.292 -0.88 . . . . 0.0 109.131 179.902 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.577 ' HB3' ' CE1' ' A' ' 34' ' ' TYR . 7.5 m-20 . . . . . 0 N--CA 1.49 1.546 0 N-CA-C 109.218 -0.66 . . . . 0.0 109.218 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.537 ' O ' ' CE1' ' A' ' 64' ' ' PHE . 0.0 OUTLIER -137.15 128.01 27.33 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.163 -0.96 . . . . 0.0 109.986 -179.658 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.577 ' CE1' ' HB3' ' A' ' 32' ' ' ASP . 1.1 m-85 -124.8 141.17 52.3 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.388 -0.82 . . . . 0.0 109.008 179.531 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.643 ' HD2' HD22 ' A' ' 49' ' ' LEU . 9.7 m-85 -118.17 143.9 46.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.004 -1.06 . . . . 0.0 109.751 -179.767 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.432 ' HB2' ' CZ3' ' A' ' 5' ' ' TRP . 8.7 tp-100 -117.86 134.43 54.94 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.371 -0.831 . . . . 0.0 109.474 179.931 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.454 ' OG ' ' HB3' ' A' ' 41' ' ' ASP . 0.0 OUTLIER -81.92 171.77 11.21 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.354 -0.841 . . . . 0.0 109.172 179.852 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.435 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 35.6 Cg_endo -78.01 6.13 4.85 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.486 2.124 . . . . 0.0 110.343 179.841 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.9 p -114.31 -9.92 12.75 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.185 -0.947 . . . . 0.0 109.409 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 102.82 17.3 19.29 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.894 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.567 ' OD2' ' CE1' ' A' ' 52' ' ' TYR . 19.5 t0 -96.61 111.0 23.31 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.135 -1.215 . . . . 0.0 109.327 179.805 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.88 121.63 31.43 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.277 -0.889 . . . . 0.0 109.778 -179.715 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.578 HG21 ' CA ' ' A' ' 49' ' ' LEU . 3.9 mt -121.72 150.02 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.344 -0.847 . . . . 0.0 109.202 179.74 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.569 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 1.8 ttp180 -128.51 -6.59 5.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.233 -0.917 . . . . 0.0 109.94 179.758 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.572 ' HB3' ' CB ' ' A' ' 48' ' ' GLU . 12.9 t -90.29 142.66 27.51 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.093 -1.005 . . . . 0.0 108.923 179.598 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.504 ' HG2' ' N ' ' A' ' 47' ' ' VAL . 21.0 ttpt -63.97 -74.79 0.09 Allowed 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.338 -0.851 . . . . 0.0 110.862 -178.692 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.504 ' N ' ' HG2' ' A' ' 46' ' ' LYS . 58.3 t -62.16 -26.81 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.218 -0.926 . . . . 0.0 110.604 -178.431 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.572 ' CB ' ' HB3' ' A' ' 45' ' ' SER . 1.7 tt0 -66.45 -52.14 49.47 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.697 -1.252 . . . . 0.0 109.059 179.861 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.752 HD12 HD11 ' A' ' 53' ' ' LEU . 1.3 pp -63.51 -23.3 67.33 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.331 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.539 ' CG2' ' HB2' ' A' ' 59' ' ' LEU . 25.2 m -67.86 -70.83 0.24 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.235 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.469 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 0.1 OUTLIER -46.95 -24.43 0.61 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.402 -0.811 . . . . 0.0 109.131 179.975 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.567 ' CE1' ' OD2' ' A' ' 41' ' ' ASP . 69.8 t80 -62.96 -55.8 22.66 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.279 -0.888 . . . . 0.0 109.439 179.761 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.752 HD11 HD12 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -65.78 -50.0 66.29 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.178 -0.951 . . . . 0.0 109.344 179.996 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 121.23 -152.79 16.74 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 -179.697 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.9 -9.51 16.85 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.553 2.169 . . . . 0.0 110.462 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.96 -24.86 58.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.299 -0.875 . . . . 0.0 109.3 179.9 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.442 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 54.5 m -127.98 94.77 4.01 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.292 -0.88 . . . . 0.0 109.0 179.741 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.456 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 2.2 m-20 -76.91 157.26 31.47 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.347 -0.846 . . . . 0.0 110.168 -179.343 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.932 HD23 ' CB ' ' A' ' 62' ' ' PHE . 1.2 mp -152.09 39.56 0.6 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.538 -0.726 . . . . 0.0 109.062 -179.709 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.947 ' O ' HD23 ' A' ' 61' ' ' LEU . 0.1 OUTLIER -38.51 -44.72 0.97 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.669 -0.644 . . . . 0.0 110.421 -179.447 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.947 HD23 ' O ' ' A' ' 60' ' ' THR . 10.8 mt -142.35 33.41 1.49 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.096 -1.002 . . . . 0.0 109.759 -179.813 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.932 ' CB ' HD23 ' A' ' 59' ' ' LEU . 10.9 t80 -47.27 117.35 1.71 Allowed 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.283 -0.885 . . . . 0.0 109.617 179.907 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.511 ' O ' ' N ' ' A' ' 65' ' ' LYS . 1.5 m-20 -79.42 102.34 8.67 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.388 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.569 ' CE2' ' O ' ' A' ' 44' ' ' ARG . 0.1 OUTLIER -67.35 62.07 0.06 Allowed 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.292 -0.88 . . . . 0.0 109.568 -178.914 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.511 ' N ' ' O ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER 171.82 -30.48 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.285 -0.884 . . . . 0.0 109.51 179.895 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -99.58 -42.77 6.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.204 -0.935 . . . . 0.0 109.411 179.843 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.469 ' HA2' ' NE ' ' A' ' 17' ' ' ARG . . . 101.78 30.79 5.67 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.733 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.459 HD11 ' OD2' ' A' ' 63' ' ' ASP . 2.4 pp -140.21 178.45 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.246 -1.149 . . . . 0.0 109.573 179.994 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.549 ' HB3' ' HA ' ' A' ' 62' ' ' PHE . 0.8 OUTLIER -164.7 -176.79 4.44 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.334 -0.854 . . . . 0.0 109.427 179.809 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.64 ' HB3' HD12 ' A' ' 61' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.28 -0.888 . . . . 0.0 109.537 179.693 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.579 ' CE3' ' HB2' ' A' ' 18' ' ' ARG . 73.7 m95 . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.425 ' O ' ' C ' ' A' ' 7' ' ' ASP . 0.5 OUTLIER -106.93 147.88 29.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.216 -0.927 . . . . 0.0 109.702 -179.757 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.484 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 12.3 m-20 -43.85 130.04 5.69 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.294 -0.879 . . . . 0.0 109.257 179.819 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.52 ' SG ' ' CZ ' ' A' ' 17' ' ' ARG . 12.2 t -86.56 113.37 52.4 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.294 -0.878 . . . . 0.0 109.583 -179.796 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 36.6 Cg_endo -80.62 -47.97 0.07 OUTLIER 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 122.411 2.074 . . . . 0.0 110.33 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.645 ' HB3' ' NH1' ' A' ' 17' ' ' ARG . . . -41.66 -35.58 0.79 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.327 -0.858 . . . . 0.0 109.85 -179.716 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.863 HD12 ' CD1' ' A' ' 15' ' ' TRP . 14.7 mt -106.1 -65.94 1.03 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.176 -0.952 . . . . 0.0 109.659 -179.873 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 153.5 -150.91 22.7 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.949 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.7 153.55 30.02 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.651 2.234 . . . . 0.0 110.535 -179.9 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.436 ' O ' ' HD3' ' A' ' 38' ' ' PRO . . . 90.18 -24.98 13.49 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.854 -1.299 . . . . 0.0 109.854 179.667 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 0.863 ' CD1' HD12 ' A' ' 11' ' ' LEU . 10.9 t-105 -98.74 133.38 43.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.176 -1.191 . . . . 0.0 109.752 -179.749 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.458 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 26.1 mmtp -105.67 116.87 32.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.246 -0.909 . . . . 0.0 109.546 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.645 ' NH1' ' HB3' ' A' ' 10' ' ' ALA . 0.4 OUTLIER -89.97 103.82 16.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.156 -0.965 . . . . 0.0 109.228 179.869 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.579 ' HB2' ' CE3' ' A' ' 5' ' ' TRP . 2.0 ttm180 -97.12 140.62 31.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.244 -0.91 . . . . 0.0 110.006 -179.537 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 21.8 pt-20 -138.45 132.65 31.65 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.309 -0.869 . . . . 0.0 109.026 179.582 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.531 HG12 ' O ' ' A' ' 20' ' ' VAL . 16.3 t . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.179 -0.951 . . . . 0.0 109.719 -179.681 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.564 ' HB3' ' CZ ' ' A' ' 34' ' ' TYR . 22.3 m-20 . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.339 0.59 . . . . 0.0 109.557 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.494 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 0.0 OUTLIER -127.61 90.92 3.2 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.276 -0.89 . . . . 0.0 109.595 -179.966 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.567 ' CD1' ' HG2' ' A' ' 44' ' ' ARG . 10.4 m-85 -99.68 140.66 33.55 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.309 -0.87 . . . . 0.0 109.086 179.758 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.598 ' HD2' HD22 ' A' ' 49' ' ' LEU . 4.8 m-85 -116.58 158.21 24.06 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.214 -0.929 . . . . 0.0 109.99 -179.324 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -138.88 121.74 16.57 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.477 -0.764 . . . . 0.0 109.229 179.904 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.486 ' HB2' ' HD2' ' A' ' 38' ' ' PRO . 1.1 p -73.68 173.61 6.04 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.331 -0.856 . . . . 0.0 109.253 179.911 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.486 ' HD2' ' HB2' ' A' ' 37' ' ' SER . 36.2 Cg_endo -79.38 9.7 3.31 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.664 2.242 . . . . 0.0 110.662 -179.871 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.4 p -120.24 12.53 11.8 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.097 -1.002 . . . . 0.0 109.83 -179.76 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 85.47 18.92 59.46 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.811 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.504 ' OD2' ' CE2' ' A' ' 52' ' ' TYR . 44.0 t0 -97.21 114.14 25.83 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.205 -1.174 . . . . 0.0 109.339 179.84 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.406 ' C ' HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -108.3 135.94 48.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.189 -0.944 . . . . 0.0 109.814 -179.726 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.62 HD13 ' HB2' ' A' ' 49' ' ' LEU . 2.4 mp -138.28 156.72 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.277 -0.889 . . . . 0.0 109.292 179.81 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.58 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 0.3 OUTLIER -140.69 17.6 2.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.132 -0.98 . . . . 0.0 109.739 -179.994 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.541 ' H ' HG22 ' A' ' 43' ' ' ILE . 0.6 OUTLIER -91.4 -87.21 0.21 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.202 -0.936 . . . . 0.0 108.805 179.445 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.534 ' CB ' ' O ' ' A' ' 45' ' ' SER . 4.9 ttpp 159.4 -60.49 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 179.632 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.41 HG23 ' HE3' ' A' ' 46' ' ' LYS . 26.9 t -87.71 -20.67 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.389 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -69.61 -42.92 73.73 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.802 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.726 ' O ' HD12 ' A' ' 53' ' ' LEU . 2.8 pp -75.99 -32.65 59.55 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.951 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.694 ' OG1' HD12 ' A' ' 59' ' ' LEU . 0.4 OUTLIER -64.01 -42.99 96.96 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 178.687 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.42 ' N ' HG22 ' A' ' 50' ' ' THR . 5.7 mmt85 -66.02 -26.61 67.6 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.18 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.504 ' CE2' ' OD2' ' A' ' 41' ' ' ASP . 28.8 t80 -68.53 -62.66 1.29 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.515 -0.741 . . . . 0.0 109.308 179.87 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.729 HD21 ' CE3' ' A' ' 15' ' ' TRP . 0.7 OUTLIER -53.74 -54.26 40.52 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.193 -0.942 . . . . 0.0 109.222 179.797 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 137.62 -156.33 23.55 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -179.807 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.35 -6.43 15.56 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.581 2.188 . . . . 0.0 110.442 179.915 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -78.44 -23.53 46.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.196 -0.94 . . . . 0.0 109.568 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.459 ' HB2' HD13 ' A' ' 53' ' ' LEU . 91.1 m -129.79 98.08 4.69 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.248 -0.908 . . . . 0.0 109.534 -179.911 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.19 148.05 22.36 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.214 -0.929 . . . . 0.0 109.49 -179.933 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 1.025 HD23 ' CD2' ' A' ' 62' ' ' PHE . 0.4 OUTLIER -138.78 16.94 2.68 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.374 -0.829 . . . . 0.0 109.18 -179.98 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.602 ' C ' HD22 ' A' ' 61' ' ' LEU . 2.8 m -50.1 -50.32 48.69 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.429 -0.794 . . . . 0.0 109.579 -179.968 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.666 HD22 ' N ' ' A' ' 61' ' ' LEU . 3.6 mm? -100.89 11.37 39.72 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.292 -0.88 . . . . 0.0 109.676 -179.704 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 1.025 ' CD2' HD23 ' A' ' 59' ' ' LEU . 70.9 t80 -68.86 129.68 40.62 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.233 -0.917 . . . . 0.0 109.826 -179.754 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.509 ' O ' ' N ' ' A' ' 65' ' ' LYS . 3.0 t0 -82.32 103.43 11.89 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.331 -0.855 . . . . 0.0 108.973 179.555 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.58 ' CE1' ' CE2' ' A' ' 35' ' ' TYR . 0.8 OUTLIER -67.44 67.74 0.09 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.126 -0.984 . . . . 0.0 109.126 -179.616 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.509 ' N ' ' O ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER 171.23 -32.43 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -179.899 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -95.15 -46.32 6.83 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.344 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.538 ' HA2' ' CE1' ' A' ' 62' ' ' PHE . . . 104.48 30.13 5.09 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 179.426 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.478 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 1.1 pp -141.01 162.02 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.898 -1.354 . . . . 0.0 110.106 179.845 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.551 ' N ' HD23 ' A' ' 69' ' ' LEU . 1.5 pt? -151.83 164.78 36.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.327 -0.858 . . . . 0.0 109.364 179.973 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 6.1 p . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.204 -0.935 . . . . 0.0 109.269 179.704 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.586 ' CZ2' ' HD3' ' A' ' 18' ' ' ARG . 93.0 m95 . . . . . 0 N--CA 1.488 1.467 0 N-CA-C 109.373 -0.603 . . . . 0.0 109.373 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -99.36 166.39 11.22 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.239 -0.913 . . . . 0.0 109.488 -179.816 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.48 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 0.7 OUTLIER -66.72 145.27 55.73 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.242 -0.911 . . . . 0.0 109.1 179.711 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.507 ' SG ' ' N ' ' A' ' 17' ' ' ARG . 13.8 m -87.57 112.98 52.08 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.277 -0.89 . . . . 0.0 109.74 -179.595 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.48 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 36.3 Cg_endo -79.51 -40.87 0.23 Allowed 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.239 1.96 . . . . 0.0 109.749 179.441 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.904 ' HB3' ' NH1' ' A' ' 17' ' ' ARG . . . -61.4 -53.27 58.79 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.429 -0.794 . . . . 0.0 109.782 -179.951 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 1.031 HD12 ' CD1' ' A' ' 15' ' ' TRP . 6.6 mt -82.46 -47.94 11.65 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.164 -0.96 . . . . 0.0 109.676 -179.751 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 130.02 -148.18 18.39 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -76.71 155.59 35.2 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.624 2.216 . . . . 0.0 110.717 -179.879 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.91 -46.33 3.1 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.963 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 1.031 ' CD1' HD12 ' A' ' 11' ' ' LEU . 5.1 t-105 -80.31 131.14 35.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.259 -1.142 . . . . 0.0 110.074 -179.621 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.423 ' C ' ' SG ' ' A' ' 8' ' ' CYS . 17.5 mmtp -105.65 126.88 52.66 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.3 -0.875 . . . . 0.0 109.365 179.696 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.904 ' NH1' ' HB3' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -99.12 107.47 19.85 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.294 -0.879 . . . . 0.0 109.587 -179.713 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.586 ' HD3' ' CZ2' ' A' ' 5' ' ' TRP . 25.1 ttp180 -100.54 143.72 30.38 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.247 -0.908 . . . . 0.0 109.853 -179.887 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -113.58 149.47 34.45 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.311 -0.868 . . . . 0.0 109.326 179.64 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.821 HG21 ' CE2' ' A' ' 34' ' ' TYR . 13.6 t . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.213 -0.93 . . . . 0.0 109.55 -179.981 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.476 ' HB2' ' CZ ' ' A' ' 34' ' ' TYR . 4.7 m-20 . . . . . 0 N--CA 1.489 1.518 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.448 HG22 ' CE1' ' A' ' 35' ' ' TYR . 5.6 m -136.98 121.86 18.8 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.153 -0.967 . . . . 0.0 110.105 -179.444 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.821 ' CE2' HG21 ' A' ' 20' ' ' VAL . 1.4 m-85 -123.3 149.22 45.08 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.292 -0.88 . . . . 0.0 108.717 179.168 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.677 ' HD2' HD22 ' A' ' 49' ' ' LEU . 7.2 m-85 -113.91 150.87 33.08 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.933 -1.105 . . . . 0.0 109.809 -179.89 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.46 ' HB2' ' CZ3' ' A' ' 5' ' ' TRP . 12.4 tt0 -129.79 124.88 34.45 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.331 -0.856 . . . . 0.0 109.595 -179.835 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.508 ' HB3' ' HD2' ' A' ' 38' ' ' PRO . 0.9 OUTLIER -71.3 173.15 5.38 Favored Pre-proline 0 N--CA 1.488 1.437 0 O-C-N 121.347 -0.845 . . . . 0.0 109.04 179.785 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.508 ' HD2' ' HB3' ' A' ' 37' ' ' SER . 34.9 Cg_endo -78.34 8.82 3.4 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.55 2.167 . . . . 0.0 110.9 -179.895 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.417 HG22 ' HB2' ' A' ' 37' ' ' SER . 15.3 t -115.55 -24.37 8.35 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.013 -1.054 . . . . 0.0 109.514 179.899 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 122.73 16.09 3.8 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.36 111.24 23.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.158 -1.201 . . . . 0.0 109.674 -179.924 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.69 148.59 22.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.191 -0.943 . . . . 0.0 109.34 179.79 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.562 ' CG2' ' HB3' ' A' ' 49' ' ' LEU . 4.5 mp -140.39 158.27 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.11 -0.994 . . . . 0.0 109.921 -179.825 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.514 ' HA ' ' CZ ' ' A' ' 64' ' ' PHE . 0.9 OUTLIER -137.05 -8.63 1.79 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.249 -0.907 . . . . 0.0 110.737 -179.778 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.543 ' CB ' ' HB2' ' A' ' 48' ' ' GLU . 0.6 OUTLIER -63.48 -86.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.782 -1.199 . . . . 0.0 109.334 179.905 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.502 ' HB2' ' O ' ' A' ' 45' ' ' SER . 42.7 tttm 161.97 -63.99 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 -179.769 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 75.0 t -87.94 -19.98 7.59 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 178.518 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.543 ' HB2' ' CB ' ' A' ' 45' ' ' SER . 2.8 mt-10 -66.83 -43.62 83.29 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.353 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.677 HD22 ' HD2' ' A' ' 35' ' ' TYR . 1.9 pp -70.07 -23.63 63.1 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 178.647 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.861 ' OG1' HD13 ' A' ' 59' ' ' LEU . 30.3 m -70.96 -64.48 0.9 Allowed 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.969 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -49.73 -29.46 7.66 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.361 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.431 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 86.2 t80 -57.82 -60.93 2.95 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.377 -0.827 . . . . 0.0 108.909 179.417 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 1.007 HD21 ' CE3' ' A' ' 15' ' ' TRP . 0.4 OUTLIER -58.17 -51.94 67.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.287 -0.883 . . . . 0.0 109.221 179.576 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 133.19 -154.1 21.05 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.394 -1.483 . . . . 0.0 109.394 -179.914 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.76 -17.93 13.72 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.614 2.209 . . . . 0.0 110.176 179.752 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.57 -24.47 66.35 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.31 -0.869 . . . . 0.0 109.507 179.925 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.485 ' CB ' HD13 ' A' ' 53' ' ' LEU . 1.7 m -117.13 156.15 28.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.242 -0.911 . . . . 0.0 109.517 179.991 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.793 ' C ' HD12 ' A' ' 59' ' ' LEU . 62.0 t0 -149.22 147.95 29.02 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.334 -0.854 . . . . 0.0 109.291 179.937 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.889 HD23 ' CD1' ' A' ' 62' ' ' PHE . 5.7 mp -148.51 17.56 1.03 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.188 -0.945 . . . . 0.0 109.489 -179.64 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.632 ' C ' HD22 ' A' ' 61' ' ' LEU . 3.6 m -42.52 -49.25 5.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.422 -0.799 . . . . 0.0 109.29 -179.876 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.632 HD22 ' C ' ' A' ' 60' ' ' THR . 1.2 mm? -113.09 18.64 17.85 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.395 -0.816 . . . . 0.0 109.455 -179.92 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.889 ' CD1' HD23 ' A' ' 59' ' ' LEU . 9.8 t80 -77.24 133.97 38.72 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.315 -0.866 . . . . 0.0 109.289 179.945 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.569 ' O ' ' CE1' ' A' ' 62' ' ' PHE . 0.9 OUTLIER -84.92 136.08 33.78 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.355 -0.84 . . . . 0.0 109.211 179.792 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.654 ' CE1' ' CE2' ' A' ' 35' ' ' TYR . 0.3 OUTLIER -86.79 43.61 1.1 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.141 -0.974 . . . . 0.0 109.2 179.957 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.429 ' HA ' ' OG1' ' A' ' 33' ' ' THR . 0.0 OUTLIER -165.12 -44.15 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.409 -0.807 . . . . 0.0 109.052 -179.898 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -81.59 -36.1 29.38 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.328 -0.858 . . . . 0.0 109.259 179.73 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.526 ' HA2' ' CE2' ' A' ' 62' ' ' PHE . . . 88.89 35.15 8.45 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.854 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.484 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 1.8 pp -140.04 155.97 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.172 -1.193 . . . . 0.0 109.781 -179.823 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.544 ' N ' HD23 ' A' ' 69' ' ' LEU . 1.3 pt? -143.56 166.92 23.49 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.31 -0.869 . . . . 0.0 109.043 179.667 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.437 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.483 0 O-C-N 121.129 -0.982 . . . . 0.0 109.658 -179.987 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.626 ' CH2' ' NH1' ' A' ' 18' ' ' ARG . 67.4 m95 . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 6' ' ' LEU . 54.2 mt -109.75 153.24 24.61 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.149 -0.97 . . . . 0.0 109.63 -179.809 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.407 ' C ' ' O ' ' A' ' 6' ' ' LEU . 7.5 t70 -45.64 140.39 3.4 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.255 -0.903 . . . . 0.0 109.062 179.77 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.524 ' HG ' ' HE1' ' A' ' 35' ' ' TYR . 44.5 t -102.29 108.79 58.5 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.182 -0.949 . . . . 0.0 109.869 -179.599 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.423 ' HD2' ' CZ ' ' A' ' 17' ' ' ARG . 34.1 Cg_endo -77.01 -32.77 3.06 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.154 1.903 . . . . 0.0 109.767 179.194 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.679 ' O ' HD23 ' A' ' 11' ' ' LEU . . . -50.55 -30.13 12.36 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.302 -0.874 . . . . 0.0 108.954 179.319 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 1.053 HD12 ' CD1' ' A' ' 15' ' ' TRP . 9.6 mt -117.25 -65.54 1.17 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.383 -0.823 . . . . 0.0 109.485 179.848 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.412 ' O ' ' O ' ' A' ' 8' ' ' CYS . . . 168.38 -147.42 11.39 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -179.885 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . 0.514 ' O ' ' N ' ' A' ' 15' ' ' TRP . 35.9 Cg_endo -78.08 175.39 11.2 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.681 2.254 . . . . 0.0 110.618 -179.701 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . 0.426 ' O ' ' C ' ' A' ' 15' ' ' TRP . . . 65.66 -68.39 0.11 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.97 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 1.053 ' CD1' HD12 ' A' ' 11' ' ' LEU . 4.5 t-105 -43.55 119.62 1.7 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.374 -1.074 . . . . 0.0 109.515 179.9 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.451 ' HD2' ' HB3' ' A' ' 5' ' ' TRP . 1.0 OUTLIER -101.7 114.91 29.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.185 -0.947 . . . . 0.0 109.659 -179.937 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.486 ' HD3' ' OH ' ' A' ' 35' ' ' TYR . 10.4 ttp85 -92.95 111.2 22.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.232 -0.917 . . . . 0.0 109.309 179.771 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.626 ' NH1' ' CH2' ' A' ' 5' ' ' TRP . 41.2 ttp180 -100.38 148.47 24.67 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.185 -0.947 . . . . 0.0 109.488 -179.933 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -102.98 145.15 30.3 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.221 -0.924 . . . . 0.0 109.369 179.924 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.691 HG21 ' CE2' ' A' ' 34' ' ' TYR . 2.9 t . . . . . 0 N--CA 1.489 1.521 0 O-C-N 121.187 -0.946 . . . . 0.0 109.547 -179.918 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 . . . . . 0 N--CA 1.49 1.525 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.528 ' O ' ' CE1' ' A' ' 64' ' ' PHE . 9.7 m -131.15 144.14 51.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.255 -0.903 . . . . 0.0 109.428 179.972 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.691 ' CE2' HG21 ' A' ' 20' ' ' VAL . 20.0 m-85 -124.75 164.94 18.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.383 -0.823 . . . . 0.0 109.142 179.819 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.893 ' HD2' HD22 ' A' ' 49' ' ' LEU . 10.4 m-85 -121.27 147.99 44.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.058 -1.026 . . . . 0.0 110.483 -179.332 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.606 ' HB2' ' CZ3' ' A' ' 5' ' ' TRP . 0.1 OUTLIER -131.81 114.37 14.63 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.352 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.505 ' CB ' ' HD2' ' A' ' 38' ' ' PRO . 0.9 OUTLIER -72.4 173.79 5.17 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.354 -0.841 . . . . 0.0 109.455 -179.719 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.505 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 35.1 Cg_endo -76.89 -7.05 17.26 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.549 2.166 . . . . 0.0 110.246 179.939 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 p -105.07 -23.19 12.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.373 -0.829 . . . . 0.0 109.243 179.842 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 122.2 27.33 1.69 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -90.36 114.92 27.12 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.255 -1.144 . . . . 0.0 109.531 179.968 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.1 99.82 11.11 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.265 -0.897 . . . . 0.0 109.351 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.554 ' CG2' ' HB3' ' A' ' 49' ' ' LEU . 1.9 mp -114.44 146.95 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.2 -0.937 . . . . 0.0 109.661 -179.995 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.608 ' HA ' ' CZ ' ' A' ' 64' ' ' PHE . 7.5 ptt180 -140.28 3.41 1.95 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.37 -0.831 . . . . 0.0 109.995 179.962 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.529 ' O ' ' CB ' ' A' ' 46' ' ' LYS . 1.9 t -62.16 -82.39 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.049 -1.032 . . . . 0.0 109.292 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.529 ' CB ' ' O ' ' A' ' 45' ' ' SER . 6.6 ttmt 159.71 -61.74 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.502 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 21.5 t -96.19 -18.3 6.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.795 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.501 ' HB2' ' HB3' ' A' ' 45' ' ' SER . 40.2 mt-10 -73.54 -32.05 63.99 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.884 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.893 HD22 ' HD2' ' A' ' 35' ' ' TYR . 1.7 pp -78.81 -29.56 44.9 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.283 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.748 ' OG1' HD12 ' A' ' 59' ' ' LEU . 0.5 OUTLIER -70.16 -50.17 43.13 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.181 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.528 ' N ' ' CG2' ' A' ' 50' ' ' THR . 0.0 OUTLIER -59.62 -29.68 68.17 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.18 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.448 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 36.6 t80 -56.7 -57.15 13.65 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.327 -0.858 . . . . 0.0 108.702 179.252 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.825 HD21 ' CE3' ' A' ' 15' ' ' TRP . 0.5 OUTLIER -62.33 -40.7 97.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.228 -0.92 . . . . 0.0 109.077 179.536 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 127.17 -158.71 21.13 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 -179.689 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.91 -7.16 16.35 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.421 2.081 . . . . 0.0 110.304 179.852 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.79 -12.79 60.48 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.227 -0.921 . . . . 0.0 109.578 -179.985 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.444 ' HB2' HD13 ' A' ' 53' ' ' LEU . 69.6 m -138.77 132.06 30.07 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.263 -0.898 . . . . 0.0 109.514 -179.96 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -119.66 155.68 31.91 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.182 -0.949 . . . . 0.0 109.532 179.873 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.93 HD23 ' CD2' ' A' ' 62' ' ' PHE . 0.5 OUTLIER -148.83 16.78 0.98 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.204 -0.935 . . . . 0.0 109.779 -179.758 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.638 ' C ' HD22 ' A' ' 61' ' ' LEU . 13.1 m -56.0 -37.41 69.08 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.257 -0.902 . . . . 0.0 109.415 -179.973 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.638 HD22 ' C ' ' A' ' 60' ' ' THR . 1.9 mm? -110.37 8.88 23.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.327 -0.858 . . . . 0.0 109.776 -179.653 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.93 ' CD2' HD23 ' A' ' 59' ' ' LEU . 63.7 t80 -71.29 133.54 46.13 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.25 -0.906 . . . . 0.0 110.074 -179.617 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.519 ' O ' ' N ' ' A' ' 65' ' ' LYS . 15.9 t70 -86.98 100.72 12.81 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.248 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.608 ' CZ ' ' HA ' ' A' ' 44' ' ' ARG . 0.1 OUTLIER -66.22 67.87 0.05 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.299 -0.876 . . . . 0.0 109.391 -179.23 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 63' ' ' ASP . 0.3 OUTLIER 176.01 -40.96 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.481 -0.762 . . . . 0.0 108.957 -179.917 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.72 -27.53 18.0 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.318 -0.864 . . . . 0.0 109.195 179.709 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . 0.469 ' HA3' ' NH2' ' A' ' 17' ' ' ARG . . . 90.55 33.52 8.5 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.851 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.722 ' C ' HD12 ' A' ' 68' ' ' ILE . 2.3 pp -140.42 174.84 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.086 -1.244 . . . . 0.0 109.76 179.967 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.611 ' N ' HD12 ' A' ' 68' ' ' ILE . 0.6 OUTLIER -155.4 -167.97 2.69 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.373 -0.829 . . . . 0.0 109.277 179.676 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.443 ' SG ' ' O ' ' A' ' 69' ' ' LEU . 7.8 m . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.33 -0.856 . . . . 0.0 109.27 179.67 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' TRP . . . . . 0.633 ' CE3' ' CB ' ' A' ' 18' ' ' ARG . 52.7 m95 . . . . . 0 N--CA 1.49 1.538 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 57.0 mt -100.51 159.59 15.03 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.327 -0.858 . . . . 0.0 109.585 -179.698 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . 0.473 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 0.3 OUTLIER -49.83 132.71 22.37 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.256 -0.902 . . . . 0.0 109.319 179.792 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' CYS . . . . . 0.533 ' CB ' ' HB2' ' A' ' 17' ' ' ARG . 29.3 t -88.26 112.82 52.09 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.26 -0.9 . . . . 0.0 109.718 -179.74 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 36.5 Cg_endo -79.75 -59.41 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.46 2.107 . . . . 0.0 110.75 179.905 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.785 ' HB3' ' NH1' ' A' ' 17' ' ' ARG . . . -38.52 -39.66 0.49 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.59 -0.694 . . . . 0.0 110.424 -179.455 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 1.044 HD12 ' CD1' ' A' ' 15' ' ' TRP . 13.3 mt -95.34 -64.61 1.04 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.054 -1.029 . . . . 0.0 109.711 -179.931 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.404 ' O ' ' O ' ' A' ' 8' ' ' CYS . . . 152.98 -152.05 23.76 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -179.824 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.13 148.51 21.62 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.655 2.237 . . . . 0.0 110.399 -179.878 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.17 -51.82 1.64 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.893 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 1.044 ' CD1' HD12 ' A' ' 11' ' ' LEU . 15.3 t-105 -69.24 126.68 30.53 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.307 -1.114 . . . . 0.0 109.504 -179.991 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -94.87 114.03 25.84 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.249 -0.907 . . . . 0.0 108.947 179.751 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.785 ' NH1' ' HB3' ' A' ' 10' ' ' ALA . 2.9 ttm180 -94.67 96.71 9.58 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.161 -0.962 . . . . 0.0 109.844 -179.534 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.633 ' CB ' ' CE3' ' A' ' 5' ' ' TRP . 9.7 tpt180 -100.7 146.0 27.75 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.198 -0.939 . . . . 0.0 109.526 179.63 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.531 ' HG2' ' NH1' ' A' ' 18' ' ' ARG . 8.6 pt-20 -109.0 164.36 12.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.191 -0.943 . . . . 0.0 109.43 179.871 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.591 HG12 ' O ' ' A' ' 20' ' ' VAL . 96.7 t . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.216 -0.928 . . . . 0.0 109.463 -179.948 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' ASP . . . . . 0.469 ' HB2' ' HB ' ' A' ' 20' ' ' VAL . 8.5 m-20 . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.351 -0.611 . . . . 0.0 109.351 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.579 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 0.0 OUTLIER -103.94 110.1 22.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.165 -0.959 . . . . 0.0 109.637 -179.727 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.55 ' CD1' ' HB3' ' A' ' 44' ' ' ARG . 19.3 m-30 -106.26 143.1 34.87 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.138 -0.976 . . . . 0.0 109.164 179.803 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.573 ' CE1' ' HG3' ' A' ' 17' ' ' ARG . 5.0 m-85 -122.02 156.71 32.92 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.172 -0.955 . . . . 0.0 109.832 -179.507 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.437 ' OE1' ' HD2' ' A' ' 42' ' ' ARG . 44.5 tt0 -130.61 121.45 25.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.385 -0.822 . . . . 0.0 109.166 179.953 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.493 ' HB2' HG22 ' A' ' 39' ' ' THR . 0.5 OUTLIER -76.37 171.56 11.88 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.154 -0.966 . . . . 0.0 109.746 -179.748 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.46 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 36.0 Cg_endo -77.93 -4.58 14.57 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.729 2.286 . . . . 0.0 110.437 179.994 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.903 HG21 ' OH ' ' A' ' 52' ' ' TYR . 12.3 t -100.11 -12.82 19.32 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.225 -0.922 . . . . 0.0 109.343 179.881 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 106.04 18.06 11.96 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.996 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.8 112.23 24.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -1.131 . . . . 0.0 109.354 -179.978 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' ARG . . . . . 0.437 ' HD2' ' OE1' ' A' ' 36' ' ' GLN . 2.2 mtp180 -99.1 121.04 40.47 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.179 -0.95 . . . . 0.0 109.503 -179.943 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.8 HD13 ' HB2' ' A' ' 49' ' ' LEU . 2.2 mp -118.46 168.03 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.251 -0.906 . . . . 0.0 109.472 179.98 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . 0.574 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 0.0 OUTLIER -153.74 14.99 0.49 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.338 -0.851 . . . . 0.0 109.845 -179.627 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.558 ' H ' HG22 ' A' ' 43' ' ' ILE . 7.5 t -95.67 -79.31 0.44 Allowed 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.028 -1.045 . . . . 0.0 108.452 179.346 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.576 ' HB2' ' CD1' ' A' ' 64' ' ' PHE . 4.6 ttpm? 153.45 -61.77 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 179.421 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.524 ' O ' ' CG ' ' A' ' 51' ' ' ARG . 50.0 t -82.93 -24.52 8.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 178.63 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.439 ' O ' ' HG3' ' A' ' 51' ' ' ARG . 23.3 tt0 -64.66 -48.21 75.6 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 179.012 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' LEU . . . . . 0.8 ' HB2' HD13 ' A' ' 43' ' ' ILE . 2.3 pp -68.8 -30.81 69.46 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 178.918 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' THR . . . . . 0.67 ' OG1' HD13 ' A' ' 59' ' ' LEU . 24.0 m -61.24 -67.96 0.36 Allowed 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.857 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.524 ' CG ' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -47.19 -31.13 3.39 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.375 -0.828 . . . . 0.0 108.934 179.456 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . 0.903 ' OH ' HG21 ' A' ' 39' ' ' THR . 2.1 t80 -64.68 -62.56 1.5 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.287 -0.883 . . . . 0.0 108.95 179.422 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 1.002 HD21 ' CZ3' ' A' ' 15' ' ' TRP . 0.8 OUTLIER -49.82 -51.91 36.29 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.285 -0.884 . . . . 0.0 109.238 179.569 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 124.19 -151.23 17.13 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 -179.592 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.45 -12.74 16.91 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.562 2.174 . . . . 0.0 110.168 179.746 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.18 -3.18 31.5 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.337 -0.852 . . . . 0.0 109.358 179.749 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' CYS . . . . . 0.478 ' CB ' HD13 ' A' ' 53' ' ' LEU . 60.0 m -135.53 -176.2 4.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.196 -0.94 . . . . 0.0 109.5 -179.906 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.817 ' C ' HD12 ' A' ' 59' ' ' LEU . 12.1 t70 179.26 142.31 0.12 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.348 -0.845 . . . . 0.0 108.964 179.876 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.824 HD23 ' CD2' ' A' ' 62' ' ' PHE . 5.1 mp -152.89 16.77 0.58 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.135 -0.978 . . . . 0.0 109.55 -179.483 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.575 ' C ' HD22 ' A' ' 61' ' ' LEU . 58.5 m -44.38 -40.23 5.24 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.377 -0.827 . . . . 0.0 109.412 -179.956 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' LEU . . . . . 0.575 HD22 ' C ' ' A' ' 60' ' ' THR . 1.4 mm? -111.57 -8.54 14.23 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.395 -0.815 . . . . 0.0 109.67 -179.834 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.824 ' CD2' HD23 ' A' ' 59' ' ' LEU . 80.6 t80 -50.53 138.45 17.54 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.227 -0.921 . . . . 0.0 109.835 -179.368 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.525 ' OD1' ' CG ' ' A' ' 65' ' ' LYS . 3.9 t0 -89.44 113.52 24.88 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.447 -0.783 . . . . 0.0 109.158 179.714 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.579 ' CE2' ' O ' ' A' ' 33' ' ' THR . 1.1 t80 -72.06 63.78 0.51 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.126 -0.984 . . . . 0.0 109.728 -179.781 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.525 ' CG ' ' OD1' ' A' ' 63' ' ' ASP . 0.0 OUTLIER 167.82 -36.32 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.394 -0.816 . . . . 0.0 109.079 179.639 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -83.77 -41.57 17.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.142 -0.974 . . . . 0.0 108.948 179.411 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.84 28.0 8.07 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 179.666 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' ILE . . . . . 0.5 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 2.6 pp -140.52 179.47 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.114 -1.227 . . . . 0.0 109.668 179.938 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' LEU . . . . . 0.533 ' HB3' ' HA ' ' A' ' 62' ' ' PHE . 0.6 OUTLIER -160.34 -175.78 5.24 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.409 -0.807 . . . . 0.0 109.111 179.934 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' CYS . . . . . 0.418 ' SG ' HD12 ' A' ' 61' ' ' LEU . 32.1 p . . . . . 0 N--CA 1.489 1.513 0 O-C-N 121.237 -0.914 . . . . 0.0 109.444 179.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.471 ' O ' ' HB2' ' A' ' 2' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.486 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.471 ' HB2' ' O ' ' A' ' 1' ' ' MET . . . 176.54 -175.54 0.12 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.317 -0.864 . . . . 0.0 109.276 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.415 ' HG2' ' HD3' ' A' ' 18' ' ' ARG . 0.5 OUTLIER -127.67 -92.16 0.48 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.229 -0.919 . . . . 0.0 109.587 -179.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.458 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 1.2 t0 -139.32 35.45 2.07 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.173 -0.954 . . . . 0.0 109.585 -179.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.491 ' CE3' ' HB2' ' A' ' 18' ' ' ARG . 69.7 m95 -54.68 94.55 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.2 -0.938 . . . . 0.0 109.431 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.458 ' HG ' ' O ' ' A' ' 4' ' ' ASP . 18.1 mt -109.28 160.87 15.78 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.215 -0.928 . . . . 0.0 109.615 -179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.438 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 0.2 OUTLIER -49.72 130.36 20.93 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.323 -0.861 . . . . 0.0 109.592 -179.885 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.522 ' SG ' ' CZ ' ' A' ' 17' ' ' ARG . 26.9 t -81.61 115.17 55.19 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.276 -0.89 . . . . 0.0 109.4 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.455 ' O ' ' C ' ' A' ' 10' ' ' ALA . 36.2 Cg_endo -78.57 -55.62 0.04 OUTLIER 'Trans proline' 0 C--N 1.311 -1.436 0 C-N-CA 122.498 2.132 . . . . 0.0 111.088 -179.76 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.646 ' HB3' ' NH1' ' A' ' 17' ' ' ARG . . . -39.69 -56.73 1.65 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.36 -0.838 . . . . 0.0 110.098 -179.502 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.756 HD12 ' CD1' ' A' ' 15' ' ' TRP . 12.0 mt -83.31 -56.94 3.48 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.282 -0.886 . . . . 0.0 109.706 -179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 140.04 -146.48 17.96 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.656 -1.378 . . . . 0.0 109.656 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.57 158.15 32.26 Favored 'Trans proline' 0 C--N 1.309 -1.5 0 C-N-CA 122.62 2.214 . . . . 0.0 110.802 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.15 -38.89 3.14 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.774 -1.331 . . . . 0.0 109.774 179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.983 ' CZ3' HD21 ' A' ' 53' ' ' LEU . 17.1 t-105 -89.0 130.0 35.55 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.268 -1.137 . . . . 0.0 109.585 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.462 ' HG2' ' HB3' ' A' ' 5' ' ' TRP . 0.1 OUTLIER -97.54 127.75 43.75 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.2 -0.937 . . . . 0.0 108.919 179.626 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.646 ' NH1' ' HB3' ' A' ' 10' ' ' ALA . 1.6 ttm180 -107.32 98.84 8.42 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.142 -0.974 . . . . 0.0 109.917 -179.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.491 ' HB2' ' CE3' ' A' ' 5' ' ' TRP . 0.4 OUTLIER -100.24 145.65 27.82 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.316 -0.865 . . . . 0.0 109.201 179.601 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -121.91 158.33 29.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.11 -0.994 . . . . 0.0 109.802 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.463 HG22 HH11 ' A' ' 18' ' ' ARG . 2.3 t -139.9 161.13 26.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.396 -0.815 . . . . 0.0 109.205 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.402 ' HB2' ' HA ' ' A' ' 31' ' ' SER . 9.8 m-85 48.59 27.95 1.63 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.141 -0.974 . . . . 0.0 109.328 -179.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.41 ' HG2' ' CB ' ' A' ' 31' ' ' SER . 0.0 OUTLIER -103.23 -40.07 6.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.258 -0.901 . . . . 0.0 109.65 -179.821 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.67 -83.92 0.09 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.224 -0.922 . . . . 0.0 109.422 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.2 t -64.54 133.85 53.21 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.238 -0.914 . . . . 0.0 109.459 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 142.21 153.6 5.95 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.92 172.55 0.08 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.314 -1.109 . . . . 0.0 109.463 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 6.2 m -59.96 -14.84 17.77 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.27 -0.894 . . . . 0.0 109.485 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 37.1 t -119.38 31.59 6.52 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.195 -0.94 . . . . 0.0 109.385 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.86 99.88 0.88 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.601 -1.4 . . . . 0.0 109.601 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 -46.66 116.42 1.31 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.24 -1.153 . . . . 0.0 109.361 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.453 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 2.2 p -96.95 122.44 39.94 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.256 -0.903 . . . . 0.0 109.486 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 11.7 m-20 -79.42 157.14 27.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.21 -0.931 . . . . 0.0 108.652 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.444 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 0.3 OUTLIER -135.26 124.36 24.36 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.983 -1.073 . . . . 0.0 110.254 -179.456 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.561 ' CD1' ' HG2' ' A' ' 44' ' ' ARG . 16.7 m-85 -123.62 143.8 50.01 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 179.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.584 ' CE1' ' HG3' ' A' ' 17' ' ' ARG . 9.8 m-85 -116.01 154.42 29.89 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.107 -0.995 . . . . 0.0 110.204 -179.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -122.41 120.41 33.87 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 179.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.507 ' HB3' ' HD2' ' A' ' 38' ' ' PRO . 0.7 OUTLIER -68.41 168.35 14.46 Favored Pre-proline 0 N--CA 1.488 1.462 0 O-C-N 121.394 -0.816 . . . . 0.0 109.023 179.915 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.507 ' HD2' ' HB3' ' A' ' 37' ' ' SER . 34.7 Cg_endo -78.0 6.12 4.85 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 122.502 2.134 . . . . 0.0 110.577 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 12.3 t -116.56 -21.7 9.04 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.131 -0.981 . . . . 0.0 109.498 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 119.18 15.91 5.42 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 -179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.448 ' O ' ' OG ' ' A' ' 37' ' ' SER . 3.5 m-20 -96.81 107.03 19.44 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.248 -1.149 . . . . 0.0 109.297 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.26 132.29 33.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.132 -0.98 . . . . 0.0 109.658 -179.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.729 HG21 ' N ' ' A' ' 49' ' ' LEU . 3.0 mp -130.04 149.93 34.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.325 -0.859 . . . . 0.0 109.239 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.561 ' HG2' ' CD1' ' A' ' 34' ' ' TYR . 51.5 mtm180 -142.17 9.35 1.88 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.091 -1.006 . . . . 0.0 110.058 -179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.529 ' HB3' ' CB ' ' A' ' 48' ' ' GLU . 0.5 OUTLIER -97.19 14.08 27.14 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.039 -1.038 . . . . 0.0 109.393 179.904 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.584 ' HA ' ' CE1' ' A' ' 64' ' ' PHE . 5.9 ttpp 62.73 -94.09 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.442 -0.786 . . . . 0.0 109.98 179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.44 ' N ' ' HG2' ' A' ' 46' ' ' LYS . 48.6 t -52.87 -31.9 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 120.904 -1.122 . . . . 0.0 109.485 -179.442 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.529 ' CB ' ' HB3' ' A' ' 45' ' ' SER . 67.4 tt0 -53.33 -45.54 69.1 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.067 -1.021 . . . . 0.0 108.784 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.832 ' O ' HD12 ' A' ' 53' ' ' LEU . 0.9 OUTLIER -71.88 -28.71 63.7 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.114 -0.991 . . . . 0.0 108.547 179.281 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.658 ' HG1' ' HB2' ' A' ' 59' ' ' LEU . 2.3 m -61.96 -65.28 0.71 Allowed 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 178.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.0 -24.26 16.26 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.465 -0.772 . . . . 0.0 109.23 179.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.41 ' O ' ' C ' ' A' ' 53' ' ' LEU . 29.9 t80 -70.55 -68.11 0.45 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.227 -0.92 . . . . 0.0 108.992 179.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.983 HD21 ' CZ3' ' A' ' 15' ' ' TRP . 1.0 OUTLIER -45.17 -36.03 3.55 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.267 -0.896 . . . . 0.0 109.293 179.661 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 112.69 -157.6 14.84 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.343 -1.503 . . . . 0.0 109.343 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.81 6.13 4.77 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.567 2.178 . . . . 0.0 110.532 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -85.31 -21.45 28.95 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.216 -0.928 . . . . 0.0 109.614 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 50.9 m -135.89 164.38 28.08 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.037 -1.039 . . . . 0.0 109.663 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.593 ' HA ' HG23 ' A' ' 50' ' ' THR . 26.3 p30 -152.97 150.73 29.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.243 -0.91 . . . . 0.0 109.433 179.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 1.158 HD23 ' CD2' ' A' ' 62' ' ' PHE . 2.6 mp -143.71 12.09 1.67 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.242 -0.911 . . . . 0.0 109.593 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.55 ' C ' HD22 ' A' ' 61' ' ' LEU . 3.4 m -46.04 -46.08 16.47 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.174 -0.954 . . . . 0.0 109.401 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.585 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 2.4 mm? -101.58 0.53 36.55 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.272 -0.893 . . . . 0.0 109.512 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 1.158 ' CD2' HD23 ' A' ' 59' ' ' LEU . 65.1 t80 -66.36 137.48 56.92 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.364 -0.835 . . . . 0.0 109.944 -179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.454 ' O ' ' N ' ' A' ' 65' ' ' LYS . 0.4 OUTLIER -89.31 111.75 22.66 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.261 -0.899 . . . . 0.0 109.04 179.712 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.584 ' CE1' ' HA ' ' A' ' 46' ' ' LYS . 0.6 OUTLIER -70.26 59.33 0.18 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.207 -0.933 . . . . 0.0 109.11 -179.632 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.454 ' N ' ' O ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -179.52 -40.46 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.378 -0.826 . . . . 0.0 109.093 -179.825 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 3.8 mt-30 -90.4 -29.25 18.13 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.293 -0.88 . . . . 0.0 109.356 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.574 ' HA2' ' CE1' ' A' ' 62' ' ' PHE . . . 87.15 33.93 11.37 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.934 -1.266 . . . . 0.0 109.934 179.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.441 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 1.3 pt -140.98 155.39 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.065 -1.256 . . . . 0.0 110.004 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.603 ' N ' HD23 ' A' ' 69' ' ' LEU . 1.9 pt? -143.26 146.24 33.44 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 179.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 3.5 m -121.49 156.79 32.03 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 120.983 -1.073 . . . . 0.0 109.937 -179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.571 ' CG ' ' O ' ' A' ' 71' ' ' TYR . 5.0 p90 -146.11 98.84 4.33 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.407 -0.808 . . . . 0.0 109.251 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -76.74 91.12 1.17 Allowed 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.46 2.107 . . . . 0.0 110.367 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 48.22 91.24 0.07 OUTLIER Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.243 -0.911 . . . . 0.0 109.401 -179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -77.4 69.88 7.03 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.581 2.187 . . . . 0.0 110.277 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.6 mttt . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 117.978 -1.01 . . . . 0.0 109.527 -179.902 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.436 ' HG2' ' O ' ' A' ' 1' ' ' MET . 17.4 ttt . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.15 0.5 . . . . 0.0 109.671 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -55.75 133.24 50.79 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.247 -0.908 . . . . 0.0 109.278 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.542 ' OE1' HG22 ' A' ' 20' ' ' VAL . 1.0 OUTLIER -97.66 -71.63 0.68 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.224 -0.922 . . . . 0.0 109.554 -179.808 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.579 ' O ' HD23 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -148.06 27.12 0.96 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.183 -0.948 . . . . 0.0 109.479 -179.921 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.595 ' CZ2' ' HD3' ' A' ' 18' ' ' ARG . 66.6 m95 -49.54 92.24 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.309 -0.869 . . . . 0.0 109.338 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.579 HD23 ' O ' ' A' ' 4' ' ' ASP . 0.6 OUTLIER -101.54 159.16 15.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.279 -0.888 . . . . 0.0 109.538 -179.82 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.484 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 12.3 t70 -48.85 132.55 18.21 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.282 -0.886 . . . . 0.0 109.213 179.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.457 ' HB3' ' HB3' ' A' ' 15' ' ' TRP . 23.5 t -96.42 109.33 47.19 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.24 -0.912 . . . . 0.0 109.337 -179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 36.1 Cg_endo -78.43 -32.96 2.02 Favored 'Trans proline' 0 C--N 1.31 -1.466 0 C-N-CA 122.297 1.998 . . . . 0.0 110.552 179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.417 ' CB ' ' CE1' ' A' ' 62' ' ' PHE . . . -49.1 -56.99 7.4 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.272 -0.892 . . . . 0.0 109.506 -179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.921 HD12 ' CD1' ' A' ' 15' ' ' TRP . 4.7 mt -87.28 -56.36 3.4 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.177 -0.952 . . . . 0.0 109.613 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 8' ' ' CYS . . . 155.2 -150.37 21.83 Favored Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.19 159.47 33.4 Favored 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.681 2.254 . . . . 0.0 110.409 -179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 83.54 -52.77 4.78 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.357 -1.497 . . . . 0.0 109.357 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.921 ' CD1' HD12 ' A' ' 11' ' ' LEU . 4.4 t-105 -64.62 126.15 26.99 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.213 -1.169 . . . . 0.0 109.505 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.512 ' CG ' ' HB3' ' A' ' 5' ' ' TRP . 5.5 tptt -107.28 112.75 25.75 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.135 -0.978 . . . . 0.0 109.316 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.58 ' HG3' ' CE2' ' A' ' 35' ' ' TYR . 1.0 OUTLIER -87.15 116.28 25.12 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.242 -0.911 . . . . 0.0 109.457 -179.964 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.671 ' CZ ' HG21 ' A' ' 20' ' ' VAL . 10.0 ttp180 -95.63 141.04 29.6 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.222 -0.924 . . . . 0.0 109.483 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.495 ' CG ' ' O ' ' A' ' 19' ' ' GLU . 3.4 pt-20 -115.05 119.47 36.57 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.229 -0.92 . . . . 0.0 109.472 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.671 HG21 ' CZ ' ' A' ' 18' ' ' ARG . 20.5 t -126.36 156.89 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.529 0 O-C-N 121.233 -0.917 . . . . 0.0 109.634 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.49 ' CB ' ' HA ' ' A' ' 31' ' ' SER . 7.5 m-85 56.57 16.36 2.52 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.337 -0.852 . . . . 0.0 109.61 -179.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.478 ' HA ' ' CB ' ' A' ' 31' ' ' SER . 0.0 OUTLIER -80.99 -20.37 41.98 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.121 -0.987 . . . . 0.0 108.882 179.619 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.523 ' O ' ' N ' ' A' ' 25' ' ' GLY . 25.9 mttt -119.79 -76.26 0.58 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.429 -0.795 . . . . 0.0 109.299 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.471 ' HB3' ' O ' ' A' ' 23' ' ' LYS . 13.3 t 63.2 -70.89 0.06 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.436 -0.79 . . . . 0.0 109.67 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.523 ' N ' ' O ' ' A' ' 23' ' ' LYS . . . -158.52 -107.18 0.24 Allowed Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -76.16 -159.11 0.11 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.284 -1.127 . . . . 0.0 109.109 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -96.96 84.45 3.56 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.096 -1.003 . . . . 0.0 109.288 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 7.7 p -158.18 64.64 0.45 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.348 -0.845 . . . . 0.0 109.572 -179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -168.5 113.54 0.53 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.421 ' HD3' ' O ' ' A' ' 31' ' ' SER . 0.0 OUTLIER -54.3 -20.42 7.11 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.199 -1.177 . . . . 0.0 109.591 -179.94 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.49 ' HA ' ' CB ' ' A' ' 21' ' ' PHE . 3.6 p 63.81 123.52 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.28 -0.887 . . . . 0.0 109.664 179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 9.2 m-20 -94.84 144.31 25.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.357 -0.84 . . . . 0.0 109.317 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 57.6 m -115.05 121.46 43.16 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.188 -0.945 . . . . 0.0 109.711 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.56 ' CD2' ' HG3' ' A' ' 44' ' ' ARG . 12.5 m-85 -103.8 157.25 17.21 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.258 -0.901 . . . . 0.0 109.179 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.58 ' CE2' ' HG3' ' A' ' 17' ' ' ARG . 11.5 m-85 -129.33 139.66 51.66 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.111 -0.993 . . . . 0.0 109.897 -179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.562 ' HB2' ' CZ3' ' A' ' 5' ' ' TRP . 22.0 tt0 -124.83 130.16 51.84 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.364 -0.835 . . . . 0.0 109.385 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.533 ' HA ' ' CZ3' ' A' ' 15' ' ' TRP . 0.5 OUTLIER -69.94 175.92 2.07 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.227 -0.92 . . . . 0.0 109.368 179.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.514 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 35.0 Cg_endo -78.11 -2.03 12.16 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.6 2.2 . . . . 0.0 110.283 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 p -109.38 -17.24 13.84 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.327 -0.858 . . . . 0.0 109.29 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 119.75 4.35 11.74 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.427 ' CB ' ' OG ' ' A' ' 37' ' ' SER . 0.1 OUTLIER -77.67 109.0 11.28 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.199 -1.177 . . . . 0.0 109.155 179.87 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 8.6 mtt180 -97.05 124.36 41.02 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.336 -0.852 . . . . 0.0 109.889 -179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.546 HG22 ' N ' ' A' ' 44' ' ' ARG . 3.0 mp -118.56 163.5 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.379 -0.826 . . . . 0.0 109.047 179.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.587 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 4.5 ttp180 -126.77 -23.82 3.63 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.126 -0.984 . . . . 0.0 110.327 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.842 ' O ' HD23 ' A' ' 49' ' ' LEU . 0.5 OUTLIER -75.24 166.47 23.58 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 120.76 -1.212 . . . . 0.0 108.615 179.543 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.673 ' HE3' HG23 ' A' ' 47' ' ' VAL . 7.6 ttpt -86.56 -63.77 1.26 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.123 -0.985 . . . . 0.0 110.529 -178.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.673 HG23 ' HE3' ' A' ' 46' ' ' LYS . 89.3 t -76.58 -16.8 14.93 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 O-C-N 121.11 -0.994 . . . . 0.0 109.773 -179.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.585 ' HB2' ' CB ' ' A' ' 45' ' ' SER . 14.3 mt-10 -72.57 -46.86 52.31 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.965 -1.084 . . . . 0.0 108.495 179.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.86 HD13 ' CZ2' ' A' ' 15' ' ' TRP . 2.9 pp -66.76 -21.64 66.05 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 178.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.923 ' OG1' HD13 ' A' ' 59' ' ' LEU . 27.3 m -73.07 -64.49 0.96 Allowed 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.519 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -49.66 -23.73 1.88 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.224 -0.922 . . . . 0.0 108.611 179.665 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.48 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 63.9 t80 -62.68 -61.5 2.38 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.319 -0.863 . . . . 0.0 108.732 179.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.832 HD21 ' CE3' ' A' ' 15' ' ' TRP . 0.9 OUTLIER -53.36 -59.25 4.82 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.294 -0.879 . . . . 0.0 109.227 179.521 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 147.88 -162.55 28.75 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.378 -1.489 . . . . 0.0 109.378 -179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.72 -2.96 13.09 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.566 2.177 . . . . 0.0 110.144 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.87 -28.62 35.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.292 -0.88 . . . . 0.0 109.61 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 5.8 m -115.32 139.52 49.91 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.171 -0.955 . . . . 0.0 109.353 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.819 ' C ' HD12 ' A' ' 59' ' ' LEU . 2.0 p30 -132.76 153.26 51.38 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.078 -1.013 . . . . 0.0 109.905 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.923 HD13 ' OG1' ' A' ' 50' ' ' THR . 6.0 mp -146.35 12.04 1.18 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.412 -0.805 . . . . 0.0 109.223 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.611 ' C ' HD22 ' A' ' 61' ' ' LEU . 97.2 m -50.59 -31.55 16.23 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.237 -0.915 . . . . 0.0 109.093 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.611 HD22 ' C ' ' A' ' 60' ' ' THR . 1.2 mm? -111.11 -9.04 14.38 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.452 -0.78 . . . . 0.0 109.053 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.493 ' CZ ' ' HA2' ' A' ' 67' ' ' GLY . 61.7 t80 -56.08 129.68 40.95 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.412 -0.805 . . . . 0.0 109.168 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.525 ' O ' ' N ' ' A' ' 65' ' ' LYS . 19.2 t0 -79.04 104.01 9.38 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.246 -0.909 . . . . 0.0 109.141 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.587 ' CE2' ' O ' ' A' ' 44' ' ' ARG . 1.1 t80 -66.94 63.0 0.05 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.477 -0.764 . . . . 0.0 109.452 -179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.525 ' N ' ' O ' ' A' ' 63' ' ' ASP . 37.4 ttpt -179.65 -43.7 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.458 -0.776 . . . . 0.0 109.173 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 22.8 mt-30 -88.31 -45.57 9.92 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.314 -0.866 . . . . 0.0 109.315 179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.493 ' HA2' ' CZ ' ' A' ' 62' ' ' PHE . . . 110.48 31.86 2.89 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.574 ' C ' HD12 ' A' ' 68' ' ' ILE . 2.8 pp -140.35 166.85 19.13 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.208 -1.172 . . . . 0.0 109.431 179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.48 ' CB ' ' HA ' ' A' ' 62' ' ' PHE . 0.7 OUTLIER -145.54 177.63 8.72 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.202 -0.936 . . . . 0.0 109.482 -179.869 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.446 ' SG ' ' O ' ' A' ' 69' ' ' LEU . 72.2 m -153.11 -179.33 7.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.366 -0.833 . . . . 0.0 109.292 179.63 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.519 ' CD1' ' N ' ' A' ' 71' ' ' TYR . 7.4 m-85 -117.02 154.35 49.74 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.151 -0.968 . . . . 0.0 109.497 179.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.71 -161.02 0.13 Allowed 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 122.559 2.173 . . . . 0.0 110.18 179.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . 56.79 78.73 0.36 Allowed Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.203 -0.935 . . . . 0.0 109.428 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.91 -174.11 2.1 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 122.657 2.238 . . . . 0.0 110.37 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 117.975 -1.012 . . . . 0.0 109.541 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -54.59 134.58 46.74 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.284 -0.885 . . . . 0.0 109.553 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -92.69 -147.25 0.23 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.289 -0.882 . . . . 0.0 109.411 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -104.45 40.38 1.49 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.157 -0.965 . . . . 0.0 109.664 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.568 ' CE3' ' HB2' ' A' ' 18' ' ' ARG . 73.3 m95 -57.88 104.89 0.22 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.243 -0.911 . . . . 0.0 109.534 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.476 HD23 ' HA ' ' A' ' 6' ' ' LEU . 51.8 mt -114.49 148.97 37.09 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.214 -0.929 . . . . 0.0 109.358 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.452 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 0.2 OUTLIER -43.63 133.74 4.45 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.297 -0.877 . . . . 0.0 109.424 179.947 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.521 ' HB3' ' HB3' ' A' ' 15' ' ' TRP . 39.7 t -88.37 113.38 55.03 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.298 -0.876 . . . . 0.0 109.563 -179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 34.8 Cg_endo -77.47 -40.02 0.48 Allowed 'Trans proline' 0 C--N 1.311 -1.419 0 C-N-CA 122.287 1.992 . . . . 0.0 110.003 179.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.673 ' HB3' ' NH1' ' A' ' 17' ' ' ARG . . . -47.04 -42.44 18.48 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.318 -0.864 . . . . 0.0 109.452 179.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.626 HD12 ' CG ' ' A' ' 15' ' ' TRP . 13.1 mt -101.15 -61.34 1.38 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.322 -0.861 . . . . 0.0 109.491 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.436 ' O ' ' O ' ' A' ' 8' ' ' CYS . . . 156.7 -149.06 19.73 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 109.511 -1.435 . . . . 0.0 109.511 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -77.27 153.21 31.37 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 C-N-CA 122.517 2.145 . . . . 0.0 110.327 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.408 ' O ' ' C ' ' A' ' 15' ' ' TRP . . . 93.76 -74.79 1.13 Allowed Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 -179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.799 ' CE3' HD21 ' A' ' 53' ' ' LEU . 22.2 t-105 -44.24 122.6 3.04 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.275 -1.133 . . . . 0.0 109.304 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.3 mmtt -97.04 108.75 21.55 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.173 -0.954 . . . . 0.0 109.66 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.673 ' NH1' ' HB3' ' A' ' 10' ' ' ALA . 1.0 OUTLIER -87.1 106.33 17.79 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.199 -0.938 . . . . 0.0 109.389 179.863 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.568 ' HB2' ' CE3' ' A' ' 5' ' ' TRP . 5.1 ttt180 -100.02 147.52 25.52 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.235 -0.915 . . . . 0.0 109.749 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.468 ' HA ' HG23 ' A' ' 33' ' ' THR . 22.0 pt-20 -116.67 155.27 29.11 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.356 -0.84 . . . . 0.0 109.241 179.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.783 HG21 ' CE1' ' A' ' 34' ' ' TYR . 0.9 OUTLIER -140.28 143.35 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.165 -0.96 . . . . 0.0 109.407 -179.972 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.515 ' O ' ' N ' ' A' ' 23' ' ' LYS . 2.3 p90 -110.91 40.56 2.0 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.273 -0.892 . . . . 0.0 109.469 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.439 ' HB2' ' O ' ' A' ' 21' ' ' PHE . 29.4 mtp180 60.68 -79.8 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.312 -0.867 . . . . 0.0 109.329 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.515 ' N ' ' O ' ' A' ' 21' ' ' PHE . 1.3 mttt -153.57 -169.23 3.23 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.278 -0.889 . . . . 0.0 109.396 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.8 p -80.3 124.48 28.88 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.253 -0.904 . . . . 0.0 109.398 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 123.35 103.14 1.62 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -88.82 137.74 32.04 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.245 -1.15 . . . . 0.0 109.684 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -134.05 -46.16 0.78 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.292 -0.88 . . . . 0.0 109.399 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 6.4 m -138.89 47.72 1.92 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.277 -0.89 . . . . 0.0 109.388 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.461 ' O ' ' HB3' ' A' ' 30' ' ' ARG . . . 49.88 -131.77 27.83 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 -179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.462 ' HG3' ' N ' ' A' ' 31' ' ' SER . 2.5 tpt85 65.07 153.99 0.07 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.276 -1.132 . . . . 0.0 109.611 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.462 ' N ' ' HG3' ' A' ' 30' ' ' ARG . 0.0 OUTLIER -177.77 133.01 0.16 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.298 -0.876 . . . . 0.0 109.363 -179.991 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.74 157.91 27.03 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.225 -0.922 . . . . 0.0 109.291 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.512 ' CG2' ' O ' ' A' ' 18' ' ' ARG . 2.1 m -139.56 142.9 37.15 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.245 -0.909 . . . . 0.0 109.619 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.783 ' CE1' HG21 ' A' ' 20' ' ' VAL . 6.1 m-85 -135.58 151.86 50.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.337 -0.852 . . . . 0.0 109.243 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.895 ' HD2' HD22 ' A' ' 49' ' ' LEU . 9.8 m-85 -117.61 146.34 43.71 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.207 -0.933 . . . . 0.0 109.735 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.508 ' HB2' ' CZ3' ' A' ' 5' ' ' TRP . 35.7 tt0 -131.27 123.62 28.77 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.373 -0.83 . . . . 0.0 109.259 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.474 ' CB ' ' HD2' ' A' ' 38' ' ' PRO . 0.4 OUTLIER -66.15 173.07 2.41 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 121.263 -0.898 . . . . 0.0 108.965 179.823 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.474 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 36.1 Cg_endo -78.0 4.13 6.42 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.51 2.14 . . . . 0.0 110.291 179.747 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.4 p -111.62 -17.37 13.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.331 -0.855 . . . . 0.0 109.444 -179.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 120.46 5.41 10.29 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.615 -1.394 . . . . 0.0 109.615 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.464 ' O ' ' HA ' ' A' ' 36' ' ' GLN . 6.7 t0 -74.9 136.78 41.43 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.199 -1.177 . . . . 0.0 109.364 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 3.4 mtp180 -121.07 116.46 25.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.196 -0.94 . . . . 0.0 109.277 -179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.64 HG21 ' CA ' ' A' ' 49' ' ' LEU . 4.4 mt -123.35 152.93 28.57 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.228 -0.92 . . . . 0.0 109.924 -179.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.577 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 4.9 ttt-85 -128.49 -24.04 3.11 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.282 -0.886 . . . . 0.0 109.909 179.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.681 ' O ' HD23 ' A' ' 49' ' ' LEU . 1.7 m -73.56 147.89 43.5 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.979 -1.076 . . . . 0.0 108.909 179.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.639 ' HE2' HG23 ' A' ' 47' ' ' VAL . 24.4 ttpt -68.96 -71.84 0.2 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.287 -0.883 . . . . 0.0 110.811 -178.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.639 HG23 ' HE2' ' A' ' 46' ' ' LYS . 62.5 t -67.37 -14.96 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.031 -1.043 . . . . 0.0 110.274 -178.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.554 ' HB2' ' CB ' ' A' ' 45' ' ' SER . 2.4 tt0 -72.45 -51.97 17.9 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.884 -1.135 . . . . 0.0 108.502 179.081 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.895 HD22 ' HD2' ' A' ' 35' ' ' TYR . 1.9 pp -63.17 -28.7 70.24 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 179.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.84 ' HA ' HD12 ' A' ' 53' ' ' LEU . 0.2 OUTLIER -68.2 -55.41 12.38 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 178.376 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.429 ' HD3' ' HA ' ' A' ' 51' ' ' ARG . 48.6 mmt-85 -52.0 -24.3 6.39 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 179.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.477 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 44.4 t80 -73.3 -50.76 20.41 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.532 -0.73 . . . . 0.0 109.196 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.84 HD12 ' HA ' ' A' ' 50' ' ' THR . 0.4 OUTLIER -66.57 -53.0 39.33 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.246 -0.909 . . . . 0.0 109.063 179.739 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 121.9 -146.42 17.01 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.62 -34.74 1.28 Allowed 'Trans proline' 0 C--N 1.307 -1.646 0 C-N-CA 122.512 2.141 . . . . 0.0 110.495 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -45.18 -33.95 2.52 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.302 -0.874 . . . . 0.0 109.837 -179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 67.2 m -122.07 148.51 44.77 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.165 -0.959 . . . . 0.0 109.767 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 40.0 t0 -126.82 146.27 50.32 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.276 -0.89 . . . . 0.0 109.422 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.833 HD23 ' CD2' ' A' ' 62' ' ' PHE . 0.2 OUTLIER -144.99 6.85 1.18 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.277 -0.889 . . . . 0.0 110.332 -179.157 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.581 ' C ' HD22 ' A' ' 61' ' ' LEU . 5.0 m -47.09 -41.88 17.95 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.062 -1.024 . . . . 0.0 109.861 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.581 HD22 ' C ' ' A' ' 60' ' ' THR . 1.4 mm? -110.1 13.2 23.3 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.166 -0.959 . . . . 0.0 110.113 -179.445 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.833 ' CD2' HD23 ' A' ' 59' ' ' LEU . 51.5 t80 -69.5 136.1 51.01 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.201 -0.937 . . . . 0.0 109.549 179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.429 ' O ' ' N ' ' A' ' 65' ' ' LYS . 0.3 OUTLIER -89.81 105.13 17.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.315 -0.866 . . . . 0.0 109.248 179.728 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.649 ' CZ ' ' CE2' ' A' ' 35' ' ' TYR . 0.4 OUTLIER -69.98 61.33 0.19 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.245 -0.909 . . . . 0.0 109.411 -179.594 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.429 ' N ' ' O ' ' A' ' 63' ' ' ASP . 5.6 ttpt -174.46 -37.37 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.318 -0.864 . . . . 0.0 109.018 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -97.59 -38.74 9.43 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.419 -0.801 . . . . 0.0 109.111 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 103.67 32.36 4.51 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.695 ' C ' HD12 ' A' ' 68' ' ' ILE . 2.7 pp -139.87 173.38 10.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.162 -1.199 . . . . 0.0 109.58 -179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.504 ' CB ' ' HA ' ' A' ' 62' ' ' PHE . 0.6 OUTLIER -149.89 -165.07 2.17 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.243 -0.911 . . . . 0.0 109.385 -179.992 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.44 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 0.5 OUTLIER -160.36 168.46 25.19 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.334 -0.854 . . . . 0.0 109.344 179.628 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -138.71 77.42 33.28 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.179 -0.95 . . . . 0.0 109.408 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.717 ' O ' ' HB2' ' A' ' 73' ' ' ALA . 35.1 Cg_endo -77.75 -159.67 0.1 Allowed 'Trans proline' 0 C--N 1.309 -1.518 0 C-N-CA 122.603 2.202 . . . . 0.0 110.187 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.947 ' HB3' ' HD3' ' A' ' 74' ' ' PRO . . . 164.07 -52.97 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.171 -0.956 . . . . 0.0 109.989 -179.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.947 ' HD3' ' HB3' ' A' ' 73' ' ' ALA . 35.8 Cg_endo -77.75 -61.25 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.501 0 C-N-CA 122.435 2.09 . . . . 0.0 110.46 -179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 118.007 -0.996 . . . . 0.0 109.486 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 tpt . . . . . 0 N--CA 1.49 1.545 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -54.72 178.1 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.285 -0.884 . . . . 0.0 109.608 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.449 ' O ' ' OD1' ' A' ' 4' ' ' ASP . 82.3 mt-10 -95.6 156.29 16.39 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.282 -0.886 . . . . 0.0 109.392 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.668 ' O ' HD23 ' A' ' 6' ' ' LEU . 47.2 m-20 -150.63 67.86 0.95 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.182 -0.949 . . . . 0.0 109.647 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.575 ' CE3' ' HB2' ' A' ' 18' ' ' ARG . 84.1 m95 -44.14 102.73 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.234 -0.916 . . . . 0.0 109.416 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.668 HD23 ' O ' ' A' ' 4' ' ' ASP . 0.5 OUTLIER -110.26 154.33 23.58 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.221 -0.924 . . . . 0.0 109.509 -179.947 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.419 ' C ' ' O ' ' A' ' 6' ' ' LEU . 2.0 m-20 -43.9 146.31 0.6 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.291 -0.881 . . . . 0.0 109.471 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.472 ' CB ' ' HB2' ' A' ' 17' ' ' ARG . 45.4 t -111.88 100.75 49.7 Favored Pre-proline 0 N--CA 1.489 1.515 0 O-C-N 121.197 -0.94 . . . . 0.0 109.457 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.504 ' HD2' ' NH2' ' A' ' 17' ' ' ARG . 34.4 Cg_endo -76.6 -33.89 2.85 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 C-N-CA 122.438 2.092 . . . . 0.0 110.569 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.47 ' C ' HD23 ' A' ' 11' ' ' LEU . . . -42.47 -48.43 5.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.308 -0.87 . . . . 0.0 109.609 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.824 HD12 ' CD1' ' A' ' 15' ' ' TRP . 3.1 mt -94.13 -61.99 1.42 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.247 -0.908 . . . . 0.0 109.457 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 8' ' ' CYS . . . 168.69 -158.67 31.45 Favored Glycine 0 N--CA 1.488 2.138 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.94 145.92 20.11 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.592 2.195 . . . . 0.0 110.452 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 99.03 -49.83 1.22 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.483 -1.447 . . . . 0.0 109.483 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.824 ' CD1' HD12 ' A' ' 11' ' ' LEU . 15.7 t-105 -65.66 129.77 40.93 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.233 -1.157 . . . . 0.0 109.468 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 14.8 mmtp -100.99 123.02 44.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.172 -0.955 . . . . 0.0 109.394 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.504 ' NH2' ' HD2' ' A' ' 9' ' ' PRO . 7.7 ttp85 -94.19 110.65 22.37 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.16 -0.962 . . . . 0.0 109.588 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.575 ' HB2' ' CE3' ' A' ' 5' ' ' TRP . 0.5 OUTLIER -99.71 141.77 32.08 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.325 -0.859 . . . . 0.0 109.053 179.653 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.487 ' OE1' HD21 ' A' ' 6' ' ' LEU . 4.5 pt-20 -124.46 141.84 51.77 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.186 -0.947 . . . . 0.0 109.875 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 87.7 t -132.64 146.82 32.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.24 -0.913 . . . . 0.0 109.349 179.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -98.59 71.26 1.97 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.286 -0.884 . . . . 0.0 109.592 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.408 ' O ' ' C ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -72.46 81.89 1.07 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.263 -0.898 . . . . 0.0 109.391 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.408 ' C ' ' O ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -45.82 138.75 4.6 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.225 -0.922 . . . . 0.0 109.162 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 5.1 t -125.24 -47.57 1.75 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.212 -0.93 . . . . 0.0 109.641 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -126.84 -144.99 6.16 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -69.77 -71.45 0.23 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.285 -1.126 . . . . 0.0 109.57 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.404 ' O ' ' C ' ' A' ' 28' ' ' CYS . 21.1 p -135.65 27.56 3.34 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.215 -0.928 . . . . 0.0 109.596 -179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.404 ' C ' ' O ' ' A' ' 27' ' ' THR . 35.9 m -46.09 -76.98 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.169 -0.957 . . . . 0.0 109.27 179.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 115.85 41.08 0.8 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.75 -69.14 0.4 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.263 -1.14 . . . . 0.0 109.571 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.1 m 65.86 175.01 0.22 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.26 -0.9 . . . . 0.0 109.22 -179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -136.09 164.36 28.21 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.179 -0.951 . . . . 0.0 109.406 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.469 ' O ' ' CE1' ' A' ' 35' ' ' TYR . 4.5 m -139.34 98.52 3.52 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.298 -0.876 . . . . 0.0 109.542 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.54 ' CD1' ' HB3' ' A' ' 44' ' ' ARG . 13.0 m-85 -99.95 160.65 14.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.401 -0.812 . . . . 0.0 108.984 179.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.64 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 1.6 m-85 -131.78 156.46 45.94 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.977 -1.077 . . . . 0.0 109.912 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.559 ' HB2' ' CZ3' ' A' ' 5' ' ' TRP . 11.3 tt0 -129.66 129.97 44.97 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.441 -0.787 . . . . 0.0 109.047 179.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.46 ' CB ' ' HD2' ' A' ' 38' ' ' PRO . 0.6 OUTLIER -68.68 172.06 5.25 Favored Pre-proline 0 N--CA 1.488 1.475 0 O-C-N 121.269 -0.894 . . . . 0.0 109.257 -179.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.46 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 35.1 Cg_endo -77.66 4.56 5.92 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 122.623 2.215 . . . . 0.0 110.408 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.6 t -122.13 -20.23 6.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.307 -0.871 . . . . 0.0 109.58 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 128.59 6.51 4.62 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.416 ' CB ' ' HB2' ' A' ' 37' ' ' SER . 0.5 OUTLIER -80.29 105.88 11.88 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.123 -1.222 . . . . 0.0 109.146 179.79 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.439 ' HG3' ' HG3' ' A' ' 36' ' ' GLN . 15.6 mtp180 -97.5 125.43 42.18 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.181 -0.95 . . . . 0.0 110.078 -179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.653 HG21 ' CA ' ' A' ' 49' ' ' LEU . 4.8 mt -127.65 163.91 30.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.333 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.54 ' HB3' ' CD1' ' A' ' 34' ' ' TYR . 0.0 OUTLIER -160.31 18.17 0.14 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.894 -1.129 . . . . 0.0 110.654 -179.575 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.567 ' HB2' ' CB ' ' A' ' 48' ' ' GLU . 0.4 OUTLIER -99.98 18.13 19.24 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.856 -1.152 . . . . 0.0 109.397 179.761 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.586 ' HB2' ' CD1' ' A' ' 64' ' ' PHE . 12.7 tttt 64.36 -92.49 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.502 -0.749 . . . . 0.0 110.473 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.488 ' HA ' ' OG1' ' A' ' 50' ' ' THR . 74.8 t -62.33 -27.93 43.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.018 -1.051 . . . . 0.0 109.369 -179.331 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.567 ' CB ' ' HB2' ' A' ' 45' ' ' SER . 23.9 tt0 -61.06 -49.28 77.99 Favored 'General case' 0 C--N 1.304 -1.393 0 N-CA-C 108.161 -1.051 . . . . 0.0 108.161 179.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.683 HD12 HD11 ' A' ' 53' ' ' LEU . 0.8 OUTLIER -68.13 -23.72 64.93 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.814 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.544 ' OG1' ' CB ' ' A' ' 59' ' ' LEU . 26.9 m -65.65 -70.87 0.21 Allowed 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.425 ' C ' ' O ' ' A' ' 50' ' ' THR . 0.0 OUTLIER -43.57 -26.79 0.24 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.507 -0.746 . . . . 0.0 109.028 179.547 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.422 ' N ' ' O ' ' A' ' 50' ' ' THR . 37.1 t80 -64.16 -62.95 1.29 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.286 -0.884 . . . . 0.0 109.565 179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.683 HD11 HD12 ' A' ' 49' ' ' LEU . 0.5 OUTLIER -55.57 -57.94 9.84 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.125 -0.984 . . . . 0.0 109.274 -179.92 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 131.06 -155.01 21.07 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 -179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.48 -9.5 16.11 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.623 2.216 . . . . 0.0 110.528 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -81.14 -13.99 58.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.302 -0.874 . . . . 0.0 109.638 -179.902 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.47 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 88.1 m -134.07 79.27 1.8 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.191 -0.943 . . . . 0.0 109.596 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -66.54 137.23 56.64 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.145 -0.972 . . . . 0.0 109.133 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.775 HD23 ' HB3' ' A' ' 62' ' ' PHE . 0.1 OUTLIER -140.46 5.42 2.04 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.276 -0.89 . . . . 0.0 109.878 -179.288 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.629 ' C ' HD22 ' A' ' 61' ' ' LEU . 54.5 m -62.15 -21.36 64.98 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.215 -0.928 . . . . 0.0 109.156 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.629 HD22 ' C ' ' A' ' 60' ' ' THR . 1.7 mm? -107.31 -11.74 15.49 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.387 -0.821 . . . . 0.0 109.217 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.775 ' HB3' HD23 ' A' ' 59' ' ' LEU . 6.1 t80 -54.81 133.41 47.56 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.399 -0.813 . . . . 0.0 109.735 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.547 ' O ' ' CE1' ' A' ' 62' ' ' PHE . 2.4 t0 -80.57 104.74 11.31 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.283 -0.886 . . . . 0.0 108.882 179.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.586 ' CD1' ' HB2' ' A' ' 46' ' ' LYS . 0.6 OUTLIER -67.19 65.04 0.06 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.264 -0.898 . . . . 0.0 109.319 -179.426 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 63' ' ' ASP . 6.3 mtpt 171.48 -37.9 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.396 -0.815 . . . . 0.0 109.388 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -88.16 -46.63 9.11 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.163 -0.961 . . . . 0.0 109.3 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.494 ' HA2' ' CZ ' ' A' ' 62' ' ' PHE . . . 111.77 25.69 4.75 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 110.055 -1.218 . . . . 0.0 110.055 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.467 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -140.72 171.43 12.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.011 -1.288 . . . . 0.0 109.69 179.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 62' ' ' PHE . 1.1 pt? -140.49 -174.3 3.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.22 -0.925 . . . . 0.0 109.337 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 23.0 m -147.09 146.24 29.89 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.187 -0.945 . . . . 0.0 109.592 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.452 ' HB3' ' HD2' ' A' ' 72' ' ' PRO . 56.4 m-85 -97.35 161.31 26.47 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.253 -0.905 . . . . 0.0 109.4 -179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.452 ' HD2' ' HB3' ' A' ' 71' ' ' TYR . 35.7 Cg_endo -78.2 173.11 14.36 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.655 2.237 . . . . 0.0 110.664 -179.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -144.11 79.76 12.81 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.3 -0.875 . . . . 0.0 109.277 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.25 116.74 3.95 Favored 'Trans proline' 0 C--N 1.309 -1.529 0 C-N-CA 122.674 2.249 . . . . 0.0 110.374 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 117.979 -1.01 . . . . 0.0 109.487 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.7 ttt . . . . . 0 N--CA 1.489 1.517 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.17 -166.98 1.66 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.278 -0.889 . . . . 0.0 109.403 -179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.54 ' HG2' ' CZ ' ' A' ' 18' ' ' ARG . 23.4 mp0 -86.07 -171.81 3.76 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.222 -0.924 . . . . 0.0 109.428 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -102.85 55.98 0.77 Allowed 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.3 -0.875 . . . . 0.0 109.42 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.576 ' CZ3' ' HB2' ' A' ' 18' ' ' ARG . 97.9 m95 -64.86 97.93 0.25 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.202 -0.936 . . . . 0.0 109.398 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 81.4 mt -111.3 164.35 12.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.22 -0.925 . . . . 0.0 109.562 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.478 ' OD1' ' N ' ' A' ' 7' ' ' ASP . 0.5 OUTLIER -59.99 145.06 47.59 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.262 -0.898 . . . . 0.0 109.572 179.975 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.514 ' SG ' ' N ' ' A' ' 17' ' ' ARG . 7.1 m -91.24 113.89 59.85 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.258 -0.901 . . . . 0.0 109.886 -179.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.415 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 36.3 Cg_endo -78.98 -27.35 4.66 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.344 2.029 . . . . 0.0 110.412 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.77 ' HB3' HH12 ' A' ' 17' ' ' ARG . . . -70.71 -37.34 73.54 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.106 -0.996 . . . . 0.0 109.839 -179.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.813 HD12 ' CD1' ' A' ' 15' ' ' TRP . 6.5 mt -105.08 -46.37 4.28 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.134 -0.979 . . . . 0.0 109.635 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 135.06 -145.98 18.04 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.38 164.66 26.23 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 122.626 2.217 . . . . 0.0 110.405 -179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 82.8 -51.97 4.64 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.416 -1.473 . . . . 0.0 109.416 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.813 ' CD1' HD12 ' A' ' 11' ' ' LEU . 7.9 t-105 -75.72 125.75 29.66 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.292 -1.122 . . . . 0.0 109.346 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.427 ' C ' ' SG ' ' A' ' 8' ' ' CYS . 10.6 mmtp -103.14 132.4 49.43 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.213 -0.929 . . . . 0.0 109.526 -179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.77 HH12 ' HB3' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -99.22 111.43 23.81 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.507 -0.745 . . . . 0.0 109.413 -179.6 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.576 ' HB2' ' CZ3' ' A' ' 5' ' ' TRP . 1.6 ttt180 -100.11 131.76 45.87 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.174 -0.954 . . . . 0.0 109.61 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -112.35 142.79 44.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.299 -0.876 . . . . 0.0 109.328 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.407 ' O ' ' C ' ' A' ' 21' ' ' PHE . 39.3 t -140.34 91.66 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.139 -0.976 . . . . 0.0 109.778 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.407 ' C ' ' O ' ' A' ' 20' ' ' VAL . 0.7 OUTLIER -44.71 102.16 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.205 -0.934 . . . . 0.0 109.193 179.736 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.484 ' CG ' ' OD2' ' A' ' 32' ' ' ASP . 0.5 OUTLIER -75.05 -69.06 0.49 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.348 -0.845 . . . . 0.0 110.026 -179.596 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.509 ' O ' ' CB ' ' A' ' 24' ' ' SER . 4.7 mttm -73.46 -58.86 3.02 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.224 -0.923 . . . . 0.0 109.906 -179.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.509 ' CB ' ' O ' ' A' ' 23' ' ' LYS . 5.2 t 75.39 111.74 0.07 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.164 -0.96 . . . . 0.0 109.417 -179.795 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 129.83 -30.95 3.46 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.58 65.8 0.69 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.213 -1.169 . . . . 0.0 109.523 -179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.415 ' O ' ' C ' ' A' ' 28' ' ' CYS . 0.1 OUTLIER 45.09 53.69 7.59 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.29 -0.881 . . . . 0.0 109.546 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.415 ' C ' ' O ' ' A' ' 27' ' ' THR . 1.2 m 43.77 50.34 6.8 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.278 -0.889 . . . . 0.0 109.414 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -131.47 156.28 21.77 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 67.63 133.41 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.248 -1.148 . . . . 0.0 109.53 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 44.3 p -178.43 165.86 1.79 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.302 -0.874 . . . . 0.0 109.38 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.497 ' HB3' ' CZ ' ' A' ' 34' ' ' TYR . 3.7 m-20 -87.84 123.75 32.93 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.243 -0.911 . . . . 0.0 109.225 179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.78 109.4 17.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.203 -0.936 . . . . 0.0 109.827 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.591 ' CD1' ' CD ' ' A' ' 44' ' ' ARG . 11.4 m-85 -112.49 138.07 49.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.256 -0.902 . . . . 0.0 108.992 179.502 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.638 ' HD2' HD22 ' A' ' 49' ' ' LEU . 5.3 m-85 -108.18 151.11 26.36 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.136 -0.977 . . . . 0.0 109.827 -179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.4 tt0 -132.24 128.73 38.52 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.361 -0.837 . . . . 0.0 109.533 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.517 ' OG ' ' CB ' ' A' ' 41' ' ' ASP . 0.4 OUTLIER -71.94 174.68 3.77 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.28 -0.888 . . . . 0.0 109.511 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.509 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 35.9 Cg_endo -78.61 -4.49 14.15 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.722 2.282 . . . . 0.0 110.417 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.458 HG22 ' HB2' ' A' ' 37' ' ' SER . 2.4 t -103.92 -18.55 14.57 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.241 -0.912 . . . . 0.0 109.518 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 120.71 12.44 6.04 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.599 -1.4 . . . . 0.0 109.599 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.517 ' CB ' ' OG ' ' A' ' 37' ' ' SER . 0.4 OUTLIER -83.25 127.6 33.78 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.243 -1.151 . . . . 0.0 109.571 -179.908 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.08 131.71 56.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.244 -0.91 . . . . 0.0 109.277 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.603 HG22 ' H ' ' A' ' 45' ' ' SER . 2.6 mp -137.64 161.49 33.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.225 -0.922 . . . . 0.0 109.611 -179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.591 ' CD ' ' CD1' ' A' ' 34' ' ' TYR . 34.8 mtm180 -143.79 18.42 1.81 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.316 -0.865 . . . . 0.0 109.557 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.603 ' H ' HG22 ' A' ' 43' ' ' ILE . 0.5 OUTLIER -91.88 -88.54 0.2 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.293 -0.879 . . . . 0.0 108.907 179.504 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.563 ' HB2' ' CD1' ' A' ' 64' ' ' PHE . 19.3 ttpt 159.52 -63.39 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.479 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 77.2 t -85.38 -21.54 7.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.489 ' O ' ' HG3' ' A' ' 51' ' ' ARG . 98.3 mt-10 -68.71 -44.81 73.13 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 178.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.638 HD22 ' HD2' ' A' ' 35' ' ' TYR . 3.4 pp -71.05 -25.07 62.49 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 178.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.856 ' OG1' HD13 ' A' ' 59' ' ' LEU . 20.5 m -68.59 -63.29 1.09 Allowed 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 178.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.489 ' HG3' ' O ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -49.45 -23.96 1.79 Allowed 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.394 -0.816 . . . . 0.0 108.872 179.391 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.503 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 2.6 t80 -67.32 -64.64 0.81 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.303 -0.873 . . . . 0.0 109.159 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.676 HD21 ' CE3' ' A' ' 15' ' ' TRP . 0.6 OUTLIER -51.1 -57.85 7.63 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.04 -1.038 . . . . 0.0 109.257 179.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 141.16 -157.15 25.94 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -78.07 -9.7 16.62 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.592 2.195 . . . . 0.0 110.248 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.17 -13.56 59.93 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.297 -0.877 . . . . 0.0 109.438 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 73.3 m -132.99 130.23 39.23 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.356 -0.84 . . . . 0.0 109.19 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.685 ' C ' HD12 ' A' ' 59' ' ' LEU . 25.4 t0 -126.19 152.56 45.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.168 -0.958 . . . . 0.0 109.832 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.856 HD13 ' OG1' ' A' ' 50' ' ' THR . 5.2 mp -148.64 14.7 0.96 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.388 -0.82 . . . . 0.0 109.395 179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.609 ' C ' HD22 ' A' ' 61' ' ' LEU . 22.3 m -46.35 -37.35 7.38 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.323 -0.861 . . . . 0.0 109.84 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.609 HD22 ' C ' ' A' ' 60' ' ' THR . 1.1 mm? -111.38 2.43 17.58 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.3 -0.875 . . . . 0.0 109.606 -179.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.579 ' CE1' ' CB ' ' A' ' 10' ' ' ALA . 78.3 t80 -58.68 146.33 36.8 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.353 -0.842 . . . . 0.0 109.656 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.496 ' O ' ' N ' ' A' ' 65' ' ' LYS . 5.1 t0 -98.44 103.32 15.26 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.33 -0.856 . . . . 0.0 108.972 179.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.622 ' CE1' ' CE2' ' A' ' 35' ' ' TYR . 0.7 OUTLIER -66.61 69.64 0.07 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.149 -0.97 . . . . 0.0 109.426 -179.36 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.496 ' N ' ' O ' ' A' ' 63' ' ' ASP . 11.9 ttpp 177.07 -46.22 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.266 -0.896 . . . . 0.0 109.579 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -92.41 -39.35 11.48 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.24 -0.912 . . . . 0.0 109.728 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.481 ' HA2' ' CZ ' ' A' ' 62' ' ' PHE . . . 106.03 35.17 3.02 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.469 ' O ' ' N ' ' A' ' 63' ' ' ASP . 2.0 pp -140.52 173.41 9.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.16 -1.2 . . . . 0.0 109.628 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.471 ' HB3' ' HA ' ' A' ' 62' ' ' PHE . 0.7 OUTLIER -147.24 -164.83 2.09 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 179.78 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.451 ' SG ' ' O ' ' A' ' 69' ' ' LEU . 62.1 m -151.71 -162.23 1.48 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.947 -1.096 . . . . 0.0 110.134 179.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.536 ' CD1' ' N ' ' A' ' 71' ' ' TYR . 1.7 p90 -147.82 164.37 22.8 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.432 -0.792 . . . . 0.0 109.424 -179.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.486 ' HD2' ' HB2' ' A' ' 71' ' ' TYR . 35.1 Cg_endo -77.41 -175.02 2.45 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.486 2.124 . . . . 0.0 110.348 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -139.72 154.75 71.35 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.282 -0.886 . . . . 0.0 109.514 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.53 140.66 17.08 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.683 2.255 . . . . 0.0 110.296 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.565 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.523 ' O ' ' HB3' ' A' ' 2' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.523 ' HB3' ' O ' ' A' ' 1' ' ' MET . . . 65.53 17.9 11.08 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.292 -0.88 . . . . 0.0 109.546 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.456 ' OE1' ' NE ' ' A' ' 18' ' ' ARG . 48.0 mt-10 -151.92 145.05 24.59 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.272 -0.892 . . . . 0.0 109.413 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.436 ' O ' ' C ' ' A' ' 5' ' ' TRP . 0.7 OUTLIER -123.15 66.62 0.98 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.245 -0.909 . . . . 0.0 109.597 -179.933 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.436 ' C ' ' O ' ' A' ' 4' ' ' ASP . 71.9 m95 -43.4 108.39 0.11 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.301 -0.874 . . . . 0.0 109.316 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.72 158.77 17.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.194 -0.941 . . . . 0.0 109.684 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.449 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 0.5 OUTLIER -53.16 138.93 30.35 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.222 -0.923 . . . . 0.0 109.126 179.695 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.455 ' HB2' ' HB2' ' A' ' 17' ' ' ARG . 40.3 t -98.99 109.17 52.99 Favored Pre-proline 0 N--CA 1.489 1.506 0 O-C-N 121.101 -0.999 . . . . 0.0 109.878 -179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.463 ' HD2' ' CZ ' ' A' ' 17' ' ' ARG . 34.4 Cg_endo -77.23 -38.79 0.69 Allowed 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.205 1.937 . . . . 0.0 110.111 179.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.633 ' C ' HD23 ' A' ' 11' ' ' LEU . . . -42.97 -32.18 0.61 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.28 -0.887 . . . . 0.0 109.473 179.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.969 HD12 ' CD1' ' A' ' 15' ' ' TRP . 5.3 mt -115.93 -67.01 1.03 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.21 -0.931 . . . . 0.0 109.48 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 167.1 -149.1 14.17 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -77.88 169.21 20.99 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 C-N-CA 122.688 2.259 . . . . 0.0 110.666 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 75.35 -56.18 2.84 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.634 -1.387 . . . . 0.0 109.634 179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.969 ' CD1' HD12 ' A' ' 11' ' ' LEU . 10.0 t-105 -62.15 123.41 18.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.256 -1.143 . . . . 0.0 109.774 -179.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -103.54 120.53 41.05 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.281 -0.887 . . . . 0.0 109.547 179.738 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.576 ' HG3' ' CE2' ' A' ' 35' ' ' TYR . 3.2 ttp85 -95.3 114.94 26.78 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.217 -0.927 . . . . 0.0 109.347 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.456 ' NE ' ' OE1' ' A' ' 3' ' ' GLU . 4.0 tmm_? -100.24 139.37 36.01 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.183 -0.948 . . . . 0.0 109.571 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -108.68 144.69 36.12 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.209 -0.932 . . . . 0.0 109.482 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.48 HG12 ' N ' ' A' ' 21' ' ' PHE . 42.7 t -128.14 159.89 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.184 -0.947 . . . . 0.0 109.428 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.517 ' O ' ' N ' ' A' ' 23' ' ' LYS . 13.1 p90 -116.09 66.28 0.71 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.318 -0.864 . . . . 0.0 109.192 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.459 ' CG ' ' O ' ' A' ' 22' ' ' ARG . 0.0 OUTLIER -52.15 88.85 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.439 -0.788 . . . . 0.0 109.613 -179.886 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.517 ' N ' ' O ' ' A' ' 21' ' ' PHE . 7.7 mtmt 60.22 168.1 0.08 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.277 -0.889 . . . . 0.0 109.467 179.904 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.4 t -120.05 158.03 27.67 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.267 -0.895 . . . . 0.0 109.531 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -168.53 -117.8 0.42 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.163 -1.575 . . . . 0.0 109.163 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.7 169.0 0.16 Allowed 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.129 -1.218 . . . . 0.0 109.12 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.726 ' O ' HG23 ' A' ' 27' ' ' THR . 7.9 t -61.88 96.92 0.07 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.134 -0.979 . . . . 0.0 109.401 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 48.89 52.06 14.88 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.199 -0.938 . . . . 0.0 109.279 -179.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.51 -60.55 8.32 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -152.64 155.97 38.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.201 -1.176 . . . . 0.0 109.672 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.0 p -141.17 148.81 40.6 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.357 -0.839 . . . . 0.0 109.201 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.439 ' OD2' ' HB3' ' A' ' 22' ' ' ARG . 9.8 m-20 -79.81 139.85 37.06 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.193 -0.942 . . . . 0.0 109.245 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.52 HG22 ' CZ ' ' A' ' 35' ' ' TYR . 31.2 m -128.72 126.06 39.26 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.22 -0.925 . . . . 0.0 109.778 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.615 ' CD1' ' N ' ' A' ' 34' ' ' TYR . 1.7 m-85 -115.14 167.18 11.05 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.38 -0.97 . . . . 0.0 108.38 179.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.64 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 2.5 m-85 -136.72 146.27 45.64 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.866 -1.146 . . . . 0.0 110.08 -179.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 10.4 tt0 -128.49 124.8 37.0 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.478 -0.763 . . . . 0.0 109.344 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.514 ' CB ' ' HD2' ' A' ' 38' ' ' PRO . 0.3 OUTLIER -68.19 174.98 2.02 Favored Pre-proline 0 N--CA 1.487 1.417 0 O-C-N 121.285 -0.884 . . . . 0.0 109.32 179.988 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.514 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 35.1 Cg_endo -78.14 5.35 5.46 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.65 2.234 . . . . 0.0 110.335 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.462 HG22 ' HB2' ' A' ' 37' ' ' SER . 15.3 t -114.6 -24.83 8.58 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.254 -0.904 . . . . 0.0 109.417 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 124.24 13.34 3.98 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 179.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.469 ' HB2' ' OH ' ' A' ' 52' ' ' TYR . 0.3 OUTLIER -90.95 112.53 24.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.132 -1.217 . . . . 0.0 109.24 179.882 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.485 ' CZ ' ' HB2' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -95.57 139.33 31.99 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.274 -0.891 . . . . 0.0 109.618 -179.75 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.645 HD13 ' HA ' ' A' ' 49' ' ' LEU . 4.0 mt -135.98 161.21 38.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.187 -0.946 . . . . 0.0 109.566 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.591 ' HG3' ' CD2' ' A' ' 34' ' ' TYR . 0.1 OUTLIER -152.6 15.12 0.58 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.239 -0.913 . . . . 0.0 110.257 -179.37 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.579 ' CB ' ' HB3' ' A' ' 48' ' ' GLU . 0.3 OUTLIER -99.61 21.55 12.15 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.924 -1.11 . . . . 0.0 109.456 179.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.612 ' HA ' ' CE1' ' A' ' 64' ' ' PHE . 8.1 ttpt 59.3 -94.01 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.365 -0.834 . . . . 0.0 109.973 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.464 ' HA ' ' OG1' ' A' ' 50' ' ' THR . 26.3 t -59.0 -38.0 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.036 -1.04 . . . . 0.0 109.314 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.579 ' HB3' ' CB ' ' A' ' 45' ' ' SER . 71.3 tt0 -51.26 -43.44 61.56 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.002 -1.061 . . . . 0.0 108.356 179.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.693 HD21 HD22 ' A' ' 59' ' ' LEU . 0.5 OUTLIER -66.45 -27.86 68.15 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 179.393 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.526 ' N ' ' HG ' ' A' ' 49' ' ' LEU . 1.5 m -71.27 -66.22 0.65 Allowed 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.07 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.467 ' CD ' ' HA ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -47.84 -24.33 0.97 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.357 -0.839 . . . . 0.0 108.778 179.321 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.479 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 62.4 t80 -63.34 -60.18 3.73 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.264 -0.898 . . . . 0.0 109.114 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.672 HD21 ' CE3' ' A' ' 15' ' ' TRP . 0.3 OUTLIER -60.74 -55.19 36.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.182 -0.949 . . . . 0.0 108.969 179.642 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 142.74 -155.33 25.78 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.27 -1.532 . . . . 0.0 109.27 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_endo -78.02 -18.84 12.71 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.537 2.158 . . . . 0.0 110.366 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -67.22 -10.52 51.37 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.326 -0.859 . . . . 0.0 109.56 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.466 ' CB ' HD13 ' A' ' 53' ' ' LEU . 18.0 m -133.41 136.71 45.42 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.227 -0.921 . . . . 0.0 109.522 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.63 ' C ' HD12 ' A' ' 59' ' ' LEU . 18.3 t70 -130.95 148.59 52.73 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.272 -0.893 . . . . 0.0 109.49 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.693 HD22 HD21 ' A' ' 49' ' ' LEU . 4.1 mp -148.24 10.5 0.88 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.208 -0.932 . . . . 0.0 109.696 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.629 ' C ' HD22 ' A' ' 61' ' ' LEU . 94.5 m -49.92 -29.06 7.59 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.146 -0.971 . . . . 0.0 109.145 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.629 HD22 ' C ' ' A' ' 60' ' ' THR . 1.5 mm? -111.07 -8.42 14.44 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.322 -0.861 . . . . 0.0 109.381 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.618 ' CD2' HD23 ' A' ' 59' ' ' LEU . 48.0 t80 -59.18 131.1 50.01 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.378 -0.826 . . . . 0.0 109.337 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.63 117.49 20.6 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.192 -0.943 . . . . 0.0 109.261 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.612 ' CE1' ' HA ' ' A' ' 46' ' ' LYS . 0.4 OUTLIER -73.89 56.75 0.59 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.219 -0.926 . . . . 0.0 109.065 -179.94 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.14 -41.6 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.378 -0.826 . . . . 0.0 109.022 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -81.14 -46.66 14.58 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.267 -0.895 . . . . 0.0 109.113 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.503 ' HA3' ' NH1' ' A' ' 17' ' ' ARG . . . 104.22 28.63 5.74 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 110.085 -1.206 . . . . 0.0 110.085 179.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.469 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 1.1 pp -140.6 161.48 24.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.022 -1.281 . . . . 0.0 109.757 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.427 ' HB3' ' HA ' ' A' ' 62' ' ' PHE . 0.7 OUTLIER -143.74 173.84 11.33 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.339 -0.851 . . . . 0.0 108.935 179.74 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 21.6 p -159.85 -169.08 2.42 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.118 -0.989 . . . . 0.0 109.767 179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -162.92 88.54 1.3 Allowed Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.331 -0.856 . . . . 0.0 109.4 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.695 ' O ' ' HB2' ' A' ' 73' ' ' ALA . 35.5 Cg_endo -78.27 147.47 23.2 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 C-N-CA 122.663 2.242 . . . . 0.0 110.544 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.934 ' HB3' ' HD3' ' A' ' 74' ' ' PRO . . . 163.41 -53.28 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.362 -0.837 . . . . 0.0 109.48 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.934 ' HD3' ' HB3' ' A' ' 73' ' ' ALA . 36.2 Cg_endo -78.7 -27.51 4.87 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 C-N-CA 122.48 2.12 . . . . 0.0 110.394 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.6 mttt . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 117.989 -1.005 . . . . 0.0 109.414 -179.905 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.9 ptt? . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -112.1 154.7 25.05 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.301 -0.874 . . . . 0.0 109.453 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.429 ' HG2' ' HD3' ' A' ' 18' ' ' ARG . 0.1 OUTLIER -116.37 -149.56 0.45 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.292 -0.88 . . . . 0.0 109.578 -179.877 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.401 ' O ' HD23 ' A' ' 6' ' ' LEU . 3.2 m-20 -95.81 30.42 2.37 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.248 -0.908 . . . . 0.0 109.644 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.555 ' CZ3' ' HB2' ' A' ' 36' ' ' GLN . 98.7 m95 -48.77 104.06 0.05 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.221 -0.924 . . . . 0.0 109.212 179.814 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.401 HD23 ' O ' ' A' ' 4' ' ' ASP . 0.6 OUTLIER -110.8 160.75 16.46 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.181 -0.949 . . . . 0.0 109.617 -179.78 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -56.39 149.32 17.03 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.237 -0.914 . . . . 0.0 109.206 179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.448 ' SG ' ' HG ' ' A' ' 11' ' ' LEU . 38.0 t -111.75 103.83 55.51 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.128 -0.983 . . . . 0.0 109.848 -179.716 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.92 -26.21 6.88 Favored 'Trans proline' 0 C--N 1.31 -1.472 0 C-N-CA 122.373 2.049 . . . . 0.0 109.878 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.475 ' CB ' ' CE2' ' A' ' 62' ' ' PHE . . . -54.06 -34.63 60.56 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.406 -0.809 . . . . 0.0 109.314 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 1.03 HD12 ' CD1' ' A' ' 15' ' ' TRP . 12.2 mt -105.88 -66.79 0.97 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.292 -0.88 . . . . 0.0 109.358 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 157.98 -153.16 24.37 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.604 -1.398 . . . . 0.0 109.604 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.79 137.34 15.89 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.669 2.246 . . . . 0.0 110.353 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.29 23.25 17.35 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 1.03 ' CD1' HD12 ' A' ' 11' ' ' LEU . 27.6 t-105 -150.1 125.59 10.24 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.24 -1.153 . . . . 0.0 109.334 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 1.9 mmmt -105.9 134.66 48.67 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.15 -0.969 . . . . 0.0 109.538 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.508 ' HG3' ' CE2' ' A' ' 35' ' ' TYR . 3.7 ttp85 -103.6 111.68 24.26 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.311 -0.868 . . . . 0.0 109.643 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.548 ' HG3' ' CE2' ' A' ' 5' ' ' TRP . 0.3 OUTLIER -97.65 155.41 17.0 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.224 -0.923 . . . . 0.0 109.151 179.716 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -123.03 168.61 12.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.116 -0.99 . . . . 0.0 109.731 -179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.622 HG21 ' CE2' ' A' ' 34' ' ' TYR . 3.4 t -140.03 103.2 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.349 -0.845 . . . . 0.0 109.383 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -89.13 54.32 2.94 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.151 -0.968 . . . . 0.0 109.531 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.94 -25.37 3.2 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.332 -0.855 . . . . 0.0 109.489 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 47.0 25.19 0.45 Allowed 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.156 -0.965 . . . . 0.0 109.362 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.24 90.74 3.13 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.304 -0.873 . . . . 0.0 109.443 -179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 175.03 135.21 2.03 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.29 -165.3 0.18 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.287 -1.125 . . . . 0.0 109.497 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.98 72.17 0.56 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.209 -0.932 . . . . 0.0 109.492 -179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 25.2 p -150.13 18.97 0.87 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.22 -0.925 . . . . 0.0 109.485 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 161.68 -159.47 31.38 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.491 ' CB ' ' HD3' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -161.46 -163.99 1.07 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.296 -1.12 . . . . 0.0 109.241 179.989 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.3 p -51.35 167.71 0.08 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.188 -0.945 . . . . 0.0 109.27 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -110.43 150.21 29.17 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.223 -0.923 . . . . 0.0 109.33 179.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.38 106.31 11.33 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.129 -0.982 . . . . 0.0 109.772 -179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.622 ' CE2' HG21 ' A' ' 20' ' ' VAL . 15.0 m-85 -101.99 167.27 10.15 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.275 -0.89 . . . . 0.0 109.054 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.578 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 3.9 m-85 -135.1 155.16 51.2 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.067 -1.02 . . . . 0.0 109.913 -179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.555 ' HB2' ' CZ3' ' A' ' 5' ' ' TRP . 4.4 tt0 -141.96 132.82 25.79 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.357 -0.839 . . . . 0.0 109.156 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.518 ' CB ' ' HD2' ' A' ' 38' ' ' PRO . 0.1 OUTLIER -70.78 176.13 2.18 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.238 -0.913 . . . . 0.0 109.213 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.518 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 35.7 Cg_endo -78.69 0.29 10.1 Favored 'Trans proline' 0 C--N 1.307 -1.65 0 C-N-CA 122.535 2.156 . . . . 0.0 110.289 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.475 HG22 ' HB2' ' A' ' 37' ' ' SER . 10.1 t -106.48 -21.58 13.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.338 -0.851 . . . . 0.0 109.575 -179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 122.51 10.95 5.76 Favored Glycine 0 N--CA 1.492 2.374 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.437 ' CB ' ' OG ' ' A' ' 37' ' ' SER . 0.1 OUTLIER -79.76 102.97 9.34 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.232 -1.158 . . . . 0.0 109.472 179.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 9.3 mtp85 -90.48 117.3 29.07 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.281 -0.887 . . . . 0.0 109.477 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.647 HG21 ' N ' ' A' ' 49' ' ' LEU . 2.9 mp -121.63 153.04 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.277 -0.889 . . . . 0.0 109.494 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.47 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 8.7 mtm-85 -148.73 16.9 1.0 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.233 -0.917 . . . . 0.0 110.237 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.561 ' HB3' ' CB ' ' A' ' 48' ' ' GLU . 1.6 t -100.66 16.75 23.84 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.979 -1.076 . . . . 0.0 110.368 -179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.612 ' HA ' ' CE1' ' A' ' 64' ' ' PHE . 25.6 tttt 63.73 -94.18 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.221 -0.924 . . . . 0.0 110.92 178.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.448 ' HA ' ' OG1' ' A' ' 50' ' ' THR . 54.9 t -58.72 -27.88 35.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.906 -1.121 . . . . 0.0 109.656 -178.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.561 ' CB ' ' HB3' ' A' ' 45' ' ' SER . 14.7 tt0 -61.12 -47.79 84.65 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.093 -1.004 . . . . 0.0 108.525 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 1.012 HD13 ' CZ2' ' A' ' 15' ' ' TRP . 1.0 OUTLIER -67.75 -23.79 65.28 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.94 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.547 ' OG1' ' CB ' ' A' ' 59' ' ' LEU . 17.0 m -66.92 -68.76 0.35 Allowed 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.074 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.66 -20.41 2.04 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.533 -0.73 . . . . 0.0 109.23 179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.485 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 44.5 t80 -66.76 -50.57 62.3 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.223 -0.923 . . . . 0.0 109.276 179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.851 HD11 HD12 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -70.56 -48.52 55.0 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.19 -0.944 . . . . 0.0 109.093 179.93 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 121.6 -156.59 16.5 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.183 -1.567 . . . . 0.0 109.183 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -78.9 8.08 3.96 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.574 2.183 . . . . 0.0 110.552 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -88.53 -23.56 23.14 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.141 -0.974 . . . . 0.0 109.558 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.464 ' HB2' HD13 ' A' ' 53' ' ' LEU . 95.8 m -133.28 101.1 5.05 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.285 -0.884 . . . . 0.0 109.499 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -75.62 131.12 39.76 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.178 -0.951 . . . . 0.0 109.448 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.869 HD13 HD11 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -132.37 0.9 3.74 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.369 -0.832 . . . . 0.0 109.697 -179.689 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.434 ' O ' HD22 ' A' ' 61' ' ' LEU . 8.2 m -47.54 -34.35 7.53 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.335 -0.853 . . . . 0.0 110.24 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.499 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 0.7 OUTLIER -108.09 0.24 21.55 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.057 -1.027 . . . . 0.0 109.93 -179.321 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.748 ' CB ' HD23 ' A' ' 59' ' ' LEU . 3.4 t80 -51.61 131.55 29.8 Favored 'General case' 0 C--N 1.3 -1.575 0 O-C-N 121.17 -0.956 . . . . 0.0 109.358 -179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.486 ' O ' ' N ' ' A' ' 65' ' ' LYS . 99.0 m-20 -79.22 104.16 9.65 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.21 -0.931 . . . . 0.0 108.768 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.612 ' CE1' ' HA ' ' A' ' 46' ' ' LYS . 0.5 OUTLIER -68.62 58.86 0.09 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.337 -0.852 . . . . 0.0 109.658 -179.138 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.491 ' HD3' ' CB ' ' A' ' 30' ' ' ARG . 2.7 tmmt? 178.09 -33.63 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.272 -0.892 . . . . 0.0 109.432 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -92.12 -44.04 9.03 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.18 -0.95 . . . . 0.0 109.501 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.442 ' O ' ' HB2' ' A' ' 10' ' ' ALA . . . 110.95 25.31 5.16 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.567 HD12 ' N ' ' A' ' 69' ' ' LEU . 1.3 pp -140.31 -170.96 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.286 -1.126 . . . . 0.0 109.557 -179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.58 ' N ' HD23 ' A' ' 69' ' ' LEU . 1.1 pt? -153.42 178.53 9.69 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.378 -0.826 . . . . 0.0 109.0 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.471 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 0.8 OUTLIER -155.24 -165.16 1.94 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.139 -0.976 . . . . 0.0 109.24 179.635 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.489 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 0.3 OUTLIER -177.76 63.02 0.18 Allowed Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.166 -0.959 . . . . 0.0 109.909 -179.896 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.489 ' HD3' ' N ' ' A' ' 71' ' ' TYR . 35.0 Cg_endo -77.99 177.91 8.22 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.526 2.151 . . . . 0.0 110.123 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.422 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . . . -80.49 139.67 51.57 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.076 -1.015 . . . . 0.0 109.436 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 73' ' ' ALA . 36.2 Cg_endo -78.83 61.75 8.18 Favored 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.548 2.165 . . . . 0.0 110.621 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 36.1 tttt . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.435 179.921 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.681 ' O ' ' HB3' ' A' ' 2' ' ' ALA . 1.4 mpt? . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.253 0.549 . . . . 0.0 109.565 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.681 ' HB3' ' O ' ' A' ' 1' ' ' MET . . . 75.89 179.49 0.17 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.362 -0.836 . . . . 0.0 109.377 -179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.4 105.0 17.02 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.232 -0.918 . . . . 0.0 109.588 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.482 ' O ' ' O ' ' A' ' 5' ' ' TRP . 11.5 m-20 -143.71 15.39 1.77 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.221 -0.925 . . . . 0.0 109.578 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.598 ' CZ3' ' HB2' ' A' ' 36' ' ' GLN . 73.5 m95 48.41 102.38 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.656 -0.653 . . . . 0.0 109.912 179.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.9 mt -102.78 152.62 21.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.117 -0.989 . . . . 0.0 109.685 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.474 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 5.3 m-20 -50.75 131.12 25.79 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.282 -0.886 . . . . 0.0 109.587 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.522 ' SG ' ' CZ ' ' A' ' 17' ' ' ARG . 12.1 t -82.06 113.94 47.11 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.33 -0.856 . . . . 0.0 109.629 -179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 36.5 Cg_endo -80.63 -55.61 0.04 OUTLIER 'Trans proline' 0 C--N 1.314 -1.282 0 C-N-CA 122.508 2.139 . . . . 0.0 110.909 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.64 ' HB3' ' NH1' ' A' ' 17' ' ' ARG . . . -37.99 -58.62 0.92 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.559 -0.713 . . . . 0.0 110.216 -179.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.88 HD12 ' CD1' ' A' ' 15' ' ' TRP . 13.6 mt -79.38 -58.52 3.17 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.323 -0.861 . . . . 0.0 109.633 -179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 131.29 -140.82 12.11 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.81 138.0 16.44 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 C-N-CA 122.509 2.139 . . . . 0.0 110.477 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.464 ' O ' ' HD3' ' A' ' 38' ' ' PRO . . . 99.3 14.14 36.63 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 1.028 ' CZ3' HD21 ' A' ' 53' ' ' LEU . 7.5 t-105 -148.36 137.06 21.59 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.229 -1.159 . . . . 0.0 109.532 -179.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -109.76 129.22 55.64 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.261 -0.899 . . . . 0.0 109.313 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.64 ' NH1' ' HB3' ' A' ' 10' ' ' ALA . 0.6 OUTLIER -98.38 98.04 9.32 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.249 -0.907 . . . . 0.0 109.436 -179.914 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.59 ' HB2' ' CE3' ' A' ' 5' ' ' TRP . 1.5 ttm180 -100.45 134.81 42.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.253 -0.904 . . . . 0.0 109.337 179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.1 pt-20 -115.14 156.91 24.4 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.19 -0.944 . . . . 0.0 109.379 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.639 HG12 ' H ' ' A' ' 21' ' ' PHE . 3.6 t -130.71 175.27 11.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.153 -0.967 . . . . 0.0 109.434 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.639 ' H ' HG12 ' A' ' 20' ' ' VAL . 0.0 OUTLIER -116.46 80.81 1.52 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.189 -0.944 . . . . 0.0 109.635 -179.869 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 15.9 tpt180 -46.53 -59.37 3.03 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.28 -0.888 . . . . 0.0 109.379 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 62.6 83.97 0.15 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.286 -0.884 . . . . 0.0 109.371 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.2 p -129.74 61.02 1.57 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.226 -0.921 . . . . 0.0 109.471 179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 117.88 -162.37 13.09 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.454 -1.458 . . . . 0.0 109.454 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -91.73 65.99 5.14 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.2 -1.176 . . . . 0.0 109.496 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 90.8 m -129.9 85.04 2.26 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.25 -0.906 . . . . 0.0 109.435 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 12.4 t -72.29 87.29 1.12 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.268 -0.895 . . . . 0.0 109.458 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 169.84 -34.46 0.17 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.48 149.55 47.08 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.298 -1.119 . . . . 0.0 109.343 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -179.14 138.24 0.14 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.185 -0.947 . . . . 0.0 109.7 -179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -80.26 127.66 32.62 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.374 -0.829 . . . . 0.0 109.079 179.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.477 ' HB ' ' O ' ' A' ' 64' ' ' PHE . 87.2 m -114.9 132.96 56.36 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.171 -0.956 . . . . 0.0 109.525 -179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.44 ' CD1' ' HB3' ' A' ' 44' ' ' ARG . 27.9 m-85 -129.68 149.27 51.5 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.293 -0.88 . . . . 0.0 109.409 179.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.689 ' CD2' ' CZ ' ' A' ' 64' ' ' PHE . 12.3 m-85 -113.81 154.2 27.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.254 -0.904 . . . . 0.0 109.178 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.598 ' HB2' ' CZ3' ' A' ' 5' ' ' TRP . 0.7 OUTLIER -131.11 126.45 35.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.188 -0.945 . . . . 0.0 109.613 -179.877 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.534 ' HB3' HG22 ' A' ' 39' ' ' THR . 0.4 OUTLIER -62.97 170.97 2.15 Favored Pre-proline 0 N--CA 1.489 1.511 0 O-C-N 121.356 -0.84 . . . . 0.0 109.364 179.864 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 14' ' ' GLY . 35.6 Cg_endo -78.41 5.99 5.1 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.577 2.185 . . . . 0.0 110.472 179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.534 HG22 ' HB3' ' A' ' 37' ' ' SER . 1.7 t -115.14 -16.13 11.61 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.247 -0.908 . . . . 0.0 109.524 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 124.55 3.52 7.82 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.658 -1.377 . . . . 0.0 109.658 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.462 ' O ' ' HA ' ' A' ' 36' ' ' GLN . 0.7 OUTLIER -76.87 157.0 31.74 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.276 -1.132 . . . . 0.0 109.325 -179.988 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.441 ' O ' ' HG2' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -143.32 122.75 13.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.224 -0.922 . . . . 0.0 109.618 -179.874 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.517 HD13 ' CB ' ' A' ' 49' ' ' LEU . 2.6 mp -128.95 153.44 38.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.277 -0.89 . . . . 0.0 109.559 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.589 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 8.5 ptt85 -117.3 -15.14 10.41 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.273 -0.892 . . . . 0.0 109.242 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.579 ' CB ' ' HB2' ' A' ' 48' ' ' GLU . 1.1 m -91.02 124.82 35.55 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.217 -0.927 . . . . 0.0 108.813 179.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.551 ' CG ' ' N ' ' A' ' 47' ' ' VAL . 33.6 pttt -60.46 -48.18 82.88 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.268 -0.895 . . . . 0.0 110.442 -178.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.551 ' N ' ' CG ' ' A' ' 46' ' ' LYS . 86.6 t -77.22 -31.49 18.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.067 -1.021 . . . . 0.0 109.668 -179.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.579 ' HB2' ' CB ' ' A' ' 45' ' ' SER . 39.1 tt0 -59.25 -51.71 68.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.96 -1.087 . . . . 0.0 108.604 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.731 ' O ' HD12 ' A' ' 53' ' ' LEU . 3.2 pp -69.22 -33.62 73.59 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 178.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.645 ' OG1' HD13 ' A' ' 59' ' ' LEU . 22.8 m -52.33 -67.27 0.26 Allowed 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 178.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.472 ' HG3' ' O ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -50.05 -30.88 11.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.416 -0.803 . . . . 0.0 109.213 179.801 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.516 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 28.5 t80 -64.41 -63.01 1.25 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.122 -0.986 . . . . 0.0 108.861 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 1.028 HD21 ' CZ3' ' A' ' 15' ' ' TRP . 0.5 OUTLIER -55.27 -48.49 73.94 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.989 -1.069 . . . . 0.0 108.898 179.391 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 125.84 -159.26 20.27 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.277 -1.529 . . . . 0.0 109.277 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.23 -2.34 12.55 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.541 2.161 . . . . 0.0 110.225 179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.98 -25.15 55.53 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.287 -0.883 . . . . 0.0 109.348 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.401 ' O ' HG23 ' A' ' 50' ' ' THR . 59.7 m -135.11 103.03 5.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.242 -0.911 . . . . 0.0 109.231 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.839 ' C ' HD12 ' A' ' 59' ' ' LEU . 10.0 p30 -95.41 161.43 14.08 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.177 -0.952 . . . . 0.0 109.869 -179.624 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.911 HD23 ' CD2' ' A' ' 62' ' ' PHE . 5.0 mp -154.6 20.02 0.47 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.441 -0.787 . . . . 0.0 109.282 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.566 ' C ' HD22 ' A' ' 61' ' ' LEU . 21.0 m -47.24 -40.3 16.12 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.326 -0.859 . . . . 0.0 109.75 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.585 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 0.8 OUTLIER -110.78 5.22 20.56 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.206 -0.934 . . . . 0.0 109.873 -179.387 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.911 ' CD2' HD23 ' A' ' 59' ' ' LEU . 54.7 t80 -71.88 136.07 46.79 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.192 -0.943 . . . . 0.0 109.418 -179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.481 ' HB2' ' HB2' ' A' ' 66' ' ' GLN . 2.4 m-20 -95.94 120.09 35.59 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.34 -0.85 . . . . 0.0 108.977 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.689 ' CZ ' ' CD2' ' A' ' 35' ' ' TYR . 0.6 OUTLIER -66.61 -11.72 54.75 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.278 -0.888 . . . . 0.0 109.512 -179.55 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -101.92 -41.71 6.38 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.208 -0.933 . . . . 0.0 110.112 -179.573 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.481 ' HB2' ' HB2' ' A' ' 63' ' ' ASP . 5.9 mt-30 -83.22 -37.8 23.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.101 -1.0 . . . . 0.0 109.856 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.584 ' HA2' ' CZ ' ' A' ' 62' ' ' PHE . . . 89.31 29.65 16.37 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.652 -1.379 . . . . 0.0 109.652 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.486 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -139.58 160.26 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.202 -1.176 . . . . 0.0 109.367 179.914 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.617 ' N ' HD23 ' A' ' 69' ' ' LEU . 1.3 pt? -143.25 172.26 12.98 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.233 -0.917 . . . . 0.0 109.377 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 1.3 m -160.2 156.25 26.29 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.345 -0.847 . . . . 0.0 109.274 179.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 31.5 p90 -160.07 144.6 10.88 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.162 -0.961 . . . . 0.0 109.577 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.428 ' O ' ' O ' ' A' ' 73' ' ' ALA . 35.8 Cg_endo -78.59 108.75 2.5 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 C-N-CA 122.647 2.231 . . . . 0.0 110.466 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.428 ' O ' ' O ' ' A' ' 72' ' ' PRO . . . 60.04 154.98 0.1 Allowed Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.294 -0.879 . . . . 0.0 109.408 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.09 102.99 1.63 Allowed 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 122.624 2.216 . . . . 0.0 110.457 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.576 0 CA-C-O 117.99 -1.005 . . . . 0.0 109.536 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.477 ' O ' ' N ' ' A' ' 3' ' ' GLU . 5.7 ttt . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.256 0.551 . . . . 0.0 109.578 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.433 ' HB3' ' O ' ' A' ' 1' ' ' MET . . . 61.77 -81.71 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.249 -0.907 . . . . 0.0 109.468 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.477 ' N ' ' O ' ' A' ' 1' ' ' MET . 19.8 mm-40 -124.72 -178.03 4.02 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.216 -0.927 . . . . 0.0 109.307 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.456 ' N ' ' HD3' ' A' ' 18' ' ' ARG . 1.5 t0 -129.74 84.86 2.25 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.157 -0.964 . . . . 0.0 109.647 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.594 ' CE3' ' HB2' ' A' ' 18' ' ' ARG . 62.6 m95 -54.87 132.33 46.22 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.383 -0.823 . . . . 0.0 109.468 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.485 HD23 ' O ' ' A' ' 5' ' ' TRP . 17.9 mt -119.28 165.44 14.25 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.2 -0.937 . . . . 0.0 109.429 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -55.58 131.87 47.35 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.11 -0.994 . . . . 0.0 109.483 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.532 ' CB ' ' HB2' ' A' ' 17' ' ' ARG . 53.9 t -82.03 117.43 68.32 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.275 -0.891 . . . . 0.0 109.642 -179.735 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.95 -51.24 0.06 OUTLIER 'Trans proline' 0 C--N 1.311 -1.422 0 C-N-CA 122.418 2.079 . . . . 0.0 110.698 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -49.69 -38.05 31.34 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.177 -0.952 . . . . 0.0 109.929 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 1.032 HD12 ' CD1' ' A' ' 15' ' ' TRP . 13.1 mt -98.73 -54.87 2.89 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.139 -0.976 . . . . 0.0 109.656 -179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 134.45 -152.54 20.68 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.769 -1.333 . . . . 0.0 109.769 179.826 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.77 159.36 31.43 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.695 2.263 . . . . 0.0 110.533 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 83.71 -10.13 60.57 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 1.032 ' CD1' HD12 ' A' ' 11' ' ' LEU . 15.6 t-105 -118.06 131.42 56.45 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.313 -1.11 . . . . 0.0 109.264 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.469 ' HB3' ' HB3' ' A' ' 5' ' ' TRP . 21.4 mmtt -95.71 116.6 29.11 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.185 -0.947 . . . . 0.0 109.316 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.617 ' CZ ' HG21 ' A' ' 33' ' ' THR . 3.2 ttt-85 -104.45 100.04 9.74 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.255 -0.903 . . . . 0.0 109.294 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.77 ' O ' HG23 ' A' ' 33' ' ' THR . 1.4 tpt180 -100.7 144.18 29.99 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.149 -0.97 . . . . 0.0 110.052 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.449 ' O ' ' OE1' ' A' ' 3' ' ' GLU . 15.0 pt-20 -113.83 144.94 42.17 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.349 -0.844 . . . . 0.0 109.258 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.526 HG21 ' CE2' ' A' ' 34' ' ' TYR . 20.8 t -134.7 144.27 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.112 -0.993 . . . . 0.0 109.72 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -88.64 49.04 1.72 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.316 -0.865 . . . . 0.0 109.423 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 48.64 35.22 5.87 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.145 -0.972 . . . . 0.0 109.233 -179.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 49.44 39.49 16.67 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.269 -0.894 . . . . 0.0 109.393 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 69.3 m -142.69 -61.27 0.44 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.206 -0.934 . . . . 0.0 109.669 -179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 124.92 11.43 4.36 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -72.52 127.95 34.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.229 -1.159 . . . . 0.0 109.391 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 8.8 t -113.42 27.01 9.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.226 -0.921 . . . . 0.0 109.575 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 98.3 m -60.91 -67.2 0.43 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.234 -0.916 . . . . 0.0 109.363 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 175.09 76.14 0.05 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.669 -1.372 . . . . 0.0 109.669 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.511 ' HG2' ' N ' ' A' ' 31' ' ' SER . 2.7 ttm180 -168.31 -92.84 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.272 -1.134 . . . . 0.0 109.257 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.511 ' N ' ' HG2' ' A' ' 30' ' ' ARG . 1.4 p 65.21 152.94 0.06 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.19 -0.944 . . . . 0.0 109.957 179.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -114.49 145.01 42.42 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.459 -0.776 . . . . 0.0 108.939 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.77 HG23 ' O ' ' A' ' 18' ' ' ARG . 56.5 m -125.4 122.0 35.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.084 -1.01 . . . . 0.0 110.126 -179.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.526 ' CE2' HG21 ' A' ' 20' ' ' VAL . 3.3 m-85 -100.76 159.68 14.98 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 179.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.528 ' HB3' ' NE1' ' A' ' 15' ' ' TRP . 16.4 m-85 -130.49 137.08 49.59 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.943 -1.098 . . . . 0.0 110.114 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -118.99 116.18 25.89 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.489 -0.757 . . . . 0.0 109.327 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.839 ' OG ' HG22 ' A' ' 39' ' ' THR . 0.7 OUTLIER -57.07 168.86 0.78 Allowed Pre-proline 0 N--CA 1.49 1.559 0 O-C-N 121.327 -0.858 . . . . 0.0 109.448 -179.943 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.38 5.39 5.52 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.641 2.227 . . . . 0.0 110.379 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.839 HG22 ' OG ' ' A' ' 37' ' ' SER . 6.5 t -115.61 -11.63 11.69 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.155 -0.966 . . . . 0.0 109.648 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 116.98 3.86 17.26 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -76.81 142.45 40.3 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.163 -1.199 . . . . 0.0 109.108 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.0 117.5 24.15 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.227 -0.92 . . . . 0.0 109.707 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.61 HG21 ' HB3' ' A' ' 49' ' ' LEU . 3.4 mp -123.19 162.53 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.347 -0.845 . . . . 0.0 109.332 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.513 ' N ' HG22 ' A' ' 43' ' ' ILE . 34.6 mtp180 -149.1 15.57 0.93 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.141 -0.975 . . . . 0.0 109.805 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.546 ' O ' ' CB ' ' A' ' 46' ' ' LYS . 0.6 OUTLIER -85.34 -85.45 0.14 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.212 -0.93 . . . . 0.0 109.119 179.609 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.546 ' CB ' ' O ' ' A' ' 45' ' ' SER . 12.4 ttpt 157.92 -62.82 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.458 HG23 ' HE2' ' A' ' 46' ' ' LYS . 61.0 t -88.52 -21.83 6.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 178.5 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.483 ' O ' ' HG3' ' A' ' 51' ' ' ARG . 18.0 mt-10 -69.05 -41.78 77.18 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 178.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.757 ' O ' HD12 ' A' ' 53' ' ' LEU . 3.0 pp -71.87 -25.16 61.83 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 178.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.54 ' OG1' ' HB2' ' A' ' 59' ' ' LEU . 8.8 m -69.75 -61.5 1.75 Allowed 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.483 ' HG3' ' O ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -51.11 -23.21 2.98 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 179.297 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.481 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 65.2 t80 -69.63 -65.99 0.64 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.334 -0.854 . . . . 0.0 108.982 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.906 HD21 ' CE3' ' A' ' 15' ' ' TRP . 0.9 OUTLIER -49.9 -58.68 4.92 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.163 -0.961 . . . . 0.0 109.124 179.611 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 132.04 -146.89 18.47 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.303 -1.519 . . . . 0.0 109.303 -179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.71 -29.35 3.61 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 C-N-CA 122.599 2.2 . . . . 0.0 110.139 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -54.63 -26.3 32.15 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.33 -0.856 . . . . 0.0 109.287 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 11.7 m -121.71 170.58 9.6 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.323 -0.861 . . . . 0.0 109.22 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.669 ' C ' HD12 ' A' ' 59' ' ' LEU . 17.6 p-10 -165.19 148.57 8.33 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.164 -0.96 . . . . 0.0 109.441 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 1.028 HD23 ' CD2' ' A' ' 62' ' ' PHE . 4.1 mp -153.0 21.02 0.58 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.206 -0.934 . . . . 0.0 109.716 -179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.45 ' C ' HD22 ' A' ' 61' ' ' LEU . 1.9 m -43.59 -49.59 7.52 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.268 -0.895 . . . . 0.0 109.647 -179.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.506 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 1.5 mm? -106.97 9.8 30.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.324 -0.86 . . . . 0.0 109.755 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 1.028 ' CD2' HD23 ' A' ' 59' ' ' LEU . 72.0 t80 -55.87 139.94 44.2 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.402 -0.811 . . . . 0.0 109.999 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.528 ' O ' ' N ' ' A' ' 65' ' ' LYS . 0.7 OUTLIER -95.08 96.86 9.52 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.973 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.479 ' CE2' ' O ' ' A' ' 44' ' ' ARG . 0.5 OUTLIER -63.0 73.67 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.369 -0.832 . . . . 0.0 109.311 -179.119 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.528 ' N ' ' O ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER 168.35 -32.37 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.457 -0.777 . . . . 0.0 109.057 -179.757 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -103.57 -27.31 12.42 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.296 -0.878 . . . . 0.0 109.389 179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.479 ' HA2' ' CZ ' ' A' ' 62' ' ' PHE . . . 89.42 33.16 9.57 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.67 -1.372 . . . . 0.0 109.67 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.472 ' O ' ' N ' ' A' ' 63' ' ' ASP . 1.0 OUTLIER -140.43 169.67 15.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.197 -1.178 . . . . 0.0 109.914 -179.833 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.725 ' N ' HD23 ' A' ' 69' ' ' LEU . 0.7 OUTLIER -145.11 -165.94 2.29 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 179.376 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.454 ' C ' ' CD2' ' A' ' 71' ' ' TYR . 0.0 OUTLIER -160.05 169.98 22.24 Favored 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.094 -1.004 . . . . 0.0 109.897 179.766 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.549 ' N ' ' HD3' ' A' ' 72' ' ' PRO . 2.9 p90 -177.58 60.87 0.16 Allowed Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.421 -0.8 . . . . 0.0 109.283 179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.549 ' HD3' ' N ' ' A' ' 71' ' ' TYR . 35.2 Cg_endo -78.04 65.86 8.31 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.639 2.226 . . . . 0.0 110.482 -179.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -104.14 156.42 35.76 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.222 -0.924 . . . . 0.0 109.394 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.47 149.05 26.98 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.576 2.184 . . . . 0.0 110.426 179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.9 ttmt . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 118.019 -0.991 . . . . 0.0 109.422 -179.931 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.54 -170.58 0.54 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.318 -0.864 . . . . 0.0 109.529 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.491 ' HG3' ' CZ ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -132.96 -169.3 2.23 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.186 -0.946 . . . . 0.0 109.487 179.912 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.49 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 1.4 m-20 -87.51 46.92 1.43 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.258 -0.902 . . . . 0.0 109.523 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.594 ' CE3' ' HB2' ' A' ' 18' ' ' ARG . 72.6 m95 -55.44 111.66 0.93 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.255 -0.903 . . . . 0.0 109.658 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' A' ' 4' ' ' ASP . 69.2 mt -114.05 151.17 32.89 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.22 -0.925 . . . . 0.0 109.328 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.471 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 7.7 m-20 -44.42 139.23 2.83 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.188 -0.945 . . . . 0.0 109.484 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.494 ' HB2' ' N ' ' A' ' 17' ' ' ARG . 38.3 t -103.65 104.78 44.16 Favored Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.302 -0.874 . . . . 0.0 109.639 -179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 35.1 Cg_endo -76.87 -35.26 1.96 Allowed 'Trans proline' 0 C--N 1.312 -1.373 0 C-N-CA 122.441 2.094 . . . . 0.0 110.415 179.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.431 ' C ' ' O ' ' A' ' 9' ' ' PRO . . . -43.89 -45.57 7.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.264 -0.897 . . . . 0.0 109.401 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 1.034 HD12 ' CD1' ' A' ' 15' ' ' TRP . 11.5 mt -97.67 -60.63 1.53 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.201 -0.937 . . . . 0.0 109.404 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 154.3 -153.15 24.61 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -78.07 145.0 21.67 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.71 2.273 . . . . 0.0 110.323 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.94 -24.44 31.19 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.253 -1.539 . . . . 0.0 109.253 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 1.034 ' CD1' HD12 ' A' ' 11' ' ' LEU . 5.5 t-105 -98.61 132.64 43.86 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.41 -1.053 . . . . 0.0 109.264 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.442 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -111.08 120.48 42.47 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.108 -0.995 . . . . 0.0 109.888 -179.793 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.494 ' N ' ' HB2' ' A' ' 8' ' ' CYS . 1.3 ttp85 -93.35 115.97 28.53 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.346 -0.846 . . . . 0.0 108.891 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.594 ' HB2' ' CE3' ' A' ' 5' ' ' TRP . 12.0 ttt180 -100.15 147.33 25.8 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.291 -0.88 . . . . 0.0 110.28 -179.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.481 ' O ' ' HG3' ' A' ' 19' ' ' GLU . 6.1 pt-20 -125.11 144.16 50.56 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 179.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.581 HG22 ' HE ' ' A' ' 18' ' ' ARG . 2.5 t -131.12 159.08 43.3 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.076 -1.015 . . . . 0.0 109.843 -179.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.444 ' O ' ' CB ' ' A' ' 22' ' ' ARG . 1.6 m-30 -95.41 10.03 37.84 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.324 -0.86 . . . . 0.0 109.211 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.444 ' CB ' ' O ' ' A' ' 21' ' ' PHE . 0.0 OUTLIER 73.11 -70.26 0.17 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.32 -0.863 . . . . 0.0 109.349 -179.868 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.79 -57.62 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.269 -0.894 . . . . 0.0 109.435 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 17.1 m -87.79 176.94 7.15 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.245 -0.909 . . . . 0.0 109.425 179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -122.24 28.17 5.89 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -68.66 170.42 9.35 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.25 -1.147 . . . . 0.0 109.509 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 5.6 p -92.51 15.13 14.82 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.255 -0.903 . . . . 0.0 109.628 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 4.3 t -121.34 -26.92 4.93 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.159 -0.963 . . . . 0.0 109.622 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -60.54 154.08 35.34 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.76 178.29 4.74 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.2 -1.176 . . . . 0.0 109.41 179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.9 m -119.94 166.37 13.41 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.183 -0.948 . . . . 0.0 109.61 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.593 ' HB3' ' CE1' ' A' ' 34' ' ' TYR . 2.2 m-20 -112.81 155.47 24.55 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.3 -0.875 . . . . 0.0 109.419 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.48 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 8.7 m -131.74 108.59 9.56 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.249 -0.907 . . . . 0.0 109.656 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.597 ' CD1' ' CG ' ' A' ' 44' ' ' ARG . 6.5 m-85 -105.69 165.2 11.34 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.232 -0.918 . . . . 0.0 109.345 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.605 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 4.3 m-85 -133.66 140.24 46.95 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.102 -0.999 . . . . 0.0 109.921 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -123.0 128.25 49.94 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.425 -0.797 . . . . 0.0 109.246 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.49 ' HB2' ' HD2' ' A' ' 38' ' ' PRO . 1.7 p -80.17 167.99 29.15 Favored Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.301 -0.874 . . . . 0.0 109.42 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.49 ' HD2' ' HB2' ' A' ' 37' ' ' SER . 35.6 Cg_endo -78.37 5.85 5.19 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.647 2.231 . . . . 0.0 110.414 179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.9 p -113.21 -24.93 9.13 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.217 -0.927 . . . . 0.0 109.479 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 123.38 16.18 3.53 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -88.17 105.35 17.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.148 -1.207 . . . . 0.0 109.254 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.75 105.1 17.59 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.318 -0.864 . . . . 0.0 109.689 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.718 HG21 ' CA ' ' A' ' 49' ' ' LEU . 3.2 mt -110.09 151.77 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.307 -0.87 . . . . 0.0 109.092 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.597 ' CG ' ' CD1' ' A' ' 34' ' ' TYR . 7.5 ttp180 -126.85 -0.25 6.65 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.133 -0.979 . . . . 0.0 110.04 -179.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.887 ' O ' HD23 ' A' ' 49' ' ' LEU . 1.1 m -93.73 172.05 8.49 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.142 -0.974 . . . . 0.0 108.525 179.21 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.568 ' HB2' ' CD1' ' A' ' 64' ' ' PHE . 22.8 ttpt -91.12 -63.27 1.29 Allowed 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.034 -1.042 . . . . 0.0 110.146 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.401 ' O ' HG12 ' A' ' 47' ' ' VAL . 61.9 t -80.8 -10.82 12.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.048 -1.033 . . . . 0.0 109.316 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.568 ' HB2' ' CB ' ' A' ' 45' ' ' SER . 0.1 OUTLIER -77.3 -46.52 22.72 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.956 -1.128 . . . . 0.0 107.956 178.485 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.887 HD23 ' O ' ' A' ' 45' ' ' SER . 2.5 pp -68.84 -25.89 64.88 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 107.688 -1.227 . . . . 0.0 107.688 178.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.899 ' OG1' HD13 ' A' ' 59' ' ' LEU . 8.5 m -72.86 -49.28 31.02 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.779 -1.193 . . . . 0.0 107.779 178.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.23 -25.99 49.58 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.349 -0.982 . . . . 0.0 108.349 178.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.413 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 40.9 t80 -65.8 -60.46 2.86 Favored 'General case' 0 N--CA 1.486 1.37 0 O-C-N 121.54 -0.725 . . . . 0.0 109.288 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.851 HD21 ' CZ3' ' A' ' 15' ' ' TRP . 0.5 OUTLIER -58.44 -56.3 23.93 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.194 -0.941 . . . . 0.0 109.3 179.908 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 131.42 -149.44 19.26 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 179.928 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -77.5 -11.85 17.08 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.556 2.171 . . . . 0.0 110.302 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -70.21 -19.11 63.18 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.211 -0.93 . . . . 0.0 109.205 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 53.0 m -135.42 146.95 48.79 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.352 -0.842 . . . . 0.0 109.194 179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.656 ' C ' HD12 ' A' ' 59' ' ' LEU . 0.6 OUTLIER -138.04 152.66 49.06 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.144 -0.972 . . . . 0.0 109.872 -179.754 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.899 HD13 ' OG1' ' A' ' 50' ' ' THR . 4.5 mp -148.47 9.88 0.84 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.266 -0.897 . . . . 0.0 109.541 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.673 HG22 ' CD2' ' A' ' 61' ' ' LEU . 23.2 m -48.93 -28.05 3.56 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.175 -0.953 . . . . 0.0 109.007 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.673 ' CD2' HG22 ' A' ' 60' ' ' THR . 1.3 mm? -111.74 -13.75 13.68 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.437 -0.79 . . . . 0.0 109.164 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.543 ' CD1' ' C ' ' A' ' 62' ' ' PHE . 7.8 t80 -49.37 131.71 20.38 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.401 -0.812 . . . . 0.0 109.517 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.539 ' O ' ' N ' ' A' ' 65' ' ' LYS . 2.3 m-20 -79.72 100.57 7.96 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.223 -0.923 . . . . 0.0 108.811 179.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.568 ' CD1' ' HB2' ' A' ' 46' ' ' LYS . 1.1 t80 -66.63 61.12 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.405 -0.809 . . . . 0.0 109.519 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.539 ' N ' ' O ' ' A' ' 63' ' ' ASP . 20.0 ttpt 177.22 -38.55 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.464 -0.772 . . . . 0.0 108.963 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -86.8 -47.8 8.76 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.313 -0.867 . . . . 0.0 109.203 179.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 115.21 23.05 4.66 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.963 -1.255 . . . . 0.0 109.963 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.569 ' C ' HD12 ' A' ' 68' ' ' ILE . 2.4 pp -140.11 -173.3 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.079 -1.247 . . . . 0.0 109.576 179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.514 ' CB ' ' HA ' ' A' ' 62' ' ' PHE . 0.7 OUTLIER -151.43 -166.64 2.57 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.282 -0.886 . . . . 0.0 109.124 -179.874 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.483 ' O ' ' HD3' ' A' ' 72' ' ' PRO . 2.7 t -160.44 137.39 9.11 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.179 -0.951 . . . . 0.0 109.72 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -110.63 96.71 29.31 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.184 -0.948 . . . . 0.0 109.009 179.547 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.688 ' O ' ' HB2' ' A' ' 73' ' ' ALA . 35.1 Cg_endo -77.06 156.47 34.01 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.518 2.146 . . . . 0.0 110.497 -179.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.924 ' HB3' ' HD3' ' A' ' 74' ' ' PRO . . . 162.92 -52.89 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.387 -0.82 . . . . 0.0 109.305 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.924 ' HD3' ' HB3' ' A' ' 73' ' ' ALA . 35.1 Cg_endo -78.24 -37.72 0.71 Allowed 'Trans proline' 0 C--N 1.311 -1.43 0 C-N-CA 122.408 2.072 . . . . 0.0 110.328 179.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.8 pttp . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 117.999 -1.001 . . . . 0.0 109.498 179.938 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.1 ttt . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 121.296 0.569 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -133.2 -143.29 0.22 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.273 -0.892 . . . . 0.0 109.251 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 5.2 pm0 -103.37 97.98 7.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.039 -1.038 . . . . 0.0 109.543 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.469 ' O ' ' O ' ' A' ' 5' ' ' TRP . 75.4 m-20 -128.93 23.53 5.7 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.268 -0.895 . . . . 0.0 109.345 179.823 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.583 ' CE2' ' HG3' ' A' ' 18' ' ' ARG . 89.1 m95 55.72 109.32 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.422 -0.799 . . . . 0.0 109.671 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.21 151.18 38.13 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.238 -0.913 . . . . 0.0 109.394 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.415 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 16.9 t70 -45.04 145.43 1.0 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.336 -0.853 . . . . 0.0 109.33 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.468 ' HB3' ' HB3' ' A' ' 15' ' ' TRP . 26.8 t -105.55 105.56 53.02 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.198 -0.939 . . . . 0.0 109.678 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.5 ' HD2' ' CZ ' ' A' ' 17' ' ' ARG . 35.2 Cg_endo -76.97 -33.57 2.69 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 C-N-CA 122.441 2.094 . . . . 0.0 110.129 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.414 ' C ' HD23 ' A' ' 11' ' ' LEU . . . -47.33 -42.23 20.9 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.226 -0.921 . . . . 0.0 109.329 179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.97 HD12 ' CD1' ' A' ' 15' ' ' TRP . 8.8 mt -99.98 -62.41 1.24 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.306 -0.871 . . . . 0.0 109.349 179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.432 ' O ' ' O ' ' A' ' 8' ' ' CYS . . . 165.5 -153.03 22.82 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.44 150.31 25.01 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.643 2.229 . . . . 0.0 110.361 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 93.55 -65.85 1.76 Allowed Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.97 ' CD1' HD12 ' A' ' 11' ' ' LEU . 6.4 t-105 -48.98 130.5 18.42 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.264 -1.139 . . . . 0.0 109.409 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -107.85 118.67 37.35 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.119 -0.988 . . . . 0.0 109.406 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.5 ' CZ ' ' HD2' ' A' ' 9' ' ' PRO . 1.2 ttp85 -93.16 116.76 29.34 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.275 -0.891 . . . . 0.0 109.368 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.583 ' HG3' ' CE2' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -96.99 142.36 29.04 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.341 -0.85 . . . . 0.0 109.437 -179.997 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.434 ' CG ' ' O ' ' A' ' 19' ' ' GLU . 17.9 pt-20 -127.24 116.68 20.95 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.231 -0.918 . . . . 0.0 109.306 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.466 ' O ' ' HB3' ' A' ' 31' ' ' SER . 82.0 t -108.35 136.26 44.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.166 -0.958 . . . . 0.0 109.683 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.7 m-30 -85.18 75.27 10.33 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.339 -0.85 . . . . 0.0 109.491 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -49.67 -62.34 1.61 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.364 -0.835 . . . . 0.0 109.438 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.461 ' O ' ' HG3' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -167.3 29.46 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.28 -0.888 . . . . 0.0 109.574 179.963 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -177.63 82.31 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.142 -0.974 . . . . 0.0 109.553 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -124.0 33.4 3.89 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.293 -1.523 . . . . 0.0 109.293 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.43 -68.95 0.57 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.341 -1.094 . . . . 0.0 109.664 -179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 48.8 p -122.67 73.46 1.13 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.184 -0.948 . . . . 0.0 109.707 -179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 62.21 40.91 11.11 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.329 -0.857 . . . . 0.0 109.756 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -64.79 -138.59 0.02 OUTLIER Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.334 -1.506 . . . . 0.0 109.334 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.464 ' HA ' ' HD2' ' A' ' 65' ' ' LYS . 0.0 OUTLIER -87.28 -79.86 0.27 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.244 -1.15 . . . . 0.0 109.227 179.727 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.466 ' HB3' ' O ' ' A' ' 20' ' ' VAL . 5.8 m 61.4 166.61 0.1 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.177 -0.952 . . . . 0.0 109.673 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.468 ' OD2' ' CZ ' ' A' ' 34' ' ' TYR . 3.0 t70 -118.99 129.8 55.35 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.272 -0.892 . . . . 0.0 109.206 179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 70.0 m -110.62 125.4 53.38 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.191 -0.943 . . . . 0.0 109.868 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.572 ' CD1' ' N ' ' A' ' 34' ' ' TYR . 3.7 m-85 -112.9 155.41 24.76 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.29 -0.881 . . . . 0.0 108.888 179.481 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.634 ' CD1' HD22 ' A' ' 49' ' ' LEU . 39.4 m-85 -126.03 131.07 52.26 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.019 -1.05 . . . . 0.0 109.905 -179.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -122.42 128.19 50.61 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.465 -0.772 . . . . 0.0 109.151 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.498 ' CB ' ' HD2' ' A' ' 38' ' ' PRO . 0.9 OUTLIER -73.54 173.58 6.02 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.309 -0.869 . . . . 0.0 109.675 -179.73 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.498 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 34.5 Cg_endo -77.35 1.23 8.97 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 C-N-CA 122.668 2.245 . . . . 0.0 110.297 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 p -111.04 -24.13 10.52 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.255 -0.903 . . . . 0.0 109.147 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 125.3 18.29 2.54 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.866 -1.294 . . . . 0.0 109.866 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.669 ' OD2' HD11 ' A' ' 43' ' ' ILE . 5.1 t70 -79.64 119.28 22.37 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.086 -1.244 . . . . 0.0 109.35 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.412 ' O ' ' HG2' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -103.4 107.74 18.69 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.285 -0.884 . . . . 0.0 109.737 -179.717 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.685 HG21 ' CA ' ' A' ' 49' ' ' LEU . 3.3 mt -120.33 151.38 23.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.321 -0.862 . . . . 0.0 109.133 179.667 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.591 ' O ' ' CZ ' ' A' ' 64' ' ' PHE . 10.6 ttm180 -126.81 -1.13 6.66 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.087 -1.008 . . . . 0.0 109.884 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.862 ' O ' HD23 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -88.84 179.26 6.24 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.073 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.559 ' HA ' ' CE1' ' A' ' 64' ' ' PHE . 28.7 ttpt -97.87 -59.68 1.72 Allowed 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.977 -1.077 . . . . 0.0 109.657 -179.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 99.2 t -84.24 -16.66 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.108 -0.995 . . . . 0.0 108.889 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.568 ' HB2' ' CB ' ' A' ' 45' ' ' SER . 1.9 tt0 -70.05 -45.36 67.28 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.59 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.862 HD23 ' O ' ' A' ' 45' ' ' SER . 2.0 pp -71.36 -27.12 63.13 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 178.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.957 ' OG1' HD13 ' A' ' 59' ' ' LEU . 27.7 m -67.36 -47.08 71.49 Favored 'General case' 0 C--N 1.306 -1.303 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 178.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.519 ' NH1' ' HG3' ' A' ' 51' ' ' ARG . 7.2 mmt85 -55.34 -31.33 61.63 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 179.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.542 ' CZ ' ' HB2' ' A' ' 41' ' ' ASP . 86.0 t80 -63.71 -51.24 65.89 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.934 -0.706 . . . . 0.0 109.431 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.86 HD21 ' CE3' ' A' ' 15' ' ' TRP . 1.5 mt -59.63 -58.86 6.75 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.305 -0.872 . . . . 0.0 109.536 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 135.71 -155.27 22.18 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.223 -1.551 . . . . 0.0 109.223 -179.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -79.41 -10.17 14.79 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 122.621 2.214 . . . . 0.0 110.494 -179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.22 -15.81 56.18 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.228 -0.92 . . . . 0.0 109.711 -179.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.4 ' CB ' HD13 ' A' ' 53' ' ' LEU . 72.7 m -128.45 139.77 52.17 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.254 -0.904 . . . . 0.0 109.39 -179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.897 ' C ' HD12 ' A' ' 59' ' ' LEU . 2.8 p30 -137.02 151.73 49.29 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.257 -0.902 . . . . 0.0 109.523 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.957 HD13 ' OG1' ' A' ' 50' ' ' THR . 6.6 mp -142.53 -0.2 1.24 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.22 -0.925 . . . . 0.0 110.076 -179.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.573 ' C ' HD22 ' A' ' 61' ' ' LEU . 17.1 m -48.16 -27.44 2.39 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 120.996 -1.065 . . . . 0.0 108.521 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.602 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 1.3 mm? -105.53 -21.08 13.28 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.542 ' CE1' ' HA2' ' A' ' 67' ' ' GLY . 51.2 t80 -55.85 140.62 41.86 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.64 -0.662 . . . . 0.0 109.267 179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.519 ' O ' ' N ' ' A' ' 65' ' ' LYS . 4.9 m-20 -88.32 108.64 19.44 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.189 -0.945 . . . . 0.0 109.578 -179.699 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.591 ' CZ ' ' O ' ' A' ' 44' ' ' ARG . 1.7 t80 -66.62 66.9 0.06 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.288 -0.882 . . . . 0.0 109.214 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 63' ' ' ASP . 1.2 ttpm? 166.92 -36.55 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.722 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -88.18 -40.45 13.7 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.413 -0.804 . . . . 0.0 109.46 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.542 ' HA2' ' CE1' ' A' ' 62' ' ' PHE . . . 98.56 25.22 10.16 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.643 -1.383 . . . . 0.0 109.643 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.46 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 1.6 pp -140.47 160.31 24.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.201 -1.176 . . . . 0.0 109.812 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.478 ' CA ' ' HA ' ' A' ' 62' ' ' PHE . 0.6 OUTLIER -137.45 -167.57 2.14 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.338 -0.852 . . . . 0.0 108.875 179.481 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 37.7 t -153.11 148.92 27.53 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.085 -1.01 . . . . 0.0 109.61 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 44.9 t80 -133.48 87.54 37.14 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.309 -0.87 . . . . 0.0 109.353 -179.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -78.29 137.36 15.02 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.682 2.255 . . . . 0.0 110.365 -179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.805 ' HB1' ' HD2' ' A' ' 74' ' ' PRO . . . -163.02 169.9 8.27 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.274 -0.891 . . . . 0.0 109.419 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.805 ' HD2' ' HB1' ' A' ' 73' ' ' ALA . 35.7 Cg_endo -77.85 -5.57 15.39 Favored 'Trans proline' 0 C--N 1.308 -1.585 0 C-N-CA 122.591 2.194 . . . . 0.0 110.286 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.005 -0.998 . . . . 0.0 109.418 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.9 mmm . . . . . 0 N--CA 1.488 1.465 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -128.04 0.55 5.89 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.269 -0.894 . . . . 0.0 109.509 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 18.2 mt-10 -133.87 137.37 44.95 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.259 -0.901 . . . . 0.0 109.012 179.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.461 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 0.6 OUTLIER -145.83 76.4 1.46 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.136 -0.978 . . . . 0.0 110.081 -179.601 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.591 ' CE3' ' HB2' ' A' ' 18' ' ' ARG . 64.3 m95 -66.14 96.58 0.34 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.272 -0.892 . . . . 0.0 108.78 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' A' ' 4' ' ' ASP . 1.3 mt -106.06 169.31 8.57 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.13 -0.981 . . . . 0.0 109.855 -179.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.474 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 0.7 OUTLIER -56.85 132.25 51.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.338 -0.851 . . . . 0.0 109.474 -179.853 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.519 ' SG ' ' CZ ' ' A' ' 17' ' ' ARG . 18.9 t -89.02 112.76 52.89 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.224 -0.922 . . . . 0.0 109.398 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 35.9 Cg_endo -77.72 -52.86 0.07 OUTLIER 'Trans proline' 0 C--N 1.312 -1.391 0 C-N-CA 122.366 2.044 . . . . 0.0 110.822 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.646 ' HB3' ' NH1' ' A' ' 17' ' ' ARG . . . -39.81 -46.77 2.01 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.427 -0.795 . . . . 0.0 110.045 -179.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 1.023 HD12 ' CD1' ' A' ' 15' ' ' TRP . 11.6 mt -94.16 -60.63 1.69 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.169 -0.957 . . . . 0.0 109.467 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.443 ' O ' ' O ' ' A' ' 8' ' ' CYS . . . 148.36 -145.4 13.81 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.04 156.48 30.29 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 C-N-CA 122.608 2.205 . . . . 0.0 110.342 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 87.99 -57.82 4.31 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.299 -1.521 . . . . 0.0 109.299 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 1.023 ' CD1' HD12 ' A' ' 11' ' ' LEU . 4.8 t-105 -65.49 129.27 39.17 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.298 -1.119 . . . . 0.0 109.526 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.47 123.08 46.84 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.305 -0.872 . . . . 0.0 109.59 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.646 ' NH1' ' HB3' ' A' ' 10' ' ' ALA . 0.2 OUTLIER -93.48 106.03 18.04 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.273 -0.892 . . . . 0.0 109.365 179.881 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.591 ' HB2' ' CE3' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -100.35 142.68 31.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.239 -0.913 . . . . 0.0 109.524 -179.891 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.525 ' N ' ' HG2' ' A' ' 18' ' ' ARG . 6.1 pt-20 -99.95 159.09 15.35 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.292 -0.88 . . . . 0.0 109.825 -179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.511 ' HB ' ' CB ' ' A' ' 32' ' ' ASP . 98.9 t -128.94 158.68 41.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.325 -0.86 . . . . 0.0 109.038 179.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.449 ' N ' HG12 ' A' ' 20' ' ' VAL . 0.3 OUTLIER -104.5 45.28 0.97 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.105 -0.997 . . . . 0.0 109.799 -179.821 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.435 ' O ' ' HG2' ' A' ' 23' ' ' LYS . 0.0 OUTLIER 65.59 50.15 1.68 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.22 -0.925 . . . . 0.0 109.665 179.757 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.435 ' HG2' ' O ' ' A' ' 22' ' ' ARG . 0.9 OUTLIER -139.7 112.17 7.76 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.131 -0.98 . . . . 0.0 109.668 -179.968 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.448 ' HB2' ' OH ' ' A' ' 34' ' ' TYR . 1.6 t -176.86 -81.45 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.303 -0.873 . . . . 0.0 109.327 179.78 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -143.43 -141.22 3.78 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.481 -1.448 . . . . 0.0 109.481 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -83.07 55.94 3.3 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.299 -1.118 . . . . 0.0 109.509 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -104.93 95.34 5.8 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.297 -0.877 . . . . 0.0 109.496 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -86.42 76.26 9.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.304 -0.873 . . . . 0.0 109.506 179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -133.0 -163.45 10.55 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.424 ' O ' ' OG ' ' A' ' 31' ' ' SER . 2.2 tpt180 -102.65 95.94 6.55 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.246 -1.149 . . . . 0.0 109.438 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.424 ' OG ' ' O ' ' A' ' 30' ' ' ARG . 4.2 p 63.3 128.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.25 -0.907 . . . . 0.0 109.534 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.511 ' CB ' ' HB ' ' A' ' 20' ' ' VAL . 0.9 OUTLIER -83.91 158.43 21.59 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.21 -0.931 . . . . 0.0 109.495 -179.892 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -134.81 116.0 14.32 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.239 -0.913 . . . . 0.0 109.585 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.503 ' CE1' ' HD3' ' A' ' 44' ' ' ARG . 20.8 m-30 -116.22 140.06 49.71 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.245 -0.91 . . . . 0.0 109.247 179.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.551 ' CE2' ' CE1' ' A' ' 64' ' ' PHE . 4.3 m-85 -112.02 147.05 36.8 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.199 -0.938 . . . . 0.0 109.636 -179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.454 ' HA ' ' O ' ' A' ' 41' ' ' ASP . 26.1 tt0 -131.24 128.17 39.34 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.334 -0.854 . . . . 0.0 109.342 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.508 ' HB3' ' HD2' ' A' ' 38' ' ' PRO . 0.9 OUTLIER -69.72 173.9 3.64 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.249 -0.907 . . . . 0.0 109.304 179.999 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.508 ' HD2' ' HB3' ' A' ' 37' ' ' SER . 36.3 Cg_endo -78.12 -3.79 13.76 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 C-N-CA 122.597 2.198 . . . . 0.0 110.602 -179.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.477 HG22 ' HB2' ' A' ' 37' ' ' SER . 10.7 t -101.42 -9.78 20.8 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.2 -0.938 . . . . 0.0 109.594 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 111.46 9.68 21.06 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.621 -1.392 . . . . 0.0 109.621 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.494 ' HB2' ' OG ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -78.76 141.56 37.72 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.186 -1.185 . . . . 0.0 109.424 179.889 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.467 ' O ' ' HG2' ' A' ' 42' ' ' ARG . 0.1 OUTLIER -128.37 120.41 26.92 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.154 -0.966 . . . . 0.0 109.703 -179.753 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.642 HG21 ' HB3' ' A' ' 49' ' ' LEU . 2.4 mp -126.73 162.23 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.19 -0.944 . . . . 0.0 109.328 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.576 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 29.3 mtt85 -147.35 20.07 1.21 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.217 -0.927 . . . . 0.0 109.756 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.585 ' H ' HG22 ' A' ' 43' ' ' ILE . 0.5 OUTLIER -95.06 -86.78 0.29 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.386 -0.821 . . . . 0.0 108.821 179.433 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.549 ' HB2' ' CD1' ' A' ' 64' ' ' PHE . 24.2 ttmt 159.72 -64.96 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.89 -1.152 . . . . 0.0 107.89 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 43.7 t -87.25 -19.58 7.92 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.572 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 178.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.501 ' HB2' ' HB2' ' A' ' 45' ' ' SER . 16.2 mt-10 -69.89 -41.44 74.73 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.07 -1.085 . . . . 0.0 108.07 178.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.642 ' HB3' HG21 ' A' ' 43' ' ' ILE . 3.0 pp -72.39 -33.09 66.94 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 178.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.86 ' HA ' HD12 ' A' ' 53' ' ' LEU . 1.4 m -63.91 -48.62 75.87 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 178.402 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.22 -28.13 57.28 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.487 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 41.6 t80 -72.58 -56.98 4.51 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.624 -0.672 . . . . 0.0 109.353 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.915 HD21 ' CE3' ' A' ' 15' ' ' TRP . 0.5 OUTLIER -55.03 -57.09 13.13 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.098 -1.001 . . . . 0.0 109.139 179.681 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 134.28 -157.98 23.16 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.219 -1.552 . . . . 0.0 109.219 -179.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.1 3.17 7.29 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.559 2.173 . . . . 0.0 110.343 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -84.87 -27.27 26.81 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.228 -0.92 . . . . 0.0 109.465 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.525 ' O ' ' CG2' ' A' ' 50' ' ' THR . 54.3 m -122.33 138.48 54.5 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.303 -0.873 . . . . 0.0 109.245 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.553 ' HA ' HG21 ' A' ' 50' ' ' THR . 29.0 t70 -127.05 142.83 51.44 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.165 -0.96 . . . . 0.0 109.511 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.747 HD23 ' CD2' ' A' ' 62' ' ' PHE . 3.6 mp -141.3 8.89 2.04 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.191 -0.943 . . . . 0.0 109.803 -179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.443 ' C ' HD22 ' A' ' 61' ' ' LEU . 4.0 m -47.43 -42.78 23.02 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.113 -0.992 . . . . 0.0 109.282 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.58 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 1.7 mm? -99.66 -3.08 33.87 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.333 -0.854 . . . . 0.0 109.56 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.747 ' CD2' HD23 ' A' ' 59' ' ' LEU . 83.3 t80 -61.51 139.37 58.25 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.354 -0.841 . . . . 0.0 109.744 -179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.434 ' O ' ' N ' ' A' ' 65' ' ' LYS . 3.4 m-20 -92.24 104.65 16.99 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.443 -0.786 . . . . 0.0 108.967 179.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.576 ' CE2' ' O ' ' A' ' 44' ' ' ARG . 0.8 OUTLIER -68.51 65.11 0.11 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.239 -0.913 . . . . 0.0 109.479 -179.526 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.434 ' N ' ' O ' ' A' ' 63' ' ' ASP . 1.7 ttpt -178.41 -33.36 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.17 -0.956 . . . . 0.0 109.625 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 15.8 mt-30 -107.23 -32.85 7.62 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.264 -0.898 . . . . 0.0 109.704 -179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.571 ' HA2' ' CZ ' ' A' ' 62' ' ' PHE . . . 97.92 38.63 4.06 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.479 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 1.9 pp -139.88 165.84 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.246 -1.15 . . . . 0.0 109.581 -179.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.513 ' CB ' ' HA ' ' A' ' 62' ' ' PHE . 0.5 OUTLIER -153.79 -176.04 5.65 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.276 -0.89 . . . . 0.0 109.589 179.946 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.474 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 0.1 OUTLIER -157.27 152.63 26.33 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.361 -0.837 . . . . 0.0 109.355 179.797 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.6 t80 178.82 99.23 0.16 Allowed Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.107 -0.996 . . . . 0.0 109.653 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.456 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 36.3 Cg_endo -79.39 174.19 12.24 Favored 'Trans proline' 0 C--N 1.311 -1.427 0 C-N-CA 122.65 2.233 . . . . 0.0 110.615 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 72' ' ' PRO . . . 62.48 71.53 0.69 Allowed Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.326 -0.859 . . . . 0.0 109.602 179.72 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -78.51 54.56 5.08 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.655 2.237 . . . . 0.0 110.432 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.02 -0.991 . . . . 0.0 109.561 -179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.401 ' O ' ' HB3' ' A' ' 2' ' ' ALA . 0.8 OUTLIER . . . . . 0 N--CA 1.49 1.53 0 N-CA-C 109.079 -0.712 . . . . 0.0 109.079 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 1' ' ' MET . . . 59.31 -170.19 0.13 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.151 -0.968 . . . . 0.0 108.993 -179.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.483 ' HG2' ' HG2' ' A' ' 18' ' ' ARG . 13.8 tp10 -117.59 156.78 27.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.024 -1.047 . . . . 0.0 109.532 179.893 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.474 ' O ' ' O ' ' A' ' 5' ' ' TRP . 0.4 OUTLIER -148.99 26.29 0.89 Allowed 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.214 -0.929 . . . . 0.0 109.358 179.884 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.544 ' CE3' ' HB2' ' A' ' 18' ' ' ARG . 76.7 m95 55.03 107.38 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.375 -0.828 . . . . 0.0 109.45 179.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.2 mt -107.18 161.32 14.88 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.148 -0.97 . . . . 0.0 109.739 -179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -53.91 149.28 9.15 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.394 -0.816 . . . . 0.0 109.519 -179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.467 ' HB3' ' HB3' ' A' ' 15' ' ' TRP . 50.2 t -111.18 103.42 54.89 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.369 -0.832 . . . . 0.0 109.331 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -77.03 -23.85 10.23 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.354 2.036 . . . . 0.0 110.31 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.436 ' C ' HD23 ' A' ' 11' ' ' LEU . . . -52.65 -48.66 66.28 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.189 -0.944 . . . . 0.0 109.173 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.715 HD12 ' CD1' ' A' ' 15' ' ' TRP . 0.7 OUTLIER -96.64 -59.86 1.72 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.375 -0.828 . . . . 0.0 109.245 179.882 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 158.82 -153.69 24.81 Favored Glycine 0 N--CA 1.487 2.076 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -179.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -78.35 154.41 28.17 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.614 2.209 . . . . 0.0 110.596 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 90.18 -12.32 68.24 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.715 ' CD1' HD12 ' A' ' 11' ' ' LEU . 16.5 t-105 -111.7 126.21 54.8 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.175 -1.191 . . . . 0.0 109.52 -179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 18.3 mmtp -101.27 119.58 38.97 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.282 -0.887 . . . . 0.0 109.581 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.519 ' HG3' ' CE2' ' A' ' 35' ' ' TYR . 5.8 ttp85 -94.89 114.69 26.57 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.224 -0.922 . . . . 0.0 109.359 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.544 ' HB2' ' CE3' ' A' ' 5' ' ' TRP . 0.2 OUTLIER -100.29 128.47 46.35 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.351 -0.843 . . . . 0.0 109.321 179.997 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.448 ' HG2' ' OE2' ' A' ' 3' ' ' GLU . 9.3 pt-20 -118.24 134.06 55.35 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.263 -0.898 . . . . 0.0 109.248 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 32' ' ' ASP . 0.2 OUTLIER -111.51 -178.51 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.246 -0.909 . . . . 0.0 109.474 -179.834 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.456 ' O ' ' HB2' ' A' ' 22' ' ' ARG . 28.1 m-85 -124.95 44.21 2.84 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.281 -0.887 . . . . 0.0 109.186 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.486 ' O ' ' CB ' ' A' ' 23' ' ' LYS . 0.8 OUTLIER 69.25 -60.83 0.45 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.325 -0.859 . . . . 0.0 109.532 -179.944 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.486 ' CB ' ' O ' ' A' ' 22' ' ' ARG . 1.3 tmtt? 74.98 -56.98 0.62 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.267 -0.896 . . . . 0.0 109.458 -179.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.438 ' OG ' ' N ' ' A' ' 25' ' ' GLY . 9.9 t -161.91 179.79 7.77 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.184 -0.947 . . . . 0.0 109.435 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.438 ' N ' ' OG ' ' A' ' 24' ' ' SER . . . 119.4 -132.58 9.62 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -97.03 -175.89 3.39 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.256 -1.144 . . . . 0.0 109.518 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 20.2 p -92.44 27.65 2.2 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.267 -0.896 . . . . 0.0 109.375 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 85.9 m -48.05 -68.03 0.22 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.263 -0.898 . . . . 0.0 109.57 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 107.01 35.02 2.84 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.687 -1.365 . . . . 0.0 109.687 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 9.9 ptt85 -127.79 144.19 51.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.197 -1.178 . . . . 0.0 109.4 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 1.5 p -97.23 133.79 41.39 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.297 -0.877 . . . . 0.0 109.612 -179.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 32' ' ' ASP . 0.3 OUTLIER -80.04 149.4 30.72 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.291 -0.881 . . . . 0.0 109.108 179.774 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.466 ' HA ' ' O ' ' A' ' 18' ' ' ARG . 46.2 m -128.78 108.94 10.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.087 -1.008 . . . . 0.0 110.042 -179.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.535 ' CD1' ' N ' ' A' ' 34' ' ' TYR . 2.7 m-30 -99.66 151.73 20.88 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.333 -0.854 . . . . 0.0 108.922 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.603 ' CD1' ' N ' ' A' ' 35' ' ' TYR . 3.8 m-85 -123.68 148.77 46.22 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.962 -1.086 . . . . 0.0 109.914 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.521 ' HB2' ' CZ3' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -128.32 119.59 25.39 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.497 -0.752 . . . . 0.0 109.01 179.753 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.417 ' HB3' ' HD2' ' A' ' 38' ' ' PRO . 0.6 OUTLIER -63.99 170.32 3.52 Favored Pre-proline 0 N--CA 1.488 1.437 0 O-C-N 121.317 -0.865 . . . . 0.0 109.374 -179.918 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.417 ' HD2' ' HB3' ' A' ' 37' ' ' SER . 35.1 Cg_endo -78.26 -2.58 12.64 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.619 2.213 . . . . 0.0 110.161 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.8 p -102.75 -23.8 13.78 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.269 -0.895 . . . . 0.0 109.645 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 123.81 9.44 5.76 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.471 ' HB2' ' OH ' ' A' ' 52' ' ' TYR . 0.7 OUTLIER -92.07 112.3 24.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.19 -1.182 . . . . 0.0 109.362 179.951 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.462 ' HB3' ' HG3' ' A' ' 36' ' ' GLN . 0.0 OUTLIER -99.43 122.36 42.43 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.343 -0.848 . . . . 0.0 109.808 -179.738 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.613 HG22 ' H ' ' A' ' 45' ' ' SER . 2.7 mp -117.68 154.04 19.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.346 -0.846 . . . . 0.0 109.169 179.789 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.583 ' O ' ' CZ ' ' A' ' 64' ' ' PHE . 5.6 ttp180 -123.46 -0.21 8.75 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.001 -1.062 . . . . 0.0 109.956 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.752 ' O ' HD23 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -96.61 154.54 17.22 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.231 -0.918 . . . . 0.0 108.558 179.228 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.551 ' HB2' ' CD1' ' A' ' 64' ' ' PHE . 17.4 ttpt -72.85 -67.36 0.57 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.069 -1.019 . . . . 0.0 110.402 -178.968 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.483 ' O ' ' CG ' ' A' ' 51' ' ' ARG . 53.5 t -72.1 -25.69 24.03 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 120.862 -1.149 . . . . 0.0 109.956 -179.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.553 ' HB2' ' CB ' ' A' ' 45' ' ' SER . 6.9 tt0 -62.72 -49.03 76.68 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.759 -1.213 . . . . 0.0 108.278 179.021 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.752 HD23 ' O ' ' A' ' 45' ' ' SER . 1.8 pp -70.26 -23.85 62.96 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.636 HG23 ' HB2' ' A' ' 59' ' ' LEU . 33.0 m -65.5 -68.55 0.36 Allowed 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 178.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.485 ' HG3' ' O ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -42.9 -31.56 0.52 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 179.269 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.494 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 51.4 t80 -55.09 -56.88 14.81 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.326 -0.859 . . . . 0.0 108.74 179.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.574 HD12 ' HA ' ' A' ' 50' ' ' THR . 0.3 OUTLIER -65.07 -43.14 93.17 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.214 -0.929 . . . . 0.0 109.16 179.379 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 110.26 -152.7 17.28 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.284 -1.527 . . . . 0.0 109.284 -179.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.43 -10.92 15.99 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 122.545 2.163 . . . . 0.0 110.205 179.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -72.1 -32.15 66.73 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.296 -0.878 . . . . 0.0 109.371 179.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.512 ' HB2' ' CB ' ' A' ' 53' ' ' LEU . 4.0 m -121.86 97.84 5.68 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.226 -0.921 . . . . 0.0 109.251 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 15.3 t0 -74.99 137.42 41.53 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.255 -0.903 . . . . 0.0 109.731 -179.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.798 HD23 ' CB ' ' A' ' 62' ' ' PHE . 0.1 OUTLIER -142.21 7.91 1.8 Allowed 'General case' 0 N--CA 1.487 1.391 0 O-C-N 121.37 -0.831 . . . . 0.0 109.54 -179.731 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.673 ' C ' HD22 ' A' ' 61' ' ' LEU . 97.9 m -56.69 -28.39 60.73 Favored 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.348 -0.845 . . . . 0.0 109.645 -179.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.673 HD22 ' C ' ' A' ' 60' ' ' THR . 2.4 mm? -107.33 -10.47 15.78 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.261 -0.899 . . . . 0.0 109.485 -179.786 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.798 ' CB ' HD23 ' A' ' 59' ' ' LEU . 38.5 t80 -45.27 128.83 7.9 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.361 -0.837 . . . . 0.0 109.53 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.495 ' O ' ' N ' ' A' ' 65' ' ' LYS . 11.1 m-20 -79.67 100.99 8.12 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.326 -0.859 . . . . 0.0 109.194 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.583 ' CZ ' ' O ' ' A' ' 44' ' ' ARG . 0.7 OUTLIER -65.55 72.95 0.06 Allowed 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.374 -0.829 . . . . 0.0 109.333 -179.672 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.495 ' N ' ' O ' ' A' ' 63' ' ' ASP . 0.6 OUTLIER 166.5 -43.6 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -179.824 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.433 ' HG3' ' HD3' ' A' ' 65' ' ' LYS . 3.8 mt-30 -86.33 -44.67 11.9 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.373 -0.829 . . . . 0.0 109.305 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.408 ' HA2' ' CZ ' ' A' ' 62' ' ' PHE . . . 108.77 25.18 5.78 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.891 -1.283 . . . . 0.0 109.891 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.464 HG13 ' OD2' ' A' ' 63' ' ' ASP . 1.1 pt -140.23 162.58 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.199 -1.177 . . . . 0.0 109.48 179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.624 ' H ' HD23 ' A' ' 69' ' ' LEU . 1.7 pt? -133.0 146.38 51.72 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.125 -0.984 . . . . 0.0 109.472 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.418 ' H ' ' HB3' ' A' ' 61' ' ' LEU . 40.7 m -129.33 -148.94 0.39 Allowed 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.325 -0.859 . . . . 0.0 108.824 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.463 ' HA ' ' HG ' ' A' ' 61' ' ' LEU . 1.3 m-85 -123.71 165.39 23.59 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.08 -1.013 . . . . 0.0 109.394 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.453 ' HD2' ' CD2' ' A' ' 71' ' ' TYR . 35.1 Cg_endo -77.99 122.91 5.98 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 122.72 2.28 . . . . 0.0 110.623 -179.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -135.39 93.33 16.61 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.326 -0.859 . . . . 0.0 109.296 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.418 ' O ' ' CB ' ' A' ' 75' ' ' LYS . 35.2 Cg_endo -77.12 139.91 19.45 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 C-N-CA 122.579 2.186 . . . . 0.0 110.422 -179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.418 ' CB ' ' O ' ' A' ' 74' ' ' PRO . 11.8 mttm . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 117.997 -1.002 . . . . 0.0 109.442 -179.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 70.7 mtm . . . . . 0 N--CA 1.489 1.492 0 CA-C-O 121.246 0.546 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.523 ' O ' ' CZ ' ' A' ' 21' ' ' PHE . . . -156.0 32.82 0.34 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.236 -0.915 . . . . 0.0 109.392 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.418 ' HB2' ' HG2' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -116.94 -178.75 3.51 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.26 -0.9 . . . . 0.0 109.567 -179.949 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.929 ' O ' HD23 ' A' ' 6' ' ' LEU . 0.2 OUTLIER -154.18 80.34 1.12 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.385 -0.822 . . . . 0.0 108.9 179.844 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.412 ' C ' ' O ' ' A' ' 4' ' ' ASP . 73.3 m95 -42.42 119.31 1.38 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.469 -0.769 . . . . 0.0 109.773 -179.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.929 HD23 ' O ' ' A' ' 4' ' ' ASP . 0.4 OUTLIER -130.92 147.97 52.63 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.29 -0.881 . . . . 0.0 109.487 179.839 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.484 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 48.4 t0 -44.02 138.07 3.03 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.348 -0.845 . . . . 0.0 109.104 179.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.462 ' SG ' ' HD3' ' A' ' 17' ' ' ARG . 32.6 t -102.77 105.67 46.02 Favored Pre-proline 0 N--CA 1.489 1.483 0 O-C-N 121.198 -0.939 . . . . 0.0 109.505 -179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 34.4 Cg_endo -77.33 -27.49 6.46 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.297 1.998 . . . . 0.0 109.991 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.658 ' O ' HD21 ' A' ' 69' ' ' LEU . . . -45.5 -57.95 3.74 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.347 -0.846 . . . . 0.0 109.41 179.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.651 ' N ' HD23 ' A' ' 11' ' ' LEU . 0.9 OUTLIER -89.34 -58.44 2.53 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.321 -0.862 . . . . 0.0 109.327 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 159.02 -152.88 23.99 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.84 164.1 28.06 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.557 2.172 . . . . 0.0 110.351 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.447 ' O ' ' HD3' ' A' ' 38' ' ' PRO . . . 75.49 8.81 84.36 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.918 ' CE3' HD21 ' A' ' 53' ' ' LEU . 9.2 t-105 -130.6 126.08 35.77 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.171 -1.194 . . . . 0.0 109.46 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 12.5 mmtt -106.4 120.32 41.57 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.225 -0.922 . . . . 0.0 109.579 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.462 ' HD3' ' SG ' ' A' ' 8' ' ' CYS . 1.4 ttp85 -88.38 115.86 26.19 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.474 -0.766 . . . . 0.0 109.325 179.883 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.429 ' HD2' ' CG2' ' A' ' 20' ' ' VAL . 3.8 ttm180 -99.53 131.14 45.73 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.173 -0.955 . . . . 0.0 109.371 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.5 ' CG ' ' O ' ' A' ' 19' ' ' GLU . 1.7 pp20? -116.39 117.38 29.8 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.209 -0.932 . . . . 0.0 109.352 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.53 ' O ' ' N ' ' A' ' 22' ' ' ARG . 8.5 t -113.71 83.73 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.423 0 O-C-N 121.229 -0.92 . . . . 0.0 109.172 179.895 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.523 ' CZ ' ' O ' ' A' ' 2' ' ' ALA . 1.1 p90 -45.95 91.75 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.413 -0.805 . . . . 0.0 109.878 -179.7 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.53 ' N ' ' O ' ' A' ' 20' ' ' VAL . 0.2 OUTLIER -56.07 -35.27 66.79 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.254 -0.904 . . . . 0.0 109.138 179.784 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -176.01 42.07 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.394 -0.816 . . . . 0.0 109.21 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.9 p -57.31 105.86 0.27 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.216 -0.928 . . . . 0.0 109.338 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -86.42 -120.18 1.19 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -62.81 -89.09 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.281 -1.129 . . . . 0.0 109.485 -179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.416 ' O ' ' OG1' ' A' ' 27' ' ' THR . 0.3 OUTLIER -142.97 19.57 1.96 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.254 -0.904 . . . . 0.0 109.401 -179.96 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 2.5 m -126.35 45.28 2.69 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.191 -0.943 . . . . 0.0 109.403 -179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -99.81 -154.85 28.05 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.407 ' O ' ' O ' ' A' ' 31' ' ' SER . 0.0 OUTLIER -134.22 -50.28 0.81 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.252 -1.146 . . . . 0.0 109.417 179.957 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.407 ' O ' ' O ' ' A' ' 30' ' ' ARG . 1.9 m 60.95 116.39 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.37 -0.832 . . . . 0.0 109.657 179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -81.49 149.61 28.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.263 -0.898 . . . . 0.0 109.152 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 42.0 m -127.49 111.51 13.89 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.122 -0.987 . . . . 0.0 109.953 -179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.477 ' CD1' ' N ' ' A' ' 34' ' ' TYR . 19.8 m-85 -99.76 152.98 19.48 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.295 -0.878 . . . . 0.0 108.806 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.622 ' CE1' ' CE1' ' A' ' 64' ' ' PHE . 7.5 m-85 -124.5 142.74 51.1 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.983 -1.073 . . . . 0.0 109.934 -179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -126.63 138.98 53.5 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.375 -0.828 . . . . 0.0 109.402 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.924 ' OG ' HG22 ' A' ' 39' ' ' THR . 0.9 OUTLIER -77.89 172.52 9.59 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.287 -0.883 . . . . 0.0 109.506 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.451 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 35.0 Cg_endo -79.29 13.4 2.04 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.77 2.313 . . . . 0.0 110.98 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.924 HG22 ' OG ' ' A' ' 37' ' ' SER . 14.6 t -123.34 -21.62 5.3 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.981 -1.074 . . . . 0.0 109.852 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 127.27 8.23 4.59 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 110.031 -1.228 . . . . 0.0 110.031 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.456 ' OD2' ' OH ' ' A' ' 52' ' ' TYR . 6.0 m-20 -88.86 133.3 34.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.083 -1.245 . . . . 0.0 109.324 179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.41 ' O ' ' HG2' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -116.37 137.06 52.46 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.263 -0.898 . . . . 0.0 109.432 -179.734 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.747 HD13 ' HA ' ' A' ' 49' ' ' LEU . 4.5 mt -132.7 156.21 42.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.264 -0.897 . . . . 0.0 109.922 -179.81 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.592 ' O ' ' CZ ' ' A' ' 64' ' ' PHE . 13.3 ttp180 -123.5 -45.72 2.06 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.581 -0.699 . . . . 0.0 110.067 -179.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.578 ' HB2' ' CB ' ' A' ' 48' ' ' GLU . 0.6 OUTLIER -59.28 122.7 14.54 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.915 -1.115 . . . . 0.0 108.831 -179.965 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.575 ' HA ' ' CE1' ' A' ' 64' ' ' PHE . 4.9 ttpm? -40.34 -83.17 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.543 -0.723 . . . . 0.0 110.724 -179.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.499 ' HA ' ' OG1' ' A' ' 50' ' ' THR . 42.7 t -55.64 -30.4 26.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.205 -0.935 . . . . 0.0 110.641 -178.581 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.578 ' CB ' ' HB2' ' A' ' 45' ' ' SER . 14.2 tt0 -54.8 -45.88 74.4 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.663 -1.273 . . . . 0.0 108.813 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.747 ' HA ' HD13 ' A' ' 43' ' ' ILE . 1.4 pp -69.83 -20.67 63.42 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 179.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.78 ' OG1' HD13 ' A' ' 59' ' ' LEU . 17.0 m -71.95 -67.21 0.55 Allowed 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.46 ' HG3' ' O ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -44.58 -26.96 0.42 Allowed 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.795 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.456 ' OH ' ' OD2' ' A' ' 41' ' ' ASP . 76.5 t80 -67.75 -64.68 0.81 Allowed 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.455 -0.778 . . . . 0.0 109.191 179.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.918 HD21 ' CE3' ' A' ' 15' ' ' TRP . 1.3 mt -44.5 -57.27 3.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.189 -0.945 . . . . 0.0 109.04 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 141.01 -162.16 26.75 Favored Glycine 0 N--CA 1.489 2.207 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.95 -16.17 14.45 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 122.648 2.232 . . . . 0.0 110.218 179.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.29 -8.19 56.54 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.307 -0.871 . . . . 0.0 109.585 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 39.8 m -124.98 168.17 13.69 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.242 -0.911 . . . . 0.0 109.553 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.928 ' C ' HD12 ' A' ' 59' ' ' LEU . 9.3 p-10 -165.46 141.95 5.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.273 -0.892 . . . . 0.0 109.44 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.928 HD12 ' C ' ' A' ' 58' ' ' ASP . 6.7 mp -139.43 1.28 1.95 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.097 -1.002 . . . . 0.0 109.955 -179.956 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.619 ' C ' HD22 ' A' ' 61' ' ' LEU . 67.5 m -47.25 -31.28 3.62 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.044 -1.035 . . . . 0.0 108.876 179.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.813 HD22 ' N ' ' A' ' 61' ' ' LEU . 2.7 mm? -103.43 -15.95 15.74 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 179.843 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.538 ' CZ ' ' HA2' ' A' ' 67' ' ' GLY . 64.9 t80 -57.61 132.87 54.53 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.551 -0.718 . . . . 0.0 109.702 -179.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.497 ' O ' ' N ' ' A' ' 65' ' ' LYS . 1.1 m-20 -79.71 104.79 10.54 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.331 -0.856 . . . . 0.0 108.915 179.656 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.622 ' CE1' ' CE1' ' A' ' 35' ' ' TYR . 0.4 OUTLIER -67.74 63.81 0.08 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.183 -0.948 . . . . 0.0 109.424 -179.584 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.497 ' N ' ' O ' ' A' ' 63' ' ' ASP . 1.4 ttmm 173.61 -32.62 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -94.01 -46.45 7.14 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.374 -0.829 . . . . 0.0 109.012 179.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.538 ' HA2' ' CZ ' ' A' ' 62' ' ' PHE . . . 108.45 28.54 4.55 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 110.073 -1.211 . . . . 0.0 110.073 179.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.468 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 1.3 pp -140.74 159.13 24.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.017 -1.284 . . . . 0.0 109.909 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.695 ' N ' HD23 ' A' ' 69' ' ' LEU . 1.1 pt? -141.54 -176.09 4.61 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.612 -0.884 . . . . 0.0 108.612 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 1.2 m -157.16 173.92 16.25 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.037 -1.04 . . . . 0.0 109.828 179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 16.4 t80 -151.78 77.63 7.02 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.409 -0.807 . . . . 0.0 109.307 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.69 69.05 7.49 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.618 2.212 . . . . 0.0 110.346 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.932 ' HB3' ' HD3' ' A' ' 74' ' ' PRO . . . -63.84 -52.39 57.79 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.319 -0.863 . . . . 0.0 109.911 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.932 ' HD3' ' HB3' ' A' ' 73' ' ' ALA . 35.4 Cg_endo -78.13 -176.75 3.41 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 C-N-CA 122.39 2.06 . . . . 0.0 110.611 -179.658 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.6 pttm . . . . . 0 N--CA 1.49 1.538 0 CA-C-O 117.996 -1.002 . . . . 0.0 109.336 -179.862 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.532 0 N-CA-C 109.467 -0.568 . . . . 0.0 109.467 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -169.54 -61.52 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.344 -0.848 . . . . 0.0 109.405 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.526 ' HB2' ' CZ ' ' A' ' 18' ' ' ARG . 1.7 pm0 -103.28 73.09 1.19 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.202 -0.936 . . . . 0.0 109.481 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.45 ' O ' ' O ' ' A' ' 5' ' ' TRP . 12.3 m-20 -110.16 27.2 9.85 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.292 -0.88 . . . . 0.0 109.287 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.592 ' CZ3' ' HB2' ' A' ' 36' ' ' GLN . 65.3 m95 47.01 93.24 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.258 -0.901 . . . . 0.0 109.241 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.444 HD11 ' OE2' ' A' ' 19' ' ' GLU . 3.0 mt -103.86 176.48 5.14 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.37 -0.831 . . . . 0.0 109.644 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.504 ' OD1' ' N ' ' A' ' 7' ' ' ASP . 6.6 p-10 -62.17 137.27 58.23 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.391 -0.818 . . . . 0.0 109.422 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.528 ' SG ' ' CZ ' ' A' ' 17' ' ' ARG . 13.4 t -95.5 109.99 48.48 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.259 -0.901 . . . . 0.0 109.231 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 36.2 Cg_endo -79.45 -46.7 0.1 OUTLIER 'Trans proline' 0 C--N 1.31 -1.448 0 C-N-CA 122.446 2.097 . . . . 0.0 110.795 -179.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.646 ' HB3' ' NH1' ' A' ' 17' ' ' ARG . . . -43.21 -44.03 5.02 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.162 -0.962 . . . . 0.0 109.935 -179.715 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.785 HD12 ' CD1' ' A' ' 15' ' ' TRP . 10.7 mt -97.23 -61.53 1.39 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.203 -0.936 . . . . 0.0 109.777 -179.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.461 ' O ' ' O ' ' A' ' 8' ' ' CYS . . . 155.74 -155.02 25.97 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.95 158.63 30.92 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.582 2.188 . . . . 0.0 110.335 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.4 -43.01 3.09 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.88 ' CE3' HD21 ' A' ' 53' ' ' LEU . 15.9 t-105 -79.35 130.66 35.65 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.221 -1.164 . . . . 0.0 109.424 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.3 mmtm -97.97 124.04 42.25 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.256 -0.903 . . . . 0.0 109.235 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.646 ' NH1' ' HB3' ' A' ' 10' ' ' ALA . 0.7 OUTLIER -99.63 108.92 21.42 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.256 -0.902 . . . . 0.0 109.318 -179.944 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.526 ' CZ ' ' HB2' ' A' ' 3' ' ' GLU . 0.2 OUTLIER -99.85 137.78 37.84 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.175 -0.953 . . . . 0.0 109.744 -179.779 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.444 ' OE2' HD11 ' A' ' 6' ' ' LEU . 1.5 pt-20 -123.83 152.93 41.74 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.37 -0.831 . . . . 0.0 109.272 179.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.542 HG12 ' H ' ' A' ' 21' ' ' PHE . 1.9 t -129.05 175.26 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.22 -0.925 . . . . 0.0 109.467 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.542 ' H ' HG12 ' A' ' 20' ' ' VAL . 15.5 m-85 -129.16 60.01 1.56 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.316 -0.865 . . . . 0.0 109.094 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . . . . . . . . . 5.1 mtt85 -73.02 90.29 1.49 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.388 -0.82 . . . . 0.0 109.779 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -58.5 -47.67 83.35 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.095 -1.003 . . . . 0.0 108.974 179.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 47.93 -167.08 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.297 -0.877 . . . . 0.0 109.595 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -128.49 -57.33 0.11 Allowed Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.11 162.14 0.52 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.213 -1.169 . . . . 0.0 109.42 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -100.91 56.74 0.87 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.288 -0.882 . . . . 0.0 109.516 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.9 m -125.65 84.37 2.27 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.253 -0.905 . . . . 0.0 109.449 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.43 124.65 5.43 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.48 ' O ' ' CB ' ' A' ' 31' ' ' SER . 4.9 tpt180 -109.75 94.62 5.12 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.223 -1.163 . . . . 0.0 109.338 179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.48 ' CB ' ' O ' ' A' ' 30' ' ' ARG . 0.9 OUTLIER 72.91 136.12 0.05 OUTLIER 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.246 -0.909 . . . . 0.0 109.27 -179.887 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.595 ' HB3' ' CZ ' ' A' ' 34' ' ' TYR . 0.4 OUTLIER -95.66 157.6 15.83 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.215 -0.928 . . . . 0.0 109.454 -179.896 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.412 HG23 ' O ' ' A' ' 18' ' ' ARG . 2.7 m -139.79 123.61 17.5 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.184 -0.948 . . . . 0.0 109.546 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.595 ' CZ ' ' HB3' ' A' ' 32' ' ' ASP . 0.7 OUTLIER -120.63 163.06 18.61 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.258 -0.901 . . . . 0.0 109.474 179.911 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.813 ' HD2' HD22 ' A' ' 49' ' ' LEU . 8.8 m-85 -130.45 156.99 43.83 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.182 -0.949 . . . . 0.0 109.834 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.592 ' HB2' ' CZ3' ' A' ' 5' ' ' TRP . 12.4 tt0 -139.18 114.33 9.55 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.398 -0.814 . . . . 0.0 109.001 179.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.584 ' HB2' HG22 ' A' ' 39' ' ' THR . 0.8 OUTLIER -63.2 163.05 19.53 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.291 -0.88 . . . . 0.0 109.615 -179.686 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.58 3.08 7.15 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.625 2.217 . . . . 0.0 110.241 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.584 HG22 ' HB2' ' A' ' 37' ' ' SER . 2.8 t -103.56 -16.77 15.43 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.334 -0.854 . . . . 0.0 109.233 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 114.0 14.8 8.96 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.513 ' OD2' ' CE1' ' A' ' 52' ' ' TYR . 0.8 OUTLIER -95.39 115.93 28.1 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.221 -1.164 . . . . 0.0 109.504 179.947 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.428 ' O ' ' HG2' ' A' ' 42' ' ' ARG . 0.0 OUTLIER -99.51 121.35 41.04 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.184 -0.948 . . . . 0.0 109.541 179.961 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.502 ' CG2' ' HB3' ' A' ' 49' ' ' LEU . 2.7 mp -126.36 156.53 36.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.337 -0.852 . . . . 0.0 109.207 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.584 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 2.2 ttm180 -133.37 -8.68 2.92 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.088 -1.007 . . . . 0.0 110.773 -179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.986 ' O ' HD23 ' A' ' 49' ' ' LEU . 0.4 OUTLIER -79.71 -178.27 6.3 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.73 -1.231 . . . . 0.0 108.391 179.296 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.557 ' HA ' ' CE1' ' A' ' 64' ' ' PHE . 29.4 ttpt -102.15 -57.32 2.09 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.988 -1.07 . . . . 0.0 109.845 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 57.4 t -84.57 -14.8 11.2 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.12 -0.988 . . . . 0.0 109.387 -179.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.574 ' HB2' ' CB ' ' A' ' 45' ' ' SER . 1.9 mt-10 -74.7 -42.21 58.78 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.066 -1.021 . . . . 0.0 108.389 179.083 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.986 HD23 ' O ' ' A' ' 45' ' ' SER . 1.5 pp -70.96 -29.13 65.05 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 179.023 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.886 ' OG1' HD12 ' A' ' 59' ' ' LEU . 0.4 OUTLIER -71.86 -43.8 64.87 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.301 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.421 ' N ' HG22 ' A' ' 50' ' ' THR . 0.3 OUTLIER -61.24 -21.81 64.22 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.993 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.513 ' CE1' ' OD2' ' A' ' 41' ' ' ASP . 90.2 t80 -75.81 -60.21 2.42 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.558 -0.714 . . . . 0.0 109.448 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.88 HD21 ' CE3' ' A' ' 15' ' ' TRP . 1.0 OUTLIER -56.02 -46.28 78.87 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.155 -0.965 . . . . 0.0 109.254 179.726 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 128.63 -151.34 18.92 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -79.08 -24.31 6.94 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 122.638 2.225 . . . . 0.0 110.504 -179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -64.7 -20.47 66.34 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.269 -0.894 . . . . 0.0 109.854 -179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 49.3 m -133.52 103.48 5.94 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.179 -0.95 . . . . 0.0 109.687 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -104.49 150.82 24.25 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.226 -0.921 . . . . 0.0 109.044 179.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 1.007 HD23 ' CD2' ' A' ' 62' ' ' PHE . 0.6 OUTLIER -134.42 9.11 3.69 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.236 -0.915 . . . . 0.0 109.466 -179.876 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.572 ' C ' HD22 ' A' ' 61' ' ' LEU . 2.5 m -47.76 -46.8 30.51 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.326 -0.858 . . . . 0.0 109.303 179.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.63 HD22 ' N ' ' A' ' 61' ' ' LEU . 3.5 mm? -99.26 -2.15 37.32 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.353 -0.842 . . . . 0.0 109.528 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 1.007 ' CD2' HD23 ' A' ' 59' ' ' LEU . 69.2 t80 -60.1 129.04 39.81 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.264 -0.898 . . . . 0.0 109.488 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.503 ' O ' ' N ' ' A' ' 65' ' ' LYS . 3.2 m-20 -79.3 101.05 7.84 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.242 -0.911 . . . . 0.0 108.931 179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.584 ' CE2' ' O ' ' A' ' 44' ' ' ARG . 0.9 OUTLIER -67.32 61.21 0.06 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.35 -0.844 . . . . 0.0 109.435 -179.494 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.503 ' N ' ' O ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -174.08 -38.54 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.312 -0.868 . . . . 0.0 109.449 -179.819 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 11.8 mt-30 -100.37 -39.87 7.77 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.288 -0.882 . . . . 0.0 109.511 179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.437 ' HA2' ' CZ ' ' A' ' 62' ' ' PHE . . . 107.22 35.96 2.6 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 2.0 pp -140.64 163.73 22.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.129 -1.218 . . . . 0.0 109.726 179.838 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.482 ' HB3' ' HA ' ' A' ' 62' ' ' PHE . 0.7 OUTLIER -145.59 173.66 11.86 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.271 -0.893 . . . . 0.0 109.032 179.76 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.468 ' O ' ' HG ' ' A' ' 61' ' ' LEU . 1.6 p -151.9 139.23 19.41 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.184 -0.948 . . . . 0.0 109.362 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.4 p90 -129.7 154.3 80.93 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.235 -0.916 . . . . 0.0 109.635 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.439 ' O ' ' HB3' ' A' ' 73' ' ' ALA . 35.2 Cg_endo -77.49 -160.38 0.12 Allowed 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.671 2.248 . . . . 0.0 110.441 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 72' ' ' PRO . . . 61.32 79.05 0.29 Allowed Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.211 -0.93 . . . . 0.0 109.472 -179.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -77.81 -85.57 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.644 2.229 . . . . 0.0 110.463 -179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.9 pttm . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.477 179.978 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.238 0.542 . . . . 0.0 109.605 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.41 144.42 31.43 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.264 -0.897 . . . . 0.0 109.494 -179.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.5 ' OE2' HG22 ' A' ' 20' ' ' VAL . 0.3 OUTLIER -86.03 -158.44 0.4 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.187 -0.946 . . . . 0.0 109.373 179.913 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -102.46 50.12 0.83 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.127 -0.983 . . . . 0.0 109.642 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . . . . . . . . . 67.7 m95 -62.05 99.11 0.12 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.159 -0.963 . . . . 0.0 109.42 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.425 ' O ' ' C ' ' A' ' 7' ' ' ASP . 89.9 mt -113.62 145.9 40.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.24 -0.912 . . . . 0.0 109.284 179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.484 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 12.5 t0 -43.21 129.07 4.76 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.183 -0.948 . . . . 0.0 109.469 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.473 ' HB3' ' O ' ' A' ' 15' ' ' TRP . 14.8 t -80.36 113.25 37.64 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.408 -0.808 . . . . 0.0 109.505 -179.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 36.5 Cg_endo -80.14 -53.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.353 2.036 . . . . 0.0 110.461 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.52 ' CB ' ' CE1' ' A' ' 62' ' ' PHE . . . -42.66 -33.4 0.71 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.38 -0.825 . . . . 0.0 109.867 -179.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 1.14 HD12 ' CD1' ' A' ' 15' ' ' TRP . 16.8 mt -105.89 -63.78 1.22 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.189 -0.944 . . . . 0.0 109.299 179.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 146.8 -151.5 23.77 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.602 -1.399 . . . . 0.0 109.602 179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_endo -77.66 155.04 31.18 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 C-N-CA 122.639 2.226 . . . . 0.0 110.26 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.423 ' O ' ' HD3' ' A' ' 38' ' ' PRO . . . 90.57 -33.55 4.54 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.262 -1.535 . . . . 0.0 109.262 -179.764 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 1.14 ' CD1' HD12 ' A' ' 11' ' ' LEU . 13.7 t-105 -94.91 122.85 37.97 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.394 -1.062 . . . . 0.0 108.958 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.6 121.52 39.6 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.142 -0.973 . . . . 0.0 109.172 -179.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.598 ' CG ' ' CE1' ' A' ' 35' ' ' TYR . 0.2 OUTLIER -90.56 104.91 17.44 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.365 -0.834 . . . . 0.0 109.772 -179.774 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.802 ' O ' HG23 ' A' ' 33' ' ' THR . 0.7 OUTLIER -97.55 143.34 28.34 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.397 -0.815 . . . . 0.0 109.028 179.584 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -137.35 141.97 41.79 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.014 -1.054 . . . . 0.0 109.92 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.638 HG12 ' H ' ' A' ' 21' ' ' PHE . 2.2 t -127.11 178.57 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.348 -0.845 . . . . 0.0 109.24 179.677 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.638 ' H ' HG12 ' A' ' 20' ' ' VAL . 0.2 OUTLIER -116.08 3.6 13.58 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.191 -0.943 . . . . 0.0 109.739 -179.849 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.471 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 1.6 tmt_? 67.68 -73.6 0.08 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.19 -0.943 . . . . 0.0 109.748 179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 22' ' ' ARG . 0.2 OUTLIER 177.36 -35.89 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.301 -0.875 . . . . 0.0 109.083 -179.916 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.6 m -151.01 178.01 9.6 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.292 -0.88 . . . . 0.0 109.384 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 171.83 81.39 0.05 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -80.23 -85.61 0.09 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.243 -1.151 . . . . 0.0 109.391 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.98 7.08 16.75 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.283 -0.885 . . . . 0.0 109.396 179.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 42.6 t -142.63 52.59 1.42 Allowed 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.32 -0.862 . . . . 0.0 109.272 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -97.18 -177.15 34.68 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.933 -1.267 . . . . 0.0 109.933 -179.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -167.97 -36.55 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.498 -1.001 . . . . 0.0 109.079 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.44 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 0.0 OUTLIER 68.82 132.59 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.271 -0.893 . . . . 0.0 109.73 179.55 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.571 ' HB3' ' CE1' ' A' ' 34' ' ' TYR . 60.9 m-20 -87.88 124.55 33.77 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.333 -0.854 . . . . 0.0 109.068 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.802 HG23 ' O ' ' A' ' 18' ' ' ARG . 6.1 m -113.35 138.29 50.27 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.23 -0.919 . . . . 0.0 109.385 -179.875 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.571 ' CE1' ' HB3' ' A' ' 32' ' ' ASP . 13.1 m-85 -131.13 151.18 51.71 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.235 -0.916 . . . . 0.0 109.393 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.682 ' CZ ' ' CE1' ' A' ' 64' ' ' PHE . 14.7 m-85 -122.17 133.93 54.73 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.291 -0.881 . . . . 0.0 109.224 179.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.444 ' HG3' ' HG3' ' A' ' 42' ' ' ARG . 39.6 tt0 -115.85 124.73 51.39 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.215 -0.928 . . . . 0.0 109.606 -179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.534 ' CB ' ' HD2' ' A' ' 38' ' ' PRO . 0.1 OUTLIER -75.48 175.66 3.91 Favored Pre-proline 0 N--CA 1.489 1.512 0 O-C-N 121.234 -0.916 . . . . 0.0 109.368 179.888 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.534 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 35.2 Cg_endo -77.63 -4.75 14.89 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.64 2.227 . . . . 0.0 110.55 -179.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.488 HG22 ' HB2' ' A' ' 37' ' ' SER . 8.1 t -101.85 -0.43 34.13 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.212 -0.93 . . . . 0.0 109.536 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 94.99 19.6 30.64 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.271 -1.532 . . . . 0.0 109.271 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.457 ' HB2' ' OG ' ' A' ' 37' ' ' SER . 0.2 OUTLIER -84.77 118.02 24.19 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.291 -1.123 . . . . 0.0 109.335 -179.996 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.444 ' HG3' ' HG3' ' A' ' 36' ' ' GLN . 0.0 OUTLIER -105.58 107.08 17.88 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.362 -0.836 . . . . 0.0 109.535 -179.839 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.529 HG21 ' HB3' ' A' ' 49' ' ' LEU . 1.8 mp -120.5 153.53 23.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.289 -0.882 . . . . 0.0 109.448 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.586 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 13.6 ptt180 -122.11 -26.16 4.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.135 -0.978 . . . . 0.0 109.466 179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.5 ' CB ' ' HB2' ' A' ' 48' ' ' GLU . 0.3 OUTLIER -83.2 139.9 32.87 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.217 -0.927 . . . . 0.0 109.022 179.751 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.582 ' HG3' HG23 ' A' ' 47' ' ' VAL . 9.0 pttt -66.91 -52.01 48.32 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.304 -0.872 . . . . 0.0 110.932 -178.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.582 HG23 ' HG3' ' A' ' 46' ' ' LYS . 48.4 t -74.92 -23.25 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 120.818 -1.176 . . . . 0.0 109.958 -179.17 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.5 ' HB2' ' CB ' ' A' ' 45' ' ' SER . 28.8 mt-10 -65.28 -50.49 65.55 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.895 -1.128 . . . . 0.0 108.297 179.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.655 ' O ' HD12 ' A' ' 53' ' ' LEU . 3.7 pp -72.58 -35.81 68.03 Favored 'General case' 0 C--N 1.305 -1.335 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.623 ' OG1' HD12 ' A' ' 59' ' ' LEU . 0.5 OUTLIER -59.29 -39.66 83.68 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.025 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 14.1 mmt180 -69.38 -25.11 64.0 Favored 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 108.329 -0.989 . . . . 0.0 108.329 179.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.485 ' OH ' HG21 ' A' ' 39' ' ' THR . 5.6 t80 -71.32 -57.66 4.26 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.658 -0.651 . . . . 0.0 109.326 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.998 HD21 ' CZ3' ' A' ' 15' ' ' TRP . 0.2 OUTLIER -65.95 -40.21 91.12 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.094 -1.004 . . . . 0.0 109.248 179.724 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 122.44 -153.86 16.89 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.425 -1.47 . . . . 0.0 109.425 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.422 ' O ' ' C ' ' A' ' 56' ' ' ALA . 34.8 Cg_endo -77.57 -36.23 1.3 Allowed 'Trans proline' 0 C--N 1.309 -1.55 0 C-N-CA 122.534 2.156 . . . . 0.0 110.331 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.422 ' C ' ' O ' ' A' ' 55' ' ' PRO . . . -44.86 -39.86 5.73 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.213 -0.93 . . . . 0.0 109.227 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.419 ' O ' ' OG1' ' A' ' 50' ' ' THR . 1.3 m -114.48 84.0 1.98 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.32 -0.862 . . . . 0.0 109.05 179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -77.86 163.97 25.58 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.224 -0.922 . . . . 0.0 109.883 -179.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.975 HD23 ' CD2' ' A' ' 62' ' ' PHE . 0.5 OUTLIER -160.01 23.23 0.17 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.444 -0.785 . . . . 0.0 109.27 179.964 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.491 ' C ' HD22 ' A' ' 61' ' ' LEU . 3.6 m -55.35 -48.2 74.59 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.331 -0.856 . . . . 0.0 109.95 -179.644 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.535 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 2.2 mm? -103.98 4.07 34.18 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.28 -0.887 . . . . 0.0 109.95 -179.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.975 ' CD2' HD23 ' A' ' 59' ' ' LEU . 54.3 t80 -63.64 136.75 57.73 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.205 -0.934 . . . . 0.0 109.909 -179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -93.98 114.95 27.25 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.501 -0.749 . . . . 0.0 108.995 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.711 ' HE1' HG22 ' A' ' 33' ' ' THR . 0.3 OUTLIER -74.58 62.27 1.02 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.222 -0.924 . . . . 0.0 109.797 -179.458 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.443 ' HB3' ' O ' ' A' ' 64' ' ' PHE . 17.5 pttt 178.91 -38.41 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.273 -0.892 . . . . 0.0 109.178 179.633 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.402 ' N ' ' CG ' ' A' ' 65' ' ' LYS . 0.4 OUTLIER -94.23 -18.46 21.67 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.285 -0.884 . . . . 0.0 108.991 179.407 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.58 ' CA ' ' CZ ' ' A' ' 17' ' ' ARG . . . 73.32 43.08 39.83 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.894 -1.282 . . . . 0.0 109.894 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 1.4 pp -140.48 -167.47 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.152 -1.205 . . . . 0.0 109.511 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.578 ' HB3' ' HA ' ' A' ' 62' ' ' PHE . 0.6 OUTLIER 179.95 178.47 0.59 Allowed 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.799 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -160.44 167.37 27.43 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.007 -1.058 . . . . 0.0 109.909 179.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -115.93 153.63 48.24 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.303 -0.873 . . . . 0.0 109.308 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.73 56.44 5.62 Favored 'Trans proline' 0 C--N 1.308 -1.575 0 C-N-CA 122.531 2.154 . . . . 0.0 110.576 -179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.535 ' N ' ' HD3' ' A' ' 74' ' ' PRO . . . -169.45 61.35 0.42 Allowed Pre-proline 0 N--CA 1.489 1.502 0 O-C-N 121.14 -0.975 . . . . 0.0 109.672 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.535 ' HD3' ' N ' ' A' ' 73' ' ' ALA . 36.3 Cg_endo -78.28 142.15 18.79 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.603 2.202 . . . . 0.0 110.328 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.422 ' HE3' ' O ' ' A' ' 73' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 117.986 -1.007 . . . . 0.0 109.461 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.581 0 N-CA-C 109.431 -0.581 . . . . 0.0 109.431 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -107.36 -62.32 1.44 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.243 -0.91 . . . . 0.0 109.471 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.531 ' HB2' ' NE ' ' A' ' 18' ' ' ARG . 7.2 mm-40 -116.71 -88.7 0.59 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.239 -0.913 . . . . 0.0 109.605 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.464 ' O ' ' HG ' ' A' ' 6' ' ' LEU . 5.9 m-20 -157.96 69.18 0.52 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.199 -0.938 . . . . 0.0 109.818 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.602 ' CE3' ' HB2' ' A' ' 18' ' ' ARG . 48.4 m95 -67.51 97.54 0.6 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.141 -0.974 . . . . 0.0 109.203 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.464 ' HG ' ' O ' ' A' ' 4' ' ' ASP . 28.6 mt -103.0 152.52 21.23 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.153 -0.967 . . . . 0.0 109.484 -179.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.471 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 37.1 m-20 -47.43 129.57 13.19 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.211 -0.931 . . . . 0.0 109.133 179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.531 ' CB ' ' HB2' ' A' ' 17' ' ' ARG . 54.1 t -79.9 114.05 43.06 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.302 -0.874 . . . . 0.0 109.653 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 36.4 Cg_endo -78.64 -46.1 0.12 Allowed 'Trans proline' 0 C--N 1.31 -1.455 0 C-N-CA 122.292 1.995 . . . . 0.0 110.195 179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.657 ' O ' HD23 ' A' ' 11' ' ' LEU . . . -46.57 -29.83 1.99 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.307 -0.871 . . . . 0.0 109.644 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.934 HD12 ' CD1' ' A' ' 15' ' ' TRP . 10.2 mt -115.54 -61.76 1.69 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.082 -1.011 . . . . 0.0 110.004 -179.772 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.47 ' O ' ' O ' ' A' ' 8' ' ' CYS . . . 158.79 -152.14 23.19 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.858 -1.297 . . . . 0.0 109.858 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.52 ' O ' ' N ' ' A' ' 15' ' ' TRP . 35.1 Cg_endo -77.79 179.32 6.62 Favored 'Trans proline' 0 C--N 1.311 -1.446 0 C-N-CA 122.633 2.222 . . . . 0.0 110.352 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.45 ' O ' ' HD3' ' A' ' 16' ' ' LYS . . . 67.2 -63.95 0.23 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 108.951 -1.66 . . . . 0.0 108.951 -179.646 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.934 ' CD1' HD12 ' A' ' 11' ' ' LEU . 6.2 t-105 -53.09 126.95 22.41 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.385 -1.068 . . . . 0.0 109.089 179.356 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.45 ' HD3' ' O ' ' A' ' 14' ' ' GLY . 0.3 OUTLIER -100.33 114.71 28.42 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.061 -1.024 . . . . 0.0 109.761 -179.579 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 1.008 ' NH2' HG21 ' A' ' 33' ' ' THR . 8.7 ttt-85 -95.93 102.99 14.85 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.361 -0.837 . . . . 0.0 109.174 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.602 ' HB2' ' CE3' ' A' ' 5' ' ' TRP . 8.4 ttt180 -99.94 151.41 21.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.154 -0.966 . . . . 0.0 109.973 -179.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 2.0 pt-20 -126.16 138.46 53.66 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.393 -0.817 . . . . 0.0 109.316 179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.44 HG22 ' HE ' ' A' ' 18' ' ' ARG . 11.4 t -136.18 152.66 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.242 -0.912 . . . . 0.0 109.359 -179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.544 ' CB ' ' HA ' ' A' ' 31' ' ' SER . 6.4 m-85 62.56 17.5 9.69 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.255 -0.903 . . . . 0.0 109.481 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.549 ' CA ' ' HB3' ' A' ' 31' ' ' SER . 0.0 OUTLIER -91.19 -53.01 4.54 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.286 -0.884 . . . . 0.0 109.726 -179.891 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.01 170.31 9.51 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.171 -0.956 . . . . 0.0 109.742 -179.723 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 3.1 t 66.12 89.97 0.09 Allowed 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.295 -0.878 . . . . 0.0 109.456 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 167.22 165.24 24.29 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.66 -79.38 0.17 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.247 -1.149 . . . . 0.0 109.444 -179.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 1.5 t -146.81 74.94 1.37 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.249 -0.907 . . . . 0.0 109.432 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.7 t -89.96 -70.96 0.64 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.287 -0.883 . . . . 0.0 109.395 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 84.47 67.83 1.42 Allowed Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.481 ' O ' ' O ' ' A' ' 31' ' ' SER . 0.0 OUTLIER -168.2 -62.64 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.294 -1.121 . . . . 0.0 109.3 179.892 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.549 ' HB3' ' CA ' ' A' ' 22' ' ' ARG . 0.1 OUTLIER 51.6 173.05 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.399 -0.813 . . . . 0.0 109.913 179.828 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.566 ' HB3' ' CE1' ' A' ' 34' ' ' TYR . 7.8 m-20 -130.58 117.64 19.85 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.295 -0.878 . . . . 0.0 108.691 179.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 1.008 HG21 ' NH2' ' A' ' 17' ' ' ARG . 18.5 m -101.87 137.02 40.71 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.138 -0.976 . . . . 0.0 110.061 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.566 ' CE1' ' HB3' ' A' ' 32' ' ' ASP . 46.5 m-85 -129.13 148.49 51.07 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 108.612 -0.885 . . . . 0.0 108.612 179.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.784 ' HD2' HD22 ' A' ' 49' ' ' LEU . 38.6 m-85 -110.81 137.64 48.2 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.079 -1.013 . . . . 0.0 109.897 -179.577 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.545 ' HB2' ' CZ3' ' A' ' 5' ' ' TRP . 0.0 OUTLIER -116.38 116.86 28.49 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.273 -0.892 . . . . 0.0 109.257 179.536 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.478 ' CB ' ' HD2' ' A' ' 38' ' ' PRO . 0.6 OUTLIER -58.12 173.65 0.38 Allowed Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.303 -0.873 . . . . 0.0 109.309 -179.971 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.478 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 35.7 Cg_endo -78.72 0.67 9.77 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.621 2.214 . . . . 0.0 110.382 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.444 HG22 ' HB3' ' A' ' 37' ' ' SER . 5.5 t -111.88 -22.9 10.86 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.295 -0.878 . . . . 0.0 109.417 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 131.8 -2.37 5.22 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.726 -1.349 . . . . 0.0 109.726 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.433 ' CB ' ' HB2' ' A' ' 37' ' ' SER . 0.2 OUTLIER -65.31 171.09 4.09 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.188 -1.184 . . . . 0.0 109.427 179.952 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.465 ' HA ' ' O ' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -154.67 108.31 2.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.26 -0.9 . . . . 0.0 109.277 -179.962 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.63 HG21 ' CA ' ' A' ' 49' ' ' LEU . 2.4 mp -107.49 163.36 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.279 -0.888 . . . . 0.0 109.623 -179.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.567 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 7.7 ttp180 -130.59 -32.51 1.71 Allowed 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.316 -0.865 . . . . 0.0 109.851 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.842 ' O ' HD23 ' A' ' 49' ' ' LEU . 0.6 OUTLIER -68.13 151.75 46.53 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.056 -1.027 . . . . 0.0 108.877 179.825 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.441 ' HD2' ' O ' ' A' ' 59' ' ' LEU . 7.5 ttpm? -70.59 -68.78 0.4 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.272 -0.893 . . . . 0.0 111.185 -178.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.477 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 54.5 t -71.9 -18.6 19.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.052 -1.03 . . . . 0.0 110.705 -178.53 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.576 ' HB2' ' CB ' ' A' ' 45' ' ' SER . 5.5 mt-10 -72.12 -42.74 65.71 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.656 -1.278 . . . . 0.0 108.745 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.842 HD23 ' O ' ' A' ' 45' ' ' SER . 1.6 pp -69.42 -25.83 64.31 Favored 'General case' 0 C--N 1.304 -1.382 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 178.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.891 ' OG1' HD13 ' A' ' 59' ' ' LEU . 20.6 m -70.44 -62.7 1.29 Allowed 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.49 ' HG3' ' O ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -51.0 -22.56 2.36 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.477 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.496 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 59.2 t80 -64.03 -56.25 16.36 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.39 -0.819 . . . . 0.0 108.92 179.351 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.756 HD21 ' CE3' ' A' ' 15' ' ' TRP . 0.7 OUTLIER -61.87 -49.27 76.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.197 -0.94 . . . . 0.0 109.221 179.704 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 130.91 -156.03 21.53 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.457 -1.457 . . . . 0.0 109.457 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.79 3.42 6.95 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.536 2.157 . . . . 0.0 110.231 179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -87.83 -12.89 43.62 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.384 -0.823 . . . . 0.0 109.325 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.46 ' O ' ' CG2' ' A' ' 50' ' ' THR . 52.9 m -139.02 131.68 28.95 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.233 -0.917 . . . . 0.0 109.703 -179.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.84 ' C ' HD12 ' A' ' 59' ' ' LEU . 12.4 t70 -124.27 155.11 39.19 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.274 -0.891 . . . . 0.0 109.472 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.891 HD13 ' OG1' ' A' ' 50' ' ' THR . 5.5 mp -148.49 15.06 0.99 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.191 -0.943 . . . . 0.0 109.61 -179.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.645 ' C ' HD22 ' A' ' 61' ' ' LEU . 12.7 m -46.01 -37.54 6.74 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.22 -0.925 . . . . 0.0 109.484 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.645 HD22 ' C ' ' A' ' 60' ' ' THR . 1.4 mm? -112.72 11.1 19.39 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.22 -0.925 . . . . 0.0 109.744 -179.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.804 ' CD2' HD23 ' A' ' 59' ' ' LEU . 51.5 t80 -69.3 151.05 46.7 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.329 -0.857 . . . . 0.0 110.317 -179.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -107.08 106.42 16.91 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 179.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.567 ' CE2' ' O ' ' A' ' 44' ' ' ARG . 0.2 OUTLIER -71.09 60.76 0.27 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.182 -0.949 . . . . 0.0 109.577 -179.224 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 15.5 ttpt -177.28 -35.14 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.196 -0.94 . . . . 0.0 109.585 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -101.08 -30.83 11.37 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.216 -0.928 . . . . 0.0 109.529 -179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 91.18 39.72 5.65 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.609 -1.397 . . . . 0.0 109.609 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.424 ' O ' ' CD1' ' A' ' 62' ' ' PHE . 2.2 pp -140.11 -178.64 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.168 -1.195 . . . . 0.0 109.967 -179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.524 ' HB3' ' HA ' ' A' ' 62' ' ' PHE . 0.8 OUTLIER -172.17 -175.97 1.54 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.36 -0.838 . . . . 0.0 108.99 -179.954 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.477 ' SG ' HD12 ' A' ' 61' ' ' LEU . 31.9 p -160.24 168.82 24.51 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.183 -0.948 . . . . 0.0 109.337 179.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -142.38 78.3 16.71 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.238 -0.914 . . . . 0.0 109.693 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -78.01 -169.18 0.71 Allowed 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 122.617 2.212 . . . . 0.0 110.06 179.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -167.05 83.43 0.87 Allowed Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.161 -0.962 . . . . 0.0 109.551 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.68 102.92 1.59 Allowed 'Trans proline' 0 C--N 1.309 -1.536 0 C-N-CA 122.695 2.263 . . . . 0.0 110.272 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.4 mttt . . . . . 0 N--CA 1.49 1.543 0 CA-C-O 118.036 -0.983 . . . . 0.0 109.405 -179.906 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.9 tpt . . . . . 0 N--CA 1.49 1.548 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -168.66 54.75 0.05 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.223 -0.923 . . . . 0.0 109.578 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -140.55 124.96 17.74 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.266 -0.896 . . . . 0.0 109.453 179.845 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.473 ' O ' ' O ' ' A' ' 5' ' ' TRP . 61.0 t0 -144.69 24.08 1.55 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.268 -0.895 . . . . 0.0 109.379 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.588 ' CE2' ' HD2' ' A' ' 18' ' ' ARG . 62.5 m95 50.29 100.52 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.389 -0.82 . . . . 0.0 109.584 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.658 HD12 ' O ' ' A' ' 17' ' ' ARG . 0.3 OUTLIER -107.58 150.26 27.07 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.234 -0.916 . . . . 0.0 109.596 179.984 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.537 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 0.4 OUTLIER -45.88 147.53 0.96 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.3 -0.875 . . . . 0.0 109.352 179.774 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.529 ' HB2' ' HB3' ' A' ' 15' ' ' TRP . 52.3 m -93.8 109.81 43.67 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.329 -0.857 . . . . 0.0 109.77 179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.537 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 35.8 Cg_endo -80.02 -29.43 2.66 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.26 1.973 . . . . 0.0 109.561 179.291 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.968 ' HB3' ' NH1' ' A' ' 17' ' ' ARG . . . -69.55 -34.77 74.68 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.376 -0.827 . . . . 0.0 109.357 179.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.952 HD12 ' CD1' ' A' ' 15' ' ' TRP . 10.4 mt -105.51 -50.27 3.25 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.208 -0.932 . . . . 0.0 109.509 179.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 139.08 -151.68 21.9 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -77.74 161.66 30.41 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.627 2.218 . . . . 0.0 110.268 179.726 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 84.94 -48.61 4.09 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.255 -1.538 . . . . 0.0 109.255 -179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 1.001 ' CZ2' HD13 ' A' ' 49' ' ' LEU . 11.4 t-105 -76.61 125.78 29.84 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.26 -1.141 . . . . 0.0 109.195 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.491 ' N ' ' HD3' ' A' ' 16' ' ' LYS . 0.1 OUTLIER -102.21 127.53 49.11 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.386 -0.821 . . . . 0.0 109.448 -179.655 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.968 ' NH1' ' HB3' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -100.58 104.1 15.43 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.423 -0.798 . . . . 0.0 109.899 -179.311 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.588 ' HD2' ' CE2' ' A' ' 5' ' ' TRP . 1.0 OUTLIER -100.74 135.09 42.72 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.17 -0.956 . . . . 0.0 109.569 179.624 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -115.49 146.51 41.61 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.274 -0.891 . . . . 0.0 109.351 179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.49 ' O ' ' N ' ' A' ' 32' ' ' ASP . 2.9 t -139.6 152.86 23.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.175 -0.953 . . . . 0.0 109.876 -179.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 7.3 m-30 56.06 27.75 11.86 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.409 -0.807 . . . . 0.0 109.775 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.408 ' O ' ' CB ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -90.96 95.79 10.3 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.269 -0.894 . . . . 0.0 109.354 179.757 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.408 ' CB ' ' O ' ' A' ' 22' ' ' ARG . 0.6 OUTLIER 69.76 98.79 0.06 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.295 -0.878 . . . . 0.0 109.557 -179.936 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 17.5 m -153.91 -67.77 0.14 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.286 -0.884 . . . . 0.0 109.244 179.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -100.3 -59.4 0.84 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.469 ' O ' ' N ' ' A' ' 28' ' ' CYS . . . -92.31 20.17 6.34 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.25 -1.147 . . . . 0.0 109.33 179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 48.67 -94.57 0.03 OUTLIER 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.384 -0.822 . . . . 0.0 109.57 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . 0.469 ' N ' ' O ' ' A' ' 26' ' ' ALA . 1.7 m -85.92 89.8 7.89 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.127 -0.983 . . . . 0.0 109.493 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -133.49 -94.19 0.53 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 26.0 ttm-85 -146.68 121.05 9.61 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.184 -1.186 . . . . 0.0 109.645 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.415 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 1.6 p -110.22 135.45 50.97 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.251 -0.905 . . . . 0.0 109.312 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.526 ' HB3' ' CZ ' ' A' ' 34' ' ' TYR . 3.6 m-20 -86.31 103.86 15.29 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.163 -0.961 . . . . 0.0 109.24 179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.545 HG22 ' HE1' ' A' ' 35' ' ' TYR . 1.5 m -100.65 120.26 39.8 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.278 -0.889 . . . . 0.0 109.841 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.554 ' CG ' ' HD3' ' A' ' 44' ' ' ARG . 15.2 m-85 -123.35 152.92 41.01 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.355 -0.84 . . . . 0.0 108.979 179.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.692 ' CE2' ' CE1' ' A' ' 64' ' ' PHE . 4.1 m-85 -118.57 145.16 45.59 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.117 -0.989 . . . . 0.0 109.593 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.491 ' NE2' ' O ' ' A' ' 37' ' ' SER . 0.0 OUTLIER -132.93 141.71 48.5 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.216 -0.928 . . . . 0.0 109.868 -179.802 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.534 ' HG ' ' HZ3' ' A' ' 15' ' ' TRP . 0.3 OUTLIER -81.26 173.4 7.75 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.45 -0.781 . . . . 0.0 109.183 179.616 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.463 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 36.0 Cg_endo -78.89 7.2 4.43 Favored 'Trans proline' 0 C--N 1.308 -1.565 0 C-N-CA 122.605 2.203 . . . . 0.0 110.573 -179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.2 p -110.49 -13.59 14.23 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.212 -0.93 . . . . 0.0 109.502 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 110.59 24.3 5.64 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.877 ' OD2' HD11 ' A' ' 43' ' ' ILE . 9.5 t70 -97.42 123.23 41.19 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.279 -1.13 . . . . 0.0 109.393 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.689 ' C ' HD12 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -107.26 124.84 50.35 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.29 -0.881 . . . . 0.0 109.645 -179.912 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.877 HD11 ' OD2' ' A' ' 41' ' ' ASP . 3.1 mp -128.05 150.43 33.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.255 -0.903 . . . . 0.0 109.447 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.572 ' HA ' ' CZ ' ' A' ' 64' ' ' PHE . 11.9 mtt180 -144.92 9.68 1.31 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.253 -0.904 . . . . 0.0 110.235 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.549 ' CB ' ' HB2' ' A' ' 48' ' ' GLU . 0.3 OUTLIER -98.41 12.66 34.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.033 -1.042 . . . . 0.0 109.355 179.833 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.584 ' HA ' ' CE1' ' A' ' 64' ' ' PHE . 0.0 OUTLIER 63.22 -93.4 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.365 -0.834 . . . . 0.0 110.225 179.374 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.459 ' HA ' ' OG1' ' A' ' 50' ' ' THR . 75.5 t -55.35 -22.45 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.127 -0.983 . . . . 0.0 109.812 -179.161 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.549 ' HB2' ' CB ' ' A' ' 45' ' ' SER . 2.5 mt-10 -63.56 -47.83 79.96 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.038 -1.039 . . . . 0.0 108.766 179.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 1.076 HD12 HD11 ' A' ' 53' ' ' LEU . 1.3 pp -67.56 -24.92 65.58 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 107.998 -1.112 . . . . 0.0 107.998 179.113 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.526 ' HA ' HD12 ' A' ' 53' ' ' LEU . 4.9 m -66.95 -62.59 1.36 Allowed 'General case' 0 N--CA 1.487 1.418 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.501 ' HG3' ' O ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -52.4 -21.64 3.84 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.306 -0.957 . . . . 0.0 108.459 179.299 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.418 ' O ' ' C ' ' A' ' 53' ' ' LEU . 2.0 t80 -77.19 -64.51 1.12 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.463 -0.773 . . . . 0.0 108.989 179.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 1.076 HD11 HD12 ' A' ' 49' ' ' LEU . 2.2 mt -45.07 -63.64 0.88 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.18 -0.95 . . . . 0.0 109.047 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 143.8 -163.6 27.61 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.97 -7.26 16.32 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.604 2.203 . . . . 0.0 110.116 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -79.36 -11.3 59.93 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.341 -0.849 . . . . 0.0 109.453 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.409 ' SG ' ' HB3' ' A' ' 11' ' ' LEU . 1.0 OUTLIER -136.74 150.41 48.39 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.245 -0.909 . . . . 0.0 109.456 -179.986 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.924 ' C ' HD12 ' A' ' 59' ' ' LEU . 13.7 p-10 -139.97 156.15 46.79 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.234 -0.916 . . . . 0.0 109.43 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.924 HD12 ' C ' ' A' ' 58' ' ' ASP . 6.0 mp -150.86 15.51 0.75 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.167 -0.958 . . . . 0.0 109.549 -179.926 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.695 ' C ' HD22 ' A' ' 61' ' ' LEU . 32.1 m -47.32 -41.03 18.45 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.277 -0.889 . . . . 0.0 109.336 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.695 HD22 ' C ' ' A' ' 60' ' ' THR . 2.4 mm? -109.27 -4.62 16.33 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.279 -0.888 . . . . 0.0 109.597 -179.665 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.577 ' CD2' HD23 ' A' ' 59' ' ' LEU . 33.4 t80 -56.93 136.48 56.0 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.273 -0.892 . . . . 0.0 109.73 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.571 ' O ' ' CE2' ' A' ' 62' ' ' PHE . 11.6 m-20 -85.13 129.23 34.84 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.361 -0.837 . . . . 0.0 109.11 179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.692 ' CE1' ' CE2' ' A' ' 35' ' ' TYR . 0.6 OUTLIER -84.39 54.92 3.16 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.133 -0.98 . . . . 0.0 109.489 -179.61 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.449 ' HA ' ' OG1' ' A' ' 33' ' ' THR . 7.3 ttmt -175.91 -42.72 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.428 -0.795 . . . . 0.0 109.033 179.856 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 12.5 mt-30 -83.25 -45.69 13.54 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.36 -0.838 . . . . 0.0 109.105 179.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.553 ' O ' ' HB2' ' A' ' 10' ' ' ALA . . . 103.32 32.64 4.51 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.477 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 2.2 pp -140.52 162.21 23.87 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.108 -1.231 . . . . 0.0 109.692 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.465 ' HB3' ' HA ' ' A' ' 62' ' ' PHE . 1.1 pt? -143.6 164.16 31.19 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.301 -0.875 . . . . 0.0 108.982 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.56 ' O ' ' CB ' ' A' ' 71' ' ' TYR . 7.7 p -157.41 176.45 12.65 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.12 -0.987 . . . . 0.0 109.577 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.607 ' HB3' ' HD3' ' A' ' 72' ' ' PRO . 6.7 t80 158.98 -47.98 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.723 -0.61 . . . . 0.0 109.477 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.607 ' HD3' ' HB3' ' A' ' 71' ' ' TYR . 36.6 Cg_endo -79.57 93.43 1.08 Allowed 'Trans proline' 0 C--N 1.316 -1.179 0 C-N-CA 122.023 1.816 . . . . 0.0 110.212 179.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.415 ' HA ' ' HD3' ' A' ' 74' ' ' PRO . . . -174.62 145.75 0.99 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.103 -0.998 . . . . 0.0 109.525 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 73' ' ' ALA . 36.2 Cg_endo -78.35 110.01 2.77 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.573 2.182 . . . . 0.0 110.378 179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 117.949 -1.024 . . . . 0.0 109.42 -179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.449 ' O ' ' HB3' ' A' ' 2' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 1' ' ' MET . . . 62.1 118.45 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.277 -0.89 . . . . 0.0 109.475 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 39.3 mm-40 -85.14 179.9 7.15 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.295 -0.878 . . . . 0.0 109.531 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.413 ' O ' ' C ' ' A' ' 5' ' ' TRP . 0.3 OUTLIER -135.85 76.65 1.62 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.307 -0.871 . . . . 0.0 109.449 -179.973 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.59 ' CZ3' ' HB2' ' A' ' 18' ' ' ARG . 71.2 m95 -42.62 124.48 3.0 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.322 -0.862 . . . . 0.0 109.585 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.46 ' HG ' ' O ' ' A' ' 17' ' ' ARG . 0.2 OUTLIER -110.01 148.74 31.1 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.237 -0.914 . . . . 0.0 109.527 179.921 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.413 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 0.6 OUTLIER -47.43 147.32 1.71 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.203 -0.936 . . . . 0.0 109.49 -179.884 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.532 ' HB2' ' HB3' ' A' ' 15' ' ' TRP . 6.1 m -89.69 114.46 60.69 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.344 -0.848 . . . . 0.0 109.818 -179.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.451 ' HD2' ' HD3' ' A' ' 17' ' ' ARG . 36.0 Cg_endo -79.04 -39.51 0.34 Allowed 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 122.362 2.041 . . . . 0.0 110.371 179.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.499 ' HB2' ' O ' ' A' ' 67' ' ' GLY . . . -64.58 -46.26 83.45 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.213 -0.93 . . . . 0.0 109.595 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 1.01 HD12 ' CD1' ' A' ' 15' ' ' TRP . 6.8 mt -90.12 -48.06 7.42 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.117 -0.989 . . . . 0.0 109.776 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 129.81 -153.26 19.93 Favored Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.815 -1.314 . . . . 0.0 109.815 -179.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_endo -77.41 155.81 32.44 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 C-N-CA 122.732 2.288 . . . . 0.0 110.497 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 88.71 -26.66 8.0 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.229 -1.549 . . . . 0.0 109.229 -179.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 1.01 ' CD1' HD12 ' A' ' 11' ' ' LEU . 8.7 t-105 -101.74 132.8 47.26 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.345 -1.091 . . . . 0.0 108.9 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.423 ' C ' ' SG ' ' A' ' 8' ' ' CYS . 14.5 mptt -106.39 129.24 54.42 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.191 -0.943 . . . . 0.0 110.078 -179.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.601 ' HG3' ' CE2' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -105.27 113.25 26.72 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.376 -0.828 . . . . 0.0 109.097 179.611 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.59 ' HB2' ' CZ3' ' A' ' 5' ' ' TRP . 0.1 OUTLIER -100.16 144.44 29.19 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.365 -0.834 . . . . 0.0 109.588 -179.728 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -130.83 131.06 44.39 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.341 -0.849 . . . . 0.0 109.197 179.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.516 ' O ' ' N ' ' A' ' 32' ' ' ASP . 14.5 t -138.34 161.57 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.205 -0.934 . . . . 0.0 109.514 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.461 ' HB2' ' O ' ' A' ' 20' ' ' VAL . 0.5 OUTLIER 68.69 32.27 4.25 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.185 -0.947 . . . . 0.0 109.41 -179.994 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.485 ' HG3' ' HB3' ' A' ' 31' ' ' SER . 4.1 ttp180 -75.82 81.39 2.75 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.318 -0.864 . . . . 0.0 109.488 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 61.55 95.38 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.283 -0.886 . . . . 0.0 109.634 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -169.53 -66.16 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.288 -0.883 . . . . 0.0 109.606 179.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -84.56 -98.48 0.65 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.627 -1.389 . . . . 0.0 109.627 -179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -99.33 119.62 38.23 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.254 -1.145 . . . . 0.0 109.565 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -90.88 53.81 2.49 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.26 -0.9 . . . . 0.0 109.405 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 6.0 t -83.09 -15.75 49.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.336 -0.852 . . . . 0.0 109.641 -179.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.469 ' O ' ' HG2' ' A' ' 30' ' ' ARG . . . -152.4 -88.76 0.07 OUTLIER Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.469 ' HG2' ' O ' ' A' ' 29' ' ' GLY . 0.0 OUTLIER -171.56 165.54 6.83 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.229 -1.159 . . . . 0.0 109.614 -179.837 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.485 ' HB3' ' HG3' ' A' ' 22' ' ' ARG . 0.3 OUTLIER -46.52 163.46 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.309 -0.869 . . . . 0.0 109.429 179.913 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 20' ' ' VAL . 0.9 OUTLIER -89.6 170.1 10.77 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.214 -0.929 . . . . 0.0 109.154 179.751 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 3.6 m -137.82 109.28 6.95 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.11 -0.994 . . . . 0.0 109.829 -179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.575 ' CE1' ' HD2' ' A' ' 44' ' ' ARG . 8.8 m-30 -109.11 160.25 16.21 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.338 -0.851 . . . . 0.0 108.748 179.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.601 ' CE2' ' HG3' ' A' ' 17' ' ' ARG . 19.6 m-85 -131.76 145.56 51.66 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.047 -1.033 . . . . 0.0 109.776 -179.84 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.436 ' HA ' ' O ' ' A' ' 41' ' ' ASP . 0.9 OUTLIER -133.17 130.44 39.15 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.286 -0.884 . . . . 0.0 109.248 179.931 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.427 ' HA ' ' CZ3' ' A' ' 15' ' ' TRP . 0.8 OUTLIER -71.54 170.42 12.04 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.247 -0.908 . . . . 0.0 109.386 -179.951 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.422 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 35.9 Cg_endo -78.27 5.61 5.32 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.592 2.195 . . . . 0.0 110.457 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 4.3 p -113.09 -23.03 10.24 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.251 -0.905 . . . . 0.0 109.227 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 125.47 23.36 1.72 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.836 -1.305 . . . . 0.0 109.836 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.573 ' OD2' ' CE1' ' A' ' 52' ' ' TYR . 2.8 t70 -87.73 136.16 33.07 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.153 -1.204 . . . . 0.0 109.07 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.96 100.71 7.74 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.219 -0.925 . . . . 0.0 109.844 -179.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.626 HG21 ' CA ' ' A' ' 49' ' ' LEU . 3.3 mt -112.87 154.09 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.404 -0.81 . . . . 0.0 109.146 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.575 ' HD2' ' CE1' ' A' ' 34' ' ' TYR . 8.1 ttp180 -129.02 -2.76 5.15 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.108 -0.995 . . . . 0.0 109.981 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.753 ' O ' HD23 ' A' ' 49' ' ' LEU . 5.8 t -88.57 173.27 8.74 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 179.23 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.553 ' HA ' ' CE1' ' A' ' 64' ' ' PHE . 5.6 ttpm? -91.98 -60.49 1.84 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 120.894 -1.129 . . . . 0.0 110.113 -179.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.443 ' O ' ' CG ' ' A' ' 51' ' ' ARG . 77.6 t -81.48 -22.04 10.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 O-C-N 121.01 -1.057 . . . . 0.0 109.33 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.554 ' HB2' ' CB ' ' A' ' 45' ' ' SER . 1.2 tt0 -66.21 -45.95 78.96 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.05 -1.092 . . . . 0.0 108.05 178.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.824 HD13 ' CZ2' ' A' ' 15' ' ' TRP . 1.7 pp -69.95 -22.53 63.16 Favored 'General case' 0 N--CA 1.486 1.342 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 178.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.705 ' OG1' HD13 ' A' ' 59' ' ' LEU . 25.5 m -69.09 -69.11 0.35 Allowed 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.515 -0.92 . . . . 0.0 108.515 178.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.443 ' CG ' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -44.15 -28.45 0.5 Allowed 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 179.494 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.573 ' CE1' ' OD2' ' A' ' 41' ' ' ASP . 87.5 t80 -59.23 -60.02 4.52 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.173 -0.954 . . . . 0.0 108.845 179.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.871 HD21 ' CE3' ' A' ' 15' ' ' TRP . 1.0 OUTLIER -52.7 -54.8 28.56 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.305 -0.872 . . . . 0.0 109.265 179.616 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 137.43 -162.74 25.44 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.413 -1.475 . . . . 0.0 109.413 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.44 -5.51 15.64 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.559 2.173 . . . . 0.0 110.192 179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -77.19 -26.93 53.37 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.387 -0.82 . . . . 0.0 109.396 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . . . . . . . . . 1.1 m -109.55 -171.61 1.88 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.302 -0.874 . . . . 0.0 109.323 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.886 ' C ' HD12 ' A' ' 59' ' ' LEU . 6.9 t0 -178.81 149.43 0.46 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.245 -0.909 . . . . 0.0 109.655 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.886 HD12 ' C ' ' A' ' 58' ' ' ASP . 5.5 mp -153.86 14.46 0.47 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.187 -0.945 . . . . 0.0 109.705 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.521 HG22 ' CD2' ' A' ' 61' ' ' LEU . 98.4 m -47.94 -39.88 20.48 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.122 -0.987 . . . . 0.0 109.16 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.574 ' CD2' ' N ' ' A' ' 61' ' ' LEU . 1.3 mm? -104.42 -14.05 15.87 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.396 -0.815 . . . . 0.0 109.229 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.761 ' CD2' HD23 ' A' ' 59' ' ' LEU . 64.6 t80 -44.96 156.19 0.09 Allowed 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.441 -0.787 . . . . 0.0 109.811 -179.776 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.499 ' O ' ' N ' ' A' ' 65' ' ' LYS . 5.1 m-20 -109.34 108.35 18.87 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.282 -0.887 . . . . 0.0 109.403 -179.927 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.575 ' CZ ' ' O ' ' A' ' 44' ' ' ARG . 0.9 OUTLIER -67.48 61.72 0.06 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.405 -0.809 . . . . 0.0 109.03 179.964 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.499 ' N ' ' O ' ' A' ' 63' ' ' ASP . 0.7 OUTLIER 173.75 -28.11 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.319 -0.863 . . . . 0.0 109.69 -179.738 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -103.75 -26.45 12.73 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.125 -0.984 . . . . 0.0 110.11 -179.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.502 ' CA ' ' NH2' ' A' ' 17' ' ' ARG . . . 85.53 30.26 24.9 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.686 -1.365 . . . . 0.0 109.686 -179.826 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.511 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 1.9 pp -140.09 173.2 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 O-C-N 121.226 -1.161 . . . . 0.0 109.517 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.498 ' HB3' ' HA ' ' A' ' 62' ' ' PHE . 0.8 OUTLIER -150.38 -168.48 3.12 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.393 -0.817 . . . . 0.0 109.416 179.984 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -153.55 153.01 31.59 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.219 -0.926 . . . . 0.0 109.358 179.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.541 ' O ' ' CD2' ' A' ' 71' ' ' TYR . 12.9 p90 -134.55 96.4 15.21 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.129 -0.982 . . . . 0.0 109.688 -179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.66 104.36 1.86 Allowed 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 122.589 2.193 . . . . 0.0 110.43 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.543 ' HB1' ' HD2' ' A' ' 74' ' ' PRO . . . -146.32 162.03 36.36 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.349 -0.845 . . . . 0.0 109.217 179.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.543 ' HD2' ' HB1' ' A' ' 73' ' ' ALA . 35.6 Cg_endo -78.44 -10.79 16.0 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 122.548 2.165 . . . . 0.0 110.489 -179.744 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . 0.407 ' HB2' ' O ' ' A' ' 74' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.462 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.5 mmt . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.22 143.12 30.1 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.302 -0.874 . . . . 0.0 109.468 -179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.454 ' HG3' ' NH1' ' A' ' 18' ' ' ARG . 13.9 mm-40 -119.18 -91.34 0.56 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.209 -0.932 . . . . 0.0 109.789 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -153.95 65.33 0.72 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.238 -0.914 . . . . 0.0 109.532 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.584 ' CE3' ' HB2' ' A' ' 18' ' ' ARG . 84.2 m95 -66.7 99.22 0.58 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.265 -0.897 . . . . 0.0 109.695 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 79.6 mt -112.69 154.05 26.72 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.27 -0.894 . . . . 0.0 109.366 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.495 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 0.4 OUTLIER -49.01 139.52 10.25 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.232 -0.918 . . . . 0.0 108.897 179.704 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.484 ' HG ' ' HE2' ' A' ' 35' ' ' TYR . 44.0 t -91.04 111.94 51.07 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.219 -0.925 . . . . 0.0 109.696 -179.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.495 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 36.7 Cg_endo -79.63 -48.68 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.255 1.97 . . . . 0.0 109.975 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.647 ' HB3' ' CE2' ' A' ' 62' ' ' PHE . . . -50.15 -35.44 26.03 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.398 -0.814 . . . . 0.0 109.476 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 1.138 HD12 ' CD1' ' A' ' 15' ' ' TRP . 14.5 mt -98.16 -64.98 0.99 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.262 -0.899 . . . . 0.0 109.555 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.455 ' O ' ' O ' ' A' ' 8' ' ' CYS . . . 158.61 -158.88 29.72 Favored Glycine 0 N--CA 1.493 2.438 0 N-CA-C 109.769 -1.332 . . . . 0.0 109.769 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -76.77 159.91 34.63 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.551 2.167 . . . . 0.0 110.402 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 81.91 -68.15 3.54 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 109.136 -1.586 . . . . 0.0 109.136 -179.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 1.138 ' CD1' HD12 ' A' ' 11' ' ' LEU . 26.9 t-105 -49.87 128.64 18.82 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.296 -1.12 . . . . 0.0 108.82 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.3 mmtm -99.33 120.83 40.21 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.118 -0.989 . . . . 0.0 109.552 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.583 ' CZ ' ' CA ' ' A' ' 67' ' ' GLY . 23.7 ttt-85 -93.4 105.11 17.21 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.366 -0.834 . . . . 0.0 109.295 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.792 HH11 HG22 ' A' ' 20' ' ' VAL . 1.2 tmm_? -100.23 152.21 20.56 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.206 -0.934 . . . . 0.0 110.055 -179.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 17.7 pt-20 -137.98 155.13 49.18 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.932 -0.766 . . . . 0.0 108.932 179.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.792 HG22 HH11 ' A' ' 18' ' ' ARG . 1.0 OUTLIER -125.52 -179.28 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.983 -1.073 . . . . 0.0 109.735 -179.675 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.551 ' H ' HG12 ' A' ' 20' ' ' VAL . 35.4 p90 -127.75 42.37 3.33 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.307 -0.871 . . . . 0.0 109.493 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.433 ' HB3' ' OD2' ' A' ' 32' ' ' ASP . 0.0 OUTLIER -79.72 77.95 6.32 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.244 -0.91 . . . . 0.0 109.392 179.94 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 6.2 ptmt -170.26 51.35 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.215 -0.928 . . . . 0.0 109.411 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 34.5 t -108.75 15.54 23.53 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.277 -0.889 . . . . 0.0 109.44 -179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -131.56 -70.15 0.1 OUTLIER Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -92.9 168.4 11.19 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.186 -1.185 . . . . 0.0 109.42 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.18 31.68 6.27 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.216 -0.927 . . . . 0.0 109.667 -179.833 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.3 m -103.61 67.69 0.91 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.233 -0.917 . . . . 0.0 109.47 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 146.44 155.74 6.64 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.425 ' O ' ' HB3' ' A' ' 31' ' ' SER . 0.0 OUTLIER -120.63 64.72 0.85 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.238 -1.154 . . . . 0.0 109.56 -179.959 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.426 ' OG ' ' O ' ' A' ' 20' ' ' VAL . 0.1 OUTLIER 68.04 139.6 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.159 -0.963 . . . . 0.0 109.493 179.861 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.433 ' OD2' ' HB3' ' A' ' 22' ' ' ARG . 21.0 m-20 -80.85 160.63 24.73 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.262 -0.899 . . . . 0.0 109.251 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.505 HG23 ' O ' ' A' ' 18' ' ' ARG . 93.6 m -137.96 134.37 34.84 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.065 -1.022 . . . . 0.0 109.956 -179.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.44 ' CD1' ' O ' ' A' ' 33' ' ' THR . 18.1 m-85 -136.04 153.94 51.2 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.365 -0.834 . . . . 0.0 109.077 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.559 ' CE2' ' HG3' ' A' ' 17' ' ' ARG . 27.5 m-85 -121.02 161.51 21.53 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.996 -1.065 . . . . 0.0 109.752 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.58 ' HB2' ' CZ3' ' A' ' 5' ' ' TRP . 0.1 OUTLIER -128.13 115.29 18.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.289 -0.882 . . . . 0.0 109.287 179.723 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.805 ' HG ' HG22 ' A' ' 39' ' ' THR . 0.8 OUTLIER -53.44 176.41 0.11 Allowed Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.354 -0.841 . . . . 0.0 109.24 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.546 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 35.4 Cg_endo -77.62 -8.88 17.18 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.442 2.095 . . . . 0.0 110.25 179.796 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.805 HG22 ' HG ' ' A' ' 37' ' ' SER . 12.9 t -110.17 -16.08 13.85 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.231 -0.918 . . . . 0.0 109.545 179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 121.03 20.63 3.33 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.444 ' CB ' ' HB3' ' A' ' 37' ' ' SER . 0.2 OUTLIER -89.73 101.87 14.57 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.197 -1.178 . . . . 0.0 109.249 179.877 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.41 126.26 30.59 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.278 -0.889 . . . . 0.0 108.845 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.701 HG21 ' HB3' ' A' ' 49' ' ' LEU . 0.9 OUTLIER -116.47 162.61 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.148 -0.97 . . . . 0.0 110.348 -179.121 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.588 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 0.0 OUTLIER -131.83 -21.83 2.41 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.546 -0.721 . . . . 0.0 110.094 -179.909 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.477 ' HB2' ' HB2' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -99.9 119.2 37.85 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.886 -1.134 . . . . 0.0 109.269 179.865 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.567 ' HA ' HD21 ' A' ' 49' ' ' LEU . 0.1 OUTLIER -46.89 -46.69 21.32 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.382 -0.824 . . . . 0.0 110.501 -179.442 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.439 ' HA ' ' HB ' ' A' ' 50' ' ' THR . 73.5 t -74.79 -41.7 47.17 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 120.851 -1.156 . . . . 0.0 109.317 -179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.488 ' O ' ' HG3' ' A' ' 51' ' ' ARG . 28.4 tt0 -48.53 -49.94 34.03 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.204 -0.935 . . . . 0.0 109.445 179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.729 ' O ' HD12 ' A' ' 53' ' ' LEU . 1.1 pp -72.67 -34.92 67.56 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.941 -1.1 . . . . 0.0 108.739 179.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.766 ' OG1' HD12 ' A' ' 59' ' ' LEU . 0.4 OUTLIER -54.63 -54.66 38.56 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.047 -1.033 . . . . 0.0 108.413 179.124 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.576 ' N ' HG22 ' A' ' 50' ' ' THR . 0.0 OUTLIER -67.97 -16.63 64.14 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.335 -0.853 . . . . 0.0 108.937 179.496 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.495 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 24.7 t80 -71.51 -56.15 6.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.278 -0.889 . . . . 0.0 109.058 179.409 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.97 HD21 ' CE3' ' A' ' 15' ' ' TRP . 0.4 OUTLIER -66.87 -48.84 67.55 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.199 -0.938 . . . . 0.0 108.983 179.523 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 138.64 -153.88 22.81 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.17 -1.572 . . . . 0.0 109.17 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -77.91 -26.9 6.28 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 122.55 2.167 . . . . 0.0 110.294 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -59.47 -27.28 65.97 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.346 -0.846 . . . . 0.0 109.357 179.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.693 ' CB ' HD13 ' A' ' 53' ' ' LEU . 6.0 m -121.0 104.54 9.88 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.276 -0.89 . . . . 0.0 109.308 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.465 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 0.4 OUTLIER -100.4 158.66 15.73 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.297 -0.877 . . . . 0.0 109.405 -179.903 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.766 HD12 ' OG1' ' A' ' 50' ' ' THR . 0.7 OUTLIER -151.8 19.68 0.7 Allowed 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.206 -0.934 . . . . 0.0 109.414 179.932 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.601 ' C ' HD22 ' A' ' 61' ' ' LEU . 28.6 m -49.95 -40.25 43.16 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.312 -0.867 . . . . 0.0 109.724 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.601 HD22 ' C ' ' A' ' 60' ' ' THR . 1.2 mm? -112.09 2.56 16.84 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.267 -0.896 . . . . 0.0 109.887 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.717 ' CG ' HD23 ' A' ' 59' ' ' LEU . 2.4 t80 -52.44 125.27 15.69 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.193 -0.942 . . . . 0.0 110.037 -179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.523 ' O ' ' N ' ' A' ' 65' ' ' LYS . 1.4 t0 -84.77 97.84 9.92 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 178.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.588 ' CE2' ' O ' ' A' ' 44' ' ' ARG . 0.7 OUTLIER -65.7 68.14 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.344 -0.848 . . . . 0.0 109.14 -179.243 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.523 ' N ' ' O ' ' A' ' 63' ' ' ASP . 7.9 mtpt 174.82 -41.49 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.43 -0.794 . . . . 0.0 108.94 -179.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 3.2 tt0 -93.44 -39.65 10.78 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.358 -0.839 . . . . 0.0 109.092 179.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.583 ' CA ' ' CZ ' ' A' ' 17' ' ' ARG . . . 99.71 34.08 5.08 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . . . . . . . . . 1.2 pp -140.52 151.04 20.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.053 -1.263 . . . . 0.0 110.059 -179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.503 ' HB3' ' HA ' ' A' ' 62' ' ' PHE . 1.0 OUTLIER -139.59 160.52 39.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.326 -0.859 . . . . 0.0 109.179 179.305 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 1.7 p -150.27 169.01 22.38 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.15 -0.968 . . . . 0.0 109.602 179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -95.04 149.12 35.78 Favored Pre-proline 0 N--CA 1.489 1.518 0 O-C-N 121.273 -0.892 . . . . 0.0 109.376 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -77.72 139.04 17.51 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 C-N-CA 122.61 2.207 . . . . 0.0 110.565 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.634 ' HB1' ' HD2' ' A' ' 74' ' ' PRO . . . -135.59 164.66 41.93 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.283 -0.886 . . . . 0.0 109.504 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.634 ' HD2' ' HB1' ' A' ' 73' ' ' ALA . 35.9 Cg_endo -78.59 -9.85 15.93 Favored 'Trans proline' 0 C--N 1.308 -1.554 0 C-N-CA 122.71 2.273 . . . . 0.0 110.458 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 28.2 mttt . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 117.976 -1.012 . . . . 0.0 109.549 -179.939 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -129.18 3.94 5.23 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.298 -0.876 . . . . 0.0 109.639 -179.951 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.508 ' HB3' HG22 ' A' ' 20' ' ' VAL . 4.6 pm0 -136.92 165.48 25.87 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.186 -0.947 . . . . 0.0 109.439 179.923 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.438 ' O ' ' C ' ' A' ' 5' ' ' TRP . 0.7 OUTLIER -160.65 88.49 0.78 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.252 -0.905 . . . . 0.0 109.596 -179.966 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.438 ' C ' ' O ' ' A' ' 4' ' ' ASP . 75.3 m95 -42.11 106.47 0.06 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.33 -0.856 . . . . 0.0 109.535 179.844 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.463 ' HG ' ' O ' ' A' ' 17' ' ' ARG . 0.7 OUTLIER -115.92 158.63 22.72 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.236 -0.915 . . . . 0.0 109.52 -179.801 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.408 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 12.5 m-20 -50.71 145.36 6.97 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.198 -0.938 . . . . 0.0 109.453 179.96 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.482 ' HA ' ' HB2' ' A' ' 17' ' ' ARG . 42.3 t -89.45 114.5 60.71 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.224 -0.923 . . . . 0.0 109.664 -179.869 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 35.8 Cg_endo -78.47 -55.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.504 0 C-N-CA 122.284 1.99 . . . . 0.0 110.443 179.896 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.837 ' HB3' ' CE2' ' A' ' 62' ' ' PHE . . . -48.14 -39.21 19.94 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.315 -0.866 . . . . 0.0 109.937 -179.742 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.899 HD12 ' CD1' ' A' ' 15' ' ' TRP . 11.2 mt -94.18 -60.69 1.68 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.047 -1.033 . . . . 0.0 109.693 -179.996 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.478 ' O ' ' O ' ' A' ' 8' ' ' CYS . . . 147.88 -148.76 20.57 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.854 -1.299 . . . . 0.0 109.854 -179.932 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.42 159.29 32.68 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.621 2.214 . . . . 0.0 110.845 -179.652 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 85.17 -70.27 3.14 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.797 -1.321 . . . . 0.0 109.797 179.825 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.899 ' CD1' HD12 ' A' ' 11' ' ' LEU . 14.2 t-105 -50.39 126.24 14.61 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.24 -1.153 . . . . 0.0 109.728 -179.861 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.0 mmtm -98.89 110.56 23.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.208 -0.932 . . . . 0.0 109.227 179.723 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.608 ' HG3' ' CE1' ' A' ' 35' ' ' TYR . 8.6 ttt-85 -89.13 105.02 17.52 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.389 -0.82 . . . . 0.0 109.863 -179.55 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.49 ' HB3' ' O ' ' A' ' 34' ' ' TYR . 11.9 ttt180 -94.94 138.54 32.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.221 -0.924 . . . . 0.0 109.194 179.638 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -119.92 147.11 45.13 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.279 -0.888 . . . . 0.0 109.465 -179.983 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.538 HG12 ' O ' ' A' ' 20' ' ' VAL . 84.5 t -134.02 66.63 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.292 -0.88 . . . . 0.0 109.131 179.902 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -48.25 91.48 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.38 -0.825 . . . . 0.0 109.709 -179.697 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.513 ' N ' ' O ' ' A' ' 20' ' ' VAL . 12.2 mtt180 -74.79 -34.34 62.4 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.231 -0.918 . . . . 0.0 109.37 179.875 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -177.89 142.88 0.31 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.301 -0.875 . . . . 0.0 109.332 179.987 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 15.3 p -92.22 -26.42 18.19 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.209 -0.932 . . . . 0.0 109.488 -179.96 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 55.44 -164.4 4.16 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.577 -1.409 . . . . 0.0 109.577 179.925 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.534 ' O ' ' CG2' ' A' ' 27' ' ' THR . . . -84.83 91.27 7.96 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.278 -1.13 . . . . 0.0 109.484 179.913 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . 0.534 ' CG2' ' O ' ' A' ' 26' ' ' ALA . 10.2 t 40.98 35.01 0.32 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.553 -0.717 . . . . 0.0 109.973 179.947 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -147.8 24.99 1.06 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.232 -0.917 . . . . 0.0 109.246 179.702 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.44 -179.7 27.64 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.954 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.408 ' O ' ' HB2' ' A' ' 31' ' ' SER . 0.3 OUTLIER -141.22 -48.5 0.4 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.227 -1.16 . . . . 0.0 109.234 179.882 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.408 ' HB2' ' O ' ' A' ' 30' ' ' ARG . 14.6 m 64.56 144.02 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.24 -0.912 . . . . 0.0 109.552 179.773 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.577 ' HB3' ' CE1' ' A' ' 34' ' ' TYR . 7.5 m-20 -96.58 148.11 23.18 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.331 -0.855 . . . . 0.0 109.218 179.839 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.537 ' O ' ' CE1' ' A' ' 64' ' ' PHE . 0.0 OUTLIER -137.15 128.01 27.33 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.163 -0.96 . . . . 0.0 109.986 -179.658 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.577 ' CE1' ' HB3' ' A' ' 32' ' ' ASP . 1.1 m-85 -124.8 141.17 52.3 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.388 -0.82 . . . . 0.0 109.008 179.531 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.643 ' HD2' HD22 ' A' ' 49' ' ' LEU . 9.7 m-85 -118.17 143.9 46.14 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.004 -1.06 . . . . 0.0 109.751 -179.767 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.432 ' HB2' ' CZ3' ' A' ' 5' ' ' TRP . 8.7 tp-100 -117.86 134.43 54.94 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.371 -0.831 . . . . 0.0 109.474 179.931 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.454 ' OG ' ' HB3' ' A' ' 41' ' ' ASP . 0.0 OUTLIER -81.92 171.77 11.21 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.354 -0.841 . . . . 0.0 109.172 179.852 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.435 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 35.6 Cg_endo -78.01 6.13 4.85 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 122.486 2.124 . . . . 0.0 110.343 179.841 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.9 p -114.31 -9.92 12.75 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.185 -0.947 . . . . 0.0 109.409 -179.98 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 102.82 17.3 19.29 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 179.894 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.567 ' OD2' ' CE1' ' A' ' 52' ' ' TYR . 19.5 t0 -96.61 111.0 23.31 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.135 -1.215 . . . . 0.0 109.327 179.805 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.88 121.63 31.43 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.277 -0.889 . . . . 0.0 109.778 -179.715 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.578 HG21 ' CA ' ' A' ' 49' ' ' LEU . 3.9 mt -121.72 150.02 24.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.344 -0.847 . . . . 0.0 109.202 179.74 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.569 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 1.8 ttp180 -128.51 -6.59 5.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.233 -0.917 . . . . 0.0 109.94 179.758 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.572 ' HB3' ' CB ' ' A' ' 48' ' ' GLU . 12.9 t -90.29 142.66 27.51 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.093 -1.005 . . . . 0.0 108.923 179.598 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.504 ' HG2' ' N ' ' A' ' 47' ' ' VAL . 21.0 ttpt -63.97 -74.79 0.09 Allowed 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.338 -0.851 . . . . 0.0 110.862 -178.692 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.504 ' N ' ' HG2' ' A' ' 46' ' ' LYS . 58.3 t -62.16 -26.81 41.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.218 -0.926 . . . . 0.0 110.604 -178.431 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.572 ' CB ' ' HB3' ' A' ' 45' ' ' SER . 1.7 tt0 -66.45 -52.14 49.47 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.697 -1.252 . . . . 0.0 109.059 179.861 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.752 HD12 HD11 ' A' ' 53' ' ' LEU . 1.3 pp -63.51 -23.3 67.33 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 179.331 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.539 ' CG2' ' HB2' ' A' ' 59' ' ' LEU . 25.2 m -67.86 -70.83 0.24 Allowed 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.235 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.469 ' HG2' ' O ' ' A' ' 47' ' ' VAL . 0.1 OUTLIER -46.95 -24.43 0.61 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.402 -0.811 . . . . 0.0 109.131 179.975 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.567 ' CE1' ' OD2' ' A' ' 41' ' ' ASP . 69.8 t80 -62.96 -55.8 22.66 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.279 -0.888 . . . . 0.0 109.439 179.761 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.752 HD11 HD12 ' A' ' 49' ' ' LEU . 0.3 OUTLIER -65.78 -50.0 66.29 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.178 -0.951 . . . . 0.0 109.344 179.996 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 121.23 -152.79 16.74 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.241 -1.544 . . . . 0.0 109.241 -179.697 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -77.9 -9.51 16.85 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 122.553 2.169 . . . . 0.0 110.462 179.935 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.96 -24.86 58.53 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.299 -0.875 . . . . 0.0 109.3 179.9 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.442 ' HB2' ' HB2' ' A' ' 53' ' ' LEU . 54.5 m -127.98 94.77 4.01 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.292 -0.88 . . . . 0.0 109.0 179.741 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.456 ' N ' ' OD1' ' A' ' 58' ' ' ASP . 2.2 m-20 -76.91 157.26 31.47 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.347 -0.846 . . . . 0.0 110.168 -179.343 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.932 HD23 ' CB ' ' A' ' 62' ' ' PHE . 1.2 mp -152.09 39.56 0.6 Allowed 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.538 -0.726 . . . . 0.0 109.062 -179.709 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.947 ' O ' HD23 ' A' ' 61' ' ' LEU . 0.1 OUTLIER -38.51 -44.72 0.97 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.669 -0.644 . . . . 0.0 110.421 -179.447 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.947 HD23 ' O ' ' A' ' 60' ' ' THR . 10.8 mt -142.35 33.41 1.49 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.096 -1.002 . . . . 0.0 109.759 -179.813 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.932 ' CB ' HD23 ' A' ' 59' ' ' LEU . 10.9 t80 -47.27 117.35 1.71 Allowed 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.283 -0.885 . . . . 0.0 109.617 179.907 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.511 ' O ' ' N ' ' A' ' 65' ' ' LYS . 1.5 m-20 -79.42 102.34 8.67 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.388 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.569 ' CE2' ' O ' ' A' ' 44' ' ' ARG . 0.1 OUTLIER -67.35 62.07 0.06 Allowed 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.292 -0.88 . . . . 0.0 109.568 -178.914 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.511 ' N ' ' O ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER 171.82 -30.48 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.285 -0.884 . . . . 0.0 109.51 179.895 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 27.1 mt-30 -99.58 -42.77 6.76 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.204 -0.935 . . . . 0.0 109.411 179.843 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.469 ' HA2' ' NE ' ' A' ' 17' ' ' ARG . . . 101.78 30.79 5.67 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.733 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.459 HD11 ' OD2' ' A' ' 63' ' ' ASP . 2.4 pp -140.21 178.45 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.246 -1.149 . . . . 0.0 109.573 179.994 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.549 ' HB3' ' HA ' ' A' ' 62' ' ' PHE . 0.8 OUTLIER -164.7 -176.79 4.44 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.334 -0.854 . . . . 0.0 109.427 179.809 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.64 ' HB3' HD12 ' A' ' 61' ' ' LEU . 0.3 OUTLIER -160.37 166.89 28.54 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.28 -0.888 . . . . 0.0 109.537 179.693 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.62 ' N ' ' CD ' ' A' ' 72' ' ' PRO . 12.5 t80 -86.25 -45.02 0.58 Allowed Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.148 -0.97 . . . . 0.0 110.855 -179.734 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.859 ' O ' HD11 ' A' ' 61' ' ' LEU . 36.0 Cg_endo -80.55 -161.44 0.15 Allowed 'Trans proline' 0 C--N 1.313 -1.296 0 C-N-CA 122.282 1.988 . . . . 0.0 110.929 -179.106 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.539 ' N ' ' HD3' ' A' ' 74' ' ' PRO . . . 46.44 60.79 14.06 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.402 -0.811 . . . . 0.0 109.928 -179.965 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.539 ' HD3' ' N ' ' A' ' 73' ' ' ALA . 36.3 Cg_endo -79.05 168.86 20.05 Favored 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.564 2.176 . . . . 0.0 110.316 179.699 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 5.3 mttt . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 118.003 -0.998 . . . . 0.0 109.399 179.783 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.506 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.28 156.68 38.88 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.119 -0.988 . . . . 0.0 109.918 -179.774 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.541 ' HG2' ' CD ' ' A' ' 18' ' ' ARG . 0.5 OUTLIER -80.63 -172.4 3.6 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.37 -0.831 . . . . 0.0 109.397 179.755 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.443 ' O ' HD23 ' A' ' 6' ' ' LEU . 3.6 t70 -129.38 58.84 1.61 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.153 -0.967 . . . . 0.0 109.914 -179.919 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.579 ' CE3' ' HB2' ' A' ' 18' ' ' ARG . 73.7 m95 -51.4 101.27 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.178 -0.951 . . . . 0.0 109.115 179.599 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.443 HD23 ' O ' ' A' ' 4' ' ' ASP . 0.5 OUTLIER -106.93 147.88 29.3 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.216 -0.927 . . . . 0.0 109.702 -179.757 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.484 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 12.3 m-20 -43.85 130.04 5.69 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.294 -0.879 . . . . 0.0 109.257 179.819 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.52 ' SG ' ' CZ ' ' A' ' 17' ' ' ARG . 12.2 t -86.56 113.37 52.4 Favored Pre-proline 0 N--CA 1.49 1.556 0 O-C-N 121.294 -0.878 . . . . 0.0 109.583 -179.796 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 36.6 Cg_endo -80.62 -47.97 0.07 OUTLIER 'Trans proline' 0 C--N 1.313 -1.327 0 C-N-CA 122.411 2.074 . . . . 0.0 110.33 179.964 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.645 ' HB3' ' NH1' ' A' ' 17' ' ' ARG . . . -41.66 -35.58 0.79 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.327 -0.858 . . . . 0.0 109.85 -179.716 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.863 HD12 ' CD1' ' A' ' 15' ' ' TRP . 14.7 mt -106.1 -65.94 1.03 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.176 -0.952 . . . . 0.0 109.659 -179.873 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 153.5 -150.91 22.7 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.597 -1.401 . . . . 0.0 109.597 -179.949 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -77.7 153.55 30.02 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 C-N-CA 122.651 2.234 . . . . 0.0 110.535 -179.9 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.436 ' O ' ' HD3' ' A' ' 38' ' ' PRO . . . 90.18 -24.98 13.49 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.854 -1.299 . . . . 0.0 109.854 179.667 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.863 ' CD1' HD12 ' A' ' 11' ' ' LEU . 10.9 t-105 -98.74 133.38 43.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.176 -1.191 . . . . 0.0 109.752 -179.749 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.458 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 26.1 mmtp -105.67 116.87 32.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.246 -0.909 . . . . 0.0 109.546 -179.976 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.645 ' NH1' ' HB3' ' A' ' 10' ' ' ALA . 0.4 OUTLIER -89.97 103.82 16.44 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.156 -0.965 . . . . 0.0 109.228 179.869 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.579 ' HB2' ' CE3' ' A' ' 5' ' ' TRP . 2.0 ttm180 -97.12 140.62 31.36 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.244 -0.91 . . . . 0.0 110.006 -179.537 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.433 ' HA ' ' O ' ' A' ' 32' ' ' ASP . 21.8 pt-20 -138.45 132.65 31.65 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.309 -0.869 . . . . 0.0 109.026 179.582 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.531 HG12 ' O ' ' A' ' 20' ' ' VAL . 16.3 t -99.78 16.91 3.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.179 -0.951 . . . . 0.0 109.719 -179.681 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.437 ' O ' ' CB ' ' A' ' 31' ' ' SER . 0.1 OUTLIER 64.19 -66.87 0.11 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.607 -0.683 . . . . 0.0 110.188 179.524 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.498 ' N ' ' O ' ' A' ' 20' ' ' VAL . 0.0 OUTLIER 44.58 37.59 2.24 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.152 -0.967 . . . . 0.0 108.946 -179.298 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 15.9 tttp -102.16 77.0 1.63 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.469 -0.769 . . . . 0.0 109.649 -179.732 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 8.5 t -100.84 164.89 11.63 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.198 -0.939 . . . . 0.0 109.41 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.37 -40.69 98.98 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 -179.937 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.92 167.74 0.55 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.312 -1.111 . . . . 0.0 109.482 179.96 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 39.6 p -100.73 23.42 10.52 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.225 -0.922 . . . . 0.0 109.301 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 58.9 m -53.92 -55.76 24.02 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.305 -0.872 . . . . 0.0 109.433 179.917 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -156.38 -178.34 30.42 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 179.888 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.446 ' O ' ' O ' ' A' ' 22' ' ' ARG . 11.9 tpp180 -105.87 -63.46 1.25 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.311 -1.111 . . . . 0.0 109.251 179.962 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.437 ' CB ' ' O ' ' A' ' 21' ' ' PHE . 22.5 p -169.39 130.27 1.09 Allowed 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.398 -0.814 . . . . 0.0 108.927 -179.967 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.564 ' HB3' ' CZ ' ' A' ' 34' ' ' TYR . 22.3 m-20 -79.3 142.36 36.2 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.105 -0.997 . . . . 0.0 109.557 -179.718 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.494 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 0.0 OUTLIER -127.61 90.92 3.2 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.276 -0.89 . . . . 0.0 109.595 -179.966 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.567 ' CD1' ' HG2' ' A' ' 44' ' ' ARG . 10.4 m-85 -99.68 140.66 33.55 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.309 -0.87 . . . . 0.0 109.086 179.758 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.598 ' HD2' HD22 ' A' ' 49' ' ' LEU . 4.8 m-85 -116.58 158.21 24.06 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.214 -0.929 . . . . 0.0 109.99 -179.324 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -138.88 121.74 16.57 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.477 -0.764 . . . . 0.0 109.229 179.904 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.486 ' HB2' ' HD2' ' A' ' 38' ' ' PRO . 1.1 p -73.68 173.61 6.04 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.331 -0.856 . . . . 0.0 109.253 179.911 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.486 ' HD2' ' HB2' ' A' ' 37' ' ' SER . 36.2 Cg_endo -79.38 9.7 3.31 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.664 2.242 . . . . 0.0 110.662 -179.871 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 2.4 p -120.24 12.53 11.8 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.097 -1.002 . . . . 0.0 109.83 -179.76 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 85.47 18.92 59.46 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.792 -1.323 . . . . 0.0 109.792 179.811 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.504 ' OD2' ' CE2' ' A' ' 52' ' ' TYR . 44.0 t0 -97.21 114.14 25.83 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.205 -1.174 . . . . 0.0 109.339 179.84 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.406 ' C ' HG13 ' A' ' 43' ' ' ILE . 0.0 OUTLIER -108.3 135.94 48.77 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.189 -0.944 . . . . 0.0 109.814 -179.726 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.62 HD13 ' HB2' ' A' ' 49' ' ' LEU . 2.4 mp -138.28 156.72 30.64 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.277 -0.889 . . . . 0.0 109.292 179.81 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.58 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 0.3 OUTLIER -140.69 17.6 2.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.132 -0.98 . . . . 0.0 109.739 -179.994 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.541 ' H ' HG22 ' A' ' 43' ' ' ILE . 0.6 OUTLIER -91.4 -87.21 0.21 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.202 -0.936 . . . . 0.0 108.805 179.445 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.534 ' CB ' ' O ' ' A' ' 45' ' ' SER . 4.9 ttpp 159.4 -60.49 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 179.632 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.41 HG23 ' HE3' ' A' ' 46' ' ' LYS . 26.9 t -87.71 -20.67 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.434 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 178.389 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -69.61 -42.92 73.73 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 178.802 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.726 ' O ' HD12 ' A' ' 53' ' ' LEU . 2.8 pp -75.99 -32.65 59.55 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.951 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.694 ' OG1' HD12 ' A' ' 59' ' ' LEU . 0.4 OUTLIER -64.01 -42.99 96.96 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 178.687 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.42 ' N ' HG22 ' A' ' 50' ' ' THR . 5.7 mmt85 -66.02 -26.61 67.6 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 179.18 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.504 ' CE2' ' OD2' ' A' ' 41' ' ' ASP . 28.8 t80 -68.53 -62.66 1.29 Allowed 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.515 -0.741 . . . . 0.0 109.308 179.87 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.729 HD21 ' CE3' ' A' ' 15' ' ' TRP . 0.7 OUTLIER -53.74 -54.26 40.52 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.193 -0.942 . . . . 0.0 109.222 179.797 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 137.62 -156.33 23.55 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 -179.807 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -78.35 -6.43 15.56 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.581 2.188 . . . . 0.0 110.442 179.915 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -78.44 -23.53 46.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.196 -0.94 . . . . 0.0 109.568 -179.883 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.459 ' HB2' HD13 ' A' ' 53' ' ' LEU . 91.1 m -129.79 98.08 4.69 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.248 -0.908 . . . . 0.0 109.534 -179.911 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -93.19 148.05 22.36 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.214 -0.929 . . . . 0.0 109.49 -179.933 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 1.025 HD23 ' CD2' ' A' ' 62' ' ' PHE . 0.4 OUTLIER -138.78 16.94 2.68 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.374 -0.829 . . . . 0.0 109.18 -179.98 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.602 ' C ' HD22 ' A' ' 61' ' ' LEU . 2.8 m -50.1 -50.32 48.69 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.429 -0.794 . . . . 0.0 109.579 -179.968 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.666 HD22 ' N ' ' A' ' 61' ' ' LEU . 3.6 mm? -100.89 11.37 39.72 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.292 -0.88 . . . . 0.0 109.676 -179.704 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 1.025 ' CD2' HD23 ' A' ' 59' ' ' LEU . 70.9 t80 -68.86 129.68 40.62 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.233 -0.917 . . . . 0.0 109.826 -179.754 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.509 ' O ' ' N ' ' A' ' 65' ' ' LYS . 3.0 t0 -82.32 103.43 11.89 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.331 -0.855 . . . . 0.0 108.973 179.555 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.58 ' CE1' ' CE2' ' A' ' 35' ' ' TYR . 0.8 OUTLIER -67.44 67.74 0.09 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.126 -0.984 . . . . 0.0 109.126 -179.616 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.509 ' N ' ' O ' ' A' ' 63' ' ' ASP . 0.0 OUTLIER 171.23 -32.43 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -179.899 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 20.4 tt0 -95.15 -46.32 6.83 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 179.344 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.538 ' HA2' ' CE1' ' A' ' 62' ' ' PHE . . . 104.48 30.13 5.09 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.276 -1.13 . . . . 0.0 110.276 179.426 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.478 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 1.1 pp -141.01 162.02 22.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 120.898 -1.354 . . . . 0.0 110.106 179.845 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.551 ' N ' HD23 ' A' ' 69' ' ' LEU . 1.5 pt? -151.83 164.78 36.34 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.327 -0.858 . . . . 0.0 109.364 179.973 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . . . . . . . . . 6.1 p -155.2 110.19 3.01 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.204 -0.935 . . . . 0.0 109.269 179.704 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.414 ' O ' ' CG ' ' A' ' 71' ' ' TYR . 13.5 t80 -140.6 76.73 23.98 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.248 -0.908 . . . . 0.0 109.642 -179.692 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -79.04 164.46 24.86 Favored 'Trans proline' 0 C--N 1.31 -1.499 0 C-N-CA 122.598 2.199 . . . . 0.0 110.18 179.792 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.476 ' HB1' ' HD2' ' A' ' 74' ' ' PRO . . . -131.99 158.91 74.22 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.154 -0.966 . . . . 0.0 109.557 -179.915 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.476 ' HD2' ' HB1' ' A' ' 73' ' ' ALA . 35.8 Cg_endo -78.2 -75.13 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.576 2.184 . . . . 0.0 110.093 179.759 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.519 0 CA-C-O 117.982 -1.009 . . . . 0.0 109.556 179.795 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -71.4 -15.47 62.36 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.16 -0.962 . . . . 0.0 109.486 -179.926 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.46 ' CB ' ' HD2' ' A' ' 18' ' ' ARG . 1.2 mp0 -109.0 -146.41 0.4 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.282 -0.886 . . . . 0.0 109.414 -179.993 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.46 ' O ' HD23 ' A' ' 6' ' ' LEU . 20.8 m-20 -138.39 72.9 1.42 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.168 -0.958 . . . . 0.0 109.503 -179.918 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.586 ' CZ2' ' HD3' ' A' ' 18' ' ' ARG . 93.0 m95 -69.86 95.78 0.95 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.246 -0.909 . . . . 0.0 109.373 179.858 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.46 HD23 ' O ' ' A' ' 4' ' ' ASP . 2.4 mm? -99.36 166.39 11.22 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.239 -0.913 . . . . 0.0 109.488 -179.816 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.48 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 0.7 OUTLIER -66.72 145.27 55.73 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.242 -0.911 . . . . 0.0 109.1 179.711 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.507 ' SG ' ' N ' ' A' ' 17' ' ' ARG . 13.8 m -87.57 112.98 52.08 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.277 -0.89 . . . . 0.0 109.74 -179.595 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.48 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 36.3 Cg_endo -79.51 -40.87 0.23 Allowed 'Trans proline' 0 C--N 1.31 -1.449 0 C-N-CA 122.239 1.96 . . . . 0.0 109.749 179.441 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.904 ' HB3' ' NH1' ' A' ' 17' ' ' ARG . . . -61.4 -53.27 58.79 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.429 -0.794 . . . . 0.0 109.782 -179.951 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 1.031 HD12 ' CD1' ' A' ' 15' ' ' TRP . 6.6 mt -82.46 -47.94 11.65 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.164 -0.96 . . . . 0.0 109.676 -179.751 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 130.02 -148.18 18.39 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 179.972 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -76.71 155.59 35.2 Favored 'Trans proline' 0 C--N 1.31 -1.473 0 C-N-CA 122.624 2.216 . . . . 0.0 110.717 -179.879 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 89.91 -46.33 3.1 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.963 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 1.031 ' CD1' HD12 ' A' ' 11' ' ' LEU . 5.1 t-105 -80.31 131.14 35.6 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.259 -1.142 . . . . 0.0 110.074 -179.621 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.423 ' C ' ' SG ' ' A' ' 8' ' ' CYS . 17.5 mmtp -105.65 126.88 52.66 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.3 -0.875 . . . . 0.0 109.365 179.696 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.904 ' NH1' ' HB3' ' A' ' 10' ' ' ALA . 0.0 OUTLIER -99.12 107.47 19.85 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.294 -0.879 . . . . 0.0 109.587 -179.713 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.586 ' HD3' ' CZ2' ' A' ' 5' ' ' TRP . 25.1 ttp180 -100.54 143.72 30.38 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.247 -0.908 . . . . 0.0 109.853 -179.887 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 6.6 pt-20 -113.58 149.47 34.45 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.311 -0.868 . . . . 0.0 109.326 179.64 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.821 HG21 ' CE2' ' A' ' 34' ' ' TYR . 13.6 t -137.65 149.61 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.213 -0.93 . . . . 0.0 109.55 -179.981 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.547 ' CB ' ' HA ' ' A' ' 31' ' ' SER . 1.7 m-85 64.67 15.45 9.74 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.268 -0.895 . . . . 0.0 109.623 179.973 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.506 ' HA ' ' HB3' ' A' ' 31' ' ' SER . 0.0 OUTLIER -84.26 2.01 42.07 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.243 -0.911 . . . . 0.0 109.518 179.795 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -129.24 56.92 1.67 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.181 -0.949 . . . . 0.0 109.664 -179.939 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -97.33 164.5 12.44 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.179 -0.95 . . . . 0.0 109.267 179.776 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -119.25 -63.38 0.28 Allowed Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 -179.88 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -85.07 -78.82 0.24 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.251 -1.146 . . . . 0.0 109.636 -179.747 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.74 98.29 3.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.277 -0.889 . . . . 0.0 109.871 -179.588 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -69.69 -75.65 0.11 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.233 -0.917 . . . . 0.0 109.228 179.59 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 88.79 -106.06 3.24 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.728 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.425 ' O ' ' C ' ' A' ' 31' ' ' SER . 0.5 OUTLIER -170.19 99.58 0.28 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.296 -1.12 . . . . 0.0 109.359 -179.761 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.547 ' HA ' ' CB ' ' A' ' 21' ' ' PHE . 1.8 p -43.48 123.54 3.09 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.228 -0.92 . . . . 0.0 109.572 180.0 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.476 ' HB2' ' CZ ' ' A' ' 34' ' ' TYR . 4.7 m-20 -79.25 164.73 23.91 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.245 -0.91 . . . . 0.0 109.103 179.921 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.448 HG22 ' CE1' ' A' ' 35' ' ' TYR . 5.6 m -136.98 121.86 18.8 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.153 -0.967 . . . . 0.0 110.105 -179.444 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.821 ' CE2' HG21 ' A' ' 20' ' ' VAL . 1.4 m-85 -123.3 149.22 45.08 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.292 -0.88 . . . . 0.0 108.717 179.168 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.677 ' HD2' HD22 ' A' ' 49' ' ' LEU . 7.2 m-85 -113.91 150.87 33.08 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.933 -1.105 . . . . 0.0 109.809 -179.89 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.46 ' HB2' ' CZ3' ' A' ' 5' ' ' TRP . 12.4 tt0 -129.79 124.88 34.45 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.331 -0.856 . . . . 0.0 109.595 -179.835 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.508 ' HB3' ' HD2' ' A' ' 38' ' ' PRO . 0.9 OUTLIER -71.3 173.15 5.38 Favored Pre-proline 0 N--CA 1.488 1.437 0 O-C-N 121.347 -0.845 . . . . 0.0 109.04 179.785 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.508 ' HD2' ' HB3' ' A' ' 37' ' ' SER . 34.9 Cg_endo -78.34 8.82 3.4 Favored 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.55 2.167 . . . . 0.0 110.9 -179.895 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.417 HG22 ' HB2' ' A' ' 37' ' ' SER . 15.3 t -115.55 -24.37 8.35 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.013 -1.054 . . . . 0.0 109.514 179.899 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 122.73 16.09 3.8 Favored Glycine 0 N--CA 1.492 2.409 0 N-CA-C 109.685 -1.366 . . . . 0.0 109.685 179.958 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -100.36 111.24 23.49 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.158 -1.201 . . . . 0.0 109.674 -179.924 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.69 148.59 22.39 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.191 -0.943 . . . . 0.0 109.34 179.79 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.562 ' CG2' ' HB3' ' A' ' 49' ' ' LEU . 4.5 mp -140.39 158.27 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.11 -0.994 . . . . 0.0 109.921 -179.825 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.514 ' HA ' ' CZ ' ' A' ' 64' ' ' PHE . 0.9 OUTLIER -137.05 -8.63 1.79 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.249 -0.907 . . . . 0.0 110.737 -179.778 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.543 ' CB ' ' HB2' ' A' ' 48' ' ' GLU . 0.6 OUTLIER -63.48 -86.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.782 -1.199 . . . . 0.0 109.334 179.905 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.502 ' HB2' ' O ' ' A' ' 45' ' ' SER . 42.7 tttm 161.97 -63.99 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.574 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 -179.769 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 75.0 t -87.94 -19.98 7.59 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 178.518 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.543 ' HB2' ' CB ' ' A' ' 45' ' ' SER . 2.8 mt-10 -66.83 -43.62 83.29 Favored 'General case' 0 N--CA 1.484 1.253 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 178.353 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.677 HD22 ' HD2' ' A' ' 35' ' ' TYR . 1.9 pp -70.07 -23.63 63.1 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 178.647 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.861 ' OG1' HD13 ' A' ' 59' ' ' LEU . 30.3 m -70.96 -64.48 0.9 Allowed 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 178.969 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' ' 48' ' ' GLU . 0.0 OUTLIER -49.73 -29.46 7.66 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.361 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.431 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 86.2 t80 -57.82 -60.93 2.95 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.377 -0.827 . . . . 0.0 108.909 179.417 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 1.007 HD21 ' CE3' ' A' ' 15' ' ' TRP . 0.4 OUTLIER -58.17 -51.94 67.65 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.287 -0.883 . . . . 0.0 109.221 179.576 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 133.19 -154.1 21.05 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.394 -1.483 . . . . 0.0 109.394 -179.914 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -77.76 -17.93 13.72 Favored 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 122.614 2.209 . . . . 0.0 110.176 179.752 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -66.57 -24.47 66.35 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.31 -0.869 . . . . 0.0 109.507 179.925 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.485 ' CB ' HD13 ' A' ' 53' ' ' LEU . 1.7 m -117.13 156.15 28.11 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.242 -0.911 . . . . 0.0 109.517 179.991 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.793 ' C ' HD12 ' A' ' 59' ' ' LEU . 62.0 t0 -149.22 147.95 29.02 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.334 -0.854 . . . . 0.0 109.291 179.937 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.889 HD23 ' CD1' ' A' ' 62' ' ' PHE . 5.7 mp -148.51 17.56 1.03 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.188 -0.945 . . . . 0.0 109.489 -179.64 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.632 ' C ' HD22 ' A' ' 61' ' ' LEU . 3.6 m -42.52 -49.25 5.39 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.422 -0.799 . . . . 0.0 109.29 -179.876 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.632 HD22 ' C ' ' A' ' 60' ' ' THR . 1.2 mm? -113.09 18.64 17.85 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.395 -0.816 . . . . 0.0 109.455 -179.92 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.889 ' CD1' HD23 ' A' ' 59' ' ' LEU . 9.8 t80 -77.24 133.97 38.72 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.315 -0.866 . . . . 0.0 109.289 179.945 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.569 ' O ' ' CE1' ' A' ' 62' ' ' PHE . 0.9 OUTLIER -84.92 136.08 33.78 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.355 -0.84 . . . . 0.0 109.211 179.792 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.654 ' CE1' ' CE2' ' A' ' 35' ' ' TYR . 0.3 OUTLIER -86.79 43.61 1.1 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.141 -0.974 . . . . 0.0 109.2 179.957 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.429 ' HA ' ' OG1' ' A' ' 33' ' ' THR . 0.0 OUTLIER -165.12 -44.15 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.409 -0.807 . . . . 0.0 109.052 -179.898 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 18.8 mt-30 -81.59 -36.1 29.38 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.328 -0.858 . . . . 0.0 109.259 179.73 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.526 ' HA2' ' CE2' ' A' ' 62' ' ' PHE . . . 88.89 35.15 8.45 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 179.854 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.484 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 1.8 pp -140.04 155.97 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.172 -1.193 . . . . 0.0 109.781 -179.823 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.544 ' N ' HD23 ' A' ' 69' ' ' LEU . 1.3 pt? -143.56 166.92 23.49 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.31 -0.869 . . . . 0.0 109.043 179.667 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.437 ' O ' ' HB2' ' A' ' 61' ' ' LEU . 0.6 OUTLIER -155.07 -171.48 3.84 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.129 -0.982 . . . . 0.0 109.658 -179.987 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -118.49 162.12 32.05 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.288 -0.882 . . . . 0.0 109.41 179.919 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.74 55.64 5.3 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.622 2.215 . . . . 0.0 110.515 179.987 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -138.06 86.84 17.03 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.245 -0.909 . . . . 0.0 109.64 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -78.34 112.2 3.16 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 C-N-CA 122.684 2.256 . . . . 0.0 110.207 179.957 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.52 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.516 -179.873 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.561 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 51.75 40.98 28.73 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.241 -0.912 . . . . 0.0 109.314 -179.92 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -79.78 -58.79 3.01 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.329 -0.857 . . . . 0.0 109.41 -179.972 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.454 ' CB ' ' HG2' ' A' ' 19' ' ' GLU . 1.8 m-20 -153.98 26.38 0.48 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.29 -0.881 . . . . 0.0 109.429 179.905 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.626 ' CH2' ' NH1' ' A' ' 18' ' ' ARG . 67.4 m95 -65.56 92.24 0.14 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.309 -0.869 . . . . 0.0 109.331 179.868 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.445 HD23 ' HA ' ' A' ' 6' ' ' LEU . 54.2 mt -109.75 153.24 24.61 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.149 -0.97 . . . . 0.0 109.63 -179.809 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.407 ' C ' ' O ' ' A' ' 6' ' ' LEU . 7.5 t70 -45.64 140.39 3.4 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.255 -0.903 . . . . 0.0 109.062 179.77 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.524 ' HG ' ' HE1' ' A' ' 35' ' ' TYR . 44.5 t -102.29 108.79 58.5 Favored Pre-proline 0 N--CA 1.489 1.496 0 O-C-N 121.182 -0.949 . . . . 0.0 109.869 -179.599 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.423 ' HD2' ' CZ ' ' A' ' 17' ' ' ARG . 34.1 Cg_endo -77.01 -32.77 3.06 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.154 1.903 . . . . 0.0 109.767 179.194 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.679 ' O ' HD23 ' A' ' 11' ' ' LEU . . . -50.55 -30.13 12.36 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.302 -0.874 . . . . 0.0 108.954 179.319 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 1.053 HD12 ' CD1' ' A' ' 15' ' ' TRP . 9.6 mt -117.25 -65.54 1.17 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.383 -0.823 . . . . 0.0 109.485 179.848 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.412 ' O ' ' O ' ' A' ' 8' ' ' CYS . . . 168.38 -147.42 11.39 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.857 -1.297 . . . . 0.0 109.857 -179.885 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . 0.514 ' O ' ' N ' ' A' ' 15' ' ' TRP . 35.9 Cg_endo -78.08 175.39 11.2 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 C-N-CA 122.681 2.254 . . . . 0.0 110.618 -179.701 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . 0.426 ' O ' ' C ' ' A' ' 15' ' ' TRP . . . 65.66 -68.39 0.11 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 179.97 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 1.053 ' CD1' HD12 ' A' ' 11' ' ' LEU . 4.5 t-105 -43.55 119.62 1.7 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.374 -1.074 . . . . 0.0 109.515 179.9 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.451 ' HD2' ' HB3' ' A' ' 5' ' ' TRP . 1.0 OUTLIER -101.7 114.91 29.38 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.185 -0.947 . . . . 0.0 109.659 -179.937 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.486 ' HD3' ' OH ' ' A' ' 35' ' ' TYR . 10.4 ttp85 -92.95 111.2 22.73 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.232 -0.917 . . . . 0.0 109.309 179.771 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.626 ' NH1' ' CH2' ' A' ' 5' ' ' TRP . 41.2 ttp180 -100.38 148.47 24.67 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.185 -0.947 . . . . 0.0 109.488 -179.933 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.454 ' HG2' ' CB ' ' A' ' 4' ' ' ASP . 17.1 pt-20 -102.98 145.15 30.3 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.221 -0.924 . . . . 0.0 109.369 179.924 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.691 HG21 ' CE2' ' A' ' 34' ' ' TYR . 2.9 t -117.76 155.01 19.65 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.187 -0.946 . . . . 0.0 109.547 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.529 ' CD1' ' N ' ' A' ' 21' ' ' PHE . 1.0 OUTLIER -116.25 41.35 2.64 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.263 -0.898 . . . . 0.0 109.346 179.95 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.448 ' O ' ' N ' ' A' ' 24' ' ' SER . 0.0 OUTLIER 45.09 28.51 0.4 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.282 -0.886 . . . . 0.0 109.405 -179.939 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.2 mttp 67.47 -70.71 0.11 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.234 -0.916 . . . . 0.0 109.495 179.889 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.448 ' N ' ' O ' ' A' ' 22' ' ' ARG . 25.3 p -108.82 10.91 26.5 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.31 -0.869 . . . . 0.0 109.482 -179.95 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . 0.422 ' HA3' ' HA3' ' A' ' 29' ' ' GLY . . . -100.85 67.56 0.48 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -179.947 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.25 -46.92 21.54 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.305 -1.115 . . . . 0.0 109.598 -179.966 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 10.2 t -133.7 35.49 3.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.208 -0.933 . . . . 0.0 109.475 -179.932 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 1.8 p -159.98 -38.62 0.05 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.333 -0.855 . . . . 0.0 109.478 179.959 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.422 ' HA3' ' HA3' ' A' ' 25' ' ' GLY . . . -85.01 143.2 20.32 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.953 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.402 ' HG3' ' N ' ' A' ' 31' ' ' SER . 0.2 OUTLIER -52.36 157.83 1.35 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.263 -1.139 . . . . 0.0 109.359 179.97 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.402 ' N ' ' HG3' ' A' ' 30' ' ' ARG . 0.6 OUTLIER -109.44 114.41 28.03 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.221 -0.924 . . . . 0.0 109.641 -179.943 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -88.95 166.06 14.18 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.221 -0.924 . . . . 0.0 109.388 179.944 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.528 ' O ' ' CE1' ' A' ' 64' ' ' PHE . 9.7 m -131.15 144.14 51.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.255 -0.903 . . . . 0.0 109.428 179.972 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.691 ' CE2' HG21 ' A' ' 20' ' ' VAL . 20.0 m-85 -124.75 164.94 18.88 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.383 -0.823 . . . . 0.0 109.142 179.819 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.893 ' HD2' HD22 ' A' ' 49' ' ' LEU . 10.4 m-85 -121.27 147.99 44.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.058 -1.026 . . . . 0.0 110.483 -179.332 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.606 ' HB2' ' CZ3' ' A' ' 5' ' ' TRP . 0.1 OUTLIER -131.81 114.37 14.63 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.352 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.505 ' CB ' ' HD2' ' A' ' 38' ' ' PRO . 0.9 OUTLIER -72.4 173.79 5.17 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.354 -0.841 . . . . 0.0 109.455 -179.719 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.505 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 35.1 Cg_endo -76.89 -7.05 17.26 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.549 2.166 . . . . 0.0 110.246 179.939 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 p -105.07 -23.19 12.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.373 -0.829 . . . . 0.0 109.243 179.842 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 122.2 27.33 1.69 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.45 -1.46 . . . . 0.0 109.45 179.99 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -90.36 114.92 27.12 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.255 -1.144 . . . . 0.0 109.531 179.968 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -98.1 99.82 11.11 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.265 -0.897 . . . . 0.0 109.351 179.931 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.554 ' CG2' ' HB3' ' A' ' 49' ' ' LEU . 1.9 mp -114.44 146.95 18.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.2 -0.937 . . . . 0.0 109.661 -179.995 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.608 ' HA ' ' CZ ' ' A' ' 64' ' ' PHE . 7.5 ptt180 -140.28 3.41 1.95 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.37 -0.831 . . . . 0.0 109.995 179.962 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.529 ' O ' ' CB ' ' A' ' 46' ' ' LYS . 1.9 t -62.16 -82.39 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.049 -1.032 . . . . 0.0 109.292 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.529 ' CB ' ' O ' ' A' ' 45' ' ' SER . 6.6 ttmt 159.71 -61.74 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.495 0 N-CA-C 108.313 -0.995 . . . . 0.0 108.313 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.502 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 21.5 t -96.19 -18.3 6.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 178.795 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.501 ' HB2' ' HB3' ' A' ' 45' ' ' SER . 40.2 mt-10 -73.54 -32.05 63.99 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 178.884 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.893 HD22 ' HD2' ' A' ' 35' ' ' TYR . 1.7 pp -78.81 -29.56 44.9 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.283 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.748 ' OG1' HD12 ' A' ' 59' ' ' LEU . 0.5 OUTLIER -70.16 -50.17 43.13 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 179.181 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.528 ' N ' ' CG2' ' A' ' 50' ' ' THR . 0.0 OUTLIER -59.62 -29.68 68.17 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.387 -0.968 . . . . 0.0 108.387 179.18 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.448 ' HB3' ' O ' ' A' ' 49' ' ' LEU . 36.6 t80 -56.7 -57.15 13.65 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.327 -0.858 . . . . 0.0 108.702 179.252 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.825 HD21 ' CE3' ' A' ' 15' ' ' TRP . 0.5 OUTLIER -62.33 -40.7 97.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.228 -0.92 . . . . 0.0 109.077 179.536 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 127.17 -158.71 21.13 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.164 -1.574 . . . . 0.0 109.164 -179.689 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.3 Cg_endo -77.91 -7.16 16.35 Favored 'Trans proline' 0 C--N 1.307 -1.657 0 C-N-CA 122.421 2.081 . . . . 0.0 110.304 179.852 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -74.79 -12.79 60.48 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.227 -0.921 . . . . 0.0 109.578 -179.985 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.444 ' HB2' HD13 ' A' ' 53' ' ' LEU . 69.6 m -138.77 132.06 30.07 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.263 -0.898 . . . . 0.0 109.514 -179.96 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -119.66 155.68 31.91 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.182 -0.949 . . . . 0.0 109.532 179.873 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.93 HD23 ' CD2' ' A' ' 62' ' ' PHE . 0.5 OUTLIER -148.83 16.78 0.98 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.204 -0.935 . . . . 0.0 109.779 -179.758 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.638 ' C ' HD22 ' A' ' 61' ' ' LEU . 13.1 m -56.0 -37.41 69.08 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.257 -0.902 . . . . 0.0 109.415 -179.973 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.638 HD22 ' C ' ' A' ' 60' ' ' THR . 1.9 mm? -110.37 8.88 23.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.327 -0.858 . . . . 0.0 109.776 -179.653 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.93 ' CD2' HD23 ' A' ' 59' ' ' LEU . 63.7 t80 -71.29 133.54 46.13 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.25 -0.906 . . . . 0.0 110.074 -179.617 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.519 ' O ' ' N ' ' A' ' 65' ' ' LYS . 15.9 t70 -86.98 100.72 12.81 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.248 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.608 ' CZ ' ' HA ' ' A' ' 44' ' ' ARG . 0.1 OUTLIER -66.22 67.87 0.05 Allowed 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.299 -0.876 . . . . 0.0 109.391 -179.23 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 63' ' ' ASP . 0.3 OUTLIER 176.01 -40.96 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.481 -0.762 . . . . 0.0 108.957 -179.917 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.72 -27.53 18.0 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.318 -0.864 . . . . 0.0 109.195 179.709 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . 0.469 ' HA3' ' NH2' ' A' ' 17' ' ' ARG . . . 90.55 33.52 8.5 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.851 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.722 ' C ' HD12 ' A' ' 68' ' ' ILE . 2.3 pp -140.42 174.84 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.086 -1.244 . . . . 0.0 109.76 179.967 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.611 ' N ' HD12 ' A' ' 68' ' ' ILE . 0.6 OUTLIER -155.4 -167.97 2.69 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.373 -0.829 . . . . 0.0 109.277 179.676 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.443 ' SG ' ' O ' ' A' ' 69' ' ' LEU . 7.8 m -159.97 -176.28 5.59 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.33 -0.856 . . . . 0.0 109.27 179.67 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.494 ' O ' ' CD1' ' A' ' 71' ' ' TYR . 23.3 p90 -165.86 145.61 5.34 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.184 -0.948 . . . . 0.0 109.594 179.969 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -78.05 132.63 11.75 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 122.611 2.207 . . . . 0.0 110.124 179.659 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.466 ' N ' ' HD3' ' A' ' 74' ' ' PRO . . . -141.32 64.58 19.93 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.203 -0.936 . . . . 0.0 109.655 -179.838 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 0.466 ' HD3' ' N ' ' A' ' 73' ' ' ALA . 35.8 Cg_endo -78.41 126.57 7.66 Favored 'Trans proline' 0 C--N 1.309 -1.512 0 C-N-CA 122.635 2.223 . . . . 0.0 110.163 179.854 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 118.057 -0.973 . . . . 0.0 109.553 -179.817 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.415 ' O ' ' O ' ' A' ' 2' ' ' ALA . 56.8 mtm . . . . . 0 N--CA 1.489 1.516 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.415 ' O ' ' O ' ' A' ' 1' ' ' MET . . . 47.32 91.62 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.208 -0.933 . . . . 0.0 109.305 -179.976 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.551 ' HB3' ' CD ' ' A' ' 18' ' ' ARG . 1.5 mm-40 -103.19 -168.16 1.48 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.264 -0.897 . . . . 0.0 109.529 -179.893 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' ASP . . . . . 0.528 ' N ' ' HD3' ' A' ' 18' ' ' ARG . 0.3 OUTLIER -114.27 74.3 0.87 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.3 -0.875 . . . . 0.0 109.699 -179.849 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' TRP . . . . . 0.633 ' CE3' ' CB ' ' A' ' 18' ' ' ARG . 52.7 m95 -58.45 114.88 2.66 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.193 -0.942 . . . . 0.0 109.34 179.914 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 57.0 mt -100.51 159.59 15.03 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.327 -0.858 . . . . 0.0 109.585 -179.698 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.473 ' O ' ' HD3' ' A' ' 9' ' ' PRO . 0.3 OUTLIER -49.83 132.71 22.37 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.256 -0.902 . . . . 0.0 109.319 179.792 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' CYS . . . . . 0.533 ' CB ' ' HB2' ' A' ' 17' ' ' ARG . 29.3 t -88.26 112.82 52.09 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.26 -0.9 . . . . 0.0 109.718 -179.74 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' A' ' 7' ' ' ASP . 36.5 Cg_endo -79.75 -59.41 0.03 OUTLIER 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.46 2.107 . . . . 0.0 110.75 179.905 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.785 ' HB3' ' NH1' ' A' ' 17' ' ' ARG . . . -38.52 -39.66 0.49 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.59 -0.694 . . . . 0.0 110.424 -179.455 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 1.044 HD12 ' CD1' ' A' ' 15' ' ' TRP . 13.3 mt -95.34 -64.61 1.04 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.054 -1.029 . . . . 0.0 109.711 -179.931 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.404 ' O ' ' O ' ' A' ' 8' ' ' CYS . . . 152.98 -152.05 23.76 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.639 -1.384 . . . . 0.0 109.639 -179.824 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -79.13 148.51 21.62 Favored 'Trans proline' 0 C--N 1.309 -1.544 0 C-N-CA 122.655 2.237 . . . . 0.0 110.399 -179.878 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 96.17 -51.82 1.64 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.893 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 1.044 ' CD1' HD12 ' A' ' 11' ' ' LEU . 15.3 t-105 -69.24 126.68 30.53 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.307 -1.114 . . . . 0.0 109.504 -179.991 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.48 ' O ' ' HA ' ' A' ' 35' ' ' TYR . 0.0 OUTLIER -94.87 114.03 25.84 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.249 -0.907 . . . . 0.0 108.947 179.751 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.785 ' NH1' ' HB3' ' A' ' 10' ' ' ALA . 2.9 ttm180 -94.67 96.71 9.58 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.161 -0.962 . . . . 0.0 109.844 -179.534 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.633 ' CB ' ' CE3' ' A' ' 5' ' ' TRP . 9.7 tpt180 -100.7 146.0 27.75 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.198 -0.939 . . . . 0.0 109.526 179.63 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.531 ' HG2' ' NH1' ' A' ' 18' ' ' ARG . 8.6 pt-20 -109.0 164.36 12.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.191 -0.943 . . . . 0.0 109.43 179.871 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.591 HG12 ' O ' ' A' ' 20' ' ' VAL . 96.7 t -137.02 66.78 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.216 -0.928 . . . . 0.0 109.463 -179.948 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.595 ' O ' ' CD2' ' A' ' 21' ' ' PHE . 30.4 p90 -41.54 95.9 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.453 -0.78 . . . . 0.0 109.803 -179.837 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' ARG . . . . . 0.495 ' N ' ' O ' ' A' ' 20' ' ' VAL . 5.3 mmt180 -60.19 -55.37 34.57 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.13 -0.981 . . . . 0.0 109.346 179.896 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 22' ' ' ARG . 36.3 ttmt 172.75 146.93 0.05 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.285 -0.885 . . . . 0.0 109.319 -179.986 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -105.96 124.28 49.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.129 -0.982 . . . . 0.0 109.647 -179.877 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -133.87 -141.52 4.53 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.962 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -91.61 -18.95 23.26 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.294 -1.121 . . . . 0.0 109.443 179.993 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 9.2 t -153.02 20.89 0.58 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.267 -0.896 . . . . 0.0 109.368 179.898 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' CYS . . . . . . . . . . . . . 3.5 m -91.41 90.55 7.73 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.214 -0.929 . . . . 0.0 109.443 -179.985 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.443 ' O ' ' HB3' ' A' ' 30' ' ' ARG . . . -127.39 107.4 0.88 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 179.924 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.443 ' HB3' ' O ' ' A' ' 29' ' ' GLY . 0.0 OUTLIER 168.73 50.14 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.216 -1.167 . . . . 0.0 109.565 -179.949 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -53.82 149.1 9.13 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.257 -0.902 . . . . 0.0 109.264 179.921 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' ASP . . . . . 0.469 ' HB2' ' HB ' ' A' ' 20' ' ' VAL . 8.5 m-20 -90.03 121.94 32.57 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.177 -0.952 . . . . 0.0 109.351 -179.931 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.579 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 0.0 OUTLIER -103.94 110.1 22.11 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.165 -0.959 . . . . 0.0 109.637 -179.727 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.55 ' CD1' ' HB3' ' A' ' 44' ' ' ARG . 19.3 m-30 -106.26 143.1 34.87 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.138 -0.976 . . . . 0.0 109.164 179.803 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.573 ' CE1' ' HG3' ' A' ' 17' ' ' ARG . 5.0 m-85 -122.02 156.71 32.92 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.172 -0.955 . . . . 0.0 109.832 -179.507 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.437 ' OE1' ' HD2' ' A' ' 42' ' ' ARG . 44.5 tt0 -130.61 121.45 25.65 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.385 -0.822 . . . . 0.0 109.166 179.953 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.493 ' HB2' HG22 ' A' ' 39' ' ' THR . 0.5 OUTLIER -76.37 171.56 11.88 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.154 -0.966 . . . . 0.0 109.746 -179.748 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.46 ' HD2' ' CB ' ' A' ' 37' ' ' SER . 36.0 Cg_endo -77.93 -4.58 14.57 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 122.729 2.286 . . . . 0.0 110.437 179.994 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.903 HG21 ' OH ' ' A' ' 52' ' ' TYR . 12.3 t -100.11 -12.82 19.32 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.225 -0.922 . . . . 0.0 109.343 179.881 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 106.04 18.06 11.96 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.996 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.8 112.23 24.01 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.278 -1.131 . . . . 0.0 109.354 -179.978 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' ARG . . . . . 0.437 ' HD2' ' OE1' ' A' ' 36' ' ' GLN . 2.2 mtp180 -99.1 121.04 40.47 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.179 -0.95 . . . . 0.0 109.503 -179.943 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.8 HD13 ' HB2' ' A' ' 49' ' ' LEU . 2.2 mp -118.46 168.03 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.251 -0.906 . . . . 0.0 109.472 179.98 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . 0.574 ' O ' ' CE2' ' A' ' 64' ' ' PHE . 0.0 OUTLIER -153.74 14.99 0.49 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.338 -0.851 . . . . 0.0 109.845 -179.627 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.558 ' H ' HG22 ' A' ' 43' ' ' ILE . 7.5 t -95.67 -79.31 0.44 Allowed 'General case' 0 C--N 1.303 -1.423 0 O-C-N 121.028 -1.045 . . . . 0.0 108.452 179.346 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.576 ' HB2' ' CD1' ' A' ' 64' ' ' PHE . 4.6 ttpm? 153.45 -61.77 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 179.421 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.524 ' O ' ' CG ' ' A' ' 51' ' ' ARG . 50.0 t -82.93 -24.52 8.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 N-CA-C 107.991 -1.115 . . . . 0.0 107.991 178.63 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.439 ' O ' ' HG3' ' A' ' 51' ' ' ARG . 23.3 tt0 -64.66 -48.21 75.6 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 108.409 -0.959 . . . . 0.0 108.409 179.012 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' LEU . . . . . 0.8 ' HB2' HD13 ' A' ' 43' ' ' ILE . 2.3 pp -68.8 -30.81 69.46 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 107.945 -1.132 . . . . 0.0 107.945 178.918 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' THR . . . . . 0.67 ' OG1' HD13 ' A' ' 59' ' ' LEU . 24.0 m -61.24 -67.96 0.36 Allowed 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.857 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.524 ' CG ' ' O ' ' A' ' 47' ' ' VAL . 0.0 OUTLIER -47.19 -31.13 3.39 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.375 -0.828 . . . . 0.0 108.934 179.456 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . 0.903 ' OH ' HG21 ' A' ' 39' ' ' THR . 2.1 t80 -64.68 -62.56 1.5 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.287 -0.883 . . . . 0.0 108.95 179.422 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 1.002 HD21 ' CZ3' ' A' ' 15' ' ' TRP . 0.8 OUTLIER -49.82 -51.91 36.29 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.285 -0.884 . . . . 0.0 109.238 179.569 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 124.19 -151.23 17.13 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.148 -1.581 . . . . 0.0 109.148 -179.592 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -77.45 -12.74 16.91 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.562 2.174 . . . . 0.0 110.168 179.746 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.18 -3.18 31.5 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.337 -0.852 . . . . 0.0 109.358 179.749 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' CYS . . . . . 0.478 ' CB ' HD13 ' A' ' 53' ' ' LEU . 60.0 m -135.53 -176.2 4.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.196 -0.94 . . . . 0.0 109.5 -179.906 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.817 ' C ' HD12 ' A' ' 59' ' ' LEU . 12.1 t70 179.26 142.31 0.12 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.348 -0.845 . . . . 0.0 108.964 179.876 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.824 HD23 ' CD2' ' A' ' 62' ' ' PHE . 5.1 mp -152.89 16.77 0.58 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.135 -0.978 . . . . 0.0 109.55 -179.483 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.575 ' C ' HD22 ' A' ' 61' ' ' LEU . 58.5 m -44.38 -40.23 5.24 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.377 -0.827 . . . . 0.0 109.412 -179.956 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' LEU . . . . . 0.575 HD22 ' C ' ' A' ' 60' ' ' THR . 1.4 mm? -111.57 -8.54 14.23 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.395 -0.815 . . . . 0.0 109.67 -179.834 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.824 ' CD2' HD23 ' A' ' 59' ' ' LEU . 80.6 t80 -50.53 138.45 17.54 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.227 -0.921 . . . . 0.0 109.835 -179.368 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.525 ' OD1' ' CG ' ' A' ' 65' ' ' LYS . 3.9 t0 -89.44 113.52 24.88 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.447 -0.783 . . . . 0.0 109.158 179.714 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.579 ' CE2' ' O ' ' A' ' 33' ' ' THR . 1.1 t80 -72.06 63.78 0.51 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.126 -0.984 . . . . 0.0 109.728 -179.781 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.525 ' CG ' ' OD1' ' A' ' 63' ' ' ASP . 0.0 OUTLIER 167.82 -36.32 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.394 -0.816 . . . . 0.0 109.079 179.639 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 2.3 tt0 -83.77 -41.57 17.45 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.142 -0.974 . . . . 0.0 108.948 179.411 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 98.84 28.0 8.07 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 179.666 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' ILE . . . . . 0.5 ' O ' ' HA ' ' A' ' 62' ' ' PHE . 2.6 pp -140.52 179.47 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.114 -1.227 . . . . 0.0 109.668 179.938 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.533 ' HB3' ' HA ' ' A' ' 62' ' ' PHE . 0.6 OUTLIER -160.34 -175.78 5.24 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.409 -0.807 . . . . 0.0 109.111 179.934 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' CYS . . . . . 0.418 ' SG ' HD12 ' A' ' 61' ' ' LEU . 32.1 p -160.12 170.98 20.1 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.237 -0.914 . . . . 0.0 109.444 179.587 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . 0.458 ' O ' ' HD2' ' A' ' 74' ' ' PRO . 27.1 m-85 -123.19 150.82 60.9 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.196 -0.94 . . . . 0.0 109.497 -179.891 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.449 ' O ' ' HB2' ' A' ' 73' ' ' ALA . 35.2 Cg_endo -77.78 74.08 5.37 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 C-N-CA 122.684 2.256 . . . . 0.0 110.663 -179.821 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 1.004 ' HB3' ' HD3' ' A' ' 74' ' ' PRO . . . 178.34 -57.93 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.244 -0.91 . . . . 0.0 109.64 179.59 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' PRO . . . . . 1.004 ' HD3' ' HB3' ' A' ' 73' ' ' ALA . 35.6 Cg_endo -77.52 152.69 30.07 Favored 'Trans proline' 0 C--N 1.311 -1.418 0 C-N-CA 122.236 1.957 . . . . 0.0 110.176 179.531 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 2.4 pttt . . . . . 0 N--CA 1.49 1.561 0 CA-C-O 117.998 -1.001 . . . . 0.0 109.5 -179.879 . . . . . . . . 0 0 . 1 stop_ save_